Representing term id	Representing term name	Representing term size	Representing term rank	Represented term number	gwas_female_adolescent_terms_by_significance.txt term rank	gwas_female_adult_terms_by_significance.txt term rank	gwas_female_child_terms_by_significance.txt term rank	gwas_female_elderly_terms_by_significance.txt term rank	gwas_female_fetus_terms_by_significance.txt term rank	gwas_female_infant_terms_by_significance.txt term rank	gwas_female_middle_adult_terms_by_significance.txt term rank	gwas_female_old_adult_terms_by_significance.txt term rank	gwas_female_older_adult_terms_by_significance.txt term rank	gwas_female_young_adult_terms_by_significance.txt term rank	gwas_female_young_child_terms_by_significance.txt term rank	gwas_male_adolescent_terms_by_significance.txt term rank	gwas_male_adult_terms_by_significance.txt term rank	gwas_male_child_terms_by_significance.txt term rank	gwas_male_elderly_terms_by_significance.txt term rank	gwas_male_fetus_terms_by_significance.txt term rank	gwas_male_infant_terms_by_significance.txt term rank	gwas_male_middle_adult_terms_by_significance.txt term rank	gwas_male_old_adult_terms_by_significance.txt term rank	gwas_male_older_adult_terms_by_significance.txt term rank	gwas_male_young_adult_terms_by_significance.txt term rank	gwas_male_young_child_terms_by_significance.txt term rank
4032_Alcohol dependency (unrelated individuals)	4032_Alcohol dependency (unrelated individuals)	25	1	1	1	4737	2583	1355	792	3732	2434	3920	1688	1096	2082	103	3109	2657	1511	1133	2516	3497	1392	3999	339	4646
3052_EPHB6 - Ephrin type-B receptor 6	3052_EPHB6 - Ephrin type-B receptor 6	25	1	1	4681	1	900	4056	175	6	61	3206	4435	2778	2796	1947	1168	10	4700	224	8	3248	4050	2533	2320	2531
199_Urinary albumin-to-creatinine ratio (non-diabetic)	199_Urinary albumin-to-creatinine ratio (non-diabetic)	25	1	1	1355	918	1	1630	2914	899	3578	3972	4716	491	1720	395	2642	2836	771	2744	1548	1267	3899	2585	1549	2231
4674_Cingulum (hippocampus) axial diusivities	4674_Cingulum (hippocampus) axial diusivities	25	1	1	499	1609	3976	1	2924	3037	828	2641	45	1764	1261	998	659	67	4174	2682	2547	4312	2247	3289	2695	1791
2997_FGG - Fibrinogen gamma chain	2997_FGG - Fibrinogen gamma chain	25	1	1	3006	1307	218	1925	1	7	911	3947	1892	1568	3979	51	1739	29	1333	1	15	4463	2183	2972	6	2656
3414_Birth weight	3414_Birth weight	25	1	1	446	3876	629	3014	185	1	3661	516	1585	578	1895	3036	907	15	1729	176	3	1520	4035	1463	343	3443
1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	1	1	1579	2862	2044	2842	3824	308	1	2306	1429	1980	2716	4712	2909	130	3884	3023	96	3177	311	4210	129	2974
3208_Number of days/week of vigorous physical activity 10+ minutes	3208_Number of days/week of vigorous physical activity 10+ minutes	25	1	1	3173	2854	2700	4274	2246	2310	568	1	1681	1482	4543	2908	310	4334	847	1786	4492	3060	2888	708	2386	3886
1008_Stem cell growth factor beta	1008_Stem cell growth factor beta	25	1	1	822	878	3642	2223	3833	3323	233	2032	1	2582	1468	1503	1049	3579	1203	3953	3789	2403	2304	2366	4282	1115
1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	1	1	1820	293	449	1583	1868	4673	3402	830	944	1	555	4356	2482	1010	2834	4291	1822	2139	1518	3937	1364	898
719_::::X-11537	719_::::X-11537	25	1	1	114	4421	147	2446	1772	2664	3950	2776	2062	3612	1	98	3248	3206	3086	3969	1972	3096	4465	397	627	77
2629_A2M - Alpha-2-macroglobulin	2629_A2M - Alpha-2-macroglobulin	25	1	1	4224	27	593	4342	888	1481	3924	1387	1518	4628	977	1	4152	269	930	708	3423	12	1206	1735	88	4168
2415_SERPINE2 - Glia-derived nexin	2415_SERPINE2 - Glia-derived nexin	25	1	1	1233	62	1169	354	796	4391	216	1892	1264	3316	2538	1112	1	3203	1388	850	988	3529	3931	1542	3080	3184
3544_Mouth/teeth dental problems: Mouth ulcers	3544_Mouth/teeth dental problems: Mouth ulcers	25	1	1	3923	664	3045	129	47	2266	906	4056	1919	476	180	1838	2994	1	3489	50	294	861	2828	1550	1605	658
3644_Illnesses of mother: High blood pressure	3644_Illnesses of mother: High blood pressure	25	1	1	2702	830	3673	1330	1992	1188	3317	548	3401	3960	4690	3003	2841	2597	1	406	59	3239	4236	2646	1580	384
2438_CST6 - Cystatin-M	2438_CST6 - Cystatin-M	25	1	1	670	1152	2322	3071	133	3	4702	1627	2145	2900	4525	2489	163	1977	2026	93	1	3593	2921	2123	467	2596
1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	25	1	1	3609	4387	2773	4705	1901	3866	3395	88	3096	448	1174	860	3613	1372	1345	2444	497	1	93	2176	401	2767
515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	25	1	1	4355	1288	3245	23	2362	786	3264	197	2357	620	4112	429	724	1573	1692	3594	909	10	1	1722	3016	2035
2414_PIGR - Polymeric immunoglobulin receptor	2414_PIGR - Polymeric immunoglobulin receptor	25	1	1	3643	3561	2305	4230	1289	2118	4700	2673	1541	1350	2950	82	551	3215	2985	1713	325	1143	740	1	4477	2461
2283_IGF1 - Insulin-like growth factor I	2283_IGF1 - Insulin-like growth factor I	25	1	1	579	539	1375	444	3572	1663	2239	3813	135	1303	433	3790	476	306	486	3451	136	4379	1428	1987	1	1557
3596_Mineral and other dietary supplements: Iron	3596_Mineral and other dietary supplements: Iron	25	1	1	4398	3083	229	60	1331	53	483	1147	1480	908	65	1727	351	3966	740	2400	39	4380	963	1653	1239	1
3747_Happiness and subjective well-being - Belief that own life is meaningfull	3747_Happiness and subjective well-being - Belief that own life is meaningfull	25	2	1	2	3739	1385	4564	2510	4453	2945	4436	4271	1882	4214	3758	1545	474	2826	3898	1397	2899	1826	1753	1969	2815
2544_PRSS3 - Trypsin-3	2544_PRSS3 - Trypsin-3	25	2	1	1016	2	1801	828	166	262	3622	2313	4527	85	581	954	2438	3006	224	143	1658	2169	1593	3598	1299	4095
2032_Prognosis in Crohn's Disease	2032_Prognosis in Crohn's Disease	25	2	1	1721	1161	2	1069	467	1067	3412	2921	1353	680	2224	167	160	4184	2566	332	69	3971	1573	122	3156	3240
3005_EIF4A3 - Eukaryotic initiation factor 4A-III	3005_EIF4A3 - Eukaryotic initiation factor 4A-III	25	2	1	4250	3543	4094	2	2042	2595	1478	2737	1045	2468	2137	4338	1207	4182	4686	2443	455	4470	2683	599	109	233
2214_FGA FGB FGG - Fibrinogen	2214_FGA FGB FGG - Fibrinogen	25	2	1	3133	3446	1748	495	2	23	3	4500	1003	307	2015	1224	3241	1177	892	3	34	87	4464	238	4446	911
2338_MB - Myoglobin	2338_MB - Myoglobin	25	2	1	76	2890	943	468	205	2	2309	266	1159	1664	2012	3668	3250	17	1884	211	10	4125	2489	4724	254	534
3767_Depression - Recent lack of interenst of pleasure in doing things	3767_Depression - Recent lack of interenst of pleasure in doing things	25	2	1	874	1606	3314	3668	4526	1870	2	2819	4583	813	3616	4528	277	3051	3906	3225	3542	1497	3075	613	4507	2445
4128_C-reactive protein	4128_C-reactive protein	25	2	1	2995	2106	3026	1342	2646	3516	8	2	4470	571	1859	4490	28	2156	842	1938	3841	4569	1876	2645	2927	2259
4434_Measles IgG levels	4434_Measles IgG levels	25	2	1	1315	2718	4188	98	2496	597	4135	4558	2	2607	3901	3251	934	2180	3922	3135	2562	3773	3607	4189	4336	3159
4554_Left lateral occipital	4554_Left lateral occipital	25	2	1	4564	1548	4424	211	3490	3574	328	714	4530	2	31	4711	3394	4007	1209	4133	2277	81	2491	219	2595	2324
4582_Right inferior parietal	4582_Right inferior parietal	25	2	1	1367	3839	2097	3441	1679	3909	3947	3451	3816	2213	2	2321	4109	2250	1720	3264	1731	1547	2757	4155	2774	1548
2398_GNLY - Granulysin	2398_GNLY - Granulysin	25	2	1	4248	1033	1131	1828	1616	1460	1695	485	356	490	1022	2	1747	19	3878	1612	445	3486	1146	1092	315	1132
2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	25	2	1	1381	1113	373	3340	2465	2923	362	3851	2100	153	2694	269	2	852	100	2223	3323	1096	3314	9	215	573
998_Monocyte chemotactic protein-1 (CCL2)	998_Monocyte chemotactic protein-1 (CCL2)	25	2	1	4740	2823	865	510	979	63	922	4055	814	1071	41	2850	3716	2	1898	1586	23	2831	1756	741	1495	1588
3874_Eosinophil count (three-way meta)	3874_Eosinophil count (three-way meta)	25	2	1	742	1752	2739	1170	473	3293	1432	4410	2807	244	4527	2957	1017	342	2	618	3762	2271	2815	180	4083	572
4299_Vitiligo (late onset)	4299_Vitiligo (late onset)	25	2	1	350	240	1316	2401	4	328	2890	921	866	1616	1394	237	3478	209	3869	2	1058	2799	4601	1034	783	3164
2127_IL1RAP - Interleukin-1 Receptor accessory protein	2127_IL1RAP - Interleukin-1 Receptor accessory protein	25	2	1	487	816	28	1807	160	8	3588	174	2025	3666	3000	1951	914	7	2052	201	2	1932	1086	3355	881	2680
1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	25	2	1	3197	3401	3138	4394	1567	2787	1316	33	3551	1367	652	602	3539	1190	1775	1029	837	2	175	2019	754	2021
3083_PRLR - Prolactin receptor	3083_PRLR - Prolactin receptor	25	2	1	3714	180	1230	87	2462	332	3108	1792	83	2257	203	3760	1359	4463	714	1305	2030	1093	2	610	513	91
3438_Doctor diagnosed asthma	3438_Doctor diagnosed asthma	25	2	1	3239	2326	166	2809	28	1936	1694	1427	1227	1774	3827	2438	21	1376	986	21	1029	1903	4094	2	596	776
2845_MFGE8 - Lactadherin	2845_MFGE8 - Lactadherin	25	2	1	1999	3469	1983	6	455	386	4057	1889	2026	4114	2354	3915	1156	2707	1332	941	2014	2571	289	572	2	4429
170_Waist circumference (male)	170_Waist circumference (male)	25	2	1	2952	234	1744	2932	2367	4409	2671	358	4175	3733	1609	2632	4034	25	3567	3475	4743	4234	4058	2990	2340	2
1946_Visual memory composite score (FBAT, adjusted for multivariable)	1946_Visual memory composite score (FBAT, adjusted for multivariable)	25	3	1	3	3513	411	3739	4029	545	313	2374	4697	1351	3623	2724	4294	584	3120	2888	1643	707	3767	1622	292	2230
4100_Low-density-lipoprotein cholesterol	4100_Low-density-lipoprotein cholesterol	25	3	1	20	3	2139	3499	3009	273	4080	318	603	3170	879	1832	1041	803	439	3914	1109	2673	4291	2211	161	3634
690_::::X-11261	690_::::X-11261	25	3	1	2758	4162	3	3535	3990	536	211	3100	1755	2295	4659	2965	2790	2662	2891	1079	1824	1770	570	3142	2854	4666
4526_Left amygdala	4526_Left amygdala	25	3	1	578	3699	503	3	4373	1987	4518	645	1141	3150	1427	2772	1139	4309	532	564	4646	276	3308	690	1588	575
2352_C9 - Complement component C9	2352_C9 - Complement component C9	25	3	1	3184	451	1080	2486	3	70	348	4234	3742	1369	1318	1505	1649	730	1170	4	662	3931	1576	4387	936	4513
2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	25	3	1	4352	946	1410	1025	1202	190	1927	3	242	477	58	1030	3755	2013	922	871	104	3430	3979	1223	4149	4131
3167_CDH15 - Cadherin-15	3167_CDH15 - Cadherin-15	25	3	1	2492	4130	162	196	1364	4420	1232	2004	3	2343	1382	221	574	3316	3130	709	4470	317	1105	3724	1673	341
3164_BRF1 - Transcription factor IIIB 90 kDa subunit	3164_BRF1 - Transcription factor IIIB 90 kDa subunit	25	3	1	2672	3320	4348	2272	3431	2835	3654	196	499	3	2777	2212	3906	1766	2479	358	2157	1372	1695	1644	162	4282
4195_Diastolic Blood Pressure	4195_Diastolic Blood Pressure	25	3	1	565	2503	1763	2469	1315	4515	4018	254	4273	3914	3	2798	2985	1920	2872	1665	1883	2924	3239	3385	274	2902
1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	25	3	1	2832	4351	4686	414	582	4358	665	875	3237	1083	3648	3	2828	85	2542	352	2794	4590	3309	3556	2016	1244
530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	25	3	1	1175	4348	1371	1788	3578	3200	1746	1766	53	96	3093	1296	3	2220	3834	1815	1223	4013	1315	3279	595	3210
763_::::X-12216	763_::::X-12216	25	3	1	867	3804	60	2255	2009	540	685	4320	2214	2056	157	29	4156	3	2689	1608	4726	1050	1797	1222	303	419
4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	25	3	1	4294	4690	798	1350	55	4293	2971	1134	2471	747	3599	42	2390	1219	3	59	2817	3510	540	581	2010	615
3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	25	3	1	1008	3734	1452	4554	1041	1972	1145	676	1998	736	3576	4224	1126	4584	899	1644	4061	3	2905	441	566	2050
3448_Impedance measures - Impedance of leg (right)	3448_Impedance measures - Impedance of leg (right)	25	3	1	64	3294	3486	3043	1220	2968	2779	4703	3552	1880	4401	4286	3483	3980	4548	2325	2710	291	3	1114	4599	931
3232_Sleeplessness / insomnia	3232_Sleeplessness / insomnia	25	3	1	1641	1612	3445	2032	1234	2720	798	3351	186	24	2197	1610	3343	942	4286	3862	4386	138	204	3	539	4172
489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	25	3	1	95	872	2278	2085	1462	2665	2201	1652	2452	1154	659	26	1148	1735	3482	419	1619	1765	730	1630	3	828
3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	25	3	1	3912	140	1359	1164	3251	3695	3792	4329	1153	3057	3792	2869	2859	604	1046	1716	2175	1978	1357	1071	3330	3
210_Insomnia	210_Insomnia	25	4	1	4	1893	161	2823	178	1515	129	2798	327	347	3446	155	753	3649	664	616	3587	331	3293	2610	609	1560
4098_Total cholesterol	4098_Total cholesterol	25	4	1	170	4	551	748	594	147	2615	278	68	3779	487	3956	31	242	558	2173	602	3228	1293	527	1025	846
1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	25	4	1	2216	1932	4	3924	635	3814	558	3946	871	1016	2943	4055	3034	711	1762	825	3079	943	4525	381	2369	750
3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	25	4	1	1917	3249	1525	4	8	68	3575	1505	1697	4239	127	1064	1085	2130	1272	6	139	4686	1408	774	198	1074
4608_Cerebellar vermal lobules I V	4608_Cerebellar vermal lobules I V	25	4	1	1676	276	3353	1631	130	4	3674	4565	2740	1804	4643	1594	4451	898	1063	157	11	2042	547	25	108	4674
605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	25	4	1	3942	2567	3671	3922	3540	3081	4	1966	512	2675	3456	3285	375	1503	456	1283	3187	3019	1938	3740	3491	3190
2918_SERPINA6 - Corticosteroid-binding globulin	2918_SERPINA6 - Corticosteroid-binding globulin	25	4	1	3505	3197	580	3807	3495	2637	2525	4	567	2455	521	4169	4570	1248	943	3722	2407	948	3617	3750	2511	418
2815_CLEC1B - C-type lectin domain family 1 member B	2815_CLEC1B - C-type lectin domain family 1 member B	25	4	1	231	2257	4165	1955	2258	4168	409	2945	4	2089	33	2395	850	1360	516	623	511	452	2502	3075	2079	2553
1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	4	1	187	979	3304	2328	2890	2180	432	4488	4025	4	2269	1621	2596	4695	1745	1253	253	2506	4499	2090	1502	2541
1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	4	1	1132	490	1067	1406	1314	4194	3446	3804	506	596	4	3648	337	109	746	658	3073	3655	2771	374	2647	87
1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	4	1	120	3029	148	3073	2226	2827	2833	3661	4690	1559	4569	4	3747	1534	2764	4663	3650	1848	3573	2387	1759	2252
3054_GPNMB - Transmembrane glycoprotein NMB	3054_GPNMB - Transmembrane glycoprotein NMB	25	4	1	1105	2858	179	3388	251	13	4728	4260	4337	134	1711	3747	4	5	2842	284	25	218	4266	3851	405	57
4637_Right putamen	4637_Right putamen	25	4	1	4322	4266	572	3254	4523	4512	292	547	4085	4629	1656	126	825	4	4446	4223	2690	2485	4459	3126	120	1882
4099_High-density-lipoprotein cholesterol	4099_High-density-lipoprotein cholesterol	25	4	1	2975	2988	4194	3881	2947	4123	626	449	1035	2611	999	1783	2554	1654	4	4423	4000	3612	2978	3702	1677	2258
2261_C7 - Complement component C7	2261_C7 - Complement component C7	25	4	1	2942	161	1247	3728	129	5	4382	1680	3354	2792	3762	1458	362	22	4403	141	4	2950	3589	2998	1921	678
4034_Alcohol dependency (discovery)	4034_Alcohol dependency (discovery)	25	4	1	2091	3189	3287	896	1099	2132	630	2228	2484	510	4502	3107	1993	451	4569	4136	4723	4	2230	4093	906	4476
1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	4	1	4641	1176	988	15	842	4196	1368	3728	2122	2752	4573	3588	2515	2782	1211	1498	1809	160	4	1268	245	2088
3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	25	4	2	1385	4232	199	3607	18	2875	4449	2023	938	3133	3765	4346	11	1276	1141	15	1773	646	3569	4	136	928
3119_MAPK9 - Mitogen-activated protein kinase 9	3119_MAPK9 - Mitogen-activated protein kinase 9	25	4	1	8	3829	507	2556	1346	1294	3087	1464	3064	2072	3966	4086	1559	455	1116	2202	3020	4181	633	2077	4	429
4038_Schizophrenia	4038_Schizophrenia	25	4	1	4221	2160	1439	1201	502	3269	3241	3356	544	1780	2203	2767	906	312	1223	343	806	648	2898	1720	3837	4
3963_Gestational weight gain (offspring, total)	3963_Gestational weight gain (offspring, total)	25	5	1	5	3614	2991	3496	1065	2525	1838	2954	1774	2626	2680	3439	7	4718	1146	4266	763	2219	2203	2790	2973	3677
1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	25	5	1	3362	5	1653	3013	418	2001	1486	4625	4174	1864	1778	95	4619	2755	44	857	944	4529	254	3751	3279	4196
2662_EPHA5 - Ephrin type-A receptor 5	2662_EPHA5 - Ephrin type-A receptor 5	25	5	1	1587	1327	5	2739	148	3989	2616	2031	607	4408	548	1402	4183	1333	4181	171	4415	4595	1144	2659	1323	2351
2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	25	5	1	505	3210	4562	5	4695	3937	1161	412	3108	750	2094	1131	2721	3774	3430	2781	1196	1901	2695	3146	3956	4728
200_Microalbuminuria	200_Microalbuminuria	25	5	1	3987	1521	857	3732	5	24	956	2320	4173	2633	1646	2251	3805	326	1011	8	29	4347	3755	2321	1061	3441
4190_Type 2 Diabetes	4190_Type 2 Diabetes	25	5	1	1525	483	995	750	7	10	5	1469	2578	3407	3990	984	1061	1605	574	5	9	515	1016	2907	2896	2345
2121_TACSTD2 - Tumor-associated calcium signal transducer 2	2121_TACSTD2 - Tumor-associated calcium signal transducer 2	25	5	1	48	1151	2915	1545	3439	1307	56	5	357	1404	66	1374	2754	943	184	1833	478	4324	3016	2120	189	1149
350_gdT:%CM (1)	350_gdT:%CM (1)	25	5	1	1989	1559	4339	1153	1075	3445	11	790	5	3659	3941	3324	3349	2447	3926	2864	4627	3631	345	81	2277	864
716_::::X-11521	716_::::X-11521	25	5	1	1720	4215	150	2511	3846	982	184	4298	3761	5	3025	4662	3704	2162	3775	4212	1616	2164	1821	1248	2380	2055
1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	25	5	1	3323	3303	3866	671	1450	1805	443	2590	2802	4306	5	2623	373	3455	341	1893	2225	1462	3914	2963	3437	950
935_Triglycerides in small HDL	935_Triglycerides in small HDL	25	5	1	1754	3812	3937	2603	348	1121	1714	1601	1508	3425	772	5	1485	2686	810	769	1553	4158	4490	2403	2203	940
3968_Asthma (fixed effect model)	3968_Asthma (fixed effect model)	25	5	1	1573	563	514	2060	75	457	3865	2566	1926	3609	4139	916	5	389	86	68	2773	4409	1537	590	1456	1518
1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	25	5	1	2048	1815	3255	459	2705	1692	3905	1384	358	832	1185	3287	1951	361	5	3499	3876	784	4189	126	4054	1611
2517_EPHA3 - Ephrin type-A receptor 3	2517_EPHA3 - Ephrin type-A receptor 3	25	5	1	3423	1931	626	61	181	15	2847	3543	912	2302	2733	873	4631	118	290	173	5	3272	4015	4168	3399	4663
4673_Cingulum (cingulate gyrus) axial diusivities	4673_Cingulum (cingulate gyrus) axial diusivities	25	5	1	4208	1829	2644	2207	1504	2208	3634	2629	2270	3005	4442	3720	572	710	1174	4481	726	5	2126	3873	324	3104
4011_Broad depression	4011_Broad depression	25	5	1	2396	738	748	172	1519	810	995	2026	2718	3981	1305	1394	2480	120	3147	3198	1803	4736	5	3157	1277	27
2908_APOD - Apolipoprotein D	2908_APOD - Apolipoprotein D	25	5	1	676	1874	2307	2468	143	19	1537	2319	366	1248	3134	4179	1735	36	3180	150	7	2140	970	3103	5	2960
4685_Splenium of corpus callosum axial diusivities	4685_Splenium of corpus callosum axial diusivities	25	5	1	1867	893	3430	1903	2326	3181	331	3307	397	2050	2654	2232	2222	658	1611	1646	3613	124	3869	1612	37	5
1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	6	1	6	2247	3154	2553	2375	4418	3699	1988	502	570	4463	375	3691	2628	3749	2873	1506	3826	3292	1670	1284	4653
1269_Epworth Sleepiness Scale (GEE)	1269_Epworth Sleepiness Scale (GEE)	25	6	1	1181	6	1805	3507	442	2025	659	4268	3376	1899	4523	947	4099	1694	2266	1170	322	3845	780	4599	2335	2959
2200_IGFBP1 - Insulin-like growth factor-binding protein 1	2200_IGFBP1 - Insulin-like growth factor-binding protein 1	25	6	1	663	2942	6	2922	2687	1311	30	3817	1256	43	3324	4305	3567	1925	1425	3788	1995	1737	4674	4319	1348	3680
1268_Epworth Sleepiness Scale (FBAT)	1268_Epworth Sleepiness Scale (FBAT)	25	6	1	2905	2396	1997	1281	6	104	2058	4718	4428	3546	1781	1668	3846	1209	739	7	766	2145	57	1535	1352	2149
1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	25	6	1	3028	2697	2244	74	3434	2107	6	4655	247	900	3386	4306	2242	3750	107	3541	1161	4401	1450	877	1340	3000
340_NKeff:%2+337-R7-	340_NKeff:%2+337-R7-	25	6	1	1310	200	1151	1697	372	22	2964	6	122	2294	2528	3183	1573	46	1396	268	28	1040	3804	1714	610	4651
954_Total cholesterol in very large HDL	954_Total cholesterol in very large HDL	25	6	1	3615	127	1478	1719	2603	2469	3005	2058	6	1794	3936	4021	300	4700	4051	3642	1919	107	3130	4539	30	4370
4453_Left lateral occipital	4453_Left lateral occipital	25	6	1	1705	3049	3589	2707	3161	3566	2267	1196	2566	6	273	4561	2130	3445	2613	3632	432	279	2946	318	2278	1160
1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	25	6	1	1194	4000	1333	3829	1341	2980	48	3745	495	2353	6	772	3780	1734	1443	2114	165	213	1183	1988	3997	196
1135_Eczema	1135_Eczema	25	6	1	68	28	2701	1322	2883	3949	3782	572	3690	1429	894	6	3835	861	256	2834	3462	4302	1628	454	4215	791
859_CH2 groups in fatty acids	859_CH2 groups in fatty acids	25	6	1	3626	1975	2601	2637	1873	4595	4467	127	807	1287	1764	4235	6	3638	4530	3091	704	4568	1927	4131	171	683
4624_Left putamen	4624_Left putamen	25	6	1	4538	4717	1061	4362	4416	3123	882	1215	4401	3771	1660	588	1397	6	3146	4467	2868	3415	4227	2272	157	1752
3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	25	6	1	391	342	3564	58	309	846	3567	1659	2424	3008	3998	1254	994	283	6	243	358	1411	3284	996	2243	1505
3327_Had major operations	3327_Had major operations	25	6	1	686	2240	2005	483	82	11	3354	2347	1375	4263	3649	3793	4110	11	306	102	6	1421	3716	3053	987	4712
2856_ZAP70 - Tyrosine-protein kinase ZAP-70	2856_ZAP70 - Tyrosine-protein kinase ZAP-70	25	6	1	248	1681	3427	2931	2684	1681	1553	3733	1810	2351	2660	4412	4656	277	1513	1728	4251	6	373	1134	1229	403
2310_IL18RAP - Interleukin-18 receptor accessory protein	2310_IL18RAP - Interleukin-18 receptor accessory protein	25	6	1	1543	4537	1918	513	4689	1497	3214	638	4512	133	1138	981	2787	4001	2836	4626	2875	362	6	1434	4190	558
4017_Systemic Lupus Erythematosus	4017_Systemic Lupus Erythematosus	25	6	1	2245	1515	45	3747	70	2984	1799	3211	9	4161	2480	606	2115	1465	983	74	1013	2263	3685	6	2107	4388
526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	25	6	1	2843	122	3046	3409	3862	1131	1401	4333	314	253	1433	3783	3520	376	278	2061	217	266	2659	540	146	6
1947_Visual memory composite score (GEE, adjusted for multivariable)	1947_Visual memory composite score (GEE, adjusted for multivariable)	25	7	1	7	4403	2137	3979	1933	2974	2621	688	4196	1520	2397	3342	4432	4221	2557	1886	4001	3743	3575	1992	3253	707
2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	25	7	1	4484	7	1364	250	99	2453	1331	4350	1856	117	2806	3440	2853	3392	2185	111	1952	4203	3050	3062	4052	402
613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	25	7	1	353	916	7	3283	2047	522	171	1838	321	1920	1214	113	16	54	142	460	73	1155	1771	2662	1813	1503
2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	25	7	1	4045	3388	2582	7	3659	238	3525	4639	318	1153	1208	57	4668	264	1711	2186	143	4187	989	2111	3840	4742
1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	25	7	1	3990	3796	4302	1619	2376	94	7	2971	3146	45	4044	1141	3580	3692	135	3343	4216	1611	1039	4516	203	3301
2785_PKM2 - Pyruvate kinase PKM	2785_PKM2 - Pyruvate kinase PKM	25	7	1	4013	3864	3169	4653	906	3979	4434	7	2197	1413	2376	2946	3645	2442	210	607	1965	740	1717	1472	4689	1366
908_LDL diameter	908_LDL diameter	25	7	1	2803	1197	2619	1451	731	873	481	28	7	928	2794	2708	4378	1394	348	3209	343	2085	83	2042	1289	318
4102_Blood sugar	4102_Blood sugar	25	7	1	1841	708	4045	4378	2109	224	755	694	1266	7	2907	3348	4480	1607	3503	844	331	1227	357	3850	3771	4188
800_::::X-12749	800_::::X-12749	25	7	1	62	1782	82	4190	157	3481	3079	1301	2210	3979	7	2773	1255	128	1427	191	1736	3487	3701	3719	1146	3522
3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	25	7	1	1597	2584	683	621	687	4615	2705	2809	2446	403	4213	7	1220	3071	2036	3358	2807	4005	2397	1659	4018	38
2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	25	7	1	3604	2090	3928	237	3016	575	3121	720	2437	357	2601	3175	2046	1275	7	1954	496	4133	3597	3019	760	1827
1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	25	7	1	836	4583	3899	819	1019	471	2651	2982	3228	1308	40	1448	352	2270	2987	1363	2889	7	115	686	794	3882
4370_Thyroid-stimulating hormone (male)	4370_Thyroid-stimulating hormone (male)	25	7	1	2643	2529	1650	70	4058	1732	3611	1410	1807	2997	2580	3064	3308	2320	2974	4723	3670	1310	7	539	3958	4395
3319_Wheeze or whistling in the chest in last year	3319_Wheeze or whistling in the chest in last year	25	7	1	887	4660	1001	592	25	1160	2858	1981	2411	2895	3192	4034	30	2025	2546	19	765	934	3483	7	193	1318
978_Growth regulated oncogene (CXCL1)	978_Growth regulated oncogene (CXCL1)	25	7	1	2786	4709	3272	795	3388	477	2236	2720	3972	3640	69	19	1924	1019	2952	1191	1085	14	2135	1950	7	2264
1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	7	1	3041	2216	663	1124	713	1248	4569	3864	3475	4040	1943	2371	3937	3632	524	758	3584	1294	23	2625	1670	7
3572_Pain type(s) experienced in last month: Back pain	3572_Pain type(s) experienced in last month: Back pain	25	8	1	3543	8	2964	4331	4178	2619	3806	1437	1017	4025	3332	34	3984	4644	4055	4541	2823	670	1882	270	362	2131
608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	25	8	1	501	1183	8	1198	1610	4703	3134	3408	2230	3477	4196	3561	4232	3472	2605	3058	3578	4118	1924	3272	3584	3466
4487_Right medial orbitofrontal	4487_Right medial orbitofrontal	25	8	1	3969	1442	4620	8	1893	4687	3360	4205	2378	3066	3129	547	2886	462	884	667	1620	996	270	1500	1879	4616
791_::::X-12704	791_::::X-12704	25	8	1	3939	3665	3289	1592	4605	3924	4413	8	1952	122	2530	1330	313	702	3324	4332	3271	3327	2106	366	3383	952
2401_IDS - Iduronate 2-sulfatase	2401_IDS - Iduronate 2-sulfatase	25	8	1	2293	2773	52	3813	2128	3569	4342	2764	8	4694	3298	2481	4123	1863	609	1674	3886	2728	3481	3118	813	2854
3578_Social support - Leisure/social activities: Religious group	3578_Social support - Leisure/social activities: Religious group	25	8	1	1552	4572	3687	220	4511	820	1436	664	2285	8	217	2691	3012	4601	4117	4676	3900	3974	1621	2299	1004	3396
2948_CASP2 - Caspase-2	2948_CASP2 - Caspase-2	25	8	1	717	4723	1857	1550	412	3586	3826	75	3441	565	8	3708	4448	845	2608	1680	1708	1300	1319	2386	3924	80
2819_DAPK2 - Death-associated protein kinase 2	2819_DAPK2 - Death-associated protein kinase 2	25	8	1	2157	2703	1193	76	232	3013	3775	2899	4636	3708	130	8	215	4424	353	694	2770	3278	3322	2004	4726	579
2637_PTH - Parathyroid hormone	2637_PTH - Parathyroid hormone	25	8	1	1589	2667	237	765	1297	39	100	2359	3020	689	3168	876	8	760	1953	1294	1569	2568	1472	4471	3160	1147
3957_Antisocial behavior	3957_Antisocial behavior	25	8	1	2289	3447	1704	1744	1817	2489	4736	2517	4316	1504	1563	1787	2714	8	315	785	3126	2519	399	2565	4213	1626
3838_Eosinophil count (two-way meta)	3838_Eosinophil count (two-way meta)	25	8	1	4351	1372	4130	580	466	3610	1005	4008	2552	286	2283	3426	687	1068	8	703	4287	4102	1675	320	2177	623
750_::::X-12040	750_::::X-12040	25	8	1	859	3244	3887	209	553	1394	1618	168	4406	2388	3537	3523	1146	4273	936	2187	2478	8	4299	1358	4234	1635
3211_Frequency of stair climbing in last 4 weeks	3211_Frequency of stair climbing in last 4 weeks	25	8	1	3320	3283	2611	3446	1607	2506	2946	1626	4272	167	2701	3415	4350	1901	1986	1729	3735	869	8	694	4359	3157
1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	25	8	1	138	4556	1532	3690	1268	4737	247	536	475	3942	2928	388	1691	3336	2848	665	3820	929	4289	8	1149	326
537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	25	8	1	4426	108	3763	2782	4319	2119	2742	202	4595	1374	2477	122	98	1308	2214	755	3034	1527	97	1048	8	648
168_Waist circumference	168_Waist circumference	25	8	1	3885	116	1642	839	2307	3351	3852	226	4524	4094	2841	1396	3522	55	2530	2629	4561	4045	2814	2207	3113	8
1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	9	1	9	2784	2084	1085	2692	2029	4475	1320	3517	4727	3638	1489	3549	4617	3202	1782	4271	1582	476	4407	1103	3637
3199_Distance between home and job workplace	3199_Distance between home and job workplace	25	9	1	1190	9	1718	4134	3293	3778	4411	2867	648	1514	2205	2056	4529	370	3959	3501	2678	3446	2936	2256	726	1250
490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	25	9	1	504	1314	9	706	2993	827	3363	783	4199	2246	4498	2973	728	1133	2436	3239	89	1654	4036	3538	142	211
1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	9	1	3834	63	2702	9	1530	3691	3380	259	3854	1307	706	1178	1903	2106	2494	2082	4263	1270	197	691	1238	3286
208_Rheumatoid Arthritis	208_Rheumatoid Arthritis	25	9	1	1308	218	641	538	9	1356	3788	3046	775	2557	4009	432	3733	1155	1555	23	258	2528	120	159	4225	4289
3152_DLL1 - Delta-like protein 1	3152_DLL1 - Delta-like protein 1	25	9	1	2283	376	2671	4332	193	9	408	1700	4348	1435	1312	621	1401	74	3208	180	21	3004	4090	3091	1556	2593
645_Xenobiotics::Xanthine metabolism::7-methylxanthine	645_Xenobiotics::Xanthine metabolism::7-methylxanthine	25	9	1	3274	55	4154	2746	1406	100	9	1477	554	3478	117	3023	2312	1361	1476	2094	75	1106	265	400	3960	2311
516_Lipid::Long chain fatty acid::adrenate (22:4n6)	516_Lipid::Long chain fatty acid::adrenate (22:4n6)	25	9	1	4125	551	3364	1688	3606	3508	3110	9	1161	2206	3553	4661	4101	175	1378	2760	2317	4155	234	1033	475	1616
2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	25	9	1	1089	1452	398	2853	689	2067	169	2999	3790	9	3534	3243	2670	49	1569	1090	100	705	4297	873	589	4390
3538_Attendance/disability/mobility allowance: Blue badge	3538_Attendance/disability/mobility allowance: Blue badge	25	9	1	4547	4179	2598	2880	476	3012	4661	2470	2938	905	9	142	2271	935	4231	1477	3233	2648	3749	3562	4110	2169
3973_Total body BMD (45-60 years old)	3973_Total body BMD (45-60 years old)	25	9	1	4069	4637	265	291	4384	1989	371	3475	3036	4710	2647	9	1861	795	3327	4226	2551	1727	1521	562	358	4368
4106_Non-albumin protein	4106_Non-albumin protein	25	9	1	4471	2296	124	1043	4109	4685	1265	3966	1537	3895	4400	2126	9	3518	1774	3868	4030	2015	4147	1473	1328	2776
2485_IL17RD - Interleukin-17 receptor D	2485_IL17RD - Interleukin-17 receptor D	25	9	1	644	2419	1071	666	212	18	925	2276	1064	717	589	4508	592	9	2960	325	12	2492	3946	4477	1428	927
654_::::X-03003	654_::::X-03003	25	9	1	708	541	3678	571	659	1904	115	1732	577	982	812	2543	1481	2031	9	2889	150	697	4030	2890	964	3961
3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	25	9	1	517	369	105	135	10	111	2749	2111	2687	959	289	1234	524	2397	2349	9	18	855	363	2325	262	4635
4245_Left handed	4245_Left handed	25	9	1	1203	772	2815	2130	216	3178	231	61	241	1199	4604	367	2267	4078	2998	189	2130	9	3109	283	3392	127
514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	25	9	1	538	3972	4095	111	2622	1426	2227	317	958	723	3079	1083	918	268	4616	2326	3320	111	9	566	3903	101
4496_Right posterior cingulate	4496_Right posterior cingulate	25	9	1	573	4055	249	110	2828	1542	1264	1465	391	2473	231	1272	322	1678	4659	3133	2383	1924	3218	3443	9	12
3198_Frequency of travelling from home to job workplace	3198_Frequency of travelling from home to job workplace	25	9	1	3489	1821	2288	618	283	727	2369	4465	3385	1986	1532	4594	1813	23	1027	321	990	1398	2253	1246	4229	9
2545_DUSP3 - Dual specificity protein phosphatase 3	2545_DUSP3 - Dual specificity protein phosphatase 3	25	10	1	10	900	3714	3749	2837	728	608	1910	1692	2983	1131	4592	2066	4632	3806	3254	597	4693	98	3266	2984	1172
1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	25	10	1	3679	10	3050	3753	436	2198	2038	3374	2838	829	1907	316	4179	2737	465	2635	1232	3831	257	4412	3774	4729
4414_Total IgA levels	4414_Total IgA levels	25	10	1	4581	2765	10	4026	4295	4585	3451	3150	946	4309	539	4026	4676	1546	1168	4579	312	799	3451	1638	3402	41
2932_BMPR1A - Bone morphogenetic protein receptor type-1A	2932_BMPR1A - Bone morphogenetic protein receptor type-1A	25	10	1	4185	837	638	10	2336	3813	2263	118	3902	1827	3402	3637	2086	2781	2458	2368	2156	4581	4589	2949	4573	154
2577_AHSG - Alpha-2-HS-glycoprotein	2577_AHSG - Alpha-2-HS-glycoprotein	25	10	1	2080	3996	3125	2313	2482	1878	10	1396	3183	2259	262	3738	2837	4339	4661	899	2164	2334	2163	1583	1744	817
2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	25	10	1	1654	4719	2608	4019	878	2606	2486	10	539	4743	27	686	1889	4298	4088	1509	591	1786	920	2630	1294	102
865_Esterified cholesterol	865_Esterified cholesterol	25	10	1	643	69	48	728	791	88	4075	1586	10	295	87	794	2970	2336	495	968	1560	2298	1833	4338	554	4162
724_::::X-11552	724_::::X-11552	25	10	1	824	2991	2880	3350	3011	910	2101	569	4157	10	251	1257	3577	4300	1280	2003	3208	3742	4645	278	703	1672
4481_Right inferior parietal	4481_Right inferior parietal	25	10	1	2377	2683	955	4207	4226	1449	4203	4456	1693	3704	10	2424	2014	3619	1834	1817	555	1260	1874	4112	2341	1142
1194_Ulcerative colitis	1194_Ulcerative colitis	25	10	1	121	93	315	138	44	1036	1650	1697	3199	4143	1431	10	2702	1345	559	34	759	2617	4190	525	117	1504
1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	25	10	1	3659	1942	759	595	4729	461	2857	1198	889	2812	207	4037	10	838	2744	1637	241	4422	2184	2521	1807	286
3840_Eosinophil percentage of granulocytes (two-way meta)	3840_Eosinophil percentage of granulocytes (two-way meta)	25	10	1	2913	2663	3874	207	4684	335	442	406	4102	1584	2579	1944	774	1090	10	3573	3429	1707	2217	1980	3983	3782
4235_Adrenergics, inhalants	4235_Adrenergics, inhalants	25	10	1	1309	1260	215	73	13	986	653	1661	4269	2026	3984	3186	124	3809	1730	10	2705	4556	4326	36	1217	1293
256_CD32 on 11c+123+DC	256_CD32 on 11c+123+DC	25	10	1	843	1401	117	2662	4157	3218	4478	54	4024	2390	2529	68	81	4513	97	2042	2644	1525	10	3605	4121	3460
3775_Traumatic events - Able to pay rent/morgage as an adult	3775_Traumatic events - Able to pay rent/morgage as an adult	25	10	1	3468	1324	3313	1856	1164	1641	4300	2709	595	1235	680	697	1922	3920	3596	642	313	1631	4296	10	2717	2876
2790_NME1 - Nucleoside diphosphate kinase A	2790_NME1 - Nucleoside diphosphate kinase A	25	10	1	1948	1424	4265	3156	622	1846	3581	1677	952	1535	306	665	1888	4553	4059	538	2880	178	4088	2787	10	1572
4522_Left caudate	4522_Left caudate	25	10	1	2238	898	3647	2405	3354	2277	796	21	1612	3292	1841	4463	3620	243	1862	4533	1430	2065	3630	4650	93	10
1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	11	1	11	1769	4242	3029	2862	4289	2333	3747	296	2713	2790	4076	4742	3981	992	1266	1345	4093	4290	3518	1753	3212
1605_tPA (at exam 5, GEE, adjusted for multivariable)	1605_tPA (at exam 5, GEE, adjusted for multivariable)	25	11	1	2648	11	4481	4643	2196	4080	1304	2555	2845	817	603	711	1433	4057	3831	2806	4694	1425	3182	2939	2951	4058
870_Free cholesterol	870_Free cholesterol	25	11	1	262	1533	11	1479	218	3849	4267	4147	267	3039	270	4732	1701	1091	305	545	4397	1450	4550	1924	2853	216
4424_Hepatitis B HBs antigen seropositivity	4424_Hepatitis B HBs antigen seropositivity	25	11	1	719	348	3970	11	783	609	41	1352	1072	3394	3973	137	1140	1982	345	594	873	2915	1117	3986	2572	3703
3937_Fucosylation	3937_Fucosylation	25	11	1	583	2192	129	3103	11	4714	1118	1916	1717	1656	4485	1443	958	1227	1261	14	243	62	906	1139	3116	2497
3469_Impedance measures - Trunk fat mass	3469_Impedance measures - Trunk fat mass	25	11	1	4254	1978	1314	2572	4677	4068	1802	11	2682	1913	4185	3992	2937	107	705	3622	1332	4584	2749	3555	646	150
2134_MRC1 - Macrophage mannose receptor 1	2134_MRC1 - Macrophage mannose receptor 1	25	11	1	3132	1616	1899	1244	3894	1986	967	1620	11	638	1444	1393	1778	4203	1991	2886	4023	2215	4305	4610	672	3731
4042_Obsessive compulsive disorder	4042_Obsessive compulsive disorder	25	11	1	4531	4262	1409	2508	2556	282	686	3975	3704	11	3621	740	4038	2395	2873	2349	1989	1608	768	4220	462	1198
2750_PAPPA - Pappalysin-1	2750_PAPPA - Pappalysin-1	25	11	1	1135	1534	4419	2398	1603	3384	3665	3402	1582	4329	11	3322	460	441	2549	2208	4123	2667	2367	1764	365	1283
3071_SCARB2 - Lysosome membrane protein 2	3071_SCARB2 - Lysosome membrane protein 2	25	11	1	1021	3370	937	1336	380	3749	3896	15	2602	3746	2368	11	1086	1757	371	263	1452	311	308	1798	2076	232
2402_KLK12 - Kallikrein-12	2402_KLK12 - Kallikrein-12	25	11	1	3448	264	26	2350	4472	491	12	1421	3529	2104	2690	3886	700	104	11	3184	207	558	1652	168	3857	1411
3695_Diagnoses - secondary ICD10: J45 Asthma	3695_Diagnoses - secondary ICD10: J45 Asthma	25	11	1	1060	2637	101	1182	14	2990	779	314	4231	1206	1498	4623	527	1073	2144	11	2515	2620	2577	30	630	530
1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	11	1	2937	888	3216	628	2569	1736	4526	2386	4204	534	4723	2790	538	1698	4356	1818	2517	11	4026	62	1720	1084
3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	25	11	1	4576	2605	329	4553	1126	4716	119	1232	2079	1706	4674	1143	1984	32	2488	1257	4596	4175	11	1436	4003	636
4507_Cerebellar vermal lobules I V	4507_Cerebellar vermal lobules I V	25	11	1	4155	3073	765	2181	1435	3208	3989	630	1470	2374	2425	516	1595	2059	1508	2311	3351	1281	205	11	524	3545
867_OmegaL3 fatty acids	867_OmegaL3 fatty acids	25	11	1	2341	647	3785	3077	4715	4141	2793	1510	989	822	2448	2323	401	1472	2096	2926	1961	3611	2399	1647	11	1573
4623_Left caudate	4623_Left caudate	25	11	1	2992	118	3452	1924	1714	1691	1808	95	1439	3843	715	3156	2523	719	1454	3104	2411	2070	4719	4458	652	11
4177_C-reactive protein	4177_C-reactive protein	25	12	1	12	168	4434	4719	1670	1229	2046	345	3271	1641	3974	480	58	3781	981	691	346	1185	324	3162	2150	214
803_::::X-12786	803_::::X-12786	25	12	1	1732	12	2447	121	4327	138	281	3723	1348	1583	4054	690	801	955	33	1441	232	3424	2395	650	477	827
627_Xenobiotics::Drug::p-acetamidophenylglucuronide	627_Xenobiotics::Drug::p-acetamidophenylglucuronide	25	12	1	659	2977	12	1301	1282	1841	1178	1381	1259	1993	3807	3865	130	1429	2125	382	4253	1877	68	187	1216	651
1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	12	1	202	507	1092	12	2202	285	513	1527	413	2614	2323	3969	321	4340	2734	1787	492	4439	1453	869	1291	1916
4236_Glucocorticoids	4236_Glucocorticoids	25	12	1	1364	3973	42	1027	12	2959	769	383	3528	2279	3609	4079	108	669	1741	12	2707	2995	2125	50	845	391
3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	25	12	1	453	945	888	4594	179	12	1622	409	4186	489	3146	355	3427	72	3442	202	22	1540	1522	4146	1179	3566
244_CD32 on mDC	244_CD32 on mDC	25	12	1	1031	3348	1220	3011	2594	943	1456	12	1001	2640	2932	125	1893	3254	2271	1615	1729	1207	1048	208	35	2897
786_::::X-12627	786_::::X-12627	25	12	1	1264	736	1063	3046	2361	882	600	4131	12	601	3126	4043	1317	3745	2937	1533	3069	1512	1796	1152	472	2449
4335_Overall activity	4335_Overall activity	25	12	1	3836	1705	2453	2161	2600	268	3745	4458	3238	12	1496	1957	4035	1742	2400	1019	1060	4699	537	3140	20	1710
4135_Red blood cell count	4135_Red blood cell count	25	12	1	1781	790	4158	3515	2858	4584	565	2277	4066	3982	12	3229	2789	117	1988	3756	1727	2493	3406	4649	3889	3567
503_Lipid::Fatty acid, ester::n-Butyl Oleate	503_Lipid::Fatty acid, ester::n-Butyl Oleate	25	12	1	401	1562	278	4346	1214	714	3513	4148	483	277	161	12	1616	1428	3150	2358	1959	4193	2791	2463	1395	141
1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	25	12	1	3815	1928	3737	2172	3169	271	74	2158	3368	2169	672	3712	3229	12	1672	4548	2919	306	2992	157	149	1691
3967_Asthma (random effect model)	3967_Asthma (random effect model)	25	12	1	1742	612	893	4612	233	388	2277	1014	2813	2599	4229	258	42	1168	12	184	2881	2977	1447	723	2115	1014
3692_Diagnoses - secondary ICD10: I20 Angina pectoris	3692_Diagnoses - secondary ICD10: I20 Angina pectoris	25	12	1	3063	356	4523	2020	451	2467	3161	2615	781	2214	370	1521	920	3562	1025	388	689	1314	12	4026	3634	1271
3190_Number of self-reported non-cancer illnesses	3190_Number of self-reported non-cancer illnesses	25	12	1	320	1700	2377	569	42	732	806	3098	2120	3073	2072	226	4108	2583	3368	38	501	1461	1268	12	4701	2257
2055_Remission after 12 weeks of antidepressant treatment in MDD	2055_Remission after 12 weeks of antidepressant treatment in MDD	25	12	1	2422	2235	1847	337	4269	3124	1465	3826	3765	3041	765	1937	3269	3597	3574	1832	4192	2632	2245	517	12	3924
1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	25	13	1	13	4267	632	2171	3112	927	559	3640	1866	768	1212	2775	2386	394	3467	1251	3885	2998	3520	2354	4585	3709
1222_Mean Hippocampus	1222_Mean Hippocampus	25	13	1	3531	13	2920	1223	3115	2213	36	1407	3267	1068	2458	4422	4512	3963	2943	3296	2007	1382	535	4584	3947	886
131_Hip circumference (female, adjusted for BMI)	131_Hip circumference (female, adjusted for BMI)	25	13	1	4473	827	13	4226	648	857	3393	3585	3379	2011	187	3914	3500	3769	1532	383	1719	4202	4542	1767	1230	4101
84_Forearm BMD	84_Forearm BMD	25	13	1	1553	3127	168	13	3556	4557	149	4275	2152	3035	3695	1037	3742	3681	4169	2562	3001	2780	2456	2631	2746	2632
4457_Left middle temporal	4457_Left middle temporal	25	13	1	2944	1574	1368	1758	4622	965	13	3835	1495	561	1854	2097	3694	2325	1012	1663	2798	957	3904	565	1660	2818
1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	25	13	1	4492	1502	1966	3389	3826	134	2007	13	485	4678	2390	933	4384	707	2550	3118	1762	906	4171	2301	985	3300
888_Free cholesterol in large HDL	888_Free cholesterol in large HDL	25	13	1	4537	1004	1449	1589	1072	3360	690	1506	13	1224	1985	2408	4107	2009	3268	3831	2610	1154	4555	4090	951	2093
2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	25	13	1	885	713	2818	4258	1339	207	138	3231	2459	13	4088	4687	3707	893	71	697	282	4166	4415	2628	435	485
3474_Type of accommodation lived in: A house or bungalow	3474_Type of accommodation lived in: A house or bungalow	25	13	1	3625	2610	4053	474	4479	3163	1568	2324	4064	3519	13	3724	4160	1830	2564	3679	1366	1210	4115	3001	3375	2189
4418_Mumps seropositivity	4418_Mumps seropositivity	25	13	1	1880	1394	3060	1323	2917	4504	4283	3125	2611	2342	4103	13	1634	1266	3687	1922	2459	3797	1997	135	520	2710
2020_Adenocarcinoma (adjusted for age)	2020_Adenocarcinoma (adjusted for age)	25	13	1	3072	3806	2913	228	1754	160	2287	606	353	95	3029	641	13	2139	24	3516	3388	2934	230	2727	231	1179
1004_Macrophage inflammatory protein-1 (CCL4)	1004_Macrophage inflammatory protein-1 (CCL4)	25	13	1	4104	3585	1922	1374	2888	2485	3311	844	1972	4598	158	1395	1239	13	3437	4184	3431	3674	2186	4245	1487	1806
28_Extraversion (NEO-FFI)	28_Extraversion (NEO-FFI)	25	13	1	1173	3601	64	930	2604	496	651	806	2115	2750	1437	729	1226	556	13	688	149	1338	1040	240	3337	4206
4267_Asthma (adult-onset)	4267_Asthma (adult-onset)	25	13	1	1166	2401	55	1012	15	2806	1481	483	3030	2440	4324	4242	137	486	1303	13	3360	1678	1657	407	379	1858
2814_KLK3 - Prostate-specific antigen	2814_KLK3 - Prostate-specific antigen	25	13	1	1913	3440	20	1436	1602	20	382	138	709	3162	3393	409	141	225	2191	1005	13	3940	1114	3565	1475	3391
4435_Influenza A IgG levels	4435_Influenza A IgG levels	25	13	1	922	712	820	267	1895	3173	101	3401	3026	4729	604	130	1798	3651	1131	1828	630	13	4420	28	3772	3189
4369_Thyroid-stimulating hormone	4369_Thyroid-stimulating hormone	25	13	1	4039	1583	575	173	4382	940	642	4690	2911	3832	1464	3136	3868	2774	2812	4347	2854	693	13	1952	2083	2193
3939_Body Mass Index	3939_Body Mass Index	25	13	1	400	855	1298	1605	2153	2015	214	2384	4701	4155	2472	2878	1089	1149	3961	890	4041	273	4504	13	89	1677
3520_Current employment status: Retired	3520_Current employment status: Retired	25	13	1	1449	104	3702	1187	303	2274	3858	1835	2198	3111	1994	99	2405	614	834	355	3680	4211	2776	2224	13	4225
2818_ICAM1 - Intercellular adhesion molecule 1	2818_ICAM1 - Intercellular adhesion molecule 1	25	13	1	1617	1156	1835	1221	2437	46	191	2175	2041	3070	191	957	4037	2524	4520	1556	482	2045	3144	2061	1142	13
329_CD4Nv:%TFH (3)	329_CD4Nv:%TFH (3)	25	14	1	14	3932	290	3231	3116	2200	3785	2242	4606	1059	2112	1848	78	2568	4549	2593	2339	1225	365	3997	345	1875
1307_Insulin sensitivity (GEE, adjusted for age and sex)	1307_Insulin sensitivity (GEE, adjusted for age and sex)	25	14	1	4022	14	73	2034	1037	3793	2416	954	819	79	4035	544	63	3192	2809	596	1174	480	3652	1917	888	2390
2727_FGF4 - Fibroblast growth factor 4	2727_FGF4 - Fibroblast growth factor 4	25	14	1	4300	17	14	4100	4127	66	2840	1275	1197	4640	3519	275	2871	3563	3616	4071	167	2666	858	4372	1386	125
2825_FGF16 - Fibroblast growth factor 16	2825_FGF16 - Fibroblast growth factor 16	25	14	1	3737	172	3088	14	4052	2382	3431	535	4118	1509	3357	1084	3968	1430	1910	3990	276	4550	947	4018	1584	96
2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	25	14	1	451	776	1699	1796	263	14	1192	2288	1060	1610	2521	387	750	405	1178	293	27	3879	2543	1496	1109	1276
824_::::X-13553	824_::::X-13553	25	14	1	98	1190	734	1761	2742	1577	14	2616	697	1226	484	3857	2028	1270	23	1857	3260	2884	3199	2467	3435	1251
1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	25	14	1	2155	3169	3458	2425	743	3025	3051	14	1422	3355	1316	591	2707	2243	4071	306	2027	460	4731	2150	2976	2235
889_Total lipids in large HDL	889_Total lipids in large HDL	25	14	1	3422	637	3339	2614	1199	2497	631	1729	14	2522	2249	4738	4537	2555	2835	4552	1394	920	4224	3225	1145	2820
3304_Age first had sexual intercourse	3304_Age first had sexual intercourse	25	14	1	4052	3719	3865	4041	3128	1838	1489	1682	4443	14	3945	2828	2196	495	1639	3423	1363	1732	2627	3795	3726	322
1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	14	1	2092	3942	686	180	1743	4162	4639	181	481	1809	14	273	2660	808	1053	2797	471	55	1415	4199	3967	1432
1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	25	14	1	3296	1432	1953	972	4711	806	3570	128	1691	3529	2053	14	1293	546	1554	1689	1084	1960	3246	4182	2415	1706
1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	25	14	1	2191	4151	4156	2029	1092	1677	697	1357	4304	1064	2259	964	14	330	2964	1571	3461	1788	1996	2446	929	1093
2457_RGMB - RGM domain family member B	2457_RGMB - RGM domain family member B	25	14	1	2671	2070	680	2229	132	25	1069	160	1098	1422	733	3925	536	14	293	145	109	91	150	3558	3259	4060
3875_Eosinophil percentage of white cells (three-way meta)	3875_Eosinophil percentage of white cells (three-way meta)	25	14	1	1612	1462	1434	467	3760	959	1084	144	3588	1886	4409	4011	1565	986	14	3586	2847	2604	4211	2528	4407	3149
3633_Illnesses of father: High blood pressure	3633_Illnesses of father: High blood pressure	25	14	1	637	2021	2343	3522	117	120	2212	1242	2625	3795	4687	93	4418	1911	34	129	14	2093	4278	1070	280	4714
1833_Neck length (GEE, male, adjusted for multivariable)	1833_Neck length (GEE, male, adjusted for multivariable)	25	14	1	4610	804	459	1439	2633	1424	2724	2114	749	1647	2213	4135	3981	2956	1805	3537	4052	1171	14	615	2286	2919
552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	25	14	1	2101	1760	1226	3947	643	3797	2118	2563	1140	3761	1839	2063	4208	3610	2840	595	2907	2523	4064	14	2711	4300
1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	25	14	1	3826	559	3603	2872	1851	3735	3573	2316	3927	201	1902	3964	3180	1932	3686	2442	3445	4654	569	355	14	463
4014_Major depressive disorder	4014_Major depressive disorder	25	14	1	2781	1683	3835	690	3069	1733	971	2357	3617	221	4454	3621	2400	673	3573	1507	4541	3913	267	172	300	14
4730_Superior corona radiata mode of anisotropy	4730_Superior corona radiata mode of anisotropy	25	15	1	15	2518	4468	1865	1764	3647	4298	1276	3306	1670	1587	2582	4270	237	1581	3124	3175	3277	3704	4332	3606	272
2979_ATP5B - ATP synthase subunit beta, mitochondrial	2979_ATP5B - ATP synthase subunit beta, mitochondrial	25	15	1	2327	15	1508	3255	3718	2791	2554	1345	2162	4342	2252	1044	2442	1658	2894	2657	1835	3008	2401	31	3002	1891
101_Pubertal growth	101_Pubertal growth	25	15	1	556	1115	15	1476	228	944	1287	2705	3162	3344	4072	1775	2757	3970	4057	228	1417	2685	1435	528	3639	2029
4316_Smoking cessation	4316_Smoking cessation	25	15	1	833	4643	3029	681	2298	824	15	2240	4266	2271	4075	2920	4118	2920	2439	3221	1344	507	491	1602	3430	3773
886_Total cholesterol in large HDL	886_Total cholesterol in large HDL	25	15	1	4513	609	1575	1806	1002	1983	289	1267	15	4267	636	2544	4020	3925	3015	4527	2689	1832	4507	1922	738	962
3746_Happiness and subjective well-being - General happiness with own health	3746_Happiness and subjective well-being - General happiness with own health	25	15	1	2328	3115	1154	3768	2427	1510	4309	942	3580	15	2444	3953	69	1077	2966	1453	2467	3910	2893	3571	2430	3867
4597_Right posterior cingulate	4597_Right posterior cingulate	25	15	1	24	2476	445	1232	4402	1955	1970	1001	1357	1486	15	3613	1343	1301	4202	2647	2305	2308	3943	2686	368	32
2874_CBX5 - Chromobox protein homolog 5	2874_CBX5 - Chromobox protein homolog 5	25	15	1	3866	4582	3593	2206	4160	172	2784	3646	956	3961	305	15	2503	274	4614	2250	179	3848	1905	2902	3548	2983
3818_Asthma, hay fever or eczema	3818_Asthma, hay fever or eczema	25	15	1	1991	2263	115	1606	264	774	3300	1240	1312	4392	1896	2521	15	2819	1776	155	1211	3247	482	3513	81	49
3876_Eosinophil percentage of granulocytes (three-way meta)	3876_Eosinophil percentage of granulocytes (three-way meta)	25	15	1	4474	4534	3662	385	4243	346	244	107	3847	2332	2229	2208	886	1907	15	3971	3702	2688	2500	1121	3036	2871
4659_Posterior corona radiata fractional anisotropy	4659_Posterior corona radiata fractional anisotropy	25	15	1	4730	1182	1398	3527	734	2739	4200	99	2828	4744	605	428	469	3279	1647	3610	1295	15	651	1193	414	2234
4455_Left lingual	4455_Left lingual	25	15	1	4292	4310	1544	4291	3640	2866	1451	67	3975	171	2189	1609	4550	3849	3477	2101	2996	207	15	3078	1073	943
1090_Alcohol dependence	1090_Alcohol dependence	25	15	1	2230	1553	1969	4193	727	3536	2092	632	1751	3279	128	1136	1771	93	18	400	2626	288	1436	15	147	4250
4695_Cingulum (cingulate gyrus) mean diusivities	4695_Cingulum (cingulate gyrus) mean diusivities	25	15	1	3250	2507	2642	4003	1228	1205	2522	164	1013	1464	3989	3424	2821	3636	1212	2268	1777	1160	228	986	15	277
531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	25	15	1	4193	2440	4111	3513	4340	4134	3518	2298	2620	412	405	1067	2251	4072	534	4239	1974	3757	4324	2288	4435	15
2914_OLFM4 - Olfactomedin-4	2914_OLFM4 - Olfactomedin-4	25	16	1	16	3727	1421	4549	730	653	305	4529	2615	365	2377	2226	3472	2913	4425	679	183	931	1101	3659	438	790
1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	16	1	598	16	4653	2752	2624	317	1298	2848	266	3873	4340	4716	4340	1583	1228	4203	777	1764	551	2472	976	4360
3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	25	16	1	392	2488	16	3402	119	3651	1191	2446	183	810	1192	1384	1910	2961	828	106	4639	2342	2151	3429	293	201
141_Waist-hip ratio (female, adjusted for BMI)	141_Waist-hip ratio (female, adjusted for BMI)	25	16	1	301	2339	605	16	4080	2520	364	3167	777	3319	2398	553	2990	2593	1943	948	1224	3339	1969	2258	3009	3156
3332_Taking other prescription medications	3332_Taking other prescription medications	25	16	1	1406	1673	4186	202	16	837	1863	3296	2227	1782	1692	105	4501	3555	4398	18	306	2803	1367	37	2029	2243
2084_KIT - Mast/stem cell growth factor receptor Kit	2084_KIT - Mast/stem cell growth factor receptor Kit	25	16	1	85	3314	4268	4430	257	16	1455	2323	2508	232	3838	1303	101	41	1584	196	19	1705	4161	2851	3199	2766
4465_Left posterior cingulate	4465_Left posterior cingulate	25	16	1	506	3248	2178	898	1953	3707	16	1089	102	1699	2856	2697	604	324	3124	3234	4250	4222	1723	435	179	2276
3804_Mean corpuscular hemoglobin concentration	3804_Mean corpuscular hemoglobin concentration	25	16	1	4359	2229	2297	791	996	2539	4287	16	2086	421	2674	2117	4646	1753	4517	317	2681	1905	4011	1082	1162	258
3141_APOE - Apolipoprotein E (isoform E2)	3141_APOE - Apolipoprotein E (isoform E2)	25	16	1	2978	428	801	2716	2748	3641	4666	2594	16	3118	259	3874	755	1014	91	3098	2369	83	4096	3042	1329	44
1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	25	16	1	3841	3698	293	96	3068	2350	94	3557	4734	16	3153	872	386	402	1070	345	4460	567	516	4675	4445	2717
2476_CD207 - C-type lectin domain family 4 member K	2476_CD207 - C-type lectin domain family 4 member K	25	16	1	3998	3662	1687	42	1363	1366	4440	3711	77	113	16	890	4610	3495	1254	3570	4261	949	3881	3717	4587	3946
3504_Non-butter spread type details: Flora Pro-Active or Benecol	3504_Non-butter spread type details: Flora Pro-Active or Benecol	25	16	1	243	869	877	1241	188	711	543	2693	280	187	3645	16	2098	2565	115	411	440	3995	127	3491	4322	2618
3352_Age started smoking in former smokers	3352_Age started smoking in former smokers	25	16	1	4688	4212	670	2324	2192	1513	3710	1476	3685	1411	2968	2134	3654	16	1018	3653	3917	3342	1037	4243	2679	1782
1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	16	1	380	1226	544	1502	4379	1178	2435	4514	4189	4289	457	851	1953	2168	16	3388	737	4438	2107	1676	28	3842
3625_Treatment/medication code: levothyroxine sodium	3625_Treatment/medication code: levothyroxine sodium	25	16	1	497	2782	3575	3598	59	51	3145	1723	3751	4247	525	935	3538	3727	2910	53	16	1713	1207	262	900	3911
4111_Uric acid	4111_Uric acid	25	16	1	1998	3631	2271	1051	3651	848	4568	2082	4357	3331	222	2339	280	1479	4650	1226	4422	16	3189	1228	4204	2659
1834_Neck width (FBAT, female, adjusted for multivariable)	1834_Neck width (FBAT, female, adjusted for multivariable)	25	16	1	3840	3928	4644	1637	4733	2753	4333	4025	583	3827	2692	3417	3541	1747	193	2696	380	1230	16	2746	3226	2487
2197_HPX - Hemopexin	2197_HPX - Hemopexin	25	16	1	2045	3173	3311	4106	3909	4153	1330	4673	407	3599	1222	3508	712	1666	2882	3936	428	734	4387	16	1853	3982
819_::::X-13435	819_::::X-13435	25	16	1	1448	1418	2683	3404	3953	2517	468	3241	1446	154	2691	1757	2112	3721	929	3728	2466	2031	1823	3629	16	4421
1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	25	16	1	4626	2220	1347	1994	4562	756	1457	484	2587	381	640	1375	2802	698	4274	4407	962	3217	3758	2011	2372	16
276_CD4:%RTE	276_CD4:%RTE	25	17	1	17	262	599	272	241	1302	2963	3001	4614	3907	3235	2418	1685	820	1613	287	95	2421	922	3733	404	79
4049_Achilles tendon injury	4049_Achilles tendon injury	25	17	1	1165	3852	17	2609	3801	3785	2974	2741	4229	3744	4015	1039	3719	1040	3965	2633	3738	538	1947	267	4523	1304
3926_Total-body less head BMD	3926_Total-body less head BMD	25	17	1	4353	3291	3413	17	3531	1506	3563	4235	2940	933	4614	4010	4166	2044	1060	4289	4444	285	3912	183	559	932
2576_SERPINA1 - Alpha-1-antitrypsin	2576_SERPINA1 - Alpha-1-antitrypsin	25	17	1	4440	3613	574	281	17	21	1273	915	538	4022	1759	3761	1535	34	134	24	47	1729	384	2324	1418	1333
331_NKeff:%Act(314+)	331_NKeff:%Act(314+)	25	17	1	3773	2517	1089	69	21	17	1723	3395	1772	1111	2271	1180	4693	2738	72	31	60	2012	3312	2834	1788	4483
4084_Type 2 Diabetes (adjusted for BMI)	4084_Type 2 Diabetes (adjusted for BMI)	25	17	1	3266	944	220	1066	239	294	17	620	1320	1798	4517	1372	564	4229	2575	347	1559	3857	3915	3473	664	4261
226_B Mem:%IgG	226_B Mem:%IgG	25	17	1	1808	1171	2933	2527	1056	2694	3148	17	1517	3989	2113	1282	4707	314	2093	1690	4362	3055	4214	1454	831	4383
3263_Average weekly champagne plus white wine intake	3263_Average weekly champagne plus white wine intake	25	17	1	974	938	2390	1620	4709	2034	3666	4344	17	2890	2344	1077	463	990	3252	4715	3553	1058	4666	2248	3979	2393
982_Interleukin-12p70	982_Interleukin-12p70	25	17	1	325	4218	4550	4251	3563	3617	3681	4596	4471	17	1203	3975	143	2611	4622	2957	1509	1324	2625	1793	21	3592
2062_CCL27 - C-C motif chemokine 27	2062_CCL27 - C-C motif chemokine 27	25	17	1	3882	1114	4688	4311	478	3694	2929	3286	466	848	17	4480	96	2338	3645	1063	899	3193	3168	3726	2986	2930
3308_Long-standing illness, disability or infirmity	3308_Long-standing illness, disability or infirmity	25	17	1	730	3817	2185	1621	41	1304	1112	1536	1799	4689	4282	17	4466	4680	3353	46	212	2913	1195	77	4681	2065
863_Double bonds in fatty acids	863_Double bonds in fatty acids	25	17	1	1167	2514	4191	3927	1274	4717	2497	1065	651	1254	1965	2890	17	332	622	3533	2077	3554	1515	2985	295	292
4447_Left cuneus	4447_Left cuneus	25	17	1	3715	4319	519	546	2145	434	4047	4403	3220	974	2268	1979	3861	2364	17	922	2338	1951	1369	2593	791	860
3614_Treatment/medication code: ventolin 100micrograms inhaler	3614_Treatment/medication code: ventolin 100micrograms inhaler	25	17	1	1973	4002	1335	465	19	3588	1133	2990	3014	2961	3086	2844	731	1200	2946	17	1905	1248	2366	29	2384	993
4178_White blood cells	4178_White blood cells	25	17	1	4333	4492	3544	2409	1227	92	2692	3608	2844	4713	4483	4187	2408	4205	3796	1131	17	3157	3088	3004	1531	1443
1296_Adiponectin (FBAT, adjusted for age and sex)	1296_Adiponectin (FBAT, adjusted for age and sex)	25	17	1	2043	1813	910	964	1049	2062	3063	3951	2368	1896	3699	3913	1824	1434	1176	2538	2597	17	26	4665	4615	1965
3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	25	17	1	1334	2962	4668	320	3147	101	3348	693	757	2266	1229	1519	1354	2985	1474	3243	719	4710	17	3915	663	3288
3783_Depression - Waking too early	3783_Depression - Waking too early	25	17	1	2367	575	2649	2288	4323	679	400	227	258	2618	673	4453	2506	1525	3531	4202	459	241	2752	17	2197	3525
1224_Mean Putamen	1224_Mean Putamen	25	17	1	723	2253	767	511	3890	1352	3179	4723	4000	1848	3744	1382	170	3694	2975	1564	3225	3877	1704	850	17	635
4641_Right accumbens area	4641_Right accumbens area	25	17	1	1146	998	3079	1988	2324	3399	1184	2678	999	3527	23	2122	2904	2296	3284	1827	4542	2200	2715	4689	2793	17
1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	25	18	1	18	4489	2124	1165	2408	2552	2249	1072	1766	3334	32	1201	2108	372	1194	4577	2658	1657	1301	3731	4157	1383
2522_GZMA - Granzyme A	2522_GZMA - Granzyme A	25	18	1	2691	18	4009	3294	98	2361	1549	258	2779	1180	1135	484	3017	3163	2429	117	154	1179	2159	870	4487	3989
2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	25	18	1	1170	341	18	2244	2563	2169	2413	4358	1360	2472	2549	3327	4403	4422	4450	1312	780	695	4366	1925	1654	218
2092_CCL21 - C-C motif chemokine 21	2092_CCL21 - C-C motif chemokine 21	25	18	1	359	4251	1039	18	255	50	1783	4143	3294	4494	4338	3859	3788	4455	1908	242	234	3621	1682	2577	431	3228
2377_IDUA - alpha-L-iduronidase	2377_IDUA - alpha-L-iduronidase	25	18	1	3057	466	4716	3371	4490	4207	18	1640	1594	4615	3674	2628	1710	3926	3507	2667	3786	3800	1205	2835	1786	2709
3977_Lean body mass (whole body)	3977_Lean body mass (whole body)	25	18	1	689	1350	4588	3641	1654	1251	3498	18	3592	2127	911	2601	2332	2654	1353	1977	110	543	987	1799	41	116
891_Phospholipids in large HDL	891_Phospholipids in large HDL	25	18	1	4404	2852	4308	4550	765	3453	1096	2975	18	695	419	1741	2360	3405	3814	853	1720	617	1955	3715	1200	3825
3907_Intraocular pressure	3907_Intraocular pressure	25	18	1	346	1257	4014	1626	764	2763	1888	3665	90	18	2153	3858	4117	959	2102	2075	1964	1908	3245	1336	3550	1024
4672_Body of corpus callosum axial diusivities	4672_Body of corpus callosum axial diusivities	25	18	1	2291	3661	3993	3972	1988	3405	238	1212	4619	413	18	4116	301	3061	2157	3161	2413	296	4119	209	4086	33
2741_IL25 - Interleukin-25	2741_IL25 - Interleukin-25	25	18	1	1065	1771	30	2509	1038	2691	107	612	4371	1932	2688	18	20	1572	404	3123	3358	4180	2944	206	3667	1600
625_Xenobiotics::Drug::ibuprofen	625_Xenobiotics::Drug::ibuprofen	25	18	1	3722	58	913	3486	261	4444	2256	614	3215	3884	690	1904	18	473	3855	597	3699	3262	2933	926	2448	3493
2514_CMA1 - Chymase	2514_CMA1 - Chymase	25	18	1	961	3099	1874	2720	1185	3245	4719	3073	2159	1500	4572	1658	1611	18	2310	959	3713	3078	3078	3242	4295	2479
2223_CD97 - CD97 antigen	2223_CD97 - CD97 antigen	24	18	1	3529	4092	2211	2420	156	2943	1429	1207	4048	3788	1315	3700	3450	2277	3059	190	2333	18	1299	2952	3050	1214
2255_RAD51 - DNA repair protein RAD51 homolog 1	2255_RAD51 - DNA repair protein RAD51 homolog 1	25	18	1	1671	4481	2238	398	4016	3065	3310	4543	4624	302	1905	654	2510	518	1574	1943	4018	2283	18	450	464	1955
4326_Depressive symptoms (MA GWAMA)	4326_Depressive symptoms (MA GWAMA)	25	18	1	2653	2459	1043	3680	3014	4464	1504	1839	948	3532	3564	1915	3351	1838	4310	2207	4180	1362	3521	18	4601	106
854_ApoA1	854_ApoA1	25	18	1	1746	729	4502	2061	523	2936	3366	3786	28	1716	3136	460	3878	3588	709	746	3313	1692	1845	1918	18	1341
1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	18	1	3024	4163	2025	4268	2286	1245	1661	855	3308	968	42	2132	4462	3547	835	2065	131	3163	73	4337	583	18
67_Inflammatory Bowel Disease	67_Inflammatory Bowel Disease	25	19	1	19	49	236	40	76	778	4605	343	3657	923	94	1428	261	4117	2155	67	194	4441	2504	176	331	1282
811_::::X-12851	811_::::X-12851	25	19	1	2555	19	2696	4559	1028	4620	1959	3604	2790	28	633	2816	4234	3924	4444	422	2838	54	1764	704	1335	2941
4423_Helicobacter pylori seropositivity	4423_Helicobacter pylori seropositivity	25	19	1	87	4609	19	2613	1492	1637	2669	4108	1648	3577	2347	4513	3164	1915	342	1650	2541	1529	1420	2273	2940	3763
4588_Right medial orbitofrontal	4588_Right medial orbitofrontal	25	19	1	2183	4394	3166	19	484	2023	2100	2449	2408	3838	968	1655	4367	4615	788	246	1884	834	1255	4017	83	3242
3778_Traumatic events - Victim of physically violent crime	3778_Traumatic events - Victim of physically violent crime	25	19	1	1387	1812	929	3026	2237	115	19	307	3532	2002	2317	4668	1843	4391	158	2925	81	314	3105	4358	721	482
1196_Asthma (female)	1196_Asthma (female)	25	19	1	4350	270	2003	1711	1911	1071	1482	19	3359	2921	4449	4736	2012	4691	4093	3332	2445	193	647	4313	833	4260
955_Cholesterol esters in very large HDL	955_Cholesterol esters in very large HDL	25	19	1	882	961	3663	1040	1217	3010	4573	3281	19	388	3305	4365	1258	4651	2555	4682	1915	418	4157	3339	221	4412
2206_CCL4L1 - C-C motif chemokine 4-like	2206_CCL4L1 - C-C motif chemokine 4-like	25	19	1	2434	2490	4022	3236	3672	1601	2332	2034	2178	19	35	349	1136	721	3484	3047	379	2582	3540	823	821	156
3645_Illnesses of mother: Diabetes	3645_Illnesses of mother: Diabetes	25	19	1	3333	274	4594	297	200	3451	3855	4035	1171	592	19	629	4131	1169	1305	133	3133	721	761	3902	112	2584
3638_Illnesses of mother: Heart disease	3638_Illnesses of mother: Heart disease	25	19	1	3103	3106	2386	2820	2092	173	3717	769	2455	335	3220	2668	19	3991	4710	1874	1316	504	3019	2896	778	1762
3966_Asthma (fixed effect model)	3966_Asthma (fixed effect model)	25	19	1	2576	572	766	4539	230	499	1944	912	3438	3539	4288	331	45	1123	19	183	3023	3393	1353	878	2246	1252
2157_IGFBP6 - Insulin-like growth factor-binding protein 6	2157_IGFBP6 - Insulin-like growth factor-binding protein 6	25	19	1	4629	2642	3694	4603	737	3249	1286	1313	2276	2494	4033	1700	150	392	4283	1654	3419	19	4498	666	1100	1324
3449_Impedance measures - Impedance of leg (left)	3449_Impedance measures - Impedance of leg (left)	25	19	1	393	3080	3239	1094	1149	3379	2643	2571	4009	3622	2930	2573	3585	2341	4168	2707	2718	644	19	1218	2402	759
2045_Primary angle closure glaucoma	2045_Primary angle closure glaucoma	25	19	1	2214	1783	729	617	916	1292	372	4537	2077	138	2014	3487	537	2511	3023	3883	747	1234	2932	19	741	895
4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	25	19	1	4507	1296	711	2677	4001	4710	4050	2097	2028	3063	278	2191	95	1236	22	2041	500	281	4566	3198	19	1631
1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	25	19	1	2335	450	272	2115	4010	392	2873	2520	1215	3222	663	2685	3383	1741	1436	2121	859	1750	2014	386	1497	19
1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	25	20	1	3119	20	979	2351	3829	672	3105	3455	108	1407	4111	1478	3821	1748	295	3844	4015	367	2459	1702	1776	4083
1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	25	20	1	323	4597	3742	20	1366	1696	3204	518	3917	1667	96	4566	582	168	843	1707	51	164	602	920	370	1150
1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	25	20	1	2730	3555	3391	4421	1165	55	20	3704	994	441	3455	1941	4293	4712	2218	3842	3560	2195	1495	4170	420	2769
2887_IL34 - Interleukin-34	2887_IL34 - Interleukin-34	25	20	1	1027	1668	3322	2558	192	2280	2066	20	1146	78	1710	3093	2225	2542	1081	193	3111	4448	1382	1073	707	1394
4051_Anterior cruciate ligament rupture (random effect model)	4051_Anterior cruciate ligament rupture (random effect model)	25	20	1	472	2972	1380	1671	1571	370	127	1251	20	22	3940	443	2006	769	1354	4232	476	3199	1075	1083	3139	4141
4293_Depression	4293_Depression	25	20	1	1095	1128	2147	2284	2671	4469	417	4550	1217	20	2671	3962	680	912	3280	1031	3452	3755	649	663	3142	40
264_CD4:%SCM	264_CD4:%SCM	25	20	1	1943	2246	1404	4546	4420	2186	1276	4553	3994	2408	20	3755	1218	944	3116	3858	1587	2592	402	2739	3321	2072
3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	25	20	1	489	2387	200	508	66	606	2359	1177	3098	3302	1892	20	1406	1606	2188	58	31	1577	629	314	762	2955
356_IgG+B:%20+24+27+	356_IgG+B:%20+24+27+	25	20	1	425	4119	3800	4204	434	1948	745	4332	27	1528	3421	248	4674	20	1681	511	244	3066	4556	413	218	451
1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	20	1	687	4464	2477	1086	3497	1871	2186	2683	4450	3303	770	465	286	4738	20	3444	1010	814	3648	2684	867	4027
3938_Bisecting GlcNAc	3938_Bisecting GlcNAc	25	20	1	136	2895	163	455	23	1215	1562	3845	2670	2428	3057	3033	3435	662	369	20	250	503	30	2927	1468	2297
3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	25	20	1	179	1300	4385	1837	61	56	3019	1449	4039	3624	688	1185	3624	3576	3064	54	20	1151	2109	145	564	3963
520_Lipid::Long chain fatty acid::margarate (17:0)	520_Lipid::Long chain fatty acid::margarate (17:0)	25	20	1	279	248	3181	3129	620	4268	4290	1531	2621	553	3450	1338	48	91	3615	1851	2311	20	2823	809	256	1401
1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	25	20	1	1143	891	1156	945	2848	835	2151	2651	2877	2492	115	422	1991	1635	1578	1204	3617	2113	20	845	4456	3613
1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	20	1	3031	2880	3456	1056	2333	257	441	3048	2144	2830	4634	3025	2736	3407	1187	644	229	1479	134	20	2513	2420
3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	25	20	1	1876	182	3411	3357	1879	234	3301	4431	1135	4076	196	4318	2415	3252	1251	1724	1595	4731	1544	1252	653	20
4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	25	21	1	21	189	4273	549	1368	394	2243	3410	4155	1786	349	3798	3784	2256	4284	1735	626	204	2382	656	2288	2699
671_::::X-06350	671_::::X-06350	25	21	1	3143	21	3210	293	1729	675	1460	169	2316	2899	4003	374	1338	3784	2471	2066	740	3701	269	3145	1273	3622
3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	25	21	1	2654	2937	21	3427	3249	2587	2745	1575	2258	2036	1566	2639	2695	1549	2818	2244	3179	956	2816	3741	2179	134
3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	25	21	1	1503	727	523	21	583	2616	3827	1867	1849	2670	759	1670	247	2840	207	369	2529	146	4230	573	2201	1153
3193_Number in household	3193_Number in household	25	21	1	1569	3894	1490	4051	2943	3042	21	3398	3133	3339	118	4255	4724	263	2517	4638	1728	2392	3653	1599	3462	2330
960_Triglycerides in very large HDL	960_Triglycerides in very large HDL	25	21	1	1885	1242	2675	47	939	1212	2054	2339	21	2088	3283	702	1243	1896	3599	3980	1401	2231	2805	1627	4220	1312
2115_EIF5 - Eukaryotic translation initiation factor 5	2115_EIF5 - Eukaryotic translation initiation factor 5	25	21	1	428	953	2319	2399	701	3753	939	130	1629	21	4471	1990	2915	3906	1022	1865	491	3455	1473	1451	1629	566
1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	25	21	1	990	4283	598	1467	4393	87	2350	2025	1564	4582	21	3835	129	3448	4416	4103	71	2286	1638	4705	1877	2217
3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	25	21	1	3832	1507	597	1683	147	1907	1717	1422	4418	3861	546	21	3373	4036	4489	147	2519	3603	307	3980	685	1072
1089_Alcohol dependence	1089_Alcohol dependence	25	21	1	2119	711	703	2962	4271	162	4060	1596	2510	2032	551	4154	1135	21	2705	3668	164	3474	3627	4123	71	3654
873_Glycerol	873_Glycerol	25	21	1	1440	3236	1022	3817	748	739	1996	3450	2888	3896	4364	1841	1421	3303	21	1078	2822	2556	3618	426	1422	3595
1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	25	21	1	2008	625	246	3058	4220	3655	1741	4071	863	2307	1767	491	1399	595	1883	2762	4499	21	3429	106	1934	78
4688_Superior longitudinal fasciculus axial diusivities	4688_Superior longitudinal fasciculus axial diusivities	25	21	1	1926	533	2893	3056	3217	3487	2388	470	3423	4254	930	2192	1383	3599	3648	4277	2064	2867	21	772	26	72
3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	25	21	1	1846	4367	4497	3643	4712	2364	546	3051	4522	1915	144	3026	539	1628	4563	4280	2947	3218	4004	21	2603	523
2586_CHIT1 - Chitotriosidase-1	2586_CHIT1 - Chitotriosidase-1	25	21	1	139	2543	403	2238	1306	1478	3036	3217	2613	1184	374	28	1750	1999	2324	1829	4626	664	1098	1485	521	21
2049_Periodontal complex trait 4	2049_Periodontal complex trait 4	25	22	1	22	1354	3956	1653	3512	2206	2057	3986	2734	1041	2800	471	3712	2552	3856	2258	2894	3052	202	1792	3157	1907
2404_KLK5 - Kallikrein-5	2404_KLK5 - Kallikrein-5	25	22	1	3889	22	2824	2686	1945	1963	1685	3970	4628	4531	2979	734	2323	2142	3677	3545	2090	1218	2811	4450	4544	1862
4610_Cerebellar vermal lobules VIII X	4610_Cerebellar vermal lobules VIII X	25	22	1	3658	4695	22	974	664	1666	4459	2171	2925	1011	1649	1638	1877	2309	2730	513	1488	2489	802	2402	2220	3917
3278_Father still alive	3278_Father still alive	25	22	1	873	1101	1157	22	1293	507	4549	2161	1088	1619	2722	1809	600	1262	54	1738	738	39	1913	2146	3944	2932
267_CD4:%Exhausted	267_CD4:%Exhausted	25	22	1	1376	4745	2943	1894	22	26	1238	1986	2222	837	2908	1387	388	3259	4217	25	42	545	3561	91	2549	2666
2296_CD36 - Platelet glycoprotein 4	2296_CD36 - Platelet glycoprotein 4	25	22	1	3336	1025	2881	2135	1593	3561	22	3663	2176	670	2322	2565	3642	4114	1812	1766	4156	3504	3343	4151	1001	2613
3365_Back pain for 3+ months	3365_Back pain for 3+ months	25	22	1	2278	3015	2987	530	4209	3676	3850	22	3400	1635	4590	2532	4472	3504	1291	1643	4418	3201	2047	2570	4636	1413
2247_NR3C1 - Glucocorticoid receptor	2247_NR3C1 - Glucocorticoid receptor	25	22	1	1002	1742	707	4216	1751	1288	2175	3605	22	3769	377	371	3146	3707	2819	571	451	599	3789	812	1506	733
260_CD8:%TE	260_CD8:%TE	25	22	1	3541	2601	3467	445	2063	1590	327	1086	1142	2655	22	4138	2974	1237	4519	465	1504	1122	841	1726	2443	1040
578_Lipid::Sterol, Steroid::estrone 3-sulfate	578_Lipid::Sterol, Steroid::estrone 3-sulfate	25	22	1	3636	592	4490	2413	2634	347	2454	3294	2020	208	2554	22	2284	80	426	1853	4249	627	3801	2397	3684	2637
3410_Interpolated Year when non-cancer illness first diagnosed	3410_Interpolated Year when non-cancer illness first diagnosed	25	22	2	1821	1639	1208	1256	122	437	3325	2640	2470	3055	4175	2926	22	297	490	87	4289	4056	1131	3100	285	1699
3813_CD4+ T cell level	3813_CD4+ T cell level	25	22	1	360	746	295	2911	32	4084	2678	97	1674	692	3707	408	762	3431	2616	22	4087	641	452	75	4424	2356
1755_Cancer (GEE, adjusted for age and sex)	1755_Cancer (GEE, adjusted for age and sex)	25	22	1	1639	3514	1291	1523	3254	510	934	3288	1481	1036	479	1240	1368	4218	1263	1752	3703	22	3952	2816	3000	4707
3637_Illnesses of father: Prostate cancer	3637_Illnesses of father: Prostate cancer	25	22	1	1878	4103	1785	362	2243	1660	3106	117	3470	4627	1152	2061	3009	375	4036	1903	720	683	22	3723	836	1714
3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	25	22	1	4390	2112	228	2267	4362	4317	1046	3488	947	940	4486	1891	238	1214	2737	4600	3664	2814	294	22	1296	4286
86_Lumbar Spine BMD	86_Lumbar Spine BMD	25	22	1	2468	4186	50	1037	521	539	1322	1217	3800	1048	3415	577	973	3530	3797	1366	1016	2549	611	469	22	641
30_Agreablenes (NEO-FFI)	30_Agreablenes (NEO-FFI)	25	22	1	3989	2069	2469	585	1395	1865	2503	4627	4492	580	2067	254	4389	520	1766	622	2734	340	4228	1391	1801	22
1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	25	23	1	23	1471	2816	523	1061	2877	4485	689	459	200	235	1685	434	2369	168	3086	3552	1424	2563	992	3055	3702
691_::::X-11299	691_::::X-11299	25	23	1	1643	23	3292	732	2976	4048	4184	4484	2409	972	1337	1501	4364	3862	1153	2508	1063	3337	1918	4732	3965	2120
3728_Anxiety - Ever worried more than most people would in similar situation	3728_Anxiety - Ever worried more than most people would in similar situation	25	23	1	462	316	23	1692	2754	3146	404	2143	447	3664	3786	2515	634	2266	881	3250	3167	847	3223	2523	1259	2292
4094_Proxy and clinically diagnosed Alzheimer's disease	4094_Proxy and clinically diagnosed Alzheimer's disease	25	23	1	485	4167	3472	4208	323	311	23	4492	155	1076	168	3550	4527	219	3115	156	1781	2327	676	2277	993	514
2574_DDC - Aromatic-L-amino-acid decarboxylase	2574_DDC - Aromatic-L-amino-acid decarboxylase	25	23	1	3510	212	1808	1850	501	3595	4294	23	4279	3886	783	1684	2175	723	3190	518	821	2562	867	344	56	4558
4631_Right lateral ventricle	4631_Right lateral ventricle	25	23	1	2824	1591	4576	113	851	118	1040	3185	23	497	2227	1349	2159	3035	2502	1240	416	2383	45	256	932	4159
4103_Hemoglobin A1c	4103_Hemoglobin A1c	25	23	1	3052	2647	4202	72	2297	3402	3969	3576	3687	23	1676	3918	3148	1522	1374	1339	1402	1325	1393	3748	3370	3949
548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	25	23	1	161	1395	628	1577	1304	404	3915	754	570	1138	2403	23	866	1269	567	1513	1607	761	597	3552	98	4704
2073_FGFR1 - Fibroblast growth factor receptor 1	2073_FGFR1 - Fibroblast growth factor receptor 1	25	23	1	2885	3292	2429	1428	4033	2916	1968	835	3930	2831	1512	4170	926	3271	2928	2222	3518	23	3005	1737	4425	366
4363_Strenuous sports or other exercises	4363_Strenuous sports or other exercises	25	23	1	1252	1997	3515	3066	4331	2091	2471	2420	4442	3877	1821	4239	2179	1639	3952	4245	3834	1120	566	23	3456	2521
4332_Erectile dysfunction	4332_Erectile dysfunction	25	23	1	2499	4060	1290	1082	2214	423	2583	2753	3555	2911	3958	4147	182	1673	1538	3932	2125	2981	2889	3749	23	3841
4024_Excessive hairiness	4024_Excessive hairiness	25	23	1	3558	1810	1770	888	1180	61	660	212	2953	3556	4477	3966	2464	2743	804	598	581	2194	1493	4694	2447	23
3738_Depression - Lifetime number of depressed periods	3738_Depression - Lifetime number of depressed periods	25	24	1	1388	24	894	2111	1116	2564	1978	3470	1804	2114	1379	1073	4335	3895	4099	4029	1225	488	1765	389	827	1690
1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	24	1	4217	2554	24	1764	1721	1346	579	2996	3877	4706	3133	3472	949	2852	1045	2755	1251	3711	1397	3699	2593	2586
1063_Schizophrenia	1063_Schizophrenia	25	24	1	4215	3823	2083	24	1396	975	1526	3050	601	4004	3327	592	662	3212	3218	3312	2827	4608	3524	4289	1540	1439
4227_Immunosuppressants	4227_Immunosuppressants	25	24	1	2274	435	854	560	24	1457	3618	3104	1184	2110	4348	875	4584	720	1882	28	357	1939	280	264	2826	3901
346_NKearly:%337+335+2-	346_NKearly:%337+335+2-	25	24	1	1891	2803	2082	3762	2529	883	24	517	656	803	4336	3759	4016	4215	4194	1400	2412	1617	959	102	1018	3937
1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	25	24	1	1635	994	4466	2064	3160	2837	715	24	3827	4577	2625	4734	4245	3634	4460	2226	3378	3368	3150	607	2551	1713
3758_Anxiety - Recent easy annoyance or irritability	3758_Anxiety - Recent easy annoyance or irritability	25	24	1	399	4068	2957	194	4019	1614	4489	3058	24	1675	4333	1061	4214	2912	2403	2759	2101	2463	3444	554	1446	1642
1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	24	1	1887	452	2299	1529	1949	2374	3877	2336	3600	1909	24	2560	4332	3064	4066	4665	2297	4366	3726	61	3162	123
1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	25	24	1	4621	4414	1204	2346	3926	2659	3292	2824	3999	1590	4019	24	3796	1794	931	3670	3890	117	1525	3543	141	90
4107_Albumin/globulin ratio	4107_Albumin/globulin ratio	25	24	1	4482	2805	430	827	1977	2715	4142	2017	3633	2076	239	692	24	794	1315	1683	3996	977	4059	3105	1044	1386
1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	25	24	1	2359	4646	746	493	4352	4160	633	1822	3270	3970	1107	3942	1799	24	1905	4732	1429	112	4587	4597	3087	162
2936_ANG - Angiogenin	2936_ANG - Angiogenin	25	24	1	449	150	1910	616	2904	113	1059	4097	63	605	2702	3716	679	818	2327	4189	24	1387	2567	3025	814	2207
1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	24	1	3100	1660	505	1275	995	1728	4472	2690	3252	875	1002	107	1541	4719	1899	1704	1289	24	755	308	4559	4614
1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	25	24	1	2724	1143	2834	1394	2895	1968	3083	4306	3540	2232	218	4322	4576	2907	213	3303	2252	3490	24	2722	478	754
8_Major depressive disorder	8_Major depressive disorder	25	24	1	610	4509	1819	45	4264	3918	4436	2881	1443	1813	76	1955	3995	2870	3928	1020	4446	4733	245	24	1589	3290
1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	24	1	3222	2857	1944	2784	2320	132	3418	1139	4353	3576	299	1378	832	2641	1661	2495	880	556	712	1863	24	1106
167_Waist circumference	167_Waist circumference	25	24	1	2198	39	1736	998	2028	2775	3642	136	3570	2643	3023	427	3388	90	2980	2676	4485	4723	2062	1942	3320	24
3144_ANXA6 - Annexin A6	3144_ANXA6 - Annexin A6	25	25	1	25	3190	875	2646	1448	4543	3571	4092	2342	2758	2743	2702	4732	1193	2651	4512	2539	2618	923	3627	4089	2783
3361_Neck/shoulder pain for 3+ months	3361_Neck/shoulder pain for 3+ months	25	25	1	3106	25	239	4343	2225	530	2407	4093	323	743	2346	1766	1549	814	2160	3028	41	173	3013	3691	2650	3749
832_::::X-14086	832_::::X-14086	25	25	1	3628	3326	25	4489	2233	1610	4603	2437	2458	2819	4253	1927	4637	2953	3033	1129	2638	978	3940	1213	4400	1400
2654_CDH2 - Cadherin-2	2654_CDH2 - Cadherin-2	25	25	1	2608	754	1182	25	1596	1981	76	3298	476	1637	962	3350	2511	979	2676	2842	3831	74	3137	2495	674	1485
2793_PON1 - Serum paraoxonase/arylesterase 1	2793_PON1 - Serum paraoxonase/arylesterase 1	25	25	1	3707	3417	4169	2239	4467	4294	25	944	178	1735	2944	3286	2161	2146	3716	3291	4625	1127	4333	4572	482	920
3339_Age when periods started (menarche) (female)	3339_Age when periods started (menarche) (female)	25	25	1	4284	1013	86	2166	4171	3521	4155	25	3677	3465	693	548	1665	152	2759	1426	2136	4660	1834	4391	3878	2456
890_Concentration of large HDL particles	890_Concentration of large HDL particles	25	25	1	4164	621	3158	3672	1089	2215	1447	2942	25	2396	466	3739	2348	2678	1901	1580	1796	822	3570	3967	1951	3569
2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	25	25	1	523	4334	2162	384	1181	45	520	3208	1592	25	1652	1105	1791	3361	192	1047	101	4524	3991	4089	2211	783
1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	25	1	3438	4315	3846	433	571	353	3547	953	755	2710	25	2491	2988	1515	4219	2807	707	3648	1484	4138	2127	83
2556_IFNA2 - Interferon alpha-2	2556_IFNA2 - Interferon alpha-2	25	25	1	2104	4460	2397	1674	3932	358	3815	4701	4445	3457	4254	25	2918	3627	4184	2986	605	2105	2634	4024	1943	1787
676_::::X-08988	676_::::X-08988	25	25	1	4397	2921	3545	4492	2013	2912	358	2913	4170	4011	805	35	25	3314	953	1273	467	4328	2010	624	4576	3070
4225_HMG CoA reductase inhibitors	4225_HMG CoA reductase inhibitors	25	25	1	592	237	2985	41	347	1849	1448	3194	911	1971	4497	795	451	121	25	259	546	2563	2386	2005	1221	1159
580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	25	25	1	3138	1094	62	1932	2599	3928	3694	1593	2820	882	3540	3519	2529	1085	978	1374	2596	25	4607	825	119	4322
1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	25	25	1	3079	2566	2126	1289	4152	2018	324	3318	4001	587	725	299	343	4368	268	2335	3305	172	25	900	2933	1526
2160_OSM - Oncostatin-M	2160_OSM - Oncostatin-M	25	25	1	3693	2884	687	3455	4215	4191	4348	1961	769	2854	3085	3220	2644	4735	3681	4050	2304	3385	3532	2465	25	170
341_NKeff:%314-R7-	341_NKeff:%314-R7-	25	25	1	1337	1371	973	2084	2820	790	3656	1398	1591	3054	441	2689	3144	2386	1201	3984	3234	3372	453	68	1068	25
2974_ANXA1 - Annexin A1	2974_ANXA1 - Annexin A1	25	26	1	26	1077	294	4189	512	538	3195	660	1090	1785	2276	915	503	386	3655	396	4440	790	2002	2234	4631	155
1167_HOMA-B	1167_HOMA-B	25	26	1	3186	26	1222	375	2722	1702	1216	1295	662	1309	186	394	2428	524	4511	2255	342	4500	750	3534	400	1853
2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	25	26	1	560	1501	1858	26	3380	1942	3347	3107	3543	733	4113	403	320	3658	971	2736	1432	3610	1400	1709	479	1036
4300_Vitiligo (early onset)	4300_Vitiligo (early onset)	25	26	1	2424	1075	1293	4608	26	1171	1664	1353	669	2199	4187	3338	4450	207	2789	36	772	1306	827	937	4624	4005
2024_Alcohol dependence	2024_Alcohol dependence	25	26	1	1386	2273	2445	966	3493	476	26	1895	2335	105	288	1750	2424	1285	2931	3784	1104	3498	3896	930	525	3339
3302_Seen a psychiatrist for nerves, anxiety, tension or depression	3302_Seen a psychiatrist for nerves, anxiety, tension or depression	25	26	1	3216	3918	1397	230	2593	4577	3034	26	115	301	3864	3421	506	1729	547	1622	1640	3203	4047	4169	3033	4407
877_HDL diameter	877_HDL diameter	25	26	1	2385	407	4185	4403	569	3855	1004	3158	26	3120	1488	4265	3188	2398	288	1111	3833	1144	4162	3714	3194	3787
2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	25	26	1	86	1703	4030	3458	3706	745	502	3300	4248	26	1461	278	786	660	4674	4321	336	2347	4706	4340	1489	2117
1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	25	26	1	2811	1706	2783	188	1068	2110	3098	360	2683	1654	26	2930	3205	3561	2071	2154	147	381	2839	191	1463	1306
532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	25	26	1	2082	3175	3541	4467	1270	1085	3339	648	4518	2889	4102	3403	26	1315	2217	1324	61	2527	2654	4714	190	1512
169_Waist circumference (male)	169_Waist circumference (male)	25	26	1	1757	585	2070	3684	2369	3423	1842	450	2989	2683	3503	3337	3873	26	4108	3922	2289	4489	4382	2230	4532	26
3969_Asthma (random effect model)	3969_Asthma (random effect model)	25	26	1	3660	487	639	3640	154	415	2191	1448	4441	4643	3172	820	213	485	26	135	3795	4652	1225	336	4070	804
3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	25	26	1	939	1271	360	245	27	1665	487	4441	190	2445	4268	210	218	1537	3972	26	1044	4743	2707	623	1433	1111
4179_Mean corpuscular hemoglobin concentration	4179_Mean corpuscular hemoglobin concentration	25	26	1	4673	2180	2417	2974	690	232	2795	3418	2445	2425	3640	601	1488	3855	2244	1541	26	3560	776	1746	276	1445
92_Birth weight	92_Birth weight	25	26	1	4079	863	1239	1403	2187	1072	2642	1733	1061	1186	3935	4410	2170	1496	4136	2196	4168	26	2146	2419	210	3269
2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	25	26	1	2121	51	4682	2645	2156	3340	1917	3787	3805	2205	4048	4236	4046	1303	2103	1596	860	2969	65	26	80	2358
4027_Alcohol dependency (full discovery samples)	4027_Alcohol dependency (full discovery samples)	25	27	1	27	1600	1856	3604	1367	1177	357	1545	2523	278	3108	775	3402	4663	4388	4400	2375	4626	1124	3245	4678	1360
3742_Depression - Feelings of tiredness during worst episode of depression	3742_Depression - Feelings of tiredness during worst episode of depression	25	27	1	1903	3682	27	3194	4126	333	782	115	2608	2269	831	412	3004	2970	4137	2396	3949	1730	156	4560	395	2529
2031_Inflammatory Bowel Disease	2031_Inflammatory Bowel Disease	25	27	1	118	250	33	27	86	1280	4212	380	4738	843	280	3658	826	3018	1773	77	353	4445	2830	188	591	525
4187_HbA1c	4187_HbA1c	25	27	1	79	1121	3109	3824	3322	27	148	1552	2594	3770	347	413	2341	89	4412	1391	4546	2856	90	4081	1014	2790
2655_CA9 - Carbonic anhydrase 9	2655_CA9 - Carbonic anhydrase 9	25	27	1	568	617	1443	3047	2442	295	27	1233	1277	3785	820	2472	191	4053	822	3318	1293	3604	4540	27	4503	147
4545_Total brain volume	4545_Total brain volume	25	27	1	1465	3770	4353	2378	336	1327	588	27	4642	845	2639	2454	2116	777	3672	425	2549	250	654	2407	3547	390
1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	27	1	331	1602	4136	4138	528	4360	2285	1157	381	27	2644	2659	1020	4726	3631	788	225	598	4053	3124	2500	3239
2502_TPSG1 - Tryptase gamma	2502_TPSG1 - Tryptase gamma	25	27	1	4095	2463	968	4392	1263	182	137	1534	2431	2873	1530	27	1729	3438	1930	1243	2397	3807	3275	2584	1970	2347
796_::::X-12728	796_::::X-12728	25	27	1	3855	1295	2531	3674	1103	4042	2877	1042	2236	437	2512	2500	27	3557	1751	1272	3085	3016	1403	2519	2517	2455
2699_SEZ6L2 - Seizure 6-like protein 2	2699_SEZ6L2 - Seizure 6-like protein 2	25	27	1	3680	2938	2093	466	4498	4408	1834	1322	809	3323	4707	904	3359	27	1076	1044	1528	794	2321	2966	2604	4579
2633_IFNGR1 - Interferon gamma receptor 1	2633_IFNGR1 - Interferon gamma receptor 1	25	27	1	2262	413	3968	2713	2630	2011	329	29	4260	2788	4371	1265	980	835	27	3940	3004	3156	1814	146	3674	1473
3820_Type 1 Diabetes	3820_Type 1 Diabetes	25	27	1	2505	2876	262	1286	31	393	2906	1846	699	3161	4440	2114	4126	1195	331	27	968	3310	3929	532	1219	1656
2364_ULBP1 - NKG2D ligand 1	2364_ULBP1 - NKG2D ligand 1	25	27	1	929	2741	4023	1643	2260	519	4130	765	2072	4075	535	3202	1615	4313	4101	2306	1487	27	3632	249	4646	4247
2368_DDX19B - ATP-dependent RNA helicase DDX19B	2368_DDX19B - ATP-dependent RNA helicase DDX19B	25	27	1	890	1758	1836	808	3158	4527	1824	1372	625	1569	3914	132	576	2944	2228	1411	603	4512	27	457	805	2554
495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	25	27	1	4312	652	843	4221	2706	2362	1126	2224	4374	646	3639	4468	3177	750	2314	4004	2790	2771	645	713	27	604
4090_Family history of Alzheimer's disease	4090_Family history of Alzheimer's disease	25	28	1	28	4388	4432	1760	505	891	369	2525	184	2733	3991	2717	1361	106	2821	334	598	3287	1469	4388	4017	1002
80_Femoral Neck BMD	80_Femoral Neck BMD	25	28	1	4709	4598	2530	28	2134	1141	1116	2283	193	475	2350	1704	929	4399	4728	3067	1393	2006	1991	3186	44	4571
4325_Neuroticism (MA GWAMA)	4325_Neuroticism (MA GWAMA)	24	28	1	4384	1715	619	1976	4702	28	1227	251	1125	47	3565	4652	499	4676	2716	3021	643	4525	3894	1032	1876	1241
4058_Estimated glomerular filtration rate based on serum creatinine	4058_Estimated glomerular filtration rate based on serum creatinine	25	28	1	1791	2087	2345	4220	3144	3171	28	3752	2337	1010	622	2706	890	3503	1972	1881	782	370	217	504	2637	3372
1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	28	1	4172	2107	1688	3638	2203	3355	1122	3890	2054	1582	28	1429	875	3976	1453	1904	4147	522	1258	3116	3265	3261
3241_Salad / raw vegetable intake	3241_Salad / raw vegetable intake	25	28	1	1091	83	1909	4733	1468	267	120	2666	3321	1727	516	31	1351	28	1389	1036	3968	2857	4520	3829	2530	2591
3651_Illnesses of siblings: High blood pressure	3651_Illnesses of siblings: High blood pressure	25	28	1	475	4663	2081	1499	1392	3420	4353	3712	1771	2947	3237	551	2065	2618	28	731	691	3254	2809	3409	3562	2179
3700_Diagnoses - secondary ICD10: M13 Other arthritis	3700_Diagnoses - secondary ICD10: M13 Other arthritis	25	28	1	3565	1364	1019	2124	4145	3859	1285	3110	2164	3287	2165	2839	1536	4664	541	2923	3598	28	4378	1482	498	653
423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	25	28	1	1457	1726	4370	4155	3213	1001	3881	2029	2481	1119	1376	2822	2476	1080	3228	1076	2296	857	28	1229	4420	1984
2734_FGF6 - Fibroblast growth factor 6	2734_FGF6 - Fibroblast growth factor 6	25	28	1	1153	37	851	712	3491	1945	4718	3630	4095	1275	1218	2019	1303	1102	1227	3302	4114	4421	2469	1050	3982	28
1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	25	29	1	29	4005	2854	667	1082	1274	379	3038	164	3080	3700	119	4114	137	2049	472	2034	4717	3461	2643	2285	593
3557_Medication for pain relief, constipation, heartburn: Aspirin	3557_Medication for pain relief, constipation, heartburn: Aspirin	25	29	1	4245	29	4556	2069	376	1170	4677	428	1876	934	542	181	485	2922	4441	554	1314	2089	4003	3647	4344	3231
4226_Thyroid preparations	4226_Thyroid preparations	25	29	1	1773	273	29	2433	39	288	1550	544	1627	598	4474	4516	3041	1663	1957	40	166	3522	2855	268	4389	2765
344_NKearly:%335+314-	344_NKearly:%335+314-	25	29	1	1484	171	866	29	3515	562	257	1683	827	1110	959	2821	2501	1672	2151	1982	3899	2532	4107	46	1069	197
4265_Ankylosing spondylitis	4265_Ankylosing spondylitis	25	29	1	1585	4188	3252	576	29	1306	1449	1650	1261	1000	3763	2915	2285	3850	4060	41	2159	257	101	4298	1612	259
2208_CCL8 - C-C motif chemokine 8	2208_CCL8 - C-C motif chemokine 8	25	29	1	4057	3676	2157	3127	3311	29	3714	3537	2215	3923	489	4256	1539	4194	2649	2144	54	1973	3699	3658	3831	2167
3306_Ever had same-sex intercourse	3306_Ever had same-sex intercourse	25	29	1	672	2278	2228	2471	2291	4580	29	4570	1091	1793	286	3715	4188	2706	3163	4308	3653	342	2333	3711	1222	3582
1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	25	29	1	1106	3711	3824	3175	1701	3963	1677	35	29	3783	4669	863	3243	3934	562	4671	607	873	819	301	974	3785
1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	25	29	1	1187	1547	4039	3710	925	3680	4364	2027	2218	29	4458	4094	3931	2008	1330	1549	2116	3460	2591	3184	3025	4167
70_Low-density lipoprotein cholesterol	70_Low-density lipoprotein cholesterol	25	29	1	975	40	371	1540	1335	123	3736	534	52	672	29	1335	4699	4546	335	1202	507	3774	793	4109	145	2912
857_Ratio of bisLallylic bonds to total fatty acids in lipids	857_Ratio of bisLallylic bonds to total fatty acids in lipids	25	29	1	1382	4640	2062	2143	1379	3137	1565	556	2165	1258	1111	3089	29	2492	58	2770	1783	4030	1004	4221	1026	548
1151_Disposition index	1151_Disposition index	25	29	1	1792	1016	2682	3788	2701	3265	243	2570	3856	801	2761	3592	3175	2817	29	4028	2792	2872	3465	2279	3202	2470
2030_Ulcerative colitis	2030_Ulcerative colitis	25	29	1	247	429	1006	1075	38	583	3391	644	1770	3944	965	76	3952	776	459	29	245	3819	571	248	2273	2202
3364_Age last used hormone-replacement therapy (HRT) (female)	3364_Age last used hormone-replacement therapy (HRT) (female)	25	29	1	2223	4441	4248	4443	1914	396	616	480	66	1245	2445	4703	1555	2300	488	3853	4064	29	2523	2673	2007	3619
335_NKeff:%314-158a+	335_NKeff:%314-158a+	25	29	1	3231	457	1446	788	1782	4739	495	4161	3697	3471	3688	2979	3612	1502	792	3438	2430	385	29	1306	2870	3082
4680_Inferior fronto-occipital fasciculus axial diusivities	4680_Inferior fronto-occipital fasciculus axial diusivities	25	29	1	3070	1429	4607	3345	1238	258	2998	336	832	2693	1447	3332	1935	2526	4144	3082	4442	4511	133	2492	29	3530
3441_Impedance measures - Body fat percentage	3441_Impedance measures - Body fat percentage	25	29	1	4166	2206	1311	1584	4299	3316	2252	183	4359	3652	2056	3710	4640	101	3788	4055	4293	3318	872	3936	503	29
1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	25	30	1	30	2815	999	477	1073	760	4026	2734	733	4124	558	526	2318	1852	183	4165	1203	1426	4010	1586	880	136
4204_Estimated glomerular filtration rate	4204_Estimated glomerular filtration rate	25	30	1	1802	30	3532	3827	3516	3621	274	4277	3644	1767	2598	3302	1480	4115	1937	3465	1193	1318	2845	3036	2925	937
3601_Non-cancer illness code, self-reported: diabetes	3601_Non-cancer illness code, self-reported: diabetes	25	30	1	2891	4226	348	30	49	1635	675	1800	3631	4495	3672	50	2591	3720	2642	51	481	2010	1251	124	979	1602
1085_Behcet disease	1085_Behcet disease	25	30	1	2598	3578	4390	985	30	2258	2451	3056	3651	507	2622	1385	4643	437	4449	33	2256	1530	2295	3035	966	4539
488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	25	30	1	512	4621	36	4739	2894	30	4105	3419	1100	3261	1794	184	2413	341	2272	2700	32	3818	1324	237	1351	3672
3631_Illnesses of father: Bowel cancer	3631_Illnesses of father: Bowel cancer	25	30	1	2023	1024	3363	3124	616	2853	3478	30	1581	2407	550	2342	1109	4303	3609	517	1241	421	2095	3400	3284	510
2052_Age-related Macular Degeneration	2052_Age-related Macular Degeneration	25	30	1	2539	1937	915	1623	318	4120	723	2795	30	1816	1285	2065	62	3751	1088	961	2366	2936	4463	2920	1055	2124
3093_SCARF2 - Scavenger receptor class F member 2	3093_SCARF2 - Scavenger receptor class F member 2	25	30	1	968	4616	3658	1627	285	110	4739	1581	4060	30	1238	3817	390	717	1190	229	187	1561	1599	1780	442	1621
2777_FER - Tyrosine-protein kinase Fer	2777_FER - Tyrosine-protein kinase Fer	25	30	1	3308	2140	2315	4112	2171	3958	3701	3420	2646	3038	30	2020	942	3083	2753	4034	3119	509	3190	3372	1854	1156
2238_SPINT2 - Kunitz-type protease inhibitor 2	2238_SPINT2 - Kunitz-type protease inhibitor 2	25	30	1	3068	3021	4253	4282	2070	699	2418	2955	1482	4400	875	30	306	3575	2626	1843	2602	4371	2963	2964	4483	739
4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	30	1	2391	3063	3282	3106	2393	2896	689	4657	3825	407	686	1114	562	30	1155	1777	1384	4647	1812	2089	4196	2727
3920_Total cholesterol	3920_Total cholesterol	25	30	1	1207	1303	364	3197	361	72	3358	253	105	548	136	1693	188	203	30	867	1772	2975	1009	2052	282	806
2034_Primary sclerosing cholangitis	2034_Primary sclerosing cholangitis	25	30	1	2311	644	525	2816	33	505	403	1878	343	614	3247	3328	2534	1960	2375	30	1395	2354	2430	459	4406	1556
783_::::X-12524	783_::::X-12524	25	30	1	1036	3406	3321	1921	1398	32	3385	1532	411	4668	2129	150	556	971	1490	346	30	3110	3374	1509	947	4044
4019_Age spot	4019_Age spot	25	30	1	3091	1514	3453	3574	1309	3535	909	2722	2099	3000	1558	622	4515	2631	375	1495	1732	30	910	1093	2022	3510
1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	25	30	1	49	943	3778	406	610	2969	1258	4018	1345	112	2904	825	3745	321	663	502	525	557	3857	3441	4356	30
3806_White blood cell count	3806_White blood cell count	25	31	1	31	4182	1917	4745	271	4247	4625	2083	3518	4236	68	2497	1718	1258	233	370	4549	3927	1626	2547	3111	1498
3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	25	31	1	351	31	1698	2910	1381	3391	3632	3273	1167	364	788	791	4533	3939	1705	2026	508	1458	4221	4481	1510	1571
2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	25	31	1	3062	211	31	2956	562	568	699	3648	2920	4315	2064	3801	531	3411	4706	479	3120	4162	683	2060	3416	4474
2263_CCL28 - C-C motif chemokine 28	2263_CCL28 - C-C motif chemokine 28	25	31	1	1582	2982	658	31	3113	2804	1875	1602	433	3637	3312	2138	2220	3600	2677	710	3087	907	4512	4617	4274	2861
2530_KLK6 - Kallikrein-6	2530_KLK6 - Kallikrein-6	25	31	1	2917	3074	1806	1537	2127	31	1543	119	3895	1288	712	435	2976	2045	715	2518	3082	1841	3861	3998	1097	938
34_Alzheimer's disease	34_Alzheimer's disease	25	31	1	223	3696	431	4222	319	911	31	4516	298	1383	83	4514	2640	221	4494	174	1467	2134	995	901	3099	1507
4228_Anti-inflammatory and antirheumatic products, non-steroids	4228_Anti-inflammatory and antirheumatic products, non-steroids	25	31	1	4144	1985	4382	641	3886	2829	2941	31	4286	1009	4714	4548	1031	3446	1295	3024	3736	1238	517	468	243	1088
1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	25	31	1	3864	4429	72	1957	1076	1826	3847	333	31	1891	806	2372	4434	4709	271	1203	78	3887	825	2961	3081	3897
1888_Shaft Width (FBAT, female, adjussted for age)	1888_Shaft Width (FBAT, female, adjussted for age)	25	31	1	3343	353	596	3375	4578	2104	2488	2650	144	31	1947	4452	939	4082	3829	3919	2761	2076	1245	634	191	1044
487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	25	31	1	1461	3529	2556	763	2090	1947	2785	76	675	128	1050	3082	2258	31	1248	1013	434	2554	538	810	127	1321
4222_Beta blocking agents	4222_Beta blocking agents	25	31	1	47	4052	719	4459	507	1208	201	3582	3474	4470	2645	160	4673	4336	31	3215	43	4042	4439	4010	2172	1654
3486_Bread type: Brown	3486_Bread type: Brown	25	31	1	3661	434	1234	2600	1569	4242	1686	1458	474	3060	1391	2779	285	1797	4083	2505	4663	31	4123	185	1246	3461
4168_Open-angle glaucoma (fixed-effect model)	4168_Open-angle glaucoma (fixed-effect model)	25	31	1	3719	1637	3044	1325	493	368	2094	490	4022	3122	2698	572	874	4069	2039	793	2971	1551	31	2404	3558	129
1168_HOMA-IR	1168_HOMA-IR	25	31	1	2000	2725	2798	4568	1467	1211	2437	398	1903	4264	324	2254	73	2315	3550	2105	1447	4285	1910	4399	31	3226
160_Hip circumference (female)	160_Hip circumference (female)	25	31	1	1800	328	327	2165	1461	4181	3771	514	3862	2333	450	4660	2851	87	1393	3768	2826	3352	3566	1846	3003	31
1964_MMSE score (at exam 5, FBAT, adjusted for age)	1964_MMSE score (at exam 5, FBAT, adjusted for age)	25	32	1	32	4743	1383	2688	793	2917	4521	906	641	3092	1873	38	1234	1692	2938	768	254	4623	2786	1249	4370	2812
3732_Depression - Fraction of day affected during worst episode of depression	3732_Depression - Fraction of day affected during worst episode of depression	25	32	1	3482	32	1780	1382	3185	1962	97	1334	2410	1176	3785	3521	2662	1743	275	2934	3618	4526	3849	2357	2054	3287
2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	25	32	1	211	4480	32	1735	4049	1179	3233	3824	1614	4462	2041	1491	3102	1420	2025	4443	4090	2712	4370	2758	2946	2119
4634_Right cerebellum white matter	4634_Right cerebellum white matter	25	32	1	1627	3703	4361	32	2425	4632	381	1865	3105	280	2449	1323	3211	1478	784	1805	3934	2379	2182	2497	1392	557
2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	25	32	1	758	1871	4380	3886	967	43	32	1154	426	33	3389	2868	2940	1047	1066	716	477	286	2058	1493	3438	2833
4163_Generalized epilepsy with tonic-clonic seizures	4163_Generalized epilepsy with tonic-clonic seizures	25	32	1	3153	3289	753	4329	4527	1672	482	32	1696	781	1089	2962	1422	4281	3057	3106	2637	863	4708	1179	3070	2928
2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	25	32	1	1500	3508	617	278	658	1411	237	396	32	236	418	1987	3711	897	3394	1480	1554	4219	2169	1912	3672	4593
4278_FEV1	4278_FEV1	25	32	1	3936	693	3165	2293	1527	2250	1000	2607	151	32	3328	3926	2131	2502	2044	1649	1097	4244	177	3960	3618	153
3296_Risk taking	3296_Risk taking	25	32	1	2677	3265	2641	2426	1832	818	3060	4338	3586	2525	3205	32	175	2033	4341	2046	2356	174	1407	2860	4680	3357
2171_EPOR - Erythropoietin receptor	2171_EPOR - Erythropoietin receptor	25	32	1	147	4671	412	565	774	4014	4035	3075	2293	3781	2201	3430	32	2561	1907	1792	1431	2851	128	3238	441	3590
66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	25	32	1	1244	2184	1503	2273	2568	3016	2855	2030	2104	4585	4385	2414	4065	768	32	4580	1286	2529	2149	1791	2318	207
3823_Systemic Lupus Erythematosus	3823_Systemic Lupus Erythematosus	25	32	1	3514	4356	700	1332	36	4503	204	2502	120	2010	2527	2918	2148	1433	811	32	667	1543	687	139	2869	2474
2069_FLT4 - Vascular endothelial growth factor receptor 3	2069_FLT4 - Vascular endothelial growth factor receptor 3	25	32	1	4024	343	3466	2004	2114	4093	385	3496	3095	3732	3280	3862	2638	1466	1800	1067	4319	32	3974	4489	919	4007
3450_Impedance measures - Impedance of arm (right)	3450_Impedance measures - Impedance of arm (right)	25	32	1	969	4265	1498	3020	1512	1694	3729	3868	4714	979	4593	3580	2996	4666	3461	2479	4523	3922	32	1027	3204	2205
2155_C3 - Complement C3b, inactivated	2155_C3 - Complement C3b, inactivated	25	32	1	635	3379	831	80	874	181	4537	570	3883	4064	3471	2027	241	1477	4209	1318	83	1076	2669	32	1515	1510
1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	25	32	1	3724	3366	1492	1594	4348	217	3111	3283	2500	1450	3702	363	2362	4246	2664	1087	129	181	3273	1024	32	2612
474_Lipid::Bile acid metabolism::ursodeoxycholate	474_Lipid::Bile acid metabolism::ursodeoxycholate	25	33	1	33	4468	2483	115	4077	2457	889	2338	1426	3682	2757	389	3961	3814	1452	4039	697	375	2756	3828	2305	1543
2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	25	33	1	569	33	4241	1625	196	2135	462	152	4617	3408	3644	1356	1671	1033	2721	384	1888	1789	2280	3084	2574	2581
2454_CADM1 - Cell adhesion molecule 1	2454_CADM1 - Cell adhesion molecule 1	25	33	1	2111	2307	2561	33	4613	4534	3870	3171	4555	858	4094	2322	4526	2708	3245	4598	1252	1847	4060	1065	1432	4572
3338_Years since last cervical smear test (female)	3338_Years since last cervical smear test (female)	25	33	1	3237	3287	1765	1954	1612	33	45	4090	368	1403	3452	4208	1990	1948	3213	448	3332	1072	2838	651	556	176
1055_Inflammatory Bowel Disease	1055_Inflammatory Bowel Disease	25	33	1	733	2679	2735	1259	1196	3644	33	4393	4345	49	584	4549	1479	498	2962	4551	1049	3997	945	200	1126	3275
1033_Neck Section Modulus (GEE, adjusted for age and sex)	1033_Neck Section Modulus (GEE, adjusted for age and sex)	25	33	1	715	3726	2016	2248	2181	1855	3935	2546	33	542	941	4414	279	559	4562	3324	3420	1592	4452	3713	3671	1583
2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	25	33	1	2696	762	3628	1712	1812	3227	2714	2529	3307	3606	1763	33	4096	2403	702	4180	2352	1358	2763	1663	3149	108
3918_High-density lipoprotein cholesterol	3918_High-density lipoprotein cholesterol	25	33	1	1934	924	3962	4030	1253	2384	4562	1928	4588	4272	198	1261	33	2532	1728	4733	3561	3886	3388	2672	1003	1164
2167_SERPINA7 - Thyroxine-Binding Globulin	2167_SERPINA7 - Thyroxine-Binding Globulin	25	33	1	911	580	1038	321	3345	3304	2288	726	1456	3688	3120	2248	2353	33	244	4597	2641	2594	1533	2942	1927	4699
1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	25	33	1	4198	3279	540	3785	1784	479	1423	1779	2883	2215	2742	809	99	3013	2224	1883	33	4547	2361	4389	2114	254
2996_FGFR4 - Fibroblast growth factor receptor 4	2996_FGFR4 - Fibroblast growth factor receptor 4	25	33	1	1848	743	4126	2506	763	3418	3790	2912	1580	469	670	4075	751	2845	2469	779	4029	33	656	4734	2806	2063
3549_Mouth/teeth dental problems: Dentures	3549_Mouth/teeth dental problems: Dentures	25	33	1	930	1265	1319	231	3725	661	1877	1083	931	227	474	934	899	3345	2196	3325	219	4407	33	507	3239	4255
973_Beta nerve growth factor	973_Beta nerve growth factor	25	33	1	2670	3427	4555	1885	2738	431	1306	1956	4223	4361	3184	1556	2378	2295	917	3983	1451	2222	2734	33	1618	4023
2025_10 mg response to amphetamine	2025_10 mg response to amphetamine	25	33	1	965	836	2122	3578	3271	1095	210	2758	4521	121	933	2730	2017	3622	406	3132	2440	249	2438	1215	33	3604
1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	25	34	1	34	1217	3879	4402	1355	1789	1764	3936	344	2258	2901	4051	1960	1143	4020	935	74	4634	235	994	1583	3496
1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	34	1	3713	34	2071	4509	2866	1230	654	4043	2031	1284	1529	2434	4173	1016	3982	3197	522	1766	572	3283	1846	2392
1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	25	34	1	4048	2775	34	4197	2648	775	3700	4407	2885	2755	71	2811	2555	993	2655	987	206	1791	3193	56	3101	122
4329_Fractures	4329_Fractures	25	34	1	4004	409	835	34	1025	4150	716	3988	1330	4179	4164	2031	289	2915	401	1523	3202	1095	171	221	2751	4526
1061_Multiple Sclerosis	1061_Multiple Sclerosis	25	34	1	4718	829	479	81	34	150	2241	2688	1478	2513	3284	749	2533	713	868	43	458	4664	4104	769	2789	2498
1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	25	34	1	2829	1798	1885	4398	1350	34	492	1909	1117	710	2098	1666	4349	1930	2062	4362	377	1769	2263	3759	4087	1689
1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	34	1	3310	3581	1514	3392	2328	1407	34	862	2133	272	591	2991	841	3730	3611	1548	3905	3945	4205	1254	3058	2723
4320_Positive affect (univariate)	4320_Positive affect (univariate)	25	34	1	901	469	985	2326	4505	2072	2957	34	585	264	3495	3425	333	2545	2139	4722	1751	3537	4231	2592	1357	1830
4151_Left ventricular mass index	4151_Left ventricular mass index	25	34	1	2451	174	4671	226	182	3310	3721	1960	34	2146	4283	535	2278	3363	2361	277	172	159	3551	4288	223	2802
3254_Salt added to food	3254_Salt added to food	25	34	1	630	1329	4127	1526	3064	458	733	2647	4544	34	881	3288	1157	1576	853	3090	1185	493	2649	1023	4521	954
2622_CFHR5 - Complement factor H-related protein 5	2622_CFHR5 - Complement factor H-related protein 5	25	34	1	1362	2973	918	745	704	1761	1024	2592	884	3234	34	1595	111	907	2031	905	786	4721	3391	4632	4392	2863
3373_Knee pain for 3+ months	3373_Knee pain for 3+ months	25	34	1	427	2755	1077	714	588	78	4553	779	1180	1573	1470	151	34	1483	3416	776	677	4684	2660	4359	4185	2567
3299_Frequency of tenseness / restlessness in last 2 weeks	3299_Frequency of tenseness / restlessness in last 2 weeks	25	34	1	3574	3405	3375	3229	4014	1308	1660	4479	4545	754	1786	3352	3471	378	2579	2323	3242	34	429	2546	712	431
2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	25	34	1	1144	3634	1487	2183	4610	2339	2493	1844	1655	2743	3912	404	3158	867	755	4413	4472	3976	34	3585	3909	4547
2010_High-density lipoprotein cholesterol	2010_High-density lipoprotein cholesterol	25	34	1	620	2211	2224	4121	3183	3690	3444	1711	400	2038	940	4626	406	689	3633	3244	4213	742	1485	34	2916	2999
3940_Body Mass Index (male)	3940_Body Mass Index (male)	25	34	1	50	181	153	152	1419	1921	268	1037	1449	3695	373	2734	265	891	2237	744	3349	4067	1847	1414	34	3072
668_::::X-06246	668_::::X-06246	25	34	1	771	2638	2313	2419	953	2824	1010	748	3985	3104	1914	1497	2263	547	313	3050	2649	3941	1446	1761	3274	34
2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	25	35	1	35	4089	3251	661	954	3147	241	3066	110	4734	829	1747	761	714	1416	981	3477	4330	3106	3265	1901	2874
756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	25	35	1	935	35	1511	2980	514	4456	254	2665	255	155	2865	4163	492	3524	3174	847	2700	179	4518	2901	2825	4045
309_CD4nv:%Th2	309_CD4nv:%Th2	25	35	1	3526	2080	35	1068	1924	918	4307	1412	4676	1384	2524	3442	3391	4261	2961	1733	1334	4585	362	2975	3317	4744
4016_Central corneal thickness	4016_Central corneal thickness	25	35	1	3440	351	1755	35	700	2736	4685	2257	1288	1037	506	2140	4486	487	1561	663	2727	900	3732	4098	3776	3094
1067_Type 1 Diabetes	1067_Type 1 Diabetes	25	35	1	2947	412	1399	168	35	1329	1603	3629	331	1043	1919	2070	822	1174	236	39	4009	3733	2011	49	1209	1447
1056_Systemic Lupus Erythematosus	1056_Systemic Lupus Erythematosus	25	35	1	1905	1671	397	253	170	35	2405	2417	3038	956	3395	1728	3544	1798	3607	233	784	2794	3172	399	4015	330
3385_Happiness	3385_Happiness	25	35	1	4647	2312	532	3961	221	764	35	3870	1966	2754	1823	3714	4190	3892	830	216	3317	1985	1517	2181	1507	2373
958_Concentration of very large HDL particles	958_Concentration of very large HDL particles	25	35	1	2034	845	1447	924	1877	4020	1814	4698	35	804	3604	2200	4446	1910	204	4602	2590	2059	1885	3028	1121	3681
1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	25	35	1	1432	2886	1455	2983	3275	3923	824	1255	559	35	1137	1199	2197	4230	4418	3734	1801	4632	3112	2300	225	3668
3776_Traumatic events - Been in serious accident believed to be life-threatening	3776_Traumatic events - Been in serious accident believed to be life-threatening	25	35	1	4683	400	539	2783	2317	972	2956	2723	2060	2992	778	2792	35	3733	1603	1798	539	3392	4225	1219	273	2724
2166_CCL25 - C-C motif chemokine 25	2166_CCL25 - C-C motif chemokine 25	25	35	1	1703	1538	122	1081	1257	1793	3948	3971	4049	3416	3150	478	4209	35	1154	1639	590	4044	4124	1481	4376	2048
3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	25	35	1	2866	821	3302	1271	1622	705	1767	1420	1638	2944	3307	1603	705	4565	35	463	516	1600	4346	3267	2590	4143
69_Ulcerative Colitis	69_Ulcerative Colitis	25	35	1	41	178	47	668	45	602	3206	1556	2732	2720	2190	215	4256	1706	998	35	426	1687	4166	55	411	4306
1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	25	35	1	3300	3689	2794	2981	1557	494	2088	3022	70	2415	4695	204	3486	1784	1348	1302	35	3915	1842	152	1648	1877
1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	25	35	1	1741	752	928	1803	1774	1279	3872	749	500	1515	3841	2594	79	1223	3987	4711	2213	35	3412	530	1088	1702
3451_Impedance measures - Impedance of arm (left)	3451_Impedance measures - Impedance of arm (left)	25	35	1	852	3518	633	2700	1560	2380	2617	1558	2581	648	4152	4089	4211	3777	2313	2965	4741	3673	35	927	3285	1888
1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	35	1	1712	2686	964	3965	4381	2684	1682	1225	4017	688	2191	1290	2494	3671	4557	2670	2357	3804	741	35	803	2491
3046_CD55 - Complement decay-accelerating factor	3046_CD55 - Complement decay-accelerating factor	25	35	1	1544	2696	775	1725	3804	1196	4516	4497	365	4508	1593	982	344	3807	3267	3987	44	2743	3236	2635	2533	35
4601_Right rostral middle frontal	4601_Right rostral middle frontal	25	36	1	36	3757	2196	3379	1816	2223	225	2750	3333	1688	3082	4379	2238	4637	4138	2507	303	3283	1201	2336	3538	2982
2735_FN1 - Fibronectin	2735_FN1 - Fibronectin	25	36	1	3757	36	2191	520	4401	1193	255	4612	3926	390	1998	4120	2960	691	2118	1775	3041	3718	3916	3011	3312	2146
2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	25	36	1	1100	4642	1083	36	1106	2949	2330	980	3546	3538	4685	391	4685	2095	1019	2830	2716	198	214	728	1397	3406
804_::::X-12798	804_::::X-12798	25	36	1	803	1819	4442	4460	2906	36	1379	981	1232	4562	4278	2047	1467	61	1885	1761	2731	4574	2661	215	4227	426
1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	25	36	1	1029	1313	1576	4485	2987	2106	321	36	4391	4086	3218	3187	2143	4157	4737	1540	3178	3854	3686	1444	3913	722
73_Total cholesterol	73_Total cholesterol	25	36	1	1160	289	2383	458	475	274	1652	1027	36	705	1797	874	935	272	357	1557	2302	4256	1310	1822	1316	775
4007_Osteoarthritis of hip (hospital diagnosed)	4007_Osteoarthritis of hip (hospital diagnosed)	25	36	1	4599	2436	3780	528	2238	642	823	559	4100	36	1780	2108	1883	1892	1599	4469	3290	2654	881	4051	3663	2692
3576_Social support - Leisure/social activities: Sports club or gym	3576_Social support - Leisure/social activities: Sports club or gym	25	36	1	525	2189	2626	3193	1123	3597	2487	331	3129	3213	36	205	1518	1575	1422	631	190	2430	1539	1296	2354	4280
574_Lipid::Sterol, Steroid::cortisol	574_Lipid::Sterol, Steroid::cortisol	25	36	1	1961	2615	1471	4481	2329	1845	4362	3653	4101	2483	3053	36	2187	1292	1878	3345	1649	244	1358	1937	2373	2780
1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	36	1	3390	864	2467	1162	3966	3091	4042	3899	54	1271	1514	4455	36	665	2311	2734	4228	3477	3629	3501	2191	295
1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	25	36	1	2888	971	4707	4661	779	4736	516	3978	3508	2379	2615	730	1879	962	36	349	561	1205	2643	3838	4280	2133
4666_Superior longitudinal fasciculus fractional anisotropy	4666_Superior longitudinal fasciculus fractional anisotropy	25	36	1	2573	2483	4135	3108	4688	85	3273	3109	3802	2975	1590	2305	417	2463	2715	2254	36	1698	2920	3459	3762	972
2623_IGF2R - Cation-independent mannose-6-phosphate receptor	2623_IGF2R - Cation-independent mannose-6-phosphate receptor	25	36	1	1588	1315	864	2278	3576	1157	3778	3248	98	3468	3039	1985	931	1322	976	4233	1584	36	1405	598	2441	630
1840_Neck width (FBAT, male, adjusted for age)	1840_Neck width (FBAT, male, adjusted for age)	25	36	1	237	192	1323	4024	356	4551	394	539	3905	3336	88	3372	370	3276	262	247	2877	947	36	4083	755	3553
437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	25	36	1	683	2649	1933	3932	2774	3438	960	3931	4327	281	4275	1220	3191	2394	1232	4603	3050	1086	2875	2576	36	3426
4735_Anterior corona radiata radial diusivities	4735_Anterior corona radiata radial diusivities	25	36	1	3301	1282	4741	3471	1838	131	2691	1064	2765	899	3020	1172	1104	901	3590	2909	655	3937	700	3818	1017	36
4157_Focal Epilepsy	4157_Focal Epilepsy	25	37	1	37	209	1387	422	3223	1375	2960	1101	3689	1580	2593	732	445	3793	3803	4049	1362	3579	4663	988	3974	1725
1126_Visceral adipose tissue sttenutation	1126_Visceral adipose tissue sttenutation	25	37	1	3828	4680	37	739	328	723	177	4518	3838	4359	2813	4106	3187	3299	1609	946	3562	3083	3529	2345	1307	3987
298_CD4mem:%preTh17 (2)	298_CD4mem:%preTh17 (2)	25	37	1	130	1116	1106	37	2727	380	4317	3495	1301	51	3484	2563	2466	3099	4411	2124	4230	116	75	4011	1672	2166
3832_Vitiligo	3832_Vitiligo	25	37	1	4592	3787	492	1941	37	164	957	1168	162	3994	4234	2014	3659	398	3768	42	1140	3033	4209	521	4049	2933
2006_Paternal transmission distortion	2006_Paternal transmission distortion	25	37	1	1137	2963	98	2361	2433	37	4519	1681	3876	3506	3157	657	4021	290	319	1311	226	1161	153	3777	634	2178
2940_GDF2 - Growth/differentiation factor 2	2940_GDF2 - Growth/differentiation factor 2	25	37	1	2763	439	2063	2862	712	3818	37	3598	3760	463	2339	4520	4142	4252	710	955	4016	2193	3425	1102	2400	3696
4328_Estimated bone mineral density from heel ultrasounds	4328_Estimated bone mineral density from heel ultrasounds	25	37	1	3169	3675	193	1383	1442	1270	2627	37	3269	1432	1190	640	2498	2424	1421	2920	1115	4206	1038	508	480	964
4699_Fornix (column and body of fornix) mean diusivities	4699_Fornix (column and body of fornix) mean diusivities	25	37	1	1695	2946	4219	1930	1236	3254	234	4115	37	4545	4330	684	3443	2129	634	2493	3948	1055	178	2636	4655	1894
1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	37	1	4456	3566	2630	3417	1136	1928	340	2378	3317	37	545	2349	2981	1129	3812	2136	2294	3712	1119	4247	3571	2187
3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	25	37	1	1371	4386	2311	105	151	3632	816	950	2468	3581	37	1674	3068	66	4681	96	261	258	1373	1136	3191	515
456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	25	37	1	793	3742	930	4299	4699	3308	4622	2041	2644	1454	345	37	1733	4707	3022	690	668	692	3192	309	2357	1183
2758_TGFB2 - Transforming growth factor beta-2	2758_TGFB2 - Transforming growth factor beta-2	25	37	1	3415	3131	3360	4224	4473	3104	4402	310	4654	3481	1003	2749	37	2642	2232	3448	442	1243	1289	3485	618	2842
3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	25	37	1	1093	600	837	691	1805	1583	3515	1667	3282	2959	1071	630	257	37	623	1743	963	1871	1720	3278	3515	1124
596_Peptide::Dipeptide::pro-hydroxy-pro	596_Peptide::Dipeptide::pro-hydroxy-pro	25	37	1	4016	301	114	3143	1140	1432	4423	625	3626	4696	1343	1100	2203	40	37	445	679	103	4241	2292	1838	2010
3191_Number of treatments/medications taken	3191_Number of treatments/medications taken	25	37	1	2358	4716	1866	1254	40	1479	856	1580	2171	3600	1889	858	3959	2949	3802	37	158	4517	313	229	3502	2008
1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	25	37	1	4425	4008	1895	3695	2404	791	4470	4711	1516	4596	4163	1066	136	2023	677	1858	37	3770	4083	3961	3318	4585
952_Valine	952_Valine	25	37	1	3141	777	1921	1370	3811	3506	2149	3268	3440	791	4380	3014	2364	3736	3411	3776	2943	37	3843	223	116	3769
4175_Heel bone mineral density	4175_Heel bone mineral density	25	37	1	1899	3360	149	480	1125	2476	849	176	1886	1313	2289	1919	1469	3295	1260	2089	1354	4263	37	1399	418	1471
3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	37	1	2167	1532	4504	2807	2758	560	2501	1943	598	3865	825	3993	4184	3261	1409	3142	864	2681	3788	1302	4671	37
989_Interleukin-2	989_Interleukin-2	25	38	1	38	1140	198	887	2898	3278	4114	3060	908	4330	1025	2751	2735	2172	1021	1445	274	3664	1987	4745	4614	3918
3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	25	38	1	352	38	4305	2812	1500	514	4612	1745	629	3879	3443	424	194	161	1125	1280	789	1367	4353	3600	3196	2400
3472_Age at cancer diagnosis	3472_Age at cancer diagnosis	25	38	1	4054	3826	38	778	270	1114	2108	105	3840	3898	1181	3482	1348	4593	4509	195	318	3829	2972	193	528	4363
1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	38	1	2929	2873	2329	38	2797	2712	2738	2472	4721	1253	3554	3816	865	3873	320	3607	845	4321	2155	4196	2436	4361
4510_Left basal forebrain	4510_Left basal forebrain	25	38	1	2853	3964	2546	1763	2165	38	1068	1107	2011	3948	3796	2942	72	59	996	4348	112	1614	89	789	1120	4441
1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	25	38	1	2491	3548	92	4219	1954	4243	38	3270	4278	4046	641	2260	802	2848	1322	3099	1212	730	1529	2537	2280	2282
1319_Resistin (GEE, adjusted for age and sex)	1319_Resistin (GEE, adjusted for age and sex)	25	38	1	1325	3765	2654	704	2366	3946	226	38	4440	4553	790	1876	1105	2204	1653	3488	2129	3021	4256	4249	3629	1595
2298_CTGF - Connective tissue growth factor	2298_CTGF - Connective tissue growth factor	25	38	1	3663	3243	434	2445	444	1823	1099	340	38	4045	3916	2944	2227	1076	2763	489	1032	2351	250	3251	937	736
290_CD4:%Act(DR+)	290_CD4:%Act(DR+)	25	38	1	2066	1818	4521	1676	1599	3442	2273	4384	2748	38	951	584	1887	2075	2536	3551	2781	2608	3606	545	4740	3923
374_Amino acid::Glutamate metabolism::glutamate	374_Amino acid::Glutamate metabolism::glutamate	25	38	1	498	4529	3860	2952	987	4452	2307	418	445	522	38	1060	2689	4113	3019	3222	1717	575	1582	3819	2249	621
3376_Number of stillbirths (female)	3376_Number of stillbirths (female)	25	38	1	3029	686	2560	2292	1266	2070	3799	2246	1981	600	2439	245	38	4197	4615	2209	466	252	2303	3067	2599	3674
1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	25	38	1	4394	3363	2075	1895	1302	2623	4457	2201	1907	841	2168	626	2454	38	352	4166	2553	1895	2453	3262	2630	2426
1117_Pericardial adipose tissue volume	1117_Pericardial adipose tissue volume	25	38	1	4281	2348	3000	3565	969	352	1266	760	628	3858	3780	3436	4372	830	38	2626	556	4009	3436	1618	3310	1169
753_::::X-12092	753_::::X-12092	25	38	1	464	570	1691	4468	215	124	720	558	3894	124	893	3316	75	1279	2709	359	38	3577	4310	2875	1471	1612
749_::::X-12039	749_::::X-12039	25	38	1	2073	3240	921	3560	3005	4484	1288	4012	1241	4081	1917	3705	1202	4050	3883	2765	810	38	911	2084	4069	3031
3896_Neutrophil percentage of white cells (three-way meta)	3896_Neutrophil percentage of white cells (three-way meta)	25	38	1	3727	2945	3237	3114	2636	141	4620	330	514	783	2971	1764	132	3060	1383	2245	528	3348	38	2026	885	777
2393_TMPRSS15 - Enteropeptidase	2393_TMPRSS15 - Enteropeptidase	25	38	1	1378	4062	1426	454	1336	2602	1957	149	714	790	1793	2645	1224	404	1770	4557	4363	1052	165	38	4138	4584
4745_Genu of corpus callosum radial diusivities	4745_Genu of corpus callosum radial diusivities	25	38	1	3869	1527	2600	3611	1528	592	915	72	3892	2572	2519	2071	1184	1440	390	4012	2259	264	1448	137	38	1974
1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	25	39	1	39	3692	4635	2256	1356	3751	1524	4671	3305	1866	1668	2988	1829	3484	774	1926	1428	4107	2615	1889	861	3518
4509_Cerebellar vermal lobules VIII X	4509_Cerebellar vermal lobules VIII X	25	39	1	2163	2984	39	870	845	2669	2301	4078	4397	3333	4404	2243	529	2966	1273	587	2118	4742	1875	1691	1240	1191
4218_Antithrombotic agents	4218_Antithrombotic agents	25	39	1	3248	662	3214	39	402	1605	4479	3156	2677	2219	183	4363	1278	2878	552	486	3411	1114	56	4716	753	4252
348_CD8:%R5+	348_CD8:%R5+	25	39	1	1043	778	1029	4569	3920	3608	39	3827	860	3693	2009	4126	2947	1652	4419	4522	389	3868	2076	1163	723	4191
2695_PSMA6 - Proteasome subunit alpha type-6	2695_PSMA6 - Proteasome subunit alpha type-6	25	39	1	923	2528	1147	2474	1054	4089	1546	39	236	3346	3900	2145	1724	2185	4543	4681	1209	1604	2485	3318	548	2794
4080_Waist-hip ratio (adjusted for BMI)	4080_Waist-hip ratio (adjusted for BMI)	25	39	1	143	2662	102	1858	234	313	2931	719	39	2434	2520	2215	203	4397	4546	168	1976	616	2518	3687	788	95
3739_Depression - Ever had prolonged feelings of sadness or depression	3739_Depression - Ever had prolonged feelings of sadness or depression	25	39	1	2389	354	2899	1934	4522	3167	2870	3020	3557	39	4273	651	2966	3653	1546	2236	4314	759	2687	4254	534	1826
1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	39	1	3439	2833	1413	2427	2066	2698	1177	328	1633	3946	39	3384	2168	4649	647	1490	1319	952	3484	3568	4022	442
3774_Traumatic events - Been in aconfiding relationship as an adult	3774_Traumatic events - Been in aconfiding relationship as an adult	25	39	1	3303	2987	3393	1742	4567	3041	2700	3939	1174	4424	3828	39	1413	1933	4084	3418	2808	1043	1385	3017	3207	906
3147_CASP10 - Caspase-10	3147_CASP10 - Caspase-10	25	39	1	1974	3482	440	2999	806	3908	2727	787	1024	2546	3369	2947	39	1558	4712	585	252	3355	403	3154	3366	4263
2572_CD40LG - CD40 ligand	2572_CD40LG - CD40 ligand	25	39	1	3567	1936	4047	4035	1806	1495	602	1176	3179	789	1524	2914	3696	39	1967	1563	2354	56	1173	4654	3287	3345
1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	39	1	3933	3276	2151	644	695	2544	4438	4668	3663	4724	3615	3160	2573	3915	39	939	404	516	899	4261	1917	1291
3398_Leg pain on walking	3398_Leg pain on walking	25	39	1	2809	3362	1334	4234	3679	3545	4626	1642	3812	1629	3293	2433	3992	2975	3774	2804	2065	2290	39	302	1056	1120
1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	39	1	3571	114	95	1853	1284	1004	3278	4121	3784	2953	4097	623	3309	1338	89	910	2980	652	2780	39	2087	1204
660_::::X-04495	660_::::X-04495	25	39	1	173	529	2337	2961	4445	1220	1380	1326	1986	203	3350	1403	3492	1119	1135	3709	569	341	3655	4701	39	2478
444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	25	39	1	4110	728	410	3787	1740	3511	4291	2679	1448	1311	1655	2954	2257	409	4633	3462	2056	4629	4216	4538	890	39
2199_CCL1 - C-C motif chemokine 1	2199_CCL1 - C-C motif chemokine 1	25	40	1	40	1923	4402	4678	4474	493	1156	1608	60	3273	1806	2055	1127	2356	4256	2875	838	916	4309	948	2098	2442
1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	25	40	1	4506	4366	40	2343	694	4285	1281	2233	4638	2340	2136	292	1138	4704	3533	2108	3081	2374	697	4607	121	4265
387_Amino acid::Histidine metabolism::histidine	387_Amino acid::Histidine metabolism::histidine	25	40	1	377	3317	1670	4319	3208	40	2275	3607	1641	2610	4352	2529	3738	965	2889	4281	1588	3202	148	3592	3124	84
1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	40	1	3651	337	3174	3509	1673	2697	40	3362	4249	4212	3603	2577	878	585	722	1794	4194	1606	4184	2784	3210	1199
3185_Waist circumference	3185_Waist circumference	25	40	1	1414	1468	1988	3808	3680	2970	620	40	2926	4559	3953	3626	3630	533	3010	4252	2351	4665	3787	4240	931	1613
222_B:%Mature	222_B:%Mature	25	40	1	3219	4376	489	913	722	1056	336	2832	40	3818	696	4556	2352	454	73	2771	3329	1428	3706	4405	1816	1842
4072_First PC of the four riskly behaviours	4072_First PC of the four riskly behaviours	25	40	1	3348	56	3571	1122	4550	478	2549	2490	4685	40	4208	3804	4345	345	695	2160	2657	208	343	3609	2938	1346
3734_Depression - Duration of worst depression	3734_Depression - Duration of worst depression	25	40	1	2331	623	977	629	2262	1330	1197	66	3879	1355	2366	40	3657	1474	4143	3432	1953	78	2134	2009	4013	1821
1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	25	40	1	2742	156	2693	4090	2299	632	1605	2710	430	2699	3907	2982	40	3696	1684	3483	2883	4186	1958	2231	1101	1320
3839_Eosinophil percentage of white cells (two-way meta)	3839_Eosinophil percentage of white cells (two-way meta)	25	40	1	2178	1713	2173	146	1248	1217	2721	228	2058	1477	3479	4550	793	632	40	1332	4002	1656	3149	1386	2942	2950
259_CD8:%TM-like	259_CD8:%TM-like	25	40	1	3060	2506	1679	2849	2842	95	1340	3535	383	2628	1304	4303	1538	4037	1210	4453	40	3443	1302	434	2827	4620
3943_HbA1c	3943_HbA1c	25	40	1	107	4589	2876	4513	3611	3282	1115	2728	4655	4269	900	2478	3393	677	1839	2138	4403	40	4620	1059	4381	3794
1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	40	1	4304	3216	3096	4076	4624	707	3359	1182	988	1516	1345	382	3508	812	2614	470	595	267	40	1294	2983	949
3381_Prospective memory test - Time to answer	3381_Prospective memory test - Time to answer	25	40	1	4657	1743	391	4180	991	1239	2673	456	3309	1533	2726	43	3875	244	2754	727	186	3798	3778	40	3440	1108
4037_Autism spectrum disorder	4037_Autism spectrum disorder	25	40	1	1747	524	3552	2364	2925	193	2076	2063	3499	2095	4710	1883	1763	1676	4218	1765	559	2577	426	1074	40	477
1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	25	41	1	3920	41	3258	4247	922	738	193	238	1335	4100	3712	673	901	784	3679	736	4544	3017	2432	2922	1769	4634
1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	25	41	1	2955	263	41	2197	598	3541	3334	3974	1037	4199	3356	975	2822	4426	2983	1173	1235	278	2517	1245	4708	822
3151_CCNB1 - G2/mitotic-specific cyclin-B1	3151_CCNB1 - G2/mitotic-specific cyclin-B1	25	41	1	324	3861	3834	2385	2872	41	4106	2715	1898	333	292	3571	167	3011	3420	4640	235	985	2554	3110	2490	4227
3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	25	41	1	1326	629	314	4730	486	2556	924	41	3796	3716	2221	2141	4206	3030	2037	715	1680	3525	4441	2946	1440	3395
2905_LTA - Lymphotoxin-alpha	2905_LTA - Lymphotoxin-alpha	25	41	1	797	4452	2412	2027	4076	222	672	3065	41	2044	2535	755	424	3880	103	1796	1932	1824	3198	117	1521	668
3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	25	41	1	2823	110	1832	1654	3291	2808	272	3377	3641	41	648	1865	954	322	791	1964	2799	3626	2961	1446	1473	4049
2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	25	41	1	770	3934	3704	2834	887	3186	701	793	1453	1233	4451	41	1508	2222	2804	4550	4255	614	1514	4078	1630	3649
1127_Visceral adipose tissue sttenutation (male)	1127_Visceral adipose tissue sttenutation (male)	25	41	1	3226	1599	1822	190	4334	2303	4078	433	3111	4503	1248	1217	41	910	3517	3286	2242	2635	4383	3240	3826	2173
2772_CFL1 - Cofilin-1	2772_CFL1 - Cofilin-1	25	41	1	2458	3738	3310	3713	2887	4175	2126	2521	4552	3888	2101	1528	4669	2826	41	2246	4101	4349	986	1790	4300	1909
2409_MEPE - Matrix extracellular phosphoglycoprotein	2409_MEPE - Matrix extracellular phosphoglycoprotein	25	41	1	4111	978	2710	4735	4039	2356	4231	3417	4703	3065	2720	3356	790	45	2697	1780	435	41	2279	2650	1561	382
2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	25	41	1	3095	113	1883	1297	1153	4314	2751	1436	3752	4190	1162	106	1942	2630	4264	1971	4067	4666	41	2573	606	2270
4131_Eosinophil count	4131_Eosinophil count	25	41	1	3996	1293	3366	2455	90	1384	1869	233	4080	4134	4468	2198	657	126	2741	99	2619	2390	157	41	2063	1354
1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	25	42	1	42	1059	2637	2363	4149	1937	583	2694	695	633	530	1211	1702	234	2004	1417	1715	4075	3056	4354	3299	1961
1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	42	1	3791	42	1777	4029	2940	2068	1253	3202	1185	953	3142	3977	2740	1400	3980	2669	676	3100	763	3718	2763	2433
2403_KLK13 - Kallikrein-13	2403_KLK13 - Kallikrein-13	25	42	1	2961	2055	1597	1377	2423	42	4444	3911	1944	4496	437	3192	694	198	308	3943	927	3098	1715	2605	4118	4372
1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	25	42	1	3591	3605	3975	865	1549	161	42	3602	2365	142	1639	937	2385	915	4280	628	417	187	412	4173	49	2271
124_Body Mass Index (male)	124_Body Mass Index (male)	25	42	1	4006	2812	2795	2898	3010	3414	668	42	2962	4377	1635	1076	3550	3947	1994	3996	1910	3050	1006	890	3386	2639
2966_MMP1 - Interstitial collagenase	2966_MMP1 - Interstitial collagenase	25	42	1	412	2429	4517	3310	2158	211	4284	2334	42	1162	4602	679	186	453	128	3364	992	563	2241	4739	3145	994
4473_Left supramarginal	4473_Left supramarginal	25	42	1	775	2137	3703	1601	3077	1556	3726	3584	1244	42	1906	988	1698	742	4531	3796	1372	3439	1956	4095	4041	495
1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	25	42	1	1644	771	4572	718	2813	3019	396	3613	300	4739	2746	1648	2525	42	660	1103	1155	3622	2452	3670	2532	3930
2215_APOB - Apolipoprotein B	2215_APOB - Apolipoprotein B	25	42	1	1507	3798	3330	741	342	1847	470	1647	3710	3043	2195	2964	4359	509	42	477	4402	4019	3348	370	1491	1334
2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	25	42	1	4663	2878	3912	2947	1431	3973	2637	2783	3564	2530	1180	3879	3617	2727	799	937	1804	42	2842	499	806	3979
3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	25	42	1	4413	903	2227	1192	769	3555	4044	3222	3898	3275	1855	1846	4074	2497	67	1043	267	3991	42	3049	4442	3692
1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	25	42	1	83	2452	1400	2627	1597	3350	2075	1618	2329	2362	826	312	3729	999	942	1552	4197	1445	757	42	3011	4138
4398_Menstruation quality of life impact: Bowel movement	4398_Menstruation quality of life impact: Bowel movement	25	42	1	3244	1239	3891	2670	3152	4497	2481	1546	80	604	74	810	3469	537	4336	3269	3843	2843	2104	860	42	3021
4220_Antihypertensives	4220_Antihypertensives	25	42	1	4008	2559	231	1175	1018	1519	3398	2681	4290	3563	221	4130	4723	364	1250	2164	618	1796	490	968	3026	42
4311_Diverticular disease	4311_Diverticular disease	25	43	1	43	90	3284	2958	568	3406	2000	3021	2107	1843	319	4523	1426	3236	2563	1876	1413	1893	853	921	1627	1339
1200_Genetic generalized epilepsy	1200_Genetic generalized epilepsy	25	43	1	2334	43	978	845	4223	3679	2280	3397	4563	1437	887	959	3482	3372	641	3442	2202	3756	1574	3304	330	984
1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	43	1	3108	858	43	2415	2677	284	1223	4630	3421	1121	1937	173	255	650	1995	3241	593	1758	4229	3579	2012	1948
4213_Glycine level (female)	4213_Glycine level (female)	25	43	1	4223	2215	3209	43	1643	3626	1575	4258	1915	4371	4101	2787	1292	697	599	3336	2206	2407	1480	903	1016	2019
3652_Illnesses of siblings: Diabetes	3652_Illnesses of siblings: Diabetes	25	43	1	2548	2231	796	114	43	1181	1484	2088	3182	3309	2099	44	4638	2854	901	45	238	3929	1296	767	4311	3570
2661_ESM1 - Endothelial cell-specific molecule 1	2661_ESM1 - Endothelial cell-specific molecule 1	25	43	1	3843	3020	4427	2671	2026	1139	43	4461	674	4044	3668	1826	3429	953	3006	1254	3976	182	54	875	4035	404
413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	25	43	1	650	1491	1800	155	298	2383	95	43	2778	3975	2193	2473	4056	4377	1023	752	1407	2161	2268	2971	992	4356
3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	25	43	1	3249	587	1978	1869	1404	1116	1408	986	43	52	3349	2824	824	4118	4123	843	2745	4488	2766	4553	632	1683
1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	25	43	1	3104	3866	4003	746	1564	569	1508	1150	1588	3980	43	3001	1501	3912	508	3430	3997	3002	4712	3512	2799	1812
618_Xenobiotics::Benzoate metabolism::hippurate	618_Xenobiotics::Benzoate metabolism::hippurate	25	43	1	3670	3396	3535	191	2152	673	1100	1057	3247	4196	3190	4622	43	4491	1172	4040	2936	1725	2019	2689	3545	1099
3850_Mean corpuscular hemoglobin concentration (two-way meta)	3850_Mean corpuscular hemoglobin concentration (two-way meta)	25	43	1	4719	2831	3135	2986	1327	2013	4500	1648	2383	4194	853	3221	3918	43	2979	498	3770	1315	3042	1054	3976	2002
3873_Sum eosinophil basophil count (three-way meta)	3873_Sum eosinophil basophil count (three-way meta)	25	43	1	3286	1477	2674	3091	57	1425	2755	2698	3594	679	2997	4247	742	1059	43	61	4380	2110	2510	161	1691	693
3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	25	43	1	2135	148	4645	2174	609	4628	3064	520	2395	2159	3636	1101	159	4106	1641	1653	3207	43	3405	2708	1171	4016
362_1c+mDC:%32+	362_1c+mDC:%32+	25	43	1	1222	1686	2793	1497	4055	3548	488	187	2929	344	3300	401	156	4405	808	1635	3722	1486	43	2667	757	4077
1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	43	1	4432	4075	4404	2118	1876	622	581	1837	4723	1480	2369	3293	1872	2803	3232	1193	281	536	348	43	2296	4503
1907_Hippocampal volume (GEE, adjusted for multivariable)	1907_Hippocampal volume (GEE, adjusted for multivariable)	25	43	1	834	2930	4289	4233	2589	341	4232	1489	4137	3754	843	3057	1301	4376	2807	2639	905	1085	2566	3021	43	547
949_Total phosphoglycerides	949_Total phosphoglycerides	25	43	1	4401	1698	4694	518	427	4256	2993	3383	2016	1195	1008	1421	374	275	484	310	997	2717	3053	3458	1309	43
2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	25	44	1	44	3153	2050	3329	3131	3221	2428	3528	1126	4336	2881	2966	1128	390	3882	734	4567	1980	4175	625	3708	4460
3613_Treatment/medication code: simvastatin	3613_Treatment/medication code: simvastatin	25	44	1	135	44	2518	703	1476	425	3625	4564	377	4546	3470	696	2166	201	527	1099	1810	3148	4637	2360	2687	3100
3761_Depression - Recent trouble concentrating on things	3761_Depression - Recent trouble concentrating on things	25	44	1	2122	2603	44	2601	4425	2410	1277	4140	2048	1870	2765	2346	1158	2413	3047	965	3793	343	4196	1448	2328	4067
2956_GOT1 - Aspartate aminotransferase, cytoplasmic	2956_GOT1 - Aspartate aminotransferase, cytoplasmic	25	44	1	3988	2244	3741	44	3567	1541	4481	576	1877	2502	308	789	1455	2251	1759	1431	3657	1989	2773	3317	3519	3671
2007_Parental transmission distortion	2007_Parental transmission distortion	25	44	1	805	1105	169	3115	1184	44	3988	4415	3810	4626	3494	118	1366	690	59	806	181	581	967	3826	1535	925
1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	44	1	4523	2498	2808	215	490	2311	44	2100	268	2287	3486	1571	2451	2919	3263	2009	2844	4483	140	3261	593	3759
3186_Hip circumference	3186_Hip circumference	25	44	1	304	2872	2285	3935	3264	2882	250	44	2434	4061	2929	3620	4180	215	2623	4081	1875	3962	1272	1528	2070	603
3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	25	44	1	4382	4134	2689	3347	3755	1167	2339	887	44	999	1623	3653	1558	1425	3185	3199	1465	2261	1254	828	955	847
3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	25	44	1	934	2349	406	4280	3865	157	2680	4607	1661	44	645	739	459	2739	1714	4632	2988	3832	4627	1845	1336	3651
3078_NOTCH3 - Neurogenic locus notch homolog protein 3	3078_NOTCH3 - Neurogenic locus notch homolog protein 3	25	44	1	4142	492	2336	204	1160	1632	2916	3352	636	2359	44	3227	3331	53	699	794	2323	1594	456	4500	3107	459
3378_Number of pregnancy terminations (female)	3378_Number of pregnancy terminations (female)	25	44	1	2626	190	184	4397	2764	301	2538	2442	635	69	845	2561	44	309	4395	3851	2574	1316	2538	4622	958	574
3879_Hematocrit (three-way meta)	3879_Hematocrit (three-way meta)	25	44	1	3688	3457	4028	2669	2674	3957	1626	3591	1713	794	1473	3873	3108	44	3291	4346	4148	2613	1667	4028	2592	2148
1202_Rheumatoid Arthritis	1202_Rheumatoid Arthritis	25	44	1	1767	3046	1408	270	46	967	3173	4089	2832	4003	3801	4682	3434	3453	1638	44	2236	1753	4688	103	699	2887
270_CD4:%Naive	270_CD4:%Naive	25	44	1	1437	195	3478	1409	2254	4330	3532	3590	216	1328	4576	1204	1645	1158	4739	1948	4396	44	3456	637	2221	3813
249_CD27 on CD4 T	249_CD27 on CD4 T	25	44	1	3818	639	1187	2221	269	2209	373	2464	1811	4646	834	4478	2814	3113	3476	520	3200	1974	44	3152	859	209
525_Lipid::Long chain fatty acid::palmitate (16:0)	525_Lipid::Long chain fatty acid::palmitate (16:0)	25	44	1	1632	2073	1081	3247	1445	2187	4097	2255	2225	1385	1099	2470	2373	1989	764	2220	3265	1922	1335	44	311	1913
4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	25	45	1	45	477	3323	892	1009	468	3728	3935	1574	1370	1217	2297	3387	4163	4402	1629	688	2027	2746	1827	2104	1792
510_Lipid::Inositol metabolism::chiro-inositol	510_Lipid::Inositol metabolism::chiro-inositol	25	45	1	343	45	2415	813	278	1757	894	2906	3169	4051	1250	3867	1522	3424	2267	371	162	2541	1775	3467	4552	2458
4646_Total brain volume	4646_Total brain volume	25	45	1	1673	4486	4484	3462	111	2615	1181	45	2135	1129	2468	1052	2343	1171	4678	115	1859	72	1940	1285	4494	1055
706_::::X-11444	706_::::X-11444	25	45	1	3792	3542	1047	1400	4050	780	1564	1671	632	1897	45	733	3260	869	2784	4309	2925	4484	1327	1796	749	3337
440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	25	45	1	3042	1276	1159	3711	3976	3766	937	2916	1295	2391	1232	45	4380	3138	3760	2940	2759	2553	663	1878	693	1478
1856_Neck average buckling ratio (FBAT, male, adjussted for age)	1856_Neck average buckling ratio (FBAT, male, adjussted for age)	25	45	1	2668	1712	2091	2865	4690	4493	1609	2126	704	352	1664	3885	2022	638	45	4196	2962	1246	3683	403	1668	533
2719_NAGK - N-acetyl-D-glucosamine kinase	2719_NAGK - N-acetyl-D-glucosamine kinase	25	45	1	2242	1790	2948	1734	4198	693	3361	4173	2519	1087	1170	1213	567	3116	1699	4576	45	4374	4019	3412	2011	3589
567_Lipid::Sphingolipid::palmitoyl sphingomyelin	567_Lipid::Sphingolipid::palmitoyl sphingomyelin	25	45	1	3456	782	1612	829	2036	712	3594	3108	103	3792	67	3863	877	3989	3200	4608	3368	45	2926	558	201	1681
3653_Illnesses of siblings: Severe depression	3653_Illnesses of siblings: Severe depression	25	45	1	1394	4602	1610	1054	3867	3904	3875	4617	4190	4316	3697	1522	1906	2133	606	4620	1923	2499	2211	45	2494	3336
3983_Type 2 Diabetes	3983_Type 2 Diabetes	25	45	1	338	1881	103	604	88	1669	2020	3774	4368	744	1554	2381	2636	4223	1124	83	4301	427	3769	303	45	747
4540_Right accumbens area	4540_Right accumbens area	25	45	1	2090	747	2978	3307	2385	2413	3798	1907	2604	3139	253	1364	2029	3898	1083	2211	4657	3062	2684	3641	2167	45
4543_Gray matter	4543_Gray matter	25	46	1	46	3837	823	3967	1001	2014	306	4541	2528	4467	3363	2917	828	2018	3355	2198	3867	1286	3750	3779	716	457
920_Phospholipids in medium LDL	920_Phospholipids in medium LDL	25	46	1	275	46	559	729	1477	266	1981	3958	1134	4244	740	1671	3553	659	155	1407	2012	4657	3885	3574	2656	1311
2330_CGA FSHB - Follicle stimulating hormone	2330_CGA FSHB - Follicle stimulating hormone	25	46	1	3397	53	46	921	4395	4536	2555	56	3218	1609	3032	1962	3152	3289	3441	1536	3229	335	216	3202	2734	1466
518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	25	46	1	1481	1233	2995	46	2011	2405	801	1055	3148	1216	3248	1080	3708	579	3483	2296	4060	4672	2112	2249	2274	1797
3205_Duration of walks	3205_Duration of walks	25	46	1	1204	131	2103	1915	4210	1062	46	2600	3178	4448	1452	2137	912	4216	3868	3037	1458	2835	346	4263	1637	3450
174_Waist circumference (adjusted for BMI)	174_Waist circumference (adjusted for BMI)	25	46	2	4098	4586	1971	125	344	682	3131	46	2605	1236	1145	905	4147	3322	649	925	577	3079	91	2020	94	4649
876_Total cholesterol in HDL	876_Total cholesterol in HDL	25	46	1	3243	806	4665	2345	379	1334	3372	3078	46	1134	1275	3529	4202	2996	1696	515	4682	283	2362	3676	47	3027
4362_Acceleration average	4362_Acceleration average	25	46	1	2412	802	1523	1749	2644	430	3769	1375	1604	46	800	2350	4199	3724	2553	1192	1229	3134	355	4229	90	1515
2099_IGFBP3 - Insulin-like growth factor-binding protein 3	2099_IGFBP3 - Insulin-like growth factor-binding protein 3	25	46	1	92	2252	2694	2908	1787	3112	3117	924	3159	3371	46	1246	493	3722	3666	4356	3581	4130	3310	1914	2202	2398
1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	25	46	1	266	4298	187	3587	1869	3668	3157	1973	2928	2386	3286	46	940	434	4560	1694	1831	651	3394	4591	4508	3424
1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	46	1	2925	1060	221	3424	623	584	4408	320	1007	517	3406	1383	46	259	751	327	1913	479	4116	1513	512	2191
1072_Systemic Lupus Erythematosus	1072_Systemic Lupus Erythematosus	25	46	1	4613	504	2253	2168	121	49	1461	1832	339	1304	2415	4016	2221	3457	46	128	386	2381	2916	849	1027	1634
4344_Sleep sedentary (conditioning sex and BMI)	4344_Sleep sedentary (conditioning sex and BMI)	25	46	1	388	1304	66	2766	1888	305	4377	3084	4694	2301	730	2963	3181	83	882	896	46	965	2204	1491	2752	904
3310_Age started wearing glasses or contact lenses	3310_Age started wearing glasses or contact lenses	25	46	1	1619	1073	2774	3931	2944	593	4116	3291	4041	321	4397	2045	1786	3201	4502	1467	1864	46	1841	2995	153	3684
4499_Right rostral anterior cingulate	4499_Right rostral anterior cingulate	25	46	1	3656	701	2865	906	2506	1912	4456	2927	1554	1448	4727	1457	1664	4627	2915	3005	1673	3652	46	636	1881	4375
864_22:6, docosahexaenoic acid (DHA)	864_22:6, docosahexaenoic acid (DHA)	25	46	1	1263	2362	3480	1635	4151	753	122	1306	128	775	3992	1807	2106	3195	1816	4461	713	2863	2968	1421	46	1680
1982_Walking speed (at exam 7, FBAT)	1982_Walking speed (at exam 7, FBAT)	25	46	1	2229	2574	3005	2916	1439	2412	3506	873	4019	2551	188	4576	1969	1727	1373	1562	72	1130	1589	847	3336	46
1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	47	1	2315	47	2717	1168	1498	655	224	4111	1863	2079	2496	940	1954	2768	1936	2898	4524	1870	1342	337	4352	3315
853_Albumin	853_Albumin	25	47	1	2572	2119	219	1793	481	47	1831	2862	4646	3353	2672	750	1789	1421	2319	808	1019	2739	4207	2423	74	3202
4045_Type 2 Diabetes	4045_Type 2 Diabetes	25	47	1	536	334	56	1147	256	2273	47	218	4743	265	2422	854	3354	1561	3756	170	1593	728	1787	375	2044	831
4304_Legs-leg fat ratio (female)	4304_Legs-leg fat ratio (female)	25	47	1	685	3694	1984	3159	168	2263	2928	47	2460	830	104	2099	571	3270	2249	248	141	1976	2866	428	1930	267
3412_Sitting height	3412_Sitting height	25	47	1	3461	1486	456	2192	590	700	765	1727	47	4681	3551	4261	1333	3827	1590	555	2095	3679	3175	1951	1638	3130
3923_Heart rate variability (RMSSD)	3923_Heart rate variability (RMSSD)	25	47	1	1651	843	3555	4297	3619	2735	2422	1840	3393	1611	47	3766	1709	2779	1491	2691	4501	1731	4711	2442	143	202
1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	24	47	1	4295	4156	2731	2678	2295	1540	2599	1363	3094	2284	599	47	2376	1721	4645	3517	4610	464	238	2151	2819	1457
4097_Colorectal cancer	4097_Colorectal cancer	25	47	1	4684	2048	3952	3251	1045	578	1779	1153	3327	693	2838	619	47	3525	4275	283	1738	3120	580	2312	188	332
1171_Body fat percentage	1171_Body fat percentage	25	47	1	1006	3008	1418	3879	1922	2660	577	3736	3939	855	871	2460	2013	47	2305	1661	998	2761	1965	1270	4037	569
404_Amino acid::Tryptophan metabolism::indoleacetate	404_Amino acid::Tryptophan metabolism::indoleacetate	25	47	1	1567	1469	634	4335	4596	3150	4055	3479	1652	1522	3659	1000	402	3337	47	3119	1656	4620	4579	1879	457	2814
2037_Immunoglobulin A deficiency	2037_Immunoglobulin A deficiency	25	47	1	1920	4011	1985	2088	58	4561	1003	3186	3995	645	1946	179	3304	1923	1742	47	1061	3595	1404	496	2289	2171
3017_AK1 - Adenylate kinase isoenzyme 1	3017_AK1 - Adenylate kinase isoenzyme 1	25	47	1	4282	2516	4519	1236	2938	3419	2140	1265	2381	2829	3265	2082	3320	4284	125	3846	2376	47	413	444	3999	2796
3426_Fluid intelligence test - FI3 : word interpolation	3426_Fluid intelligence test - FI3 : word interpolation	25	47	1	2410	3970	2424	3412	3884	2934	4476	4079	4407	664	3775	910	3247	4461	3905	845	1784	4451	47	166	899	3648
1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	25	47	1	807	183	4646	570	2351	3211	535	1461	2254	4679	3148	3641	1298	1602	753	2576	2569	2785	3306	47	131	2558
327_CD4mem:%Th9	327_CD4mem:%Th9	25	47	1	4399	4665	1322	1008	2927	482	2762	2296	2113	4285	133	2864	885	1970	4473	2699	4150	2061	1742	242	1234	47
3074_NCR1 - Natural cytotoxicity triggering receptor 1	3074_NCR1 - Natural cytotoxicity triggering receptor 1	25	48	1	596	48	1162	3642	3110	2583	314	1718	1387	1713	828	1994	1203	781	2527	2775	2219	2393	2293	2045	1024	2805
79_Femoral Neck BMD (females)	79_Femoral Neck BMD (females)	25	48	1	1683	2392	2354	48	1958	3962	1666	4455	1659	195	3823	2660	612	3366	2518	3273	2684	888	2196	3569	73	3632
3893_Sum neutrophil eosinophil count (three-way meta)	3893_Sum neutrophil eosinophil count (three-way meta)	25	48	2	671	1221	2213	2905	48	814	4248	2465	2277	1227	1490	779	3579	1840	1781	49	4522	1301	3902	88	2688	1536
1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	48	1	2120	1425	1919	3481	3899	48	2644	2511	2742	2253	2433	850	2154	4064	2184	2861	2909	2147	2447	3597	2131	3653
2636_NPPB - Brain natriuretic peptide 32	2636_NPPB - Brain natriuretic peptide 32	25	48	1	195	4462	130	136	4502	1350	4424	3259	48	1849	1920	4739	2096	3921	2662	2995	3056	4259	3642	1911	4269	3811
3200_Job involves mainly walking or standing	3200_Job involves mainly walking or standing	25	48	1	3335	4082	1078	1150	3103	2792	2772	2704	3295	48	1865	2932	3883	2615	3536	2039	2177	3706	1759	2383	2046	2947
1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	48	1	2267	2673	2030	2160	517	1654	1551	2746	4679	2496	48	3649	569	3987	4242	251	2941	3588	839	2098	2450	1692
2508_BTK - Tyrosine-protein kinase BTK	2508_BTK - Tyrosine-protein kinase BTK	25	48	1	1419	638	1476	3242	2882	610	4644	1714	2278	1740	1323	48	3285	2867	51	2315	1794	765	4178	2826	3959	882
3871_Basophil percentage of granulocytes (three-way meta)	3871_Basophil percentage of granulocytes (three-way meta)	25	48	1	3035	2587	2333	4336	3942	3437	2718	1426	176	2140	4658	4226	2963	48	467	4115	113	2444	1561	733	1669	3669
1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	25	48	1	1297	3486	558	3823	740	209	1703	863	2810	3137	2217	3351	4127	676	48	1603	273	919	2860	484	2655	271
4266_Asthma (child-onset)	4266_Asthma (child-onset)	25	48	1	1141	1238	76	328	63	2918	3200	3819	4193	3558	4696	4349	60	3133	944	48	2986	2471	3711	467	58	1381
2230_KLK4 - Kallikrein-4	2230_KLK4 - Kallikrein-4	25	48	1	2097	3905	4001	2163	165	750	4379	4578	1971	3941	2117	3277	1847	1807	2213	237	48	1395	4269	2138	383	880
672_::::X-06351	672_::::X-06351	25	48	1	3645	3161	3217	4139	4106	3791	4653	3282	839	2031	3595	2871	4312	3241	680	4301	3512	48	703	1201	1787	305
1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	25	48	1	1322	3078	352	2715	738	1467	589	2476	2681	1014	1849	2159	350	902	2699	3159	3398	4078	48	4691	2411	1357
3812_CD3+ T cell level	3812_CD3+ T cell level	25	48	1	116	3820	347	176	186	74	1790	2299	2982	4651	291	2538	2158	1814	960	139	473	1686	3438	48	3695	280
4744_Fornix (cres) / Stria terminalis radial diusivities	4744_Fornix (cres) / Stria terminalis radial diusivities	25	48	1	980	1656	2217	3334	2398	397	3122	1785	1120	1033	4265	4500	4290	2980	3445	1693	4206	1437	3595	738	48	4723
1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	25	48	1	1475	1595	3997	326	2358	1126	2739	1130	1285	3564	119	70	831	3473	2507	2904	211	217	1343	53	1310	48
1782_Artial fibrillation (FBAT, adjusted for multivariable)	1782_Artial fibrillation (FBAT, adjusted for multivariable)	25	49	1	3383	3448	49	3082	2426	2849	3410	1722	1200	703	1443	83	1453	4456	3308	1617	2944	2770	1510	2660	1883	2609
4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	25	49	1	732	3056	2012	49	3132	4373	993	776	1786	728	4675	207	1257	3674	4485	1508	140	260	1414	1963	1857	4463
1321_Adiponectin (GEE, adjusted for age, sex and BMI)	1321_Adiponectin (GEE, adjusted for age, sex and BMI)	25	49	1	4716	185	1599	83	711	3996	49	103	2891	2244	1758	3669	3079	2349	4062	639	3268	3315	1852	1058	3269	3503
3593_Mineral and other dietary supplements: Glucosamine	3593_Mineral and other dietary supplements: Glucosamine	25	49	1	2623	4689	4454	475	1801	698	1488	49	3776	3611	1658	2888	4343	4126	1438	1756	174	1001	3209	3439	3722	4244
2078_FGF8 - Fibroblast growth factor 8 isoform B	2078_FGF8 - Fibroblast growth factor 8 isoform B	25	49	1	903	277	2623	584	1384	1191	2125	4374	49	2571	4532	4608	4001	3247	1132	2855	4536	813	4277	848	3833	3540
1231_Usual weekday bedtime (GEE)	1231_Usual weekday bedtime (GEE)	25	49	1	127	4091	3423	160	1552	183	2908	2644	3192	2005	49	1552	3644	1594	2949	1373	3741	131	164	4492	4224	2997
2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	25	49	1	2037	4291	3796	4566	2235	858	2969	2133	470	1953	1702	49	3018	1686	3139	761	70	3919	3326	1996	3907	1846
3909_Vertical cup-disc ratio	3909_Vertical cup-disc ratio	25	49	1	1504	2789	133	3840	2370	1195	3812	1112	2294	285	575	3744	49	469	1200	4546	2635	122	1159	4071	4330	3614
3837_Sum eosinophil basophil count (two-way meta)	3837_Sum eosinophil basophil count (two-way meta)	25	49	1	4305	2363	4537	2538	110	1786	1979	1918	2432	1054	2609	3353	214	424	49	116	4653	3784	2991	92	2971	805
3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	25	49	1	199	2747	2678	1101	68	153	3708	2551	3377	4655	945	4423	4217	2726	4208	65	49	839	2614	325	1037	4176
1096_Pulse pressure	1096_Pulse pressure	25	49	1	4089	4624	3131	3440	1377	2288	1243	4158	647	2060	594	931	518	1720	985	3048	2084	49	2275	2453	3882	2357
2737_GZMB - Granzyme B	2737_GZMB - Granzyme B	25	49	1	531	3745	3988	68	1807	2179	1606	3579	1610	980	153	1397	4714	3483	472	1605	3557	2842	49	3425	344	2658
2273_APOE - Apolipoprotein E (isoform E4)	2273_APOE - Apolipoprotein E (isoform E4)	25	50	1	3844	50	2593	3151	2135	4017	3586	2353	55	3328	1244	3294	415	2802	1055	2369	1468	659	2922	2947	4092	433
2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	25	50	1	3824	2374	3114	50	605	1505	3692	1998	4581	3402	850	3305	809	3493	4415	1771	3170	1826	2353	2742	4325	986
2325_CAST - Calpastatin	2325_CAST - Calpastatin	25	50	1	1603	1246	217	1290	3900	2584	50	3039	584	2856	2383	415	1016	3408	4360	3748	3576	3869	4405	2291	600	2893
150_Body Mass Index (female <= 50 yrs)	150_Body Mass Index (female <= 50 yrs)	25	50	1	1081	445	3611	1702	2548	3273	3485	50	3516	4537	4204	4547	2866	393	2520	3294	1890	4434	3196	536	607	53
1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	25	50	1	1836	1989	354	1305	1937	582	3038	3067	50	334	3776	923	915	4204	446	3055	3780	3658	1959	1288	735	2688
3634_Illnesses of father: Diabetes	3634_Illnesses of father: Diabetes	25	50	1	2612	74	886	66	189	768	4118	2311	446	50	792	1117	3825	2948	2569	140	4574	1343	3181	2675	59	4121
251_CD27 on CD8 T	251_CD27 on CD8 T	25	50	1	4285	448	74	1517	537	3747	629	1325	920	3893	50	3017	4230	3258	3737	842	3902	3286	323	1905	68	3585
860_CH2 groups to double bonds ratio	860_CH2 groups to double bonds ratio	25	50	1	367	3717	4367	1437	850	2562	2011	377	3292	1969	2144	2580	50	4274	83	2514	403	2521	225	4534	1445	2233
3468_Impedance measures - Trunk fat percentage	3468_Impedance measures - Trunk fat percentage	25	50	1	4119	1283	1256	1731	4329	2566	1818	62	3901	4703	3586	4505	3527	50	3839	4540	3999	4746	843	3260	540	61
1223_Mean Pallidum	1223_Mean Pallidum	25	50	1	474	691	4379	2082	4089	179	1683	3626	2913	525	4034	1690	3107	887	50	4587	1750	2629	2291	765	617	2069
1985_Age at natural menopause (GEE, adjusted for multivariable)	1985_Age at natural menopause (GEE, adjusted for multivariable)	25	50	1	2640	1988	128	482	1760	1253	1776	1762	653	404	4408	986	3813	2643	2687	2992	50	3710	2296	3716	2849	491
2140_PRKCZ - Protein kinase C zeta type	2140_PRKCZ - Protein kinase C zeta type	25	50	1	3760	2400	4132	3410	1505	1996	4303	1480	3806	3088	317	3458	1864	2973	1791	1770	3186	50	2034	4493	2629	4097
720_::::X-11538	720_::::X-11538	25	50	1	1000	2902	126	1184	2395	1759	2940	4636	623	2327	1264	3903	3638	4013	3330	3621	2606	1885	50	3689	3496	2690
4670_Anterior limb of internal capsule axial diusivities	4670_Anterior limb of internal capsule axial diusivities	25	50	1	65	3527	3422	2025	164	649	684	909	1911	346	2658	131	1238	3074	3941	579	4583	1837	4466	4717	50	2822
1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	50	1	1909	3633	2552	1267	4720	215	449	397	288	2769	1226	2715	1936	1113	1961	1906	592	1643	1921	2124	4075	50
3221_Time spent driving	3221_Time spent driving	25	51	1	51	3164	1761	3605	2856	412	2681	799	2698	2672	75	2794	381	1584	1448	4521	439	1785	3954	3893	1859	528
1783_Artial fibrillation (GEE, adjusted for multivariable)	1783_Artial fibrillation (GEE, adjusted for multivariable)	25	51	1	222	1697	51	394	1483	1836	280	2994	95	4230	4239	2348	2152	4151	3037	1217	4040	508	3887	2527	1747	4256
1854_Neck average buckling ratio (FBAT, female, adjussted for age)	1854_Neck average buckling ratio (FBAT, female, adjussted for age)	25	51	1	1592	3752	2406	51	2547	4104	1430	348	801	3421	989	3982	944	2905	1306	2350	1365	3195	2524	3511	1276	1071
3815_CD4:CD8 lymphocyte ratio	3815_CD4:CD8 lymphocyte ratio	25	51	1	1025	853	1329	392	51	2957	1392	1886	2770	1625	3727	1877	1350	2416	4193	56	2201	2133	3342	975	4569	845
1188_Tetralogy of Fallot	1188_Tetralogy of Fallot	25	51	1	3955	1459	2234	2439	3416	408	51	3230	4648	3340	1621	2857	893	3085	3468	2305	116	84	870	575	3477	1928
129_Hip circumference (female)	129_Hip circumference (female)	25	51	1	2220	1223	4196	514	295	1218	541	51	2106	3332	318	1487	3141	3496	653	455	1863	2517	181	538	679	360
2615_TEC - Tyrosine-protein kinase Tec	2615_TEC - Tyrosine-protein kinase Tec	25	51	1	3598	4238	967	899	555	376	1296	1472	51	1095	2877	104	1205	428	4255	348	589	1456	686	1079	1022	1549
2835_CHST6 - Carbohydrate sulfotransferase 6	2835_CHST6 - Carbohydrate sulfotransferase 6	25	51	1	3007	2032	3605	3854	682	1142	484	148	2817	883	51	2181	2929	1354	587	1237	4142	3613	172	4620	192	409
1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	25	51	1	4560	2797	4592	1907	4504	4738	3766	501	2035	1826	4014	3080	51	1358	1444	1144	3610	2276	3123	3218	2336	289
4140_Mean corpuscular hemoglobin concentration	4140_Mean corpuscular hemoglobin concentration	25	51	1	3902	1216	3108	2585	2865	3645	3211	4211	3462	1730	493	3413	4194	51	765	1568	2332	752	4629	3323	227	3388
441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	25	51	1	2070	4667	3936	2332	2467	2648	3101	656	4633	1149	986	4420	436	3378	1499	2382	363	51	1047	2769	3301	3884
3990_Neuroticism sum score	3990_Neuroticism sum score	25	51	1	2261	2865	4107	403	3565	2695	3289	2670	4275	2135	2140	2534	1837	2756	330	4623	2559	401	51	902	2229	2463
2656_CA3 - Carbonic anhydrase 3	2656_CA3 - Carbonic anhydrase 3	25	51	1	1359	2633	3009	2492	2313	2983	3980	4498	1687	3553	2471	3701	1072	1508	2772	3181	1119	477	2570	51	2196	1347
3671_Diagnoses - main ICD10: K40 Inguinal hernia	3671_Diagnoses - main ICD10: K40 Inguinal hernia	25	51	1	4062	981	2529	1098	3720	2780	2281	1881	2375	3440	2231	2256	1069	2830	1037	2381	3752	4362	291	1786	51	135
1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	51	1	411	226	1244	3487	2148	4415	4084	4535	3695	123	393	73	1476	4439	4114	2890	286	2822	773	2513	2001	51
479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	25	52	1	52	1806	4441	283	2745	860	1411	4658	2834	1874	990	3309	3743	270	3559	4594	3306	4535	543	347	468	3497
932_Pyruvate	932_Pyruvate	25	52	1	813	52	642	1904	777	247	1541	2911	3841	257	2027	4491	3093	1620	2383	1398	1173	1293	1990	281	1925	1925
49_Age at first birth (male)	49_Age at first birth (male)	25	52	1	3273	2340	4249	52	3211	1532	3071	3372	3577	4149	1467	761	2319	4025	3341	3413	1740	4695	1567	547	3533	1009
3868_White blood cell count (two-way meta)	3868_White blood cell count (two-way meta)	25	52	1	330	2998	2334	4490	52	2100	2679	3121	806	1620	3358	2603	3843	2674	2538	57	3468	3783	2551	195	2915	3215
1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	52	1	255	241	473	3492	4660	52	3239	3532	3203	2704	1048	1516	4589	2551	4029	3109	266	3441	2444	1864	751	3054
752_::::X-12063	752_::::X-12063	25	52	1	1068	308	1946	3369	2055	3744	52	667	99	3251	3445	3806	2542	3858	1188	2857	3068	2414	4598	2674	1818	3498
2056_Rheumatoid Arthritis	2056_Rheumatoid Arthritis	25	52	1	2322	4445	4221	63	279	4602	1785	52	1950	3129	3708	202	4647	1028	144	204	3813	3112	1840	3223	2755	3008
3225_Hands-free device/speakerphone use with mobile phone in last 3 month	3225_Hands-free device/speakerphone use with mobile phone in last 3 month	25	52	1	3215	1753	724	814	1046	4728	2849	1350	2711	3741	52	3134	4081	1115	1384	2520	2758	4442	4583	2741	2279	2795
1005_Platelet derived growth factor BB	1005_Platelet derived growth factor BB	25	52	1	2535	1305	260	2090	661	2593	2019	1816	1319	1428	4446	52	1448	630	2411	1124	2388	3183	644	3906	3225	789
2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	25	52	1	3561	4433	1693	2936	578	1082	2808	240	419	4373	1729	2157	52	2514	4042	329	3508	472	2974	2938	1173	2490
3276_Facial ageing	3276_Facial ageing	25	52	1	3408	2168	3542	88	3967	2856	3933	2379	4573	431	4412	1017	2381	52	3748	3295	2180	577	1803	4060	237	1555
2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	25	52	1	1159	152	1788	881	766	3734	2569	3375	156	62	741	156	3240	3368	52	1206	4628	4049	3693	2278	1888	345
2698_SBDS - Ribosome maturation protein SBDS	2698_SBDS - Ribosome maturation protein SBDS	25	52	1	3246	2541	825	1251	957	1483	2349	1761	2933	3058	3691	2727	2382	3949	151	439	52	999	756	4320	3836	3627
2888_KIRREL3 - Kin of IRRE-like protein 3	2888_KIRREL3 - Kin of IRRE-like protein 3	25	52	1	2611	1604	3077	2551	797	1850	3419	2871	3849	892	667	4373	3135	3209	70	1963	3908	52	2066	304	196	4226
68_Crohn's Disease	68_Crohn's Disease	25	52	1	3342	632	2241	2774	3675	1508	341	2864	3227	917	3501	2774	4242	4323	4638	4484	3515	3077	52	529	1947	3697
109_Coronary artery disease	109_Coronary artery disease	25	52	1	1163	2487	3403	4215	2812	853	419	1913	1096	731	1830	573	1902	178	1785	4642	1580	2182	1153	52	2534	672
3336_Ever had breast cancer screening / mammogram (female)	3336_Ever had breast cancer screening / mammogram (female)	25	52	1	3279	1889	1473	2832	265	3775	940	3289	2313	2267	1535	2518	862	3842	1547	390	3059	4343	4174	3536	52	764
144_Body Mass Index (male)	144_Body Mass Index (male)	25	52	1	2880	649	4017	4595	2744	4655	1982	246	1274	2373	3933	1813	3989	165	3458	3101	2148	4726	1604	165	4612	52
4095_Atrial Fibrillation	4095_Atrial Fibrillation	25	53	1	53	1090	608	3654	982	3075	2927	1007	1435	3874	2604	4266	3746	3187	1889	4338	4130	793	1700	3804	2106	3755
1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	25	53	1	4612	3313	53	2755	3051	3920	2709	401	1406	1649	2706	2524	2164	3629	2708	672	3802	3653	4226	392	675	1087
4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	25	53	1	4001	4344	1271	53	559	2673	4663	4430	2968	997	3423	3776	1167	4557	141	255	1523	3341	320	3462	1966	2641
4018_Systemic Lupus Erythematosus	4018_Systemic Lupus Erythematosus	25	53	1	3379	2796	1509	3678	53	3425	1636	3690	93	1958	2850	3525	1759	2160	824	60	996	3780	2176	205	1738	4219
3275_Childhood sunburn occasions	3275_Childhood sunburn occasions	25	53	1	4227	2242	3383	399	1606	3642	53	159	1331	3987	4233	3139	488	1659	754	3657	3575	368	4487	1558	2212	2188
3406_Fluid intelligence test - FI8 : chained arithmetic	3406_Fluid intelligence test - FI8 : chained arithmetic	25	53	1	3345	2607	1515	1872	2458	2546	1522	53	1782	3296	3161	2559	376	1740	4303	4672	2019	2025	1523	2510	2744	1227
3305_Lifetime number of sexual partners	3305_Lifetime number of sexual partners	25	53	1	4677	4516	1881	3191	1143	1285	4045	3430	529	53	3835	1008	380	575	1799	2516	2831	2534	2698	4669	220	2431
3267_Alcohol usually taken with meals	3267_Alcohol usually taken with meals	25	53	1	818	1186	1735	4413	602	2742	1656	762	3705	1200	53	265	2797	4474	3521	469	2132	2983	4687	4303	1062	1493
1780_Artial fibrillation (FBAT, adjusted for age and sex)	1780_Artial fibrillation (FBAT, adjusted for age and sex)	25	53	1	1493	2935	946	794	2004	4049	4230	2061	438	2234	4528	53	1437	1497	947	1912	4233	2980	690	4250	1343	3097
632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	25	53	1	3005	4043	4089	4063	2483	4651	3529	3412	811	4594	791	3686	53	3039	4442	3500	3088	2299	1090	1320	1873	465
3894_Neutrophil percentage of granulocytes (three-way meta)	3894_Neutrophil percentage of granulocytes (three-way meta)	25	53	1	3711	2914	3873	701	4180	151	240	736	4108	1365	1103	3552	363	1224	53	4154	2258	2918	2234	2498	3876	3981
1916_Temporal brain volume (FBAT, adjusted for multivariable)	1916_Temporal brain volume (FBAT, adjusted for multivariable)	25	53	1	212	4510	3130	926	691	339	2023	2259	1224	569	2274	674	1851	3539	2612	1578	53	3219	2131	4390	628	1868
628_Xenobiotics::Drug::salicylate	628_Xenobiotics::Drug::salicylate	25	53	1	625	1104	4642	1481	563	86	160	1760	2205	2701	1553	2258	2139	4154	4207	490	465	53	112	1106	3408	1836
465_Lipid::Bile acid metabolism::deoxycholate	465_Lipid::Bile acid metabolism::deoxycholate	25	53	1	1218	3558	1012	4671	4557	1628	4690	3198	1630	3135	2226	1176	3783	824	368	2550	4025	4687	53	1086	1148	4024
4096_Open-angle glaucoma	4096_Open-angle glaucoma	25	53	1	3602	4308	2791	872	4531	4250	3316	4340	3442	1799	3113	4036	4722	3700	1379	2452	1154	1507	2484	2706	53	2530
2436_CNTN5 - Contactin-5	2436_CNTN5 - Contactin-5	25	54	1	54	3180	446	3463	3282	3182	879	1117	845	1300	416	2149	2155	1245	3500	1577	817	1165	198	4523	990	3463
781_::::X-12465	781_::::X-12465	25	54	1	3725	54	2340	1212	838	1742	1008	172	75	2962	1478	2124	1800	4255	3450	2134	3380	3056	1982	2968	560	1608
280_CD8:%DR+73+39-25-	280_CD8:%DR+73+39-25-	25	54	1	3880	1465	54	4500	1969	2226	4540	2214	4423	3450	101	340	2954	2589	1671	882	1177	1501	2139	3938	2268	1469
2779_HSPA8 - Heat shock cognate 71 kDa protein	2779_HSPA8 - Heat shock cognate 71 kDa protein	25	54	1	3619	132	817	54	621	1595	2296	1980	497	4574	1808	2655	797	3333	3426	1353	4385	115	2699	522	538	2571
3328_Diabetes (diagnosed by doctor)	3328_Diabetes (diagnosed by doctor)	25	54	1	2616	2824	176	93	54	1715	393	1630	2757	3825	3705	72	1900	3639	2776	55	572	1938	1168	128	736	1029
2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	25	54	1	2814	1199	3894	329	4131	54	1291	766	2842	897	4457	3893	65	4693	3212	4078	3830	206	4528	1348	2850	2917
284_CD4:%Act(38+)	284_CD4:%Act(38+)	25	54	1	4301	2726	661	551	1475	264	54	3773	472	1945	2958	111	1873	4039	175	3716	1275	3987	3208	3041	2153	2577
4532_Right cerebellum exterior	4532_Right cerebellum exterior	25	54	1	2269	1607	1913	627	1494	4495	3438	3191	448	54	3635	980	2663	241	4617	2959	4238	1531	1536	380	386	1972
3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	25	54	1	196	3930	279	543	95	702	1081	2360	2746	2803	54	1032	2864	354	3074	64	128	363	1666	3773	1163	99
408_Amino acid::Tryptophan metabolism::serotonin (5HT)	408_Amino acid::Tryptophan metabolism::serotonin (5HT)	25	54	1	1307	2874	2158	886	1241	1054	3606	217	4465	1672	2851	54	4090	1824	4246	2719	419	4643	4574	2293	148	1119
3924_Heart rate variability (pvRSA/HF)	3924_Heart rate variability (pvRSA/HF)	25	54	1	1028	175	4192	1845	3529	1414	3946	3345	1400	1968	2218	901	54	4598	4718	3593	3667	2448	3751	3044	4346	1921
1155_Insulin sensitivity index	1155_Insulin sensitivity index	25	54	1	982	3198	317	4716	2609	4553	1786	3634	1546	2254	3255	2493	1029	588	1091	3658	1833	1965	2457	54	1450	4508
1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	54	1	4091	2950	2221	4132	2836	4574	2866	4485	3181	1966	353	4167	147	954	4679	1855	3053	2606	1676	3094	54	1651
4361_Atrial fibrillation	4361_Atrial fibrillation	25	54	1	4096	267	2194	1650	1853	1272	3491	265	1273	720	2342	341	4237	4698	3546	606	3155	905	4432	1328	4385	54
152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	25	55	1	55	4112	180	456	4096	611	4266	2279	4511	488	885	2891	1214	3433	737	3255	4355	3624	4283	3287	1915	3271
794_::::X-12719	794_::::X-12719	25	55	1	3804	1800	1330	55	4681	3634	3180	1347	4674	524	3014	3127	2999	1373	2427	4639	4452	3920	4700	2368	1789	2600
1343_Resistin (GEE, adjusted for age, sex and BMI)	1343_Resistin (GEE, adjusted for age, sex and BMI)	25	55	1	2698	4487	3811	4588	3646	1664	55	102	1147	3869	624	3452	1779	892	2112	2618	580	4621	4390	791	771	3902
3312_Electronic device use - Plays computer games	3312_Electronic device use - Plays computer games	25	55	1	4465	3628	3273	1441	2933	2997	457	55	422	290	3489	1119	3005	3250	4154	4692	660	1116	1748	974	843	4307
4020_Freckles	4020_Freckles	25	55	1	1112	2344	1210	781	973	2551	4621	1017	101	55	3527	1623	2003	336	2640	1045	2857	2515	2029	2594	2635	2443
2594_ECE1 - Endothelin-converting enzyme 1	2594_ECE1 - Endothelin-converting enzyme 1	25	55	1	780	4617	4534	734	4071	2393	3793	2967	2349	3602	55	1773	3348	751	2165	2642	2363	2966	2426	3460	4245	3519
4233_Antimigraine preparations	4233_Antimigraine preparations	25	55	1	1074	1280	1776	4318	3097	1531	2746	3538	3534	1795	3889	55	1208	1051	429	1885	2152	1211	3515	2551	1005	1264
1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	25	55	1	4042	3414	2018	3437	2031	405	722	3258	660	1653	2401	751	55	4033	251	2330	2503	1889	168	2872	1518	1001
934_Concentration of small HDL particles	934_Concentration of small HDL particles	25	55	1	3339	3191	1513	986	3503	1176	1458	2514	1292	4663	1861	1133	2182	1139	55	3060	4158	3138	236	4562	3894	2164
3830_Amyotrophic lateral sclerosis (meta-analysis)	3830_Amyotrophic lateral sclerosis (meta-analysis)	25	55	1	1254	3565	1304	4545	3256	628	3056	4677	879	2868	4051	4312	2453	2839	3801	2177	55	2068	3793	3489	2096	3834
3287_Sensitivity / hurt feelings	3287_Sensitivity / hurt feelings	25	55	1	3429	3053	2765	1519	3573	2246	896	273	4520	1177	3387	4250	2236	1083	3530	3158	4672	1272	55	3246	1829	1989
4660_Posterior limb of internal capsule fractional anisotropy	4660_Posterior limb of internal capsule fractional anisotropy	25	55	1	3312	1096	1510	1274	2353	1216	1964	1764	4062	3679	2245	4355	4342	1438	856	2658	1984	870	3823	4566	55	230
1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	25	55	1	1488	1504	1938	1958	1014	435	4164	841	1955	1142	4746	1613	1285	2549	4081	3624	987	3409	81	3426	3766	55
1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	25	56	1	56	4405	2216	810	4607	1016	2052	763	1837	4065	970	2781	1732	3691	2380	3228	1481	4233	2406	2389	2493	2615
874_Glycine	874_Glycine	25	56	1	1424	2532	4139	56	1522	3900	3673	4110	1946	3389	3732	295	1784	1712	1390	4340	3093	546	1909	1154	485	3220
4026_Childhood idiopathic nephrotic syndrome	4026_Childhood idiopathic nephrotic syndrome	25	56	1	932	1524	1665	1427	56	337	3546	2812	756	2657	3499	769	563	492	908	63	156	4708	2678	631	489	1541
866_Fatty acid length	866_Fatty acid length	25	56	1	1957	4362	334	299	4020	4734	217	4672	56	518	1929	563	3832	239	3162	3806	3394	3912	4402	4465	2310	3035
3217_Time spend outdoors in summer	3217_Time spend outdoors in summer	25	56	1	3916	3746	1701	672	4599	3411	1995	3833	4495	56	2721	2768	4623	2166	4366	3477	2538	1176	1356	550	1898	4258
4353_Tuberculosis	4353_Tuberculosis	25	56	1	3759	4360	3141	3201	4714	3816	347	4045	4241	1457	56	2032	1456	1044	4049	2885	2218	3018	2225	3192	507	131
3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	25	56	1	937	4256	527	3623	337	518	144	2631	2636	4062	106	56	2292	3399	365	1809	133	2456	2903	2800	4074	2215
1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	56	1	2810	3516	1272	2214	2198	4190	609	2851	4625	3027	1393	2332	56	479	795	2628	2670	4579	2724	286	2566	4068
232_mDC (2):%CD1c+	232_mDC (2):%CD1c+	25	56	1	433	3278	2699	3211	1130	4617	930	4086	57	1371	498	2144	3739	56	625	3368	1722	3885	3536	4063	2174	407
2710_EIF5A - Eukaryotic translation initiation factor 5A-1	2710_EIF5A - Eukaryotic translation initiation factor 5A-1	25	56	1	2826	1106	2043	2942	226	3049	4046	306	2626	3945	2097	397	1588	1146	56	227	1557	1664	3132	3185	2529	4519
2805_TK1 - Thymidine kinase, cytosolic	2805_TK1 - Thymidine kinase, cytosolic	25	56	1	1113	2816	1105	3277	709	245	2835	859	3437	4461	190	1616	1088	1283	4180	820	56	411	1516	3153	252	2460
4322_Depressive symptoms (univariate)	4322_Depressive symptoms (univariate)	25	56	1	1117	826	1173	2885	2670	3824	330	3442	929	66	4384	3812	1959	551	3417	1344	2073	4578	1879	230	3623	56
4306_Trunk-trunk fat ratio (female)	4306_Trunk-trunk fat ratio (female)	25	57	1	57	515	2202	1163	231	1009	4242	659	1829	1029	1246	495	119	4148	1002	236	111	2992	975	2418	3851	2777
4231_Salicylic acid and derivatives	4231_Salicylic acid and derivatives	25	57	1	783	57	4059	351	128	1231	434	2000	2866	2671	1072	1577	359	3019	2499	132	950	4197	3206	289	2056	1129
100_Pubertal growth (male)	100_Pubertal growth (male)	25	57	1	356	2869	57	2770	4601	4193	4373	3252	4746	2794	1259	1225	2615	3810	3591	4720	1898	1959	2318	214	2910	398
321_CD8mem:%R6+PD1+161-	321_CD8mem:%R6+PD1+161-	25	57	1	4136	2460	4394	57	755	3523	2061	2902	1354	3018	1359	2547	309	4625	4240	1384	3807	1926	2796	2882	3660	3007
4658_Inferior fronto-occipital fasciculus fractional anisotropy	4658_Inferior fronto-occipital fasciculus fractional anisotropy	25	57	1	3084	2466	963	4596	1107	57	253	1051	3042	77	3194	3999	598	4481	3787	943	1823	3128	1326	602	1609	4335
997_Interferon gamma-induced protein 10 (CXCL10)	997_Interferon gamma-induced protein 10 (CXCL10)	25	57	1	312	3361	4007	4683	4023	3184	57	2959	2465	241	3873	4722	651	2745	3595	2829	680	293	4177	1453	275	4133
184_Waist-hip ratio (female)	184_Waist-hip ratio (female)	25	57	1	132	646	705	2798	4587	136	3440	57	2013	2241	4582	884	4458	4646	4121	801	3173	376	3980	3525	3414	2592
1912_Occipital brain volume (FBAT, adjusted for multivariable)	1912_Occipital brain volume (FBAT, adjusted for multivariable)	25	57	1	4555	313	1435	2489	3273	3281	783	3240	4243	57	3487	616	2477	1220	3256	2969	4128	1988	2852	2999	924	3181
1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	25	57	1	3728	4467	441	659	2081	1456	1713	2587	1733	2966	57	4082	2439	2697	3188	1482	3631	1636	100	385	2358	296
2683_UFM1 - Ubiquitin-fold modifier 1	2683_UFM1 - Ubiquitin-fold modifier 1	25	57	1	2306	206	3372	588	3364	2283	4465	2910	3085	1883	1193	1170	57	1181	334	3767	441	4195	3295	4618	3158	2889
1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	25	57	1	270	3383	2059	3099	3546	926	3803	3214	181	3964	2921	1890	2581	57	2176	2899	1486	757	3822	317	1270	2562
3097_HAVCR2 - Hepatitis A virus cellular receptor 2	3097_HAVCR2 - Hepatitis A virus cellular receptor 2	25	57	1	177	1189	3250	4431	1771	3339	3147	458	790	2145	81	1835	1868	3307	57	3771	1184	3999	2409	1274	3041	3020
2359_IL13 - Interleukin-13	2359_IL13 - Interleukin-13	25	57	1	4676	779	3738	1300	2923	1276	2403	4223	1477	2874	4261	2743	4174	3865	270	1115	57	3450	3285	2205	998	2308
842_::::X-14625	842_::::X-14625	25	57	1	4368	3302	3708	3925	2685	3408	1437	3741	1730	1255	3738	1159	1245	4503	3700	4444	3580	57	1851	3527	481	2310
4292_Asthma	4292_Asthma	25	57	1	1380	2072	2209	988	2019	3298	2214	4289	3004	243	3275	2427	4698	2570	4625	3535	3253	303	3775	57	1285	4305
1024_Femoral Neck Length (FBAT, adjusted for age and sex)	1024_Femoral Neck Length (FBAT, adjusted for age and sex)	25	57	1	1563	1443	610	3601	3298	1619	479	3272	1424	2980	2903	3060	354	2693	2561	2456	3920	2237	372	3169	57	3158
3180_STIP1 - Stress-induced-phosphoprotein 1	3180_STIP1 - Stress-induced-phosphoprotein 1	25	58	1	58	1960	3326	1419	1717	4090	3436	696	2418	4234	2553	1592	3774	2438	3544	650	4642	2148	1705	4462	3987	3560
3184_Esophageal squamous cell carcinoma	3184_Esophageal squamous cell carcinoma	25	58	1	2024	4220	58	4575	943	4231	1136	2275	3258	2401	839	1419	3078	3667	4649	2206	1612	2189	3960	1580	1918	1856
4408_Vaginal discharge: Itching	4408_Vaginal discharge: Itching	25	58	1	97	643	427	4287	2954	58	591	3083	750	2563	3296	1196	4579	3646	4164	837	2214	1716	1926	3430	1997	3379
2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	25	58	1	2865	2398	501	2708	803	108	58	1497	1665	59	2157	2263	2268	1556	326	583	370	4021	4043	4419	465	306
2013_Response following treatment of MDD subjects	2013_Response following treatment of MDD subjects	25	58	1	1477	362	4298	2312	1308	3663	3675	58	1930	1157	4344	1745	3273	4177	4593	4535	2081	1128	2405	771	3411	2469
3087_RTN4 - Reticulon-4	3087_RTN4 - Reticulon-4	25	58	1	1514	3228	3122	436	1642	1096	1584	1359	58	3696	2795	2084	1185	1145	4383	413	1381	2433	240	218	2962	3526
4533_Right cerebellum white matter	4533_Right cerebellum white matter	25	58	1	660	3654	856	224	2024	4412	959	837	2096	58	1719	2995	3054	2350	1652	1010	4611	772	4013	4186	1811	539
3935_Disialylation	3935_Disialylation	25	58	1	4695	2609	1136	3613	3384	973	3219	3045	1599	2406	1018	58	4298	540	3191	1659	3715	781	3240	4506	3406	3941
231_mDC (2):%CD1c-	231_mDC (2):%CD1c-	25	58	1	945	3221	1795	3774	4707	3839	3291	2166	542	1734	448	4044	3128	58	757	3018	1197	2640	3195	2619	2924	1451
3501_Male-specific factors - Hair/balding pattern: Pattern 2	3501_Male-specific factors - Hair/balding pattern: Pattern 2	25	58	1	1708	1500	4630	3405	532	1118	2517	2033	1909	1824	639	1908	4308	4608	255	565	58	856	113	1067	2680	4396
354_IgE+B:%27+20-38+	354_IgE+B:%27+20-38+	25	58	1	1803	4473	3328	598	2999	1593	3004	4091	1488	1165	1086	3663	252	914	2359	4480	2244	58	417	2332	4718	3377
3994_Sensitivity / hurt feelings (HURT)	3994_Sensitivity / hurt feelings (HURT)	25	58	1	2867	304	1959	726	4552	2645	501	902	3845	1460	3760	2110	2867	2029	4261	4323	2828	294	58	3417	4176	1922
2939_F10 - Coagulation Factor X	2939_F10 - Coagulation Factor X	25	58	1	2125	718	1026	920	2088	2817	4527	2205	2921	1249	4691	1439	964	3615	4352	2710	1507	1569	2722	58	3850	1376
4710_Superior longitudinal fasciculus mean diusivities	4710_Superior longitudinal fasciculus mean diusivities	25	58	1	599	1254	2286	417	1786	1320	455	1743	2764	4041	1227	141	1252	3364	3759	2866	1876	3853	661	287	3679	58
458_Energy::Krebs cycle::alpha-ketoglutarate	458_Energy::Krebs cycle::alpha-ketoglutarate	25	59	1	59	3160	4206	2524	2330	1639	1872	1828	2241	3647	1913	1302	223	3362	4695	1351	2706	4370	577	2483	3035	362
2827_IFNL1 - Interferon lambda-1	2827_IFNL1 - Interferon lambda-1	25	59	1	3550	59	259	137	3231	3392	1561	3014	1916	343	3338	3771	2587	4011	2731	2067	1836	3232	1155	3665	1578	89
4217_Drugs used in diabetes	4217_Drugs used in diabetes	25	59	1	4017	1334	59	521	80	1080	1044	1096	4168	3922	4225	350	2132	1887	3629	84	474	3760	1632	376	3555	447
4254_Sleep duration (SD)	4254_Sleep duration (SD)	25	59	1	1128	2456	1655	59	1972	3087	1658	1441	3566	1007	3040	3640	2646	2328	1746	3063	2999	2465	3678	3503	1459	2836
1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	59	1	3497	914	1845	2037	4668	59	1435	4712	1148	1937	2019	4231	2211	862	2079	2513	868	4095	2685	1279	3453	250
3076_NOTCH2 - Neurogenic locus notch homolog protein 2	3076_NOTCH2 - Neurogenic locus notch homolog protein 2	25	59	1	2317	1414	164	3256	2642	680	59	2507	439	2034	265	3937	3601	987	3465	4161	1457	824	3715	3449	706	308
1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	25	59	1	2646	4157	3476	3539	944	4523	450	59	2531	3857	1671	4063	4658	3308	2693	1496	4500	4718	3073	1896	3353	3483
905_18:2, linoleic acid (LA)	905_18:2, linoleic acid (LA)	25	59	1	2728	2786	4618	2220	324	2253	1188	649	59	4550	4167	599	4710	3657	104	523	157	3412	888	1105	1012	3760
2651_TEK - Angiopoietin-1 receptor, soluble	2651_TEK - Angiopoietin-1 receptor, soluble	25	59	1	2628	1047	3494	1961	3216	979	2536	2835	1643	1598	59	1520	3447	1966	615	4528	2298	4336	2899	1295	3206	2051
2212_SOD1 - Superoxide dismutase [Cu-Zn]	2212_SOD1 - Superoxide dismutase [Cu-Zn]	25	59	1	1915	1963	3316	3557	4542	2279	3226	1085	3370	3006	4534	59	3358	949	703	4703	2048	3214	3476	3985	3654	124
4476_Right caudal anterior cingulate	4476_Right caudal anterior cingulate	25	59	1	2794	3709	4129	246	3284	4719	2335	1019	870	1835	1521	3576	59	3267	3614	2563	2203	227	3225	567	3565	2800
1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	59	1	1657	4674	3461	1628	1506	4449	4159	4734	2524	1622	2679	2723	4054	3744	513	1999	315	59	1610	198	4499	532
1915_Parietal brain volume (GEE, adjusted for multivariable)	1915_Parietal brain volume (GEE, adjusted for multivariable)	25	59	1	575	618	230	3900	3067	4650	617	1841	354	1976	2375	3908	4310	671	1244	2614	2849	829	59	184	2999	4059
4193_PR interval	4193_PR interval	25	59	1	3255	3352	694	982	656	2770	2618	3080	1923	173	623	2274	4006	231	1300	1898	1056	2990	1154	59	1421	4734
1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	25	59	1	3842	696	3465	1366	2768	4116	4271	4641	4741	1836	3757	3612	2315	3365	1347	3455	1082	1357	2738	3763	3363	59
3927_Total-body lean mass	3927_Total-body lean mass	25	60	1	60	3686	483	3333	496	3283	1018	987	4667	862	296	3455	2070	2981	3904	252	3985	3942	2658	740	1035	3208
4298_Thin vs extreme obese	4298_Thin vs extreme obese	25	60	1	348	60	4031	1840	3279	2569	1727	2772	659	1999	4638	3718	4729	2595	2416	4370	3203	3884	3085	3973	3409	166
2548_B2M - Beta-2-microglobulin	2548_B2M - Beta-2-microglobulin	25	60	1	1571	4330	718	928	60	261	3277	248	2966	3485	1219	4092	4438	3430	1064	70	4134	2303	3845	1189	2782	4543
3919_Low-density lipoprotein cholesterol	3919_Low-density lipoprotein cholesterol	25	60	1	883	455	292	836	1536	60	2988	355	269	384	197	474	3656	2293	64	3281	775	2727	723	4527	238	3241
2539_STK16 - Serine/threonine-protein kinase 16	2539_STK16 - Serine/threonine-protein kinase 16	25	60	1	540	4233	3929	1379	3776	613	60	4296	992	711	476	3719	3110	878	2153	4237	2942	1970	545	951	1615	761
1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	25	60	1	3014	2781	3568	4570	3736	4548	2261	60	2019	3811	2550	2721	3582	3835	1350	4613	4056	4530	1298	4570	3465	4207
2901_IL6 - Interleukin-6	2901_IL6 - Interleukin-6	25	60	1	3540	4587	2349	1781	4543	4230	1418	2997	4540	60	769	1034	3818	734	676	4386	2390	1699	1279	1781	1457	1903
1022_Neck Cross-Sectional Moment of Inertia (FBAT)	1022_Neck Cross-Sectional Moment of Inertia (FBAT)	25	60	1	2032	1399	972	4523	2478	977	739	3673	392	2175	60	2326	4618	1337	2459	324	4477	2203	3237	4621	4540	3106
1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	25	60	1	4272	2669	404	4373	4309	1667	4036	1023	550	3605	3891	60	1330	1823	798	2690	398	2912	4087	2793	4438	2066
432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	25	60	1	1259	3097	253	1309	3247	2890	2161	1451	1318	3231	4640	595	4688	60	1575	2185	4576	3753	1653	4639	2425	4234
3858_Neutrophil percentage of granulocytes (two-way meta)	3858_Neutrophil percentage of granulocytes (two-way meta)	25	60	1	855	2035	2372	583	4308	233	267	697	2917	805	1373	3002	1004	879	60	4716	4340	1653	2140	3917	1972	4303
1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	25	60	1	4083	128	2545	4023	3420	516	87	3897	2825	3974	1406	4125	234	611	3566	3165	98	60	3351	3456	2242	4086
3503_Male-specific factors - Hair/balding pattern: Pattern 4	3503_Male-specific factors - Hair/balding pattern: Pattern 4	25	60	1	2366	3879	3324	3776	1420	1737	2953	1035	1028	4671	3425	1719	3576	4178	2601	436	1423	246	60	2426	863	2213
1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	60	1	182	3704	2747	3341	2709	686	637	4213	4551	3883	125	3148	783	4579	923	3422	340	3630	481	60	3121	1525
535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	25	60	1	4636	661	3374	1963	1481	662	3837	269	226	863	3906	3218	138	896	4675	3122	656	4417	2227	712	60	4688
3509_Reason for reducing amount of alcohol drunk: Illness or ill health	3509_Reason for reducing amount of alcohol drunk: Illness or ill health	25	60	1	2504	2227	509	3715	1793	122	2750	4183	3312	3395	3179	4314	3266	1687	4496	1850	341	3943	3114	1692	4700	60
3042_ICOSLG - ICOS ligand	3042_ICOSLG - ICOS ligand	25	61	1	61	1526	2540	1352	646	4110	2635	823	2868	4349	210	638	4113	2038	4332	848	578	687	2882	1393	3948	4341
148_Body Mass Index (male <= 50 yrs)	148_Body Mass Index (male <= 50 yrs)	25	61	1	1869	61	2388	1855	4350	3375	4464	214	3168	2645	4539	1093	2530	2928	4413	4197	3077	3114	4670	1235	2035	113
4548_Left cuneus	4548_Left cuneus	25	61	1	3382	2445	61	240	3635	1683	4345	4215	1352	2811	4197	3210	4159	3843	123	2370	4703	2938	1232	2401	581	2115
4650_Body of corpus callosum fractional anisotropy	4650_Body of corpus callosum fractional anisotropy	25	61	1	1208	799	3813	3751	1531	923	2056	2668	61	4127	64	1601	1754	4326	1939	2385	4387	1190	2201	715	1019	2953
1930_Occipital brain volume (FBAT, adjusted for age and sex)	1930_Occipital brain volume (FBAT, adjusted for age and sex)	25	61	1	163	905	3837	1202	4280	1003	532	4141	4034	61	2723	710	1801	715	2521	2586	919	2098	3958	4429	2569	1145
3757_Mania - Ever had period extreme irritability	3757_Mania - Ever had period extreme irritability	25	61	1	3532	1292	1348	2633	4606	4656	1272	186	1432	655	61	3311	369	2135	4176	4302	995	3370	3250	3006	1563	2678
2876_CLU - Clusterin	2876_CLU - Clusterin	25	61	1	749	950	2685	1193	1935	1931	4089	2307	3780	1871	1386	61	3626	1128	3040	2345	4152	2408	1365	3756	3596	2037
4625_Left pallidum	4625_Left pallidum	25	61	1	2849	989	4172	2018	2791	3454	1459	3390	1103	1847	2842	2879	61	81	4253	2272	2155	4567	2758	445	1315	4631
4088_Paternal history of Alzheimer's disease	4088_Paternal history of Alzheimer's disease	25	61	1	4574	1134	2767	3636	3441	585	2447	4309	3861	1643	112	2390	2655	756	61	1667	1194	2220	1641	2379	1297	3707
620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	25	61	1	1403	458	2010	3971	4090	2840	3182	1453	4387	3814	4489	3018	2961	3990	4273	3524	356	61	4502	1581	1228	4507
3137_SLC25A18 - Mitochondrial glutamate carrier 2	3137_SLC25A18 - Mitochondrial glutamate carrier 2	25	61	1	3498	2421	3788	1293	3025	3050	953	2923	4183	2580	818	4720	2968	216	3221	718	3235	3872	61	3024	2720	2547
2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	25	61	1	988	4074	1549	2626	207	4334	312	203	4104	3159	3322	2255	1629	2103	1403	182	2766	2469	213	114	61	2104
3905_Intraocular pressure	3905_Intraocular pressure	25	62	1	4627	2630	223	62	750	2409	4099	2863	3918	4592	3475	683	3966	2402	2172	1902	3676	3574	4063	754	1620	1174
3824_Celiac disease	3824_Celiac disease	25	62	1	4188	911	429	1368	62	1482	913	1259	983	1930	1811	2369	2024	4631	1552	85	1361	1739	3450	907	4577	3631
4269_Neuroticism general factor	4269_Neuroticism general factor	25	62	1	3406	2568	1889	330	3444	62	822	4471	2454	706	4186	2234	947	4359	1649	4588	1421	1906	485	1237	1713	1574
375_Amino acid::Glutamate metabolism::glutamine	375_Amino acid::Glutamate metabolism::glutamine	25	62	1	152	3831	4709	171	848	955	62	2146	1679	2013	1953	1236	2805	4639	4070	924	257	1703	4704	746	3637	1707
1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	25	62	1	955	2230	3992	2859	2414	4395	4228	3914	62	4609	4636	4276	4597	563	2917	3577	4448	979	298	2021	4468	3757
1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	62	1	4549	812	233	1136	2897	2089	903	533	4182	838	62	1939	2416	3532	1480	3742	1769	4025	2514	1284	1666	1798
414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	25	62	1	3962	4144	2768	4083	2575	724	3910	1160	1393	136	841	62	396	695	3029	3071	800	3249	3407	4074	742	2576
3063_JAG1 - Protein jagged-1	3063_JAG1 - Protein jagged-1	25	62	1	728	2251	947	635	2497	2884	2817	3155	2774	1179	2047	4040	3910	62	912	4741	1949	4387	507	4680	2308	1225
1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	25	62	1	4593	1670	2099	2093	4328	4425	1020	538	2880	3119	4178	4174	3413	1424	62	1890	4712	859	378	4651	1590	2888
3932_Digalactosylation	3932_Digalactosylation	25	62	1	490	3224	171	1015	67	2807	1163	1235	2464	4360	537	2763	672	1402	3764	62	2088	86	143	3252	4719	4464
569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	25	62	1	190	380	2172	4126	500	128	900	2900	2036	1114	1362	2093	3913	2692	2631	257	62	967	222	1287	921	2772
4031_Alcohol dependency (discovery)	4031_Alcohol dependency (discovery)	25	62	1	192	2540	1076	3459	1463	249	775	3620	627	3288	1525	796	3949	1751	2652	4690	193	2274	62	2778	1906	3211
2033_Cluster headache	2033_Cluster headache	25	62	1	463	3100	3017	3145	778	589	1247	3126	610	4413	2966	3773	2290	2499	948	773	3279	144	2446	3247	62	2746
2960_IGHD  IGK@ IGL@ - Immunoglobulin D	2960_IGHD  IGK@ IGL@ - Immunoglobulin D	25	62	1	4133	347	478	931	208	1410	719	3921	901	1391	97	3657	2264	3008	866	221	160	4323	464	3373	4556	62
1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	25	63	1	63	3761	170	2574	1931	1339	2178	4226	590	2378	431	687	2136	159	2336	1316	4435	1349	1844	70	1206	3646
3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	25	63	1	2035	4484	63	1942	1151	4445	3243	3326	3563	2931	1518	2719	2897	4685	2342	1947	1664	1375	2375	1338	3380	4057
2601_LY86 - Lymphocyte antigen 86	2601_LY86 - Lymphocyte antigen 86	25	63	1	899	2613	811	4192	1887	3965	63	3842	141	4740	3585	2605	1912	2440	230	1645	4272	4210	1743	4304	2820	3327
1875_Shaft average buckling ratio (GEE, female, adjussted for age)	1875_Shaft average buckling ratio (GEE, female, adjussted for age)	25	63	1	3120	2188	2752	832	3500	2214	4575	63	2051	4284	3281	976	4204	3098	4506	2701	376	3811	3780	3344	1115	3438
2557_IL17A - Interleukin-17A	2557_IL17A - Interleukin-17A	25	63	1	1859	2134	1376	1531	3950	2155	1569	1247	2427	63	4666	240	4697	4346	2182	1461	1950	4498	4285	3892	4459	2135
4303_Legs-leg fat ratio (male)	4303_Legs-leg fat ratio (male)	25	63	1	2860	1444	172	4696	470	1988	447	457	569	1732	63	2535	1037	102	850	1255	311	180	159	4381	812	1162
239_CD24 on IgA+ B	239_CD24 on IgA+ B	25	63	1	2079	2266	65	4530	3090	2268	2595	4221	707	2597	3376	63	3972	2517	955	2372	1551	3892	3908	169	3988	2468
1142_Sleep duration	1142_Sleep duration	25	63	1	3351	1789	4624	767	3550	2031	1023	1264	153	4240	541	3791	1894	63	1931	4067	1623	3440	2098	2213	1370	2162
4110_Estimated glomerular filtration rate	4110_Estimated glomerular filtration rate	25	63	1	2126	4260	3974	927	1541	4255	872	1129	4215	327	902	4466	1486	1589	63	1739	4019	1433	2873	4397	4729	2044
1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	63	1	1550	2121	934	1219	873	1650	1303	4339	1076	4082	3019	2953	3060	2150	826	1811	63	1126	279	4129	194	1563
845_::::X-14658	845_::::X-14658	25	63	1	875	676	2607	4012	4051	4669	1229	4587	3040	3508	2286	4145	905	623	3404	994	3156	63	980	1658	4314	3973
328_CD4mem:%preTh17 (3)	328_CD4mem:%preTh17 (3)	25	63	1	2521	1877	3870	86	268	402	215	1229	139	103	1348	1720	3511	572	1473	194	942	4254	63	4636	471	656
2970_F3 - Tissue Factor	2970_F3 - Tissue Factor	25	63	1	651	909	3095	4644	358	336	1835	2136	532	4165	598	1930	2796	2237	887	849	820	1431	3274	63	86	625
4669_Anterior corona radiata axial diusivities	4669_Anterior corona radiata axial diusivities	25	63	1	880	1779	3963	4478	2034	502	3963	364	558	759	4718	2264	2300	2485	2680	3378	4680	2321	1872	3521	63	3720
121_Obesity class 2	121_Obesity class 2	25	63	1	1245	1019	1541	1680	2601	4301	4453	2838	3245	2469	873	2035	1760	1239	654	4417	886	4194	2636	604	3433	63
2788_NME2 - Nucleoside diphosphate kinase B	2788_NME2 - Nucleoside diphosphate kinase B	25	64	1	3623	64	3761	2127	4302	1918	1920	1393	4296	4311	3666	1827	4520	706	3676	1166	2221	1679	3243	2059	3015	4416
3808_Lymphocyte count	3808_Lymphocyte count	25	64	1	4392	1336	1351	64	240	369	474	2831	915	2040	919	3847	1222	2994	1294	146	1180	4058	361	1036	2399	279
1204_Rheumatoid Arthritis	1204_Rheumatoid Arthritis	25	64	1	2586	1137	511	1482	64	748	974	3806	276	1469	3980	120	3777	2152	3995	71	751	2569	916	257	4467	4716
1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	64	1	1445	3807	2298	3355	4456	64	2949	1676	4715	4468	1817	1055	3858	4448	1123	3078	2387	2455	1460	4036	4016	1874
1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	25	64	1	694	1252	4666	802	1672	3758	64	4720	3645	1410	3394	4025	109	2757	1267	2435	2851	520	2416	3876	378	1633
299_CD4mem:%Th1* (2)	299_CD4mem:%Th1* (2)	25	64	1	4606	4650	3946	3630	3538	816	1083	64	3152	366	743	3556	1340	2647	201	4525	3272	525	4431	3593	3007	1047
1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	25	64	1	3908	489	794	1795	4661	446	510	1038	64	1390	3533	2664	2723	1188	1065	3904	1041	2019	4322	3953	3150	1393
53_Educational attainment	53_Educational attainment	25	64	1	3337	1302	1356	2263	1656	4323	3373	3141	2915	64	1322	3040	4088	3559	3085	873	470	2730	243	1314	1480	3577
2388_CTSS - Cathepsin S	2388_CTSS - Cathepsin S	25	64	1	2595	2239	3624	3798	927	785	4705	1811	2584	886	2451	64	4484	4056	1577	1834	1426	2264	274	743	978	4548
1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	25	64	1	3965	109	648	798	4437	4368	446	1731	2579	2357	4006	2221	64	169	935	1075	2954	2041	3820	113	3535	3356
1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	25	64	1	2336	2899	4359	1145	2372	3195	3352	4651	1890	609	1031	1539	407	64	1455	4182	2043	3196	2516	2318	2444	4364
4010_Amyotrophic lateral sclerosis	4010_Amyotrophic lateral sclerosis	25	64	1	2709	1643	1355	1059	2360	205	1766	4600	4670	258	949	4690	2910	4198	2420	3895	64	2974	1744	277	597	4309
3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	25	64	1	2398	441	3872	1556	2269	3250	261	1553	1000	1878	699	4331	3811	860	1288	3267	2008	64	3346	1584	954	4457
2266_IL4 - Interleukin-4	2266_IL4 - Interleukin-4	25	64	1	3055	1200	4105	2421	2833	2345	4063	4069	4197	4115	4074	1473	372	2790	4576	3270	3585	502	64	1814	2570	2747
521_Lipid::Long chain fatty acid::myristate (14:0)	521_Lipid::Long chain fatty acid::myristate (14:0)	25	64	1	4053	3510	1228	1050	884	804	1747	3527	2331	2323	1870	853	154	4344	2090	1060	2094	3049	873	64	1937	85
2942_CCL7 - C-C motif chemokine 7	2942_CCL7 - C-C motif chemokine 7	25	64	1	1756	479	4387	3707	3292	324	2547	592	2649	376	2088	1409	4263	3214	2264	1584	2747	430	1226	4035	64	4402
2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	25	64	1	1441	358	4363	3300	721	3807	71	1110	524	240	1197	1997	2391	3993	229	2589	685	1744	2195	3991	4342	64
3000_GRN - Granulins	3000_GRN - Granulins	25	65	1	3004	65	1429	145	4583	3700	1246	4683	1834	4455	944	279	3844	2596	3021	3598	1128	336	1295	4628	3643	744
1235_Usual weekday sleep duration (GEE)	1235_Usual weekday sleep duration (GEE)	25	65	1	1227	4241	2743	65	1080	1228	134	729	1704	3756	2687	1545	3150	3068	550	557	2834	3260	689	3314	4367	1624
4263_Ankylosing spondylitis	4263_Ankylosing spondylitis	25	65	1	3708	2629	997	1477	65	1093	807	2355	787	67	2434	1583	4443	2806	1057	78	2263	392	1307	3292	2967	1542
2005_Maternal transmission distortion	2005_Maternal transmission distortion	25	65	1	1279	1766	75	1599	3100	65	3448	1584	3675	2382	3927	510	3589	531	118	1434	248	1135	151	2595	1235	3169
389_Amino acid::Lysine metabolism::lysine	389_Amino acid::Lysine metabolism::lysine	25	65	1	4268	3082	2704	3864	2675	4280	65	3399	113	3157	3050	4371	3161	4295	3784	3130	3706	4121	1288	535	1597	3931
985_Interleukin-17	985_Interleukin-17	25	65	1	2739	2661	4056	4657	365	1498	4643	65	518	2558	862	231	1190	682	377	185	1490	2798	1751	2107	2567	3605
4232_Anilides	4232_Anilides	25	65	1	3192	1426	1552	3804	107	3748	1038	3054	65	2605	3921	1793	1295	2637	2468	113	1700	3178	79	576	209	951
3220_Time spent using computer	3220_Time spent using computer	25	65	1	850	1876	3710	1538	911	3268	811	2791	2857	65	4425	470	317	2810	767	1372	3972	297	2891	643	2125	2873
4622_Left thalamus proper	4622_Left thalamus proper	25	65	1	2426	3431	4309	1997	4491	799	576	1975	4237	1879	2052	65	3962	874	2351	2525	3078	2505	951	3077	2690	4136
2386_CTSA - Lysosomal protective protein	2386_CTSA - Lysosomal protective protein	25	65	1	1318	3758	400	4660	4301	390	905	184	2268	4399	3716	4741	3902	65	1693	3704	1756	3124	3994	2776	1872	666
767_::::X-12236	767_::::X-12236	25	65	1	2620	123	2763	3339	1799	1511	2769	1380	589	1349	1547	948	1627	639	65	4679	2133	3839	1788	2883	1625	637
1138_Mother's age at death	1138_Mother's age at death	25	65	1	869	2689	1818	3546	1118	625	1983	476	2413	4142	3198	1768	544	3296	2973	588	65	4087	3586	138	4254	3962
995_Interleukin-8 (CXCL8)	995_Interleukin-8 (CXCL8)	25	65	1	638	1729	2622	4109	2283	2370	2548	1190	791	1003	3614	2289	4259	997	4481	3864	1004	65	1273	439	166	2176
1113_Visceral sdipose tissue volume (female)	1113_Visceral sdipose tissue volume (female)	25	65	1	513	1886	2036	3564	1147	1405	2553	3074	663	549	767	1630	4133	3477	4715	3236	339	2763	2713	65	4038	3913
1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	25	65	1	3467	4195	319	4527	3700	2252	2918	3893	3200	4320	926	3030	348	1986	2084	3431	1531	4545	3301	2018	65	1718
159_Hip circumference (female)	159_Hip circumference (female)	25	65	1	1930	399	268	2286	1187	2800	3127	796	4256	3211	321	3985	3123	124	1265	3759	3102	2723	3847	1174	3216	65
702_::::X-11438	702_::::X-11438	25	66	1	66	2314	768	2075	2396	4410	3406	220	3545	2452	4321	69	338	3290	3187	2878	2247	706	124	1750	387	3098
3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	25	66	1	405	66	2132	2210	291	184	3840	4106	2811	1032	1888	2445	752	3108	3741	2644	1489	2255	3663	2482	2609	3808
3821_Celiac disease	3821_Celiac disease	25	66	1	2764	2118	1644	1936	1601	4275	66	1794	1569	199	510	4084	2488	1172	3352	3464	638	1724	4590	4470	2105	4423
2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	25	66	1	3472	3600	1053	532	3809	3188	3002	931	2881	219	1294	66	3652	775	2274	1500	974	2297	364	1723	2151	1154
3510_Reason for reducing amount of alcohol drunk: Health precaution	3510_Reason for reducing amount of alcohol drunk: Health precaution	25	66	1	757	1915	2980	4334	820	3345	1784	4624	4490	3808	151	2602	66	1459	240	1425	4469	3967	3156	3428	1722	1474
799_::::X-12740	799_::::X-12740	25	66	1	3220	3750	827	4011	4347	803	955	1876	2269	1658	4430	1564	3206	4460	66	4199	2022	1607	4557	2331	1926	3083
3930_N-glycosylation	3930_N-glycosylation	25	66	1	704	1848	333	1146	72	2704	1162	1567	3242	3773	445	3814	867	1356	3783	66	2335	135	474	3033	2575	2076
3829_Posterior cortical atrophy	3829_Posterior cortical atrophy	25	66	1	2878	141	1005	2729	2901	148	1450	1530	4623	4442	3509	2399	759	2762	408	4211	66	739	77	3014	1587	4597
3324_Relative age of first facial hair (male)	3324_Relative age of first facial hair (male)	25	66	1	111	605	379	4525	3711	4672	4724	4247	2903	336	2613	4426	4664	2208	1487	3854	756	66	672	235	2008	1345
4611_Left basal forebrain	4611_Left basal forebrain	25	66	1	1984	768	2207	3018	1451	69	748	519	1651	3850	2309	3566	908	256	1059	3879	338	902	66	1458	705	2712
4324_Positive affect (MA GWAMA)	4324_Positive affect (MA GWAMA)	25	66	1	4385	2905	2203	306	3236	1965	1809	4346	3670	3456	1263	862	1052	1542	3652	1673	2452	3037	554	66	228	1876
2640_SST - Somatostatin-28	2640_SST - Somatostatin-28	25	66	1	67	1022	2095	2432	1695	149	695	2181	4493	3048	3505	2246	232	3175	4734	508	271	830	111	3522	66	690
3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	25	66	1	1831	1448	1049	3158	2908	4490	2752	96	3762	87	201	3260	184	3043	3639	1822	3134	1051	2315	3387	2610	66
1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	67	1	2139	67	4119	178	485	2948	1113	2548	2482	1247	685	552	1858	4351	711	638	3609	3938	249	82	1808	2408
3023_PRDX6 - Peroxiredoxin-6	3023_PRDX6 - Peroxiredoxin-6	25	67	1	1554	1118	67	457	345	4587	4384	4365	2730	1770	2076	2552	2243	1632	729	621	236	3229	1795	1045	3582	3170
4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	25	67	1	4631	4264	1015	67	558	2831	4380	4475	2635	1521	3359	3690	2019	3794	129	249	2178	3336	522	3720	2077	2644
4413_Total IgE levels	4413_Total IgE levels	25	67	1	3432	2694	4476	1480	2316	67	741	2440	157	1760	4488	1866	1458	558	1928	1307	124	3856	1410	2290	4702	967
1052_Ischemic stroke	1052_Ischemic stroke	25	67	1	1407	3526	2558	395	1365	1022	67	2195	1995	3579	703	1324	1880	1916	2114	496	628	136	2334	4558	3751	1516
1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	25	67	1	4499	2994	1566	3128	1761	4102	1591	140	67	4228	3141	1886	2857	2563	934	3694	394	4538	1983	1156	4466	1544
3213_Duration walking for pleasure	3213_Duration walking for pleasure	25	67	1	2370	2766	418	2561	3346	2762	1625	86	4678	2501	2750	67	3286	3017	2577	1660	862	4635	4539	2562	447	1845
2912_TFF3 - Trefoil factor 3	2912_TFF3 - Trefoil factor 3	25	67	1	2021	4067	451	1435	197	413	753	2643	4152	555	2873	1654	67	2339	1650	203	414	3034	376	470	67	4515
2151_TDGF1 - Teratocarcinoma-derived growth factor 1	2151_TDGF1 - Teratocarcinoma-derived growth factor 1	25	67	1	4128	4142	1611	665	401	3484	1261	2270	4375	4200	1659	2130	743	245	376	299	67	2781	2728	3509	3277	2971
1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	67	1	4379	4447	1826	4639	1042	2529	1047	1337	2250	3962	2837	2115	3461	3386	2108	3880	793	67	1989	4487	4554	1521
3795_Neuroticism	3795_Neuroticism	25	67	1	2075	3472	3610	1007	4163	2035	3118	2358	2297	2554	3160	1863	4563	3340	174	4421	1869	195	67	842	1984	3033
3863_Platelet count (two-way meta)	3863_Platelet count (two-way meta)	25	67	1	215	3786	4326	1854	2032	1837	375	2868	4709	861	406	2050	399	3422	1516	1758	3733	194	2487	67	2796	4163
2826_FGF8 - Fibroblast growth factor 8 isoform A	2826_FGF8 - Fibroblast growth factor 8 isoform A	25	67	1	3372	1087	3591	1914	1568	1419	2848	2859	2685	2377	3754	1042	3668	4605	2512	724	3286	4055	499	3135	795	67
538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	25	68	1	2401	68	4499	4690	382	2534	2610	150	604	3026	3830	1660	112	3342	4451	417	2013	4223	4652	3590	1011	2380
407_Amino acid::Tryptophan metabolism::kynurenine	407_Amino acid::Tryptophan metabolism::kynurenine	25	68	1	2967	213	68	2590	3774	3622	3041	371	4733	2519	4443	1664	1044	3874	4709	3411	486	4377	1579	2188	1207	2627
2739_IGHE IGK@ IGL@ - Immunoglobulin E	2739_IGHE IGK@ IGL@ - Immunoglobulin E	25	68	1	3994	4662	4696	3444	4703	2795	68	2285	2253	3448	4078	3480	4476	1288	1572	2532	850	1919	2964	3866	3721	869
3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	25	68	1	1290	480	524	2542	998	2809	2876	68	4464	869	2999	358	3863	4469	4292	505	3062	3061	4071	1521	2564	165
3218_Time spent outdoors in winter	3218_Time spent outdoors in winter	25	68	1	2065	3501	3439	1078	4363	2314	207	2369	516	68	362	892	3029	2321	2902	3833	3773	3312	3283	3176	2252	1953
1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	25	68	1	4078	2394	1528	3647	4105	3155	2597	4307	1854	1737	3970	682	68	2668	1362	4556	3364	1839	3077	2540	722	3838
3171_TNNI3 - Troponin I, cardiac muscle	3171_TNNI3 - Troponin I, cardiac muscle	25	68	1	1342	2225	1702	4272	4448	1097	2800	3062	1178	2942	4039	4546	3756	68	1114	3666	4042	836	1172	3805	3577	2078
4450_Left inferior parietal	4450_Left inferior parietal	25	68	1	959	1309	1280	1028	3845	3052	567	4429	1412	137	346	4035	3982	419	68	2697	3987	2733	1031	4583	298	3344
3657_Alcohol - Alcohol drinker status: Previous vs Current	3657_Alcohol - Alcohol drinker status: Previous vs Current	25	68	1	1837	1493	2753	1770	4612	917	3282	3423	4212	2220	3493	1873	3485	4080	4247	883	68	1524	3995	2606	4064	838
186_Waist-hip ratio (adjusted for BMI)	186_Waist-hip ratio (adjusted for BMI)	25	68	2	666	1175	234	2554	1167	531	1894	966	972	4318	2506	1245	2770	2923	3826	484	4698	68	1158	3350	1533	1126
4627_Left amygdala	4627_Left amygdala	25	68	1	486	1382	216	166	3215	2563	1002	842	2216	1916	440	1440	1870	3811	832	573	1009	324	2289	4001	2485	68
4574_Left supramarginal	4574_Left supramarginal	25	69	1	69	3009	2348	1411	2059	716	1949	4647	1561	234	2233	453	1667	1140	4097	2860	3954	1663	3001	4203	1828	712
2023_Skin fluorescence	2023_Skin fluorescence	25	69	1	227	883	69	1808	1685	1011	4499	4598	2047	83	625	2889	1964	886	1184	2011	755	926	3482	608	999	4466
3684_Diagnoses - main ICD10: R31 Hematuria	3684_Diagnoses - main ICD10: R31 Hematuria	25	69	1	2036	4027	839	766	69	1087	4681	1576	1847	4716	1408	2397	2685	2206	3543	75	3829	123	1433	709	4697	1228
3782_Depression - Sleeping too much	3782_Depression - Sleeping too much	25	69	1	1330	1883	1150	210	1970	4174	69	442	3792	1128	3201	3929	3067	2368	724	2741	4077	2212	4142	2053	1066	3907
2680_PTK6 - Protein-tyrosine kinase 6	2680_PTK6 - Protein-tyrosine kinase 6	25	69	1	952	4633	3048	1356	2769	4114	3171	69	290	4214	4514	1416	799	4418	2448	440	4182	391	4576	105	1466	4568
4518_Left inferior lateral ventricle	4518_Left inferior lateral ventricle	25	69	1	4589	2022	510	3844	3537	685	2367	869	69	881	3409	1744	1674	4741	3844	2640	1499	4394	1914	2091	2591	2453
172_Waist circumference (female)	172_Waist circumference (female)	25	69	1	2665	999	1772	1429	990	3128	3416	1591	2590	3176	1228	4149	3149	69	3845	3531	733	2675	3971	801	3844	599
739_::::X-11850	739_::::X-11850	25	69	1	1084	2757	3801	3548	2699	2693	1252	3357	4640	1274	368	3485	3664	1817	69	3017	2913	2658	1311	1119	421	1522
3933_Galactosylation	3933_Galactosylation	25	69	1	924	2183	207	579	73	1656	2343	4032	578	2003	4419	493	938	929	3362	69	599	189	1263	4323	1373	4195
3268_Alcohol intake versus 10 years previously	3268_Alcohol intake versus 10 years previously	25	69	1	3477	4018	2761	1399	2487	3225	1305	3477	1731	687	3820	3450	1040	2766	2589	2748	3919	4561	69	2917	4596	1637
1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	69	1	4383	2081	657	3898	4648	1903	734	1048	888	2535	1188	1518	1095	1802	4075	4450	1099	2422	483	69	3511	1896
1164_Glucose levels 2 h after an oral glucose challenge	1164_Glucose levels 2 h after an oral glucose challenge	25	69	1	4328	1268	2179	478	3459	2798	3407	1104	1608	2043	4510	1548	1926	1850	1195	2883	3397	3335	237	1946	69	4401
3803_Mean corpuscular hemoglobin	3803_Mean corpuscular hemoglobin	25	69	1	1656	4113	1331	1647	1443	1447	587	3228	450	2809	2353	2356	4715	1903	4120	996	1025	3796	2009	1457	2598	69
2456_PGLYRP1 - Peptidoglycan recognition protein 1	2456_PGLYRP1 - Peptidoglycan recognition protein 1	25	70	1	70	288	723	1021	1280	1668	221	2186	370	2669	4516	1899	4587	823	1255	2895	2631	939	1338	1117	4031	2018
1051_Parkinson disease (tier 2b)	1051_Parkinson disease (tier 2b)	25	70	1	3809	70	1646	689	2454	3203	2894	1022	4620	3952	156	3207	1974	772	2770	3564	1287	2241	1044	4746	1052	3204
419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	25	70	1	4114	101	70	4624	2660	3496	3263	4022	4664	912	4206	2804	3927	798	619	3553	2165	3285	2232	2186	2374	3828
2193_FGF19 - Fibroblast growth factor 19	2193_FGF19 - Fibroblast growth factor 19	25	70	1	4441	3087	1925	1385	2905	2189	70	695	2909	1887	2111	85	1770	3476	3349	3087	1315	1366	2381	944	3699	4153
1034_Neck Section Modulus (FBAT, adjusted for multivariable)	1034_Neck Section Modulus (FBAT, adjusted for multivariable)	25	70	1	1863	424	135	3168	3933	4318	3663	70	1757	1769	3793	3009	511	1346	2573	599	3595	3432	1650	1292	4630	2964
3518_How are people in household related to participant: Son and/or daughter (include step-children)	3518_How are people in household related to participant: Son and/or daughter (include step-children)	25	70	1	4464	2859	2679	4351	3574	3971	316	1693	3328	70	2922	1770	1875	1738	2257	1821	3457	1108	4604	3285	2195	2366
158_Hip circumference (male)	158_Hip circumference (male)	25	70	1	389	3985	1879	4555	4654	2321	2904	608	2229	2963	70	3928	1115	4015	2742	4637	1614	3870	1623	2836	2208	714
2550_CXCL13 - C-X-C motif chemokine 13	2550_CXCL13 - C-X-C motif chemokine 13	25	70	1	550	3772	191	3908	1620	4362	540	223	496	1125	2890	2294	70	778	1360	2127	3391	4348	2676	3874	2714	4506
3007_LGALS3BP - Galectin-3-binding protein	3007_LGALS3BP - Galectin-3-binding protein	25	70	1	3491	4413	684	453	2949	1172	1403	803	1358	3926	4349	1513	1475	70	164	1996	209	852	4500	222	3516	830
4721_Fornix (column and body of fornix) mode of anisotropy	4721_Fornix (column and body of fornix) mode of anisotropy	25	70	1	1860	3591	3370	1067	1163	3409	4102	3474	3311	480	4476	2936	2671	2872	2914	580	2568	70	2272	1427	1478	3956
206_Serum Urate	206_Serum Urate	25	70	1	2662	1289	3926	356	2056	847	3149	4643	1220	1708	4646	255	3296	3860	1489	3944	4092	171	70	1617	4670	1688
3456_Impedance measures - Leg fat percentage (left)	3456_Impedance measures - Leg fat percentage (left)	25	70	1	4396	3520	3524	2879	4700	2862	3738	1565	1784	554	1429	3907	3497	4084	3857	4299	3714	318	615	2634	70	1284
554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	25	70	1	3196	527	2979	1072	366	4283	4541	4444	3725	2315	1159	477	1590	88	3569	705	4141	718	2312	2666	2525	70
2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	25	71	1	71	2839	316	238	1779	3223	2989	1460	4166	2648	1964	2549	1307	3606	1933	742	4697	4172	4656	419	4332	4608
2207_CCL3L1 - C-C motif chemokine 3-like 1	2207_CCL3L1 - C-C motif chemokine 3-like 1	25	71	1	4237	71	3864	1413	3039	4618	1602	1361	227	2939	1365	380	923	3159	1377	2702	2474	211	4538	3000	3620	2908
4188_Fasting insulin	4188_Fasting insulin	25	71	1	4068	3754	71	2442	1841	4637	3154	1997	1874	659	934	542	745	2116	3137	2084	3930	1798	2818	4104	4137	3078
741_::::X-11858	741_::::X-11858	25	71	1	1313	2927	568	71	3542	1771	1297	4197	2073	2532	452	4665	514	1347	3113	2439	4191	1069	4635	369	2701	1866
4264_Ankylosing spondylitis	4264_Ankylosing spondylitis	25	71	1	3520	2526	672	1600	71	2003	1204	3950	2400	98	4300	1675	3744	2701	3402	82	2372	1672	1931	1452	2757	1647
1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	71	1	2930	723	4145	1442	224	71	776	990	976	3849	4331	2608	1153	2310	3747	637	77	3453	2737	446	4604	3999
1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	71	1	3131	3867	1497	1571	2881	2523	2958	71	2638	378	182	344	674	3885	4045	3988	1637	4382	1467	1667	2066	333
4191_QT interval	4191_QT interval	25	71	1	2493	1076	3087	1000	1822	3703	98	2258	71	360	3092	1749	3254	1945	4189	2735	472	1556	4384	711	2754	1835
2466_ADRBK1 - beta-adrenergic receptor kinase 1	2466_ADRBK1 - beta-adrenergic receptor kinase 1	25	71	1	3709	158	2049	1344	677	2043	1039	618	3045	71	2972	1632	730	3294	257	392	1529	2548	2545	2703	1944	3042
1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	71	1	3819	3353	3484	97	3404	2134	1042	1614	1258	1651	3629	71	740	4362	232	1267	1326	2900	353	785	1946	857
1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	25	71	1	3641	1887	3380	2845	4592	3685	1740	464	875	2849	671	4666	71	1548	4293	3266	3577	747	2173	1166	4633	1963
4488_Right middle temporal	4488_Right middle temporal	25	71	1	155	1028	1903	1539	3121	2075	2900	4585	3946	3134	2430	4395	796	71	3494	3982	785	3650	3549	2811	1057	3073
3944_HbA1c	3944_HbA1c	25	71	1	4741	3503	3607	3968	3713	3467	2466	2352	3428	3324	3794	2620	1525	73	1032	4555	856	71	179	4032	1461	3478
4698_External capsule mean diusivities	4698_External capsule mean diusivities	25	71	1	3716	1403	4449	4235	3828	772	3820	492	2630	1733	2766	4529	653	4683	2016	4391	1054	2690	71	1688	680	215
544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	25	71	1	3373	4539	1102	3725	827	2722	2726	4686	4590	4138	2392	579	3534	1745	4037	1452	3401	1665	1180	71	2808	3419
3681_Diagnoses - main ICD10: R07 Pain in throat and chest	3681_Diagnoses - main ICD10: R07 Pain in throat and chest	25	71	1	2881	3449	3371	3733	3123	2778	1213	1674	463	3801	3424	3687	3798	4475	4417	1582	4449	4618	688	2417	4386	71
3230_Morning/evening person (chronotype)	3230_Morning/evening person (chronotype)	25	72	1	72	801	1160	415	2213	1210	1366	2582	2267	2658	4693	353	2147	1300	707	1494	3563	3808	1552	2740	1546	364
4274_Short sleep	4274_Short sleep	25	72	1	2193	72	1264	953	2282	1354	4600	892	4393	4345	1303	450	4736	265	2656	3328	1138	1299	854	348	984	3765
2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	25	72	1	1270	2034	1325	3724	3918	916	72	3179	4553	2243	227	966	1371	2197	2083	3608	199	4592	3353	3050	1827	1303
4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	25	72	1	4614	3721	506	3050	1604	1047	2132	1535	72	2941	872	639	2720	4254	2838	3182	2447	3979	1470	697	160	3829
3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	25	72	1	2859	1536	990	3203	2473	2555	1911	2106	511	72	4677	3428	827	1760	3726	1033	3625	2013	722	3803	4272	208
2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	25	72	1	1901	2802	3867	2593	1998	3701	3753	1228	3676	1277	72	802	2639	3059	4542	3631	185	2787	2849	1255	1782	818
3529_Never eat eggs, dairy, wheat, sugar: Wheat products	3529_Never eat eggs, dairy, wheat, sugar: Wheat products	25	72	1	1013	420	353	149	77	759	1011	3982	301	2422	1694	244	3864	3220	786	72	351	1994	182	73	2282	654
2533_POSTN - Periostin	2533_POSTN - Periostin	25	72	1	3107	3113	4088	3801	3721	4538	4329	335	606	2840	1224	92	126	3568	2119	2605	4284	3322	72	1923	2472	546
3899_Platelet count (three-way meta)	3899_Platelet count (three-way meta)	25	72	1	256	3957	4398	2031	2029	1680	424	2411	4485	1314	409	1822	392	4262	1522	1749	3528	186	2697	72	2968	4489
549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	25	72	1	1939	124	2770	1860	1707	3550	2097	91	1479	140	814	1889	684	4585	3713	4472	1164	3677	312	1989	72	1489
2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	25	73	1	73	2323	1180	1602	1865	2577	2710	3174	1715	3549	4055	4330	4306	2332	3214	1656	3626	1295	3222	3139	871	369
1012_TNF-related apoptosis inducing ligand	1012_TNF-related apoptosis inducing ligand	25	73	1	2842	73	4610	1440	1410	2306	2483	3884	1065	4217	3799	832	2156	1874	359	2242	262	3697	2646	4295	408	3030
4229_Drugs affecting bone structure and mineralization	4229_Drugs affecting bone structure and mineralization	25	73	1	1568	573	447	311	3087	73	339	3210	3286	2913	1390	169	3470	573	1815	1838	424	803	549	378	1391	1417
622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	25	73	1	3046	2561	2152	938	1416	4528	73	3183	380	2548	3416	4134	4651	2893	2591	530	4196	2144	3599	4016	1318	3657
3247_Poultry intake	3247_Poultry intake	25	73	1	1933	3517	2998	2706	636	1748	2375	73	2354	2441	4050	4211	4467	4042	4125	641	1904	1053	335	739	509	2006
4082_Waist-hip ratio (adjusted for BMI, female)	4082_Waist-hip ratio (adjusted for BMI, female)	25	73	1	1075	3051	435	1288	1084	934	2364	1033	73	2745	492	4655	106	1603	3237	401	3421	655	3933	3336	677	422
3949_MYCN amplification neuroblastoma	3949_MYCN amplification neuroblastoma	25	73	1	4460	1720	3588	4174	3035	2178	1075	1740	2912	73	1114	3707	2084	2733	1148	2816	1570	2171	909	2100	2615	2504
612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	25	73	1	1411	4697	97	2977	2859	941	4205	3463	1193	1806	73	3262	3112	3907	1343	800	2788	3596	3349	2616	1469	3353
4442_Epstein Barr Virus antigen EBNA IgG levels	4442_Epstein Barr Virus antigen EBNA IgG levels	25	73	1	609	913	807	3320	85	651	4740	2922	2271	1925	4416	1078	932	3219	2916	73	884	1007	135	557	1319	2773
1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	25	73	1	4521	579	1758	1307	1839	3738	2303	877	1933	1382	3711	4022	379	3441	2007	3723	3616	73	4631	3346	156	1524
2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	25	73	1	3416	1346	421	4047	3182	2019	2500	3556	1063	4197	4016	2752	2924	3520	2028	2870	723	184	921	3128	4328	73
975_Eotaxin (CCL11)	975_Eotaxin (CCL11)	25	74	1	74	3639	222	2055	351	4338	2455	3906	4210	4677	4249	1459	3201	1657	4190	1149	3487	2260	3242	3918	4564	2251
4129_White blood cell count	4129_White blood cell count	25	74	1	2561	231	1861	3820	74	3826	351	3676	557	3800	3679	2629	2218	1683	4065	80	585	1138	1218	2409	1060	253
1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	25	74	1	559	4525	390	939	2446	2375	4071	74	3791	3550	485	138	355	1864	3981	3935	2240	625	3880	2451	3941	4672
4117_Total bilirubin	4117_Total bilirubin	25	74	1	1058	1366	926	450	3907	2237	3544	1672	74	2838	4123	3446	3948	158	4122	3669	1546	2807	4560	2097	4373	4169
1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	25	74	2	2461	325	1982	4693	4547	3720	3314	903	4681	74	3641	2523	4238	4066	2243	1920	3965	1612	4356	1298	3243	4026
2347_HP - Haptoglobin	2347_HP - Haptoglobin	25	74	1	986	856	3455	910	2781	1824	1350	368	1575	2341	3920	74	3591	337	2392	1901	606	3597	3040	1168	110	174
534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	25	74	1	927	1626	2431	1353	4123	1503	1439	182	3593	1630	2575	1088	74	1431	3867	2150	1218	3071	1323	3654	590	3297
2203_IL17F - Interleukin-17F	2203_IL17F - Interleukin-17F	25	74	1	2494	3109	3981	1285	246	867	4496	775	679	1987	1795	2227	897	3124	74	241	3864	4617	4730	2709	2061	212
1028_Neck Width (FBAT, adjusted for age and sex)	1028_Neck Width (FBAT, adjusted for age and sex)	25	74	1	4393	2145	4613	4101	3392	830	1649	147	886	547	350	234	2414	3300	4015	3309	408	925	74	2210	4401	4711
731_::::X-11799	731_::::X-11799	25	74	1	1611	1841	2361	2430	1594	2978	89	367	4028	4270	1930	2306	4420	4081	4655	2972	2046	2001	370	74	114	4549
1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	25	74	1	2185	2158	4141	4377	1936	2905	2728	637	4149	1456	1570	4537	1270	3982	1811	1825	87	1194	1093	1002	1710	74
555_Lipid::Medium chain fatty acid::caprate (10:0)	555_Lipid::Medium chain fatty acid::caprate (10:0)	25	75	1	75	2382	3527	496	3053	4324	464	1784	4226	1150	2626	1816	413	4193	1098	4206	4652	2941	3099	661	169	2900
4312_White matter hyperintensities	4312_White matter hyperintensities	25	75	1	408	75	141	682	3411	3332	1255	277	465	1442	148	1631	1264	4496	3863	2057	2848	1263	1560	203	4294	4527
4433_Mumps IgG levels	4433_Mumps IgG levels	25	75	1	2094	1568	2836	75	714	4348	3538	3908	316	2638	795	1788	296	333	4269	2786	3261	4522	1110	851	1183	2440
2335_CXCL11 - C-X-C motif chemokine 11	2335_CXCL11 - C-X-C motif chemokine 11	25	75	1	1980	2279	2838	401	1611	75	2419	2849	4486	1553	4117	3087	1055	1565	1029	2947	1101	4372	4066	3532	3176	752
4083_Type 2 Diabetes	4083_Type 2 Diabetes	25	75	1	812	459	1238	558	3517	807	75	2585	2105	2054	1283	4184	3345	4489	1278	2352	1017	1818	3318	4321	625	2401
624_Xenobiotics::Drug::hydroquinone sulfate	624_Xenobiotics::Drug::hydroquinone sulfate	25	75	1	4510	4346	2733	4428	3164	2159	4609	1371	78	988	4118	75	2039	2531	481	2487	4709	4184	4354	3389	377	1133
2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	25	75	1	1238	3285	3961	1157	3253	2843	4696	3207	1852	2022	3164	209	1572	75	3861	3061	2609	2590	3015	2268	3045	2563
3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	25	75	1	1817	3005	3449	1939	135	406	460	3299	4045	453	254	2197	504	250	75	148	3716	354	1699	4038	1798	3270
434_Carbohydrate::Aminosugars metabolism::erythronate*	434_Carbohydrate::Aminosugars metabolism::erythronate*	25	75	1	2459	2912	2847	3009	377	630	2620	2321	4534	3768	3506	4581	3939	2113	3762	503	1418	75	4069	824	2661	240
2096_POMC - Beta-endorphin	2096_POMC - Beta-endorphin	25	75	1	2288	2139	3897	1270	4497	1476	2580	1554	3804	1164	4521	1762	3031	420	770	3711	4179	1221	3357	4195	75	2977
143_Body Mass Index	143_Body Mass Index	25	75	1	1235	793	1467	4383	2592	1031	2799	567	1830	2528	1687	2681	4233	654	1984	3981	956	4637	2883	1534	2222	75
4052_25-Hydroxyvitamin D level	4052_25-Hydroxyvitamin D level	25	76	1	2445	76	4472	3209	903	2431	2995	2755	1366	2084	1262	2244	3607	3766	413	1473	2886	2160	443	3790	1940	4283
4331_Postburn scar height	4331_Postburn scar height	25	76	1	4519	3490	4375	3155	1946	76	4295	1699	1025	2503	2540	2666	1949	863	3053	1469	1133	2129	1941	479	2049	3756
843_::::X-14626	843_::::X-14626	25	76	1	160	1647	852	4228	4082	3529	4187	643	76	606	255	194	520	3458	1808	3901	1371	3485	998	2764	177	1226
1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	76	1	3420	3305	1781	409	3728	2458	4154	487	504	76	3752	3509	2958	502	3009	4445	4257	456	1465	258	1912	3772
2156_IGFBP5 - Insulin-like growth factor-binding protein 5	2156_IGFBP5 - Insulin-like growth factor-binding protein 5	25	76	1	1682	1688	2934	3897	809	1180	3153	191	429	3480	734	1943	76	2082	1673	1007	4451	4740	2789	2232	504	2026
1148_AUC insulin	1148_AUC insulin	25	76	1	2268	2624	3892	2693	2431	3053	3984	2482	2922	3526	1511	174	764	76	2523	3237	2939	2305	2616	1315	3019	3624
1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	25	76	1	1052	3416	896	373	4200	2921	3164	3117	1777	691	2957	2105	2505	508	76	3659	4111	2707	4347	3362	247	1939
4334_Asthma	4334_Asthma	25	76	1	2388	4029	3915	3187	92	4198	948	145	3698	4404	2920	2398	104	1380	3216	76	4080	4663	4611	706	1292	855
1002_Monokine induced by interferon-gamma (CXCL9)	1002_Monokine induced by interferon-gamma (CXCL9)	25	76	1	4028	1603	4477	688	2946	99	2586	4075	1263	607	2158	2941	1497	4297	1985	2761	76	1274	2612	888	641	3912
2243_ARG1 - Arginase-1	2243_ARG1 - Arginase-1	25	76	1	2920	3767	4019	3269	3461	240	1077	261	4293	2547	4172	4152	859	1829	4535	2262	4270	76	1130	1017	4529	1766
1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	76	1	3573	3871	2890	2531	4646	3543	3894	979	2081	806	1766	3685	1605	4065	2126	4599	3152	4415	76	784	1771	3778
1234_Usual weekday sleep duration (FBAT)	1234_Usual weekday sleep duration (FBAT)	25	76	1	2003	2990	2013	4629	2386	2352	1854	820	2791	651	611	1123	1103	2181	1891	875	2572	3531	4510	76	2236	3174
2429_CD109 - CD109 antigen	2429_CD109 - CD109 antigen	25	76	1	4113	3737	3791	1982	1119	777	2914	856	3448	3677	3677	2049	4557	238	1527	1511	1484	4680	4042	2953	76	4268
1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	25	76	1	3785	2849	1037	2259	1664	2128	3672	3552	317	2376	582	2646	4609	4379	3613	4502	1105	2598	765	4606	2691	76
1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	25	77	1	77	4711	2418	1055	1648	4031	3057	2901	1019	2365	2220	746	3339	4257	4222	1066	1565	2750	3153	437	3114	2405
2968_SHBG - Sex hormone-binding globulin	2968_SHBG - Sex hormone-binding globulin	25	77	1	1711	77	1949	946	1966	4169	4671	1210	594	3321	1385	2972	4348	4688	1539	2314	2815	1981	4720	4713	2040	4075
933_Total lipids in small HDL	933_Total lipids in small HDL	25	77	1	3190	1773	77	334	1328	144	669	3473	692	4293	2808	1268	652	431	185	4126	3586	3321	698	3164	1184	661
2756_SELP - P-Selectin	2756_SELP - P-Selectin	25	77	1	102	1062	345	77	1373	1882	164	3030	2874	2099	981	368	4322	3958	1675	1732	4521	1634	705	1609	316	2811
4558_Left middle temporal	4558_Left middle temporal	25	77	1	3175	186	725	3921	1434	77	133	2933	761	576	2107	3645	2165	1432	425	781	4278	1807	939	1680	1905	2650
1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	25	77	1	1458	1081	3716	140	2499	808	77	2197	3186	3653	2419	828	3507	4419	4278	2792	3334	2752	2024	3884	2253	4241
3006_JAK2 - Tyrosine-protein kinase JAK2	3006_JAK2 - Tyrosine-protein kinase JAK2	25	77	1	1184	2173	2580	3846	3347	3314	246	77	1530	3683	3584	4481	2945	2093	3658	915	1770	1504	2723	972	801	4316
4399_Menstruation quality of life impact: Depression	4399_Menstruation quality of life impact: Depression	25	77	1	2735	1250	702	2547	968	4121	3456	3735	2050	894	77	3549	1504	3919	1166	3059	1766	2993	4300	868	3648	872
3_Attention deficit hyperactivity disorder	3_Attention deficit hyperactivity disorder	25	77	1	2096	4455	3233	4304	2412	4733	293	1102	1742	3562	3844	77	2862	2367	1109	3478	2234	269	4744	410	2067	2466
3048_DSG2 - Desmoglein-2	3048_DSG2 - Desmoglein-2	25	77	1	3691	4343	4545	3353	4147	4654	2195	2744	1775	2807	1469	4607	77	262	4394	3351	176	1995	2546	4108	3906	1719
483_Lipid::Carnitine metabolism::octanoylcarnitine	483_Lipid::Carnitine metabolism::octanoylcarnitine	25	77	1	4697	2537	3923	2188	1362	4245	3761	2077	2699	1362	2321	1798	3382	77	630	822	4528	3358	529	196	1425	2199
3822_Primary biliary cirrhosis	3822_Primary biliary cirrhosis	25	77	1	510	2385	2028	440	87	991	3434	1187	3358	3359	2300	4619	3967	2088	77	94	727	1610	1782	1973	3052	1604
4137_Hematocrit	4137_Hematocrit	25	77	1	3793	4725	2505	4602	1562	4463	683	587	2150	3856	1565	2152	2545	2911	2663	3882	4438	77	598	3529	4020	4084
2271_SERPINE1 - Plasminogen activator inhibitor 1	2271_SERPINE1 - Plasminogen activator inhibitor 1	25	77	1	1740	2383	2670	1960	2417	906	3637	4419	2798	3487	4407	3632	389	3888	2209	3602	92	4112	4364	3115	77	4656
2163_PF4 - Platelet factor 4	2163_PF4 - Platelet factor 4	25	78	1	78	4693	468	3119	1948	3661	4601	1485	287	2037	1643	3393	449	285	4698	1950	1369	2022	88	431	2036	2394
1902_Frontal lobe volume (FBAT, adjusted for multivariable)	1902_Frontal lobe volume (FBAT, adjusted for multivariable)	25	78	1	3504	78	2827	3670	2549	3614	2786	402	995	4268	1039	469	3074	4185	1051	2264	1144	4720	2365	1605	1454	1565
83_Lumbar Spine BMD	83_Lumbar Spine BMD	25	78	1	3389	3250	78	1816	1295	1069	4278	2834	4420	1478	3895	272	1792	1353	2994	1567	1963	4061	231	584	104	184
2074_C8A C8B C8G - Complement component C8	2074_C8A C8B C8G - Complement component C8	25	78	1	1578	2388	1045	78	2683	2455	1431	624	2332	2604	1926	3518	787	1629	3888	4455	4110	232	3594	702	1977	2471
2285_MMP8 - Neutrophil collagenase	2285_MMP8 - Neutrophil collagenase	25	78	1	2430	2986	2077	3761	78	921	2184	1248	1987	4664	2918	4522	2653	2466	2844	86	3583	3082	4122	1755	170	612
4160_Focal Epilepsy, hippocampal sclerosis (HS)	4160_Focal Epilepsy, hippocampal sclerosis (HS)	25	78	1	3928	4686	3797	2152	2852	3126	78	838	4499	3451	294	4140	1048	2926	1202	3571	1665	256	319	1876	875	4681
2712_KPNB1 - Importin subunit beta-1	2712_KPNB1 - Importin subunit beta-1	25	78	1	3589	620	1042	1888	399	4295	3641	78	84	3317	4608	2690	2036	4387	731	376	2667	4313	4302	3747	3853	2154
2041_Attention function - Hit reaction time - Child	2041_Attention function - Hit reaction time - Child	25	78	1	4487	2221	4281	4486	1219	1130	4533	1303	88	3528	78	555	1428	142	96	2112	3632	2653	4625	1820	460	4447
1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	25	78	1	3199	258	174	4366	1124	3502	317	1425	1790	621	1648	78	3750	1764	2574	1006	4730	842	2168	3081	1658	4695
3460_Impedance measures - Arm fat percentage (right)	3460_Impedance measures - Arm fat percentage (right)	25	78	1	4236	954	903	2155	4563	2232	3878	506	2610	3374	2945	4273	2078	78	1320	3899	4577	3162	4330	2173	1542	383
3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	25	78	1	2030	2992	189	3223	461	1818	4321	1288	4117	1319	779	4175	2522	3718	78	286	1968	3921	1329	2356	3112	1686
1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	78	1	2375	219	1075	4260	4046	4085	300	3219	4321	1684	341	2002	2228	3265	3949	2000	4059	2888	78	1352	1850	2803
90_Body Mass Index - Child	90_Body Mass Index - Child	25	78	1	375	1225	815	4177	3186	2621	1066	4652	581	3237	3144	4219	293	4296	4131	4477	1977	2927	1850	78	2483	1328
3655_Smoking status: Previous vs Current	3655_Smoking status: Previous vs Current	25	78	1	593	2464	2112	895	4742	722	4446	4392	1741	508	449	4459	3641	3180	1068	2976	2196	2670	129	2233	78	3293
4125_Fibrinogen	4125_Fibrinogen	25	79	1	1709	79	4743	247	940	2652	2102	1329	2546	2725	4302	3586	3430	3413	1340	4005	2780	4364	122	3865	4209	2761
3524_Transport type for commuting to job workplace: Car/motor vehicle	3524_Transport type for commuting to job workplace: Car/motor vehicle	25	79	1	3827	3586	79	449	4405	4058	1198	3216	3935	4238	1689	877	3683	2354	2865	4534	4568	1070	3321	882	2420	2262
1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	25	79	1	3403	3697	4327	79	4508	3338	2702	2883	4711	4444	415	1856	1355	1849	273	4255	4259	601	3478	2319	2934	469
3819_Multiple Sclerosis	3819_Multiple Sclerosis	25	79	1	3542	513	2302	1624	79	4238	485	1795	2433	398	4606	229	3192	2378	1944	105	3193	2484	1692	4059	2960	3482
4321_Neuroticism (univariate)	4321_Neuroticism (univariate)	24	79	1	4047	2446	1823	1446	4234	79	1384	2455	3640	405	1494	1725	454	4452	3670	2176	2772	704	772	970	3589	540
3397_Shortness of breath walking on level ground	3397_Shortness of breath walking on level ground	25	79	1	2550	3380	3156	387	1999	4039	79	327	768	2086	1685	1653	1250	500	1580	3313	2446	2982	2171	2602	4384	1237
3413_Fluid intelligence score	3413_Fluid intelligence score	25	79	1	3147	2272	2444	4301	3337	4707	3999	79	4347	625	4475	2268	2879	787	3102	2891	1183	984	1973	288	1458	3295
3044_CD300C - CMRF35-like molecule 6	3044_CD300C - CMRF35-like molecule 6	25	79	1	2599	2531	502	3146	520	3446	533	3090	79	2863	215	4253	1175	1806	570	2170	468	1477	3254	1604	942	251
2297_CNTN1 - Contactin-1	2297_CNTN1 - Contactin-1	25	79	1	1634	1173	2565	3464	3313	3970	4336	1751	3603	2197	79	4148	4198	2814	1707	1442	2966	2947	1145	1374	4543	1731
875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	25	79	1	1467	722	698	116	1283	208	1082	1922	1827	868	1421	79	4318	2898	1082	2908	1208	4481	4516	4037	1338	1745
4138_Mean corpuscular volume	4138_Mean corpuscular volume	25	79	1	4168	2315	2484	3199	2186	1138	1021	1041	4472	1306	1503	3412	4106	79	1301	824	3675	396	2868	3402	3372	3459
683_::::X-10429	683_::::X-10429	25	79	1	3157	4273	1064	3786	4450	3175	283	455	310	2765	1028	1679	1025	4556	79	3129	259	3830	2645	1107	1806	454
4237_Antihistamines for systemic use	4237_Antihistamines for systemic use	25	79	1	2432	3373	4142	279	89	1810	304	2429	1895	2260	2018	1299	773	2312	671	79	4458	2364	938	100	2173	2518
1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	79	1	3210	4559	1453	962	1720	1448	3030	4591	1383	4393	1615	311	458	609	1734	421	79	4572	1957	2587	4715	3197
582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	25	79	1	3947	456	2019	229	1778	4178	4614	444	3288	4097	1177	2362	606	3545	575	2964	1080	79	984	3316	1295	2610
4123_Activated partial thromboplastin time	4123_Activated partial thromboplastin time	25	79	1	1040	4208	119	3469	3314	4735	625	1990	478	572	732	1441	3023	958	543	1086	652	4670	2571	79	1058	1205
41_Educational attainment	41_Educational attainment	25	79	1	3433	3539	1138	4141	2715	2482	2401	2282	3530	267	531	2143	2101	3644	916	2813	2850	1572	116	1774	79	3370
1979_Hand grip (at exam 7, GEE)	1979_Hand grip (at exam 7, GEE)	25	80	1	80	770	3064	2454	2429	3558	3533	2202	1559	2080	2382	290	1282	1645	3338	2426	2580	1304	4217	874	3452	1592
2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	25	80	1	1638	80	3821	762	1909	629	2305	468	201	3990	2697	283	3284	1934	2769	859	3845	4509	2128	1440	3410	2013
2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	25	80	1	2680	1178	80	2279	629	3083	1179	2039	702	1613	2048	537	2195	2396	3805	341	1613	404	2283	1872	517	4615
188_Waist-hip ratio (male, adjusted for BMI)	188_Waist-hip ratio (male, adjusted for BMI)	25	80	1	2343	3908	879	3368	321	80	1947	3444	1902	2986	4692	1845	3121	1299	2619	218	731	4724	2008	3315	3658	2038
1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	80	1	3221	1201	91	3147	2853	4236	80	672	3582	4692	263	1759	4082	2046	2551	3326	576	3948	2324	766	1198	1932
539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	25	80	1	3155	706	2257	786	4588	2598	4394	80	2719	3138	2297	2477	364	4673	2455	3811	2874	1142	3697	800	2623	4385
903_Phospholipids in large VLDL	903_Phospholipids in large VLDL	25	80	1	3926	3297	3008	2705	660	2767	1012	1879	4037	80	4122	1929	722	2974	340	1803	586	1743	3978	749	1558	503
4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	80	1	2203	4349	931	263	1169	1281	3008	1498	3244	1211	80	1713	2995	3157	1600	1333	2495	4603	1214	3230	1405	3919
2179_NOV - Protein NOV homolog	2179_NOV - Protein NOV homolog	25	80	1	851	305	1613	4617	4443	2443	998	4264	4177	1773	164	80	2984	4049	3083	1795	395	1026	3659	799	444	1705
4118_Zinc sulfate turbidity test	4118_Zinc sulfate turbidity test	25	80	1	544	296	2740	3431	2951	3882	732	3203	3964	3707	654	564	80	807	2610	2623	4171	3224	3664	1831	3806	1073
1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	25	80	1	2078	2406	1085	1064	3838	3994	1623	3118	3754	2370	3171	4701	590	4101	80	4083	4198	954	2412	1148	3505	1760
2593_DPP7 - Dipeptidyl peptidase 2	2593_DPP7 - Dipeptidyl peptidase 2	25	80	1	502	3207	1036	3480	236	239	2937	3991	3407	3171	807	2574	1631	382	1917	304	80	3209	627	401	2034	4629
3974_Total body BMD (30-45 years old)	3974_Total body BMD (30-45 years old)	25	80	1	1914	2092	4473	223	4262	1563	333	1462	3976	2836	1979	813	3557	2982	1182	4249	4479	80	2929	1171	2829	2621
4388_Epithelial ovarian cancer (Endometrioid)	4388_Epithelial ovarian cancer (Endometrioid)	25	80	1	3405	2814	2940	1754	1831	1688	4008	4382	4091	4167	2121	4115	4210	2548	3542	3333	359	2954	80	4588	2350	3824
2353_CTSB - Cathepsin B	2353_CTSB - Cathepsin B	25	80	1	2067	2010	493	3315	1858	107	3507	87	2328	426	3211	881	145	1482	4130	1944	3869	2500	798	80	1985	3594
2026_Baseline positive affect factor score	2026_Baseline positive affect factor score	25	81	1	81	2606	2603	2994	615	2803	3039	1833	2474	1406	214	3577	3801	2229	393	725	2916	3852	3792	4592	382	2168
1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	25	81	1	1557	81	366	2540	951	946	494	4139	503	3201	884	677	1782	2947	3314	3918	4551	4023	2744	4157	260	4487
1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	25	81	1	3786	591	81	1128	2531	627	145	469	351	1567	3647	1912	4611	2917	4435	3216	2308	732	940	4292	1360	1206
2920_Human-virus - gp41 C34 peptide, HIV	2920_Human-virus - gp41 C34 peptide, HIV	25	81	1	926	852	1905	3457	81	398	3032	3008	926	745	2778	1311	2450	3456	4014	130	732	2400	2696	722	1553	4425
151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	25	81	1	1520	4670	4712	561	317	81	1210	1324	2098	3166	1200	1754	2784	740	2594	250	1473	727	1498	1450	1508	2654
2809_DCTPP1 - dCTP pyrophosphatase 1	2809_DCTPP1 - dCTP pyrophosphatase 1	25	81	1	2857	879	1862	1897	2532	1150	81	2671	2674	635	430	1357	1102	3928	4297	1505	3171	3024	2777	2466	323	4093
243_CXCR3 on CD4n	243_CXCR3 on CD4n	25	81	1	4261	2959	438	447	3649	674	1140	81	97	158	261	2029	3994	3689	2788	1973	1988	1467	117	2298	505	111
3784_Depression - Weight change during worst episode of depression	3784_Depression - Weight change during worst episode of depression	25	81	1	4362	2735	508	1771	2928	859	508	4255	81	2245	2243	3031	528	3380	1457	3200	1591	565	3029	4235	258	2620
4440_Hepatitis B HBc antigen IgG levels	4440_Hepatitis B HBc antigen IgG levels	25	81	1	1969	461	3011	3880	1478	1441	808	4494	3842	81	3251	2327	329	154	1727	2692	3449	4392	3432	1993	775	1396
2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	25	81	1	554	359	1607	4096	3772	2027	815	1466	842	1894	4596	81	637	1906	4424	1492	4356	4012	4746	1360	655	1579
770_::::X-12261	770_::::X-12261	25	81	1	2790	2989	1756	3087	749	3800	1142	2719	3941	2579	1860	4206	1411	162	81	717	2968	2288	278	3034	933	424
4280_FEV1/FVC ratio	4280_FEV1/FVC ratio	25	81	1	2757	3357	3634	1922	118	3274	2672	1783	2525	3674	3825	314	433	2043	897	81	3988	1454	2273	1329	4004	3423
748_::::X-12038	748_::::X-12038	25	81	1	3932	3537	2041	1019	433	4046	3561	3271	2696	1073	674	3570	1430	254	3777	1583	566	2365	2309	2580	4323	81
481_Lipid::Carnitine metabolism::hexanoylcarnitine	481_Lipid::Carnitine metabolism::hexanoylcarnitine	25	82	1	82	2909	1194	3135	504	1512	2453	4706	4322	440	3877	4583	3439	4554	2024	558	778	3495	341	721	2480	3618
233_Lymph:%T	233_Lymph:%T	25	82	1	2799	82	3529	3920	2447	2966	2611	451	856	1225	414	2758	2561	1862	1192	1376	3404	2454	232	148	1279	2273
4371_Thyroid-stimulating hormone (female)	4371_Thyroid-stimulating hormone (female)	25	82	1	2569	2947	388	82	2445	595	4144	4342	2870	4518	4045	2410	3573	3779	3156	4593	2771	635	470	3203	1009	4387
3333_Frequency of heavy DIY in last 4 weeks	3333_Frequency of heavy DIY in last 4 weeks	25	82	1	467	4630	681	3426	2230	82	456	1230	2404	326	1852	704	998	1461	3119	3993	1130	3795	2478	1177	3593	460
1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	82	1	898	223	3359	844	1174	924	82	992	330	1845	4068	227	1530	3528	2124	1515	666	2838	1241	4314	3665	799
3183_SNRPF - Small nuclear ribonucleoprotein F	3183_SNRPF - Small nuclear ribonucleoprotein F	25	82	1	217	295	1174	3131	835	3776	2943	82	1032	141	2621	855	216	2644	545	1211	1110	230	3891	4556	1916	4706
1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	25	82	1	2687	4187	3132	1387	1769	733	1512	2397	82	727	3241	3513	4246	1296	1946	3120	506	817	306	1784	1697	300
2070_C5 - Complement C5	2070_C5 - Complement C5	25	82	1	1246	4180	2150	3429	902	4270	2640	1368	1747	82	1352	301	312	857	1392	556	2080	4307	1141	1335	2568	2968
666_::::X-06126	666_::::X-06126	25	82	1	1044	4631	310	2418	988	2127	729	2496	1304	2461	82	831	4733	888	4527	1098	3428	3768	584	2831	270	2512
1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	25	82	1	3026	1384	721	1426	1535	3136	2666	301	2887	1978	334	1557	82	1638	2405	1297	624	854	2701	2415	2112	3873
156_Hip circumference	156_Hip circumference	25	82	1	886	867	211	2652	2251	3938	3080	161	4497	1339	2652	3470	2349	82	2159	3400	2106	3536	4311	3377	3313	988
807_::::X-12833	807_::::X-12833	25	82	1	714	4564	517	3408	3458	3878	128	3396	146	2880	3497	1160	4709	4671	82	3552	2477	4725	3336	1687	1686	1859
1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	25	82	1	710	92	1112	2772	1947	994	2983	392	179	2186	4467	3310	298	699	4148	4104	82	240	1423	3847	3434	582
2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	25	82	1	4421	4503	3139	3343	3623	1020	964	1254	1471	2152	160	3644	941	1967	3319	2440	4686	82	4089	3018	3270	164
4676_External capsule axial diusivities	4676_External capsule axial diusivities	25	82	1	3160	4284	4103	3516	2166	1088	3558	1220	291	3621	3084	2005	371	3995	2107	1699	2487	1878	82	4107	638	849
2833_BCL2L1 - Bcl-2-like protein 1	2833_BCL2L1 - Bcl-2-like protein 1	25	82	1	4210	660	3327	4572	1427	3336	555	3879	530	2151	972	3303	4139	4529	2945	2397	4704	3928	810	2072	82	2245
56_Depressive symptoms	56_Depressive symptoms	25	82	1	2909	3803	4068	1798	3848	3220	789	3220	4072	4209	92	4467	3480	1074	3350	3872	2279	313	1196	2535	4461	82
950_Tyrosine	950_Tyrosine	25	83	1	1815	4482	83	912	4604	1158	4202	599	2717	3517	1622	2448	4702	1630	4721	4141	2307	3717	637	2564	3119	2175
3859_Neutrophil count (two-way meta)	3859_Neutrophil count (two-way meta)	25	83	2	809	984	1839	2371	83	2171	2863	991	1305	2457	576	971	3404	1328	3795	91	4237	3072	2621	110	4182	1409
4087_Neuroticism	4087_Neuroticism	24	83	1	3270	2964	1764	683	3969	83	1709	2866	4144	532	2816	2508	1464	3732	1001	4073	1885	1482	290	3060	4158	4109
2311_IL1RL2 - Interleukin-1 receptor-like 2	2311_IL1RL2 - Interleukin-1 receptor-like 2	25	83	1	3290	238	1658	1562	1852	3317	83	2187	3416	4295	1419	2426	2042	2205	865	796	3256	3864	371	2582	2685	2280
4210_Chronic kidney disease	4210_Chronic kidney disease	25	83	1	122	2298	3572	3606	1226	3513	528	83	1110	4684	1126	171	770	2324	3513	1861	975	2958	2801	1660	3590	1726
2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	25	83	1	3235	1571	4667	1767	2777	121	927	1183	4587	1151	4706	502	83	977	4401	2962	1774	1213	1033	3956	2857	3422
1835_Neck width (GEE, female, adjusted for multivariable)	1835_Neck width (GEE, female, adjusted for multivariable)	25	83	1	4469	485	3982	976	761	3152	2351	4219	626	2389	1740	1844	3647	593	4514	817	2283	229	3131	83	2123	4500
1170_Leptin (adjusted for BMI)	1170_Leptin (adjusted for BMI)	25	84	1	84	2840	2055	1263	3549	4546	3488	2219	2893	3380	3089	3451	4457	1533	1765	2423	915	4018	3622	1233	1505	4347
1212_Type 2 Diabetes	1212_Type 2 Diabetes	25	84	1	1294	84	785	345	3775	3515	179	1570	225	721	4215	2548	410	4055	1690	3072	4126	3451	1527	802	2381	281
308_CD4nv:%Th0	308_CD4nv:%Th0	25	84	1	3835	2836	84	4664	836	2175	4214	2013	4096	379	1258	2677	2483	2666	1633	450	4391	3361	105	962	3023	4473
703_::::X-11440	703_::::X-11440	25	84	1	4573	1941	668	84	374	4024	1052	4167	1646	2278	3181	4320	2704	4311	4409	1715	4683	348	317	3043	2327	1645
2136_MST1R - Macrophage-stimulating protein receptor	2136_MST1R - Macrophage-stimulating protein receptor	25	84	1	2180	3872	3464	1401	2341	84	2086	4680	3899	3958	313	3128	4323	3941	905	2111	344	2694	3203	274	4226	315
1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	25	84	1	251	4171	1206	4547	3981	3006	84	2218	2000	2128	2212	617	1648	1179	2148	1011	3694	2607	3724	2339	4565	559
4114_Chloride	4114_Chloride	25	84	1	2439	2692	3996	498	275	3443	2119	84	2283	2514	2267	518	605	4441	4223	212	2433	1603	3188	4141	2473	4580
3245_Non-oily fish intake	3245_Non-oily fish intake	25	84	1	1857	1747	2629	4061	3450	4540	288	3000	2899	84	4553	2422	1745	1754	4334	4440	3095	2079	1219	4505	4175	353
4149_Left ventricular internal dimension in systole	4149_Left ventricular internal dimension in systole	25	84	1	3673	179	2772	1009	1277	116	1592	4163	1075	1265	84	3491	1931	1096	3767	1127	1651	3615	4455	3134	2731	344
2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	25	84	1	3434	3156	2661	4740	3124	740	2759	2499	418	4343	1507	84	496	3789	886	2555	4195	4147	2633	4421	4029	4650
1227_Life span	1227_Life span	25	84	1	919	3988	4345	3562	1051	2154	4365	3439	4050	1387	297	661	84	3135	121	2215	4273	1259	3541	1146	3043	461
977_Granulocyte colony-stimulating factor	977_Granulocyte colony-stimulating factor	25	84	1	1968	3439	898	3504	3874	4328	2484	1402	2045	4110	1014	3499	361	84	1950	1923	3914	4443	1995	3849	3489	1915
3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	25	84	1	2413	2238	1358	1753	4214	1966	1452	858	4580	1752	561	4041	1946	4105	84	1436	203	3102	103	1431	3595	1438
1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	25	84	1	760	3052	3950	4305	169	329	1397	3829	4154	2331	1545	4615	1886	3478	2712	207	84	714	2552	3604	3263	3233
3765_Anxiety - Recent feelings of foreboding	3765_Anxiety - Recent feelings of foreboding	25	84	1	1398	2544	3570	165	2160	1568	1215	2547	3447	4369	4391	3597	3510	3171	2722	3392	648	2083	84	1763	4348	2587
111_Coronary artery disease	111_Coronary artery disease	25	84	1	4556	4577	624	117	579	704	4400	3070	742	1634	3285	844	1451	2064	136	482	521	1768	3360	84	965	1799
82_Lumbar Spine BMD (females)	82_Lumbar Spine BMD (females)	25	84	1	1966	3549	142	2033	459	641	1827	2261	3834	1917	3354	249	1651	1287	3032	674	547	3097	728	1162	84	275
3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	25	85	1	283	85	3263	4275	389	3510	4634	1208	3857	2996	497	3734	3775	1349	2779	683	3551	862	3207	1900	970	1910
1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	85	1	1875	4656	85	1242	4701	281	163	2241	1191	3252	751	399	713	2663	1368	2418	1696	2718	1452	1398	3075	2689
3138_CCL11 - Eotaxin	3138_CCL11 - Eotaxin	25	85	1	1955	3188	1000	85	1221	343	4471	2635	4238	1122	2357	4345	342	2746	3889	2612	4398	3728	4517	1283	4122	298
4403_Menstruation quality of life impact: Loss of concentration	4403_Menstruation quality of life impact: Loss of concentration	25	85	1	657	2418	121	1016	4597	893	85	2890	1491	2102	3062	2537	3226	4018	854	3583	1571	3268	745	2306	205	3801
517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	25	85	1	746	2033	1915	2945	580	2349	4327	85	2923	358	3316	3005	785	519	3154	1367	3159	2979	1202	448	3961	2404
600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	25	85	1	233	3506	349	1010	1585	4498	4662	562	85	4054	3033	2202	1472	2818	3600	2430	3319	1866	1192	3117	1706	2346
117_Extreme Body Mass Index	117_Extreme Body Mass Index	25	85	1	1327	119	4730	4591	725	4593	2753	192	2046	2444	85	3416	2782	1775	3274	1179	3943	3115	2320	908	3514	146
4755_Sagittal stratum radial diusivities	4755_Sagittal stratum radial diusivities	25	85	1	1812	1896	1025	1160	860	801	143	713	1534	3140	3736	308	85	4732	1351	3173	1832	100	901	2432	3432	1822
940_Free cholesterol in small VLDL	940_Free cholesterol in small VLDL	25	85	1	909	3282	3443	3454	300	4423	2915	861	3483	931	757	3875	3672	970	85	429	708	688	3727	1380	2194	1316
4050_Anterior cruciate ligament rupture (fixed effect model)	4050_Anterior cruciate ligament rupture (fixed effect model)	25	85	1	860	4470	2750	2989	1618	210	996	3823	637	145	3096	1151	3310	2528	1583	2607	85	3950	4148	3358	182	371
3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	25	85	1	1662	3484	2143	3261	2121	2920	647	4422	854	464	412	648	4481	357	1179	3902	3814	85	2193	760	2287	107
1157_Fasting glucose main effect (adjusted for BMI)	1157_Fasting glucose main effect (adjusted for BMI)	25	85	1	3822	2059	4648	2217	4424	2240	2658	1934	1445	2521	3996	259	840	4648	616	4449	2560	1327	85	2182	1306	2599
3786_Insomnia	3786_Insomnia	25	85	1	216	2051	361	1812	1023	2940	1417	1222	4383	1113	1922	2318	1320	3136	3491	4428	670	1548	2742	85	3739	4205
697_::::X-11381	697_::::X-11381	25	85	1	4289	97	1470	2484	917	869	1528	1467	2377	1219	4165	3099	169	1689	3316	487	4102	1028	3966	3165	85	4047
2002_Serum YKL-40 level	2002_Serum YKL-40 level	25	86	1	361	86	1190	503	3108	3233	759	1473	2391	901	310	1148	1925	1509	2234	3490	1526	2894	1003	553	1442	1960
3277_Maternal smoking around birth	3277_Maternal smoking around birth	25	86	1	3462	2739	2860	4477	1252	4154	86	3685	4579	3352	4684	2842	4225	1127	4627	659	3096	494	1270	4207	914	4198
887_Cholesterol esters in large HDL	887_Cholesterol esters in large HDL	25	86	1	4653	454	2871	1253	921	1156	947	1045	86	3248	615	4440	4363	3701	2513	4397	3104	1080	3856	2411	1008	1387
3423_Trail making test - Duration to complete alphanumeric path (trail #2)	3423_Trail making test - Duration to complete alphanumeric path (trail #2)	25	86	1	3863	3882	4181	2564	3137	1958	2991	3568	4160	86	2420	3488	3705	4171	1400	3727	917	1090	527	3919	2562	3805
862_Creatinine	862_Creatinine	25	86	1	1284	603	2715	4548	894	2117	154	1078	350	2188	86	4415	2901	4539	1090	2048	1812	530	3160	1837	3091	674
3228_Sleep duration	3228_Sleep duration	25	86	1	269	476	644	3619	2331	776	3046	2993	4110	3566	2188	86	3969	1792	3561	3290	433	1544	1244	526	3148	288
1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	25	86	1	1047	1228	2543	636	2268	3084	4525	4038	2256	3694	3225	3968	86	3425	769	1867	218	1254	4472	115	3977	4445
2350_WISP1 - WNT1-inducible-signaling pathway protein 1	2350_WISP1 - WNT1-inducible-signaling pathway protein 1	25	86	1	422	666	1662	3472	1885	185	3415	650	1016	2235	3574	2911	2018	86	1418	3772	2163	1149	530	3517	3554	4078
195_Chronic kidney disease	195_Chronic kidney disease	25	86	1	186	471	4422	3949	1649	2848	976	222	3737	419	664	1063	2359	3306	3585	2413	86	636	4345	2915	3697	594
2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	25	86	1	3262	3559	1787	2810	3021	3598	3829	3542	2483	4365	1412	1153	2854	4061	3178	294	4256	959	86	3911	1470	1012
54_Subjective well being	54_Subjective well being	25	86	1	1936	795	1286	3394	406	1110	3743	3364	2702	1474	1708	2658	3479	2425	4639	578	2965	4432	447	86	3813	821
1911_Temporal horn volume (GEE, adjusted for multivariable)	1911_Temporal horn volume (GEE, adjusted for multivariable)	25	86	1	2503	4607	3207	1708	2978	2586	2193	3754	2749	4120	3842	128	2933	1011	4318	2553	2821	918	3591	3968	2091	86
821_::::X-13496	821_::::X-13496	25	87	1	4528	87	3730	4432	2221	1254	1394	1120	710	1797	360	4570	3372	1997	4611	4006	684	3793	3316	2600	278	2568
411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	25	87	1	3346	4149	87	3034	4101	3929	2532	1194	1465	3752	2146	3164	4301	2812	4370	4328	4027	4367	2781	3578	1214	814
1220_Mean Amygdala	1220_Mean Amygdala	25	87	1	4219	1224	3597	3933	2275	3363	412	2286	87	3177	4741	1526	818	2111	4521	4471	3927	1079	3378	1976	3068	1476
2558_IL17B - Interleukin-17B	2558_IL17B - Interleukin-17B	25	87	1	4478	2825	1317	651	2912	4401	2499	2138	1702	4522	4081	87	2407	411	604	2961	1844	152	2858	3617	2204	1630
2125_Human-virus - Protein E7_HPV18	2125_Human-virus - Protein E7_HPV18	25	87	1	819	780	1199	4368	2997	2717	1485	3927	732	2808	3502	2060	87	2590	3172	4190	1592	3954	1701	253	349	542
2068_TGFB1 - Transforming growth factor beta-1	2068_TGFB1 - Transforming growth factor beta-1	25	87	1	4706	1185	109	1269	235	4466	3374	3992	930	1910	1574	546	2296	1664	87	1779	3971	603	480	1594	398	417
4066_Educational attainment	4066_Educational attainment	25	87	1	3369	3044	3151	1843	2916	2618	4418	2575	2878	161	771	3970	4168	4000	4636	2828	1480	1229	87	1113	1041	2708
218_T:%NKT	218_T:%NKT	25	87	1	2402	3306	1973	1565	2143	3305	3609	2492	3073	2527	4599	3554	304	1423	4030	1671	4713	1123	2038	87	2418	3183
2848_RASA1 - Ras GTPase-activating protein 1	2848_RASA1 - Ras GTPase-activating protein 1	25	87	1	4639	568	4595	1135	443	1045	521	3603	4127	3030	1492	1404	1689	779	2404	865	2769	1502	1157	2626	87	1148
606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	25	88	1	88	2122	1303	2526	4144	987	2518	1488	4324	3804	3107	4671	581	3284	4641	4394	1733	3188	454	2352	4357	2304
1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	25	88	1	3943	88	4527	343	593	1551	3693	2372	3110	3009	3860	1791	260	4245	750	1550	2699	4609	3115	2444	925	1090
3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	25	88	1	508	138	88	4667	720	708	590	3877	4419	3067	1612	189	959	4667	424	2072	2439	2270	152	1800	2877	357
4091_Proxy and clinically diagnosed Alzheimer's disease	4091_Proxy and clinically diagnosed Alzheimer's disease	25	88	1	305	3134	3036	4597	341	414	88	4314	519	332	2062	3921	1723	146	3534	166	2068	3730	428	4457	1754	396
2724_SNX4 - Sorting nexin-4	2724_SNX4 - Sorting nexin-4	25	88	1	4458	2005	2270	573	1239	2058	2934	94	374	88	2659	1358	1749	2453	1335	748	3346	4707	732	3963	2715	4606
1016_Femoral BMD (FBAT, adjusted for multivariable)	1016_Femoral BMD (FBAT, adjusted for multivariable)	25	88	1	914	1908	1146	1937	892	3098	2638	4692	3569	1499	3269	88	1410	2167	1914	971	1581	500	590	1049	2811	2438
428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	25	88	1	207	1249	735	1554	3421	2491	1101	1133	150	356	2556	3742	88	535	3058	4187	2991	1635	2358	534	657	4574
3417_Neuroticism score	3417_Neuroticism score	25	88	1	2621	4649	3994	779	4068	1887	2420	2431	3887	2458	1474	1156	4024	2231	88	4678	3129	521	163	2159	2941	3039
3841_Granulocyte count (two-way meta)	3841_Granulocyte count (two-way meta)	25	88	2	585	1002	1196	2876	93	870	4557	3416	1935	916	2479	3209	3138	2200	3735	88	2882	2244	4618	179	4281	3932
1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	25	88	1	3167	2295	4340	547	4266	119	2656	836	1044	1310	747	2513	4138	2834	2802	2831	88	709	3017	3798	2041	4200
3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	25	88	1	2407	2772	3803	3906	2759	3648	1971	4265	3510	3415	1970	2545	3706	1707	2970	3737	1231	88	3824	1066	4141	1157
473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	25	88	1	3324	1737	1774	2397	2504	2901	4729	2775	3378	369	3270	3677	1656	139	2247	2357	3201	2084	2677	1983	4737	88
2116_EFNA4 - Ephrin-A4	2116_EFNA4 - Ephrin-A4	25	89	1	89	941	3094	2794	3232	2176	3166	2297	127	2160	1688	4401	2772	4531	3946	3257	1274	4128	4262	3274	1856	1060
1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	89	1	645	89	2449	3503	3393	3210	1536	1984	1031	4163	2571	1425	1624	1446	3112	2820	3219	254	2451	4034	1646	2864
938_Concentration of small LDL particles	938_Concentration of small LDL particles	25	89	1	236	1287	89	3387	404	3017	4256	4548	963	3311	1116	3912	1365	792	781	521	2250	4129	3463	4642	3238	329
1217_Alcohol consumption (dichotomous, male)	1217_Alcohol consumption (dichotomous, male)	25	89	1	991	2171	3072	89	1495	484	1654	3302	4139	719	815	152	1060	3577	2053	3279	3887	669	475	1461	1575	1756
4692_Anterior limb of internal capsule mean diusivities	4692_Anterior limb of internal capsule mean diusivities	25	89	1	1531	2177	4731	2963	2129	89	429	1135	436	3036	3467	848	748	2573	4572	3480	517	1157	4168	3846	173	2314
4648_Anterior limb of internal capsule fractional anisotropy	4648_Anterior limb of internal capsule fractional anisotropy	25	89	1	3458	2204	3117	1737	2215	200	3349	89	2154	2216	4600	4723	4365	2721	1739	3526	1261	2558	1045	1259	172	3392
304_CD4mem:%Th1* (5)	304_CD4mem:%Th1* (5)	25	89	1	2303	1117	4500	4232	1121	3271	4193	4327	89	1173	123	2400	532	1951	4477	903	3003	2460	1239	2512	2838	1883
4302_Arms-arm fat ratio (female)	4302_Arms-arm fat ratio (female)	25	89	1	4527	1416	496	4128	1979	634	1138	3650	3735	89	1925	2123	3928	3799	4032	1969	3493	3899	1187	1014	868	3739
3206_Number of days/week of moderate physical activity 10+ minutes	3206_Number of days/week of moderate physical activity 10+ minutes	25	89	1	4160	1949	1125	3555	1630	4077	3898	2601	4477	527	89	4435	2513	932	2887	3619	3314	4482	3506	4065	643	1789
1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	25	89	1	2047	2837	1634	1887	1291	2337	1710	3122	3912	3308	3436	89	3379	2935	2957	2671	3135	1958	546	3427	168	3163
1076_Pancreatic cancer	1076_Pancreatic cancer	25	89	1	206	2317	3126	2631	1162	1607	3655	2779	2760	4527	3003	143	89	2904	1764	488	1724	3192	2472	3782	4578	509
2323_SERPINF2 - Alpha-2-antiplasmin	2323_SERPINF2 - Alpha-2-antiplasmin	25	89	1	2171	4246	4495	552	465	4345	554	3993	4610	3899	978	1012	4254	3704	4621	497	3459	89	147	1396	2888	3433
2852_CHST15 - Carbohydrate sulfotransferase 15	2852_CHST15 - Carbohydrate sulfotransferase 15	25	90	1	90	2580	4027	4266	926	3532	1301	2467	231	971	1033	4450	1955	899	410	2789	3811	2777	3229	852	624	2550
3878_Granulocyte percentage of myeloid white cells (three-way meta)	3878_Granulocyte percentage of myeloid white cells (three-way meta)	25	90	1	4056	3800	90	1278	2073	600	4617	3315	501	1188	1249	218	3810	3543	4354	2241	1325	4619	3313	3761	1196	802
848_Xenobiotics::Food component/Plant::X-14977--vanillin	848_Xenobiotics::Food component/Plant::X-14977--vanillin	25	90	1	345	374	154	90	522	596	4302	2084	3718	1099	2102	414	425	2671	3939	296	4105	1140	4703	2394	3289	3338
3917_Adiponectin	3917_Adiponectin	25	90	1	863	4379	3549	3401	3018	90	1445	2608	3464	1700	2934	2479	3216	406	4722	1142	1200	631	2896	412	1099	4610
2953_LGALS8 - Galectin-8	2953_LGALS8 - Galectin-8	25	90	1	4704	3290	4421	524	685	890	90	2168	3583	1927	3753	1810	2308	1828	160	3391	3739	1101	4578	3413	839	2987
2762_MMP2 - 72 kDa type IV collagenase	2762_MMP2 - 72 kDa type IV collagenase	25	90	1	409	4093	547	2008	3559	1485	4668	90	1900	1507	2964	165	682	205	4702	4409	348	1081	4541	4291	4361	180
2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	25	90	1	520	284	3419	3593	1762	631	2901	3959	517	90	399	4461	2256	3269	3688	1896	278	3304	929	3765	2640	924
1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	90	1	2209	1868	416	2648	2082	2318	1098	573	2220	2223	90	3070	1744	3791	800	2764	1255	1667	4609	3570	1791	570
2571_VIP - Vasoactive Intestinal Peptide	2571_VIP - Vasoactive Intestinal Peptide	25	90	1	1298	4300	4657	2726	3701	1690	1413	4077	3330	1204	552	90	3692	3782	3456	1840	515	550	4085	4653	1779	3014
4555_Left lateral orbitofrontal	4555_Left lateral orbitofrontal	25	90	1	2083	4198	1415	292	745	2324	1009	910	3145	3658	2511	1988	90	4714	2104	1028	4062	3803	1354	3775	3995	1757
3623_Treatment/medication code: atorvastatin	3623_Treatment/medication code: atorvastatin	25	90	1	1443	438	3080	687	357	1452	4032	634	2226	2326	2507	2546	328	143	90	297	710	3176	2023	1303	1154	825
3550_Vascular/heart problems diagnosed by doctor: Angina	3550_Vascular/heart problems diagnosed by doctor: Angina	25	90	1	2787	1005	2461	1503	4732	4082	777	577	2783	1055	463	2873	1329	1297	1127	4595	90	2516	2863	1704	3886	2328
1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	25	90	1	4539	1079	989	3590	1908	4149	1560	1343	510	3367	4633	2309	554	2483	3778	3830	4146	90	1546	4116	296	1818
402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	25	90	1	2384	398	3221	757	4324	3311	1896	4469	2315	541	2531	4456	3157	4233	1723	3713	3019	4043	1055	90	3506	1003
603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	25	91	1	91	595	2398	785	3648	4569	1239	885	489	779	2888	1456	997	890	1682	4383	1477	1823	367	3179	440	1219
3095_IL27RA - Interleukin-27 receptor subunit alpha	3095_IL27RA - Interleukin-27 receptor subunit alpha	25	91	1	387	91	1167	2792	2138	3381	3992	3571	2091	2177	3169	277	1321	1388	876	2045	1475	1884	1915	4301	4662	4231
4211_Glycine level	4211_Glycine level	25	91	1	2754	3556	2938	91	1631	4702	2129	2788	3456	4540	3745	4150	1272	758	1349	3327	1199	2123	1819	2106	1762	4257
1203_Rheumatoid Arthritis	1203_Rheumatoid Arthritis	25	91	1	3001	1487	961	3709	91	1154	2653	2510	734	1818	1314	319	2552	3756	4311	123	1811	2724	2323	341	2260	1666
187_Waist-hip ratio (male, adjusted for BMI)	187_Waist-hip ratio (male, adjusted for BMI)	25	91	1	1798	2289	958	4429	325	91	2368	3763	1234	2775	3264	1884	4624	712	2389	225	874	3786	2313	3533	3295	694
836_Peptide::Dipeptide::X-14304--leucylalanine	836_Peptide::Dipeptide::X-14304--leucylalanine	25	91	1	3752	205	3201	3815	1265	1783	91	3335	880	501	2559	857	2468	3602	1137	1975	3402	308	4056	3582	3458	3573
74_Age-related Macular Degeneration	74_Age-related Macular Degeneration	25	91	1	2577	4240	1622	3789	204	1184	661	3589	91	3173	293	4281	103	900	311	548	724	2946	3725	3822	1664	3405
3219_Time spent watching television (TV)	3219_Time spent watching television (TV)	25	91	1	2525	3094	3771	3332	2702	4012	4439	4660	2999	91	1522	2884	2269	4415	3664	1205	2161	922	994	241	318	2349
64_Insulin sensitivity index (adjusted for age, sex)	64_Insulin sensitivity index (adjusted for age, sex)	25	91	1	3328	1891	2380	4357	4485	2196	3045	827	3809	3266	91	372	3760	3763	2786	1897	4535	2149	2325	2618	1254	3036
2903_FABP3 - Fatty acid-binding protein, heart	2903_FABP3 - Fatty acid-binding protein, heart	25	91	1	2989	2197	2393	3023	3206	2701	4222	3071	2444	4456	4093	91	3735	3435	974	3781	4517	4150	259	411	2134	4690
1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	25	91	1	1759	4733	2912	2045	3971	1361	3067	1912	3399	3568	4703	4686	91	741	1847	3361	3946	2332	2213	3488	1834	829
3952_Amyotrophic lateral sclerosis (logistic)	3952_Amyotrophic lateral sclerosis (logistic)	25	91	1	4454	3625	976	4165	1007	1682	2810	4746	4159	1712	3091	4329	4005	1641	2707	1826	91	4252	3593	406	844	2039
2228_IL27 EBI3 - Interleukin-27	2228_IL27 EBI3 - Interleukin-27	25	91	1	1206	426	2615	2129	3226	1362	3580	1771	379	2436	184	2021	3560	3016	3121	864	1129	1495	1934	3022	91	2045
711_::::X-11478	711_::::X-11478	25	92	1	4189	3246	2898	92	2985	1913	841	1079	900	3014	3868	3477	3734	850	2790	1531	4108	1674	102	2217	1467	1867
1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	25	92	1	2156	4363	1177	555	3341	1815	92	679	1498	1425	2655	533	2265	2098	2600	2267	2543	3154	2915	4068	3172	4732
1075_Leprosy	1075_Leprosy	25	92	1	2381	1317	2065	609	220	765	844	92	1990	284	1125	2959	3342	1647	449	161	456	3294	2243	1385	2886	3041
3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	25	92	1	1209	2671	1791	3632	4142	2874	2883	4539	92	2531	1327	701	3988	1110	1010	1264	750	1287	1034	1893	1385	1270
3045_CRTAM - Cytotoxic and regulatory T-cell molecule	3045_CRTAM - Cytotoxic and regulatory T-cell molecule	25	92	1	1374	3028	1859	1696	4421	4044	3623	3726	367	92	2109	2887	2459	761	1375	2893	4419	4373	3562	601	2189	309
1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	25	92	1	1494	3974	2835	4502	4143	1941	3329	757	4171	887	4149	2990	92	921	2085	3939	2720	1910	3220	4273	305	4595
1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	25	92	1	3354	4304	4460	3890	3825	2050	2391	4377	2600	2402	1631	384	2777	92	2756	3102	275	3540	1083	4006	1441	1807
855_ApoB	855_ApoB	25	92	1	879	1294	1099	602	335	1014	2893	4354	1006	3259	1715	2896	1499	2495	92	271	510	1900	1088	2885	2589	378
4108_Blood urea nitrogen	4108_Blood urea nitrogen	25	92	1	2444	2045	1068	2660	1269	432	1972	1408	4013	2121	4588	2259	268	151	520	2794	2172	92	733	1133	1632	4362
3279_Father's age at death	3279_Father's age at death	25	92	1	3088	2767	919	4741	1744	4598	4002	3094	2794	2203	462	4213	3670	4354	2969	4149	3188	1624	3098	1526	92	3394
815_Lipid::Fatty acid amide::X-13183--stearamide	815_Lipid::Fatty acid amide::X-13183--stearamide	25	92	1	2140	1499	3104	479	4739	2624	3267	1236	1596	4332	528	2511	3044	3994	778	3540	657	1588	4360	2281	2403	92
1173_Chronotype (continuous)	1173_Chronotype (continuous)	25	93	1	93	1801	1828	1264	2452	2700	912	1952	3136	3639	3723	4617	3436	3052	1283	1504	1662	1400	3089	167	2014	1519
3525_Transport type for commuting to job workplace: Walk	3525_Transport type for commuting to job workplace: Walk	25	93	1	3148	2153	93	983	474	2163	4022	2458	3195	4052	827	642	4440	3184	3822	476	3198	1642	2286	830	1716	1765
183_Waist-hip ratio (female)	183_Waist-hip ratio (female)	25	93	1	137	1272	758	2050	4591	93	3807	113	1721	2053	4729	647	4219	4697	3750	811	2992	379	4454	3303	3785	1982
1781_Artial fibrillation (GEE, adjusted for age and sex)	1781_Artial fibrillation (GEE, adjusted for age and sex)	25	93	1	759	2621	328	95	2276	2222	93	2059	305	4602	1837	2437	1232	2591	4580	805	4382	268	4110	2804	3316	3278
3726_Frequency of consuming six or more units of alcohol	3726_Frequency of consuming six or more units of alcohol	25	93	1	857	3140	956	2080	3641	3635	3089	93	959	4669	4029	2343	3917	3379	4667	2621	3108	1852	2913	305	1129	4182
1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	25	93	1	509	1038	880	4133	1826	1646	3327	3035	3923	93	443	2392	2926	2778	821	3718	4489	1391	2390	1554	2347	3746
281_CD8:%Act(25+38+RO+)	281_CD8:%Act(25+38+RO+)	25	93	1	2222	1563	1108	820	194	1617	2923	945	2379	2742	93	3713	1449	3585	1617	230	945	1448	3884	1492	1749	1066
3921_Triglycerides cholesterol	3921_Triglycerides cholesterol	25	93	1	736	1898	1520	784	432	2368	173	3438	580	566	1182	479	93	1105	772	927	1845	2507	3020	3356	487	875
2542_THBS1 - Thrombospondin-1	2542_THBS1 - Thrombospondin-1	25	93	1	1428	2590	2516	1245	2346	4187	2996	2010	415	1298	2551	3679	3921	417	93	1924	2468	3672	1557	2247	4428	554
2210_MMP7 - Matrilysin	2210_MMP7 - Matrilysin	25	93	1	2904	3822	855	2451	4177	1780	4170	2231	1954	678	1105	2421	3002	3964	2622	1873	93	2746	4039	4687	4417	1968
1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	25	93	1	3747	166	2738	4182	2667	3840	3819	166	3052	995	2312	1191	4423	3754	1749	4357	215	93	1612	3701	3389	4737
1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	93	1	4408	3884	1810	1378	349	1166	1224	3874	3578	2679	3417	1164	695	4458	3179	220	2897	1549	1200	93	4738	2397
2867_MMP12 - Macrophage metalloelastase	2867_MMP12 - Macrophage metalloelastase	25	93	1	1540	2433	2155	2745	1990	2504	3421	474	1673	889	279	888	472	3883	2419	1942	2892	2840	258	2930	1689	93
2704_ARID3A - AT-rich interactive domain-containing protein 3A	2704_ARID3A - AT-rich interactive domain-containing protein 3A	25	94	1	94	3678	1109	772	864	3388	4399	1174	1055	2268	958	2257	4025	3818	1296	1306	3531	3222	1770	4106	2297	2948
2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	25	94	1	2181	94	1935	2864	1370	2944	1441	2408	2203	3710	4426	3344	336	4212	2645	1148	2420	141	2979	3334	3054	3266
3038_TYMS - Thymidylate synthase	3038_TYMS - Thymidylate synthase	25	94	1	274	2352	94	2009	4683	3808	2842	3180	1202	1608	330	1313	2337	4130	836	4306	4258	4242	3687	1339	969	389
2161_PECAM1 - Platelet endothelial cell adhesion molecule	2161_PECAM1 - Platelet endothelial cell adhesion molecule	25	94	1	4170	3270	1158	94	2605	2158	1313	2598	2694	3654	735	766	2739	3515	3422	3320	1107	2468	4437	2743	2159	117
956_Free cholesterol in very large HDL	956_Free cholesterol in very large HDL	25	94	1	2062	1847	1516	911	1388	3286	2887	1399	94	304	3755	1667	2838	3266	2884	4134	2505	482	3180	2429	186	3387
3301_Seen doctor (GP) for nerves, anxiety, tension or depression	3301_Seen doctor (GP) for nerves, anxiety, tension or depression	25	94	1	2112	4057	3312	1073	2533	604	1737	4654	800	94	3840	4052	3663	2559	3081	2297	2098	1015	4313	1198	810	2275
2857_SERPING1 - Plasma protease C1 inhibitor	2857_SERPING1 - Plasma protease C1 inhibitor	25	94	1	1054	142	623	4691	4064	2588	2837	399	2063	4156	2522	94	3178	3183	2260	4259	3647	3373	3577	1084	4629	2075
1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	94	1	3833	251	3290	4396	2896	796	3582	2675	543	3357	4664	1325	94	608	4601	1588	2228	3119	2569	3329	3858	4669
155_Hip circumference	155_Hip circumference	25	94	1	480	983	470	3001	2580	2725	2829	234	4382	1967	1911	3029	3115	94	3026	3637	2075	3207	4658	3806	2601	414
2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	25	94	1	2889	444	1254	3184	503	3950	3633	846	1756	3268	4595	603	2659	1323	94	816	2139	4255	1228	1128	4247	3080
3678_Diagnoses - main ICD10: M23 Internal derangement of knee	3678_Diagnoses - main ICD10: M23 Internal derangement of knee	25	94	1	1593	1278	2107	2545	293	523	3237	4663	1269	1347	2315	1635	1362	4400	3934	3139	94	4390	2488	1261	768	2713
1832_Neck length (FBAT, male, adjusted for multivariable)	1832_Neck length (FBAT, male, adjusted for multivariable)	25	94	1	3516	4165	3473	3694	4432	1025	4429	3632	2557	247	3809	1940	4662	1495	1482	3802	617	94	406	1819	476	4499
693_::::X-11317	693_::::X-11317	25	94	1	3074	1503	4617	1508	513	216	1189	243	2864	179	789	2626	1816	2365	4112	1408	4081	2903	94	3470	249	2574
1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	25	94	1	3524	3269	1104	1751	728	1700	1231	479	723	3271	3892	3796	4614	3773	4571	722	4127	3026	4514	94	1577	1050
275_CD8:%CM	275_CD8:%CM	25	94	1	2987	2474	1993	3271	2982	2145	3639	4104	1399	3363	4578	4637	2144	2096	706	2990	1076	3340	3460	433	4170	94
2148_DCN - Decorin	2148_DCN - Decorin	25	95	1	244	95	4480	323	3237	382	737	4123	403	1112	973	3249	2331	3460	762	2803	334	4527	3888	1552	2216	2942
2434_CNTN2 - Contactin-2	2434_CNTN2 - Contactin-2	25	95	1	2084	1820	3396	1003	281	2575	714	4137	4482	761	95	1824	936	771	3697	360	200	2897	4186	2169	178	1981
462_Energy::Oxidative phosphorylation::acetylphosphate	462_Energy::Oxidative phosphorylation::acetylphosphate	25	95	1	1122	2951	298	3140	383	1856	2139	3290	4284	3108	249	4378	3355	95	1895	389	808	2472	3091	1226	4516	4036
939_Total cholesterol in small VLDL	939_Total cholesterol in small VLDL	25	95	1	2218	1702	3412	1586	306	2578	4211	967	2430	2467	925	3371	2812	1680	95	320	388	974	4380	489	4451	470
3931_Monogalactosylation	3931_Monogalactosylation	25	95	1	1928	3460	1538	3100	134	1337	1844	515	3831	589	580	2310	766	3147	3203	95	3007	1474	2475	3368	4198	2721
2678_PDGFC - Platelet-derived growth factor C	2678_PDGFC - Platelet-derived growth factor C	25	95	1	4175	1232	283	313	882	2325	2551	1555	348	626	1567	3642	1803	3058	995	491	1936	95	3705	2588	2872	2153
1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	25	95	1	261	1895	3868	940	3989	3514	2314	1756	3978	3501	1456	2900	760	2109	3678	4745	3973	1835	95	343	4647	4165
1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	95	1	1735	4014	1914	967	2739	228	1440	4052	4012	3700	1939	4733	2141	2017	1481	1454	1220	1438	223	95	4672	1650
3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	25	96	1	96	3338	1297	999	4581	1300	4529	3720	873	4481	682	3300	2831	4501	919	4235	4738	2581	2103	745	1020	1605
2089_GFRA3 - GDNF family receptor alpha-3	2089_GFRA3 - GDNF family receptor alpha-3	25	96	1	2487	96	679	3065	4693	372	2725	2691	464	1458	2335	4181	1896	1069	2248	1022	2859	2643	2682	4722	3497	4351
4176_Type 2 Diabetes	4176_Type 2 Diabetes	25	96	1	1813	392	96	1505	752	2873	3702	1805	4724	3766	1100	3889	3749	1208	802	353	1217	4640	4682	2142	3048	3598
3892_Myeloid white cell count (three-way meta)	3892_Myeloid white cell count (three-way meta)	25	96	1	943	2832	2532	2194	96	1459	3346	2516	1420	1065	3805	3811	4680	1627	1133	98	4689	3010	2949	212	4186	3583
634_Xenobiotics::Food component, Plant::quinate	634_Xenobiotics::Food component, Plant::quinate	25	96	1	845	3000	1565	2157	2332	96	1607	2098	2389	3310	2408	1163	2026	4596	1097	3445	614	3371	322	1765	381	1820
1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	96	1	419	346	1274	1375	824	1164	96	2778	746	618	4289	4000	1125	1022	3931	743	1067	841	2089	1064	1199	646
1213_Alcohol consumption	1213_Alcohol consumption	25	96	1	581	2254	627	225	3494	1766	2661	920	96	1075	4702	1449	3323	2735	987	2567	609	1191	2947	4347	4408	1046
110_Coronary artery disease	110_Coronary artery disease	25	96	1	2219	1461	4446	1434	736	1342	851	2934	4453	4132	4518	96	3605	170	4035	2163	3485	2782	3151	4274	2665	852
587_Nucleotide::Purine metabolism, urate metabolism::allantoin	587_Nucleotide::Purine metabolism, urate metabolism::allantoin	25	96	1	4713	1008	824	2200	2131	1106	2104	1234	4185	2945	1133	1010	4436	96	2701	4191	1692	221	505	677	2512	219
1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	25	96	1	4019	3385	1248	2692	2239	2395	2362	1891	3265	4595	2641	3276	272	1845	542	3410	437	96	1262	3447	701	1811
1027_Femoral Neck Length (GEE, adjusted for multivariable)	1027_Femoral Neck Length (GEE, adjusted for multivariable)	25	96	1	2984	1910	458	3532	2581	4037	3085	3760	3466	2063	1266	3194	4416	2529	1579	4589	3174	3645	96	620	952	1372
4152_Relative wall thickness	4152_Relative wall thickness	25	96	1	3899	1132	2314	4638	2698	2036	3287	416	2875	1405	4230	4479	1323	4035	3365	2620	1786	1503	3695	96	3971	4378
3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	25	96	1	2040	143	4189	3244	2720	509	1236	1678	867	913	3228	1909	3639	2264	1983	2817	908	4480	283	764	96	4324
3856_Myeloid white cell count (two-way meta)	3856_Myeloid white cell count (two-way meta)	25	97	1	1083	634	461	2767	97	615	4717	2884	1501	698	3545	2648	2595	2387	4248	108	3299	2039	4176	116	3065	3871
823_::::X-13549	823_::::X-13549	25	97	1	2017	239	2087	4369	398	97	2598	4232	1639	316	245	361	4602	946	678	270	487	2537	305	560	3493	1513
4174_Social support - Leisure/social activities: Religious group	4174_Social support - Leisure/social activities: Religious group	25	97	1	2515	3045	675	2310	3588	1640	1645	781	1291	97	3189	3528	1533	4168	844	3885	3928	4676	659	1850	4152	1674
393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	25	97	1	110	503	4237	4499	4139	2493	552	157	1788	835	3993	97	3874	3683	4472	1051	4383	1795	850	541	2445	4218
75_Geographic atrophy	75_Geographic atrophy	25	97	1	2556	4235	1584	3895	190	1111	1373	3529	202	3244	234	3957	97	957	514	531	834	2935	3743	3319	1593	3048
1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	25	97	1	2175	3993	2353	3755	3481	2445	4563	1965	1067	2125	3725	178	4023	97	4386	2686	1820	1352	1570	3305	1568	536
4132_Basophil count	4132_Basophil count	25	97	1	2296	1438	3416	3434	108	2548	2743	3276	2103	3593	1818	3161	2011	2028	3570	97	239	2753	1590	4318	2442	4000
1934_Temporal brain volume (FBAT, adjusted for age and sex)	1934_Temporal brain volume (FBAT, adjusted for age and sex)	25	97	1	278	3104	4695	933	1137	364	3985	3816	1768	1419	980	867	2254	1725	2954	2053	97	3187	2966	3710	347	4291
1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	25	97	1	2059	1882	2128	4186	3437	3593	503	3567	3455	3686	4455	1043	3881	2127	2378	3506	2220	97	650	4525	2790	1116
2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	25	97	1	1722	3715	4486	2367	2058	2611	1492	1927	4601	4174	560	3842	2444	3690	3683	1476	1970	4389	2522	97	2152	3555
398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	25	97	1	2655	1659	914	2024	1474	3090	2121	3807	1351	2649	2396	1469	4517	3230	4128	1180	3259	403	1603	2928	97	2936
1884_Shaft Width (FBAT, female, adjussted for multivariable)	1884_Shaft Width (FBAT, female, adjussted for multivariable)	25	97	1	149	1404	1276	214	3348	1299	374	1600	1047	259	1628	2729	456	2815	3072	1579	1350	574	420	3123	496	97
1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	25	98	1	4424	98	3666	1911	4073	3303	4227	4037	1326	3305	2775	3169	1613	1417	3173	2171	4505	3833	748	3206	3543	803
3606_Non-cancer illness code, self-reported: eczema/dermatitis	3606_Non-cancer illness code, self-reported: eczema/dermatitis	25	98	1	339	582	2338	1992	3813	98	4125	3303	211	632	163	466	1188	2215	3660	2743	494	2503	4408	692	4480	2881
3315_Use of sun/uv protection	3315_Use of sun/uv protection	25	98	1	1332	2458	3618	439	1534	4383	130	98	1989	3208	3902	1894	1161	739	806	2248	4594	738	4733	2341	3429	2034
1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	25	98	1	4624	3838	1931	2235	889	997	4490	4081	3938	3306	98	2487	3174	1614	2299	3263	2322	3627	696	3161	2810	2502
571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	25	98	1	2226	3252	3726	4046	3120	178	2698	3076	2272	2916	444	4095	780	98	3234	2466	952	2973	1300	2115	1848	987
2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	25	98	1	303	2664	261	1787	152	4581	4201	2708	3958	3242	2635	816	2816	3355	98	101	900	3828	724	2454	2233	866
4603_Right superior parietal	4603_Right superior parietal	25	98	1	2948	1900	688	4610	301	4677	2018	3301	1893	4722	1699	2885	3852	2487	1842	363	3024	98	4726	4411	1645	1461
3134_GRAP2 - GRB2-related adapter protein 2	3134_GRAP2 - GRB2-related adapter protein 2	25	98	1	4310	3891	3148	1152	4074	433	3762	1205	4487	3902	2893	3537	3646	1871	4725	3044	2365	3666	425	98	4396	4652
3453_Impedance measures - Leg fat mass (right)	3453_Impedance measures - Leg fat mass (right)	25	98	1	3649	2190	3766	4585	3745	2373	1131	323	1813	1190	4077	3557	3100	293	1238	3769	2026	1652	338	805	284	98
3895_Neutrophil count (three-way meta)	3895_Neutrophil count (three-way meta)	25	99	1	99	453	3598	4082	101	1144	2826	2619	2426	456	1736	2379	4112	1263	975	103	4103	1808	1148	952	4659	2101
3962_Gestational weight gain (maternal, late)	3962_Gestational weight gain (maternal, late)	25	99	1	1434	99	1301	4203	3590	905	1692	2436	3722	1686	587	2737	2684	4689	4688	3852	4160	4091	955	2853	4222	1300
2128_IL10RB - Interleukin-10 receptor subunit beta	2128_IL10RB - Interleukin-10 receptor subunit beta	25	99	1	1509	4608	99	792	1529	695	4707	1649	1111	3479	1422	3102	3171	1444	2540	3861	2946	1896	2934	2477	3345	1768
4365_Moderate to vigorous physical activity levels	4365_Moderate to vigorous physical activity levels	25	99	1	866	2712	494	99	355	3113	438	678	1347	392	2358	4180	3741	859	4110	288	2784	4074	4606	4549	1554	4677
2220_AGRP - Agouti-related protein	2220_AGRP - Agouti-related protein	25	99	1	655	611	2832	154	2270	325	99	334	2517	1027	3561	2376	4442	2026	2280	2401	1684	4688	2028	3168	4519	1220
1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	25	99	1	3569	2342	1279	3508	4189	4157	584	4155	4496	99	1579	3445	3578	1187	914	3026	3301	3704	666	3191	1389	3966
1230_Usual weekday bedtime (FBAT)	1230_Usual weekday bedtime (FBAT)	25	99	1	925	1767	2635	1398	4197	3520	345	3809	2946	1169	99	610	1057	4244	3911	2506	3881	3275	1870	3045	2692	1203
1836_Neck width (FBAT, male, adjusted for multivariable)	1836_Neck width (FBAT, male, adjusted for multivariable)	25	99	1	203	3935	2755	1899	3528	608	1868	1098	1840	893	232	3794	3823	99	3985	2337	2010	3558	604	751	135	643
3617_Treatment/medication code: atenolol	3617_Treatment/medication code: atenolol	25	99	1	2158	401	254	1408	1000	3226	3867	2223	4547	1973	1610	2656	3449	2154	99	677	2985	3502	1900	2532	3394	4229
3953_Amyotrophic lateral sclerosis (LMM)	3953_Amyotrophic lateral sclerosis (LMM)	25	99	1	4348	2270	1033	2441	1311	659	1494	2627	1725	1743	2646	1113	4571	1761	2860	2172	99	2868	3882	290	124	4554
1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	25	99	1	3749	2557	2732	3775	1862	2987	3389	1302	1752	1354	3480	1823	287	3828	2719	3647	2475	99	4407	3599	3014	3302
296_CD4mem:%preTh17 (1)	296_CD4mem:%preTh17 (1)	25	99	1	3080	2763	2647	1138	3968	237	649	4744	1394	377	2363	4447	2716	851	4594	2471	369	1718	99	2515	3986	1448
4489_Right parahippocampal	4489_Right parahippocampal	25	99	1	452	3898	3792	1660	4368	855	3433	4474	1881	3890	1140	3208	4711	1649	1978	2588	1716	1311	4377	99	3989	3253
1150_Corrected insulin response (adjusted for insulin sensitivity index)	1150_Corrected insulin response (adjusted for insulin sensitivity index)	25	99	1	3459	3071	2885	1557	1423	4327	507	3548	2255	1841	1287	2239	616	1822	416	1745	3606	2984	3601	2276	99	1941
4566_Left posterior cingulate	4566_Left posterior cingulate	25	100	1	100	1721	2000	442	2785	3242	512	344	278	2147	3789	3872	549	1557	1614	1239	2809	439	3496	653	1079	4125
1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	100	1	1045	100	2170	4187	2968	2131	1218	2660	1887	3721	608	136	2747	3641	4288	2115	1513	339	4239	3227	776	3600
5_Bipolar disorder	5_Bipolar disorder	25	100	1	1067	3226	100	4129	4537	1058	3432	1253	2321	3330	403	3587	142	1770	2609	2448	2104	4734	2378	2069	375	1871
3667_Diagnoses - main ICD10: H26 Other cataract	3667_Diagnoses - main ICD10: H26 Other cataract	25	100	1	1659	4250	733	100	2430	399	861	3499	1764	341	458	1460	2899	3262	2781	2460	452	549	4649	4501	3155	1058
3814_CD8+ T cell level	3814_CD8+ T cell level	25	100	1	1239	1952	1141	645	100	4258	4383	3274	1122	4542	3619	2571	4449	2846	4155	104	3931	4109	3010	2421	4315	1288
2313_JAM3 - Junctional adhesion molecule C	2313_JAM3 - Junctional adhesion molecule C	25	100	1	933	822	611	653	1411	4583	4168	100	2279	238	1748	3825	3095	1648	2394	836	2457	1830	2871	2395	2290	3712
2209_MMP3 - Stromelysin-1	2209_MMP3 - Stromelysin-1	25	100	1	3758	4309	4602	3101	2303	223	245	2487	100	2772	4381	4341	1704	4434	4024	1662	2693	1010	1000	4284	3759	2686
3912_Cup area	3912_Cup area	25	100	1	2014	1072	113	2597	2766	1603	3613	3489	1229	100	1632	1508	200	3223	1668	3493	3454	155	2152	1044	2006	3876
3394_Ever unenthusiastic/disinterested for a whole week	3394_Ever unenthusiastic/disinterested for a whole week	25	100	1	2485	3792	2310	1464	3198	4460	817	309	2264	4698	100	4539	3001	3633	4377	3421	3089	1118	2663	1575	2169	2100
992_Interleukin-5	992_Interleukin-5	25	100	1	3544	1750	3945	1071	2713	1797	3531	332	4645	2023	276	100	1063	3198	1313	4728	3022	4282	3037	1902	1910	3565
579_Lipid::Sterol, Steroid::lathosterol	579_Lipid::Sterol, Steroid::lathosterol	25	100	1	665	4588	1034	127	1614	323	3685	948	4399	288	348	347	100	2614	2922	792	2497	3094	553	3211	3482	1327
3464_Impedance measures - Arm fat percentage (left)	3464_Impedance measures - Arm fat percentage (left)	25	100	1	2387	1494	1479	3826	4617	3724	3484	231	3908	3299	4299	3059	3824	100	1329	4108	4211	3837	4494	2032	2071	265
2008_Dapsone hypersensitivity syndrome	2008_Dapsone hypersensitivity syndrome	25	100	1	3268	2800	1320	1306	103	3559	2365	4626	454	1022	4441	1875	3299	196	219	100	2598	840	3783	524	2939	256
2549_FGF1 - Fibroblast growth factor 1	2549_FGF1 - Fibroblast growth factor 1	25	100	1	2585	4181	1491	3862	272	4319	848	430	3084	3678	3442	1627	3132	4120	1731	210	2686	1511	4482	1508	100	3596
1119_Pericardial adipose tissue volume (female)	1119_Pericardial adipose tissue volume (female)	25	100	1	2113	4294	2045	2252	2521	306	411	1940	4143	1481	3788	2600	2547	2213	1716	2489	2636	3767	3848	326	1380	100
3358_Father's age	3358_Father's age	25	101	1	101	410	2402	2030	2057	4274	4416	478	2291	1623	716	582	4493	3760	3643	1143	3910	4002	3127	3734	1451	2981
3733_Depression - Thoughts of death during worst depression	3733_Depression - Thoughts of death during worst depression	25	101	1	3986	3498	1555	101	1104	165	2765	3209	4097	1107	762	3866	1419	4208	1222	1053	4571	3240	1887	4130	1258	1501
2924_TXNDC12 - Thioredoxin domain-containing protein 12	2924_TXNDC12 - Thioredoxin domain-containing protein 12	25	101	1	1548	522	3986	3866	4240	3605	1516	101	3402	4654	3988	402	4521	848	2211	3376	1034	2329	199	1849	4676	227
662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	25	101	1	1923	3397	1559	2240	2607	1821	4543	4364	1553	101	4496	3938	3378	2689	4064	3394	3076	3665	1139	2755	3934	3425
4275_Glycine level	4275_Glycine level	25	101	1	1489	4420	2800	143	1533	2416	266	3190	2924	4604	2235	101	4524	1538	3721	2378	1170	3973	1719	2440	2298	3615
1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	25	101	1	2425	2455	1596	206	964	356	2633	2763	2661	3780	4127	4293	146	672	101	3888	3541	320	1179	4082	800	3318
4740_Cingulum (hippocampus) radial diusivities	4740_Cingulum (hippocampus) radial diusivities	25	101	1	2144	1009	518	2576	1600	1455	4721	2220	3412	4184	2855	364	1885	1511	2704	1336	4143	101	332	647	1117	3972
987_Interleukin-1-beta	987_Interleukin-1-beta	25	101	1	1039	4496	2609	2595	3785	3987	640	4599	1127	4402	2933	903	1753	3886	1431	3908	1207	1226	2428	101	2498	3506
3452_Impedance measures - Leg fat percentage (right)	3452_Impedance measures - Leg fat percentage (right)	25	101	1	4259	4558	4528	3311	4475	2893	2982	1070	1350	734	1534	3441	4218	3635	3464	4001	3291	242	550	1595	101	1378
2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	25	102	1	2179	102	2459	842	1069	668	1338	3610	292	676	2141	4469	2623	3255	1975	495	2232	722	4600	4434	2259	1803
2715_LDHB - L-lactate dehydrogenase B chain	2715_LDHB - L-lactate dehydrogenase B chain	25	102	1	3951	4399	2853	102	3092	2981	4030	2830	2245	1885	1848	4287	2426	668	640	2459	1039	4369	4399	1192	1419	4657
3872_Sum basophil neutrophil count (three-way meta)	3872_Sum basophil neutrophil count (three-way meta)	25	102	1	145	627	2141	2250	102	1909	2660	2178	1535	229	1700	1247	4483	948	596	109	4426	1701	957	316	3297	3810
442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	25	102	1	3280	2656	731	512	3949	102	2619	3555	3851	2335	1453	1818	1714	2140	1610	1551	953	3680	4474	2478	4171	244
3646_Illnesses of mother: Alzheimer's disease/dementia	3646_Illnesses of mother: Alzheimer's disease/dementia	25	102	1	595	1181	2875	2888	529	735	102	2577	705	1626	1969	4477	4161	150	3632	238	1697	3956	1121	1477	2069	340
271_CD4:%CD244+ Naïve	271_CD4:%CD244+ Naïve	25	102	1	2802	716	618	1384	1183	603	636	2073	3310	102	1413	1984	1761	4116	3016	647	3526	1394	2427	4120	1560	1404
2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	25	102	1	1269	2454	1425	271	1574	427	538	4057	833	4208	102	475	3120	2351	455	2180	249	1517	2539	3079	832	3695
2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	25	102	1	2162	1015	890	4385	1182	2309	3383	1564	2423	2973	3624	102	1079	2759	1442	934	3642	1444	2369	4733	2405	4725
1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	102	1	1818	1965	2230	1022	440	4332	4175	923	3940	459	585	1283	102	2508	4684	314	797	3568	3779	673	2721	3358
4141_Platelet count	4141_Platelet count	25	102	1	2650	3616	4120	1649	3656	2530	2291	957	2858	2608	657	1916	404	1993	102	2149	1872	3173	2078	1985	865	3889
4462_Left pars triangularis	4462_Left pars triangularis	25	102	1	1743	1348	4323	3117	2578	849	1468	2196	2814	2518	4156	3414	2931	351	3916	1768	102	4675	821	4688	2309	2706
1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	25	102	1	3512	3014	3664	333	4738	1237	1214	810	2949	2019	627	1537	2199	2777	2743	3664	564	102	1867	923	3880	2182
3834_Basophil percentage of white cells (two-way meta)	3834_Basophil percentage of white cells (two-way meta)	25	102	1	1085	1628	2400	2681	3026	4057	2308	3369	4349	929	687	2617	2033	236	2777	4740	242	527	4698	1557	102	1946
879_Total cholesterol in IDL	879_Total cholesterol in IDL	25	103	1	103	157	320	694	828	140	2430	4676	245	2930	876	1493	3684	186	172	998	3750	3213	2586	4726	3891	1011
2090_EFNB3 - Ephrin-B3	2090_EFNB3 - Ephrin-B3	25	103	1	2488	103	4042	1013	153	635	1135	2654	4112	937	226	3063	117	2571	1095	181	463	2235	2144	4464	739	311
2385_CTSC - Dipeptidyl peptidase 1	2385_CTSC - Dipeptidyl peptidase 1	25	103	1	2936	2294	740	103	2553	2312	914	283	4421	993	3543	2176	4535	2861	4118	1224	4453	459	2559	3912	4062	3896
4314_Ever smoked regulary	4314_Ever smoked regulary	25	103	1	4491	484	4585	216	877	103	3082	1413	826	3504	233	2425	4534	4301	2054	1429	247	2426	434	2330	376	647
2937_C3 - Complement C3d fragment	2937_C3 - Complement C3d fragment	25	103	1	2874	1326	4108	2747	1004	2926	103	3116	2111	2761	3931	3390	2657	647	1686	367	2863	4127	2826	2699	2050	2279
3961_Gestational weight gain (maternal, early)	3961_Gestational weight gain (maternal, early)	25	103	1	2325	4041	4170	2619	3507	4372	2939	3010	437	879	103	2204	2969	523	726	3585	1686	2638	2022	1308	1528	1232
3635_Illnesses of father: Alzheimer's disease/dementia	3635_Illnesses of father: Alzheimer's disease/dementia	25	103	1	218	269	2939	4746	3242	1310	3986	2919	106	662	4274	1308	4253	103	1804	1706	2873	618	4735	2191	373	1367
4707_Splenium of corpus callosum mean diusivities	4707_Splenium of corpus callosum mean diusivities	25	103	1	3782	244	2963	3697	527	690	4316	3449	533	3542	1183	3146	3022	298	4072	1287	103	2236	4365	2134	1033	4116
2598_HGFAC - Hepatocyte growth factor activator	2598_HGFAC - Hepatocyte growth factor activator	25	103	1	2490	1664	4065	4673	1473	4594	256	2137	4651	1155	1880	3307	267	3737	803	2695	4294	2996	330	4660	103	4267
1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	25	103	1	245	2582	134	4679	856	384	3722	1125	2939	3459	2039	4586	4620	233	662	1349	686	2518	4067	1260	4613	103
190_Waist-hip ratio (female, adjusted for BMI)	190_Waist-hip ratio (female, adjusted for BMI)	25	104	2	104	931	3075	1169	4286	269	3114	425	838	3834	1745	3878	1862	2058	1541	1759	2318	426	1150	1841	4261	868
2631_PLG - Angiostatin	2631_PLG - Angiostatin	25	104	1	2529	3441	104	970	688	3139	803	274	2124	1201	4091	2247	769	2406	1162	614	4537	153	3339	4335	2548	4444
207_Gout	207_Gout	25	104	1	984	3057	3382	104	1412	3166	3254	2935	3992	1837	3013	1216	480	1883	685	2253	3892	118	166	173	3821	1420
3848_Lymphocyte count (two-way meta)	3848_Lymphocyte count (two-way meta)	25	104	1	832	1685	1873	1402	104	4708	4113	2802	117	2674	721	3422	2068	3118	2871	124	3244	1619	2424	657	4206	596
4154_Ejection fraction	4154_Ejection fraction	25	104	1	2580	2932	4629	1581	3539	2794	104	3808	4018	3709	298	3682	2633	3523	3453	1717	2325	139	3142	335	3326	4328
132_Waist circumference (male)	132_Waist circumference (male)	25	104	1	4112	3067	2866	1224	935	3861	3640	104	2478	485	4266	252	3496	3302	2981	2839	3792	4247	1337	2002	1993	1141
4743_Fornix (column and body of fornix) radial diusivities	4743_Fornix (column and body of fornix) radial diusivities	25	104	1	1499	2052	2008	3036	1403	4244	282	2695	104	2282	3849	1878	3049	1056	2067	1338	2751	2369	486	1429	3896	2219
3512_Type of tobacco previously smoked: Manufactured cigarettes	3512_Type of tobacco previously smoked: Manufactured cigarettes	25	104	1	2830	866	1265	2559	3814	2381	2345	3562	2582	104	120	4507	836	2433	4379	3010	3601	380	4398	904	4588	606
3146_S100A9 - Protein S100-A9	3146_S100A9 - Protein S100-A9	25	104	1	1778	4380	2125	1966	3351	2653	1501	4149	2795	373	2461	3468	691	2950	1107	4214	2978	104	3455	3093	1047	881
3272_Handedness (chirality/laterality)	3272_Handedness (chirality/laterality)	25	104	1	3281	2024	1958	3337	3486	4668	2209	610	1746	516	1810	3078	3911	4129	2401	4077	3737	970	104	2489	989	3155
1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	104	1	2816	3712	1073	2811	4487	1475	1195	2210	3143	118	2465	1237	2157	1786	3436	4198	1967	3208	1507	104	1075	2572
1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	25	104	1	1972	1633	3058	2347	4423	1053	4572	1385	1268	4661	1307	3376	2560	3511	198	4227	1956	4577	4108	3127	3816	104
431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	25	105	1	124	105	4493	4198	438	2125	1761	267	3936	1004	2518	464	176	4181	2231	1949	941	878	1789	1787	113	971
2690_MDH1 - Malate dehydrogenase, cytoplasmic	2690_MDH1 - Malate dehydrogenase, cytoplasmic	25	105	1	2979	3105	1148	304	105	2227	1183	3017	4466	4463	3112	3871	2923	2414	1706	163	1668	3436	720	422	1326	4079
55_Neuroticism	55_Neuroticism	24	105	1	4260	3953	2184	823	4342	105	1514	1483	1257	143	2332	760	1694	4190	1120	2037	2389	894	2046	687	4699	861
4136_Hemoglobin	4136_Hemoglobin	25	105	1	3854	785	4149	2768	1956	4167	105	2274	2761	2306	3219	1968	3871	2291	2935	2912	3564	610	634	4187	1481	4065
2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	25	105	1	1888	3107	177	2863	1472	3074	3043	4615	2633	3023	105	3346	3428	1636	2869	4426	3432	1616	1363	1394	4266	564
878_Histidine	878_Histidine	25	105	1	2352	2127	2017	4461	2170	1340	1841	733	1034	1324	3158	2387	105	3434	4680	3790	4368	4598	4655	1404	4262	2819
3207_Duration of moderate activity	3207_Duration of moderate activity	25	105	1	4418	3255	3670	1920	3647	3321	3355	1299	161	1529	2424	328	2927	105	3974	3777	4348	3425	227	367	2121	2085
967_Phospholipids in very small VLDL	967_Phospholipids in very small VLDL	25	105	1	529	757	842	254	746	260	3911	2908	687	3178	329	1751	1066	122	105	1279	3124	3873	4710	3896	3319	800
1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	105	1	3891	1833	2409	2340	4027	411	4324	2086	1513	1639	4030	880	621	4570	2825	4295	105	4479	1308	1407	1743	3888
1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	25	105	1	997	3307	3441	2253	214	3077	2231	3730	2137	523	4362	1524	397	513	346	159	264	105	3409	1011	3106	2285
4657_Genu of corpus callosum fractional anisotropy	4657_Genu of corpus callosum fractional anisotropy	25	105	1	4543	1795	1386	3858	919	424	2533	1142	1216	2064	4399	3115	2562	355	325	1446	683	3670	3713	1971	105	727
3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	25	105	1	1594	2943	212	4651	4059	2432	1446	2042	522	739	1931	2996	2293	3840	694	4568	2227	2820	3679	473	2632	105
2198_Human-virus - Protein Rev_HV2BE	2198_Human-virus - Protein Rev_HV2BE	25	106	1	106	2752	4652	2154	670	4267	575	1227	561	564	4554	2034	4282	4643	4076	2403	3947	1506	1371	1243	2009	497
4189_Fasting glucose	4189_Fasting glucose	25	106	1	4630	106	4739	1186	3248	2515	1295	1391	2158	669	3080	2568	1116	3640	1324	3829	1388	1463	262	2508	1141	4443
506_Lipid::Glycerolipid metabolism::choline	506_Lipid::Glycerolipid metabolism::choline	25	106	1	2215	2892	106	4680	340	779	435	639	3065	847	1877	4533	4137	1486	1924	2023	2192	4458	3835	4127	642	4308
314_CD4nv:%TFH (2)	314_CD4nv:%TFH (2)	25	106	1	2058	1754	3098	106	3741	3246	1148	3360	2043	2892	2106	3457	4644	3459	2149	4717	2715	4359	3834	2369	2557	2846
3904_White blood cell count (three-way meta)	3904_White blood cell count (three-way meta)	25	106	1	162	2442	3620	2679	106	2737	2426	4176	1015	1159	4406	3725	2200	3177	977	112	3630	3480	2096	596	2583	3523
4015_Central corneal thickness	4015_Central corneal thickness	25	106	1	4515	1131	3470	4697	2201	106	3521	4243	3638	3815	4541	1920	2592	1088	1014	2537	443	2501	286	2823	1869	2343
540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	25	106	1	806	797	1010	3218	3527	3373	106	3520	3135	765	4000	2747	231	4515	1401	4495	2243	4683	2727	531	3723	811
4064_Estimated glomerular filtration rate based on cystain C	4064_Estimated glomerular filtration rate based on cystain C	25	106	1	3647	1704	2971	1534	4155	4205	3662	106	4641	4107	2038	2062	763	2534	1809	1997	3969	2491	3387	1537	2198	1278
681_::::X-10346	681_::::X-10346	25	106	1	862	2560	4440	4465	150	170	1674	898	4436	106	2260	346	3515	1390	1309	136	444	2744	1071	4712	1194	2944
1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	25	106	1	1762	2327	2448	2800	3596	2080	1463	2159	3610	1148	1760	883	821	678	106	2509	1424	448	4594	2040	2607	1801
1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	106	1	1649	1204	3198	2577	3605	419	3907	3511	1043	825	4350	800	693	3283	3412	2978	106	3025	2045	1217	1552	4232
2394_GAS1 - Growth arrest-specific protein 1	2394_GAS1 - Growth arrest-specific protein 1	25	106	1	2446	1593	2864	3868	931	2961	2185	1294	185	3743	2853	1663	3523	1184	2967	1619	3209	106	833	3416	163	4517
3500_Male-specific factors - Hair/balding pattern: Pattern 1	3500_Male-specific factors - Hair/balding pattern: Pattern 1	25	106	1	2770	3158	1942	3297	1652	1729	3216	764	1994	2345	3186	2925	2069	3423	2070	322	3871	378	106	1267	1500	3058
4536_Right putamen	4536_Right putamen	25	106	1	1446	3391	2358	3398	3882	3383	117	1365	3721	4101	4188	442	976	134	3840	4210	3328	1236	1898	3113	106	4339
3209_Duration of vigorous activity	3209_Duration of vigorous activity	25	107	1	619	107	2861	1004	3580	1358	2144	1874	2956	4119	426	3158	1393	2174	140	4677	2185	4669	754	342	1751	2725
4585_Right lateral occipital	4585_Right lateral occipital	25	107	1	473	1400	107	1142	4630	3325	3010	4094	410	675	1924	247	1654	4432	3205	2598	2542	3692	3057	2116	1755	2025
3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	25	107	1	3538	4706	2443	107	3391	2197	3603	3564	1678	2508	2262	3418	806	3801	2939	1521	4265	4510	4045	2822	745	652
4150_Left ventricular mass	4150_Left ventricular mass	25	107	1	1790	3192	2504	2740	617	4609	2841	2184	107	1615	1814	2015	3730	4626	366	2178	2432	3559	3265	2168	1272	1329
1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	25	107	1	3646	1436	953	897	297	2251	1415	3386	2183	107	333	2880	974	1894	4187	471	2110	560	3723	2215	134	2448
3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	25	107	1	4646	3546	3567	1107	2615	4107	901	1843	4228	964	107	3304	391	2334	1225	4422	1713	1273	4734	655	346	2754
3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	25	107	1	4731	3509	4286	4077	4367	936	2535	3043	1344	2529	2100	285	107	3167	3647	4101	4006	4398	1568	4655	335	3758
3437_Doctor diagnosed hayfever or allergic rhinitis	3437_Doctor diagnosed hayfever or allergic rhinitis	25	107	1	629	3832	950	432	126	3827	663	4735	1303	4122	758	2675	155	1958	435	107	2170	2069	1779	2171	1185	352
2581_C1S - Complement C1s subcomponent	2581_C1S - Complement C1s subcomponent	25	107	1	1396	2900	4319	3847	3099	3291	3283	3761	238	4556	109	3532	3361	3211	3392	4629	107	4199	4101	4209	2213	312
2343_PRSS1 - Trypsin-1	2343_PRSS1 - Trypsin-1	25	107	1	2694	3969	3621	3453	3938	410	2315	3003	2658	1046	140	3562	2518	1631	2418	797	615	4248	107	1739	3877	1970
4484_Right lateral occipital	4484_Right lateral occipital	25	107	1	319	3372	1483	1544	2540	4394	3796	2519	125	2964	2744	431	3225	3335	3572	4052	4119	726	3170	107	1413	1026
3636_Illnesses of father: Severe depression	3636_Illnesses of father: Severe depression	25	107	1	3401	3225	613	2187	4462	4722	635	2067	308	2825	1727	3757	1794	3891	2129	3923	2036	2269	4742	4225	107	2011
1848_Neck Section Modulus (FBAT, male, adjusted for age)	1848_Neck Section Modulus (FBAT, male, adjusted for age)	25	108	1	108	1535	2206	2536	4440	2850	799	711	2637	2290	3681	4443	2955	2379	2388	3892	3146	2016	3873	2913	1929	4514
1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	25	108	1	4735	4615	108	2016	2383	4277	2284	4378	4267	1744	1572	2909	4522	754	3250	1824	4132	3835	3598	2544	1290	4010
2729_AGER - Advanced glycosylation end product-specific receptor, soluble	2729_AGER - Advanced glycosylation end product-specific receptor, soluble	25	108	1	4459	1412	776	108	2834	907	1939	3115	1767	2847	3478	2970	4562	3149	686	1275	2536	1651	4446	940	1942	210
4521_Left thalamus proper	4521_Left thalamus proper	25	108	1	1169	930	3454	803	4307	4290	108	1447	3323	808	1007	764	1673	3194	2130	4076	4394	1949	1127	2518	1532	2386
4209_Chronic kidney disease	4209_Chronic kidney disease	25	108	1	373	2971	3295	3771	1209	2938	612	108	925	3228	1548	139	1462	1045	1820	1808	876	4622	1750	2777	4597	4494
1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	108	1	4415	3036	3345	2158	2528	4429	724	4417	611	108	4174	3071	839	4021	1047	2615	4467	2181	3256	2396	2765	1151
3194_Number of vehicles in household	3194_Number of vehicles in household	25	108	1	1200	1074	380	3313	1458	3901	727	914	2514	260	108	2092	1716	3645	817	3924	4676	4293	2909	1428	4341	3667
844_::::X-14632	844_::::X-14632	25	108	1	2837	3172	3215	296	1066	187	1091	3325	1182	1788	3680	108	3944	515	380	1235	1892	1027	2025	155	3935	1973
3461_Impedance measures - Arm fat mass (right)	3461_Impedance measures - Arm fat mass (right)	25	108	2	4403	731	2368	1986	3849	2741	4579	594	2467	1191	3742	3721	3765	108	2075	3754	3929	3671	2948	4652	1822	449
2527_CXCL8 - Interleukin-8	2527_CXCL8 - Interleukin-8	25	108	1	285	4518	1392	2987	2733	1444	1928	2303	2259	3470	4559	1121	887	1398	108	3429	4572	3303	752	1524	3255	3108
4628_Left accumbens area	4628_Left accumbens area	25	108	1	1037	4099	4679	4367	3995	1267	1632	2188	3335	428	1164	365	972	2080	2239	3823	108	4134	3898	4315	388	1783
3356_Number of unsuccessful stop-smoking attempts	3356_Number of unsuccessful stop-smoking attempts	25	108	1	2601	3983	1579	2587	4691	1726	2361	615	2756	735	420	4590	3143	1921	2904	4497	375	108	3957	2693	4099	3476
1933_Parietal brain volume (GEE, adjusted for age and sex)	1933_Parietal brain volume (GEE, adjusted for age and sex)	25	108	1	516	3358	196	4010	2855	3296	1147	1518	1018	185	1728	2579	1721	1608	846	2732	1478	998	108	430	2800	3456
2164_PROS1 - Vitamin K-dependent protein S	2164_PROS1 - Vitamin K-dependent protein S	25	108	1	2706	4261	2797	2764	437	3231	3511	1703	3527	4480	225	1418	3222	1058	928	577	3757	4077	3390	108	1684	203
2721_PDXP - Pyridoxal phosphate phosphatase	2721_PDXP - Pyridoxal phosphate phosphatase	25	109	1	109	4070	4444	724	3600	1961	2183	481	3613	482	1144	1140	2717	3141	3527	4617	1106	4418	1605	781	1269	3745
3303_Able to confide	3303_Able to confide	25	109	1	2285	520	2564	109	2639	2344	4197	200	3728	3114	2977	4411	3426	1550	1643	4401	4026	1599	1236	3981	4354	1663
2175_MICA - MHC class I polypeptide-related sequence A	2175_MICA - MHC class I polypeptide-related sequence A	25	109	1	2224	957	3432	2943	109	1472	3258	947	4459	1021	4293	753	4086	2307	1631	125	1257	4060	3169	4054	3587	1006
1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	25	109	1	4330	2094	342	3991	3484	109	200	2774	4360	309	2230	1705	263	3046	872	2565	832	4106	3647	4415	222	854
2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	25	109	1	1090	3910	2955	1047	3593	1738	109	1445	253	1024	2738	4496	3650	2544	3247	2742	512	4310	2848	3393	1224	2756
330_CD4mem:%R6+	330_CD4mem:%R6+	25	109	1	1354	4500	4420	2822	4021	784	2012	109	3062	353	984	4597	3114	4542	487	4431	4506	941	3381	2937	1936	1943
4569_Left rostral anterior cingulate	4569_Left rostral anterior cingulate	25	109	1	4251	235	3965	3445	2700	1801	4686	3957	109	962	2824	1643	2776	4166	2186	1123	2205	2291	375	3156	2708	3875
972_Triglycerides in chylomicrons and extremely large VLDL	972_Triglycerides in chylomicrons and extremely large VLDL	25	109	1	1823	1902	2690	3693	4627	4261	423	2782	3380	109	3573	4225	794	1201	1509	1789	2843	4183	3507	1652	3173	1247
1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	109	1	2427	1263	1482	2448	3792	1417	4405	1685	1653	3198	3373	109	1286	3684	3553	4143	631	150	203	2125	128	1664
176_Waist circumference (male, adjusted for BMI)	176_Waist circumference (male, adjusted for BMI)	25	109	2	3457	700	2730	2685	716	1135	891	3063	4554	2248	3791	754	2967	1699	109	568	1317	4201	1856	4218	1396	2848
553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	25	109	1	1479	4249	2617	4620	3470	1464	2289	1826	1820	1997	2180	1917	2475	3482	1380	4270	3883	109	1292	664	4582	3056
2189_C3 - Complement C3	2189_C3 - Complement C3	25	109	1	4243	207	3400	1273	3743	900	2582	3965	1362	1468	4001	3961	2432	3122	4544	1939	314	2657	109	1273	4076	2750
1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	25	109	1	1893	740	4255	3363	2750	1163	3499	2401	1002	3799	4021	2786	1725	3950	169	953	122	633	3862	109	3553	1851
133_Waist circumference (female)	133_Waist circumference (female)	25	109	1	1177	1492	4737	1046	910	978	3229	1091	4071	2272	471	4724	557	634	597	1232	3311	2355	2798	1478	1534	109
810_::::X-12850	810_::::X-12850	25	110	1	4438	3608	110	709	416	3455	2534	1561	1605	1975	2747	3039	4268	3490	3925	483	3523	2224	2652	1587	3381	4679
2518_FN1 - Fibronectin Fragment 3	2518_FN1 - Fibronectin Fragment 3	25	110	1	4738	432	3705	2855	3228	1409	110	1122	4081	1181	1718	2583	1695	4024	1595	907	2378	1775	162	4258	629	4525
4632_Right inferior lateral ventricle	4632_Right inferior lateral ventricle	25	110	1	1281	904	4530	315	1349	2210	3367	110	1092	2383	3977	140	2941	292	3630	2362	932	4682	1928	2770	2042	4741
2329_FTH1 FTL - Ferritin	2329_FTH1 FTL - Ferritin	25	110	1	1927	838	3674	1188	2920	1686	618	1390	3198	110	2291	2596	1076	2536	2161	3813	2124	2949	4315	177	2238	1661
721_::::X-11540	721_::::X-11540	25	110	1	3315	3913	156	900	2787	4095	2783	232	2558	4520	110	2585	3851	4378	391	2468	1387	1276	3437	3554	336	3324
2423_ACAN - Aggrecan core protein	2423_ACAN - Aggrecan core protein	25	110	1	1956	3231	4533	903	2249	4375	3605	3623	905	3473	3532	110	2316	3436	2567	1516	4343	1542	3154	1415	3215	833
445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	25	110	1	358	2499	2970	1842	2314	4458	2747	4573	1377	3489	343	2148	110	1957	697	1839	3832	3223	1586	1564	2394	3411
10_Schizophrenia	10_Schizophrenia	25	110	1	4200	1764	920	847	116	887	3392	4218	940	1636	4396	2514	478	2308	3143	110	1944	661	2726	742	3832	161
288_CD4:%Treg(39+73+)	288_CD4:%Treg(39+73+)	25	110	1	519	1751	2713	777	1224	3863	3638	4447	4047	531	842	2059	808	412	1872	1437	1826	110	1122	2892	338	4013
3395_Ever highly irritable/argumentative for 2 days	3395_Ever highly irritable/argumentative for 2 days	25	110	1	2292	1962	1926	954	4669	2304	4096	411	2310	3616	301	3340	1987	747	2030	3725	1695	553	110	4153	2353	1398
884_Triglycerides in IDL	884_Triglycerides in IDL	25	110	1	2172	2116	300	723	145	3169	4238	2206	700	4530	1221	3282	845	1046	209	205	1327	2272	2205	3546	902	110
3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	25	111	1	2983	111	1432	3512	4417	3936	2573	685	3070	2045	3521	1864	1860	323	3927	1450	2923	3750	3277	3913	4345	4294
1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	111	1	1154	2369	111	2724	3939	3219	4006	285	1005	4322	538	4387	4272	1109	1410	4273	1291	3169	2404	1153	631	834
4446_Left caudal middle frontal	4446_Left caudal middle frontal	25	111	1	4149	3681	1849	388	696	4233	111	3061	4376	3685	1023	3591	4615	4517	4573	949	2501	1435	2410	202	3436	592
1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	111	1	4428	3931	3579	2316	2051	4612	4241	111	283	1345	1798	3684	2043	1943	801	669	846	2622	4678	3791	511	1813
4387_Epithelial ovarian cancer (Clear cell)	4387_Epithelial ovarian cancer (Clear cell)	25	111	1	4094	3519	1604	4091	679	1368	2905	3701	111	2093	635	2338	1592	344	553	898	3536	3347	982	3682	3181	2254
1978_Hand grip (at exam 7, FBAT)	1978_Hand grip (at exam 7, FBAT)	25	111	1	1566	1299	3490	4621	934	3362	4393	3223	3422	111	2709	4669	3887	1769	586	1386	2437	2575	2862	4118	2333	3111
2992_ESD - S-formylglutathione hydrolase	2992_ESD - S-formylglutathione hydrolase	25	111	1	1195	1402	3306	2269	992	1979	1318	578	2262	1093	111	4088	4047	195	1619	1974	1712	1856	4044	674	4705	358
334_NKeff:%Kir (1)	334_NKeff:%Kir (1)	25	111	1	3492	3920	2613	4271	4386	1249	4134	3279	949	3996	337	2733	2104	111	1308	3907	3866	2645	2904	2082	2831	3836
968_Triglycerides in very small VLDL	968_Triglycerides in very small VLDL	25	111	1	1454	3069	4425	1713	213	4522	2919	718	2018	1491	1448	4006	2989	476	111	318	2197	1881	3973	2669	1361	1643
2663_FGF23 - Fibroblast growth factor 23	2663_FGF23 - Fibroblast growth factor 23	25	111	1	2241	4303	408	400	1923	4568	578	2714	1560	1106	2555	1138	149	3137	2273	4095	299	2047	2049	2282	111	2184
2626_MFRP - Membrane frizzled-related protein	2626_MFRP - Membrane frizzled-related protein	25	112	1	112	1831	797	2837	4636	4442	3053	2541	556	3348	799	2831	690	2371	3110	4125	1442	1089	2458	1964	2865	148
4035_Alcohol dependency (unrelated individuals)	4035_Alcohol dependency (unrelated individuals)	25	112	1	482	112	2574	4300	2008	3258	4404	4736	2441	828	678	3575	4084	577	3294	4420	2534	407	3400	1682	3391	1450
1987_Age at natural menopause (GEE)	1987_Age at natural menopause (GEE)	25	112	1	252	1863	112	2481	1623	2389	3868	3729	2406	3484	2167	421	121	1867	4140	2693	216	2128	4260	2691	1634	1597
2012_Remission following 8-week treatment of MDD subjects	2012_Remission following 8-week treatment of MDD subjects	25	112	1	1351	357	2599	112	2966	3202	1076	4423	4343	2320	468	1343	1562	3507	510	3597	305	1660	3133	1353	2408	3346
3884_Lymphocyte count (three-way meta)	3884_Lymphocyte count (three-way meta)	25	112	1	2087	823	2100	3304	112	4542	2871	3428	326	1825	1034	1852	2032	2418	1722	127	3061	1031	4271	1389	4723	578
2021_Squamous cell (adjusted for age)	2021_Squamous cell (adjusted for age)	25	112	1	2659	4120	3482	3705	3598	112	2103	3941	2768	3071	2936	3594	467	4453	451	4371	3352	1124	1735	509	1891	3214
2447_HTRA2 - Serine protease HTRA2, mitochondrial	2447_HTRA2 - Serine protease HTRA2, mitochondrial	25	112	1	3805	1032	3656	4422	2255	4622	112	2733	1293	1998	886	2206	134	2546	3535	2523	372	394	976	3096	579	3928
1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	25	112	1	2063	3334	322	2461	4088	4474	2907	112	941	4085	3295	2907	3986	2245	399	2884	2841	4123	1063	1015	2802	2561
4345_Coronary artery disease and total cholesterol (bivariate)	4345_Coronary artery disease and total cholesterol (bivariate)	25	112	1	2344	372	205	262	396	666	3396	629	112	613	1053	1971	1378	204	2256	897	989	3989	4037	770	694	2733
2973_AGR2 - Anterior gradient protein 2 homolog	2973_AGR2 - Anterior gradient protein 2 homolog	25	112	1	1946	745	2550	1832	2382	2022	4281	1084	1176	1220	760	112	3090	334	145	1517	2199	3292	1868	2304	2263	2626
4482_Right inferior temporal	4482_Right inferior temporal	25	112	1	2279	2007	3059	3411	1619	1386	1519	4581	3621	2087	1613	1989	4058	112	1632	1518	4316	185	3737	3268	154	3284
1139_Body Mass Index (Dominance deviation model)	1139_Body Mass Index (Dominance deviation model)	25	112	1	157	3833	3003	4420	3059	4307	3054	4544	1666	3561	3687	1412	2528	570	112	4424	1981	944	356	3725	3323	616
1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	112	1	208	2331	2924	1465	2212	1740	987	3677	4138	3806	170	4400	1172	4381	1637	4188	265	4069	1079	112	3038	3440
2328_CLEC4M - C-type lectin domain family 4 member M	2328_CLEC4M - C-type lectin domain family 4 member M	25	112	1	3061	1870	939	2966	3892	2093	4370	3678	217	582	4538	2555	1482	429	1926	4297	4137	3903	4522	175	2401	112
1604_tPA (at exam 5, FBAT, adjusted for multivariable)	1604_tPA (at exam 5, FBAT, adjusted for multivariable)	25	113	1	113	4278	924	1968	4186	3272	1337	3973	3028	3868	3771	2870	3085	2705	1423	3323	3051	3259	4160	3290	3525	2607
3934_Monosialylation	3934_Monosialylation	25	113	1	3586	1390	3127	1365	113	4208	3589	1432	2555	529	2244	3105	1471	2699	968	118	3682	542	3776	1698	3371	1723
971_Phospholipids in chylomicrons and extremely large VLDL	971_Phospholipids in chylomicrons and extremely large VLDL	25	113	1	2350	2196	3966	1836	3655	4404	113	2498	1166	2027	4194	4557	1717	1914	1582	1595	485	992	2675	1860	3221	2103
1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	25	113	1	2760	4596	1438	2680	3972	3214	2080	447	1245	544	113	3341	3064	555	3343	2668	1698	1268	792	797	1093	2377
3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	25	113	1	133	3125	3695	2337	3045	2333	4119	3292	2603	896	1436	523	113	3188	1656	3051	2262	1335	655	1762	1868	3971
640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	25	113	1	2766	4021	1186	736	883	1516	1538	611	3175	1873	655	458	4468	113	2251	1117	1683	1759	4451	2016	4395	337
97_Height SDS (male at age 12)	97_Height SDS (male at age 12)	25	113	1	4218	2822	267	4290	3878	371	604	2330	2763	2787	4629	1825	3116	3702	113	1190	2127	2153	3987	2350	2921	2139
2443_FCN2 - Ficolin-2	2443_FCN2 - Ficolin-2	25	113	1	3110	922	2900	1851	2851	939	2460	1029	2005	2207	1476	2866	902	2357	4082	4314	3137	113	1056	1423	1332	4535
2677_PAK6 - Serine/threonine-protein kinase PAK 6	2677_PAK6 - Serine/threonine-protein kinase PAK 6	25	114	1	1212	2475	4207	866	114	309	3627	486	4570	1285	4220	1483	667	1267	317	119	396	1668	400	3464	4119	2645
2742_IL20 - Interleukin-20	2742_IL20 - Interleukin-20	25	114	1	2660	3667	1713	4013	4582	114	2319	4180	2064	210	1029	3258	2502	1462	2876	4333	115	3684	4159	3696	809	1187
4315_Cigarettes per day	4315_Cigarettes per day	25	114	1	148	1693	2240	3529	1824	3696	114	3832	523	3414	2198	3231	172	1711	3733	3151	1127	968	4371	4587	1585	2736
1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	25	114	1	3968	3419	238	3765	1409	3527	1127	114	3860	2506	1825	2386	2580	873	1853	2159	3180	3346	1278	3029	1203	2074
3331_Other serious medical condition/disability (diagnosed by doctor)	3331_Other serious medical condition/disability (diagnosed by doctor)	25	114	1	1546	194	783	4140	253	586	2792	1721	114	3053	4227	3733	2485	4008	1761	619	893	325	266	383	1494	3827
2334_IL1B - Interleukin-1 beta	2334_IL1B - Interleukin-1 beta	25	114	1	4557	817	1694	4135	3502	3486	4240	4192	1528	114	2653	4429	1443	1708	3547	4714	2764	975	1580	2428	2094	3521
913_Total lipids in medium HDL	913_Total lipids in medium HDL	25	114	1	3097	2577	3715	3852	4361	4494	397	4629	1474	4477	114	2230	4580	415	2250	1380	1669	2324	422	2970	1619	2281
3382_Prospective memory test - Duration screen displayed	3382_Prospective memory test - Duration screen displayed	25	114	1	4680	394	248	1252	1135	4582	3365	976	3661	1771	3971	114	647	3288	4643	3293	4364	3963	2425	804	2209	760
76_Neovascular disease	76_Neovascular disease	25	114	1	2958	3238	1766	4253	184	1699	692	3097	154	3755	467	4111	114	2400	1498	751	966	4513	2288	3727	1356	2396
2643_CTSH - Cathepsin H	2643_CTSH - Cathepsin H	25	114	1	639	1342	3182	3038	1428	758	263	4212	431	4621	2978	2898	559	114	249	3945	1880	4450	1916	2481	1175	4025
2802_NAPA - Alpha-soluble NSF attachment protein	2802_NAPA - Alpha-soluble NSF attachment protein	25	114	1	580	3241	650	285	1633	1743	4093	325	3783	2117	3544	1821	3717	3161	114	1265	2665	800	1551	2410	4111	3457
4127_Lactate dehydrogenase	4127_Lactate dehydrogenase	25	114	1	3671	1214	3978	1863	125	701	275	3821	722	3778	2179	2315	1011	2179	156	114	3212	4221	4121	544	3378	1824
3266_Average weekly fortified wine intake	3266_Average weekly fortified wine intake	25	114	1	4689	1824	2312	4317	886	621	2845	3465	4461	3488	3335	541	4031	2507	3701	3779	114	3058	3466	2670	1715	2602
3383_Prospective memory test - Number of attempts	3383_Prospective memory test - Number of attempts	25	114	1	831	3308	878	382	4438	3170	869	2946	2191	652	3318	2449	1106	3168	3136	2791	3297	114	3479	594	4375	4644
1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	114	1	1510	2439	4557	4161	4119	4398	4693	4426	3103	4144	3662	2180	2919	1785	655	2865	4075	783	114	3296	1029	2143
349_CD8:%TM (2)	349_CD8:%TM (2)	25	114	1	197	3030	4450	4482	3650	1039	688	3750	2983	1991	2788	426	3396	2669	2919	3280	3502	2641	1543	2578	4696	114
1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	25	115	1	115	4190	1103	3628	4217	2257	2490	2948	1727	684	1757	4264	2537	2677	3817	4025	1960	2705	1932	2980	895	4127
882_Concentration of IDL particles	882_Concentration of IDL particles	25	115	1	447	115	271	355	846	227	1940	4562	646	3831	878	1680	1985	261	202	1201	3438	4267	3637	3436	4136	1054
3936_Sialylation	3936_Sialylation	25	115	1	2778	1125	614	3281	115	1853	1825	2351	2739	250	2033	381	1160	4104	3682	122	2566	1528	1501	3581	3544	1884
2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	25	115	1	2537	2414	2175	1478	3823	3959	3249	459	1732	115	2384	698	943	2426	595	2119	4048	1068	4106	3662	2713	4158
4285_PEF	4285_PEF	25	115	1	4582	3384	3878	637	450	2360	3542	4635	1058	595	4271	115	661	4366	1825	506	2961	2156	2260	4275	4472	2032
2984_CTSZ - Cathepsin Z	2984_CTSZ - Cathepsin Z	25	115	1	3600	4521	873	997	3338	4003	4649	1015	490	4274	3166	3967	115	116	500	3140	2930	369	2733	1505	2352	4298
3843_Hematocrit (two-way meta)	3843_Hematocrit (two-way meta)	25	115	1	2775	4063	4650	3166	3138	2571	1966	2414	1542	1137	1695	4646	4068	115	2859	4109	3128	3570	1615	2599	3480	2378
1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	25	115	1	4616	4324	3574	3969	4618	1061	1102	3656	1779	1682	2336	1280	2274	2887	3036	4604	649	2285	1426	328	115	3964
3372_Age hay fever, rhinitis or eczema diagnosed	3372_Age hay fever, rhinitis or eczema diagnosed	25	115	1	188	1838	485	347	732	3951	3341	529	1450	3059	518	1881	446	3935	1977	651	3842	2115	3231	4019	164	115
1146_Peak insulin response (adjusted for BMI)	1146_Peak insulin response (adjusted for BMI)	25	116	1	153	1578	116	2258	3333	2406	2452	1664	2716	2308	854	2709	4590	4548	4436	1930	4159	3020	2166	478	1839	2792
409_Amino acid::Tryptophan metabolism::tryptophan	409_Amino acid::Tryptophan metabolism::tryptophan	25	116	1	2993	2228	2549	797	3769	1490	116	690	3962	2727	3946	632	735	3652	2657	4710	4370	3380	3639	1187	4299	1233
120_Obesity class 1	120_Obesity class 1	25	116	1	841	1138	402	4004	2831	3693	4246	116	4094	3844	899	3603	3850	1295	1783	4621	672	4303	2847	224	2674	434
4354_Infantile hypertrophic pyloric stenosis	4354_Infantile hypertrophic pyloric stenosis	25	116	1	165	3895	1337	3490	1033	983	3065	3658	116	3767	736	2195	166	2603	3897	1741	2000	1943	3362	2779	2205	4107
2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	25	116	1	4059	1209	3475	4560	1756	440	2830	1020	1239	116	4735	2205	3473	4292	3499	1769	192	388	4592	836	1671	1889
2371_VEGFC - Vascular endothelial growth factor C	2371_VEGFC - Vascular endothelial growth factor C	25	116	1	3017	2208	1841	3514	2799	4572	1535	4674	4707	4473	116	3932	2870	2880	2942	2819	3555	389	437	4574	1212	506
2397_GP6 - Platelet glycoprotein VI	2397_GP6 - Platelet glycoprotein VI	25	116	1	123	3733	2225	4298	394	421	1945	2099	3741	4457	4241	116	292	1881	2097	767	3546	4163	3868	3207	2648	2157
3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	25	116	1	1077	3963	1166	720	3816	3571	2271	1613	2188	2226	3496	2333	116	2170	417	818	2533	674	829	4064	1189	2899
4359_Biliary atresia	4359_Biliary atresia	25	116	1	333	4576	1961	2376	814	1261	3552	3127	3914	1720	3326	263	2795	4722	116	2604	1281	4122	1494	186	2697	1078
3433_Symbol digit substitution test - Duration to entering value	3433_Symbol digit substitution test - Duration to entering value	25	117	1	117	217	1373	472	2342	2417	2970	1977	2567	2575	3037	4474	1859	1498	221	1797	4106	3428	1362	472	1486	338
881_Total lipids in IDL	881_Total lipids in IDL	25	117	1	273	117	160	390	837	241	2773	3707	277	3540	960	1714	2310	230	146	1282	3465	3194	3420	4276	2923	1218
1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	25	117	1	366	3788	1869	874	3288	117	428	1866	1486	4405	316	2476	2479	4266	4040	1073	184	1706	1368	3964	1895	3311
1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	25	117	1	4514	1979	3150	4473	1401	279	3044	158	1936	2487	3654	117	1591	403	3610	546	2666	2265	600	2569	1358	3515
3010_MAPK11 - Mitogen-activated protein kinase 11	3010_MAPK11 - Mitogen-activated protein kinase 11	25	117	1	4263	1381	3385	2598	155	1946	4703	2244	712	2224	913	3223	1194	1062	117	209	3570	1641	1679	1775	943	1698
1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	117	1	1111	4705	2501	379	1343	3131	2529	297	2856	2101	1486	317	4417	3041	2996	1088	117	3032	2716	490	2139	3470
1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	25	118	1	3295	1762	118	563	2737	441	1477	1989	302	1109	4500	2275	3475	2333	1220	1182	2169	3609	1488	3012	3825	3793
4525_Left hippocampus	4525_Left hippocampus	25	118	1	709	3980	936	118	4067	3931	2260	1116	1503	494	3934	3028	4377	4411	3881	2894	4706	467	1280	2047	3869	3152
4732_Superior longitudinal fasciculus mode of anisotropy	4732_Superior longitudinal fasciculus mode of anisotropy	25	118	1	3794	2481	512	3396	1765	1105	118	4509	2010	498	2962	2033	3574	684	4351	3049	2646	827	3796	1388	329	2132
744_::::X-11905	744_::::X-11905	25	118	1	936	2922	4399	3366	2309	4271	4645	3469	118	2684	3926	1102	3680	4375	2329	2224	3589	2986	1283	638	644	1828
2782_IL1RL1 - Interleukin-1 receptor-like 1	2782_IL1RL1 - Interleukin-1 receptor-like 1	25	118	1	3193	493	522	713	1145	4393	326	1692	1188	2578	2095	3547	118	1598	539	1464	4474	2989	1439	1057	799	476
4563_Left pars triangularis	4563_Left pars triangularis	25	118	1	1793	2774	4210	2663	2564	884	3861	2335	1705	2678	3515	2669	3797	789	2602	2092	118	2406	3183	4427	1483	3191
3979_Estimated BMD	3979_Estimated BMD	25	118	1	1962	4185	1299	295	2000	2558	1028	429	4128	4102	1955	449	608	1194	4006	2205	1277	2943	118	1797	313	1950
4643_Right vessel	4643_Right vessel	25	118	1	1347	2997	4243	4451	1456	2219	180	3358	2580	2914	1370	1398	2295	3152	1158	2879	1405	751	2892	118	3457	2015
2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	25	118	1	2509	3128	2260	298	4117	2642	3972	2191	4516	3260	3414	3463	553	4742	3558	4366	1858	1098	1285	2177	118	4183
2306_HIST1H1C - Histone H1.2	2306_HIST1H1C - Histone H1.2	25	118	1	1672	2105	567	3855	554	2105	208	4481	4433	581	2367	2003	4414	1847	1521	323	4260	724	288	4485	1514	118
3947_11q deletion neuroblastoma	3947_11q deletion neuroblastoma	25	119	1	119	3206	338	1723	3554	174	3958	791	3035	3214	338	1784	4485	602	4558	4261	1051	4090	3689	2819	2047	2560
1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	25	119	1	4077	2271	1288	119	703	4227	4000	1969	137	1518	400	4190	703	3587	3851	630	461	2555	252	4175	785	2241
138_Waist-hip ratio (male)	138_Waist-hip ratio (male)	25	119	1	4150	1375	2578	1818	1150	1238	4016	461	119	2363	2225	817	3687	3047	4652	2230	3450	3461	1012	1813	2491	4326
1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	25	119	1	4662	2745	1719	809	3073	1247	3486	4343	4669	119	1606	1051	4255	4374	956	1593	3049	4465	2782	2694	3985	2722
2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	25	119	1	4360	871	1771	947	1197	4199	1772	1736	566	585	135	2416	153	119	3067	418	2504	1472	3955	2496	750	2410
1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	25	119	1	3975	1765	4258	2591	1628	2716	3577	1516	3835	223	2000	2432	1619	2196	119	2002	3309	337	3777	1483	4162	4504
1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	25	119	1	4346	3272	3794	502	4006	1371	3028	3825	3681	3726	1361	2231	1319	1277	4404	2991	119	2987	3083	1686	1790	3892
2587_CHL1 - Neural cell adhesion molecule L1-like protein	2587_CHL1 - Neural cell adhesion molecule L1-like protein	25	119	1	1795	243	1941	4742	4057	1807	1464	3042	332	2718	2864	1999	1130	1813	2082	3791	3409	119	4363	3452	4174	4512
792_::::X-12712	792_::::X-12712	25	119	1	2013	912	3043	2005	3307	1224	1751	1897	2697	4301	846	3939	1010	1975	2720	2975	135	2722	119	2392	3603	479
385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	25	119	1	2828	187	1275	1171	1904	684	2114	680	902	3444	4083	2430	4338	1281	1605	1737	2231	719	4585	119	2550	4112
4742_External capsule radial diusivities	4742_External capsule radial diusivities	25	119	1	1425	2817	2745	3325	4470	854	2881	847	244	3648	2602	4599	1783	2506	4459	3207	1912	3170	828	3217	2456	119
4592_Right pars opercularis	4592_Right pars opercularis	25	120	1	721	120	3836	2428	3660	3288	2984	4023	2373	591	461	4308	2347	4231	3712	1670	3690	4266	3072	732	4268	4197
333_NKeff:%337+	333_NKeff:%337+	25	120	1	2057	2085	120	2491	938	2816	951	2331	2645	2069	4689	3355	925	680	3758	1342	2295	3505	1613	4707	574	4745
1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	25	120	1	3087	2838	4389	120	668	2466	342	3081	340	4591	1864	2196	1630	2460	1049	747	4145	4337	799	4678	3661	1495
4443_Epstein Barr Virus antigen VCA IgG levels	4443_Epstein Barr Virus antigen VCA IgG levels	25	120	1	551	4318	2787	925	120	1049	1902	876	4294	1778	3886	3388	566	1848	3001	289	2816	1975	1504	3672	2084	4223
4663_Splenium of corpus callosum fractional anisotropy	4663_Splenium of corpus callosum fractional anisotropy	25	120	1	2994	519	2657	2534	1354	4013	3302	120	997	3103	1850	2510	2701	493	138	2214	1520	4667	3086	211	212	512
4493_Right pars triangularis	4493_Right pars triangularis	25	120	1	1555	1943	1732	2549	3732	3945	624	3176	673	120	3127	4444	421	2005	1177	559	532	147	4014	4685	4550	2787
3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	25	120	1	1305	2449	2073	951	1242	2842	3458	3018	401	3632	684	1558	120	3573	965	1534	1414	1173	2302	1957	3198	2737
3051_EPHB2 - Ephrin type-B receptor 2	3051_EPHB2 - Ephrin type-B receptor 2	25	120	1	675	4557	3317	4682	2310	3217	220	2493	3127	383	3288	4398	1874	2294	120	4610	912	849	2329	2768	461	2911
4004_Juvenile idiopathic arthritis with vs without uveitis	4004_Juvenile idiopathic arthritis with vs without uveitis	25	120	1	2351	876	3911	1993	124	1257	1907	2512	4652	1331	4287	3891	1996	2478	2541	120	1262	1446	3118	1132	2329	3921
3831_Amyotrophic lateral sclerosis (linear mixed model)	3831_Amyotrophic lateral sclerosis (linear mixed model)	25	120	1	3502	1355	1464	1745	2285	1554	2342	1933	4026	4035	2935	3373	1934	3703	3903	3690	120	846	2764	424	500	3869
4616_4th ventricle	4616_4th ventricle	25	120	1	2372	1723	1731	4237	1719	3088	821	1223	346	1935	3597	1782	1713	3833	3875	2269	2914	120	2341	1465	1711	3259
2950_F5 - Coagulation Factor V	2950_F5 - Coagulation Factor V	25	120	1	584	1212	932	438	468	175	4421	2561	4599	397	2442	1337	2950	3394	364	300	774	896	2785	120	997	794
4282_FEV1	4282_FEV1	25	120	1	4361	2688	4329	2805	1661	3089	839	804	313	148	3111	1925	4593	3358	2989	1845	1390	4610	272	3848	3152	120
2877_COL23A1 - Collagen alpha-1(XXIII) chain	2877_COL23A1 - Collagen alpha-1(XXIII) chain	25	121	1	2235	121	1217	2754	1085	4007	867	3748	3404	2887	1504	3884	1407	2068	1319	1112	4050	4571	2806	2866	3385	2338
2945_GCG - Glucagon	2945_GCG - Glucagon	25	121	1	4595	2115	3856	1613	2948	769	121	1366	526	1193	2385	3963	3239	179	4507	3989	173	3851	3361	1272	3517	737
112_Body Mass Index	112_Body Mass Index	25	121	1	4535	705	3229	4685	2586	1065	703	121	4280	3498	714	575	1802	3628	3128	4507	1969	4358	1757	2487	2038	349
4738_Body of corpus callosum radial diusivities	4738_Body of corpus callosum radial diusivities	25	121	1	4727	290	1257	4593	2864	225	273	1823	121	3370	143	4324	479	1491	611	2402	621	2137	4519	3286	1956	2385
3908_Vertical cup-disc ratio	3908_Vertical cup-disc ratio	25	121	1	1896	4066	3133	3493	1903	798	4598	1851	1828	308	121	3683	1047	2355	1337	4017	4667	402	4137	1965	1653	2161
2426_BGN - Biglycan	2426_BGN - Biglycan	25	121	1	1664	1133	1683	684	3349	2878	1369	2284	2039	1666	4059	121	620	127	1906	4007	2806	1442	479	3695	291	392
4288_FEV1/FVC ratio	4288_FEV1/FVC ratio	25	121	1	1595	964	901	144	161	4385	2295	1218	4222	374	2953	985	3119	4535	1449	121	2633	753	2679	4529	3218	865
953_VLDL diameter	953_VLDL diameter	25	121	1	3112	2450	566	1884	551	4575	1962	194	322	3297	3090	3629	4607	1827	199	1597	121	3515	521	2246	767	1781
4246_Right handed	4246_Right handed	25	121	1	2544	1638	3890	623	242	4693	203	865	4643	1051	1346	685	1678	881	3389	197	1276	121	1565	427	4351	660
1197_Cerebrospinal fluid levels of amyloid-beta 1-42	1197_Cerebrospinal fluid levels of amyloid-beta 1-42	25	121	1	4377	4666	4234	1449	146	3636	476	741	3055	3913	2847	243	500	4235	3266	160	3790	2348	121	726	3512	2552
2764_H2AFZ - Histone H2A.z	2764_H2AFZ - Histone H2A.z	25	121	1	1266	4428	2205	3275	3083	203	1085	3758	1769	4632	1768	780	1483	4331	2041	2717	1352	1942	3514	121	3217	2214
1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	25	121	1	4656	2357	833	3246	2800	2267	678	4044	1557	4614	774	430	1283	1122	1111	1187	949	1708	3556	616	1314	121
1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	122	1	3605	1496	1585	122	3299	4043	2120	2172	3016	4317	634	1091	4091	4389	1848	4709	2556	3513	3377	4003	3792	3816
1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	25	122	1	976	1542	782	2584	1177	1648	2096	122	3116	3442	2024	4511	3518	827	855	1929	1862	595	2465	4384	4711	217
2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	25	122	1	4511	4592	3101	943	3328	1256	1768	2256	2948	3195	122	1819	2247	2305	2222	2383	1522	2434	4562	1173	1304	3993
4327_Well-being spectrum	4327_Well-being spectrum	25	122	1	3326	254	1560	3946	3553	350	2898	1046	3628	4092	2481	2783	122	3257	1615	3472	1896	2081	3909	1244	3784	319
108_Coronary artery disease	108_Coronary artery disease	25	122	1	4135	3808	3106	1296	912	2685	3422	4337	1223	819	2682	856	891	2194	122	2016	571	353	1062	1928	1092	3488
1292_Diabetes incidence (FBAT, adjusted for age and sex)	1292_Diabetes incidence (FBAT, adjusted for age and sex)	25	122	1	992	1864	2841	3104	4188	2526	1120	3456	234	3635	1505	4296	3257	2856	3473	3019	2755	1784	1269	759	122	3229
728_::::X-11792	728_::::X-11792	25	123	1	4356	280	123	707	2030	537	1079	2807	3511	1924	4577	4081	3021	3253	200	3238	2382	1585	2244	2349	4101	2123
1040_Shaft Width (FBAT, adjusted for age and sex)	1040_Shaft Width (FBAT, adjusted for age and sex)	25	123	1	219	4136	699	123	3853	3976	2505	311	4725	4742	1260	239	3092	511	4263	4176	2138	2368	3590	2154	1394	4085
1847_Neck Section Modulus (GEE, female, adjusted for age)	1847_Neck Section Modulus (GEE, female, adjusted for age)	25	123	1	4334	1890	2681	1752	3192	4086	123	3422	1631	910	936	4357	3632	1272	3283	1778	3672	4356	943	2153	2621	1180
4535_Right caudate	4535_Right caudate	25	123	1	3993	4340	3299	1321	1737	1113	2022	123	189	3984	2517	2080	3736	4390	1365	3836	1521	3421	3354	2897	187	406
4679_Genu of corpus callosum axial diusivities	4679_Genu of corpus callosum axial diusivities	25	123	1	570	1124	3137	3219	1930	460	332	4256	123	2039	737	307	3778	3985	1955	2868	637	3985	3355	2524	3396	1947
651_::::X-02249	651_::::X-02249	25	123	1	1636	1165	4735	2380	2628	1474	1525	4355	2156	1452	388	123	1159	655	2164	2738	4431	2708	1865	1147	623	4392
452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	25	123	1	1519	2820	4538	2954	1016	3943	982	2381	4719	4028	1094	2562	123	1253	4719	1234	1176	2197	2635	1240	2633	3019
754_::::X-12093	754_::::X-12093	25	123	1	354	3481	664	4043	1058	2095	1262	2194	1106	1936	325	519	2786	123	473	1077	1386	3081	1406	2801	3203	2837
861_Citrate	861_Citrate	25	123	1	1059	1845	244	4613	596	3562	4029	758	289	4303	983	2808	3789	2731	2470	2681	123	2387	2924	2608	4358	2399
3224_Weekly usage of mobile phone in last 3 months	3224_Weekly usage of mobile phone in last 3 months	25	123	1	1498	197	2341	1948	4213	3570	4618	4693	3637	2598	4548	2224	603	1475	2878	2569	922	2596	123	3351	1611	749
1017_Femoral BMD (GEE, adjusted for multivariable)	1017_Femoral BMD (GEE, adjusted for multivariable)	25	123	1	830	784	3543	3912	3696	1192	4691	817	4639	2025	3698	1477	2252	252	3011	4529	3163	2301	2890	123	3393	3062
2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	25	123	1	4225	1517	1129	192	4545	4353	1780	3942	2932	2629	460	2530	3662	1185	2443	2994	3138	2642	3634	4659	123	3222
959_Phospholipids in very large HDL	959_Phospholipids in very large HDL	25	124	1	2685	828	1529	124	1646	710	2136	2497	187	367	2547	2525	4475	2253	518	4327	1753	251	4643	3895	797	3182
383_Amino acid::Glycine, serine and threonine metabolism::serine	383_Amino acid::Glycine, serine and threonine metabolism::serine	25	124	1	2731	4427	370	4438	3742	658	124	4435	1203	3050	631	1209	1812	3246	863	1604	1210	3859	1753	4430	1740	4340
3427_Fluid intelligence test - FI4 : positional arithmetic	3427_Fluid intelligence test - FI4 : positional arithmetic	25	124	1	2114	1914	1834	1944	1050	4189	4385	124	3319	4364	2557	3911	3246	235	1564	500	3984	552	1482	1447	764	2522
1087_Age-related Macular Degeneration	1087_Age-related Macular Degeneration	25	124	1	2896	1012	860	3833	210	1119	504	4114	124	1970	526	2693	271	2661	3548	1052	1347	3521	3531	3302	1118	1184
1111_Visceral sdipose tissue volume	1111_Visceral sdipose tissue volume	25	124	1	2176	3769	4044	4293	4061	3353	377	4405	457	619	124	2228	2314	2585	3625	2454	2512	212	2747	2113	651	4230
3998_Tense / 'highly strung' (TENSE)	3998_Tense / 'highly strung' (TENSE)	25	124	1	1902	925	2687	3118	3601	2440	3904	2203	3225	2059	3923	124	3876	4202	3711	3800	1840	2035	3517	2474	3811	685
3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	25	124	1	492	2758	1188	3720	326	4016	2764	432	1980	2077	2241	515	1911	4571	124	295	2629	386	971	4711	2561	1337
802_::::X-12776	802_::::X-12776	25	125	1	125	2222	452	2968	3046	1147	3457	3165	3250	2459	2574	2044	2888	3286	1485	2024	1799	1233	2299	1200	366	2513
3922_Heart rate variability (SDNN)	3922_Heart rate variability (SDNN)	25	125	1	4666	125	2419	2924	3418	3549	1977	996	2217	2691	1349	1605	254	4533	3471	3143	2442	865	2209	1927	484	2299
1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	25	125	1	3527	1440	125	1414	1281	555	3876	1687	4310	701	823	206	1913	4580	150	2351	1007	3161	1783	1375	2324	2220
1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	25	125	1	1536	4419	3474	2979	1466	125	4698	1192	3684	2018	3162	1639	3926	3566	966	790	611	3028	3026	2506	2848	4018
737_::::X-11847	737_::::X-11847	25	125	1	4320	169	4600	582	1048	2411	125	2792	758	1079	3678	1255	4344	1909	2666	1105	1321	1957	950	3382	4235	4619
991_Interleukin-4	991_Interleukin-4	25	125	1	3426	915	1717	3306	1369	168	2622	125	3522	4012	1756	1800	800	2863	617	3951	2223	1047	2384	3244	3754	4355
59_Childhood IQ	59_Childhood IQ	25	125	1	2015	3641	4231	3473	3066	3886	2861	2854	2166	125	1684	4165	4682	1604	1503	1057	3277	2526	2496	3065	904	4287
4711_Sagittal stratum mean diusivities	4711_Sagittal stratum mean diusivities	25	125	1	3666	2267	1680	2701	640	3873	298	951	4463	3239	2450	325	125	4526	1836	2503	2989	715	1620	4679	4148	3593
4519_Left cerebellum exterior	4519_Left cerebellum exterior	25	125	1	4518	2841	2284	1111	961	1030	4389	2001	134	1545	3124	2766	1289	125	4204	1021	1449	2952	3174	798	1974	2903
2946_C3 - C3a anaphylatoxin	2946_C3 - C3a anaphylatoxin	25	125	1	2543	684	2855	1282	2824	3940	586	3131	4265	3289	4519	662	3317	1788	1075	2645	125	2706	3435	4565	4478	2785
647_Xenobiotics::Xanthine metabolism::paraxanthine	647_Xenobiotics::Xanthine metabolism::paraxanthine	25	125	1	816	1298	867	2003	1741	3416	3424	2451	2812	401	1019	1969	2553	4724	2106	1277	3989	125	3428	4406	1784	1901
268_CD4:%TM (1)	268_CD4:%TM (1)	25	125	1	2856	756	323	4113	2537	4088	767	2048	4712	1789	174	2335	610	3519	2303	4488	464	958	125	1502	3764	2683
830_::::X-14056	830_::::X-14056	25	125	1	4602	3978	2953	4712	2794	1779	3320	4048	1925	2796	784	3802	4741	1889	4344	4337	4558	2611	3803	125	415	1908
2337_MRC2 - C-type mannose receptor 2	2337_MRC2 - C-type mannose receptor 2	25	125	1	488	3781	4395	2960	167	2972	1615	3929	2298	4020	2685	483	3761	3395	1430	319	4247	4153	1884	2199	125	2406
3736_Depression - Impact of normal roles during worst period of depression	3736_Depression - Impact of normal roles during worst period of depression	25	126	1	126	1421	4631	2265	4468	2403	4571	3580	2163	4266	1381	1166	4544	3360	1325	4157	3641	4261	2686	3132	2608	2244
733_::::X-11818	733_::::X-11818	25	126	1	3874	126	4677	2917	2612	3276	4414	1592	622	1170	877	1468	2637	2434	1229	737	4115	871	4201	452	3625	659
4153_Fractional shortening	4153_Fractional shortening	25	126	1	4587	525	2201	126	1262	737	3930	3037	2843	3928	1704	217	4447	3409	3044	1227	2290	3740	1401	3068	224	350
592_Peptide::Dipeptide::cyclo(leu-pro)	592_Peptide::Dipeptide::cyclo(leu-pro)	25	126	1	166	2047	2061	164	3454	126	4733	2038	978	424	3878	164	3459	2381	1814	2427	152	2633	533	488	1181	1365
2463_ACY1 - Aminoacylase-1	2463_ACY1 - Aminoacylase-1	25	126	1	2309	820	3189	1371	4062	3746	126	133	4388	328	3994	568	4205	1717	422	1820	699	3416	3101	2814	3169	4541
464_Lipid::Bile acid metabolism::cholate	464_Lipid::Bile acid metabolism::cholate	25	126	1	1942	222	4290	3010	840	1661	773	126	1496	251	3063	656	3865	612	354	1258	1538	2300	3518	2014	4159	1182
2391_C2 - Complement C2	2391_C2 - Complement C2	25	126	1	3130	511	2192	201	248	3697	2655	2212	126	3749	2142	1177	4337	2509	669	219	2373	3382	1092	682	2316	1736
306_CD4mem:%cFTH (2)	306_CD4mem:%cFTH (2)	25	126	1	4211	2916	4164	1984	2823	4369	4355	3461	1086	126	728	2520	732	1660	3604	3084	1714	2847	4619	3681	4231	618
2349_KLRK1 - NKG2-D type II integral membrane protein	2349_KLRK1 - NKG2-D type II integral membrane protein	25	126	1	956	1036	367	3068	857	1035	1994	1716	452	2740	126	1464	1833	918	4339	2141	1367	4516	1562	163	2321	430
966_Concentration of very small VLDL particles	966_Concentration of very small VLDL particles	25	126	1	1048	1168	1459	1002	223	2174	3828	1395	916	3545	391	3433	3075	592	126	280	913	1700	4235	2775	4570	879
3168_CD27 - CD27 antigen	3168_CD27 - CD27 antigen	24	126	1	183	4664	2375	2918	144	1727	1260	4376	2504	1372	3516	1850	2229	903	692	126	3824	3185	869	3282	892	1667
2863_IL5RA - Interleukin-5 receptor subunit alpha	2863_IL5RA - Interleukin-5 receptor subunit alpha	25	126	1	4303	2043	4396	3974	657	2427	3181	4659	1791	3061	3720	3800	2549	2587	537	423	126	2037	2099	3415	2745	2332
820_::::X-13477	820_::::X-13477	25	126	1	2316	4382	2894	1518	510	564	422	4171	2498	945	4026	2635	2328	1468	3929	2190	1830	126	4545	731	774	3748
4294_Chronotype	4294_Chronotype	25	126	1	534	4451	3238	1756	3924	4047	3070	3696	3255	3594	908	1624	2705	529	1048	2616	3464	2088	126	520	3581	890
3779_Traumatic events - Witnessed sudden violent death	3779_Traumatic events - Witnessed sudden violent death	25	126	1	1062	897	3167	2334	1510	2090	3109	3330	1089	2612	4503	2189	1247	773	1894	1484	3182	2833	3065	4482	126	1221
4708_Superior corona radiata mean diusivities	4708_Superior corona radiata mean diusivities	25	126	1	3078	3487	2256	2933	2146	1839	1128	1724	1209	4304	985	3052	1216	3954	4077	4726	2235	3027	531	2681	3454	126
1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	25	127	1	1038	4544	127	3212	2033	2054	4326	4049	4415	2256	332	4090	423	2827	2710	2416	3950	801	1111	3419	3973	3274
2859_C4A C4B - Complement C4	2859_C4A C4B - Complement C4	25	127	1	1577	406	971	721	127	2863	1795	292	741	1052	4493	3670	2366	2712	1030	186	1117	4137	2985	463	3803	3487
2027_Cryptorchidism (group 1)	2027_Cryptorchidism (group 1)	25	127	1	308	393	809	517	1303	127	3279	3572	4067	276	3767	3461	2846	2021	1069	3612	298	4283	4028	3410	1631	2963
1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	25	127	1	1690	242	3378	1720	3245	1895	1363	809	1838	127	1134	383	297	1818	3460	2051	4560	1156	840	1747	317	4622
3545_Mouth/teeth dental problems: Painful gums	3545_Mouth/teeth dental problems: Painful gums	25	127	1	3366	2097	1967	3362	572	2363	1067	3189	2824	3369	4116	127	4657	2191	1510	706	520	2429	4114	2235	1127	3452
2621_COLEC12 - Collectin-12	2621_COLEC12 - Collectin-12	25	127	1	2762	4295	1794	4534	3376	2388	2456	4010	1545	3388	1104	1853	127	1908	4337	2993	959	4433	4458	3255	2270	2416
4652_Cingulum (hippocampus) fractional anisotropy	4652_Cingulum (hippocampus) fractional anisotropy	25	127	1	1439	3436	528	2176	2219	2811	3492	3391	4572	1900	2585	2845	2713	2857	127	2073	3614	410	767	3650	1095	1135
1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	127	1	4645	1561	4274	1222	183	453	2220	721	1851	2917	2809	4077	1356	1035	2408	427	127	1967	1550	2782	4409	3013
2519_FN1 - Fibronectin Fragment 4	2519_FN1 - Fibronectin Fragment 4	25	127	1	3904	1286	4254	2081	453	1874	706	1200	2574	3829	2725	3633	835	834	1963	3285	3206	127	1064	2760	2495	3071
4208_Blood urea nitrogen	4208_Blood urea nitrogen	25	127	1	436	4111	3817	1070	4503	1649	3165	1383	2247	4350	1141	2088	4600	3929	1715	4645	309	756	3871	127	3696	3369
2295_BMP7 - Bone morphogenetic protein 7	2295_BMP7 - Bone morphogenetic protein 7	25	128	1	128	3260	385	956	1159	1298	284	3818	4306	2659	2760	1027	4231	4140	3853	862	541	3410	3754	272	4717	4438
2375_CD33 - Myeloid cell surface antigen CD33	2375_CD33 - Myeloid cell surface antigen CD33	25	128	1	1148	874	557	837	3135	1296	1056	3587	3172	2184	4046	1262	128	4222	261	3950	1707	4238	293	1545	4592	2720
1163_Hemoglobin A1C	1163_Hemoglobin A1C	25	128	1	144	2309	3629	4634	4409	4506	4664	1579	2029	1902	3087	3199	2943	1449	668	2680	2341	128	4131	552	4449	4178
4714_Anterior limb of internal capsule mode of anisotropy	4714_Anterior limb of internal capsule mode of anisotropy	25	128	1	1987	2359	3057	1343	4292	4184	1244	1705	4116	636	3068	891	1100	400	4646	4518	3768	764	1059	2157	1283	128
2321_TSLP - Thymic stromal lymphopoietin	2321_TSLP - Thymic stromal lymphopoietin	25	129	1	129	841	2562	3323	4075	2308	2179	2354	3568	821	1396	2370	1569	4665	2127	4559	2750	1566	2120	2361	2619	3678
122_Obesity class 3	122_Obesity class 3	25	129	1	1422	129	3509	1061	3219	2260	4344	4003	694	1430	229	1683	4327	560	3369	4116	1644	832	4287	2978	3472	3150
1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	25	129	1	2641	2783	3025	2565	2441	129	634	2856	3348	156	517	4696	547	3134	787	2968	852	4656	2735	1425	4150	587
3084_RELT - Tumor necrosis factor receptor superfamily member 19L	3084_RELT - Tumor necrosis factor receptor superfamily member 19L	25	129	1	3674	3465	2351	948	2457	1894	834	129	2428	3123	2801	4692	394	2890	2399	1278	746	253	3107	4154	4683	2740
451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	25	129	1	2914	2378	3622	2624	3327	4386	1335	1791	129	729	4445	1011	4603	4293	197	3437	4066	1962	3379	1707	409	2053
1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	25	129	1	4072	1358	1135	3802	2006	3189	248	3086	1570	129	1487	676	461	1927	1391	1967	4330	2340	2006	665	412	2130
3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	25	129	1	1480	2489	2134	3955	2003	2190	4427	1645	165	2646	129	2363	353	1460	3962	3847	1568	449	3665	1026	2889	3603
2276_CYP3A4 - Cytochrome P450 3A4	2276_CYP3A4 - Cytochrome P450 3A4	25	129	1	514	3922	2022	1867	2734	1070	1856	4595	2309	3131	1371	129	2294	3785	405	3644	887	4388	4448	4077	837	3382
3019_NCK1 - Cytoplasmic protein NCK1	3019_NCK1 - Cytoplasmic protein NCK1	25	129	1	374	753	331	1159	2364	3422	499	2016	2736	2397	1742	4644	3773	129	4457	2004	583	4062	502	1972	3761	3853
1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	25	129	1	4391	3592	2972	424	2206	1431	251	3523	3656	4482	3661	2542	1804	1274	4658	1165	1617	129	1869	939	1889	2672
1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	25	129	1	2773	3339	3922	3470	826	1379	4179	1523	3506	3649	1912	440	3412	746	646	1207	246	2480	2595	129	279	4533
4431_Toxoplasmosis IgG levels	4431_Toxoplasmosis IgG levels	25	130	1	2807	130	3948	692	3629	1374	4390	497	492	1251	2914	4367	3940	3725	2782	2422	1741	4486	3402	2079	3108	4493
4639_Right hippocampus	4639_Right hippocampus	25	130	1	1602	2904	992	130	780	3279	3489	477	1368	1030	2306	3315	2448	3778	4723	601	3113	4258	2042	1426	2762	3123
2694_PSMA1 - Proteasome subunit alpha type-1	2694_PSMA1 - Proteasome subunit alpha type-1	25	130	1	4123	2264	4609	3528	4434	130	3272	2630	3913	2451	2132	1936	3951	3609	4694	3626	542	3456	3508	4508	1030	751
4296_Thinness	4296_Thinness	25	130	1	605	3387	214	3349	3394	3729	1502	403	130	1508	907	4189	4546	2240	2673	2919	1368	3204	988	170	240	2340
1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	25	130	1	2252	4341	4159	3121	4554	3460	343	1619	4211	130	4611	2012	517	1138	1585	3671	2871	316	1010	2748	1399	4722
2019_Lung canger (adjusted for age)	2019_Lung canger (adjusted for age)	25	130	1	3559	3941	3489	273	2492	552	4631	925	235	970	3660	3533	871	2749	130	2270	3781	4539	1291	3697	1538	3017
3481_Milk type used: Semi-skimmed	3481_Milk type used: Semi-skimmed	25	130	1	4607	3936	4352	2470	1523	2430	2770	937	4334	537	3203	1570	303	4316	3539	2601	130	4661	3006	912	1124	2462
3942_HbA1c	3942_HbA1c	25	130	1	614	4402	3265	1362	3726	4155	2085	2672	3117	2237	2755	2199	2844	2193	355	3849	4202	130	3421	2126	4271	1435
1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	25	130	1	1854	3690	4604	275	924	4417	1599	2736	666	738	3518	3883	1768	4587	1327	3172	4267	3545	130	2253	4450	1923
1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	25	130	1	4431	760	4004	1331	4678	580	3921	3616	2941	2439	830	2286	3649	2236	3097	1951	4218	600	3103	130	3340	2342
3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	25	130	1	727	2792	2686	4073	1043	964	854	2249	743	3405	4603	717	2709	2173	2828	756	3504	2486	3063	3821	130	3061
3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	25	130	1	3207	2993	3638	2510	1078	945	2283	3783	4706	1291	3278	4230	3347	427	4002	3387	2469	2018	1169	3301	3446	130
3036_TPM1 - Tropomyosin alpha-1 chain	3036_TPM1 - Tropomyosin alpha-1 chain	25	131	1	131	2219	606	923	1773	2897	3995	2818	1423	1463	1006	3073	1213	4028	217	3242	2510	1275	3710	3059	3500	3309
4305_Trunk-trunk fat ratio (male)	4305_Trunk-trunk fat ratio (male)	25	131	1	2590	962	131	3322	277	2692	270	975	1484	400	375	2499	3608	762	871	461	1070	334	195	4426	1709	2779
1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	131	1	3756	1793	2923	131	1394	2122	4357	3139	3223	2869	4231	4191	754	2370	1159	2158	1610	3172	2821	3235	1703	3028
4133_Monocyte count	4133_Monocyte count	25	131	1	1935	2013	4360	3182	131	3236	142	505	564	3229	1555	3121	3185	2742	1938	137	436	3295	3833	319	729	900
2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	25	131	1	720	3979	1309	4201	3362	726	131	1044	3744	4300	3608	232	4539	2627	2846	2849	848	1601	4098	3987	2935	4021
4700_Fornix (cres) / Stria terminalis mean diusivities	4700_Fornix (cres) / Stria terminalis mean diusivities	25	131	1	3769	4704	3437	175	206	3180	1752	131	4163	3906	3587	3278	1914	4583	3852	208	3822	1399	4404	3307	1994	1944
1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	25	131	1	690	2478	676	1304	907	1233	1144	3963	131	3864	3798	3826	2048	2016	3555	1135	3374	3137	1194	3155	4283	2062
777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	25	131	1	3282	1832	2994	864	2902	521	2507	391	4653	131	3764	2279	4395	2538	2042	2217	182	955	693	475	962	3548
1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	25	131	1	4371	992	3528	2521	3258	2971	4672	1351	2061	772	131	4209	2021	1733	2562	3147	4214	2810	2671	3909	3468	1305
4156_Epilepsy	4156_Epilepsy	25	131	1	2812	4641	3548	1134	1453	1319	2850	1180	3624	2782	4668	1167	131	2541	4111	2271	4151	2080	4180	1629	3760	2362
345_NKearly:%337+	345_NKearly:%337+	25	131	1	2450	2891	736	4074	2453	4060	3490	2036	954	2661	2606	1242	1895	131	1855	1993	3366	2978	4029	1012	2759	2227
1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	131	1	779	2591	2385	2431	2672	3991	3285	1143	1583	3820	469	1054	3252	147	131	3403	2825	302	284	315	4337	1332
1136_Parents' age at death	1136_Parents' age at death	25	131	1	205	4581	2323	2712	322	375	1641	3881	3548	1322	2178	3095	3356	3854	659	131	3913	1105	2578	2583	1851	4485
3579_Social support - Leisure/social activities: Adult education class	3579_Social support - Leisure/social activities: Adult education class	25	131	1	2240	4257	2362	3653	3060	4457	2816	3285	2502	495	4414	2969	4453	3978	4105	3015	1608	2176	131	626	972	3093
4573_Left superior temporal	4573_Left superior temporal	25	131	1	1121	4425	2129	979	2363	1222	4628	4409	4329	4631	4504	2975	3860	1870	4053	2122	1008	1558	2127	131	3636	4458
4196_Hypertension	4196_Hypertension	25	132	1	2893	3649	132	4507	4321	3174	4372	4608	3775	1633	3301	1702	412	1326	4662	3155	3652	1918	587	4594	3865	1808
2650_STX1A - Syntaxin-1A	2650_STX1A - Syntaxin-1A	25	132	1	2324	3577	273	132	4179	3741	4192	2663	3280	697	1686	3165	1018	1278	3511	2319	1626	620	581	4145	1700	1575
2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	25	132	1	4467	1291	4415	716	290	2284	132	3234	560	4387	1056	3905	3153	1500	2136	424	1309	1677	4251	3089	3029	3175
2437_CST7 - Cystatin-F	2437_CST7 - Cystatin-F	25	132	1	3730	3840	1817	3586	4257	4363	4616	132	834	4068	1234	1546	4536	3176	3377	1198	3194	2378	187	1317	3379	2954
1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	132	1	4124	558	2187	944	2228	2042	2170	3945	132	3021	1680	3152	2497	2073	3210	2848	1851	3175	4270	3101	3398	3505
3195_Average total household income before tax	3195_Average total household income before tax	25	132	1	2501	2705	1436	1074	2807	2582	3025	3666	4671	132	4136	3780	1891	4658	1787	3798	2230	1862	2743	1825	3387	1051
4022_Eyebrows	4022_Eyebrows	25	132	1	1471	2780	190	1303	1976	1367	2641	2459	192	4648	132	3997	4329	1597	3565	702	661	1184	3064	2534	3288	2329
171_Waist circumference (female)	171_Waist circumference (female)	25	132	1	1702	974	1259	989	993	2365	2469	843	3829	2251	1252	2993	4044	132	4432	2974	739	3171	2480	372	4581	609
4382_Epithelial ovarian cancer (high -grade and low-grade serous)	4382_Epithelial ovarian cancer (high -grade and low-grade serous)	25	132	1	1745	4391	277	1786	4318	3110	1744	2637	4605	371	1577	2465	1608	356	132	4457	2320	2731	4495	3070	2704	856
961_Total lipids in very large VLDL	961_Total lipids in very large VLDL	25	132	1	1826	2281	3280	2215	2422	4213	761	1152	309	4523	2325	1946	4655	3678	420	3894	132	2239	1305	1053	1359	1662
732_::::X-11805	732_::::X-11805	25	132	1	3624	4071	4182	3164	3240	3160	945	4014	3536	4499	340	4245	3900	3549	3873	2850	4034	132	4524	1954	1555	3128
1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	25	132	1	3872	3687	2833	3629	3871	3030	4435	1309	942	457	173	1922	1384	2010	2978	3338	3944	3789	132	2876	4448	2867
4290_Frequent insomnia symptoms	4290_Frequent insomnia symptoms	25	132	1	2105	854	3839	3624	3661	4488	1974	482	329	447	2240	4117	3703	3346	1947	4544	1247	201	789	132	1244	2423
3489_Cereal type: Biscuit cereal (e.g. Weetabix)	3489_Cereal type: Biscuit cereal (e.g. Weetabix)	25	132	1	2221	1368	3955	1614	4698	1559	3978	872	1572	3722	4207	1697	2230	1409	1237	1215	1263	2238	2278	1935	132	1465
1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	25	132	1	4347	2233	308	4670	3302	3798	2336	826	1036	1679	819	3360	4531	1329	2506	3111	3940	2096	817	617	234	132
1846_Neck Section Modulus (FBAT, female, adjusted for age)	1846_Neck Section Modulus (FBAT, female, adjusted for age)	25	133	1	230	133	2990	1358	516	2224	1201	316	484	4356	4066	652	3753	1587	839	336	1471	2438	710	965	1548	4397
2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	25	133	1	2559	951	885	133	1216	1674	4139	1898	619	2730	2539	1926	4075	2329	3300	3141	4587	1059	1211	999	1817	4409
880_Free cholesterol in IDL	880_Free cholesterol in IDL	25	133	1	242	542	357	310	1044	133	3447	2676	334	3633	1078	2901	1947	998	584	964	3098	3605	2730	3408	3912	2136
3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	25	133	1	176	2338	917	2857	3898	3801	935	2292	133	2620	4654	1573	3364	2576	1813	1330	1491	858	1654	2824	1557	4730
4444_Cytomegalovirus IgG levels	4444_Cytomegalovirus IgG levels	25	133	1	2808	4555	4349	404	2500	3631	1574	3312	1230	1763	723	133	991	4388	2644	3719	1437	3691	1500	4004	1000	2980
2834_CHST2 - Carbohydrate sulfotransferase 2	2834_CHST2 - Carbohydrate sulfotransferase 2	25	133	1	4485	3037	3760	764	3901	3001	2059	2558	2347	2552	4161	4713	133	1667	4368	4607	1638	2172	1585	3900	1263	2816
2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	25	133	1	4234	3926	2922	158	1465	4526	2041	4054	2127	4565	2175	521	356	133	2947	1140	4345	4198	342	3612	2518	3796
4715_Average across all tracts mode of anisotropy	4715_Average across all tracts mode of anisotropy	25	133	1	864	2687	4371	1612	1837	300	784	546	696	151	4734	967	2368	325	133	1410	665	2751	2471	1947	4097	1897
3405_Fluid intelligence test - FI7 : synonym	3405_Fluid intelligence test - FI7 : synonym	25	133	1	4105	521	4163	1880	1166	1816	399	2232	461	3802	3507	3203	2898	3944	1573	1350	1748	133	513	1420	3051	4475
3825_Osteoarthritis of hip	3825_Osteoarthritis of hip	25	133	1	1580	4437	828	1824	479	263	760	919	797	2484	3465	154	358	2409	3127	291	412	1097	3003	133	3298	934
4336_Overall activity (conditioning sex and BMI)	4336_Overall activity (conditioning sex and BMI)	25	133	1	2392	4400	4471	2698	2996	156	3268	2475	808	996	438	4360	4076	3388	2618	714	4164	3155	670	2504	133	1609
1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	133	1	1828	2883	2709	640	3319	3542	1887	2477	1712	1960	241	1531	1118	1959	3563	3331	2461	1711	2348	3628	580	133
2995_FCAR - Immunoglobulin alpha Fc receptor	2995_FCAR - Immunoglobulin alpha Fc receptor	25	134	1	134	3257	2249	1849	3246	1873	3657	155	1801	1524	995	2010	1867	4599	1112	3559	3921	210	3139	654	1763	2943
2305_CXCL3 CXCL2 - Gro-beta/gamma	2305_CXCL3 CXCL2 - Gro-beta/gamma	25	134	1	4324	134	2896	1376	3125	3427	3035	1932	297	1901	1317	2121	1930	1731	4098	3189	2749	2114	2251	2730	4145	3084
4626_Left hippocampus	4626_Left hippocampus	25	134	1	2549	4160	1837	134	4045	3292	2756	1539	2847	1502	2341	3110	2666	4472	2658	2930	3898	1876	601	404	3327	3771
3321_Ever had bowel cancer screening	3321_Ever had bowel cancer screening	25	134	1	3579	2151	2911	1609	2988	4644	3696	134	2121	1294	4680	900	1254	640	203	4093	2195	3047	2113	1068	565	1545
1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	134	1	586	3345	155	2169	2974	3247	4602	235	841	3467	134	4462	4622	832	1328	3212	1090	3036	2753	371	604	841
524_Lipid::Long chain fatty acid::oleate (18:1n9)	524_Lipid::Long chain fatty acid::oleate (18:1n9)	25	134	1	1050	232	2759	705	2643	1102	4052	800	3811	168	2080	134	1989	148	1035	1581	2179	3566	2673	340	1281	1430
1210_FEV1/FCV	1210_FEV1/FCV	25	134	1	2700	2079	916	550	163	3172	3163	527	1169	2318	4012	2553	589	2808	1992	134	3413	2678	3404	3540	829	2361
390_Amino acid::Lysine metabolism::pipecolate	390_Amino acid::Lysine metabolism::pipecolate	25	134	1	2746	496	3581	3834	3937	1450	2821	4181	1510	3217	1908	2935	3625	4396	381	4341	134	2696	2300	1897	3829	2493
46_Baldness	46_Baldness	25	134	1	1787	3850	3118	2274	3592	1509	2489	1400	706	2860	3396	1502	2563	4022	2559	1322	1445	134	186	2607	2241	2435
1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	134	1	1288	2760	739	1100	4176	1991	230	3379	4090	2409	1662	1777	452	2462	2089	3233	4564	4092	3359	134	1591	4311
2993_FABP5 - Fatty acid-binding protein, epidermal	2993_FABP5 - Fatty acid-binding protein, epidermal	25	135	1	3294	135	341	4005	1545	4287	920	4085	4370	957	4155	2052	4383	599	4555	393	2739	329	4062	2425	2654	2515
381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	25	135	1	4049	3897	1775	2643	422	135	1687	4000	1531	4388	3713	2819	4477	3461	2477	528	2870	1869	1074	1632	263	4660
4459_Left paracentral	4459_Left paracentral	25	135	1	3754	3096	213	1648	1749	3757	135	926	774	3278	2525	212	341	2957	3336	4307	2625	2002	673	3539	2319	1422
929_Other polyunsaturated fatty acids than 18:2	929_Other polyunsaturated fatty acids than 18:2	25	135	1	3595	4514	4571	2696	1986	4597	370	135	399	1127	1608	1614	615	4247	205	2414	3448	4627	834	4212	1647	313
1082_Hemoglobin A1C level in conventional treatment group	1082_Hemoglobin A1C level in conventional treatment group	25	135	1	3966	667	690	3432	4419	2507	2684	3033	1329	135	2319	893	1743	1662	1566	2560	2117	1920	1014	1624	608	3390
3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	25	135	1	3861	2302	3565	3683	2509	2883	2306	1018	4484	2255	4306	135	235	1244	4124	2419	1562	2242	4198	151	3417	4743
2333_IL19 - Interleukin-19	2333_IL19 - Interleukin-19	25	135	1	1377	1219	4152	2535	3621	3819	3856	3659	4225	1293	2060	3944	135	2921	4268	1286	911	4533	465	2653	3828	4157
204_Urinary albumin-to-creatinine ratio	204_Urinary albumin-to-creatinine ratio	25	135	1	3177	1672	1638	3916	4260	4202	4403	1566	1822	3646	1450	1028	2079	135	2010	4023	674	1498	2276	4519	4193	2670
337_NKeff:%Kir+ (2)	337_NKeff:%Kir+ (2)	25	136	1	1884	136	284	613	3074	2055	1438	3560	4559	780	2238	2229	250	464	3409	863	734	4246	253	4634	4317	953
63_Age at menarche	63_Age at menarche	25	136	1	2565	363	136	4484	1981	4740	4613	2748	4136	2328	2003	2492	3166	941	1843	2289	3270	501	1330	1828	4219	1687
1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	25	136	1	329	2651	4357	607	136	4105	3124	1263	825	1851	1273	2118	442	4659	1163	164	2264	1320	1645	4670	2961	1843
2917_GSN - Gelsolin	2917_GSN - Gelsolin	25	136	1	3690	2978	1495	4531	1577	3689	136	1296	1826	2465	1369	4038	3965	1625	2793	4344	1191	450	3988	160	4286	1272
3025_PGK1 - Phosphoglycerate kinase 1	3025_PGK1 - Phosphoglycerate kinase 1	25	136	1	692	3562	1952	4446	3879	3232	3997	3166	136	4535	3477	2442	617	2632	3689	3208	381	2710	2007	460	1727	767
4410_Vaginal discharge: Smell	4410_Vaginal discharge: Smell	25	136	1	3937	1856	4494	1113	3561	1333	2268	2473	3817	3207	1268	2285	497	136	4237	3893	2063	3375	3023	2129	3012	634
3430_Fluid intelligence test - FI8 : chained arithmetic	3430_Fluid intelligence test - FI8 : chained arithmetic	25	136	1	3823	3174	1412	4384	2048	2846	4623	2139	3355	876	3007	1001	697	1846	2002	1941	2663	1471	136	2046	1702	2566
1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	25	136	1	3710	1321	3386	4136	1965	4163	4363	4286	423	4014	3323	2085	1412	2227	2014	2193	2832	2056	1252	136	1119	2921
3212_Frequency of walking for pleasure in last 4 weeks	3212_Frequency of walking for pleasure in last 4 weeks	25	137	1	2299	137	3342	1450	815	520	1552	4070	4134	217	2498	4650	3526	817	3361	1402	3335	4341	385	2973	4369	3334
1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	137	1	640	2133	137	1985	3569	1530	2352	740	2772	1701	4448	1004	3097	2769	3667	2749	3240	4636	2666	2633	2859	4056
3143_CD70 - CD70 antigen	3143_CD70 - CD70 antigen	25	137	1	2448	1475	1563	4131	137	1312	2526	788	4006	4675	1833	2634	1776	1992	2135	198	1205	2786	3584	2185	2200	2084
4192_QRS interval	4192_QRS interval	25	137	1	3038	2819	1480	4020	606	137	1015	1896	1371	2322	1528	3296	4713	3746	756	433	3558	584	641	354	402	782
4636_Right caudate	4636_Right caudate	25	137	1	4733	3335	4416	2249	1874	832	1328	137	363	2423	1276	2443	4648	4692	2300	3783	865	1745	3660	2516	637	241
910_Total cholesterol in medium HDL	910_Total cholesterol in medium HDL	25	137	1	2708	3286	3357	4449	2071	2444	4593	4145	1978	4563	137	1284	3338	4574	157	4373	2589	1840	2617	4061	1756	401
943_Phospholipids in small VLDL	943_Phospholipids in small VLDL	25	137	1	1916	4101	3576	3614	391	2789	2206	1283	3909	503	1600	1673	3316	2161	137	798	967	1023	3074	1635	3423	734
3139_F9 - Coagulation factor IXab	3139_F9 - Coagulation factor IXab	25	137	1	2553	4730	2597	630	2112	445	1393	2569	4206	811	1256	4263	439	282	3792	1800	137	2524	275	1728	3917	1912
1065_Schizophrenia	1065_Schizophrenia	25	137	1	1681	246	2497	3896	3309	2638	4270	359	4405	1368	3302	958	2232	505	2158	4654	3031	137	3071	563	3030	586
2864_IL11 - Interleukin-11	2864_IL11 - Interleukin-11	25	137	1	3178	4623	2592	2153	1617	310	4646	2046	1514	4260	3560	660	1502	1012	2334	2169	2575	1334	137	1355	620	960
3454_Impedance measures - Leg fat-free mass (right)	3454_Impedance measures - Leg fat-free mass (right)	25	137	2	2719	4504	804	4195	2804	2930	4221	4257	1164	2435	3919	2800	2389	4573	1016	3912	4243	815	331	2609	3455	137
2356_GDF9 - Growth/differentiation factor 9	2356_GDF9 - Growth/differentiation factor 9	25	138	1	2882	1069	138	4294	2175	163	902	1802	1175	2965	950	1198	1253	1674	179	1448	1230	1087	4681	925	3559	1863
2955_GSTP1 - Glutathione S-transferase P	2955_GSTP1 - Glutathione S-transferase P	25	138	1	3704	1248	543	1080	138	4075	1225	1056	2320	2687	1021	2167	3737	1700	4440	167	2380	3282	2413	2436	3266	3715
26_Agression	26_Agression	25	138	1	3180	2368	3747	722	3312	451	205	4126	138	2915	1288	4316	596	2055	4691	2903	781	886	1108	1125	3900	4171
1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	25	138	1	3234	3883	2359	4125	1647	4741	2477	1106	772	3267	138	282	1197	3092	673	3463	3732	1113	1611	1417	3135	4333
4164_Juvenile Absence Epilepsy (JAE)	4164_Juvenile Absence Epilepsy (JAE)	25	138	1	3049	1823	1898	2563	2637	1908	1734	2107	4355	2590	4433	4512	1537	138	1890	1406	2648	4039	2068	4402	1953	2344
2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	25	138	1	4012	1858	3356	2518	299	3063	2828	916	2947	3872	1633	3729	650	1435	248	138	2531	899	351	4030	1476	3742
2752_PLG - Plasmin	2752_PLG - Plasmin	25	138	1	2039	4172	4084	1750	897	462	1581	895	4475	640	2086	203	443	619	1144	713	138	1522	2015	1760	3463	2894
1050_Parkinson disease of unrelated individuals (tier 2a)	1050_Parkinson disease of unrelated individuals (tier 2a)	25	138	1	731	162	297	181	997	506	778	2087	2333	1857	3538	1399	2117	2448	2195	1640	1052	2356	138	1384	2404	4345
4085_Type 2 Diabetes	4085_Type 2 Diabetes	25	138	1	2636	1100	356	961	4195	1985	1529	2725	3787	1312	3885	3138	1414	2971	4364	1636	2627	2424	4128	3492	138	946
1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	138	1	1180	3635	2883	3178	469	1469	1071	1509	386	4281	1531	4504	2520	4338	4589	435	4268	4435	1780	744	1758	138
4_Autism spectrum disorder	4_Autism spectrum disorder	25	139	1	2437	139	1714	825	346	637	529	2806	982	3203	2990	4484	733	1851	3413	827	1307	3763	2223	3444	200	3799
3422_Trail making test - Duration to complete numeric path (trail #1)	3422_Trail making test - Duration to complete numeric path (trail #1)	25	139	1	3925	4507	139	2416	3239	3683	2704	2448	2769	3891	3061	3941	1527	1442	1871	866	736	3359	618	465	563	475
2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	25	139	1	1623	2793	4071	139	518	2709	4582	1568	3653	3828	4415	183	3669	4236	951	364	3623	811	1078	2878	4387	980
3950_Amyotrophic lateral sclerosis (logistic)	3950_Amyotrophic lateral sclerosis (logistic)	25	139	1	1353	887	4110	2289	139	3470	2443	4446	4232	2952	3282	2955	1742	3193	1606	142	1351	1381	4544	1406	3566	4491
3027_PSME1 - Proteasome activator complex subunit 1	3027_PSME1 - Proteasome activator complex subunit 1	25	139	1	2042	1531	1213	4286	1950	139	2406	1039	337	4580	3682	4262	1009	4633	4022	3640	1139	561	2181	443	3753	771
4389_Bust size	4389_Bust size	25	139	1	4162	4239	343	4579	2945	1149	139	2992	3205	206	248	4085	709	1018	3031	3965	3774	2538	3874	737	2807	3121
4277_Meconium ileus in cystic fibrosis	4277_Meconium ileus in cystic fibrosis	25	139	1	905	1129	3577	366	972	3769	4180	139	4668	787	2254	1591	1571	1350	1292	2043	1749	1521	3494	1771	1077	1062
1114_Visceral sdipose tissue volume (adjusted for BMI)	1114_Visceral sdipose tissue volume (adjusted for BMI)	25	139	1	2239	3364	2728	1512	3474	1504	4351	1115	4342	139	4235	1258	2781	2032	349	3365	2074	3654	4551	4461	2724	3420
790_::::X-12696	790_::::X-12696	25	139	1	4034	1717	4036	187	4003	1622	2802	3795	2397	2431	139	3225	3392	4559	1594	2706	2444	2395	4433	2799	2021	671
3522_Current employment status: Unable to work because of sickness or disability	3522_Current employment status: Unable to work because of sickness or disability	25	139	1	4005	4164	1709	2101	3842	3462	1176	2904	4548	2303	1367	1291	139	1081	2009	3404	2671	1017	2143	966	3257	2336
948_Total fatty acids	948_Total fatty acids	25	139	1	2899	4331	3556	1196	373	4670	3481	3514	2461	1994	2494	4068	2077	1952	139	916	867	2099	3544	667	4497	665
1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	25	139	1	2833	3583	4435	1846	3102	3782	793	4087	2712	3233	2849	4059	3488	4544	548	3372	2472	2196	139	4578	2315	939
2564_CCL15 - C-C motif chemokine 15	2564_CCL15 - C-C motif chemokine 15	25	139	1	3327	851	3065	1665	1413	2146	763	4616	1433	2368	3784	532	1881	2084	3474	3027	3568	395	555	2449	139	3557
1831_Neck length (GEE, female, adjusted for multivariable)	1831_Neck length (GEE, female, adjusted for multivariable)	25	139	1	2745	4094	4218	1166	3952	1440	350	405	2489	2418	4307	2700	1053	1514	1093	3513	364	3434	4558	4350	2750	139
2063_COL18A1 - Endostatin	2063_COL18A1 - Endostatin	25	140	1	140	419	1880	239	3908	557	2040	3743	804	2886	4099	201	1013	1053	2006	1972	4187	1103	1028	2829	3621	1529
1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	25	140	1	3377	3666	140	2787	2394	351	954	2002	143	1489	3606	2253	2911	3009	1796	917	2929	1580	931	4230	3966	3383
3951_Amyotrophic lateral sclerosis (LMM)	3951_Amyotrophic lateral sclerosis (LMM)	25	140	1	3387	1489	3248	2164	140	3934	3628	4590	1985	2576	4531	4186	1432	3274	1463	149	2910	1011	3911	716	2461	4233
2470_CA6 - Carbonic anhydrase 6	2470_CA6 - Carbonic anhydrase 6	25	140	1	406	2545	4271	2242	1697	1586	140	4451	1906	3821	4212	2113	1728	3398	2206	550	1928	2624	4727	1289	2388	4684
4620_Left cerebellum exterior	4620_Left cerebellum exterior	25	140	1	1030	926	1420	2516	3843	1404	4158	3032	140	355	3274	315	3238	459	4522	4474	1204	1409	902	280	611	2675
3929_QT interval	3929_QT interval	25	140	1	2858	2586	3394	4600	331	1612	3795	692	2138	3757	923	4243	140	3221	2735	1025	4347	2205	3426	3220	960	1384
835_Peptide::Dipeptide::X-14208--phenylalanylserine	835_Peptide::Dipeptide::X-14208--phenylalanylserine	25	140	1	1950	2075	3172	169	858	236	360	1537	3513	2364	4027	3007	1643	140	2684	735	543	3581	4337	440	1805	412
1124_Subcutaneous adipose tissue attenuation (male)	1124_Subcutaneous adipose tissue attenuation (male)	25	140	1	2615	1337	4612	3526	3070	3704	4215	1610	1736	2864	2334	4475	708	3242	1366	1325	3850	140	3462	3535	2879	669
1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	25	140	1	146	4442	3226	1693	2710	2751	2279	1902	620	1738	1726	725	3935	2877	3815	1710	2509	4269	1986	140	1902	2995
3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	25	140	1	4173	2169	3582	3172	3179	4063	1728	2669	4730	2489	4303	4434	580	347	3444	3093	3488	4730	2355	2697	140	877
894_Free cholesterol in large LDL	894_Free cholesterol in large LDL	25	141	2	141	596	980	256	2266	619	2238	4567	568	4723	514	2589	4251	743	515	1403	2126	2964	2248	1990	3017	1285
4366_Fraction of accelerations	4366_Fraction of accelerations	25	141	1	1686	3917	4489	141	4387	278	3737	651	1458	3905	660	3318	2007	2882	1904	3527	2327	1858	759	1916	1674	3225
2060_C4A C4B - Complement C4b	2060_C4A C4B - Complement C4b	25	141	1	1248	2888	2826	2047	141	4376	2404	366	462	1908	2021	1158	4665	4568	3605	244	2776	3978	3187	846	1247	2382
405_Amino acid::Tryptophan metabolism::indolelactate	405_Amino acid::Tryptophan metabolism::indolelactate	25	141	1	2876	4573	1904	743	2410	4296	141	3365	783	2801	3256	3786	3681	366	3254	4230	2960	1240	4636	4510	1922	4516
12_Schizophrenia/Bipolar disorder	12_Schizophrenia/Bipolar disorder	25	141	1	3669	2416	3285	4069	4345	1782	4245	141	4208	2211	1835	899	377	1385	1810	4437	2393	3867	1274	1221	4129	2142
3889_Monocyte count (three-way meta)	3889_Monocyte count (three-way meta)	25	141	1	3181	2324	3750	3025	802	1240	1467	1880	3256	1476	141	4396	1905	2359	4551	886	2358	412	1988	3742	3185	3291
2935_VEGFA - Vascular endothelial growth factor A, isoform 121	2935_VEGFA - Vascular endothelial growth factor A, isoform 121	25	141	1	1431	4412	232	567	4637	657	1206	2230	1927	3507	534	786	367	141	900	2017	177	2669	2990	3048	682	4715
1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	25	141	1	999	405	2108	2773	626	1413	2790	2204	1957	3536	3498	1913	919	1592	4486	4630	1938	2755	141	4663	4211	703
2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	25	141	1	3043	2027	241	2467	2980	3860	421	3782	220	4647	4562	4730	3890	4508	535	4434	4189	1851	3748	141	3219	535
2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	25	142	1	2982	4183	3641	142	4687	617	1041	1073	2232	1586	3361	3195	3131	1855	4106	2519	3986	4357	558	4435	2785	2334
2801_RBM39 - RNA-binding protein 39	2801_RBM39 - RNA-binding protein 39	25	142	1	2873	365	2332	984	142	3580	147	1043	3858	895	3430	724	4586	2444	783	235	1541	3253	4136	1006	3384	2993
449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	25	142	1	1470	3148	4687	4512	4377	142	2985	848	1418	3705	4245	4377	2634	3553	2758	4686	2241	1493	4323	2303	3963	3630
2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	25	142	1	786	202	653	4284	649	1125	949	142	1170	274	2860	3845	4572	828	3249	357	3094	3399	3124	2055	3998	4154
3140_ELANE - Neutrophil elastase	3140_ELANE - Neutrophil elastase	25	142	1	4015	473	386	1049	3513	3485	4257	3015	142	3031	2637	4448	2656	2885	954	4661	3636	1042	2662	458	4372	1263
1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	25	142	1	2418	4139	4148	2280	4320	1774	679	1312	2239	3189	142	878	2060	335	2661	4151	2702	2372	2589	3423	3815	3141
1993_Survival past average life expectancy (GEE, adjusted for multivariable)	1993_Survival past average life expectancy (GEE, adjusted for multivariable)	25	142	1	2910	4154	695	3928	1290	3491	1758	936	2114	3089	947	3339	560	1994	4358	474	142	1245	2110	1471	3293	2619
4180_Platelets	4180_Platelets	25	142	1	364	1618	3971	1661	3375	1383	3848	4540	3785	4573	2214	3692	1473	3654	3497	380	4651	142	3320	1536	1477	4150
3570_Pain type(s) experienced in last month: Headache	3570_Pain type(s) experienced in last month: Headache	25	142	1	3299	3012	1107	3364	3986	3856	3965	1012	1776	2621	2497	4315	165	1311	2688	2287	4482	1388	142	1304	1852	1490
4078_Waist-hip ratio (male)	4078_Waist-hip ratio (male)	25	142	1	4364	2322	1051	1195	3642	2528	2987	2479	3298	2981	1536	1657	4731	3541	522	2064	284	1405	4288	142	3251	1927
1169_Leptin	1169_Leptin	25	142	1	1613	2668	1294	1487	1554	3517	4630	662	3615	2046	929	3387	2193	187	4746	2263	2643	3261	3350	1061	4479	142
4749_Posterior thalamic radiation (include optic radiation) radial diusivities	4749_Posterior thalamic radiation (include optic radiation) radial diusivities	25	143	1	2625	4404	143	2920	2130	2782	1491	3837	3979	3087	3567	614	937	3706	1323	3439	582	1892	4268	2502	2449	231
3021_PARK7 - Protein DJ-1	3021_PARK7 - Protein DJ-1	25	143	1	2342	3749	4464	2580	1052	143	1453	1392	1310	1161	1775	1411	3985	2089	496	2720	3608	158	4546	4066	3250	2549
3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	25	143	1	4546	574	4469	855	4741	1973	907	143	3969	865	572	3398	1091	1412	927	4458	4429	4033	2336	2997	3143	3819
1078_Serum Iron concentration	1078_Serum Iron concentration	25	143	1	1764	153	4598	1283	4103	4438	1103	3686	616	305	3549	406	1593	442	143	4217	1168	3689	4027	4183	3315	3666
2075_CTSG - Cathepsin G	2075_CTSG - Cathepsin G	25	143	1	2149	3835	3578	2653	375	4351	309	4574	1836	382	1770	1407	1531	2519	3551	473	2278	143	3116	4033	1293	4435
2360_IL18BP - Interleukin-18-binding protein	2360_IL18BP - Interleukin-18-binding protein	25	143	1	3430	899	2839	1532	2919	3851	2411	1419	3733	1677	3982	578	1434	2262	1962	4459	2993	215	830	143	2669	381
4268_Atrial Fibrillation	4268_Atrial Fibrillation	25	143	1	2001	562	846	4149	1278	2225	4171	437	2793	1939	1746	1344	2993	2655	2757	468	4317	1457	4294	3370	4301	143
2660_DMP1 - Dentin matrix acidic phosphoprotein 1	2660_DMP1 - Dentin matrix acidic phosphoprotein 1	25	144	1	3748	144	4567	4713	3762	874	3251	3205	528	1434	4070	190	4289	3513	1827	3869	4306	2551	3753	486	586	3520
3178_SLAMF7 - SLAM family member 7	3178_SLAMF7 - SLAM family member 7	25	144	1	1765	544	144	4649	548	2357	1110	1062	2212	222	1341	4709	2304	4484	1157	501	2266	4628	1458	4342	2059	4478
2894_RSPO2 - R-spondin-2	2894_RSPO2 - R-spondin-2	25	144	1	4494	2038	1986	2149	3405	2064	3209	4300	4230	144	3613	1400	4176	2965	3435	4153	2326	2228	812	3343	2606	1032
3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	25	144	1	3470	1423	3399	3272	2796	3397	4495	3336	1749	2240	2675	144	464	3065	300	2500	3307	569	220	2311	3556	699
3112_KIF23 - Kinesin-like protein KIF23	3112_KIF23 - Kinesin-like protein KIF23	25	144	1	3603	2791	1485	1468	3970	3990	2596	3684	2855	3227	2896	868	144	1374	2238	3066	4735	2273	685	4296	2031	961
4207_Blood urea nitrogen	4207_Blood urea nitrogen	25	144	1	902	3923	2441	2775	3731	566	3097	4361	2055	3280	4730	2485	3564	144	3035	2544	400	333	2345	210	1562	2916
163_Hip circumference (male, adjusted for BMI)	163_Hip circumference (male, adjusted for BMI)	25	144	1	3746	2769	1884	4130	259	1576	936	2407	145	3168	284	2609	1183	1517	1058	144	1258	4557	2657	1301	3756	1068
1030_Neck Width (FBAT, adjusted for multivariable)	1030_Neck Width (FBAT, adjusted for multivariable)	25	144	1	2419	1708	2363	2144	2613	2847	2567	2918	2014	4313	755	3153	2395	882	4443	1658	144	2328	1936	3406	3133	1319
3348_Age when last used oral contraceptive pill (female)	3348_Age when last used oral contraceptive pill (female)	25	144	1	1023	4692	1440	4416	1689	1293	1619	271	1846	3180	4652	2340	3411	4073	675	2087	3339	2614	144	1038	1157	2144
1143_Acute insulin response (adjusted for BMI)	1143_Acute insulin response (adjusted for BMI)	25	144	1	363	1669	382	922	1553	2631	1912	704	4523	1062	1508	2011	1514	2260	2892	1340	3591	3014	2246	144	991	4348
81_Lumbar Spine BMD (males)	81_Lumbar Spine BMD (males)	25	144	1	1523	824	195	2307	3533	2734	1811	1021	1437	1791	3943	902	1074	937	3493	2457	2191	3708	1627	1548	144	377
3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	25	144	1	2400	3814	1739	2921	4412	1408	4112	4119	1888	2539	3110	1276	2708	4200	631	3366	1156	2510	4667	1143	1656	144
1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	25	145	1	3784	145	4312	3268	574	3802	1472	179	1339	2292	3671	2937	1638	1591	1960	407	3765	3126	1960	3039	1226	2158
3965_Gestational weight gain (offspring, total)	3965_Gestational weight gain (offspring, total)	25	145	1	765	532	145	1180	494	3853	416	1931	4446	2196	1430	3596	3721	2015	973	911	2089	3565	719	2750	1826	3975
2897_SORCS2 - VPS10 domain-containing receptor SorCS2	2897_SORCS2 - VPS10 domain-containing receptor SorCS2	25	145	1	557	4263	1708	2955	2907	145	3951	3359	3794	3362	2749	2383	854	3130	3109	3544	2856	807	2460	2979	2389	2095
21_Age of smoking initiation	21_Age of smoking initiation	25	145	1	3720	3959	2263	3599	2352	2859	4156	4330	1415	4038	145	3973	2035	1935	940	2596	2299	3790	4696	2212	506	1898
2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	25	145	1	2129	1455	3898	2051	2240	2531	2889	1551	3520	4676	2077	145	4356	645	1218	3415	1605	2090	2837	2855	2397	1057
4185_Cigarettes per day (excluding nonsmokers)	4185_Cigarettes per day (excluding nonsmokers)	25	145	1	4496	422	3884	3583	2359	3410	2107	2116	1469	1865	2438	2155	233	145	3516	3871	4157	2926	3434	2943	1760	1848
297_CD4mem:%Th22	297_CD4mem:%Th22	25	145	1	1911	2917	2573	2066	3076	2074	4059	1544	3144	2705	4223	4376	2279	4611	1213	1712	145	2312	4359	3182	3354	2853
52_Number of children ever born (male)	52_Number of children ever born (male)	25	145	1	2272	2260	1040	2819	3710	387	1730	3588	2479	1130	1213	1743	3165	1447	2932	3253	706	145	1703	1402	1604	1196
4531_Right inferior lateral ventricle	4531_Right inferior lateral ventricle	25	145	1	263	803	1745	451	2755	4648	286	557	1451	4607	3277	322	3179	188	4210	1956	3712	3850	145	3602	3267	192
4343_Sleep sedentary	4343_Sleep sedentary	25	145	1	1886	3470	777	179	1559	2009	674	1339	1275	1035	921	1543	2059	3882	1274	772	639	219	4348	1838	2523	145
3598_Non-cancer illness code, self-reported: angina	3598_Non-cancer illness code, self-reported: angina	25	146	1	4479	146	2677	2833	1071	3359	2608	250	3925	2478	761	3317	1367	2702	540	1558	210	4131	2259	1258	2884	1390
664_::::X-05426	664_::::X-05426	25	146	1	2164	2495	146	3950	2208	954	4678	385	2177	1005	2455	1918	2110	1739	4538	4646	1699	3491	3859	2644	2175	4456
1100_Diastolic Blood Pressure - Birth cohorts	1100_Diastolic Blood Pressure - Birth cohorts	25	146	1	414	4416	3021	3926	2105	146	213	1847	4609	4258	2678	1059	1129	2165	2956	2918	2419	1630	2619	3673	2074	4596
1073_Parkinson disease	1073_Parkinson disease	25	146	1	383	2017	3909	183	1400	3093	146	4201	1325	2736	915	4244	282	2279	4596	855	1670	1378	430	449	2058	4632
2817_CRP - C-reactive protein	2817_CRP - C-reactive protein	25	146	1	3552	1678	2169	3321	1276	3773	3409	146	685	4298	3790	3238	3787	1320	2338	4635	1788	3668	3547	3052	1460	4149
3334_Duration of heavy DIY	3334_Duration of heavy DIY	25	146	1	3469	404	2968	4009	1820	2367	1319	521	1700	146	1625	1085	2174	3917	4421	4117	3836	4216	706	1851	1438	1423
1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	146	1	2109	2408	358	649	3712	1445	1755	2634	2591	2526	146	4274	1431	1530	3259	4059	1121	4582	3393	1365	1511	1986
4203_End stage renal disease	4203_End stage renal disease	25	146	1	2965	1884	3601	4361	1835	961	3048	280	1403	261	3857	146	2658	2289	1061	1002	2275	2087	1681	3120	4005	242
1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	146	1	2536	4030	1792	2021	3154	171	3601	4162	1845	2898	1874	554	2286	1095	2423	1259	146	1846	188	2771	3652	3308
2526_IL18R1 - Interleukin-18 receptor 1	2526_IL18R1 - Interleukin-18 receptor 1	25	146	1	3642	4114	584	867	4083	2945	2131	4521	3954	2814	4276	782	181	3708	470	3547	4423	4015	146	967	1896	1369
3521_Current employment status: Looking after home and/or family	3521_Current employment status: Looking after home and/or family	25	147	1	395	147	563	1510	393	4521	3936	2239	981	2304	3821	3855	1169	4136	4373	493	4487	1539	3485	3613	1484	1139
2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	25	147	1	798	2983	2121	147	1208	1120	158	1951	304	2979	662	2827	1719	2843	228	1666	3075	3234	3067	2945	3508	3455
1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	147	1	3158	173	752	2988	2087	3654	176	3380	147	2411	395	3502	3076	2224	890	1731	1958	2442	4072	4476	2982	3122
1115_Visceral sdipose tissue volume (adjusted for BMI, male)	1115_Visceral sdipose tissue volume (adjusted for BMI, male)	25	147	1	4118	3785	1395	2730	2931	2726	3142	2245	3504	147	3385	2865	2002	286	4008	3128	3112	3103	4723	2121	2417	367
339_NKeff:%Kir+ (4)	339_NKeff:%Kir+ (4)	25	147	1	3984	4098	4085	2329	3467	3108	2697	4225	1723	4325	147	4023	3159	213	3781	3628	2348	3891	582	1649	2160	2020
2219_ANGPT1 - Angiopoietin-1	2219_ANGPT1 - Angiopoietin-1	25	147	1	4655	266	3679	2835	2696	573	478	3905	1869	1182	1677	147	4320	3014	3452	3678	2212	4014	747	1926	1159	3205
1917_Temporal brain volume (GEE, adjusted for multivariable)	1917_Temporal brain volume (GEE, adjusted for multivariable)	25	147	1	1873	1454	3507	1093	584	4547	4314	1100	2850	2142	1493	1597	894	4710	147	536	3440	3221	2493	358	2878	1887
4655_Fornix (column and body of fornix) fractional anisotropy	4655_Fornix (column and body of fornix) fractional anisotropy	25	147	1	2579	2320	3627	222	908	4599	3184	3295	759	1493	1901	3462	1505	822	2482	522	1829	151	2356	147	959	3812
3250_Pork intake	3250_Pork intake	25	148	1	2061	499	3917	148	2388	2242	4143	421	1272	2321	1540	3730	4738	2673	2533	3025	910	2227	4419	1109	893	1242
751_::::X-12056	751_::::X-12056	25	148	1	2294	2842	3944	2606	3365	1756	2035	2974	148	4224	1885	2707	3346	1310	3751	2129	741	1410	1762	2839	514	3538
4281_PEF	4281_PEF	25	148	1	4708	3212	4239	761	447	2369	3741	3247	1483	496	4347	148	683	4591	2192	507	2824	2557	1316	4076	4668	1421
2281_PLA2G10 - Group 10 secretory phospholipase A2	2281_PLA2G10 - Group 10 secretory phospholipase A2	25	148	1	794	417	1749	4127	1006	1103	2647	2053	540	1088	2848	214	148	1566	4272	2109	545	4159	4406	1569	855	1569
3629_Illnesses of father: Stroke	3629_Illnesses of father: Stroke	25	148	1	2308	4672	210	2475	1296	2580	2968	3981	1794	3904	3043	3538	3779	2835	148	1538	2587	676	260	3163	4030	1094
3752_Traumatic events - Felt distant from other people in past month	3752_Traumatic events - Felt distant from other people in past month	25	148	1	4093	1516	2525	1773	381	2670	884	3317	753	3179	3552	2291	4474	3426	1385	372	148	2127	3138	4072	2247	393
4073_General risk tolerance	4073_General risk tolerance	25	148	1	591	3433	422	3216	4140	2116	1851	4662	2951	3013	4183	852	872	1510	4495	4718	2599	148	2768	1885	1180	863
1920_Frontal lobe volume (FBAT, adjusted for age and sex)	1920_Frontal lobe volume (FBAT, adjusted for age and sex)	24	149	1	4502	149	3523	3234	3023	4337	2515	1053	1427	4471	1750	376	2686	4172	2101	2450	1160	2793	1707	1186	4488	2335
277_CD8:%Act(25+)	277_CD8:%Act(25+)	25	149	1	1652	3680	1947	1657	149	902	1852	4511	2346	1650	152	1020	1587	3608	4328	217	1937	3980	868	3905	3088	3335
2554_FGF17 - Fibroblast growth factor 17	2554_FGF17 - Fibroblast growth factor 17	25	149	1	3700	3830	1060	937	334	2627	4468	295	149	2264	1207	3374	429	1880	344	3419	2862	717	3038	4055	272	3232
1009_Stromal cell-derived factor-1 alpha (CXCL12)	1009_Stromal cell-derived factor-1 alpha (CXCL12)	25	149	1	1201	1097	321	3165	3335	3809	1901	1388	4021	149	2569	1125	2276	1451	576	1145	2029	1532	1132	2219	422	1696
4182_Low cholesterol lipoprotein	4182_Low cholesterol lipoprotein	25	149	1	2089	707	1451	1127	1739	1349	3612	768	228	192	149	321	2609	349	188	1620	392	4132	3161	3340	491	4203
1855_Neck average buckling ratio (GEE, female, adjussted for age)	1855_Neck average buckling ratio (GEE, female, adjussted for age)	25	149	1	2100	1520	4155	2354	1010	1357	1377	2305	451	169	2815	149	3536	4161	1341	2364	4476	3926	625	3495	887	610
460_Energy::Krebs cycle::malate	460_Energy::Krebs cycle::malate	25	149	1	3545	3888	4589	3547	2392	3902	2854	1868	3403	3680	2250	3850	4578	149	4009	4319	1563	612	1445	3498	2985	2061
911_Cholesterol esters in medium HDL	911_Cholesterol esters in medium HDL	25	149	1	4302	2292	4150	4031	4392	4400	3560	2438	3614	3064	650	2101	4062	2288	149	3108	3382	3777	3447	4193	1606	786
3258_Water intake	3258_Water intake	25	149	1	2368	2539	2246	3542	4228	4347	1169	813	3680	4733	1156	4132	1655	4576	4267	2652	544	149	4113	2372	1704	2209
2624_KLK14 - Kallikrein-14	2624_KLK14 - Kallikrein-14	25	149	1	2298	329	1825	3887	3915	2832	3927	1289	2371	1747	3191	3114	1459	466	2008	3009	3904	3584	149	4561	2207	3774
713_::::X-11485	713_::::X-11485	25	149	1	2931	970	717	1591	4100	720	3245	1514	1462	348	382	3503	2891	4416	4628	1221	1603	2067	709	149	3770	2745
4166_Body Mass Index	4166_Body Mass Index	25	149	1	1140	482	2878	1035	2399	1112	1969	156	3010	2904	4355	939	4036	839	1721	3758	1253	4301	2414	3384	728	149
3789_Morningness	3789_Morningness	25	150	1	150	4079	3369	1782	1993	1226	3822	3979	2109	3589	4138	672	2890	1407	2035	1462	991	4291	1171	648	3282	328
3086_ROBO3 - Roundabout homolog 3	3086_ROBO3 - Roundabout homolog 3	25	150	1	4339	309	4252	150	1503	3788	4169	4248	194	4158	2055	3860	1715	1860	3575	2367	4638	808	565	642	1685	4052
3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	25	150	1	2661	4199	4337	1527	2763	2065	150	1501	2147	3620	836	713	4266	304	3790	3576	4217	1232	1600	622	957	1385
573_Lipid::Sterol, Steroid::cholesterol	573_Lipid::Sterol, Steroid::cholesterol	25	150	1	3182	1472	2965	1810	2808	2465	2836	1968	984	150	4670	1098	3145	2987	2893	1457	4613	1195	2501	1637	2737	3458
1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	25	150	1	2879	1213	1615	2496	1342	259	415	1278	3997	2006	150	3212	3916	2694	952	1106	622	712	1360	4190	3159	1137
2726_DDR1 - Epithelial discoidin domain-containing receptor 1	2726_DDR1 - Epithelial discoidin domain-containing receptor 1	25	150	1	1179	4268	1258	2040	4600	3026	2913	2599	3836	4187	4592	504	2706	3853	4480	2790	2676	4431	3282	150	351	1860
4571_Left superior frontal	4571_Left superior frontal	25	150	1	628	154	4582	1133	705	1812	486	431	1787	857	3743	3091	1496	2723	782	1335	3720	2961	1786	2499	150	551
1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	25	151	1	151	3245	3854	581	2875	4234	2445	4404	4566	1962	1301	213	579	627	2665	4026	1100	566	2712	1559	2645	883
6_Anxiety disorder (case/control)	6_Anxiety disorder (case/control)	25	151	1	3449	151	4328	4495	4314	3252	3442	4195	2919	907	367	2292	486	3444	2572	2740	1502	2715	4745	4455	551	1934
209_Intelligence	209_Intelligence	25	151	1	4309	4493	151	4018	3963	4517	2683	1446	449	1595	4294	4588	1927	4729	1624	4574	3749	3982	4725	1848	3748	1979
694_::::X-11327	694_::::X-11327	25	151	1	3702	4720	3183	151	676	2194	1715	2150	1094	3787	3365	723	1181	471	419	4037	1545	1235	2402	1654	1031	3289
3196_Time employed in main current job	3196_Time employed in main current job	25	151	1	3551	2508	4282	1774	4081	4010	151	2617	1210	320	3598	1147	1526	2860	4078	2985	3158	1241	493	4239	4682	1348
3480_Milk type used: Full cream	3480_Milk type used: Full cream	25	151	1	4182	2510	1797	2246	900	293	3033	151	1104	3132	1047	1619	3505	374	166	603	1653	2748	561	3679	207	4006
2934_NTRK2 - BDNF/NT-3 growth factors receptor	2934_NTRK2 - BDNF/NT-3 growth factors receptor	25	151	1	4064	1944	4123	1284	2994	930	2990	2494	408	2541	874	3248	151	2884	3923	3930	1062	710	2603	4200	1529	1788
164_Hip circumference (male, adjusted for BMI)	164_Hip circumference (male, adjusted for BMI)	25	151	1	2329	2826	1153	2054	249	1730	453	3617	271	3900	223	3213	834	4564	1122	151	653	3501	4724	1016	4422	1166
2427_C1R - Complement C1r subcomponent	2427_C1R - Complement C1r subcomponent	25	151	1	1726	4533	2366	2073	3320	467	354	1024	3164	2776	1703	2158	2447	3389	4570	3178	151	1760	3287	1906	546	765
3835_Basophil percentage of granulocytes (two-way meta)	3835_Basophil percentage of granulocytes (two-way meta)	25	151	1	764	1539	2636	3839	3031	3868	2048	2873	3674	1397	477	2111	2892	194	2833	4264	540	356	4501	1324	151	1486
4464_Left postcentral	4464_Left postcentral	25	151	1	654	1613	887	4393	2886	3811	1228	1904	4333	2091	3438	260	2948	1679	1054	1958	4078	2586	3546	3972	3718	151
872_Glutamine	872_Glutamine	25	152	1	2345	1352	152	4352	3262	697	1235	363	2700	2007	1286	1562	3400	805	1028	3185	3923	3297	1128	1442	3683	1138
4647_Anterior corona radiata fractional anisotropy	4647_Anterior corona radiata fractional anisotropy	25	152	1	3331	3763	1876	4623	724	152	881	4633	2572	4667	4694	461	3251	870	3921	2356	373	4139	4183	3253	2990	522
4394_Heavy vaginal discharge	4394_Heavy vaginal discharge	25	152	1	4137	3929	1361	4062	2010	2757	152	3618	284	2635	610	4628	714	4621	3427	2568	4173	2389	3910	2036	1006	3642
1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	25	152	1	4387	3025	3426	3318	1437	296	1585	2234	152	4581	4296	1038	2025	4267	2001	1359	3132	3038	2440	4317	2527	1027
4556_Left lingual	4556_Left lingual	25	152	1	1299	1564	2250	1552	1770	2299	2442	210	4092	152	3002	3931	1528	985	2066	1229	1297	397	352	4543	789	1902
1219_Mean Accumbens	1219_Mean Accumbens	25	152	1	1979	889	1912	4137	1598	3786	1720	1857	1523	3720	2395	1769	152	2494	4340	4074	3769	3075	1097	1435	2302	1881
2648_PROC - Activated Protein C	2648_PROC - Activated Protein C	25	152	1	3813	4368	2514	3830	1789	4564	3620	1533	2980	3992	1872	280	266	4600	152	635	809	3494	2118	3338	4463	1092
3360_Hearing aid user	3360_Hearing aid user	25	152	1	613	881	1706	1430	266	3008	3846	3926	3932	294	566	3998	3674	4093	2179	152	2564	4290	847	3376	1382	4609
1761_Breast cancer (GEE, adjusted for age and BMI)	1761_Breast cancer (GEE, adjusted for age and BMI)	25	152	1	3653	2704	1850	2443	1397	968	3595	3627	745	954	1027	1352	3542	3199	3714	2746	754	2007	727	1256	152	3790
146_Body Mass Index	146_Body Mass Index	25	152	1	1906	672	1754	3573	2611	1381	2370	867	1744	3745	1666	1221	4401	1403	1844	4489	1149	4459	3681	2313	3630	152
673_::::X-07765	673_::::X-07765	25	153	1	232	4083	1937	153	645	2801	2203	2941	2871	3401	3462	4725	909	3534	1863	307	3399	4553	2623	2183	325	746
4092_Reaction time	4092_Reaction time	25	153	1	907	1929	4069	2607	1154	717	153	1946	3639	462	3140	1053	2151	3280	2516	2229	1378	1339	1820	2530	1849	3723
601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	25	153	1	3802	1774	3823	3752	565	4094	202	153	1046	3431	2915	2177	1956	4423	4228	693	1435	4036	2138	3783	4734	3489
253_CD123 on 11c+123+DC	253_CD123 on 11c+123+DC	25	153	1	1866	1195	4713	3017	4015	4029	1490	642	1590	3718	2798	153	1409	2795	1932	4056	233	571	3760	482	862	2465
2916_FAM107B - Protein FAM107B	2916_FAM107B - Protein FAM107B	25	153	1	1819	1319	4269	1023	3289	4683	1997	2115	196	4741	2771	2897	4706	153	2208	3933	3274	3649	1321	3870	3735	466
2094_HMGB1 - High mobility group protein B1	2094_HMGB1 - High mobility group protein B1	25	153	1	2290	2522	2528	610	3671	574	3397	2578	3549	1644	1308	2026	948	624	153	4290	4359	4108	2901	3910	2471	1377
162_Hip circumference (adjusted for BMI)	162_Hip circumference (adjusted for BMI)	25	153	2	1261	4554	1593	1327	173	3916	1487	4321	2550	4202	1005	3540	1266	2472	2287	153	230	2386	1806	1903	3657	3114
1176_Excessive daytime sleepness (male)	1176_Excessive daytime sleepness (male)	25	153	1	4153	3976	3192	1287	2629	1872	2966	4739	2729	1332	200	1924	2178	2629	3957	1657	153	2208	1690	4198	2078	3453
2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	25	153	1	2907	1119	1690	3963	895	4311	1662	2664	3691	809	707	3041	1261	1230	4510	1120	4072	4368	3328	153	1032	2364
496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	25	154	1	154	1377	1533	1528	1077	995	2363	2071	3671	3455	3961	604	1006	951	2959	3407	801	2779	3046	603	917	3477
1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	25	154	1	1116	3855	1512	2434	805	154	3556	3683	3625	1674	2940	1471	3960	2621	485	1730	1162	940	2745	417	650	1039
2316_NCR3 - Natural cytotoxicity triggering receptor 3	2316_NCR3 - Natural cytotoxicity triggering receptor 3	25	154	1	4344	3618	2142	4209	546	3658	4277	154	1004	641	1962	2389	4078	3202	2797	2104	2651	3326	542	4085	2735	160
4513_CSF	4513_CSF	25	154	1	3958	2939	4597	4326	3654	454	868	3023	2067	562	154	2078	347	2967	2421	4618	1216	3423	864	4213	2977	792
3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	25	154	1	2160	1623	1667	2875	839	4407	3853	379	1338	1214	1044	175	2780	353	154	780	1278	1485	4532	3966	2580	3957
215_NK:%Eff	215_NK:%Eff	25	154	1	1606	2717	1574	4518	1847	1896	3801	3341	1444	3003	2649	1803	1708	606	1888	3152	1015	154	3399	1424	3861	3800
4167_Parkinson disease of sibling pairs (tier 1)	4167_Parkinson disease of sibling pairs (tier 1)	25	154	1	4202	2550	2616	1103	2259	4694	4347	3431	1720	1600	3347	3555	3063	3057	2098	2788	3263	1510	154	1884	488	2564
4272_Sleep duration	4272_Sleep duration	25	154	1	2613	3325	401	2452	2318	819	2013	3204	4571	338	4621	270	3590	4736	585	4010	651	2776	924	154	4305	1222
2684_AIP - AH receptor-interacting protein	2684_AIP - AH receptor-interacting protein	25	155	1	3476	155	3010	586	1192	1899	4204	208	252	4229	1862	1367	4115	3999	2409	431	2927	767	3281	2934	4123	541
2933_BMPR2 - Bone morphogenetic protein receptor type-2	2933_BMPR2 - Bone morphogenetic protein receptor type-2	25	155	1	2821	2425	3015	380	1490	155	1153	792	2187	792	2008	4325	2551	917	3390	1147	378	4179	2844	2698	3740	4467
2348_IL4R - Interleukin-4 receptor subunit alpha	2348_IL4R - Interleukin-4 receptor subunit alpha	25	155	1	2783	2167	484	2873	4191	1068	155	2395	812	3314	868	2902	4687	601	1126	3620	4424	1133	1617	4142	3247	2926
4186_Coffee cups per day	4186_Coffee cups per day	25	155	1	897	842	3882	3233	1830	4200	3136	1942	2295	211	155	2187	1187	1319	3837	1296	2742	3834	1643	4025	3801	4212
455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	25	155	1	3452	3068	2376	4171	637	469	3845	4527	1475	3598	1799	4207	533	155	4343	764	2238	1915	2411	2393	3943	428
3011_MAPK12 - Mitogen-activated protein kinase 12	3011_MAPK12 - Mitogen-activated protein kinase 12	25	155	1	4711	3901	673	2281	3105	363	531	2766	4491	1336	1604	1992	962	1728	4212	3931	155	3651	4623	549	582	195
3797_Depressive affect subcluster	3797_Depressive affect subcluster	25	155	1	4737	4009	1923	2303	4118	1842	2313	1911	4007	275	3932	3899	710	3748	1874	3275	4332	3528	155	1932	536	263
1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	25	155	1	347	1202	4678	2814	2284	3197	1653	1028	3683	3433	1691	531	2868	4029	3418	3867	1723	2306	380	1915	155	168
201_Estimated glomerular filtration rate based on serum creatinine	201_Estimated glomerular filtration rate based on serum creatinine	25	156	1	156	1284	2595	2141	970	1287	943	199	2438	1252	1971	3264	202	3946	4090	2156	928	1478	3120	841	3990	359
4001_Loneliness, isolation (LONE)	4001_Loneliness, isolation (LONE)	25	156	1	810	1927	1640	156	4403	4201	4258	3848	740	423	1483	4527	2567	1186	2354	2711	3935	2583	3962	421	2348	3870
3439_Tobacco smoking	3439_Tobacco smoking	25	156	1	4240	3735	3442	4081	3781	1002	156	3454	551	1956	3845	338	1062	1493	3455	3452	1536	3640	607	675	428	1628
976_Basic fibroblast growth factor	976_Basic fibroblast growth factor	25	156	1	4566	1162	3220	3721	4025	4596	3550	801	4575	1828	4547	3606	2357	156	4196	3468	1305	3731	193	1655	4575	4427
1757_Cancer (GEE, adjusted for multivariable)	1757_Cancer (GEE, adjusted for multivariable)	25	156	1	572	1772	3390	885	3189	508	2801	595	3357	1440	378	2272	2681	2633	869	1164	3316	156	1142	1585	4410	1317
1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	156	1	4466	4571	3041	3964	2195	1997	2502	815	3003	3574	3500	4657	2344	3712	3603	1097	1178	387	2641	156	1111	4583
3100_UNC5D - Netrin receptor UNC5D	3100_UNC5D - Netrin receptor UNC5D	25	157	1	4363	2261	157	1424	632	829	3752	1452	3481	432	2114	385	236	4226	4467	432	4031	3739	4634	2320	541	3933
4251_M10 timing	4251_M10 timing	25	157	1	4192	4037	3639	157	3329	4266	469	2729	3693	2821	2044	1737	883	2667	4603	3741	1599	2650	1794	1216	2581	3656
3415_Reaction time test - Mean time to correctly identify matches	3415_Reaction time test - Mean time to correctly identify matches	25	157	1	2064	1964	4078	4454	2714	1977	157	4691	3173	282	2830	2554	3942	4170	3991	2274	716	2216	1648	1834	3773	2877
3741_Depression - Professional informed about depression	3741_Depression - Professional informed about depression	25	157	1	3801	1999	1461	2751	1975	3107	3574	4729	3541	157	3177	2325	2649	3078	2930	1116	3055	4115	2154	1888	2479	1892
2962_LIFR - Leukemia inhibitory factor receptor	2962_LIFR - Leukemia inhibitory factor receptor	25	157	1	309	3136	3039	3149	1639	3312	4058	3261	1993	4374	205	157	1637	3334	2382	2035	1655	374	2630	1372	294	249
1318_Resistin (FBAT, adjusted for age and sex)	1318_Resistin (FBAT, adjusted for age and sex)	25	157	1	3745	494	3431	3208	540	4662	2682	3861	4607	550	543	2670	157	2265	1206	1466	3481	3541	2031	2104	2435	4700
2491_SERPINA5 - Plasma serine protease inhibitor	2491_SERPINA5 - Plasma serine protease inhibitor	25	157	1	2538	3716	538	3312	4449	1203	3429	4560	3872	1850	2407	2757	3200	157	1175	1269	1549	3589	1512	3754	4491	691
2649_PTGS2 - Prostaglandin G/H synthase 2	2649_PTGS2 - Prostaglandin G/H synthase 2	25	157	1	2733	2933	3775	4720	683	1325	3866	956	3340	2524	323	1288	2075	1526	1570	830	4096	157	2085	835	647	1195
3081_NRXN3 - Neurexin-3-beta	3081_NRXN3 - Neurexin-3-beta	25	157	1	297	2039	3185	2323	3784	4006	1202	4335	1953	4697	3588	3751	3293	2800	1537	2524	502	4702	764	4091	1278	157
1756_Cancer (FBAT, adjusted for multivariable)	1756_Cancer (FBAT, adjusted for multivariable)	25	158	1	158	1467	3434	3579	2472	2935	1624	171	2492	1776	1743	2651	3052	3081	4491	1489	4116	4727	794	3294	4128	2633
2608_OPCML - Opioid-binding protein/cell adhesion molecule	2608_OPCML - Opioid-binding protein/cell adhesion molecule	25	158	1	1435	1256	158	2410	4304	3787	159	3614	264	2055	2634	1171	3615	815	4671	4043	4372	476	4506	3883	1981	4576
3311_Other eye problems	3311_Other eye problems	25	158	1	1658	3966	3669	3049	158	1698	3823	3934	3009	1928	3942	2863	319	4552	2304	303	1870	2676	2059	2841	4606	1784
2083_APCS - Serum amyloid P-component	2083_APCS - Serum amyloid P-component	25	158	1	4512	982	2101	4599	2868	158	4680	4631	1139	3084	4570	2861	1766	642	1239	1813	3953	1488	3694	2900	3725	2284
1047_Trochanter BMD (GEE, adjusted for multivariable)	1047_Trochanter BMD (GEE, adjusted for multivariable)	25	158	1	1383	1466	1627	4306	3790	2908	580	2193	158	1919	3163	2912	365	1704	1850	4031	2062	3953	4641	1743	3541	3616
2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	25	158	1	1994	630	2389	1210	2094	3076	1194	2110	1798	2553	2006	158	3050	4320	1286	2531	2521	4268	301	3671	4391	996
856_Ratio of bisLallylic bonds to double bonds in lipids	856_Ratio of bisLallylic bonds to double bonds in lipids	25	158	1	2054	4109	4070	3367	976	2962	395	291	1875	2486	1151	941	158	4153	301	4596	1887	942	2467	3692	2578	779
4284_FEV1/FVC ratio	4284_FEV1/FVC ratio	25	158	1	4126	2808	2548	4632	177	4744	2223	3507	1130	4000	2663	369	585	2553	991	158	3622	2425	2605	1090	4746	3991
2097_CFI - Complement factor I	2097_CFI - Complement factor I	25	158	1	2971	1029	2961	1639	3903	391	977	3349	4693	2130	2022	574	2270	3010	1321	2012	3517	3535	158	2140	4553	3710
4432_Rubella IgG levels	4432_Rubella IgG levels	25	158	1	3446	2660	2576	3167	1146	3029	1275	1457	2776	4645	595	4704	545	3248	2252	3555	1624	3174	1065	158	1950	4675
4162_Focal Epilepsy, other lesion	4162_Focal Epilepsy, other lesion	25	158	1	1393	3984	3424	307	1179	3939	1608	2422	3346	233	3213	2876	1269	3601	895	944	795	2104	832	2017	158	1880
238_CD27 on IgA+B	238_CD27 on IgA+B	25	158	1	1835	857	405	2414	1279	1008	3739	2165	1802	3419	3154	4215	482	3666	1626	1231	4085	4502	1231	1499	752	158
4396_Menstruation quality of life impact: Agressiveness	4396_Menstruation quality of life impact: Agressiveness	25	159	1	159	3816	2811	1768	4463	1960	4426	4557	990	1543	3739	558	1358	675	3893	3412	188	2086	4016	678	3132	1679
1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	25	159	1	1949	159	3462	3319	4250	3887	2083	2342	2141	4043	1571	1350	1939	1252	2060	2498	4125	2875	3416	3364	1411	1112
39_Memory	39_Memory	25	159	1	2411	2123	159	3230	2798	4004	4514	2727	4672	2242	4739	4229	3065	1413	1852	4123	1897	1552	3345	4364	1130	3376
1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	159	1	1302	4549	2877	159	2391	3299	1381	4510	2537	2998	3972	2488	4366	995	2478	3615	1280	1168	2833	3309	4208	3754
2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	25	159	1	2923	2799	4403	1974	159	4278	2716	3089	4612	3927	2714	3475	3465	1422	1089	215	3521	1402	3557	1650	3691	1618
2040_Attention function - Excutive function - Child	2040_Attention function - Excutive function - Child	25	159	1	2533	1359	2136	1493	1487	159	2302	753	1425	4693	2164	2396	1225	4367	218	1565	1793	1009	4341	3063	901	4277
957_Total lipids in very large HDL	957_Total lipids in very large HDL	25	159	1	3770	1460	1589	542	1833	1438	2341	1521	159	189	3874	2319	4677	2748	1500	3482	1385	489	3651	2030	208	2425
236_CD123 on pDC	236_CD123 on pDC	25	159	1	3534	324	3078	4238	1716	2654	1770	4166	1250	159	3410	681	2616	2763	2745	2597	2134	1828	4325	3977	994	2758
1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	159	1	906	3902	466	3205	2725	197	2340	974	3848	1669	159	1626	3319	3164	1406	3196	204	1414	1964	627	2166	3105
2830_SLPI - Antileukoproteinase	2830_SLPI - Antileukoproteinase	25	159	1	4517	2477	3784	3985	4629	4356	2748	3671	2819	770	1796	159	3528	4487	4426	1397	3859	1513	3934	2275	2005	2322
4401_Menstruation quality of life impact: Headache	4401_Menstruation quality of life impact: Headache	25	159	1	4249	1030	2009	3511	4267	2085	527	2272	265	1659	3812	2980	4352	2931	159	1718	1187	1132	2271	395	3343	1223
430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	25	159	1	4652	1158	2135	3497	1650	4663	4235	3968	2706	2798	3800	1973	3325	1416	913	1159	159	2357	1656	2075	3427	3688
2561_LTA LTB - Lymphotoxin alpha1:beta2	2561_LTA LTB - Lymphotoxin alpha1:beta2	25	159	1	3388	3965	2992	4314	2789	3194	3052	2697	4030	4712	3734	1070	1890	3023	1596	4229	2204	1984	3782	4242	159	2855
505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	25	159	1	2806	687	4655	4552	2099	1777	4727	1059	3272	3638	2514	2382	3698	2767	607	2195	3674	3778	3305	4115	3187	159
2669_IL11RA - Interleukin-11 receptor subunit alpha	2669_IL11RA - Interleukin-11 receptor subunit alpha	25	160	1	2440	160	3998	2967	981	2372	1967	3143	2326	1881	1171	1207	405	1448	4664	604	3373	2892	2307	3386	1249	1601
3972_Total body BMD (60 or older)	3972_Total body BMD (60 or older)	25	160	1	1226	396	1245	408	4235	2490	212	849	160	2767	4373	1628	2574	1484	2747	4403	4436	1351	1019	4692	1125	4145
4109_Serum creatinine	4109_Serum creatinine	25	160	1	1291	3693	4263	4016	1775	4336	471	561	3299	160	4063	2112	1395	3384	1009	540	3743	1925	2177	3066	3685	3247
2560_HAMP - Hepcidin	2560_HAMP - Hepcidin	25	160	1	2792	2868	2569	1694	4399	3585	855	2337	3471	1838	2338	1107	4511	160	2766	4570	645	535	1798	4094	2784	4746
3316_Frequency of solarium/sunlamp use	3316_Frequency of solarium/sunlamp use	25	160	1	946	2311	1626	4116	739	2655	3750	2825	3863	4427	2751	2311	1517	1375	2679	1404	4320	539	160	861	416	4532
1106_Triglycerides - Birth cohorts	1106_Triglycerides - Birth cohorts	25	161	1	2666	3638	4100	161	483	3986	4361	3980	2085	2732	3536	3178	2855	2995	4017	3232	529	4565	4509	4031	2143	4545
2278_ESR1 - Estrogen receptor	2278_ESR1 - Estrogen receptor	25	161	1	2934	593	3706	1704	1655	3968	161	294	3974	3284	3995	4524	4224	1453	1041	874	1576	3715	3903	3982	1655	1209
2746_XCL1 - Lymphotactin	2746_XCL1 - Lymphotactin	25	161	1	963	2702	3843	2929	4447	706	2467	3798	4126	2872	3368	161	2569	3025	4707	2153	1543	3688	4335	2244	1988	4431
2816_SAA1 - Serum amyloid A-1 protein	2816_SAA1 - Serum amyloid A-1 protein	25	161	1	4071	306	4383	3105	2780	2239	1493	3092	4180	1858	1714	4497	161	3572	2105	3817	4275	4057	3863	561	975	1930
1109_Subcutaneous adipose tissue volume (male)	1109_Subcutaneous adipose tissue volume (male)	25	161	1	1785	884	682	4159	4722	1705	1186	4576	3903	4590	638	3823	1598	1464	161	3138	1239	1843	3766	1182	3921	1956
4654_External capsule fractional anisotropy	4654_External capsule fractional anisotropy	25	161	1	2606	4244	2937	2749	3330	286	3439	4142	3300	3382	4217	3639	1119	866	3528	4285	161	3084	1140	2070	3694	1660
4502_Right superior parietal	4502_Right superior parietal	25	161	1	2046	2025	326	3816	360	2677	3315	2215	3049	2668	513	3149	1575	3786	1911	342	2344	161	3052	2414	2271	1262
459_Energy::Krebs cycle::citrate	459_Energy::Krebs cycle::citrate	25	161	1	4628	2050	4461	1859	2619	3051	4019	1548	3678	4576	1627	2882	1848	4394	3432	2758	1249	4294	161	2603	2966	2992
4538_Right hippocampus	4538_Right hippocampus	25	162	1	1862	3671	1183	162	4135	2461	2843	829	2979	737	3261	4050	4061	4112	3301	2556	3117	3824	993	1416	2863	2480
2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	25	162	1	1056	4677	1381	264	162	960	1471	163	3153	205	195	2377	2320	2063	938	178	4282	3381	3041	3342	4051	3439
3971_Total body BMD	3971_Total body BMD	25	162	1	1714	4217	3308	884	1440	2218	162	424	2252	1495	4403	327	2908	1843	841	4336	1838	364	3702	820	740	2483
3335_Light smokers, at least 100 smokes in lifetime	3335_Light smokers, at least 100 smokes in lifetime	25	162	1	3330	3227	4122	4152	1808	3752	1518	162	2131	545	2993	411	2512	3688	1851	3192	4008	3569	3752	1206	2536	991
1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	162	1	636	1027	1285	4001	638	4204	3818	782	1346	162	3714	3385	1231	2558	2323	1249	304	2391	3615	2717	1147	1530
2362_PGF - Placenta growth factor	2362_PGF - Placenta growth factor	25	162	1	416	3116	4515	1106	804	2925	3614	3592	1958	1766	162	1960	2180	1626	4335	2606	1304	3306	1022	4548	3492	1480
1177_Excessive daytime sleepness (female)	1177_Excessive daytime sleepness (female)	25	162	1	2748	1817	2174	950	1513	4111	3777	3389	4456	3315	189	162	2481	3685	460	1696	1092	399	3061	1486	1195	1212
4524_Left pallidum	4524_Left pallidum	25	162	1	3973	220	4211	1607	2990	3869	3388	2757	3515	1042	4250	3048	162	373	3398	2293	3181	4573	4602	717	1626	4354
944_Triglycerides in small VLDL	944_Triglycerides in small VLDL	25	162	1	3039	3951	3389	4066	539	1844	846	802	1778	921	1350	332	3963	2420	162	1113	947	1256	2919	2206	3542	304
4200_Height	4200_Height	25	162	1	2027	3849	2919	740	352	951	3494	1123	717	4718	4648	1488	4064	799	3720	162	3852	2294	4462	4023	1210	4630
2813_BOC - Brother of CDO	2813_BOC - Brother of CDO	25	162	1	3447	2457	2588	1340	1337	3765	3524	4146	456	1202	1457	434	1389	4285	3486	2782	2391	162	3446	2941	2146	4591
3574_Pain type(s) experienced in last month: Hip pain	3574_Pain type(s) experienced in last month: Hip pain	25	162	1	1534	3889	3294	1564	2861	844	944	1003	1160	2033	1802	2367	1487	3521	2534	2756	4163	2103	393	162	636	2046
1000_Macrophage colony-stimulating factor	1000_Macrophage colony-stimulating factor	25	163	1	2560	163	891	4093	1155	2216	878	706	2797	986	2280	2284	2746	1859	3045	562	3389	3095	3581	1731	3818	797
3992_Miserableness (MIS)	3992_Miserableness (MIS)	25	163	1	2741	1842	2231	163	4122	3781	2479	1131	3229	1192	592	1075	2881	4730	266	3738	3492	1977	1133	243	640	1063
3941_Body Mass Index (female)	3941_Body Mass Index (female)	25	163	1	318	2423	4372	4535	770	4571	1312	3612	163	4205	753	2994	1015	1192	1512	676	4512	429	1631	2334	2770	4621
3123_STK17B - Serine/threonine-protein kinase 17B	3123_STK17B - Serine/threonine-protein kinase 17B	25	163	1	1333	2159	2204	2309	2877	3122	3021	1872	312	163	3572	4643	204	3070	4183	3283	1267	686	774	4339	2653	3178
4451_Left inferior temporal	4451_Left inferior temporal	25	163	1	4109	249	476	268	3193	2869	1530	177	480	291	3088	163	2185	2326	2371	1503	695	3406	1284	2455	3820	2163
3870_Basophil percentage of white cells (three-way meta)	3870_Basophil percentage of white cells (three-way meta)	25	163	1	3117	1646	4510	4375	3927	4709	517	3624	922	798	2537	3572	4553	163	468	3613	178	2588	1237	1089	3183	2804
1104_Low-density lipoprotein - Birth cohorts	1104_Low-density lipoprotein - Birth cohorts	25	163	1	3421	1958	1568	3566	3442	3745	4120	1836	691	557	3817	1238	602	1094	163	2348	3114	2488	206	3040	2239	735
2048_Periodontal complex trait 3 - Aa trait	2048_Periodontal complex trait 3 - Aa trait	25	163	1	2378	4053	1030	2013	4097	3341	4692	4216	4123	2344	773	3097	3771	3451	636	4396	163	2664	268	3990	4084	3967
1182_Sleep duration (male)	1182_Sleep duration (male)	25	163	1	1304	1482	622	2297	1211	1883	556	3709	3539	2029	3703	4005	2566	3291	2426	2757	2216	163	2986	391	2815	3925
4677_Fornix (column and body of fornix) axial diusivities	4677_Fornix (column and body of fornix) axial diusivities	25	163	1	2566	3108	4346	1266	1100	4604	296	2787	215	3022	4135	304	2543	731	979	1781	1758	1041	658	1381	3680	163
4724_Inferior fronto-occipital fasciculus mode of anisotropy	4724_Inferior fronto-occipital fasciculus mode of anisotropy	25	164	1	164	1406	1673	3938	4680	1206	3192	4065	2942	4411	499	1874	2913	4516	3240	3770	2086	1722	1520	826	2326	440
663_::::X-04500	663_::::X-04500	25	164	1	293	164	4685	4246	1360	3164	1879	2091	2655	994	3894	1264	3139	3911	2843	1868	2513	3646	4203	1899	2681	2005
2893_PLXNC1 - Plexin-C1	2893_PLXNC1 - Plexin-C1	25	164	1	257	3400	3373	1543	2656	1527	1960	3781	4592	164	439	2094	2842	694	2528	1677	4167	1449	3826	1598	4207	2224
3379_Diastolic Blood Pressure (automated reading)	3379_Diastolic Blood Pressure (automated reading)	25	164	1	2627	815	3261	4103	3870	2379	1691	4517	1538	4305	4642	2680	164	246	2491	4016	4601	4414	1668	2909	1424	3238
3886_Mean corpuscular hemoglobin concentration (three-way meta)	3886_Mean corpuscular hemoglobin concentration (three-way meta)	25	164	1	2102	2985	4223	4605	1746	3324	4352	3738	1165	3713	1360	4620	4143	164	3296	940	3634	1282	3876	2488	3377	2696
2358_IL2 - Interleukin-2	2358_IL2 - Interleukin-2	25	164	1	2018	1866	3018	1038	2838	4359	4469	3175	3808	2499	1017	4483	2456	1487	4067	3206	527	3703	2527	164	3612	705
4612_Right basal forebrain	4612_Right basal forebrain	25	165	1	2567	165	3446	4292	4734	2165	2832	828	168	3345	4351	3788	244	4108	3761	2851	2347	3363	3398	3618	526	948
4086_Type 2 Diabetes (adjusted for BMI)	4086_Type 2 Diabetes (adjusted for BMI)	25	165	1	2199	955	165	4710	1875	2479	2741	2662	2908	950	3447	2927	2972	2932	1966	526	1146	466	3842	943	615	1774
969_Total lipids in chylomicrons and extremely large VLDL	969_Total lipids in chylomicrons and extremely large VLDL	25	165	1	1918	1804	2907	4202	3730	2152	165	3732	4483	1444	1319	2698	3231	1942	1767	1313	1059	583	3452	3721	2520	1052
642_Xenobiotics::Xanthine metabolism::1-methylurate	642_Xenobiotics::Xanthine metabolism::1-methylurate	25	165	1	2963	508	1500	413	1168	512	2589	165	1187	1549	230	3887	3261	2171	482	988	3037	1931	3790	2715	1112	2528
493_Lipid::Fatty acid metabolism::isovalerate	493_Lipid::Fatty acid metabolism::isovalerate	25	165	1	2302	2485	3408	3044	595	2297	2693	2655	4148	165	4688	3696	2496	1082	499	391	3101	3736	1669	1854	3213	3665
467_Lipid::Bile acid metabolism::glycocholate	467_Lipid::Bile acid metabolism::glycocholate	25	165	1	1985	2015	2533	3610	4548	4727	2851	911	1010	3803	165	1300	2951	753	4634	4363	4325	271	823	1441	3653	4302
3012_MAPK13 - Mitogen-activated protein kinase 13	3012_MAPK13 - Mitogen-activated protein kinase 13	25	165	1	3513	491	2788	4345	2356	4684	4720	523	2244	653	3267	1517	4692	3190	165	3721	1807	4105	4691	1019	226	959
4089_Maternal history of Alzheimer's disease	4089_Maternal history of Alzheimer's disease	25	165	1	238	2701	3583	1199	414	957	596	1364	285	2012	4495	4457	4708	1490	3356	165	709	4471	1791	1282	2728	255
1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	165	1	679	193	1506	1380	2816	549	323	185	3966	4253	1097	2054	189	2436	3976	1788	3669	165	3996	201	4416	4394
4748_Posterior limb of internal capsule radial diusivities	4748_Posterior limb of internal capsule radial diusivities	25	165	1	2237	2014	637	2990	4316	3912	1803	2075	4051	4237	2192	1327	3841	1307	920	3304	2189	1257	2670	4540	165	633
382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	25	166	1	2546	3994	1580	4724	1980	166	4502	3328	3048	643	3345	4340	2052	1832	1708	3210	526	1415	3643	2490	4464	4134
2087_ANGPT4 - Angiopoietin-4	2087_ANGPT4 - Angiopoietin-4	25	166	1	3251	4004	1697	3072	2420	3629	166	3136	1340	2312	2710	438	2932	2187	1434	1141	3189	2646	2887	1008	3032	2508
3096_TGFBR2 - TGF-beta receptor type-2	3096_TGFBR2 - TGF-beta receptor type-2	25	166	1	4086	3093	3958	2358	1987	4331	1515	4251	166	3390	3915	3818	3183	3042	1072	972	3447	4645	2218	4158	2631	876
1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	166	1	221	378	2498	2895	4287	2032	4325	4508	4274	166	2715	837	530	4465	2258	4578	891	475	3244	1087	533	1967
3959_Antisocial behavior (female)	3959_Antisocial behavior (female)	25	166	1	3425	1711	2304	2476	4053	2456	3133	1519	1658	4314	166	1023	2576	4657	170	3743	4172	1376	1854	4633	811	1109
2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	25	166	1	2251	4022	4637	4276	308	3475	2909	3990	3056	764	2969	166	302	1351	3820	481	3308	2721	1644	414	971	4321
61_Age at menarche	61_Age at menarche	25	166	1	2743	3713	439	2123	3662	1458	4638	204	3078	2603	882	1173	3565	166	3798	1362	3957	1361	2825	4208	473	1243
3028_ADSL - Adenylosuccinate lyase	3028_ADSL - Adenylosuccinate lyase	25	166	1	2769	4605	966	4526	2513	3082	2474	2443	810	3525	1410	849	3446	4343	2813	1347	366	166	1772	3864	2644	3471
1890_Shaft Width (FBAT, male, adjussted for age)	1890_Shaft Width (FBAT, male, adjussted for age)	25	167	1	167	3453	3947	1341	2124	2879	3566	3894	3647	1072	4686	784	3545	2198	4579	1957	2485	3955	321	1056	4112	3116
1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	25	167	1	4452	167	2222	1794	3469	2353	514	1382	1421	4618	4110	1461	3267	3611	766	2355	4035	3925	3497	4224	2254	3378
1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	25	167	1	1138	2237	167	2742	1963	2108	865	4246	1873	3241	3929	1297	892	1355	526	2768	978	3644	2344	4442	2037	1397
704_::::X-11441	704_::::X-11441	25	167	1	3338	4532	1939	167	2311	1420	3116	2430	794	2148	2939	2968	2081	2682	4632	3307	3729	3585	2332	3638	2554	2268
1011_Tumor necrosis factor beta	1011_Tumor necrosis factor beta	25	167	1	835	1277	1539	1316	3156	167	1930	1179	2554	4472	996	4409	3957	3229	679	2481	1175	2701	4051	3097	2370	4546
3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	25	167	1	2755	3914	1450	1120	1501	1749	167	584	4409	1557	464	625	4303	3401	531	1042	1419	2373	3671	3030	1913	1977
102_Late pubertal growth (female)	102_Late pubertal growth (female)	25	167	1	2530	1026	3448	1727	3446	1930	3260	167	4576	1903	2770	2451	3399	1895	2668	2821	2937	382	3645	3970	3464	3398
1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	25	167	1	3576	4269	4498	2094	4662	1496	2172	1013	167	3586	2298	2336	1977	582	3685	3556	663	3552	4052	429	499	2003
1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	25	167	1	2373	1587	2267	2103	1407	2338	932	454	219	2826	167	4663	4551	3312	4599	4628	2708	1008	3644	2194	3923	3988
3347_Age started oral contraceptive pill (female)	3347_Age started oral contraceptive pill (female)	25	167	1	3536	2082	761	4358	707	1781	4226	3079	3634	1787	3748	3965	398	167	3661	430	1485	2703	701	1668	671	657
3608_Non-cancer illness code, self-reported: high cholesterol	3608_Non-cancer illness code, self-reported: high cholesterol	25	167	1	735	714	2725	378	653	403	4337	4380	1138	2738	1999	1998	2149	359	167	680	1237	2649	4120	2096	4270	781
3502_Male-specific factors - Hair/balding pattern: Pattern 3	3502_Male-specific factors - Hair/balding pattern: Pattern 3	25	167	1	3599	4538	805	3039	1358	465	2176	613	910	975	2234	2184	2031	4623	4693	738	460	167	564	580	3333	4061
3462_Impedance measures - Arm fat-free mass (right)	3462_Impedance measures - Arm fat-free mass (right)	25	167	2	4743	2536	462	4324	3724	817	2687	3847	3497	3167	4018	3200	4525	4103	2167	4648	3977	357	167	3832	2620	1281
1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	167	1	1689	3569	1752	4583	3940	256	2587	3459	4220	961	1132	3582	4745	1505	4260	2080	3322	1814	1974	559	167	3132
369_Amino acid::Creatine metabolism::creatine	369_Amino acid::Creatine metabolism::creatine	25	167	1	661	1427	2692	1458	2103	683	2366	373	3991	2456	567	323	242	3783	186	2303	1192	1228	4049	501	3360	167
2855_RPS27A - Ubiquitin	2855_RPS27A - Ubiquitin	25	168	1	168	1987	3789	3783	2616	2454	3323	4254	4708	182	1800	1715	986	3328	2064	4288	1575	628	682	2139	1565	905
3975_Total body BMD (15-30 years old)	3975_Total body BMD (15-30 years old)	25	168	1	180	1834	2364	435	4645	3803	168	691	4125	1281	3656	2812	3915	3617	2220	2488	2722	2150	1396	1979	3076	1322
522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	25	168	1	3125	875	2553	4170	928	4576	4068	2576	3502	3698	590	168	2731	644	2286	2059	4381	3698	1790	300	4399	1010
2789_NSFL1C - NSFL1 cofactor p47	2789_NSFL1C - NSFL1 cofactor p47	25	168	1	3788	2245	4114	1053	1156	3837	2029	2977	1939	4180	4586	3756	168	3624	332	1519	2102	3271	3332	4128	4153	4422
3407_Number of older siblings	3407_Number of older siblings	25	168	1	2723	2952	1554	3301	362	4292	497	4326	3044	359	2292	1454	1547	1821	4349	704	168	3557	2549	3254	4731	4315
3329_Cancer (diagnosed by doctor)	3329_Cancer (diagnosed by doctor)	25	168	1	3992	3060	302	2357	1097	3633	623	2622	1124	3885	3005	3924	4396	481	3624	2905	1383	168	2357	3965	1680	874
1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	169	1	169	2386	1430	2264	876	289	790	2853	2388	3427	4154	1065	756	3741	1096	2408	1396	433	1553	4283	3588	3779
216_NKT:%4-8-	216_NKT:%4-8-	25	169	1	3319	397	4229	1825	1272	169	2025	4013	1613	2204	4343	3006	217	3162	3391	1631	3849	4668	3967	1047	1979	3826
1081_Alzheimer's disease	1081_Alzheimer's disease	25	169	1	1506	3146	4583	501	3096	1165	1420	4285	169	3236	1560	3581	2809	1926	1231	4601	1071	4037	3087	3201	4743	1118
4751_Splenium of corpus callosum radial diusivities	4751_Splenium of corpus callosum radial diusivities	25	169	1	2607	615	1189	1716	525	4192	3400	565	541	4383	169	1248	1150	692	177	2146	3350	2230	3990	390	340	432
1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	169	1	3610	3999	2962	336	250	1263	1989	2468	4469	2999	2589	451	3212	4186	2971	169	2362	1487	478	1196	4637	3571
4527_Left accumbens area	4527_Left accumbens area	25	169	1	4244	1739	3736	4688	3551	4588	4656	4179	3679	399	1564	2977	288	1671	1534	2486	169	1680	3690	4612	183	3237
1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	169	1	4498	3987	799	3196	1913	235	1371	1442	4259	2858	785	1590	1797	2449	3077	1475	2746	169	653	1732	802	4692
2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	25	169	1	4146	1415	2606	3836	2277	813	3305	4569	2359	2859	3374	1710	2982	2053	3334	2897	3118	2409	169	4504	4259	3804
4630_Left vessel	4630_Left vessel	25	169	1	3935	653	4625	4057	3489	3004	548	2968	3167	3623	202	2978	1420	1536	1663	3887	2576	4614	2463	4709	1592	169
469_Lipid::Bile acid metabolism::hyodeoxycholate	469_Lipid::Bile acid metabolism::hyodeoxycholate	25	170	1	1417	170	1852	2552	4281	3812	4648	2314	1219	3446	3928	1179	1277	2399	3529	4200	3878	3338	4061	997	825	266
3906_Intraocular pressure	3906_Intraocular pressure	25	170	1	2115	1144	419	170	1698	1769	4711	1717	3715	1597	3426	1137	4743	1618	725	2494	2982	3844	2864	1356	2663	1671
2186_AZU1 - Azurocidin	2186_AZU1 - Azurocidin	25	170	1	1653	1577	2590	1032	3719	4507	170	2045	2657	2624	2364	4158	4507	804	3292	4219	2336	2307	981	2843	4657	2500
136_Weight (male)	136_Weight (male)	25	170	1	1162	4457	2634	1949	227	2699	3669	170	1512	546	1108	1763	4556	3560	2355	394	3474	3657	3202	4443	4736	2885
4104_Total protein	4104_Total protein	25	170	1	966	488	1462	2615	1809	4035	3353	4066	170	4560	3336	182	698	3753	4590	686	3012	903	532	255	4476	3689
4741_Corticospinal tract radial diusivities	4741_Corticospinal tract radial diusivities	25	170	1	458	2754	4433	4510	1378	4246	627	3643	4255	170	2826	3574	4369	3743	2620	892	2071	4326	3666	864	2265	2937
25_Internalizing	25_Internalizing	25	170	1	562	4411	201	4178	2839	1271	1054	738	803	969	1417	170	736	737	4697	2924	895	431	3550	2505	3870	3491
2076_CXCL16 - C-X-C motif chemokine 16	2076_CXCL16 - C-X-C motif chemokine 16	25	170	1	1618	4553	3392	397	1548	497	3168	4105	953	866	3628	538	1315	3574	4175	3967	170	682	2851	2375	2234	1971
1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	25	170	1	1317	4570	2741	1622	4565	3262	3474	3446	1584	1001	3555	1665	568	2612	379	3428	1349	170	962	3170	2097	1978
1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	25	171	1	171	1558	4230	3994	1671	3799	2188	205	2516	4048	3949	4336	3879	352	2548	2354	1336	4094	4242	3891	3914	1408
114_Waist-hip ratio (adjusted for BMI)	114_Waist-hip ratio (adjusted for BMI)	25	171	1	241	2573	3921	193	171	4746	2320	2170	614	4280	787	3377	1021	4312	227	213	4244	990	4350	1770	2510	4342
2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	25	171	1	1421	4204	4551	3905	1508	1353	2053	3762	171	4118	1093	2894	3103	2962	4493	1107	2697	3281	3502	1489	1774	4129
1041_Shaft Width (GEE, adjusted for age and sex)	1041_Shaft Width (GEE, adjusted for age and sex)	25	171	1	2912	4474	1024	2204	1245	3215	4301	2471	1212	4568	171	970	3998	1842	3478	1016	3698	2214	4603	2287	463	4204
104_Late pubertal growth	104_Late pubertal growth	25	171	1	2431	1255	1804	669	675	1974	1111	3687	4541	3262	1724	3933	171	1284	1869	1271	3321	874	2988	4547	321	4671
2532_LYN - Tyrosine-protein kinase Lyn	2532_LYN - Tyrosine-protein kinase Lyn	25	171	1	1774	1230	2639	1690	581	3097	1874	2300	1797	1340	892	2983	784	171	436	689	1461	4499	4331	3708	4221	2726
291_CD4:%Act(DR+38+)	291_CD4:%Act(DR+38+)	25	171	1	971	1865	285	4259	1763	3376	3345	206	341	1379	2887	2308	4379	3834	171	2982	2921	1403	390	2238	3887	3267
912_Free cholesterol in medium HDL	912_Free cholesterol in medium HDL	25	171	1	3254	3263	2229	2268	1258	1277	2626	3948	3562	4425	917	3191	688	192	3654	1485	171	2280	1389	1805	696	1890
2367_AURKA - Aurora kinase A	2367_AURKA - Aurora kinase A	25	171	1	3016	1322	3325	3465	3426	908	2872	1074	1806	2726	4536	2456	3376	4519	3079	2896	2272	3794	2208	171	1750	4336
2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	25	171	1	2259	1379	2301	3975	2730	809	4547	3641	2319	2283	3078	4710	1730	3527	2650	1940	301	3935	3079	1183	714	171
4644_Gray matter	4644_Gray matter	25	172	1	172	2497	1423	1634	1484	1252	4722	3339	3953	3393	3952	3546	4300	3758	790	2181	3838	499	992	4609	333	1591
1071_Diabetic Nephropathy in Type 1 Diabetes	1071_Diabetic Nephropathy in Type 1 Diabetes	25	172	1	3341	720	305	2483	172	416	963	321	2415	1805	553	3917	3885	4145	1591	199	2070	901	1271	1031	211	438
4008_Osteoarthritis of knee (hospital diagnosed)	4008_Osteoarthritis of knee (hospital diagnosed)	25	172	1	3047	1791	3752	1033	1767	2952	172	2636	2801	2601	2736	2233	611	4488	3622	2564	4533	2226	2622	4625	3092	4642
2760_PLAU - Urokinase-type plasminogen activator	2760_PLAU - Urokinase-type plasminogen activator	25	172	1	1450	3120	2047	4441	4236	3930	2950	4708	172	800	2620	1226	1162	2107	2430	2386	2593	1309	1749	3239	3231	3340
1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	172	1	698	497	3042	4255	819	429	2190	2940	4141	172	2707	3952	4048	1857	3872	729	2310	723	2086	2240	3881	1724
1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	172	1	1338	2199	3199	1209	3277	2675	2543	2012	3648	4735	172	3609	4175	1656	3111	1962	2518	2385	3740	3523	3344	4405
2141_GDI2 - Rab GDP dissociation inhibitor beta	2141_GDI2 - Rab GDP dissociation inhibitor beta	25	172	1	1898	2161	1557	426	4663	452	606	1486	1897	329	3292	172	4727	1690	1492	2145	3458	2005	2584	3926	2658	2047
3869_Basophil count (three-way meta)	3869_Basophil count (three-way meta)	25	172	1	1675	3811	3999	3024	312	2679	1097	1611	1011	1116	2501	3235	2521	172	962	239	365	2539	389	946	2147	4578
4081_Waist-hip ratio (adjusted for BMI, male)	4081_Waist-hip ratio (adjusted for BMI, male)	25	172	1	2869	862	706	4573	225	904	236	3242	1189	409	3620	767	870	2247	471	172	1341	2267	4054	1566	3020	361
3344_Age at last live birth (female)	3344_Age at last live birth (female)	25	172	1	2379	2553	830	807	3163	4129	3909	3700	2485	442	533	1169	1134	727	3776	3218	2349	1075	1859	1227	2544	172
945_Serum total cholesterol	945_Serum total cholesterol	25	173	1	528	230	173	470	816	219	2975	3243	555	4221	1090	1961	1237	310	303	1181	3527	4083	3836	3888	4721	963
1216_Alcohol consumption (dichotomous)	1216_Alcohol consumption (dichotomous)	25	173	1	3884	2071	3481	4725	4216	1534	2717	173	3408	3706	3601	1021	3073	483	1458	2703	1775	2825	436	4056	1844	1171
3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	25	173	1	3484	1551	4279	3186	2915	885	941	2174	173	3846	3343	195	2508	4144	328	3683	982	735	1968	4257	4474	3791
1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	173	1	3878	3919	1577	717	2673	206	3786	4577	2462	818	2988	3741	173	1480	2413	3450	429	233	3807	1080	4685	2969
1159_Fasting insulin main effect	1159_Fasting insulin main effect	25	173	1	4026	4456	812	4236	3451	974	2510	2405	4016	3786	2689	306	2103	173	1920	4342	295	1645	1474	1944	3929	2239
893_Cholesterol esters in large LDL	893_Cholesterol esters in large LDL	25	173	1	317	344	577	371	1759	533	4069	3112	661	4589	315	2211	4407	591	173	1390	1980	3483	2335	2068	3488	770
4731_Superior fronto-occipital fasciculus mode of anisotropy	4731_Superior fronto-occipital fasciculus mode of anisotropy	25	173	1	4678	543	1027	2991	3104	3241	988	1834	1173	1443	1143	3652	4599	3589	1433	1823	920	4126	173	2994	4437	4122
638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	25	173	1	3775	1977	2837	4496	3430	4678	4272	3599	4227	3024	3325	3275	201	1726	3414	2997	4526	3916	1776	4451	259	173
2972_RPSA - 40S ribosomal protein SA	2972_RPSA - 40S ribosomal protein SA	25	174	1	174	3990	4147	3999	3626	1880	1554	4538	4426	1807	1334	803	3547	2577	1601	1866	3357	3813	4358	2567	1423	601
221_T:%Vg9+Vd2-low	221_T:%Vg9+Vd2-low	25	174	1	4505	4591	2422	174	1207	4124	3324	3256	2994	2606	3381	650	3272	1004	3226	1295	4058	4413	3972	3807	3504	3193
3499_Hair colour (natural, before greying): Black	3499_Hair colour (natural, before greying): Black	25	174	1	4732	4148	3563	2900	1292	2640	174	462	2640	864	4007	2796	707	1854	3809	4565	3607	699	4032	420	2110	4253
4709_Superior fronto-occipital fasciculus mean diusivities	4709_Superior fronto-occipital fasciculus mean diusivities	25	174	1	1561	2150	2960	907	1836	1892	1348	731	174	2681	4028	917	2303	4189	528	698	2135	1129	1224	2353	746	1168
3424_Symbol digit substitution test - Number of symbol digit matches made correctly	3424_Symbol digit substitution test - Number of symbol digit matches made correctly	25	174	1	2414	3163	2981	3525	2584	4565	1782	3512	969	174	4382	1893	4052	2419	430	3166	1236	1280	2228	4280	2671	2389
2538_SELE - E-Selectin	2538_SELE - E-Selectin	25	174	1	4675	997	3698	1149	1843	3216	981	4159	1240	1228	4512	3610	174	4076	3114	1298	3406	1874	4204	1749	854	2882
742_::::X-11859	742_::::X-11859	25	174	1	2563	977	3254	2569	1317	177	2891	3693	1800	2075	2578	2022	609	174	427	544	703	4386	3214	3259	4502	3216
4426_Epstein Barr Virus antigen EA seropositivity	4426_Epstein Barr Virus antigen EA seropositivity	25	174	1	4280	2759	3493	2636	4246	1129	3342	2425	3526	915	4641	4649	1839	708	432	2989	480	4169	174	1347	4194	1102
1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	25	174	1	4542	2494	3781	1765	1231	194	4539	3796	3384	2971	2595	246	1400	909	323	1844	227	1999	2001	174	555	3733
1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	25	174	1	4165	4540	1672	3004	1059	3461	3912	465	1664	1325	3299	3880	1345	2241	2033	1189	3367	1016	4646	1982	174	3188
1849_Neck Section Modulus (GEE, male, adjusted for age)	1849_Neck Section Modulus (GEE, male, adjusted for age)	25	175	1	175	2136	3518	3699	4098	3229	2735	1171	3389	505	1309	4381	1056	340	2414	4201	2292	2680	1734	3823	1253	1177
4689_Sagittal stratum axial diusivities	4689_Sagittal stratum axial diusivities	25	175	1	3240	2565	175	314	1989	2073	802	600	3424	686	2170	705	251	3726	2706	1889	2595	1597	395	703	419	1475
2747_CCL13 - C-C motif chemokine 13	2747_CCL13 - C-C motif chemokine 13	25	175	1	799	3532	1341	1407	3050	2153	175	4390	460	2806	3485	738	681	3000	902	3355	3090	1139	1853	4567	3717	2194
347_CD8:%TM (1)	347_CD8:%TM (1)	25	175	1	3018	1904	4280	4703	1907	4109	4395	175	3118	2569	2294	1413	4744	3893	2586	1793	825	3362	4031	4348	4183	376
115_Variability of Body Mass Index	115_Variability of Body Mass Index	25	175	1	3557	3183	2072	816	4631	3702	1497	2363	175	1143	1495	1072	387	2847	4325	3052	4204	2509	1456	3280	3479	3090
2708_DYNLL1 - Dynein light chain 1, cytoplasmic	2708_DYNLL1 - Dynein light chain 1, cytoplasmic	25	175	1	1220	2428	3491	2763	4165	1735	2222	655	2070	175	4049	1535	4201	738	411	2225	816	3250	4650	913	1733	4470
4234_Antidepressants	4234_Antidepressants	25	175	1	696	844	2780	3015	327	839	2592	928	1297	2115	175	1726	3996	788	4270	274	980	4063	3548	2329	2124	1097
3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	25	175	1	3019	4314	727	3094	191	2929	2740	4144	973	2020	574	1388	3096	288	312	175	4547	4096	1891	4204	2702	2256
2003_Plasma Lipoprotein A level	2003_Plasma Lipoprotein A level	25	175	1	2645	2563	3640	2583	1638	316	852	3593	1667	1860	515	1210	1610	189	3020	3745	175	2839	4149	4376	3796	1395
3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	25	175	1	2254	3512	3241	2570	3819	3531	2159	3344	1540	3719	974	3958	960	3901	4153	4179	498	175	956	942	269	4683
2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	25	175	1	1809	3809	4580	4556	3316	3806	515	4554	2356	946	547	2209	3622	4407	2851	4060	1780	632	1464	2214	175	1259
11_Schizophrenia	11_Schizophrenia	25	175	2	3613	2399	2764	3177	2232	2287	4148	1945	837	2656	1506	4272	324	3239	3260	1714	2371	457	3373	832	3932	175
3607_Non-cancer illness code, self-reported: osteoarthritis	3607_Non-cancer illness code, self-reported: osteoarthritis	25	176	1	4584	176	3184	4307	3777	2026	3049	4678	4656	3469	2045	4014	2887	2372	1517	4296	2024	2944	2795	4324	4555	1855
2453_MATN2 - Matrilin-2	2453_MATN2 - Matrilin-2	25	176	1	2326	4353	1149	4060	176	2886	3882	2544	3778	1416	4732	2815	3903	2530	350	262	4411	1987	632	3064	2929	323
3954_Ankle injury (fixed effect)	3954_Ankle injury (fixed effect)	25	176	1	767	2926	4634	4330	2840	176	4161	3441	4542	1234	4681	2999	4612	3713	4726	2411	939	4052	862	1251	939	1353
2461_THBS4 - Thrombospondin-4	2461_THBS4 - Thrombospondin-4	25	176	1	457	4178	1675	2723	4457	1390	3090	3838	273	176	1310	3698	253	319	2751	4132	2653	2396	333	1108	2613	2791
2408_MATN3 - Matrilin-3	2408_MATN3 - Matrilin-3	25	176	1	1528	980	2572	612	1003	2086	218	2103	1039	2739	176	774	3892	755	1886	1214	3184	3374	2212	1184	2911	245
1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	25	176	1	1645	333	1277	3468	4411	1697	2512	509	2352	3762	3938	176	2733	191	3864	846	307	4148	192	1025	309	2730
2565_PRTN3 - Myeloblastin	2565_PRTN3 - Myeloblastin	25	176	1	4286	2955	1087	3923	292	2769	3256	1765	4536	1981	2046	3948	3353	176	3524	234	4566	1815	786	4152	2553	2042
2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	25	176	1	1370	3650	339	949	305	4180	3467	1300	3916	3714	3605	4574	4492	2832	176	362	1693	4354	494	4641	1390	4228
2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	25	176	1	2946	4443	712	1670	2810	2235	621	4536	1286	966	1163	4087	3444	1251	299	1627	1516	176	1939	1844	2902	4071
1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	25	176	1	4690	3443	4356	3857	4238	2103	571	4593	1022	2766	4146	3402	462	1261	1858	3100	3162	272	176	1708	4048	1816
3903_Reticulocyte fraction of red cells (three-way meta)	3903_Reticulocyte fraction of red cells (three-way meta)	25	176	1	4463	4545	697	3828	2566	3458	2584	3337	2660	4128	2215	2713	1556	1762	793	789	4224	2337	1911	2736	176	4115
3018_CLIC1 - Chloride intracellular channel protein 1	3018_CLIC1 - Chloride intracellular channel protein 1	25	177	1	2205	177	3635	4681	3259	3587	926	467	599	4401	4389	3625	2858	780	963	1725	2896	3308	1908	4512	4732	2990
4454_Left lateral orbitofrontal	4454_Left lateral orbitofrontal	25	177	1	1847	1725	832	177	662	3723	228	375	2490	4603	1423	4405	656	4677	440	701	2059	1811	3445	2767	2465	1804
468_Lipid::Bile acid metabolism::glycodeoxycholate	468_Lipid::Bile acid metabolism::glycodeoxycholate	25	177	1	1087	2860	3056	423	2136	2114	1353	386	177	3736	511	2667	1248	253	1648	2666	2303	4173	585	4720	3645	4259
611_Peptide::Polypeptide::HWESASXX*	611_Peptide::Polypeptide::HWESASXX*	25	177	1	2594	3554	2300	2275	1321	1995	1671	3830	1586	177	3115	233	2527	2186	2150	1978	1586	1982	4165	2894	199	4673
3239_Exposure to tobacco smoke outside home	3239_Exposure to tobacco smoke outside home	25	177	1	3547	3604	2404	2525	1636	4649	4308	303	4684	1821	177	2754	3337	3439	1386	1626	1171	1057	196	995	934	4641
2628_ALB - Serum albumin	2628_ALB - Serum albumin	25	177	1	953	1420	2197	3885	533	3609	1385	3536	1506	563	1722	177	739	1241	1117	529	3370	533	1950	4571	2953	2834
1147_Ratio of AUC insulin to AUC glucose	1147_Ratio of AUC insulin to AUC glucose	25	177	1	1537	2026	754	2658	3272	3313	3191	3024	3701	1078	2487	222	177	2209	3510	2243	1625	2560	2846	4422	352	518
1175_Excessive daytime sleepness	1175_Excessive daytime sleepness	25	177	1	627	3222	662	2117	2572	3686	3414	4194	2436	4339	2296	1129	2987	177	4052	1599	201	282	3022	2338	2187	2277
2178_NCR2 - Natural cytotoxicity triggering receptor 2	2178_NCR2 - Natural cytotoxicity triggering receptor 2	25	177	1	378	4355	344	2375	187	3058	1954	4443	3770	1892	1923	864	855	2703	2309	177	1048	1193	1499	1165	3707	3502
3816_CD19+ B cell level	3816_CD19+ B cell level	25	177	1	1997	2734	3033	2892	2621	1012	1787	2713	1183	2542	719	3573	1121	4324	2724	4284	951	177	4318	234	3177	3994
1924_Hippocampal volume (FBAT, adjusted for age and sex)	1924_Hippocampal volume (FBAT, adjusted for age and sex)	25	178	1	178	694	826	2896	3401	4055	3225	988	820	3495	407	3654	2957	3938	3440	1862	4331	2229	3600	2468	3117	1491
2342_RETN - Resistin	2342_RETN - Resistin	25	178	1	2604	656	178	2325	556	802	1672	674	4031	3798	2630	1024	2192	532	1191	408	678	1045	2976	3298	1623	853
2435_CNTN4 - Contactin-4	2435_CNTN4 - Contactin-4	25	178	1	3485	985	2812	2996	1723	3500	178	2804	964	1895	3422	1301	1516	3514	1284	3717	4241	319	831	4297	3283	2540
687_::::X-10810	687_::::X-10810	25	178	1	4074	755	2638	4218	1469	1225	1284	178	2206	3462	832	583	4169	289	4192	2491	3479	3403	2235	2137	1766	4278
4144_Mean arterial pressure	4144_Mean arterial pressure	25	178	1	1079	607	2023	2722	4398	3140	1346	3305	891	178	1040	294	3280	3062	785	1569	1759	4534	3745	2701	3086	3909
772_::::X-12405	772_::::X-12405	25	178	1	2133	1031	3504	2287	4740	2084	1155	1734	3318	1690	178	2458	3895	2617	2294	4119	3091	2466	2084	2794	4642	3864
4101_Triglyceride	4101_Triglyceride	25	178	1	681	4169	704	1575	506	3230	195	2553	1070	484	1081	242	178	2783	494	1405	1031	1145	2423	1727	443	316
4706_Retrolenticular part of internal capsule mean diusivities	4706_Retrolenticular part of internal capsule mean diusivities	25	178	1	3127	1490	3347	774	2471	321	3326	1475	3495	3603	2986	1593	2629	3160	178	4532	1483	361	852	1497	4458	1155
1603_tPA (at exam 5, GEE, adjusted for age and sex)	1603_tPA (at exam 5, GEE, adjusted for age and sex)	25	178	1	1642	516	4313	3443	1878	3394	4111	2509	2678	514	3575	792	2647	3491	4300	963	3379	487	4684	178	1339	3846
1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	25	178	1	2637	2579	4693	2184	4182	4392	2853	2457	3054	3320	1812	2106	219	202	1923	2772	3154	2246	1167	3812	2686	178
3505_Non-butter spread type details: Soft (tub) margarine	3505_Non-butter spread type details: Soft (tub) margarine	25	179	1	2196	4088	3808	3138	2620	2272	2609	2962	402	2433	179	1758	4116	3094	2511	3246	3246	2309	3623	3737	4108	3844
4148_Left ventricular internal dimension in diastole	4148_Left ventricular internal dimension in diastole	25	179	1	2638	2928	2489	1034	1586	1813	601	3810	395	650	1186	3443	179	2004	2908	4456	4416	3475	4597	1343	1193	930
2387_CTSD - Cathepsin D	2387_CTSD - Cathepsin D	25	179	1	894	321	3790	3063	211	2745	1773	2120	486	812	1026	3830	2486	770	698	179	3759	3270	4126	4052	4173	2539
4040_Schizophrenia/Bipolar disorder	4040_Schizophrenia/Bipolar disorder	25	179	1	3876	2099	1871	4008	3363	3985	4104	3251	1468	4708	2176	4234	2020	2482	2890	3794	2016	980	3035	1510	3573	179
2058_Psoriasis	2058_Psoriasis	25	180	1	3684	364	448	484	180	3567	4466	1173	1213	984	4219	1116	1373	1254	3763	292	1916	1255	4367	477	3670	936
3026_PPA1 - Inorganic pyrophosphatase	3026_PPA1 - Inorganic pyrophosphatase	25	180	1	2583	3834	2268	1030	2037	180	3709	2179	498	319	1900	492	3366	4477	1100	612	2194	3351	3457	4227	818	1499
2823_DHH - Desert hedgehog protein N-product	2823_DHH - Desert hedgehog protein N-product	25	180	1	3800	948	1475	365	684	1890	994	180	2849	4660	4438	3011	2759	4201	1397	942	1962	3284	2761	2335	1320	823
2257_TOP1 - DNA topoisomerase 1	2257_TOP1 - DNA topoisomerase 1	25	180	1	1155	4135	2168	1158	2732	385	1211	2738	180	2707	1890	1830	3111	3205	1887	4382	861	4274	3441	1344	342	2482
1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	180	1	1341	3954	1179	3818	4593	1602	615	1814	3077	180	4061	1790	2801	2601	241	2515	3863	3067	1381	2731	374	1431
1077_Attention deficit hyperactivity disorder	1077_Attention deficit hyperactivity disorder	25	180	1	4338	3223	3193	2992	4471	838	2146	955	1078	1808	651	180	1334	836	4439	1691	551	4271	520	3144	684	4181
584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	25	180	1	229	314	1711	1114	3685	3426	2506	4638	670	1698	3122	2222	180	2594	2765	449	2721	2991	2824	1815	3874	756
4638_Right pallidum	4638_Right pallidum	25	180	1	1771	560	4350	1533	2227	3534	3135	1628	4245	4533	4142	1652	744	180	2048	2417	4266	2513	2018	807	206	3898
2369_MAPK1 - Mitogen-activated protein kinase 1	2369_MAPK1 - Mitogen-activated protein kinase 1	25	180	1	2403	523	987	3125	989	2192	3029	1105	4622	313	2858	4589	2051	2566	180	533	601	2909	2322	3420	704	3916
1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	180	1	1977	2512	2266	3479	3310	3222	2632	2089	4365	2310	2459	4600	3845	722	2087	2583	180	2778	2835	2749	1757	1330
4701_Genu of corpus callosum mean diusivities	4701_Genu of corpus callosum mean diusivities	25	180	1	2243	2953	3649	4025	1595	667	4074	201	3993	2842	1792	2288	2876	2709	2630	3689	2695	802	180	954	248	892
3284_Mood swings	3284_Mood swings	25	180	1	4107	1916	3733	744	4464	2702	1325	1355	4543	1102	1958	2154	2010	2626	3970	3289	2934	2036	628	1460	180	276
4683_Posterior thalamic radiation (include optic radiation) axial diusivities	4683_Posterior thalamic radiation (include optic radiation) axial diusivities	25	181	1	181	1325	1342	2100	1906	4665	344	1597	2897	629	563	1405	3754	4429	1186	980	3760	2668	3140	4345	2952	3562
2841_GREM1 - Gremlin-1	2841_GREM1 - Gremlin-1	25	181	1	4108	2110	181	3809	1713	3845	2006	3353	2192	4666	236	3820	3897	2579	3577	1409	3856	4404	1877	2543	1845	2156
4594_Right pars triangularis	4594_Right pars triangularis	25	181	1	1865	2727	616	3667	3652	3877	181	4418	3469	983	4076	1677	2099	2443	454	3905	923	3722	1696	4459	3141	4611
2011_Remission following treatment of MDD subjects	2011_Remission following treatment of MDD subjects	25	181	1	4277	3064	330	3189	4422	1033	1141	4203	1872	181	1544	4178	3814	922	3107	4274	2908	3190	1618	505	337	3092
789_::::X-12680	789_::::X-12680	25	181	1	201	2716	2472	284	3194	3835	2892	2022	2629	1445	181	3909	4009	1961	3885	2558	415	4279	2391	4326	1453	1113
838_Peptide::Dipeptide::X-14450--phenylalanylleucine	838_Peptide::Dipeptide::X-14450--phenylalanylleucine	25	181	1	432	2321	730	4371	3583	3072	3014	1063	2876	2096	2492	3044	552	181	3740	2445	2438	3267	4156	1839	3893	1331
2804_SPON1 - Spondin-1	2804_SPON1 - Spondin-1	25	181	1	214	2787	1796	4516	4110	1507	2322	3142	2934	3098	1713	586	4213	2925	181	3964	4388	3302	388	4494	1140	327
1998_Body Mass Index	1998_Body Mass Index	25	181	1	4299	3382	3934	2761	1733	3448	4090	244	3449	1067	1001	3214	2080	2659	959	2609	2441	3641	4084	4009	181	4135
4023_Hair (Straight/curly)	4023_Hair (Straight/curly)	25	181	1	1975	4547	1488	3112	715	3045	1222	1809	4395	3226	2846	3618	2719	1783	3207	1109	1357	3643	1152	1689	2080	181
180_Waist-hip ratio	180_Waist-hip ratio	25	182	1	4622	4659	182	2828	2021	304	3493	825	1311	3617	4465	4101	2401	4128	3056	608	1597	307	1640	3435	4340	985
2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	25	182	1	386	581	4560	182	1176	4214	2134	4732	2529	3349	3106	2359	4621	1972	666	510	3573	2146	3840	329	1602	2555
4276_Carpal tunnel syndrome	4276_Carpal tunnel syndrome	25	182	1	4230	224	1621	4669	1675	492	182	221	719	1316	1619	777	578	548	877	2300	718	2997	3841	4730	334	3051
2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	25	182	1	2253	1485	1055	4227	1880	3390	1278	1971	182	2417	3143	1795	3997	4265	2040	2433	634	4360	2790	4356	3752	4276
4184_Total cholesterol	4184_Total cholesterol	25	182	1	566	236	996	737	1757	763	4028	3232	1099	4279	1451	758	416	182	396	2446	1946	2141	3141	1738	3569	992
3925_Coronary artery disease (SOFT definition including angina)	3925_Coronary artery disease (SOFT definition including angina)	25	182	1	4548	3110	3814	868	1250	1416	1643	4088	4027	394	2035	3991	435	2230	182	3485	608	1148	427	2579	2668	688
3440_Impedance measures - Weight	3440_Impedance measures - Weight	25	182	1	892	1907	4358	4105	4528	3716	1013	389	2689	3437	2084	3558	4421	2062	1257	3033	889	3986	1015	182	3763	1825
145_Body Mass Index (female)	145_Body Mass Index (female)	25	182	1	315	437	1250	1486	3175	3433	2809	289	4745	4151	4143	2923	3295	1121	1106	3322	892	4596	4647	1640	2662	182
3099_UNC5C - Netrin receptor UNC5C	3099_UNC5C - Netrin receptor UNC5C	25	183	1	773	2125	183	258	2409	669	1948	4731	4400	3613	2130	1842	3061	1368	2325	373	1556	1717	1104	894	2365	4358
2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	25	183	1	3751	4054	2904	2507	3589	3095	183	744	3590	1876	1198	3473	1328	3338	2481	2410	3000	4224	4188	2623	2148	2957
3262_Average weekly red wine intake	3262_Average weekly red wine intake	25	183	1	1430	1687	2959	1496	3999	2446	2955	1463	4153	183	3627	2541	2330	3489	3986	4673	3210	2082	1566	3862	4727	4215
1086_Pancreatic cancer	1086_Pancreatic cancer	25	183	1	1413	894	1605	335	3037	4629	560	3996	1710	1628	2619	2662	183	4609	878	3820	3837	2066	1980	4474	3768	851
1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	25	183	1	4129	3511	2665	3899	4619	931	3119	1450	1404	1342	956	1466	4513	183	3973	4018	4093	819	4526	4452	4492	521
2498_STAB2 - Stabilin-2	2498_STAB2 - Stabilin-2	25	183	1	3917	3579	2648	3554	4726	1879	3152	4068	1054	3249	701	4297	811	783	4713	4247	2561	183	2219	2112	2913	395
631_Xenobiotics::Food component, Plant::homostachydrine*	631_Xenobiotics::Food component, Plant::homostachydrine*	25	183	1	3419	3702	3020	4515	2846	2749	3626	742	609	1898	2906	708	2237	3705	989	3519	4349	3216	183	3104	3404	2667
3991_Mood swings (MOOD)	3991_Mood swings (MOOD)	25	183	1	4032	2366	4447	587	4458	1701	2733	682	3126	816	1773	897	3233	2797	4186	3735	4674	3345	1184	2863	185	183
3571_Pain type(s) experienced in last month: Neck or shoulder pain	3571_Pain type(s) experienced in last month: Neck or shoulder pain	25	184	1	184	4682	1753	1483	3464	1645	1476	2751	1940	4489	1065	3489	1263	1445	4298	3167	2340	1125	3261	3739	2860	2875
2869_PDGFA - Platelet-derived growth factor subunit A	2869_PDGFA - Platelet-derived growth factor subunit A	25	184	1	3151	184	2534	4333	4079	2793	563	4445	4161	2746	4226	1580	3758	2943	3386	4195	3392	4711	3925	3644	4331	2622
1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	25	184	1	2138	3620	2499	184	3947	4379	1580	2209	2450	3337	3397	3236	597	2417	712	3543	1095	3758	4303	3026	4308	974
1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	184	1	2581	4494	4663	1718	3201	1676	1170	2327	4457	184	1454	613	1659	1617	2268	878	2449	2411	2494	2355	876	4563
4747_Posterior corona radiata radial diusivities	4747_Posterior corona radiata radial diusivities	25	184	1	1833	1433	1793	2790	3868	4431	2804	1318	3565	2430	3420	4343	4415	184	1181	4683	1077	4624	185	506	1038	3368
730_::::X-11795	730_::::X-11795	25	184	1	3803	2597	4321	4695	2343	3263	4224	2703	1726	2729	2919	4425	4411	4612	4428	2827	4520	255	184	4252	3137	4469
2100_LEP - Leptin	2100_LEP - Leptin	25	184	1	3146	2749	3479	2352	1320	529	4129	2388	4362	2828	3100	4162	4111	3112	1344	1136	3983	626	1235	3418	184	1817
3945_HbA1c	3945_HbA1c	25	185	1	185	3019	1336	3054	2941	291	303	581	1623	4601	356	4571	4606	586	2370	2799	2004	224	4215	633	2360	1640
4705_Posterior thalamic radiation (include optic radiation) mean diusivities	4705_Posterior thalamic radiation (include optic radiation) mean diusivities	25	185	1	1716	4192	185	2392	1438	1616	2331	2769	3249	4292	2548	437	706	1826	1447	3259	1921	2201	4654	3199	1437	226
154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	25	185	1	493	3550	4168	185	4679	4545	3917	2400	1464	1144	3167	4417	4427	2147	511	527	3860	4487	3356	1151	4163	1197
2265_CCL14 - C-C motif chemokine 14	2265_CCL14 - C-C motif chemokine 14	25	185	1	4486	3656	4587	1673	1781	348	185	3744	2366	700	1707	4526	4134	663	3659	1539	4673	576	4097	2558	2994	3721
2332_GFAP - Glial fibrillary acidic protein	2332_GFAP - Glial fibrillary acidic protein	25	185	1	1715	715	2873	2193	1702	2550	2262	3405	2745	4131	185	2943	4324	503	1004	2313	4051	2720	4638	1776	1376	1019
1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	185	1	2201	2148	1203	2341	1254	546	958	2312	4070	3533	3747	185	969	348	3592	856	4262	237	974	498	1652	2760
2177_NANOG - Homeobox protein NANOG	2177_NANOG - Homeobox protein NANOG	25	185	1	3582	4073	1354	2175	1683	985	888	4313	3839	3630	1173	1047	185	4119	3942	2014	362	3823	1082	4096	988	2303
3022_PRDX5 - Peroxiredoxin-5, mitochondrial	3022_PRDX5 - Peroxiredoxin-5, mitochondrial	25	185	1	861	1718	2214	1896	378	788	1078	4252	205	4652	4292	1796	3776	185	4564	269	3740	1049	2290	3107	2245	2081
3725_Frequency of drinking alcohol	3725_Frequency of drinking alcohol	25	185	1	3695	2502	4131	3681	3433	2536	4462	362	3743	1223	3522	2913	2038	607	4584	2167	4612	4250	2558	4027	2862	185
583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	25	186	1	2632	548	186	4727	586	3944	278	2686	968	960	1400	694	4148	2684	3821	929	2490	4117	1728	3685	3743	2603
274_CD8:%TEM	274_CD8:%TEM	25	186	1	4480	1509	2973	186	975	3300	4544	2250	2680	977	4269	2846	4346	2978	3540	1118	2526	2906	695	4666	1644	1800
4079_Waist-hip ratio (female)	4079_Waist-hip ratio (female)	25	186	1	1697	3658	847	2771	706	186	2189	933	754	1929	2324	1498	618	3961	3428	278	1260	248	2470	3288	216	1290
2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	25	186	1	978	350	2442	3346	1497	3069	186	2533	200	4168	3046	3643	2824	2375	1786	1061	833	4363	4553	4105	2458	4524
1013_Vascular endothelial growth factor	1013_Vascular endothelial growth factor	25	186	1	1881	3531	1494	2571	1800	4078	391	4160	2532	186	4511	3870	2396	4466	1381	2058	1125	3556	3344	3595	961	1361
3543_Eye problems/disorders: Cataract	3543_Eye problems/disorders: Cataract	25	186	1	402	2657	2031	4480	2182	4156	3624	4230	535	3505	1157	186	2504	2282	3145	997	3787	4597	377	3951	2214	2294
1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	186	1	840	2639	2426	3157	2661	342	1332	2613	784	4241	916	3459	2231	1831	2918	3083	690	1518	468	311	2787	186
1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	187	1	403	1935	436	2970	3791	3906	187	252	4663	2958	3570	4446	2418	3465	2920	2232	3982	4317	3418	2988	1991	4468
1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	25	187	1	2010	1110	4115	2912	1459	349	2091	1455	615	2485	931	187	4425	3275	1441	870	1633	938	3527	1991	4350	2703
2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	25	187	1	1964	403	1082	2866	2305	361	1706	3263	3989	3404	3412	3765	187	2248	2529	3245	4616	689	972	4409	1725	1716
3559_Medication for pain relief, constipation, heartburn: Paracetamol	3559_Medication for pain relief, constipation, heartburn: Paracetamol	25	187	1	4451	2925	4720	1314	3847	4743	4033	1842	4683	3274	3405	1711	1988	3429	187	3176	3926	3264	882	456	3214	1269
3072_MICB - MHC class I polypeptide-related sequence B	3072_MICB - MHC class I polypeptide-related sequence B	25	187	1	589	1648	3103	4104	276	1755	1577	3961	3332	3759	3839	1445	2577	2613	1277	187	2093	1470	3380	4518	1512	1364
1165_Fasting glucose	1165_Fasting glucose	25	187	1	3410	4722	2433	2938	4704	3772	1344	1088	2089	1556	4038	463	2692	2895	1437	3341	1444	1406	273	3881	4644	187
1289_Waist circumference by CT (GEE, adjusted for age and sex)	1289_Waist circumference by CT (GEE, adjusted for age and sex)	25	188	1	2667	188	2057	1372	4091	422	1985	1036	2536	1570	3726	3920	2546	4624	2992	4106	214	4217	1230	4580	4156	3906
401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	25	188	1	2177	3256	188	205	862	1146	3649	832	443	4323	1344	1950	4070	3466	4321	1222	4392	4515	314	3929	4418	4014
2288_PROC - Vitamin K-dependent protein C	2288_PROC - Vitamin K-dependent protein C	25	188	1	3227	2350	3681	434	1074	188	4448	564	1395	1053	1568	920	4361	4457	3657	1256	562	1074	4403	4285	2611	321
1885_Shaft Width (GEE, female, adjussted for multivariable)	1885_Shaft Width (GEE, female, adjussted for multivariable)	25	188	1	3242	3683	1802	4355	4114	4537	188	3999	2394	4135	798	3837	2100	605	683	2574	1374	2826	2987	1297	1064	3976
4667_Sagittal stratum fractional anisotropy	4667_Sagittal stratum fractional anisotropy	25	188	1	3675	1481	1161	3661	2665	1221	1704	188	3405	1751	4663	296	1390	4249	3859	3816	2728	1258	2142	1150	3047	3652
1955_Similarities raw score (GEE, adjusted for multivariable)	1955_Similarities raw score (GEE, adjusted for multivariable)	25	188	1	1648	3300	787	1295	3948	1134	3851	524	188	4352	4166	1733	4043	3249	3512	809	3324	3772	880	3241	2905	1298
4142_Systolic Blood Pressure	4142_Systolic Blood Pressure	25	188	1	1897	733	2673	2058	3204	4590	1164	4316	572	188	1079	545	4667	3884	879	1987	1482	4245	4739	2514	2626	3895
4309_Osteoarthritis of hip	4309_Osteoarthritis of hip	25	188	1	3738	553	3519	3651	3534	4640	4234	2841	3430	4526	2470	188	1600	980	533	1970	4497	3977	4153	2718	4147	757
3172_NPPA - Atrial natriuretic factor	3172_NPPA - Atrial natriuretic factor	25	188	1	1960	1840	3115	4543	353	1021	2148	2836	2307	2795	206	1596	626	1314	1651	188	493	805	2850	3129	1448	324
812_::::X-12855	812_::::X-12855	25	188	1	768	1470	1028	3298	651	4059	2552	4549	3703	1341	211	287	1736	3864	2366	2055	1254	188	2637	2820	2024	3729
1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	25	188	1	1982	4197	4518	1827	2117	3779	2224	3977	2033	4564	4260	3496	199	380	2115	2617	4149	623	2965	3586	2026	188
635_Xenobiotics::Food component, Plant::saccharin	635_Xenobiotics::Food component, Plant::saccharin	25	189	1	189	1159	4479	3316	2515	2880	1921	2070	1316	4600	4259	2467	2202	388	2138	4032	4193	4399	2574	4069	2344	3431
4544_White matter	4544_White matter	25	189	1	1776	4495	1251	189	781	2316	702	4107	766	2173	4100	1867	2102	1588	2545	1108	2592	2420	488	2845	1080	3258
4589_Right middle temporal	4589_Right middle temporal	25	189	1	821	3732	4292	1432	2223	189	3132	4027	2766	4042	1696	1271	1741	1020	888	1276	1453	3435	2536	2761	3024	3119
1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	189	1	2310	601	534	3861	3278	3270	189	3674	4742	1560	2181	1622	2340	2871	3246	3251	1159	3895	211	1812	2716	4624
3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	25	189	1	515	2468	1581	1279	4459	4166	2300	189	799	2991	2013	4019	3720	2805	3376	3539	3952	3822	1081	1506	4506	3658
2638_PYY - Peptide YY	2638_PYY - Peptide YY	25	189	1	4635	4364	834	2579	2349	4699	4564	549	1396	1714	3664	1736	4331	2119	189	1698	828	3182	891	2867	3175	3599
1838_Neck width (FBAT, female, adjusted for age)	1838_Neck width (FBAT, female, adjusted for age)	25	189	1	4414	2214	1168	848	3043	875	1678	2829	3429	4203	2370	4067	1583	2786	1658	2854	189	534	256	2729	2846	3494
370_Amino acid::Creatine metabolism::creatinine	370_Amino acid::Creatine metabolism::creatinine	25	189	1	4148	2848	2858	566	2971	2056	3201	1863	2003	1018	2793	2495	1077	1523	3447	3826	3678	2109	189	4099	3072	3620
3785_Intelligence	3785_Intelligence	25	189	1	4276	4081	4008	2519	4616	2815	3375	460	1083	298	1630	2419	3104	4228	3665	3975	1771	238	2642	189	1404	4530
3231_Nap during day	3231_Nap during day	25	189	1	3264	3986	4161	537	4005	3078	3408	1284	3688	1731	3030	3471	4280	4562	1879	4265	2410	694	1387	3183	4010	189
85_Femoral Neck BMD	85_Femoral Neck BMD	25	190	1	3846	2377	309	608	2470	1627	190	4156	1082	4357	2406	549	501	856	4742	3113	1356	483	1647	4259	732	903
698_::::X-11412	698_::::X-11412	25	190	1	2851	3599	789	1640	1305	4281	1070	190	3727	2168	1064	1678	1578	1642	1687	1783	4131	4692	3054	3158	502	3700
3210_Usual walking pace	3210_Usual walking pace	25	190	1	705	3152	2506	3284	3936	3810	1673	2462	1431	190	4676	1547	2703	3396	3894	3877	4360	622	4715	911	1091	3690
1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	25	190	1	2527	3915	2954	3904	3914	1202	969	1034	2840	1472	3829	1514	190	4095	4203	1744	1068	1476	2914	3493	389	2004
4139_Mean corpuscular hemoglobin	4139_Mean corpuscular hemoglobin	25	190	1	3570	4127	2436	4476	1024	2302	1310	219	4560	3689	1705	585	1385	190	3715	514	3909	200	2081	2473	4656	3359
3419_Pairs matching test - Number of correct matches in round	3419_Pairs matching test - Number of correct matches in round	25	190	1	4088	2877	2999	1890	1113	3073	1867	3132	2884	579	1052	3930	966	2000	190	3191	3192	3266	2417	2057	2294	1537
3828_Primary biliary cirrhosis	3828_Primary biliary cirrhosis	25	190	1	316	2834	3119	1262	2952	3660	2089	4279	638	2071	3737	4197	772	3097	2043	2212	711	190	2879	1326	3147	508
2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	25	190	1	340	1541	2420	4115	2689	4605	380	4713	2132	4154	2868	2512	2688	2153	2955	535	1403	4164	190	1669	3926	745
3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	25	190	1	3668	255	1372	2424	3071	1809	1759	2760	4036	1133	3918	3704	2333	3663	4279	1908	619	2404	1199	190	2969	675
1967_MMSE score (at age 65, GEE, adjusted for multivariable)	1967_MMSE score (at age 65, GEE, adjusted for multivariable)	25	190	1	533	3026	1661	4641	1724	576	491	4240	1105	417	1582	196	2171	1755	2417	633	2680	4007	2548	3950	1964	190
2854_TPM2 - Tropomyosin beta chain	2854_TPM2 - Tropomyosin beta chain	25	191	1	191	505	1543	4370	2207	2162	1812	1406	1684	1218	2967	1739	3853	4523	3374	1331	574	2043	2667	3374	1882	3954
1183_Sleep duration (female)	1183_Sleep duration (female)	25	191	1	2206	191	2917	2477	1828	2425	3832	4288	1253	1754	2049	4407	2224	847	1256	990	2321	358	1185	2809	2501	4034
1185_Low-density lipoprotein cholesterol	1185_Low-density lipoprotein cholesterol	25	191	1	2275	1328	1624	3655	1640	191	1193	3524	776	3524	1932	2785	3618	2580	443	2047	2661	2774	1001	1470	4298	902
4358_Diverticular disease	4358_Diverticular disease	25	191	1	2513	641	2575	4662	363	646	2605	3679	191	2495	938	3672	483	3231	2020	645	3100	3865	4425	956	733	2226
3431_Fluid intelligence test - Fluid intelligence score	3431_Fluid intelligence test - Fluid intelligence score	25	191	1	2429	4044	666	2333	3218	3740	3169	4272	2576	191	1883	2364	2978	3498	4407	4634	2131	3752	458	1443	648	3361
1186_Triglycerides cholesterol	1186_Triglycerides cholesterol	25	191	1	1827	3155	2631	1945	2602	3591	1361	3866	3163	4465	2429	191	1396	3533	3306	4388	1065	1121	630	2624	2780	3366
3085_ROBO2 - Roundabout homolog 2	3085_ROBO2 - Roundabout homolog 2	25	191	1	1710	3214	4503	3016	3062	1860	2264	2749	782	1421	4558	1003	516	1246	191	3827	3028	2659	1526	4330	3334	1379
3060_IL7R - Interleukin-7 receptor subunit alpha	3060_IL7R - Interleukin-7 receptor subunit alpha	25	191	1	1560	679	546	492	2162	2462	4596	730	899	981	763	2170	3570	1411	1622	3164	191	1799	942	3380	594	2172
2077_FGF10 - Fibroblast growth factor 10	2077_FGF10 - Fibroblast growth factor 10	25	191	1	1192	987	942	4118	3793	3733	3244	2726	2143	3412	2670	2606	4274	841	3673	3454	1517	191	1799	2981	4116	3213
2331_LGALS2 - Galectin-2	2331_LGALS2 - Galectin-2	25	191	1	4070	3195	1362	978	4385	4516	2395	621	444	1266	630	2295	879	2831	1129	2210	2546	1944	191	3760	4006	3057
3864_Red blood cell count (two-way meta)	3864_Red blood cell count (two-way meta)	25	191	1	1526	3193	1110	1151	3703	2138	928	3200	2151	1360	1509	1636	3283	1836	1903	3736	1805	3039	1837	3871	3615	191
616_Xenobiotics::Benzoate metabolism::benzoate	616_Xenobiotics::Benzoate metabolism::benzoate	25	192	1	3347	3392	192	2121	1173	1739	4304	1777	1053	1995	1211	2073	4004	3879	2255	2353	2673	1863	2419	2441	4744	2360
2671_PRKCQ - Protein kinase C theta type	2671_PRKCQ - Protein kinase C theta type	25	192	1	3612	336	2751	4200	2078	192	1998	2944	352	560	1158	3157	1734	4019	2717	1572	4038	1475	4701	3236	1545	1737
2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	24	192	1	491	928	3798	4524	1727	663	192	560	2493	1147	679	4144	2590	996	933	1478	2142	1499	795	4174	3719	1751
2987_DBNL - Drebrin-like protein	2987_DBNL - Drebrin-like protein	25	192	1	1331	721	1163	642	4454	3048	1760	2602	3479	3968	192	3646	1943	1695	638	4135	2066	2188	2033	2720	2818	595
3222_Drive faster than motorway speed limit	3222_Drive faster than motorway speed limit	25	192	1	3515	3623	911	2173	4670	607	1699	728	945	3430	3006	192	573	724	4221	3900	2616	843	548	3758	492	291
2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	25	192	1	3142	819	1722	2846	599	947	4452	3221	4692	2731	503	2558	192	2888	3135	1197	1026	2367	1240	1291	474	870
1198_Phosphorylated Tau at position 181	1198_Phosphorylated Tau at position 181	25	192	1	2699	1066	2113	934	330	550	4126	1328	2071	1947	2785	833	2575	2136	1559	192	1503	2795	4479	2921	3712	2835
391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	25	192	1	2817	588	4171	2126	3955	2839	1833	652	861	3510	3139	2732	4705	1803	591	1049	4358	192	4508	609	3444	4266
3826_Osteoarthritis of knee	3826_Osteoarthritis of knee	25	192	1	3877	557	3178	3418	4378	3774	3903	647	2382	4532	1012	2345	3193	4511	373	2570	2621	197	3171	192	2922	2249
1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	193	1	193	2203	3848	1204	983	1023	3600	3983	2515	1571	869	1437	2275	2610	3424	2085	646	2869	1519	3845	2322	3427
3400_Noisy workplace	3400_Noisy workplace	25	193	1	848	2372	2109	2893	3852	3198	3248	193	3257	2035	2285	4136	4313	367	3933	3609	3191	3799	1726	4149	3750	607
4258_Facial attractiveness (male-coder, male samples)	4258_Facial attractiveness (male-coder, male samples)	25	193	1	1614	1041	4745	2388	1742	3553	1372	2060	2288	193	532	2023	3748	1023	3915	1959	1270	994	511	516	3271	774
4458_Left parahippocampal	4458_Left parahippocampal	25	193	1	981	636	2921	2022	4225	4706	3185	3172	3521	1832	193	1560	4689	3238	3865	2984	3441	684	2564	1520	1570	4293
3793_Sleep duration	3793_Sleep duration	25	193	1	597	685	714	4487	2020	671	2935	2936	3779	3930	786	193	4028	1290	2837	4044	514	4085	1661	466	3467	467
709_::::X-11469	709_::::X-11469	25	193	1	2564	3580	3910	3585	3929	2207	4660	2614	336	1242	4584	956	193	3728	2544	3481	4410	420	622	2062	3835	3682
2991_ERP29 - Endoplasmic reticulum resident protein 29	2991_ERP29 - Endoplasmic reticulum resident protein 29	25	193	1	3921	1589	432	4338	3386	3024	1999	2621	4283	1050	4317	539	2538	193	2223	2688	4565	1734	3676	1673	3049	1436
931_Phenylalanine	931_Phenylalanine	25	193	1	494	3657	1631	2500	1374	1982	1347	1563	2704	4720	2208	3381	4464	2049	2498	1525	3437	2213	973	2078	1178	193
2103_MPO - Myeloperoxidase	2103_MPO - Myeloperoxidase	25	194	1	194	4629	1216	1755	3417	3969	2959	2390	1543	380	1080	2282	440	933	3920	2388	4578	2278	2352	1522	1809	2181
2416_FOLH1 - Glutamate carboxypeptidase 2	2416_FOLH1 - Glutamate carboxypeptidase 2	25	194	1	787	1142	194	1691	591	1076	1878	3791	2900	2985	1667	2431	3767	2382	2694	397	3907	4496	3058	3930	2617	2940
4407_Menstrual quality of life impact: Stiff neck	4407_Menstrual quality of life impact: Stiff neck	25	194	1	3796	3217	2845	529	267	1201	194	1772	3101	2709	2974	4114	1193	2090	2948	441	669	3041	2962	2241	1402	1872
3888_Mean corpuscular volume (three-way meta)	3888_Mean corpuscular volume (three-way meta)	25	194	1	2871	3557	4549	2815	2998	1148	3953	2879	1951	194	3607	2273	846	2216	601	3284	3017	1505	2561	2103	4053	1260
3233_Snoring	3233_Snoring	25	194	2	4533	4575	2903	2041	1861	3342	2662	601	1910	1660	194	2744	1680	2937	3988	1155	324	3575	1883	3784	1236	4028
364_Amino acid::Alanine and aspartate metabolism::alanine	364_Amino acid::Alanine and aspartate metabolism::alanine	25	194	1	947	3239	1888	1898	2871	1433	4034	4177	1324	4063	2565	807	3487	4558	194	1000	3434	1740	2145	1677	1701	3929
1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	25	194	1	213	3050	4118	876	817	2649	222	1525	328	3285	4501	3662	246	3890	1092	3959	4496	496	194	2677	4512	2057
4668_Uncinate fasciculus fractional anisotropy	4668_Uncinate fasciculus fractional anisotropy	25	194	1	307	1620	2944	1521	3748	4573	4675	4618	4093	1301	4459	3253	4249	3469	521	2943	969	2889	838	194	4537	1743
98_Height SDS	98_Height SDS	25	194	1	4603	3730	529	1217	4426	2420	2292	341	2575	242	3482	1932	2173	2776	2092	2428	4063	1490	4529	4743	3122	194
617_Xenobiotics::Benzoate metabolism::catechol sulfate	617_Xenobiotics::Benzoate metabolism::catechol sulfate	25	195	1	3850	366	1829	195	1518	2579	4710	3333	4539	4421	2301	1602	2233	2903	4561	1014	4281	3871	1388	3448	3008	1067
4350_Nonischemic cardiomyopathy	4350_Nonischemic cardiomyopathy	25	195	1	1629	1361	3485	1363	195	3367	489	4644	918	3256	1166	4203	1882	3787	3589	312	4575	1715	4413	2874	3125	2317
1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	195	1	1620	4453	4247	2664	4259	195	4713	4464	2890	4417	3542	4674	1447	1691	3302	3809	4511	4523	1979	3248	668	2122
4469_Left rostral middle frontal	4469_Left rostral middle frontal	25	195	1	3768	4736	2760	1445	1881	2291	1922	195	618	483	4379	4143	3101	3780	3488	591	3701	656	3613	1439	1302	4559
1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	25	195	1	421	3571	2490	1852	1780	2825	1798	3343	195	1541	1189	1360	4121	4063	937	826	1761	3099	4117	533	2398	3296
543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	25	195	1	4190	2030	841	1118	1918	4433	666	3445	2148	2841	3556	631	195	3442	433	2533	2273	1178	2310	4122	2508	2300
722_::::X-11546	722_::::X-11546	25	195	1	3944	1070	4052	4577	3049	4696	3160	3859	1896	361	1460	2671	2435	1655	195	4069	4728	1146	3538	917	4180	4120
901_Total lipids in large VLDL	901_Total lipids in large VLDL	25	195	1	3411	4234	2369	2997	614	3412	526	1004	701	2319	2261	2581	3245	3287	280	1871	195	512	2314	1088	3830	1514
3523_Current employment status: Doing unpaid or voluntary work	3523_Current employment status: Doing unpaid or voluntary work	25	195	1	3165	4702	3501	4458	2617	1345	3151	2887	3915	4613	3018	2331	2769	4317	3105	1040	3649	1797	3998	2164	195	4323
4491_Right pars opercularis	4491_Right pars opercularis	25	196	1	3044	196	1215	835	2044	2495	3095	1250	2654	4707	852	4195	3896	3311	1507	1455	3728	3519	4401	2136	2237	4594
3293_Suffer from 'nerves'	3293_Suffer from 'nerves'	25	196	1	1456	4450	3987	4743	3509	196	3543	4387	335	2297	4542	3047	1210	846	733	4452	3224	344	744	3983	4166	553
2139_PRKCA - Protein kinase C alpha type	2139_PRKCA - Protein kinase C alpha type	25	196	1	1958	4406	960	3644	718	2919	196	1201	3289	2823	4180	997	3030	960	544	1038	300	4032	2429	2656	4102	2381
2309_IL17RA - Interleukin-17 receptor A	2309_IL17RA - Interleukin-17 receptor A	25	196	1	1758	663	4577	2300	949	4272	3146	2536	643	196	1771	2835	2001	2936	1576	378	2120	3488	1713	451	2190	4697
3159_OMD - Osteomodulin	3159_OMD - Osteomodulin	25	196	1	2337	1122	2491	1879	3585	3756	2557	1114	3382	3197	4743	1661	196	517	2094	3040	1313	1036	4007	2243	658	858
1093_Glioma	1093_Glioma	25	196	1	1375	4580	3361	4607	2119	1953	3784	3860	4666	4213	4353	3736	1599	550	196	1423	385	3293	586	436	4673	4567
1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	25	196	1	2297	486	3931	2202	4488	864	3802	1243	1823	1378	2970	2837	3365	2823	4461	4099	196	3022	1769	3785	3534	3320
2176_POR - NADPH--cytochrome P450 reductase	2176_POR - NADPH--cytochrome P450 reductase	25	196	1	3964	4175	3530	4448	3488	1935	1936	2153	3463	2399	1569	1568	1551	2933	3754	3749	4428	196	4591	3177	2832	4498
1179_Insomnia (male)	1179_Insomnia (male)	25	197	1	3696	3488	197	3060	3511	4269	2371	3342	3409	3464	3464	3774	2009	1455	2121	4304	3386	2232	2938	3095	3373	3849
3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	25	197	1	3245	2282	4225	197	4032	3007	3162	1340	1607	3117	2160	2624	1819	2675	1493	2165	3066	945	2703	512	445	1325
1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	25	197	1	3306	3563	1659	1141	1132	4427	197	1888	3313	2516	376	742	2722	2391	2099	655	310	1284	1855	1547	213	926
2390_F7 - Coagulation Factor VII	2390_F7 - Coagulation Factor VII	25	197	1	4171	2249	1924	2738	209	2574	3676	3964	197	1412	602	3927	2313	1983	1149	699	4165	1817	3431	676	3945	2098
250_CD39 on CD4 T	250_CD39 on CD4 T	25	197	1	3316	3841	4706	2778	1995	2112	2344	4486	2180	197	851	4299	1500	4146	4276	777	770	1197	461	2265	1479	973
2994_PTK2 - Focal adhesion kinase 1	2994_PTK2 - Focal adhesion kinase 1	25	197	1	669	2380	365	1525	1632	2419	2458	319	409	4067	1206	197	4479	683	3204	2093	4675	4651	2822	2156	3749	1833
2252_KAT6A - Histone acetyltransferase KAT6A	2252_KAT6A - Histone acetyltransferase KAT6A	25	197	1	3871	3471	3274	3536	808	2499	352	1709	1563	3411	1858	1316	197	2318	1217	1309	3748	3301	3542	3321	4302	4160
4356_Menstrual cycle length	4356_Menstrual cycle length	25	197	1	2609	1692	1312	3575	3353	1834	4447	4304	1650	4745	2992	2290	3306	197	1604	2698	3236	3500	726	4656	2528	1593
355_IgG+B:%27+	355_IgG+B:%27+	25	197	1	1670	1360	2335	3449	1057	2999	2297	3159	798	3029	2803	2194	4489	705	1621	918	197	3013	2540	543	264	965
4105_Albumin	4105_Albumin	25	197	1	616	431	2011	3584	237	4646	1987	1845	1603	4674	2059	467	1823	1178	327	379	1114	2656	2664	197	4288	3180
4704_Posterior limb of internal capsule mean diusivities	4704_Posterior limb of internal capsule mean diusivities	25	197	1	3322	3199	2138	3637	1818	868	726	498	2853	3673	4341	457	614	4152	1465	3686	3455	2651	4552	4513	197	2862
597_Peptide::Dipeptide::pyroglutamylglycine	597_Peptide::Dipeptide::pyroglutamylglycine	25	198	1	198	1488	1091	3635	3020	2756	557	2523	868	2083	2783	845	270	1099	1876	2366	4559	3771	4140	3712	4695	3126
988_Interleukin-1 receptor antagonist	988_Interleukin-1 receptor antagonist	25	198	1	4455	198	1963	994	1540	3464	1951	471	2420	4087	891	4102	3872	2954	1136	782	2385	2132	3036	3858	2843	1676
896_Concentration of large LDL particles	896_Concentration of large LDL particles	25	198	1	385	594	565	198	950	721	4141	4534	286	2195	519	2770	2835	281	475	1527	3639	3242	3179	2267	3701	859
372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	25	198	1	1660	2098	2166	2049	198	2656	2440	1770	645	3751	1838	3301	3328	1049	4623	282	4687	653	2346	3405	4273	2331
4070_Ever smoker	4070_Ever smoker	25	198	1	1496	2617	3755	1679	1684	198	2304	604	3339	3835	1489	1492	1827	2123	1941	340	787	3433	1455	3037	257	1980
2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	25	198	1	4590	4354	3838	3483	2784	1318	198	3181	1143	3212	3155	4332	4093	303	1900	3623	1966	884	4151	1099	4725	1414
4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	25	198	1	1524	1581	2468	3324	942	1104	1433	198	1634	3651	3637	2858	4129	440	1916	2841	3705	393	4693	4441	3171	730
2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	25	198	1	3581	4422	1048	3181	1547	2177	4021	1665	198	1172	442	4648	4125	1981	3635	2019	3338	2829	2587	1881	4040	4100
4183_Triglyceride	4183_Triglyceride	25	198	1	532	2009	3724	2052	663	4132	1308	939	3214	198	2065	505	2249	3324	713	2166	596	1208	3049	3243	1571	246
3291_Tense / 'highly strung'	3291_Tense / 'highly strung'	25	198	1	2165	1885	3983	4072	3586	2985	4398	1820	1668	2158	4594	198	3676	4109	3244	3292	2085	1609	3672	3730	2957	981
1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	25	198	1	466	4258	542	1811	855	2392	3139	1557	1738	2324	1987	3015	198	826	1769	499	2997	1576	737	1081	3698	1289
1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	25	198	1	3705	1763	2215	1373	3167	1501	2976	3534	571	602	4421	953	314	2711	1737	4664	198	3508	729	2039	2291	4123
3261_Alcohol intake frequency	3261_Alcohol intake frequency	25	198	1	3764	2288	2895	3706	4656	3670	3230	1261	4650	1488	1347	3990	3628	308	2140	3750	2423	2836	3970	3548	530	198
1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	25	199	1	1447	199	3089	359	1792	4462	4506	636	2835	4366	2351	1515	1842	880	3251	3807	1271	2567	2706	4180	4131	2808
4645_White matter	4645_White matter	25	199	1	2207	2491	2002	199	904	2079	845	3059	878	1830	3202	1914	4594	1293	4327	1443	2153	2544	657	1913	3167	2986
930_Phosphatidylcholine and other cholines	930_Phosphatidylcholine and other cholines	25	199	1	3699	1573	3701	735	199	3977	2312	4519	613	4056	3353	1380	965	2259	3028	222	2092	2359	1432	2788	1841	1449
528_Lipid::Long chain fatty acid::stearate (18:0)	528_Lipid::Long chain fatty acid::stearate (18:0)	25	199	1	3314	4395	526	1629	3946	199	3197	657	3420	4273	2011	1317	1332	4096	776	4326	831	914	2486	1204	3838	4161
4529_Left vessel	4529_Left vessel	25	199	1	2736	825	2850	3559	4018	4428	199	4462	3285	3124	756	1829	2478	3538	2492	3299	4315	2427	1584	2895	1614	1949
1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	25	199	1	4127	2636	1212	2901	4156	3583	4455	4646	199	2967	2410	2375	781	2441	2227	3414	3282	1849	1151	4369	3056	4459
3948_1p deletion neuroblastoma	3948_1p deletion neuroblastoma	25	199	1	3437	3925	4548	1148	2210	1893	3308	3016	2851	268	2996	199	3552	1899	4533	2213	3355	3968	1575	2430	2918	3331
827_::::X-13671	827_::::X-13671	25	199	1	542	2318	3223	2818	1430	605	3844	2980	3612	526	2515	3065	2625	199	1331	1655	2860	3419	526	3263	1935	2319
1161_Fasting insulin interaction (adjusted for BMI)	1161_Fasting insulin interaction (adjusted for BMI)	25	199	1	2729	681	2584	494	4115	3551	3645	3082	3544	2534	2985	2104	1884	1452	3375	3715	1533	199	2609	1810	3154	2782
2800_RAN - GTP-binding nuclear protein Ran	2800_RAN - GTP-binding nuclear protein Ran	25	199	1	3096	2632	299	719	3608	3192	2394	1011	2052	1210	1813	2242	3420	1844	1147	673	457	2580	3839	199	3400	1850
1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	199	1	4275	734	1170	1513	4626	4225	980	2069	2157	1008	816	2267	3360	4662	2425	1682	1098	2336	1320	2864	4579	199
2370_DIABLO - Diablo homolog, mitochondrial	2370_DIABLO - Diablo homolog, mitochondrial	25	200	1	200	375	625	3589	1692	2059	4708	1099	3949	978	3811	3697	3263	4652	2293	4098	2796	2335	2415	2071	1381	4581
1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	200	1	2376	1722	3049	200	2147	3374	1117	1367	951	2421	423	2746	1050	3764	768	3515	3818	1492	2694	409	1349	3412
1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	25	200	1	1228	1275	3128	2537	1079	1822	2531	4699	1238	3988	1129	200	1817	2653	1973	840	3778	1779	3197	672	3931	1740
3192_Length of time at current address	3192_Length of time at current address	25	200	1	1856	2274	4574	3351	3003	1866	319	3586	2650	3636	1210	3284	2214	200	3030	1371	4619	1613	3920	2728	3794	3109
252_CD3 on CD8 T	252_CD3 on CD8 T	25	200	1	594	3143	3960	1524	201	1241	605	2814	2663	2744	2149	1479	2241	3768	2465	200	3628	2417	1818	1501	4172	1711
3482_Milk type used: Skimmed	3482_Milk type used: Skimmed	25	200	1	3054	4735	3276	2330	2242	2988	4381	1175	1932	1152	4388	1162	3370	3497	1598	2100	3494	1261	200	1865	4155	1015
31_Conscientiousness (NEO-FFI)	31_Conscientiousness (NEO-FFI)	25	200	1	3954	2057	1178	1582	1658	1618	436	2604	1249	4055	2592	1812	2355	2938	1000	1396	3724	491	1399	1300	3827	200
1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	201	1	1799	201	337	3794	385	1059	493	2364	2679	3842	1146	3188	4287	895	294	281	1027	3855	1248	291	3228	2770
3508_Non-butter spread type details: Other low or reduced fat spread	3508_Non-butter spread type details: Other low or reduced fat spread	25	201	1	2346	3885	1017	4447	3744	201	1134	635	1314	3892	4228	2921	2335	2569	2215	3841	4507	1533	913	2443	4264	2764
1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	25	201	1	4354	3170	256	340	2461	2765	1557	224	384	3521	3038	4364	3210	4668	1115	2078	450	3661	201	3861	3602	591
2490_PAK7 - Serine/threonine-protein kinase PAK 7	2490_PAK7 - Serine/threonine-protein kinase PAK 7	25	202	1	535	1148	202	1044	3962	2721	2606	2005	2374	3354	2372	2931	1660	2622	1794	2233	1945	3635	2492	989	3537	1016
3817_CD56+ NK cell level	3817_CD56+ NK cell level	25	202	1	3652	1308	1854	4519	202	1403	4152	3249	1237	4333	2605	726	2491	4402	1959	275	760	4426	2277	3347	1252	3151
3827_Osteoarthritis of hip and/or knee	3827_Osteoarthritis of hip and/or knee	25	202	1	2380	2631	4330	3723	1129	202	919	3309	3717	1803	3683	1134	243	1342	3269	563	293	2111	451	2649	850	4054
2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	25	202	1	2371	2635	821	929	2005	2017	322	2877	1824	202	579	4385	1033	3004	718	2309	2428	3150	664	4401	568	2970
2043_Bipolar disorder	2043_Bipolar disorder	25	202	1	292	2897	3066	1185	4325	689	2117	342	1079	593	3862	3675	2311	1551	3556	2876	202	2394	1716	4097	4429	4248
433_Amino acid::Valine, leucine and isoleucine metabolism::valine	433_Amino acid::Valine, leucine and isoleucine metabolism::valine	25	202	1	1324	3723	3483	4726	2918	3129	3207	1796	2421	776	1552	2025	2005	4597	1779	1872	1857	202	1091	574	1890	2374
766_::::X-12231	766_::::X-12231	25	202	1	3580	3459	2856	374	2936	4399	2922	1686	434	443	2509	1538	4092	2246	893	2380	4599	590	4729	1616	202	4357
3916_Disc area	3916_Disc area	25	203	1	1952	203	3296	2043	4031	2844	2791	3739	1880	1120	3250	4636	952	3117	789	4414	1895	2709	2606	2539	2652	4544
2913_AFM - Afamin	2913_AFM - Afamin	25	203	1	1017	3145	4179	203	1681	1388	1341	1882	1397	1527	2845	2160	4404	1213	3674	1988	2774	1831	4193	2310	1971	3820
3790_Daytime sleepiness / dozing	3790_Daytime sleepiness / dozing	25	203	1	954	2547	757	420	203	894	2482	2007	890	1243	3876	4121	4642	3508	3395	214	4714	1489	3093	4216	896	4414
4130_Neutrophil count	4130_Neutrophil count	25	203	1	4262	1153	1614	2797	913	3483	700	1456	203	2505	1820	2501	1765	3556	2284	921	4456	2687	2359	4217	1464	1352
153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	25	203	1	1616	4038	3592	2133	4506	554	1684	1479	1336	2810	3777	3824	1360	2087	215	1023	4685	203	952	1523	1731	388
257_CD8:%Senescent	257_CD8:%Senescent	25	204	1	204	1206	4043	3944	3276	3364	3261	3160	1361	3908	3850	2453	4221	3872	3772	2218	3497	4405	3155	3328	3532	1200
2294_AREG - Amphiregulin	2294_AREG - Amphiregulin	25	204	1	3259	204	2161	830	2608	3857	2822	3472	3937	3703	4672	1195	848	1612	321	1623	1324	3469	4721	4144	1241	935
883_Phospholipids in IDL	883_Phospholipids in IDL	25	204	1	372	208	204	276	1064	298	4359	4157	279	3937	1175	1902	1554	368	626	1223	2855	3582	3027	2974	3677	1646
3029_RB1 - Retinoblastoma-associated protein	3029_RB1 - Retinoblastoma-associated protein	25	204	1	2348	3403	4627	4242	3340	204	2544	1237	2506	3889	2172	2461	3648	2929	716	1748	2958	3678	3299	4310	601	3670
363_Mono:%11c-16-274+	363_Mono:%11c-16-274+	25	204	1	1590	3070	3398	3777	1115	3465	522	3323	204	2827	219	1869	1438	3347	3718	1753	1934	3243	4187	3955	2137	4318
837_::::X-14374	837_::::X-14374	25	204	1	2200	865	3227	301	1005	989	3964	2861	3324	204	2762	2193	2830	1086	2398	613	2187	3602	3626	3453	3395	2441
3484_Spread type: Butter/spreadable butter	3484_Spread type: Butter/spreadable butter	25	204	1	4287	4477	562	2291	3297	218	4488	1095	3660	1550	204	2360	803	2114	555	3691	3889	2876	631	1230	1923	1194
1763_Prostate cancer (GEE, adjusted for age)	1763_Prostate cancer (GEE, adjusted for age)	25	204	1	2456	1684	548	3213	1237	4499	3445	407	4142	2835	1154	3449	4368	2137	2374	1497	3430	1319	4020	204	1517	2121
4400_Menstruation quality of life impact: Edema	4400_Menstruation quality of life impact: Edema	25	204	1	4055	3780	1870	1566	1105	276	3849	2680	1558	3627	1698	528	4297	1107	2982	2987	387	1955	3009	2568	204	273
377_Amino acid::Glutathione metabolism::5-oxoproline	377_Amino acid::Glutathione metabolism::5-oxoproline	25	204	1	4349	2979	677	4270	1676	2553	2266	4138	2619	1709	1816	3579	4227	4634	212	1080	3727	3659	4424	2639	1110	204
4181_High cholesterol lipoprotein	4181_High cholesterol lipoprotein	25	205	1	4201	3061	2434	1277	4070	3157	676	2094	1333	3220	748	1410	205	1005	1551	1114	4166	913	2917	3383	2363	1619
4039_Bipolar disorder	4039_Bipolar disorder	25	205	1	259	1187	3417	3005	2516	377	1496	4579	1984	3765	3232	3193	4393	3887	4431	3036	205	2636	2592	589	588	1497
3337_Years since last breast cancer screening / mammogram (female)	3337_Years since last breast cancer screening / mammogram (female)	25	205	1	1647	1849	4057	234	3359	374	3026	4555	2733	694	1777	4482	4469	688	4498	4253	1042	205	4376	2141	4107	837
2110_CD80 - T-lymphocyte activation antigen CD80	2110_CD80 - T-lymphocyte activation antigen CD80	25	205	1	4130	1497	4507	799	1942	1762	1030	2396	2021	3045	4339	4587	4288	430	2641	3522	1574	1574	3382	3388	4716	205
2410_METAP1 - Methionine aminopeptidase 1	2410_METAP1 - Methionine aminopeptidase 1	25	206	1	3549	549	206	2382	923	2278	2473	1701	251	628	2326	3103	2345	450	2278	3700	2473	2095	3279	936	1735	2757
3355_Ever stopped smoking for 6+ months	3355_Ever stopped smoking for 6+ months	25	206	1	3463	2505	3110	2321	825	2872	206	4710	4398	520	4617	4442	4686	4250	4670	4697	2975	2870	1175	1364	3920	4555
849_::::X-18601	849_::::X-18601	25	206	1	4229	1759	3876	3228	2111	3687	2141	4229	206	3434	3074	517	2411	3761	479	2862	3433	4646	4582	2918	864	2092
1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	25	206	1	4313	2395	2557	2599	958	4422	2017	3857	2457	270	943	2220	206	1544	2445	3347	1406	3404	3185	2198	1955	3198
915_Phospholipids in medium HDL	915_Phospholipids in medium HDL	25	206	1	2088	4465	3972	3007	2012	3794	1060	1944	711	2174	1336	2922	4002	206	3509	1688	4005	2073	462	1487	619	1794
924_Total lipids in medium VLDL	924_Total lipids in medium VLDL	25	206	1	2173	4051	3661	4279	445	1914	975	2392	1370	682	4159	1611	2281	3027	206	765	976	1390	3440	1111	2856	1048
4570_Left rostral middle frontal	4570_Left rostral middle frontal	25	206	1	4257	761	4117	4323	222	2437	2514	3266	1194	1544	1845	1256	432	2319	4266	206	256	4474	1149	1028	4169	2575
2217_ACVR1B - Activin receptor type-1B	2217_ACVR1B - Activin receptor type-1B	25	206	1	3334	1839	4080	2485	480	1321	1923	1964	1948	213	766	2867	4012	1998	1451	1185	1018	589	3439	323	2812	206
4736_Anterior limb of internal capsule radial diusivities	4736_Anterior limb of internal capsule radial diusivities	25	207	1	1751	4505	3688	309	3577	558	2031	207	521	3428	3735	2945	1313	3376	2051	2754	2350	3043	2912	929	602	2879
3860_Neutrophil percentage of white cells (two-way meta)	3860_Neutrophil percentage of white cells (two-way meta)	25	207	1	2751	4675	952	1769	252	572	3309	2236	207	3068	3577	3400	1439	2303	4301	344	1978	1990	1660	3072	1344	228
4171_Loneliness	4171_Loneliness	25	207	1	362	1605	3368	1334	3694	4027	2133	1987	716	207	1485	4471	3976	497	4085	4510	1079	4146	3397	1116	3783	3736
1199_Epilepsy	1199_Epilepsy	25	207	1	3539	303	2721	2758	1883	4440	2574	2961	2601	499	1918	2981	207	871	4406	885	4555	4698	1160	2000	905	2634
134_Waist circumference (male, adjusted for BMI)	134_Waist circumference (male, adjusted for BMI)	25	207	1	4637	4552	3497	1590	423	3440	607	512	3581	3758	3904	2683	550	4094	4437	223	430	2740	207	865	277	269
2236_FRZB - Secreted frizzled-related protein 3	2236_FRZB - Secreted frizzled-related protein 3	25	207	1	4213	3949	4024	2649	3693	3771	2321	3788	979	1718	2568	2043	2779	2500	1784	4389	4312	4600	835	207	2776	2850
2954_PLA2G1B - Phospholipase A2	2954_PLA2G1B - Phospholipase A2	25	208	1	2854	3425	208	4586	2027	2870	4132	438	3882	2512	2695	566	249	4622	3578	2979	2918	1887	2449	3769	2521	3885
3805_Platelet count	3805_Platelet count	25	208	1	2234	1055	4704	208	1674	2332	3841	1607	3372	2217	1102	1287	3869	3863	761	4058	1081	3447	2602	4568	4199	3762
95_Birth weight	95_Birth weight	25	208	1	4429	3595	4714	1857	3303	2511	308	3867	208	1166	2105	2439	345	3749	4528	3357	2949	416	4023	1641	3916	4618
4120_Alanine aminotransferase	4120_Alanine aminotransferase	25	208	1	2520	2645	3242	2748	1122	1820	917	4386	2975	740	208	3109	1124	2085	2193	974	682	2576	1066	2148	4132	3022
4221_Diuretics	4221_Diuretics	25	208	1	3499	3342	312	2993	286	212	1174	1750	4317	769	4551	208	2606	1964	225	581	1264	2627	1328	4092	3933	2210
1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	25	208	1	3008	932	1391	1396	3415	449	1975	298	2139	3219	3626	354	208	4098	2801	3803	3805	2597	4001	461	2753	622
2600_LGMN - Legumain	2600_LGMN - Legumain	25	208	1	3200	1049	3930	1655	1726	3815	3126	1423	1247	2923	2885	926	2895	208	2109	3417	3685	247	3844	2439	1527	2211
2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	25	208	1	1701	1925	1546	3717	3818	3822	2211	893	2595	2511	844	2778	711	449	208	2295	2209	1684	3729	680	1520	2036
2709_EEF1B2 - Elongation factor 1-beta	2709_EEF1B2 - Elongation factor 1-beta	25	208	1	522	319	4418	4340	3704	559	2202	2947	3315	2956	473	235	2259	2429	1782	3845	208	2254	3720	4563	261	441
3288_Fed-up feelings	3288_Fed-up feelings	25	208	1	2123	2844	3331	3764	4652	1804	2207	1349	2473	611	3631	3695	1335	1173	3370	4432	2736	1452	208	2405	734	415
310_CD4nv:%preTh17	310_CD4nv:%preTh17	25	209	1	209	1714	2852	1494	2389	1109	1955	737	2075	2329	1416	2526	999	315	1703	3656	2846	3092	2583	1005	1187	1755
3809_Monocyte count	3809_Monocyte count	25	209	1	370	3524	209	2014	4501	2644	4461	962	3366	3115	304	4715	4191	3798	4429	3370	1055	2573	1811	3674	3604	2501
1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	209	1	290	2919	4384	2498	3406	742	209	2132	2992	3418	4615	3375	888	1038	1259	2664	2128	3993	2692	1994	4210	1733
529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	25	209	1	942	1951	226	4642	2123	3578	3874	209	2443	1505	2037	671	3804	3581	360	2344	744	4650	2841	4544	4278	2197
729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	25	209	1	1763	3528	2321	2802	4241	623	3522	940	209	4586	2061	3166	1309	2934	1697	4175	3942	3732	2840	3788	3777	4659
2028_Cryptorchidism (group 2)	2028_Cryptorchidism (group 2)	25	209	1	600	1370	332	1989	1624	3371	1676	814	4358	209	4335	2627	933	4590	4234	1990	2137	2890	1835	1626	1924	2891
1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	25	209	1	1275	3789	3692	4625	2142	459	2732	1830	2146	2715	209	2496	3530	3844	864	2977	1179	3265	3742	3141	1231	1535
2524_HIPK3 - Homeodomain-interacting protein kinase 3	2524_HIPK3 - Homeodomain-interacting protein kinase 3	25	209	1	1694	3828	3093	4055	3896	3891	3186	628	3833	2884	3448	3336	209	1489	316	2913	3436	650	3947	4432	3195	4069
3976_Total body BMD (15 or younger)	3976_Total body BMD (15 or younger)	25	209	1	3311	4606	2846	973	2579	4346	3020	934	1587	850	3955	2612	3623	4271	2364	3004	3021	209	4661	442	1676	3985
1066_Multiple Sclerosis	1066_Multiple Sclerosis	25	209	1	4400	3261	2110	1778	4638	2759	4574	4505	4561	4611	4715	1633	3980	4248	2587	1669	3047	4100	209	2696	4651	1500
3759_Anxiety - Reccent feelings or nervousness or anxiety	3759_Anxiety - Reccent feelings or nervousness or anxiety	25	210	1	210	2031	1619	1194	2704	4500	2485	387	3076	269	3243	351	4283	4654	4626	1439	2331	2091	281	3214	1880	1018
3280_Mother still alive	3280_Mother still alive	25	210	1	1120	210	2801	322	350	1901	294	2398	1248	3441	906	1507	2421	4537	2288	231	2166	1393	2242	4532	2053	413
1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	210	1	3115	2129	1171	1418	831	571	3636	2211	210	3028	1977	1880	2403	664	2646	711	1214	2008	2231	3994	4482	1506
2597_GNS - N-acetylglucosamine-6-sulfatase	2597_GNS - N-acetylglucosamine-6-sulfatase	25	210	1	2686	4661	3516	3848	2937	4614	378	4363	1363	3934	2183	3062	210	3795	867	4144	1353	729	4503	1275	2920	3418
3032_FAP - Seprase	3032_FAP - Seprase	25	210	1	2639	3204	3871	2886	526	958	542	2747	2662	4406	2085	4569	4235	210	4102	405	329	4041	2274	2828	1104	3350
2755_SERPINA3 - alpha-1-antichymotrypsin complex	2755_SERPINA3 - alpha-1-antichymotrypsin complex	25	210	1	3189	3011	2908	348	929	4076	1065	1440	4042	2438	1620	1755	3460	2112	4608	3910	2386	2684	210	3397	719	1532
191_Estimated glomerular filtration rate based on serum creatinine	191_Estimated glomerular filtration rate based on serum creatinine	25	211	1	321	988	4459	1506	1347	1038	628	211	2535	1846	1940	830	758	3825	3597	2728	632	3467	2793	4341	2636	247
475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	25	211	1	3685	1053	3350	1785	1454	1200	1199	3313	2997	4191	1082	211	4399	3669	1038	2308	333	528	4595	3365	2836	3727
219_Lymph:%CD8	219_Lymph:%CD8	25	211	1	1492	4526	4558	2314	4030	2199	3078	4582	2224	3711	1595	4283	211	4454	3594	3999	1902	1418	4486	2858	824	1388
4411_Total IgG levels	4411_Total IgG levels	25	211	1	3218	2646	240	1775	3252	3295	2675	3954	3068	4588	2799	1328	4672	211	2898	958	4513	3511	4181	1098	1353	2298
4122_Gamma-glutamyl transferase	4122_Gamma-glutamyl transferase	25	211	1	3594	2360	1013	4205	901	4613	4049	1684	2709	1038	1716	3829	1640	4442	211	1697	1165	4264	2287	3196	2824	4338
4580_Right entorhinal	4580_Right entorhinal	25	212	1	3367	995	1499	212	458	4530	1801	1921	4434	2654	4671	1068	4635	1063	717	549	1339	1453	900	4113	2325	2636
2947_PPP3CA PPP3R1 - Calcineurin	2947_PPP3CA PPP3R1 - Calcineurin	25	212	1	1542	1969	464	4087	4203	2293	4635	3549	212	1136	661	1267	1045	2376	563	2147	554	4462	3002	893	2538	2071
1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	25	212	1	1723	2920	1477	319	3172	2927	910	961	3662	212	1642	4049	2201	2865	4685	3643	2425	936	2681	3877	327	488
3988_Heart rate recovery at 40 secnds	3988_Heart rate recovery at 40 secnds	25	212	1	3795	3536	2111	3901	343	1442	302	2135	4431	2004	212	333	1442	516	644	1323	3009	775	3579	3984	3624	1570
4703_Posterior corona radiata mean diusivities	4703_Posterior corona radiata mean diusivities	25	212	1	3168	2677	1842	626	2407	1389	1820	1595	1128	1627	3073	3094	212	4308	4139	2838	1143	4249	1923	579	3669	480
2478_CSK - Tyrosine-protein kinase CSK	2478_CSK - Tyrosine-protein kinase CSK	25	212	1	4477	1261	1004	1077	1449	2760	4276	703	3736	2225	3371	949	4299	212	245	745	1642	708	1322	1610	3130	3894
2829_MST1 - Hepatocyte growth factor-like protein	2829_MST1 - Hepatocyte growth factor-like protein	25	212	1	3686	748	3070	1208	2860	3346	2878	1585	4564	2834	3593	637	4215	4369	2739	3654	2353	4611	212	3111	3575	2348
3317_Falls in the last year	3317_Falls in the last year	25	213	1	2819	4485	1456	213	4555	1275	1173	3668	730	4186	2821	1620	4207	3468	1542	4221	3764	3858	1011	307	1567	2878
2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	25	213	1	3934	3232	3725	1978	3453	213	3452	1188	3063	2585	3474	2072	3699	3839	3008	1195	447	1810	1419	1075	302	1606
1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	25	213	1	438	517	324	4415	1608	4302	3332	213	404	2016	3341	2764	1094	1470	4499	819	4503	2566	4234	4020	3235	910
240_CD27 on IgG+B	240_CD27 on IgG+B	25	213	1	2210	947	289	1871	3184	1363	3891	571	213	3295	2263	4166	3991	2100	894	2088	3855	2647	3553	1833	1152	2367
269_CD4:%TM (2)	269_CD4:%TM (2)	25	213	1	2844	886	1814	3395	1538	3624	827	1314	1913	2549	213	2201	3043	4353	2289	3549	240	2262	411	1234	3872	2762
2938_F9 - Coagulation factor IX	2938_F9 - Coagulation factor IX	25	213	1	4570	4301	1927	364	1919	1259	2665	4278	3334	1080	3472	4391	1344	1501	4724	1301	213	4113	457	1004	3598	3016
3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	25	213	1	2894	4374	4217	2216	1840	4286	1742	361	2521	3298	2248	2986	1287	2292	4711	784	3451	4345	4608	213	4666	3818
2272_APOE - Apolipoprotein E (isoform E3)	2272_APOE - Apolipoprotein E (isoform E3)	25	213	1	737	796	2756	4032	2539	2661	4023	4571	602	2523	1058	1581	1165	797	4103	1984	702	4642	1984	3680	4455	213
3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	25	214	1	4712	214	1079	4052	3119	318	1567	1871	2539	4069	4492	593	1173	3676	3167	4181	2143	1553	2061	1311	847	224
179_Waist-hip ratio	179_Waist-hip ratio	25	214	1	2055	3229	745	2851	4388	214	3871	347	1894	2592	3898	4470	1392	2454	1802	989	3123	823	1810	3479	2330	2198
2396_CNDP2 - Cytosolic non-specific dipeptidase	2396_CNDP2 - Cytosolic non-specific dipeptidase	25	214	1	2850	3058	4526	4737	3752	4079	2036	1798	214	1034	1603	4691	1852	2793	3730	3424	4563	1251	3467	3210	1416	2192
3201_Job involves heavy manual or physical work	3201_Job involves heavy manual or physical work	25	214	1	3045	4078	2802	2348	2272	4723	2346	3768	4689	214	1769	1804	3278	4256	4640	2371	1635	4257	368	1611	903	2238
1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	25	214	1	4035	4104	2480	1686	3669	2448	2353	4437	3254	831	1378	3787	477	214	1797	2722	749	1312	3110	1701	3365	4528
3845_High light scatter percentage of red cells (two-way meta)	3845_High light scatter percentage of red cells (two-way meta)	25	214	1	2190	3668	713	2327	2992	2294	1062	3667	2839	4558	2542	1730	1748	3762	214	931	3315	1037	2954	1433	777	2125
1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	25	214	1	2320	3242	615	2793	4532	2858	2250	1856	2659	2339	2453	2726	4229	4238	3192	4054	3686	214	1379	831	458	4269
2791_NUDCD3 - NudC domain-containing protein 3	2791_NUDCD3 - NudC domain-containing protein 3	25	214	1	1661	1312	3682	526	2322	1219	4289	1691	829	3410	2002	1625	4630	2604	2831	2949	4631	547	3673	2747	214	487
1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	25	215	1	4609	215	4272	2780	2747	355	4160	3238	1959	4112	1184	4210	1972	4440	2296	1932	425	2287	552	2903	1579	3878
1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	25	215	1	2630	1597	1844	2116	1012	524	2399	215	3782	590	2938	4350	2738	1924	4463	901	2640	1439	3942	2479	2891	3365
2225_EDA - Ectodysplasin-A, secreted form	2225_EDA - Ectodysplasin-A, secreted form	25	215	1	1272	3821	1052	522	3615	3116	1797	1903	3853	215	4724	4664	1003	4462	238	3497	4144	1596	226	4136	425	2027
4033_Alcohol dependency (unrelated genotyped individuals)	4033_Alcohol dependency (unrelated genotyped individuals)	25	215	1	1850	4069	1307	3200	550	2976	978	4233	222	3867	3207	2358	1503	1137	3194	1914	4480	1902	215	2398	968	2221
36_Loneliness (multivariate)	36_Loneliness (multivariate)	25	216	1	695	216	291	3842	3317	1613	1022	1138	1260	2989	401	2447	1096	1574	4488	3778	1837	3244	2970	2733	4383	2896
769_::::X-12253	769_::::X-12253	25	216	1	2019	2670	4717	942	1259	1297	3742	216	2211	1668	559	2551	4347	2092	3463	4177	316	4114	1221	4352	1962	2439
2965_AMH - Muellerian-inhibiting factor	2965_AMH - Muellerian-inhibiting factor	25	216	1	877	2592	3815	890	3637	2597	3242	3962	4504	216	4184	3661	470	3618	1700	2911	4722	1682	2999	3922	4256	1429
2035_Central corneal thickness	2035_Central corneal thickness	25	216	1	962	4610	1469	3328	570	1086	1220	346	2998	1237	216	3945	4262	512	298	589	2901	2101	614	4205	1398	248
1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	216	1	2286	4168	2495	1155	674	3377	721	2888	3154	3502	1670	216	2650	501	1044	570	2969	983	1276	1322	1188	3612
946_Serum total triglycerides	946_Serum total triglycerides	25	216	1	4157	3612	2805	2829	630	1798	886	1768	3959	299	4084	1231	1441	2868	216	1218	940	1006	3537	1055	1748	486
3157_MIF - Macrophage migration inhibitory factor	3157_MIF - Macrophage migration inhibitory factor	25	216	1	3584	4590	3728	2372	2662	2857	1444	225	4557	2634	1233	3359	4530	2939	4471	4735	1815	216	4195	964	3428	2965
2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	25	216	1	2002	818	3362	376	3222	1976	984	384	3115	1436	1176	4258	1697	251	4559	4062	4367	1936	3335	216	3179	1906
3517_How are people in household related to participant: Husband, wife or partner	3517_How are people in household related to participant: Husband, wife or partner	25	217	1	3211	642	247	217	332	2423	451	1128	3611	826	1265	3772	3517	2094	2977	624	2405	2155	926	4185	413	3153
3323_Ever had prostate specific antigen (PSA) test	3323_Ever had prostate specific antigen (PSA) test	25	217	1	4197	2028	853	4045	217	366	3559	3969	4130	4715	3562	3728	558	2775	1102	258	533	4406	1229	605	2429	2594
360_mDC:%32+	360_mDC:%32+	25	217	1	2495	1362	2566	3273	3988	1291	946	2481	1785	755	1271	1309	955	217	1987	2044	1038	4429	1281	3666	2396	4511
3214_Frequency of light DIY in last 4 weeks	3214_Frequency of light DIY in last 4 weeks	25	217	1	4100	2853	2316	605	4484	3294	3115	4100	1355	2139	2789	908	1672	1327	4185	3298	4475	1523	2709	217	4134	4550
3603_Non-cancer illness code, self-reported: migraine	3603_Non-cancer illness code, self-reported: migraine	25	217	1	1346	4020	935	4676	3280	1806	973	2252	1979	3760	390	969	494	2881	1302	2887	2286	597	4394	3468	217	4380
2521_FSTL3 - Follistatin-related protein 3	2521_FSTL3 - Follistatin-related protein 3	25	218	1	3012	1344	3247	218	3805	4025	2513	3713	2082	1296	2391	1149	1781	2455	418	2578	4484	3769	2282	4468	3970	2218
3777_Traumatic events - Diagnosed with life-threatening illness	3777_Traumatic events - Diagnosed with life-threatening illness	25	218	1	1883	1632	2239	241	1298	3761	2051	963	218	2595	4579	2300	1291	1366	2883	1216	4439	1865	1836	611	493	1464
273_CD8:%SCM	273_CD8:%SCM	25	218	1	3292	2599	1890	1698	446	3915	1542	1949	2936	218	4520	2613	2827	1979	565	804	2933	1175	2258	1395	4205	4080
3442_Impedance measures - Whole body fat mass	3442_Impedance measures - Whole body fat mass	25	218	1	3765	2290	3061	4529	4718	2643	1386	302	2170	1792	2713	4275	4604	218	1669	3799	4655	2849	791	2912	1123	287
986_Interleukin-18	986_Interleukin-18	25	218	1	4422	2152	3112	3406	3877	2647	480	299	1156	2737	4491	274	4422	1833	2396	2988	1907	2768	218	4188	2367	4417
1048_Type 2 Diabetes	1048_Type 2 Diabetes	25	219	1	2675	1699	951	219	2183	3804	3941	700	3051	2252	1075	1115	4374	3500	3936	4724	1328	1209	4417	1507	4378	4114
1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	25	219	1	1921	1082	2473	1834	219	2605	831	1825	1937	1361	4537	765	1353	510	2261	260	4614	3331	3111	4559	676	2150
19_Ever versus never beeing a regular smoker	19_Ever versus never beeing a regular smoker	25	219	1	1171	2654	2370	1215	1261	3289	219	1500	1974	237	247	3379	639	2131	4456	615	2052	1880	1801	3486	669	2290
1118_Pericardial adipose tissue volume (male)	1118_Pericardial adipose tissue volume (male)	25	219	1	2693	2907	744	2462	4249	3125	3757	994	2273	3516	4439	219	2691	4618	2391	894	3443	3532	3468	4736	2988	4428
1193_Crohn's Disease	1193_Crohn's Disease	25	219	1	3910	2954	2309	4434	3994	2902	518	2986	3226	467	1523	473	3322	1563	3731	3695	4304	3737	219	1197	2183	4201
429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	25	219	1	3098	2923	1647	3206	994	2484	4695	1050	668	2429	1539	2125	276	3022	747	4482	3612	1954	2481	4126	219	1523
4360_Biliary atresia	4360_Biliary atresia	25	220	1	220	4652	1747	1031	3715	3547	2860	4080	3643	2949	2495	3897	3053	3475	3554	2723	3963	881	3033	2179	1010	888
2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	25	220	1	1502	4632	2776	4034	3684	220	2509	2633	729	1715	2373	1978	383	4002	1531	3360	999	2812	1825	3706	4142	1839
4470_Left superior frontal	4470_Left superior frontal	25	220	1	739	371	1431	1644	1591	1787	598	591	1048	220	1594	4298	2767	4175	4308	2279	1918	3518	721	3475	1133	1017
3425_Ever smoked	3425_Ever smoked	25	220	1	910	698	2233	901	3806	956	2402	3111	3174	2694	220	1016	1706	1408	3401	1520	4488	4461	4046	2817	523	2495
2792_PA2G4 - Proliferation-associated protein 2G4	2792_PA2G4 - Proliferation-associated protein 2G4	25	220	1	1436	732	3546	663	4255	1596	4094	2882	1473	1638	2892	220	4429	802	1253	2316	1914	441	4427	4742	1431	4482
20_Number of cigarettes smoked per day	20_Number of cigarettes smoked per day	25	220	1	420	3921	2806	3883	1191	4023	2050	413	4150	4245	3266	1934	220	3977	3275	1054	3579	1434	2867	1855	3415	4603
850_Acetoacetate	850_Acetoacetate	25	220	1	3644	2143	945	4322	1133	229	4031	2771	2160	4146	3427	714	2489	220	1094	1754	1985	1564	1903	3250	838	2664
498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	25	220	1	2681	1417	4742	4734	3840	3407	2449	1919	2405	1402	260	4091	2056	2518	220	3342	3267	1202	736	2384	3272	1769
3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	25	220	1	4446	702	604	1045	2247	3988	2386	941	1817	2176	620	4402	4649	3251	276	4566	220	4227	539	1170	2805	2228
205_Microalbuminuria	205_Microalbuminuria	25	220	1	413	4408	3924	3806	541	2547	1950	4103	1097	3175	2295	3589	3904	3186	3586	684	3151	220	3125	373	737	4465
1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	25	220	1	246	597	3502	697	2956	1578	597	1694	3781	1719	1993	744	3330	685	4458	2823	2091	1369	717	220	385	1810
831_::::X-14057	831_::::X-14057	25	220	1	3620	332	892	2198	4357	2433	2768	4391	2958	1098	4092	4510	2698	4307	2791	1870	4073	573	2477	3500	326	220
2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	25	221	1	1289	221	4414	3183	1517	1429	307	1869	3505	3727	2443	4199	599	567	4740	3231	1585	2765	1745	2195	1933	2208
2682_TLR2 - Toll-like receptor 2	2682_TLR2 - Toll-like receptor 2	25	221	1	1655	4105	2414	221	4451	1137	725	1787	3708	3830	1328	722	2207	4647	551	4647	1120	419	4048	295	713	3052
4694_Body of corpus callosum mean diusivities	4694_Body of corpus callosum mean diusivities	25	221	1	4490	4446	2236	462	1485	221	3449	1430	3758	3826	1944	655	307	2244	1646	2050	836	4309	2550	3897	1948	439
1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	25	221	1	3436	1211	3744	3393	2144	1588	406	3508	221	4659	1415	2875	4455	4213	728	3677	2550	2615	2239	783	2689	4312
4116_Phosphorus	4116_Phosphorus	25	221	1	4291	3630	1591	3180	3143	362	1753	1781	3123	429	2614	1108	221	3095	4038	1326	3463	889	2810	857	2767	3974
962_Concentration of very large VLDL particles	962_Concentration of very large VLDL particles	25	221	1	1744	2818	3136	2435	631	3365	549	646	320	3463	1016	3876	4561	3383	314	1600	221	700	1655	1127	4275	1985
2981_CAPG - Macrophage-capping protein	2981_CAPG - Macrophage-capping protein	25	221	1	1301	1184	4412	2122	2958	3327	3579	1494	3262	3629	1118	2053	290	2362	3281	3433	1037	1102	221	480	798	913
3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	25	221	1	4660	4317	4297	2541	2169	3429	1251	2811	4729	1526	2827	512	1677	1126	4199	2729	4584	1655	4400	1842	3001	221
2303_LGALS4 - Galectin-4	2303_LGALS4 - Galectin-4	25	222	1	2313	2881	4703	568	947	4636	594	4697	1739	3547	4304	4347	222	2157	4127	815	3285	2789	961	447	3244	968
2205_LTF - Lactotransferrin	2205_LTF - Lactotransferrin	25	222	1	3424	2300	1327	3929	3782	4052	3238	2624	385	3572	1634	2904	2473	222	2783	872	826	2052	936	1077	3405	394
3249_Lamb/mutton intake	3249_Lamb/mutton intake	25	222	1	4184	673	2451	3993	2250	3060	2815	4707	1636	3503	1472	1002	1807	2521	222	671	3857	4378	3816	1880	3248	1144
2668_FYN - Tyrosine-protein kinase Fyn	2668_FYN - Tyrosine-protein kinase Fyn	25	222	1	4723	3022	1725	2530	3657	544	3006	3710	1740	1822	1762	1585	678	240	2611	1946	222	3555	1998	1312	2597	270
1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	222	1	747	4483	264	4157	1709	2183	3390	985	2782	1703	314	1672	2938	507	4605	4501	1955	222	3238	2114	3077	721
805_::::X-12816	805_::::X-12816	25	222	1	295	1311	4621	3656	4383	1032	1517	998	3501	1061	867	1656	3685	1878	2811	2234	223	4744	421	1037	432	222
2304_CXCL1 - Growth-regulated alpha protein	2304_CXCL1 - Growth-regulated alpha protein	25	223	1	1637	2008	790	1748	429	2713	223	532	563	2042	4660	223	2088	3397	3849	1736	4097	3323	1376	4044	963	4724
502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	25	223	1	4427	3147	554	4557	4137	4467	2920	4153	223	3188	2352	3465	3014	3207	1747	2360	3381	2094	2200	2087	2882	3848
3457_Impedance measures - Leg fat mass (left)	3457_Impedance measures - Leg fat mass (left)	25	223	1	3808	1203	4729	2089	3746	3850	3227	499	1745	898	2016	4487	3255	223	1732	3712	1878	2902	1347	1666	577	711
3750_Traumatic events - Felt irritable or had angry outbursts in past month	3750_Traumatic events - Felt irritable or had angry outbursts in past month	25	223	1	3718	834	4664	4592	2200	3251	3050	2716	1131	4312	2737	859	3513	2281	223	3685	2582	351	4559	1981	1065	2895
436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	25	223	1	3588	302	552	1453	2640	2508	359	995	1548	2695	4255	1319	4360	4482	3326	3080	1310	223	1441	3589	4255	2118
192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	223	1	1601	3590	3753	2349	2695	3329	2476	670	617	3476	1330	2769	1635	651	3794	771	3884	4633	3007	813	3376	223
376_Amino acid::Glutamate metabolism::pyroglutamine*	376_Amino acid::Glutamate metabolism::pyroglutamine*	25	224	1	224	4426	4457	2120	3400	2703	2230	4199	1815	2561	2184	3792	3671	2304	2995	2221	495	355	2077	3632	4649	704
3443_Impedance measures - Whole body fat-free mass	3443_Impedance measures - Whole body fat-free mass	25	224	2	1910	2861	224	3210	4185	3253	4296	2265	650	4091	3756	3189	3820	4408	2864	4712	3806	323	914	3796	2453	410
3142_F2 - Prothrombin	3142_F2 - Prothrombin	25	224	1	748	1582	428	811	1844	2002	743	750	224	859	1095	1808	1787	1869	2514	1089	3227	1673	1061	3553	3730	4070
2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	25	224	1	615	3995	1569	1412	3324	4690	2688	812	1050	224	3070	1506	4000	3675	4290	3763	1072	4205	1069	1035	3060	1942
1913_Occipital brain volume (GEE, adjusted for multivariable)	1913_Occipital brain volume (GEE, adjusted for multivariable)	25	224	1	2483	2801	2154	2010	1036	1885	2217	4453	3587	4474	224	3020	1662	992	3698	4254	524	1056	3747	2493	3418	1885
3584_Types of transport used (excluding work): Cycle	3584_Types of transport used (excluding work): Cycle	25	224	1	2528	3535	1281	1801	3690	2449	1442	1646	3971	871	3206	224	4516	4498	4648	3114	1818	438	510	776	3245	507
2104_PRL - Prolactin	2104_PRL - Prolactin	25	224	1	1391	2329	369	4017	4356	1544	461	4283	2001	3753	3377	2566	224	4067	351	4619	1798	668	567	2762	4548	274
4551_Left inferior parietal	4551_Left inferior parietal	25	224	1	3635	956	1300	1140	3897	2408	356	4670	2057	558	739	2611	2372	224	246	3520	4421	2610	1134	2844	549	1509
1010_Tumor necrosis factor alpha	1010_Tumor necrosis factor alpha	25	224	1	631	3327	3074	535	2761	2115	3138	272	3852	577	3239	785	3271	2820	2424	4243	224	3296	3786	4086	2020	4654
2702_TPO - Thyroid peroxidase	2702_TPO - Thyroid peroxidase	25	224	1	2474	3491	4619	1345	867	2088	3825	3168	3867	1420	1871	3432	2531	4345	1484	3753	1279	4685	224	2833	3823	2452
2471_CA7 - Carbonic anhydrase 7	2471_CA7 - Carbonic anhydrase 7	25	225	1	225	1653	4725	3722	238	942	4509	2885	2971	4447	501	1432	1670	1611	3123	272	2121	1277	3944	3216	2060	2183
4712_Uncinate fasciculus mean diusivities	4712_Uncinate fasciculus mean diusivities	25	225	1	4661	225	1955	3433	4483	1084	4082	1741	2639	1982	2991	3995	1865	1621	4704	3088	3503	1443	3858	4171	3364	2677
500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	25	225	1	3185	4371	225	2697	2746	749	4565	4356	1323	1118	4571	2147	4678	4047	3537	3053	2239	4679	492	4710	320	2927
3748_Traumatic events - Felt loved as child	3748_Traumatic events - Felt loved as child	25	225	1	3355	556	2282	3425	2451	3618	431	2134	1814	225	2063	909	723	4052	2449	2298	1745	1767	2593	3635	4639	2099
1893_Shaft Section Modulus (GEE, adjussted for multivariable)	1893_Shaft Section Modulus (GEE, adjussted for multivariable)	25	225	1	4707	3213	1223	2750	3274	2008	297	4041	525	2932	889	225	1436	4468	3619	2079	1782	4088	1339	2549	3622	1854
509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	25	225	1	3172	2700	741	3891	384	4692	1355	530	1593	1552	4560	4611	225	4493	3410	1071	1256	2631	336	2322	3814	3352
4618_Left lateral ventricle	4618_Left lateral ventricle	25	225	1	310	2960	3152	3981	4028	1790	2338	3918	4314	2822	2843	843	3122	2257	3744	3876	4716	225	3119	2821	3915	3144
1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	225	1	430	1991	4318	2360	3536	2662	1771	1900	534	2157	361	968	4357	1142	2046	1561	1427	3311	1711	225	3919	655
3982_Schizophrenia	3982_Schizophrenia	25	225	1	4634	3121	2640	1360	2638	1313	4735	1637	1391	3202	1302	251	1071	3309	4113	2069	752	4497	1164	1030	4414	225
906_Lactate	906_Lactate	25	226	1	226	831	3249	4452	3101	863	1544	3692	1831	833	1153	4202	3593	1600	2588	3282	4140	4506	3403	2713	1931	1715
1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	25	226	1	2213	919	1751	846	2751	226	2045	1026	2398	3398	283	3179	3275	4604	4003	1125	2763	1575	1051	4293	817	1837
4633_Right cerebellum exterior	4633_Right cerebellum exterior	25	226	1	3064	1463	2287	952	1215	3875	4323	3770	275	226	4651	1174	3417	791	4375	1230	2274	1627	1466	1684	690	1779
2384_CA4 - Carbonic anhydrase 4	2384_CA4 - Carbonic anhydrase 4	24	226	1	2033	1290	1716	386	854	1273	1725	3689	2401	3110	311	793	226	4079	3238	951	345	1222	2911	632	683	335
2751_PDGFB - Platelet-derived growth factor subunit B	2751_PDGFB - Platelet-derived growth factor subunit B	25	226	1	2383	3865	3967	1947	3235	2522	3073	3789	2816	1831	997	2940	4408	226	1875	4567	4246	3165	2479	1278	2126	1467
4497_Right precentral	4497_Right precentral	25	226	1	4167	3777	4013	2062	1399	3843	4419	2064	4505	3986	1580	3000	791	2331	226	2183	2814	2439	2207	885	599	3699
1209_FVC	1209_FVC	25	226	1	3293	2750	665	648	462	3469	3483	3199	3050	1229	1783	2616	1314	2313	4149	226	4691	797	1344	2225	410	4301
33_Extraversion (IRT)	33_Extraversion (IRT)	25	226	1	3086	2519	2952	4102	673	4591	311	3805	1571	1632	1551	2830	490	2363	1356	273	3529	226	3959	296	3817	1310
4419_Measles seropositivity	4419_Measles seropositivity	25	226	1	3638	4338	2842	2639	772	2828	2674	2522	2324	4206	3722	1956	1386	3592	946	653	3195	588	2655	226	2140	2823
65_Insulin sensitivity index (adjusted for age, sex. Bmi)	65_Insulin sensitivity index (adjusted for age, sex. Bmi)	25	227	1	1556	227	2115	3287	2703	2133	2392	784	1821	657	3719	2705	2402	2688	3096	4169	1579	3516	2721	3057	1908	453
588_Nucleotide::Purine metabolism, urate metabolism::urate	588_Nucleotide::Purine metabolism, urate metabolism::urate	25	227	1	369	635	4546	227	941	1075	3337	3460	904	3567	2861	1465	789	3621	2464	654	2108	1694	1223	4644	4109	1083
1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	25	227	1	1024	2341	3693	4437	2222	4616	227	1049	850	4074	616	3628	884	2437	2692	2835	3960	2579	2497	3631	853	1186
4572_Left superior parietal	4572_Left superior parietal	25	227	1	3913	300	3099	780	4002	2045	3495	4383	359	512	3632	3369	227	2916	1042	4411	1877	398	3338	3215	4077	3171
4425_Hepatitis B HBc antigen seropositivity	4425_Hepatitis B HBc antigen seropositivity	25	227	1	3774	1093	1164	3116	3740	4217	3751	2870	4035	4026	3372	3427	3781	227	4201	4701	4177	1046	2831	2707	4530	3858
4726_Posterior limb of internal capsule mode of anisotropy	4726_Posterior limb of internal capsule mode of anisotropy	25	227	1	2669	4565	3830	1173	3505	1523	1233	3628	1562	2432	2946	1729	3307	2022	797	3762	3403	3064	3059	227	3597	1581
2109_ANGPT2 - Angiopoietin-2	2109_ANGPT2 - Angiopoietin-2	25	228	1	228	4326	4093	698	1288	1395	2137	1468	4626	2372	565	4013	3086	4234	741	984	4615	4566	1156	379	3322	4639
858_3Lhydroxybutyrate	858_3Lhydroxybutyrate	25	228	1	1680	228	708	3292	2659	1657	2537	1520	3907	1911	1785	818	2664	4110	2017	1880	3592	677	2071	4181	698	4148
2314_LSAMP - Limbic system-associated membrane protein	2314_LSAMP - Limbic system-associated membrane protein	25	228	1	3825	1447	1406	2237	560	1830	1858	2389	3253	228	1637	3511	2137	504	1370	426	3719	2120	1861	4413	3227	4406
2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	25	228	1	3378	3177	813	4309	4265	290	749	236	1662	2920	228	1132	3803	4132	1543	2945	3039	2603	541	2531	3936	1005
2568_CCL17 - C-C motif chemokine 17	2568_CCL17 - C-C motif chemokine 17	25	228	1	1970	4271	4266	3380	339	3033	3103	4290	2087	2222	2071	228	951	810	239	459	2591	1219	2836	2469	930	1940
595_Peptide::Dipeptide::phenylalanylphenylalanine	595_Peptide::Dipeptide::phenylalanylphenylalanine	25	228	1	1459	4050	1407	1298	1391	2711	1572	4526	4591	4137	1136	4015	228	1693	1777	977	1123	322	2804	3150	3241	3725
3787_Insomnia (male)	3787_Insomnia (male)	25	228	1	1214	2120	2526	3533	1735	2343	1932	2079	1186	2728	2330	4390	3287	228	556	834	3473	1269	679	1631	2439	3161
254_CD3 on DN T	254_CD3 on DN T	25	228	1	2248	430	3717	2941	3290	876	427	4348	2671	1417	1501	571	3142	494	796	3495	228	1991	2865	2236	3449	1434
2317_PDCD1LG2 - Programmed cell death 1 ligand 2	2317_PDCD1LG2 - Programmed cell death 1 ligand 2	25	228	1	1344	3101	1882	412	2434	4211	3487	1166	2032	3235	2171	914	1240	3470	1625	1357	2748	228	467	2647	2043	2519
3436_Weight	3436_Weight	25	228	1	917	1938	4351	3618	4529	4226	938	419	2634	3925	1959	3631	3772	2120	2451	3043	635	3952	1386	228	4214	1997
3421_Pairs matching test - Time to complete round	3421_Pairs matching test - Time to complete round	25	229	1	3592	229	2243	622	3599	3473	3253	528	2771	256	3313	4693	534	3126	627	4088	4404	2487	1209	1742	3262	3766
1007_Stem cell factor	1007_Stem cell factor	25	229	1	481	2347	1536	3956	229	3577	1813	2301	3263	1510	387	2924	2557	1516	356	812	1290	2887	4336	1373	3040	2668
466_Lipid::Bile acid metabolism::glycochenodeoxycholate	466_Lipid::Bile acid metabolism::glycochenodeoxycholate	25	229	1	3763	4025	4092	992	2224	4126	229	1698	494	3847	1647	2353	4200	2864	3707	2420	2785	1078	3252	898	848	3131
2081_IL12A IL12B - Interleukin-12	2081_IL12A IL12B - Interleukin-12	25	229	1	3618	3171	2926	361	2932	3867	1500	229	1379	673	240	2142	2540	4074	2774	2020	2005	453	3164	2424	1699	3495
2567_CPB2 - Carboxypeptidase B2	2567_CPB2 - Carboxypeptidase B2	25	229	1	1621	3200	1809	3488	1424	892	1241	4310	229	4665	1828	4679	4502	3026	2500	775	3396	1890	876	1929	1499	2223
2038_Attention function - Alerting - Child	2038_Attention function - Alerting - Child	25	229	1	4199	1676	1070	2396	1525	2671	1058	3040	2153	3497	4566	2784	229	648	2346	3648	2105	4010	3213	1699	872	4719
1166_Fasting insulin	1166_Fasting insulin	25	229	1	682	2770	4015	4217	1666	319	832	381	4033	624	2040	3902	339	229	3699	2999	1377	2878	1824	1277	645	944
1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	25	229	1	938	3346	4334	4508	3535	2596	2508	1496	4336	2116	386	4380	2226	4143	4285	4392	1075	3401	229	4682	3131	3303
4412_Total IgM levels	4412_Total IgM levels	25	229	1	856	847	3340	4022	3075	470	1583	789	1970	4113	1809	1861	1917	3200	3304	4696	4498	2819	3854	1118	229	3581
1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	24	229	1	2060	724	1411	1174	530	1098	3541	488	1151	2948	1573	1362	779	2228	3996	444	2045	867	1531	2781	4405	229
643_Xenobiotics::Xanthine metabolism::1-methylxanthine	643_Xenobiotics::Xanthine metabolism::1-methylxanthine	25	230	1	349	4384	450	3603	4111	230	1388	1311	537	3966	3027	2625	3759	1492	1185	4008	961	3029	3580	1648	2217	585
1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	230	1	1667	3165	3067	3288	1938	3142	2874	230	315	647	597	4676	3048	4272	708	786	1002	3930	4614	1671	297	1709
1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	25	230	1	1518	4449	3623	2884	1555	275	2831	922	230	584	385	4260	3979	1819	2895	2013	4236	2940	4025	3813	4353	2232
3731_Depression - Difficulty concentrating during worst ddepression	3731_Depression - Difficulty concentrating during worst ddepression	25	230	1	1125	3582	2988	834	2179	4562	2111	785	3260	230	4370	4499	1123	864	3165	3582	1763	993	2240	1176	486	1231
3564_Vitamin and mineral supplements: Vitamin D	3564_Vitamin and mineral supplements: Vitamin D	25	230	1	1151	1654	2610	4257	3174	656	4688	2943	4111	4066	1829	230	2369	2473	4541	4011	1806	1778	2531	3055	2932	1275
707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	25	230	1	1718	292	3387	908	2829	3657	3830	1675	1905	4024	1616	1417	230	2385	4054	2967	2698	666	3950	2862	3908	3914
3215_Duration of light DIY	3215_Duration of light DIY	25	230	1	518	4626	4048	2969	4130	2992	2237	3757	3476	2894	3075	4627	3614	938	4092	4485	813	2719	2626	685	230	2128
182_Waist-hip ratio (male)	182_Waist-hip ratio (male)	25	231	1	4101	2761	4067	4687	367	231	2274	2826	1337	3626	3254	1197	1980	574	4239	575	513	1253	1454	2815	557	492
88_Type 2 Diabetes	88_Type 2 Diabetes	25	231	1	4633	2424	737	2074	284	1685	384	977	1020	231	3630	567	3848	4237	1819	403	1227	754	2897	481	2944	3698
3802_Mean erythrocyte cell volume	3802_Mean erythrocyte cell volume	25	231	1	2835	2193	1703	1664	1952	3357	3734	4164	788	452	3272	360	1408	1714	231	2659	936	1820	3288	1955	725	2511
1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	25	231	1	1061	3157	346	4647	3428	1905	2911	3645	4135	2404	1179	2240	4144	2710	4665	4447	1602	231	3227	361	348	3185
2647_MMP10 - Stromelysin-2	2647_MMP10 - Stromelysin-2	25	231	1	3503	726	4377	4511	4493	3134	2130	2433	3396	2048	3741	1901	393	2195	980	3705	2588	2316	883	231	1983	724
3740_Depression - Depression possibly related to stressful or traumatic event	3740_Depression - Depression possibly related to stressful or traumatic event	25	232	1	2186	3395	3925	232	405	4451	735	1612	3973	2454	2161	4441	3094	4111	3895	3581	4632	4196	4355	3924	2980	3821
2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	25	232	1	2071	763	1991	1097	1768	4558	232	2689	1270	2567	2611	596	2928	3955	3498	3941	3691	892	2262	2640	4115	3802
32_Neuroticism (IRT)	32_Neuroticism (IRT)	25	232	1	2420	2721	3951	2113	3923	2060	2082	4605	232	246	556	1373	833	2997	3091	4061	3621	2769	473	3885	2899	3415
3491_Cereal type: Muesli	3491_Cereal type: Muesli	25	232	1	4597	2602	1684	2335	3885	3830	2690	1950	2044	890	904	4153	2125	232	3696	3395	1033	3893	1827	3306	883	2695
1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	25	232	1	1713	3627	3034	4303	613	2733	3993	2415	4328	387	1605	4018	720	4560	3183	232	3505	3457	592	1390	782	1551
4696_Cingulum (hippocampus) mean diusivities	4696_Cingulum (hippocampus) mean diusivities	25	232	1	2031	4297	4496	755	1470	1877	1620	1290	3868	3154	1749	4317	3786	3373	1376	1150	4437	1873	3104	232	3300	2476
470_Lipid::Bile acid metabolism::taurochenodeoxycholate	470_Lipid::Bile acid metabolism::taurochenodeoxycholate	25	232	1	893	1126	4332	1351	3202	1868	3461	3226	2747	1640	3105	635	666	2998	1657	4316	1472	2177	1013	4005	232	3469
4373_Free thyroxine (FT4, male)	4373_Free thyroxine (FT4, male)	25	233	1	2582	233	3569	1747	633	901	2055	2797	3304	4252	4731	497	1154	1189	816	1618	1296	1675	2339	293	2727	3714
2082_CCL20 - C-C motif chemokine 20	2082_CCL20 - C-C motif chemokine 20	25	233	1	2502	584	392	233	1348	1573	933	4193	1685	2926	3054	653	3196	1580	2972	1392	3511	2475	3602	2614	1622	2459
2444_GFRA1 - GDNF family receptor alpha-1	2444_GFRA1 - GDNF family receptor alpha-1	25	233	1	2258	282	816	4715	3383	2510	418	3509	233	1702	397	1277	3312	1469	2021	4330	764	570	4438	2589	662	850
139_Waist-hip ratio (female)	139_Waist-hip ratio (female)	25	233	1	2797	1549	1623	1870	4452	3277	866	1424	3337	1964	1101	3497	3042	2269	3943	2062	3550	2023	233	2598	3304	4346
1877_Shaft average buckling ratio (GEE, male, adjussted for age)	1877_Shaft average buckling ratio (GEE, male, adjussted for age)	25	233	1	1932	2851	2796	2254	575	4333	1777	3138	4602	2051	3367	1495	1898	2986	1792	1132	3014	347	416	233	4347	1136
1190_Mitral annular calcification	1190_Mitral annular calcification	25	233	1	4090	4013	4391	4732	3325	2473	2646	2409	3636	3748	2421	1565	1478	973	3940	3390	2729	3745	3070	2805	233	4662
365_Amino acid::Alanine and aspartate metabolism::asparagine	365_Amino acid::Alanine and aspartate metabolism::asparagine	25	234	1	234	257	4320	4014	4641	1875	2258	1858	2833	1812	1741	3494	4276	2124	1156	3056	384	2741	489	493	3302	3845
3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	25	234	1	4279	2941	3500	4154	1669	1123	2221	767	1532	4584	1510	4609	3971	4524	234	1773	2050	4232	3511	1263	1085	4089
3446_Impedance measures - Basal metabolic rate	3446_Impedance measures - Basal metabolic rate	25	234	1	1858	3430	1144	1551	4372	976	3959	4178	1207	4294	3259	2649	4375	4023	1636	4734	4664	234	1733	4735	1887	236
2763_TF - Serotransferrin	2763_TF - Serotransferrin	25	234	1	3353	275	4744	2134	1436	1980	1314	3506	2759	2878	4585	2834	3162	801	2733	3449	1939	4400	937	4403	4191	234
454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	25	235	1	235	2200	4670	742	3296	4726	3607	4468	2892	4338	3947	1540	3905	4242	536	2347	407	3509	3668	2976	2741	3644
4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	25	235	1	2442	1825	1221	235	3238	1589	1425	4525	3884	1453	649	2036	4220	1387	4453	2704	2364	4428	3901	3925	4319	4015
1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	25	235	1	3413	3404	250	2731	2889	4260	235	1995	893	2636	987	1289	900	2751	742	3162	620	1857	1120	3878	1961	4720
130_Hip circumference (male, adjusted for BMI)	130_Hip circumference (male, adjusted for BMI)	25	235	1	4578	4176	3675	1805	1957	587	762	1061	373	235	2043	2679	1311	4043	4462	1760	3456	2346	431	4475	2542	1230
925_Concentration of medium VLDL particles	925_Concentration of medium VLDL particles	25	235	1	3071	2936	4315	3701	639	1725	632	1797	2440	322	4705	1046	2588	3204	235	1250	929	1111	3714	792	2164	545
2462_ABL1 - Tyrosine-protein kinase ABL1	2462_ABL1 - Tyrosine-protein kinase ABL1	25	235	1	302	2829	2165	1530	3266	3476	3512	2095	3057	1496	3469	580	2597	2132	3063	2901	3121	235	616	2561	537	4292
4230_Opioids	4230_Opioids	25	235	1	1824	3386	3319	3793	410	3842	3255	3123	2513	1025	2119	2064	3381	1089	3501	760	2313	713	933	2128	235	580
1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	25	235	1	496	1484	1003	1979	800	3913	756	3600	2673	2100	3770	3438	810	3127	1118	1346	798	4142	1658	3857	3846	235
3362_Mother's age at death	3362_Mother's age at death	25	236	1	3386	2729	1603	236	4469	498	4391	2260	1579	3466	1744	4131	3441	4361	483	4015	1001	1853	3552	794	562	2434
2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	25	236	1	1257	2776	1360	4223	4643	4282	989	1623	3277	877	3557	236	3088	1340	389	2359	454	2075	2164	523	570	2601
1140_Type 2 Diabetes (Dominance deviation model)	1140_Type 2 Diabetes (Dominance deviation model)	25	236	1	2484	4603	486	3123	1791	3366	2859	774	2984	2741	963	1681	3401	3531	1242	881	1103	236	2877	3270	306	4599
1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	25	236	1	3578	1786	2541	2657	3460	1492	1823	3652	1455	3554	3432	3431	2082	3536	4653	4160	3032	3140	777	236	1847	2306
2477_CHRDL1 - Chordin-like protein 1	2477_CHRDL1 - Chordin-like protein 1	25	236	1	782	3215	4343	3027	4674	2913	4674	4717	3559	3125	1550	1322	4132	1865	941	3193	1752	3009	528	4545	236	2739
3772_Depression - Recent feelings of tiredness or low enery	3772_Depression - Recent feelings of tiredness or low enery	25	237	1	1737	4519	1757	3757	3678	3998	3477	237	3425	461	3094	961	3170	626	1142	4218	4493	4314	2437	1999	3899	1717
3913_Cup area	3913_Cup area	25	237	1	4643	1449	1184	2529	2074	401	3576	2880	237	1717	3440	2756	2584	3037	3197	4689	2912	1993	4534	1290	3208	4705
1083_Hemoglobin A1C level in intensive treatment group	1083_Hemoglobin A1C level in intensive treatment group	25	237	1	973	4381	2656	2753	891	474	1426	2891	882	4072	237	3038	2798	2345	1709	1772	1425	3553	1760	4392	2747	1399
1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	237	1	4085	2443	2219	1815	3334	1396	4252	2700	3984	3458	2302	3389	237	1259	4673	3458	897	2063	2607	1368	4073	1000
2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	25	237	1	3546	3553	2452	1881	3893	3415	3303	1124	2808	3183	1351	4311	4592	2989	237	2063	2905	3634	328	2940	1043	4173
3743_Depression - Feelings of worthlessness during worst period of depression	3743_Depression - Feelings of worthlessness during worst period of depression	25	237	1	1786	936	4006	536	1098	4509	3687	1170	2690	4008	2891	882	3947	1103	4306	4674	237	434	334	3469	2269	2109
3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	25	237	1	4036	2146	1696	3383	672	4350	2461	2376	1298	3723	2327	1406	3298	2384	1678	2103	4135	3400	4505	1606	2210	237
384_Amino acid::Glycine, serine and threonine metabolism::threonine	384_Amino acid::Glycine, serine and threonine metabolism::threonine	25	238	1	2589	613	2736	407	794	3623	1793	739	2823	3701	238	2522	4632	3402	779	1055	3643	2852	2582	724	3984	1034
3237_Smoking/smokers in household	3237_Smoking/smokers in household	25	238	1	2428	2135	3336	963	3571	1055	3975	1813	428	3264	1867	238	3000	4393	1338	3698	4371	1801	4261	4611	3224	720
1054_Amyotrophic lateral sclerosis	1054_Amyotrophic lateral sclerosis	25	238	1	567	658	4304	1018	3523	1710	3932	3002	672	2118	2735	2833	3714	3902	3642	4561	701	4292	2072	3693	763	238
895_Total lipids in large LDL	895_Total lipids in large LDL	25	239	1	239	606	407	527	2274	645	2213	4073	394	4579	632	2929	3563	763	815	1460	1511	3572	2124	1705	3071	922
3853_Monocyte count (two-way meta)	3853_Monocyte count (two-way meta)	25	239	1	3298	2738	1950	854	811	4424	239	4261	2624	936	268	745	1027	3393	4371	877	4473	883	3121	3506	2786	2565
123_Overweight	123_Overweight	25	239	1	1487	688	1567	2353	2870	1891	3780	239	2364	3531	1172	569	3561	3391	4732	4208	2122	3883	4569	2996	2504	293
1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	239	1	979	2108	3402	1908	2712	709	4103	1958	239	1575	3731	1104	3724	786	3989	2840	2634	3360	2802	3941	4714	2651
4753_Superior fronto-occipital fasciculus radial diusivities	4753_Superior fronto-occipital fasciculus radial diusivities	25	239	1	460	4410	2840	541	3321	1078	1480	1673	747	239	3290	2739	4633	3847	632	1082	851	2683	3739	1920	3662	3965
1205_Serum Thyroid-stimulating hormone level	1205_Serum Thyroid-stimulating hormone level	25	239	1	1770	3642	2975	3422	4291	1089	2293	4742	2286	1160	1438	268	239	1343	3900	4746	4274	4613	4642	275	3346	763
1765_Heart failure (free of MI, GEE, adjusted for age and sex)	1765_Heart failure (free of MI, GEE, adjusted for age and sex)	25	239	1	3941	411	270	2620	3956	1964	2374	2677	2511	2070	2833	3522	1683	2118	1743	4384	625	239	2065	1042	2783	1599
3187_Standing height	3187_Standing height	25	239	1	4553	2698	954	3703	1178	4625	2980	2761	2705	2928	1693	4309	2030	1697	1718	3525	317	2074	239	4630	1621	2140
3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	25	239	1	577	4028	1707	3266	2248	2243	2168	4030	3082	2068	4698	3808	2674	2690	3786	1611	1947	672	573	239	1960	3740
2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	25	239	1	2405	1959	986	3198	4359	4139	4592	1632	1864	2663	2313	3655	1001	4133	1667	1981	4046	4295	1731	578	239	2240
2861_FGF7 - Fibroblast growth factor 7	2861_FGF7 - Fibroblast growth factor 7	25	239	1	2166	3499	1088	2463	1405	2390	4038	1957	1750	4226	4709	489	4629	4445	477	3474	3476	4576	4144	4101	4675	239
4500_Right rostral middle frontal	4500_Right rostral middle frontal	25	240	1	240	3368	4177	2487	1943	4671	467	2532	780	2300	3834	991	4574	2608	4466	4194	1573	1370	349	2015	3531	2054
4449_Left fusiform	4449_Left fusiform	25	240	1	1296	616	4456	3743	1558	3320	2972	1801	240	3037	3016	2989	3551	1540	3425	2032	3002	3741	3932	3010	3521	3983
2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	25	240	1	1001	3132	4296	857	3676	2535	390	4096	1677	4348	2469	305	240	2474	4743	3886	1726	1189	1411	4228	2541	3010
1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	25	240	1	2703	4147	2662	2295	426	1018	3369	1850	1676	3221	1934	2826	930	4003	4629	240	509	4335	2301	1422	2141	4522
3760_Depression - Recent feelings of inadequacy	3760_Depression - Recent feelings of inadequacy	25	241	1	1472	2648	2367	606	4330	4144	388	241	405	3004	4661	3124	2297	3968	4073	3352	1118	3619	4743	4041	3230	2793
262_CD8:%Naive	262_CD8:%Naive	25	241	1	4183	3086	4144	1310	1690	2340	877	661	1322	1554	2560	241	813	1316	3880	1740	2025	2630	861	3442	2057	3629
3580_Social support - Leisure/social activities: Other group activity	3580_Social support - Leisure/social activities: Other group activity	25	241	1	3856	1473	3234	4533	2373	953	2496	4236	3604	3631	1043	4536	2833	3894	3862	1613	2639	4583	241	858	1136	2253
1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	25	241	1	3171	4512	696	4124	1962	1043	2009	502	4373	470	2937	4185	1908	2383	3270	2116	1436	1186	1402	2840	241	4432
3326_Number of children fathered (male)	3326_Number of children fathered (male)	25	242	1	1249	1389	242	2699	4233	3079	3340	2402	4589	2182	2807	3365	2135	1294	2886	4092	2249	4508	775	3166	1059	3049
907_Total cholesterol in LDL	907_Total cholesterol in LDL	25	242	1	267	272	671	242	1925	640	3977	4020	767	4178	776	3239	3008	1092	642	1343	1535	3444	1961	1736	3034	1657
3227_Usual side of head for mobile phone use	3227_Usual side of head for mobile phone use	25	242	1	3739	4741	3643	463	3931	242	4250	2456	3667	3158	1878	3267	1806	2849	4669	2966	1303	287	702	1003	1337	3830
3980_Offspring birthweight (maternal)	3980_Offspring birthweight (maternal)	25	242	1	445	2201	1349	3222	678	4148	242	2105	3121	2722	512	1551	1267	3838	3780	1152	2359	554	3797	3257	2345	4426
4317_Drinks per day	4317_Drinks per day	25	242	1	3698	1274	3697	960	4085	643	3765	242	996	1393	809	3423	2250	3607	4389	3247	2786	853	787	1948	4560	1701
2551_CAT - Catalase	2551_CAT - Catalase	25	242	1	808	1579	2591	3202	4584	543	680	2591	4330	1867	242	3831	4717	3564	4578	4305	2696	2811	1736	1438	561	3986
3384_Non-accidental death in close genetic family	3384_Non-accidental death in close genetic family	25	242	1	2507	2299	3850	917	544	2614	1891	811	1428	4152	2754	3614	3451	2221	242	494	269	3181	2843	3481	2462	1344
2653_ANGPTL4 - Angiopoietin-related protein 4	2653_ANGPTL4 - Angiopoietin-related protein 4	25	242	1	3089	2310	4365	4363	2792	1107	1914	899	1589	1239	4137	1182	648	610	2340	1512	2872	4305	242	476	4665	1104
2730_BPI - Bactericidal permeability-increasing protein	2730_BPI - Bactericidal permeability-increasing protein	25	242	1	1466	3438	849	805	1246	4091	4676	4379	3498	3607	384	1270	1982	1175	3593	2705	2499	2591	3568	4238	242	627
3497_Hair colour (natural, before greying): Light brown	3497_Hair colour (natural, before greying): Light brown	25	243	1	820	2743	243	2589	1682	2915	3990	3260	1748	4490	2211	3500	2181	4522	1173	3587	2811	1632	2717	2416	3236	3995
4587_Right lingual	4587_Right lingual	25	243	1	3743	4527	4501	243	4665	2421	1909	1526	3274	1424	3730	496	1790	4349	3223	4244	3185	1997	1922	3610	2614	1732
2977_ARPP19 - cAMP-regulated phosphoprotein 19	2977_ARPP19 - cAMP-regulated phosphoprotein 19	25	243	1	561	1586	3762	554	243	1223	1910	4524	2223	4147	3309	4606	2299	3245	1160	387	4240	837	1541	331	1582	4676
718_::::X-11530	718_::::X-11530	25	243	1	3263	1961	3337	2984	4568	243	4651	2140	427	312	1270	4113	3894	4660	2792	3995	2895	964	4274	2160	1243	4313
1906_Hippocampal volume (FBAT, adjusted for multivariable)	1906_Hippocampal volume (FBAT, adjusted for multivariable)	25	243	1	376	766	1041	441	4444	2876	2432	1710	243	1146	339	4196	2436	3816	3181	2714	3099	3667	2613	2346	1823	682
1043_Shaft Width (GEE, adjusted for multivariable)	1043_Shaft Width (GEE, adjusted for multivariable)	25	243	1	299	2871	1308	1699	4632	463	1104	3900	2084	1604	243	3986	1897	963	1760	3441	448	2130	2506	1479	3939	2719
3511_Reason for reducing amount of alcohol drunk: Other reason	3511_Reason for reducing amount of alcohol drunk: Other reason	25	243	1	461	3496	4681	4419	810	1636	768	1404	4029	3420	3669	3362	3089	2452	243	975	1441	1201	3486	2178	576	2368
1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	243	1	1700	2479	4491	564	3707	2394	3194	2226	1901	3499	2942	2179	455	3687	672	2510	3480	243	3396	1646	3819	2625
4621_Left cerebellum white matter	4621_Left cerebellum white matter	25	243	1	437	3033	2986	251	3007	4100	260	3784	4410	751	1499	1215	3686	2108	1078	2726	4434	2837	1972	2088	1374	243
3642_Illnesses of mother: Breast cancer	3642_Illnesses of mother: Breast cancer	25	244	1	712	3998	1120	244	3547	2057	3688	4725	2497	2818	2127	359	2768	542	525	1212	970	2038	599	788	1139	1655
2505_BCL2A1 - Bcl-2-related protein A1	2505_BCL2A1 - Bcl-2-related protein A1	25	244	1	2500	2447	3644	1520	244	2300	673	3611	2701	1681	4147	425	2399	1947	3075	726	721	3676	1946	4346	1128	3404
1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	25	244	1	3198	1855	3277	3984	2116	244	4369	2293	3596	1466	1640	1761	3751	4083	4119	1059	2679	2791	1555	591	1687	768
2085_TIMP3 - Metalloproteinase inhibitor 3	2085_TIMP3 - Metalloproteinase inhibitor 3	25	244	1	1692	2283	1346	3811	4492	1967	2016	1730	2773	911	244	1722	2327	401	2489	4667	2632	3305	4057	1060	3431	4051
2941_INS - Insulin	2941_INS - Insulin	25	244	1	3894	3135	2723	2514	2150	3659	3473	3994	1389	4164	3045	2599	1838	4716	3320	3202	3442	1602	244	2149	2311	3738
560_Lipid::Medium chain fatty acid::pelargonate (9:0)	560_Lipid::Medium chain fatty acid::pelargonate (9:0)	25	244	1	2863	1003	3116	1507	3088	2391	1320	4719	2894	3270	2087	1569	1212	4173	875	3484	4553	4064	1524	244	3928	1665
4537_Right pallidum	4537_Right pallidum	25	244	1	2872	744	3275	1576	2939	3848	4412	3432	2390	3090	4105	1712	1402	276	4150	2475	4634	1992	1578	1172	244	3177
4197_Waist-hip ratio	4197_Waist-hip ratio	25	245	1	2282	245	1448	308	3403	3601	3140	4165	657	2574	4252	1228	4441	4102	3623	3554	3525	4200	908	1745	1325	1802
2380_ARSB - Arylsulfatase B	2380_ARSB - Arylsulfatase B	25	245	1	2435	4620	245	1105	3243	3036	4273	1893	3140	3007	2143	2578	4150	3717	4422	3471	4136	1813	3895	405	3807	2799
868_OmegaL6 fatty acids	868_OmegaL6 fatty acids	25	245	1	2076	3031	2387	1247	245	2472	3479	2101	1294	4597	1091	3763	3933	1249	388	339	802	2257	4657	1603	3421	1235
1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	245	1	3867	2894	3246	793	4659	3328	4627	245	1504	4516	2414	2610	548	2271	2277	2694	1150	1833	1588	3205	433	4104
3294_Loneliness, isolation	3294_Loneliness, isolation	25	245	1	526	907	1377	770	4000	2964	4264	4645	1792	245	1599	3919	3431	399	4635	3801	3145	3842	2153	614	2377	3945
3547_Mouth/teeth dental problems: Loose teeth	3547_Mouth/teeth dental problems: Loose teeth	25	245	1	4117	1147	4649	2436	1267	2537	3836	4493	4288	1487	3055	594	245	4678	2225	4094	827	2955	1256	3221	1551	1023
278_CD8:%Act(25+38+)	278_CD8:%Act(25+38+)	25	245	1	3577	2856	2131	2904	310	4235	644	2271	1359	4083	718	4032	729	2676	2011	245	2069	2441	2952	364	4415	3006
4134_Lymphocyte count	4134_Lymphocyte count	25	245	1	1486	2473	1460	2119	3332	1412	1473	1199	4305	1023	3428	4155	1606	3222	3095	3548	2818	245	4158	4383	2684	3947
1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	25	245	1	2973	3367	280	2232	2245	3162	3781	2754	2037	3422	1434	4353	2184	329	2384	2390	279	1648	4372	245	4168	4193
2036_Cisplatin-associated ototoxicity	2036_Cisplatin-associated ototoxicity	25	246	1	574	4417	2188	3729	4278	246	2112	3546	507	599	2859	3807	444	1042	3087	2197	948	350	595	862	4453	3606
2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	25	246	1	3568	633	907	3008	2963	292	1711	2800	246	4148	4721	736	3230	2097	3472	4649	3753	3398	2214	2989	4413	1163
3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	25	246	1	3156	475	4138	2594	1899	4074	1396	3304	796	4658	246	977	1920	2158	2362	3979	3169	1451	534	4269	3578	483
1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	25	246	1	3637	4370	3343	497	1796	481	2067	2989	272	777	2328	4419	4189	1506	2648	4515	335	511	246	821	823	283
1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	25	246	1	1460	2492	3833	1115	4337	2317	2042	1991	4432	3318	1690	3769	979	4610	2853	4539	1088	4027	2808	246	2901	4708
2507_IBSP - Bone sialoprotein 2	2507_IBSP - Bone sialoprotein 2	25	246	1	1402	1875	1741	2311	2694	2402	2026	1373	4452	3493	258	2210	4412	2828	1524	2317	1987	2331	2648	2328	246	1382
3244_Oily fish intake	3244_Oily fish intake	25	247	1	2130	247	2026	338	2686	1338	361	3321	1493	273	4332	3295	1994	2110	3765	1925	799	377	874	3496	3100	3437
2065_PLAT - Tissue-type plasminogen activator	2065_PLAT - Tissue-type plasminogen activator	25	247	1	3483	3273	2237	4285	247	2772	3770	4187	2108	1834	3071	3050	3302	1060	304	551	1871	510	3347	1700	4486	368
147_Body Mass Index (male > 50 yrs)	147_Body Mass Index (male > 50 yrs)	25	247	1	4638	1063	4388	2236	1894	2241	3338	247	1419	771	724	2841	1477	1203	2552	2526	2055	3121	3004	761	2460	1359
2279_CFD - Complement factor D	2279_CFD - Complement factor D	25	247	1	4442	2611	876	2806	1421	2078	2539	4334	2544	411	2784	1692	3651	247	4182	2779	3742	1934	2392	2289	2963	3360
965_Total lipids in very small VLDL	965_Total lipids in very small VLDL	25	247	1	1769	2265	1728	1603	370	2230	2869	1616	883	4397	612	3058	1997	983	247	475	1460	2759	3956	1169	4007	732
2327_CD209 - CD209 antigen	2327_CD209 - CD209 antigen	25	247	1	1511	3636	2792	4578	4433	2285	2414	874	3988	2990	573	1772	326	2177	3704	2120	1045	2686	247	2958	2758	314
24_Attention deficit hyperactivity disorder	24_Attention deficit hyperactivity disorder	25	247	1	439	690	368	2077	2133	3393	3018	794	4514	1455	4567	912	3105	3029	1477	4353	4088	2932	3241	247	2801	1424
4421_Herpes simplex virus 1 seropositivity	4421_Herpes simplex virus 1 seropositivity	25	248	1	4373	2887	1143	248	4306	3213	1158	761	2596	1749	647	3137	2309	339	2415	2814	904	1567	4210	2856	3592	2979
2379_APP - Amyloid beta A4 protein	2379_APP - Amyloid beta A4 protein	25	248	1	2774	261	3880	4631	3168	248	876	3163	4167	3392	3530	3133	3923	3714	687	4706	3127	2930	3703	628	3779	3859
2195_FGF9 - Fibroblast growth factor 9	2195_FGF9 - Fibroblast growth factor 9	25	248	1	608	4611	1072	3819	693	3947	4442	2909	248	1517	1602	1847	1544	3146	1372	525	3064	4236	1954	834	2797	4455
900_Free cholesterol in large VLDL	900_Free cholesterol in large VLDL	25	248	1	4051	3644	2697	2625	680	1811	923	1859	3981	248	4170	1111	601	2301	461	1849	673	1723	3809	990	1600	478
2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	25	248	1	3811	460	4214	3664	1556	3675	2299	1854	1527	1292	2118	885	248	3974	4583	4318	4531	1152	3128	1733	1982	1870
4065_Gait speed	4065_Gait speed	24	248	1	3329	4222	3538	2386	747	599	3062	542	2246	2908	2092	1954	777	248	3381	2436	2456	4562	3069	4305	3802	3851
4375_Hyperthyroidism	4375_Hyperthyroidism	25	248	1	4687	1109	2120	3190	807	1269	1980	2907	3756	2449	4736	3079	2783	1524	1062	467	4091	2445	248	4162	1366	842
2999_GPC5 - Glypican-5	2999_GPC5 - Glypican-5	25	249	1	249	4076	3301	2950	1728	879	4607	3373	3151	4728	4195	3092	2365	4699	2713	3839	1891	1392	2519	3745	1208	568
678_::::X-09108	678_::::X-09108	25	249	1	4065	885	3684	249	3607	1785	2147	4188	2363	3216	523	452	2605	3916	2328	3125	829	4478	1166	973	1287	1301
2256_TBP - TATA-box-binding protein	2256_TBP - TATA-box-binding protein	25	249	1	641	2622	2762	3821	316	1173	249	2148	3773	3200	4115	946	4616	1936	3100	553	3744	3235	935	4226	3445	2288
4239_Latent naming speed	4239_Latent naming speed	25	249	1	1624	4585	4651	4723	899	648	2165	249	2577	1356	824	4104	1122	2037	2625	960	743	2116	4605	1633	3678	813
2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	25	249	1	468	423	4220	2365	4621	2376	2856	2768	249	2589	4157	3434	1918	4325	3396	2580	1046	4288	299	4546	4079	3079
3911_Cup area	3911_Cup area	25	249	1	2710	1675	1820	4672	4476	3582	4498	3468	2652	249	918	3615	509	1362	3388	4322	2414	1048	1746	353	1116	2467
2982_CA1 - Carbonic anhydrase 1	2982_CA1 - Carbonic anhydrase 1	25	249	1	1719	3181	1853	822	2570	3361	880	2845	3537	515	2409	1361	2930	249	3969	1799	2611	2250	1920	2033	3747	1777
203_Chronic kidney disease	203_Chronic kidney disease	25	250	1	250	1794	1657	2760	4579	2386	694	2504	831	726	1237	1130	2964	2516	2081	2343	1134	1464	1189	3494	4411	2579
3842_Granulocyte percentage of myeloid white cells (two-way meta)	3842_Granulocyte percentage of myeloid white cells (two-way meta)	25	250	1	4255	3880	726	2515	1699	250	4376	1119	640	573	2464	646	3920	3139	4259	2846	933	3779	1976	3872	1886	517
4115_Calcium	4115_Calcium	25	250	1	2940	880	3435	660	1134	2111	2450	1704	250	1758	2462	719	4055	4451	297	852	1243	3994	1325	1330	820	4296
3915_Disc area	3915_Disc area	25	250	1	3444	650	4397	4042	2337	1336	1311	2550	3021	2777	250	2992	721	868	581	2375	3873	2497	1967	351	1191	3944
2865_IL12B IL23A - Interleukin-23	2865_IL12B IL23A - Interleukin-23	25	250	1	4472	1456	1175	3869	3027	1869	2142	896	3885	3518	3871	250	1078	295	4265	2107	4518	3353	1687	1596	3004	1991
2064_TIMP1 - Metalloproteinase inhibitor 1	2064_TIMP1 - Metalloproteinase inhibitor 1	25	250	1	998	3267	2810	2878	2863	2120	2073	2685	3947	4386	3582	1767	1415	4717	250	3401	1659	4081	1685	2552	2421	676
17_Anorexia nervosa	17_Anorexia nervosa	25	250	1	623	1310	1401	1255	3677	4579	2961	1953	3206	1820	865	1089	1073	4384	1483	2117	2399	3210	4218	250	3591	772
4559_Left parahippocampal	4559_Left parahippocampal	25	250	1	2005	1149	4060	2243	1333	757	4306	4259	4187	2447	2948	2412	2526	1364	1445	4688	1849	828	3712	1313	250	4353
747_::::X-12029	747_::::X-12029	25	251	1	2953	4475	251	1789	1855	4532	1733	1491	2803	4672	3031	695	2834	3729	1264	1084	2563	3878	3423	1789	3848	631
3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	25	251	1	3154	1768	2450	2789	2757	251	4358	723	1205	965	2840	1106	1850	991	4170	3863	958	3377	1773	4643	3324	2844
2990_PI3 - Elafin	2990_PI3 - Elafin	25	251	1	1474	3938	2296	2057	2321	265	3794	4302	898	1467	3378	2517	3943	1513	3793	1998	251	3211	639	3764	3860	3317
685_::::X-10506	685_::::X-10506	25	251	1	281	1353	4275	1970	1096	4691	1680	596	263	2839	4144	3943	2936	1866	1415	969	3684	1986	251	514	3746	3856
2320_TGFBR3 - Transforming growth factor beta receptor type 3	2320_TGFBR3 - Transforming growth factor beta receptor type 3	25	251	1	381	427	3559	1498	2767	4125	1359	2394	3341	4078	1876	2838	1452	2042	3160	1062	1288	1206	2101	251	3951	4254
3404_Fluid intelligence test - FI6 : conditional arithmetic	3404_Fluid intelligence test - FI6 : conditional arithmetic	25	251	1	4475	1945	2789	1083	3737	4501	4077	3099	3746	681	2782	3689	2668	3226	4525	4268	2162	1003	716	701	251	2840
4560_Left paracentral	4560_Left paracentral	25	252	1	1286	252	778	1873	2231	1535	2257	3872	4120	2491	2209	1281	625	1825	2003	685	1322	4365	2604	3422	3339	2988
127_Height (female)	127_Height (female)	25	252	1	2194	2011	252	1995	1324	966	365	1376	4677	3991	2474	2235	2074	3775	4243	519	896	2399	2473	779	2422	4623
2705_ASGR1 - Asialoglycoprotein receptor 1	2705_ASGR1 - Asialoglycoprotein receptor 1	25	252	1	4264	3584	3851	252	4141	4624	3698	3910	3444	874	4509	4222	3182	3385	1402	2971	2257	1741	519	4012	3758	1307
4746_Inferior fronto-occipital fasciculus radial diusivities	4746_Inferior fronto-occipital fasciculus radial diusivities	25	252	1	2265	3741	2085	4153	3452	252	1245	1752	4629	342	2597	4110	4057	4341	4004	3274	2530	2173	3422	4265	1617	3001
951_Urea	951_Urea	25	252	1	3053	704	4055	4006	1819	3789	252	410	4637	4121	2563	4393	1352	1087	1589	3650	2864	2928	4586	4681	2383	3708
979_Hepatocyte growth factor	979_Hepatocyte growth factor	25	252	1	3771	622	4064	3506	4414	909	746	4046	3719	252	3814	4333	4085	4733	3620	2203	4617	3599	2421	483	3039	4055
4427_Epstein Barr Virus antigen EBNA seropositivity	4427_Epstein Barr Virus antigen EBNA seropositivity	25	252	1	1631	2830	1357	2737	386	639	3824	1397	2976	3215	252	4071	2894	2159	2829	480	1003	541	3298	1711	1572	4272
980_Interferon-gamma	980_Interferon-gamma	25	252	1	4447	381	3841	4424	368	4421	3652	984	2990	3056	1440	922	3437	4088	252	2040	1600	2960	2997	1418	808	649
785_::::X-12556	785_::::X-12556	25	252	1	1229	3336	974	1715	2016	3435	1701	2238	1158	4730	3652	3123	2619	2077	3791	2235	3371	1136	2108	252	3485	1998
2555_CXCL6 - C-X-C motif chemokine 6	2555_CXCL6 - C-X-C motif chemokine 6	25	252	1	761	2437	2001	4606	1662	526	4100	1778	1042	3836	3156	357	4339	1765	4359	1161	2498	2965	1208	4579	1379	252
936_Total cholesterol in small LDL	936_Total cholesterol in small LDL	25	253	1	253	320	601	473	1916	601	4095	3565	1080	4283	1110	3767	2817	1026	911	1348	1532	2853	2224	1719	3084	1315
937_Total lipids in small LDL	937_Total lipids in small LDL	25	253	1	300	253	415	1469	1584	532	2436	2050	487	4310	954	3479	3718	652	620	1413	2932	3992	3092	3908	1076	945
4068_Automobile speeding propensity	4068_Automobile speeding propensity	25	253	1	2390	1917	1573	733	3357	253	2173	1917	2889	3965	2739	4494	3799	284	2909	4148	907	4704	2257	4197	1761	1131
285_CD4:%Treg(39+)	285_CD4:%Treg(39+)	25	253	1	826	1089	4233	1935	2847	1323	3689	3476	2872	644	2400	253	1999	4054	1352	4364	1671	4086	2984	1464	2552	3601
3001_GSTA3 - Glutathione S-transferase A3	3001_GSTA3 - Glutathione S-transferase A3	25	253	1	958	3783	2712	3176	3514	3489	1829	1985	471	4440	3379	2076	3300	858	253	4468	2334	3356	2229	4695	4027	4146
2406_LTA4H - Leukotriene A-4 hydrolase	2406_LTA4H - Leukotriene A-4 hydrolase	25	253	1	3152	1872	3111	1096	294	1133	2524	390	3025	623	2355	3163	1523	4614	2958	253	4494	1082	1646	388	4706	2520
1971_MMSE score (at exam 7, GEE, adjusted for age)	1971_MMSE score (at exam 7, GEE, adjusted for age)	25	253	1	2845	3640	1405	3865	2595	2404	4056	2182	1349	1217	4662	3206	1628	3048	3967	3070	4100	4559	985	4133	253	411
1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	25	254	1	254	4123	3267	4108	1964	1538	613	3277	2042	2311	4386	3437	1511	2219	3215	4111	1364	2121	692	3704	2135	4008
2355_LGALS3 - Galectin-3	2355_LGALS3 - Galectin-3	25	254	1	1988	1580	2932	889	254	3972	2630	4375	2110	782	300	3947	284	4401	2633	290	2160	2490	4389	1824	516	2041
2106_VEGFA - Vascular endothelial growth factor A	2106_VEGFA - Vascular endothelial growth factor A	25	254	1	4075	1974	4077	2186	3044	254	3671	276	2841	3307	1059	2637	1083	2993	2881	3149	4508	1883	1718	979	4363	3948
1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	25	254	1	2960	3328	2029	3456	3187	805	717	777	254	2371	3528	2471	4212	3089	4581	3856	1228	1681	1601	750	3563	2578
3318_Weight change compared with 1 year ago	3318_Weight change compared with 1 year ago	25	254	1	4134	896	4740	2373	3951	1943	3916	1999	4098	254	621	1691	4087	2316	1285	3720	1308	2377	1809	3171	2306	3026
615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	25	254	1	4278	1982	363	2890	2163	4607	2106	315	4121	918	3458	2587	2282	3256	254	4286	1547	2871	735	2049	2956	4320
2237_ICAM2 - Intercellular adhesion molecule 2	2237_ICAM2 - Intercellular adhesion molecule 2	25	254	1	789	3234	1287	1762	397	2549	285	3177	859	1562	2894	737	738	1352	3637	254	792	4575	1442	4385	4433	2472
2595_EPHB4 - Ephrin type-B receptor 4	2595_EPHB4 - Ephrin type-B receptor 4	25	254	1	1633	3847	1724	3540	2443	1369	3890	1197	4430	3112	1826	1550	1692	1456	3825	3288	934	345	2080	254	730	3554
2150_CKM - Creatine kinase M-type	2150_CKM - Creatine kinase M-type	25	255	1	4222	1569	255	2946	4170	4115	2010	3955	846	4109	3897	1359	3609	3625	2461	3976	3223	1455	4422	1782	2385	2090
1099_C-reactive protein - Birth cohorts	1099_C-reactive protein - Birth cohorts	25	255	1	4567	2707	4715	255	2025	1309	2228	4270	3921	3383	2730	712	985	3128	1719	2747	1190	3880	3224	1350	3793	2077
4041_Schizophrenia vs Bipolar disorder	4041_Schizophrenia vs Bipolar disorder	25	255	1	4405	2693	2273	4540	2077	255	4486	2014	2275	1912	726	4552	1940	2306	4720	1284	664	2963	814	2574	2855	1277
2131_IL2RG - Cytokine receptor common subunit gamma	2131_IL2RG - Cytokine receptor common subunit gamma	25	255	1	3682	1957	2078	1652	1940	2012	2572	255	574	1772	2728	3444	2127	1324	2018	909	1141	1595	4461	1185	3005	4240
3627_Treatment/medication code: paracetamol	3627_Treatment/medication code: paracetamol	25	255	1	3381	2337	4029	2523	2045	4491	2425	313	4178	255	2913	2755	438	4099	4384	913	2480	4416	583	2683	3955	1534
214_NK:%Term	214_NK:%Term	25	255	1	3277	2371	4487	2889	2371	1326	2210	2469	4332	2120	870	3474	814	255	3007	2363	2630	3924	2542	843	1190	2291
3170_TNNI2 - Troponin I, fast skeletal muscle	3170_TNNI2 - Troponin I, fast skeletal muscle	25	255	1	2977	352	840	3095	2345	1398	1976	2658	1983	1748	4479	379	4373	3682	274	2030	255	4641	1018	2461	4545	380
736_::::X-11845	736_::::X-11845	25	255	1	1410	1867	2537	3543	2137	3478	410	2597	1672	699	3843	4061	2778	2410	833	1846	1135	3681	255	1062	3741	1966
2460_THBS2 - Thrombospondin-2	2460_THBS2 - Thrombospondin-2	25	255	1	3892	1441	1894	3996	1081	534	2820	1319	4603	2028	1650	310	3082	2039	918	629	814	1480	779	4377	255	4179
3298_Frequency of unenthusiasm / disinterest in last 2 weeks	3298_Frequency of unenthusiasm / disinterest in last 2 weeks	25	256	1	2472	256	3869	1276	2775	2841	4219	2846	678	3186	1851	4575	1466	4268	1822	2610	3726	519	896	1207	3123	3136
2579_BSG - Basigin	2579_BSG - Basigin	25	256	1	2532	1205	1768	288	3479	3846	2446	256	2512	1020	2664	1097	2219	774	4215	2049	3393	562	2702	4521	529	3517
3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	25	256	1	3740	4653	1812	1558	1626	896	4005	1864	256	2716	2476	3740	4500	1746	3908	3363	866	2024	2910	1157	2339	2067
4158_Generalised epilepsy	4158_Generalised epilepsy	25	256	1	268	1297	621	3784	4205	2635	405	3486	682	370	256	2428	2836	1037	2285	1288	1219	864	3989	2916	1439	3018
1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	25	256	1	2777	3280	1058	2629	1479	3387	4067	508	2496	1728	2412	256	1046	445	4091	891	2009	2533	3066	487	2292	1234
1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	25	256	1	2996	4143	692	858	3015	1647	2226	771	1409	1058	1377	2895	256	1675	4330	4514	2285	3608	1538	3899	1643	3380
4077_Waist-hip ratio	4077_Waist-hip ratio	25	256	1	744	3981	2724	1568	1493	577	3437	4512	369	3544	2740	3396	426	4009	1138	256	1501	415	2483	1474	598	3224
4716_Body of corpus callosum mode of anisotropy	4716_Body of corpus callosum mode of anisotropy	25	257	1	2362	1111	257	3957	4252	4135	2024	2189	805	2910	2973	716	4627	1701	1846	4575	2552	2891	1535	2296	2215	2481
639_Xenobiotics::Tobacco metabolite::cotinine	639_Xenobiotics::Tobacco metabolite::cotinine	25	257	1	2861	590	4046	257	1300	3638	1506	4401	1021	3650	4182	2586	2819	3467	3003	2123	1828	3395	2751	1208	1225	2274
3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	25	257	1	3075	1572	2189	265	1641	1341	1637	257	4053	2852	3701	2091	4671	2813	267	2083	3330	3949	2770	4053	2027	2557
2639_SCT - Secretin	2639_SCT - Secretin	25	257	1	4520	2259	2632	1847	1570	2601	1283	3415	257	1377	3434	4237	366	3986	4048	2321	3026	741	2755	881	2312	958
607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	25	257	1	1280	648	4190	3741	1511	4705	599	1362	3434	4691	257	1617	863	2902	4233	1576	881	4281	4690	2086	3197	2354
684_::::X-10500	684_::::X-10500	25	257	1	2918	4746	2503	3518	3552	889	1395	4503	4722	4157	644	257	1809	489	4197	4241	715	1691	4391	4478	878	2186
550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	25	257	1	1491	697	4563	1889	4571	2414	1934	3901	1476	785	1857	2654	4095	257	441	2188	3231	4602	2039	3657	2337	3559
1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	25	257	1	2771	4296	2020	4036	2892	2460	3202	1145	3204	3672	946	4476	4608	2740	4445	1225	1621	3454	2640	3648	4000	257
1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	258	1	258	3774	1892	481	4300	2147	1424	3688	4172	2361	2696	1911	2434	1070	2390	4410	4334	660	3186	4322	1197	1754
637_Xenobiotics::Food component, Plant::thymol sulfate	637_Xenobiotics::Food component, Plant::thymol sulfate	25	258	1	2212	3643	258	2734	2817	1957	713	305	3075	2394	424	4585	4712	4122	1865	2600	855	963	4179	641	4135	1193
4591_Right paracentral	4591_Right paracentral	25	258	1	2086	2628	2889	2914	258	2821	4524	2018	4089	4080	3128	2223	308	4356	489	326	1873	879	1899	4267	4589	3332
3542_Reason for glasses/contact lenses: For 'astigmatism'	3542_Reason for glasses/contact lenses: For 'astigmatism'	25	258	1	718	2157	1489	3335	3181	4071	258	3324	1436	2419	4365	4654	3764	3055	2438	3032	3823	698	3572	1264	3473	3524
2287_CFP - Properdin	2287_CFP - Properdin	25	258	1	1535	4679	2618	1488	2448	3743	2429	4060	2083	1921	2290	667	258	1309	2800	841	2017	3387	2955	3735	2283	516
3320_Chest pain or discomfort	3320_Chest pain or discomfort	25	258	1	2522	1241	4626	4212	2315	762	1405	4076	2869	2770	3930	2041	2053	258	2571	3006	2076	1560	3890	2559	1300	2450
576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	25	258	1	1978	547	3786	2233	4232	490	4742	1726	957	396	4257	4080	4042	1559	258	1236	3771	988	2129	2601	4687	3679
2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	25	259	1	2150	259	819	869	4048	2887	1513	494	725	788	617	1604	2618	2908	3723	3508	1611	4554	3276	382	1800	1037
1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	25	259	1	642	4034	2245	2146	2783	1305	259	2199	4515	471	2074	1709	1521	4727	984	1378	654	2034	2462	3646	3875	4319
2051_Periodontal complex trait 5	2051_Periodontal complex trait 5	25	259	1	3901	1351	3553	1172	742	2796	2676	3088	259	3012	4540	3132	3740	3056	1828	2290	3238	2402	1866	3856	3064	1363
7_Anxiety disorder (factor score)	7_Anxiety disorder (factor score)	25	259	1	3398	3424	2659	1967	1615	1917	2862	453	1640	2276	3234	1453	259	4150	2365	3268	2837	3349	1608	1020	2025	1391
1049_Parkinson disease of sibling pairs (tier 1)	1049_Parkinson disease of sibling pairs (tier 1)	25	259	1	2170	1745	3264	2185	3224	781	4051	2344	960	4445	3539	993	1113	2599	259	3000	453	4552	4169	2105	3911	2160
2736_FST - Follistatin	2736_FST - Follistatin	25	259	1	1365	1894	4174	2042	2770	3199	4507	943	388	3998	840	2455	4581	936	3094	3473	3593	259	1297	3887	1734	3978
1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	25	259	1	3480	2248	4522	3997	2080	2666	1259	3437	2904	3164	1284	2556	3829	1000	2344	2074	853	3549	4100	259	453	4119
3487_Bread type: Wholemeal or wholegrain	3487_Bread type: Wholemeal or wholegrain	25	260	1	260	425	2330	3913	2726	1776	564	1010	2830	2107	1280	1187	1773	889	1361	3761	2585	2808	3661	4729	2464	3283
4600_Right rostral anterior cingulate	4600_Right rostral anterior cingulate	25	260	1	4586	260	4633	4702	2403	3919	4368	4127	1023	1241	4319	1069	1132	1749	269	1432	4466	4048	282	827	1498	2102
1107_Blond hair in Solomon Islanders	1107_Blond hair in Solomon Islanders	25	260	1	3297	360	1219	260	1663	1024	850	1140	2023	506	4356	4194	4568	4322	2683	4399	4129	2180	2035	4582	2178	4271
710_::::X-11470	710_::::X-11470	25	260	1	3034	4454	3329	1791	260	3047	2358	1025	913	3839	1245	709	1090	4179	3496	311	2998	1223	4434	491	2693	2059
1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	260	1	3662	1658	4596	3031	449	1799	2245	260	307	3377	1863	1859	3133	1917	648	1723	762	587	739	4062	429	2309
307_CD4mem:%cFTH (3)	307_CD4mem:%cFTH (3)	25	260	1	2470	1585	4632	3588	1112	487	1409	1415	260	3816	4237	1332	3467	1379	2596	982	2476	2419	2197	4440	3246	773
776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	25	260	1	4239	4106	3068	756	4477	2836	444	4036	3150	1475	2155	2695	1375	260	807	1502	4717	1996	2093	3683	2871	2646
3485_Bread type: White	3485_Bread type: White	25	260	1	1807	1369	4463	341	3634	1081	523	2309	3278	3936	1941	952	3046	3282	260	2504	4065	3105	3327	3561	1894	2866
1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	260	1	3136	3961	4162	4315	4161	1347	2166	4575	4558	3246	4058	597	468	3240	696	1310	260	1935	3886	3269	585	2261
2989_DSC3 - Desmocollin-3	2989_DSC3 - Desmocollin-3	25	260	1	2679	2397	516	2505	3984	2651	1289	500	2213	1676	358	3595	4718	1476	1835	3673	3131	4031	477	260	265	2049
1226_Intracranial Volume	1226_Intracranial Volume	25	260	1	1243	2967	2754	3877	4332	4313	2115	554	4586	1189	1195	1567	1191	3349	3557	4033	1710	844	801	3700	4720	260
2884_GPR114 - Probable G-protein coupled receptor 114	2884_GPR114 - Probable G-protein coupled receptor 114	25	261	1	2690	472	3735	261	2960	3600	3123	2762	2351	2074	3109	3795	4552	2616	4420	2336	1841	1912	4118	1639	4216	2096
813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	25	261	1	865	3463	2053	3241	2287	1567	3040	3521	261	3196	1148	919	1423	569	414	2394	530	1979	1714	4557	319	4194
1068_Bipolar disorder	1068_Bipolar disorder	25	261	1	3915	4065	4037	3051	2782	2565	3630	2639	3489	1213	4095	261	3173	1007	2888	3038	3571	4689	2179	1199	2023	2108
2795_PFDN5 - Prefoldin subunit 5	2795_PFDN5 - Prefoldin subunit 5	25	261	1	530	4550	592	3867	589	1884	4176	1146	295	1323	2772	2597	498	528	2295	261	4562	1077	3333	4134	3424	526
4515_4th ventricle	4515_4th ventricle	25	261	1	1035	3377	1115	4433	1515	1155	2566	1994	1547	4010	619	576	3315	4044	2219	3873	2647	261	3879	879	2880	2852
3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	25	261	1	1130	3851	3720	3276	3355	2612	3711	1204	795	4519	4011	267	3154	1256	1145	2936	3405	2142	261	1476	1255	2484
3762_Anxiety - Recent inability to stop or control worying	3762_Anxiety - Recent inability to stop or control worying	25	261	1	2050	1067	3030	418	3170	1524	3190	2837	3287	1548	3746	645	1550	2151	1949	4419	779	1535	3260	261	2299	347
292_CD4:%Act(PD1+)	292_CD4:%Act(PD1+)	25	261	1	2281	3343	3253	1052	2486	4475	3455	4397	417	2969	3449	3083	1070	433	2814	4700	2315	1359	4478	2220	2930	261
2234_MMP17 - Matrix metalloproteinase-17	2234_MMP17 - Matrix metalloproteinase-17	25	262	1	726	2241	1237	1320	262	3466	2796	1562	2583	3933	1295	3268	1152	2602	1139	366	4400	3988	1260	4437	2514	3147
3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	25	262	1	4037	2585	1246	4188	508	4502	262	2531	3320	2749	991	2832	1810	4005	2911	443	3284	3776	1694	2509	2258	444
1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	25	262	1	1663	3092	3228	4436	3582	2016	1617	262	3395	4036	3263	1463	4567	2623	988	3523	4302	3011	4469	1532	3769	2523
649_Xenobiotics::Xanthine metabolism::theophylline	649_Xenobiotics::Xanthine metabolism::theophylline	25	262	1	796	1826	2210	3746	3052	2249	452	3722	262	414	3483	2527	4053	837	1801	2575	2115	3775	3757	2388	510	3531
501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	25	262	1	2340	3971	1249	1347	2068	2746	4165	673	2284	262	1904	486	4376	4645	438	2113	3491	1515	1314	4286	1134	2415
1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	25	262	1	1010	1738	4474	316	2869	3770	4430	1417	4258	1907	1936	262	3098	1306	3177	3636	818	2199	2020	3660	4164	3617
352_NKT:%TM	352_NKT:%TM	25	262	1	702	683	1778	1710	1070	3100	1410	354	3446	4552	2902	3261	262	1781	3140	4186	3967	835	1768	2511	3686	1323
4542_Right vessel	4542_Right vessel	25	262	1	1395	3597	4166	3986	1668	2812	407	3912	1706	3225	808	1355	2620	2801	602	4045	1768	262	797	2074	266	1627
2686_DYNLRB1 - Dynein light chain roadblock-type 1	2686_DYNLRB1 - Dynein light chain roadblock-type 1	25	262	1	4550	2523	2130	2412	4326	821	1339	3695	865	3165	1956	2760	3084	3234	2670	2451	2171	2873	1591	4554	2481	262
4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	25	263	1	2514	1080	263	2071	890	450	2760	4665	376	2049	271	3623	2210	1405	2767	854	270	4560	2665	4671	454	4156
1293_Diabetes incidence (GEE, adjusted for age and sex)	1293_Diabetes incidence (GEE, adjusted for age and sex)	25	263	1	3224	3629	1522	1548	3954	4092	2246	263	4319	1273	2588	2673	2578	4137	2226	2793	3605	1167	3427	2615	2476	3444
3434_Numeric memory test - Maximum digits remembered correctly	3434_Numeric memory test - Maximum digits remembered correctly	25	263	1	4665	3018	3689	2687	3304	2672	1908	4522	4438	263	2879	2163	1971	4720	2291	3850	3044	780	4258	2058	2230	3322
2039_Attention function - Orienting - Child	2039_Attention function - Orienting - Child	25	263	1	2793	3771	3883	2384	2067	3080	3074	2435	2805	2138	2711	2598	4326	1166	263	4416	1663	4507	1312	3237	2577	3479
1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	25	263	1	3195	1136	3573	3475	719	2813	2774	2173	3797	4379	1119	488	1928	266	2233	3359	263	2916	576	2604	3808	4202
4471_Left superior parietal	4471_Left superior parietal	25	263	1	4623	674	4090	2618	3800	1382	3066	3765	414	708	4131	3602	466	2188	2803	4193	2628	263	4267	3187	4524	3168
623_Xenobiotics::Drug::4-acetaminophen sulfate	623_Xenobiotics::Drug::4-acetaminophen sulfate	25	263	1	823	1243	1466	1423	2550	2748	4282	1162	3669	3866	379	4127	628	2479	2750	2060	3412	4297	263	1562	2997	1402
4244_Rapid automised naming and rapid alternating stimulus test performance	4244_Rapid automised naming and rapid alternating stimulus test performance	25	263	1	3967	1781	4485	4517	2802	4601	691	4408	4354	674	1844	4310	3840	4502	3439	4573	4700	2621	2338	263	3580	1852
1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	25	264	1	264	3475	927	3096	566	2986	1642	1707	2585	2475	4480	3484	2487	2465	2406	446	3217	2818	3917	2434	2378	2527
410_Amino acid::Tryptophan metabolism::tryptophan betaine	410_Amino acid::Tryptophan metabolism::tryptophan betaine	25	264	1	1473	1387	2771	3122	4480	3156	264	2605	1642	4098	1366	3980	2622	2635	2700	2622	4407	1158	3081	4124	1952	2872
193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	264	1	656	1374	4616	2109	1307	4128	603	264	1313	1320	3116	393	491	2858	2794	2099	1246	2398	4055	1340	2981	726
4733_Sagittal stratum mode of anisotropy	4733_Sagittal stratum mode of anisotropy	25	264	1	3629	4563	1767	4038	2716	2689	2328	3237	2235	2644	264	562	519	4616	394	4658	4089	1170	2064	1403	3338	452
1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	264	1	1549	4731	4570	2608	4017	2286	4332	3644	2860	4327	2032	264	4548	3846	2638	2227	879	2343	1238	2687	3118	2007
4223_Calcium channel blockers	4223_Calcium channel blockers	25	264	1	4214	1405	4579	1916	2762	4718	2699	1097	1242	1607	3209	2809	264	2361	2212	2130	3435	3180	3781	3172	2555	2407
4584_Right isthmus cingulate	4584_Right isthmus cingulate	25	264	1	2110	2957	1350	4176	3866	4660	2645	4267	3795	840	2834	4327	2682	3093	264	4213	3038	2525	2521	2245	3027	1280
3004_HRG - Histidine-rich glycoprotein	3004_HRG - Histidine-rich glycoprotein	25	264	1	3427	1689	4443	852	424	2256	1125	1653	4427	2627	4326	1903	2374	793	1230	264	616	932	2719	1540	1227	2248
999_Monocyte specific chemokine 3 (CCL7)	999_Monocyte specific chemokine 3 (CCL7)	25	264	1	3817	759	1414	599	1706	1951	3058	4442	4680	3859	1442	1206	3494	646	2360	4737	1789	3696	264	2956	3442	2729
4238_Antiglaucoma preparations and miotics	4238_Antiglaucoma preparations and miotics	25	264	1	707	2422	2280	1388	2053	2604	4658	1962	2542	4701	2281	1935	3329	4328	4096	2822	1358	995	2588	4161	2492	264
1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	25	265	1	265	952	2098	696	3767	744	4477	854	2809	1931	3119	2354	807	3772	3017	4492	287	2159	617	3531	3329	4327
885_Isoleucine	885_Isoleucine	25	265	1	4525	265	2843	824	2880	2334	1559	4053	1635	4375	2510	4295	2126	2035	3680	3507	2948	1735	2498	1817	2748	4132
4577_Right caudal anterior cingulate	4577_Right caudal anterior cingulate	25	265	1	1145	564	3140	277	3987	4223	265	717	1198	479	352	2814	956	939	3848	2654	1188	3478	1554	4379	3897	4190
923_Free cholesterol in medium VLDL	923_Free cholesterol in medium VLDL	25	265	1	3099	3952	3405	3264	411	1969	1533	2080	3149	724	1776	663	2266	2969	265	730	698	1271	3012	1515	4513	766
511_Lipid::Inositol metabolism::myo-inositol	511_Lipid::Inositol metabolism::myo-inositol	25	265	1	3015	2162	1441	1953	287	2950	572	1914	1341	2735	3418	4098	2339	3698	4315	265	1153	2738	4220	2133	2964	561
3251_Cheese intake	3251_Cheese intake	25	265	1	483	1983	2425	4080	3072	2329	1367	1087	1014	1551	4176	2569	2015	2144	1593	4250	4395	265	574	2050	4061	4164
773_::::X-12407	773_::::X-12407	25	265	1	3454	2096	1564	1048	4094	1662	2561	834	3239	1256	2073	2183	2107	1702	4312	1444	3777	4580	4616	265	3161	3347
3103_KRAS - GTPase KRas	3103_KRAS - GTPase KRas	25	266	1	1329	1950	266	3873	4746	2087	2933	2938	3458	2957	504	3659	4506	2327	2522	2288	890	4104	1054	3273	3276	4400
3498_Hair colour (natural, before greying): Dark brown	3498_Hair colour (natural, before greying): Dark brown	25	266	1	4161	2680	1504	266	2380	4032	392	422	2865	4006	3569	1779	1978	3036	1215	4313	2288	1005	2784	3852	4566	1287
708_::::X-11452	708_::::X-11452	25	266	1	3611	1078	591	4700	2973	1604	3155	352	345	266	344	1837	2869	3298	1233	2022	2694	1119	1778	1041	828	2266
2872_PRSS22 - Brain-specific serine protease 4	2872_PRSS22 - Brain-specific serine protease 4	25	266	1	664	514	4035	4627	2455	1802	2397	3776	4219	1019	266	2663	3953	4427	1314	3154	4742	2976	3986	3381	3306	356
283_CD4:%Treg(39+73-)	283_CD4:%Treg(39+73-)	25	266	1	549	1130	2869	790	1693	2822	1402	3440	1466	543	4526	266	2882	704	1880	1763	1941	2256	1394	953	4462	2735
87_Asthma	87_Asthma	25	266	1	3741	4230	4364	751	307	1331	2560	3539	4686	1950	1723	824	4471	816	3346	266	2743	3551	1481	1656	1860	537
4478_Right cuneus	4478_Right cuneus	25	266	1	3412	1984	1084	1695	3114	3538	1254	4452	1718	1279	966	2780	1322	3614	3518	1546	3665	284	578	266	4161	1636
1754_Cancer (FBAT, adjusted for age and sex)	1754_Cancer (FBAT, adjusted for age and sex)	25	267	1	571	278	2786	3407	2854	2527	1349	408	2140	973	267	3681	1793	2959	4363	1493	3359	3571	2000	2494	2700	3752
4568_Left precuneus	4568_Left precuneus	25	267	1	1102	3081	3691	1104	733	561	3378	616	3158	1187	2437	2725	2437	267	1763	330	332	1816	704	284	2261	1296
3616_Treatment/medication code: omeprazole	3616_Treatment/medication code: omeprazole	25	267	1	964	2185	2054	1116	829	3530	3593	3195	3081	4123	2247	4677	3571	4299	1359	267	4324	1916	2434	2297	3734	3279
1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	25	267	1	2304	2616	3091	2231	2294	998	2039	1202	3032	867	4312	3833	2654	4569	1342	1501	1609	685	3700	980	267	1520
4552_Left inferior temporal	4552_Left inferior temporal	25	268	1	740	268	3512	286	4572	950	648	286	876	2420	2348	1370	1524	3631	2592	1361	1151	1676	3424	3020	3574	2180
2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	25	268	1	3839	4524	2140	1029	871	2157	3505	268	2370	4007	3317	3832	2839	4149	1695	1535	3083	2119	2360	2161	1682	3661
2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	25	268	1	4702	3575	3938	3067	4251	373	965	2721	2237	492	1751	3983	1339	598	2923	2485	268	2072	3311	1466	2989	2655
3091_SLAMF6 - SLAM family member 6	3091_SLAMF6 - SLAM family member 6	25	268	1	2236	4259	770	318	4400	771	2044	2495	962	4347	4243	1391	1260	3546	4126	2465	594	779	1306	474	268	4377
1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	268	1	2482	2864	3954	1739	3796	2203	2603	2657	1934	1268	752	2776	3163	1578	4236	3787	4606	492	1528	1807	3174	268
4323_Life satisfaction (MA GWAMA)	4323_Life satisfaction (MA GWAMA)	25	269	1	1358	2785	269	4736	3633	2351	3156	3387	4631	3729	1435	1013	2248	2498	2120	2184	2082	2552	3443	1643	4443	1658
1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	25	269	1	2142	311	897	269	4551	2020	2558	2833	1408	685	1087	666	1585	2520	3329	3697	1742	774	4263	2848	3403	3386
3862_Platelet distribution width (two-way meta)	3862_Platelet distribution width (two-way meta)	25	269	1	3025	373	3351	2757	955	1684	269	3462	3240	4259	2905	4368	3792	3670	820	947	2300	1094	3470	455	4641	639
3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	25	269	1	1429	1598	4708	3952	1188	4151	4659	2113	3165	4521	269	4024	1242	1886	4141	3662	2990	1953	2005	2766	2540	2707
3020_PLA2G7 - Platelet-activating factor acetylhydrolase	3020_PLA2G7 - Platelet-activating factor acetylhydrolase	25	269	1	4040	2682	2958	1638	2397	4414	4198	434	4156	3910	2089	2883	269	3419	3000	3828	2584	2467	2016	1325	3992	2272
4368_Cannabis use	4368_Cannabis use	25	269	1	2360	4546	3769	4636	2512	1751	2639	2453	3723	4185	856	1144	1552	4090	3571	4476	4529	3838	3763	269	2157	1130
3015_MSN - Moesin	3015_MSN - Moesin	25	270	1	1788	1614	3123	4312	4258	270	2516	4190	1938	3184	2872	4501	3126	343	1666	3528	3363	3694	4628	4502	661	1558
2849_SIGLEC1 - Sialoadhesin	2849_SIGLEC1 - Sialoadhesin	25	270	1	688	4323	2248	4316	1705	2000	2952	270	3067	435	3208	4639	1869	2979	1838	640	1920	665	3340	333	2301	3717
533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	25	270	1	3555	1108	4106	2650	4087	1283	1757	2844	270	4225	2386	1499	508	923	2595	1034	888	4320	3563	1785	2379	608
689_::::X-11247	689_::::X-11247	25	270	1	603	4306	2365	1790	3134	3259	4611	2486	3012	2106	342	286	274	4504	990	1921	1894	270	2337	3890	1274	3273
77_Adiponectin level	77_Adiponectin level	25	271	1	271	2410	4700	4633	2811	2845	1729	466	319	279	2700	1434	4398	2770	1479	4164	847	3642	2121	1943	1313	2535
3618_Treatment/medication code: aspirin	3618_Treatment/medication code: aspirin	25	271	1	3508	271	1207	2582	282	4384	4207	964	3820	1532	404	1905	2064	4183	1744	351	3500	1203	1625	3167	1864	2365
990_Interleukin-2 receptor, alpha subunit	990_Interleukin-2 receptor, alpha subunit	25	271	1	872	4614	581	4505	2587	4073	271	1492	3196	1473	4168	644	2519	2606	4166	4276	1373	3206	4497	1744	2639	2938
2487_PRKCI - Protein kinase C iota type	2487_PRKCI - Protein kinase C iota type	25	271	1	3233	3860	4087	2971	1900	2066	2811	2628	4079	271	3028	3004	1751	3767	4588	2480	4550	1930	1053	1870	834	2956
2269_PCNA - Proliferating cell nuclear antigen	2269_PCNA - Proliferating cell nuclear antigen	25	271	1	2558	767	1553	2957	1171	678	931	1947	396	2703	2222	271	1067	988	347	4220	1172	3000	3233	2274	2431	379
1174_Extreme chronotype	1174_Extreme chronotype	25	271	1	272	310	4104	4418	2378	2705	1754	2413	3731	3541	4387	2678	3637	271	858	3064	2015	2959	3866	2101	1695	4043
57_Educational attainment	57_Educational attainment	25	271	1	1646	1264	781	1926	1890	4297	3465	2167	630	3033	4375	4667	2762	2600	2535	2467	4248	4319	271	497	2251	2024
3955_Ankle injury (random effect)	3955_Ankle injury (random effect)	25	271	1	2195	809	1255	3002	4193	1151	1721	3182	735	2565	3778	3368	2291	4162	2547	3963	2111	3683	753	271	2065	2129
1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	25	271	1	396	3940	1630	2982	2489	1673	979	1824	4129	1534	1951	2312	3501	1031	572	2374	2987	3133	1017	4255	271	1403
757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	25	272	1	1379	1057	590	2517	1063	1041	3280	3581	1922	1209	272	4268	3270	1955	4647	1009	2952	408	725	2591	2391	4275
282_CD4:%Eff(127-PD1-)	282_CD4:%Eff(127-PD1-)	25	272	1	3959	1735	3711	3551	2306	2172	4151	4694	1008	797	1697	3789	2785	4358	272	3530	4113	4411	4554	2305	1330	2923
2446_SERPIND1 - Heparin cofactor 2	2446_SERPIND1 - Heparin cofactor 2	25	272	1	1405	534	4566	4278	978	831	2160	2427	3494	1811	2927	1193	1299	1996	3960	1151	272	1231	1234	3643	1802	839
658_::::X-04357	658_::::X-04357	25	273	1	1539	1513	3685	1233	273	3615	4591	1075	1625	4709	351	2502	1000	1593	2585	912	4354	3226	2326	1752	2266	1969
2928_EPHA2 - Ephrin type-A receptor 2	2928_EPHA2 - Ephrin type-A receptor 2	25	273	1	3865	2333	3888	3600	1802	2777	2259	1529	2002	1726	1205	2344	273	3232	2924	3795	2787	295	640	3722	4510	2086
2046_Periodontal complex trait 1 - Socransky trait	2046_Periodontal complex trait 1 - Socransky trait	25	273	1	1215	3572	908	3915	751	4083	1596	665	985	1203	3618	3737	3690	273	4708	537	1248	3727	4653	3626	3957	1697
4393_Menstrual fever	4393_Menstrual fever	25	273	1	1253	3142	586	1977	2023	800	2737	4621	1356	3496	2558	513	3808	2105	1426	4436	722	3726	410	273	1837	4174
399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	25	274	1	3830	4700	274	1319	1247	1073	650	395	2080	1566	1559	3469	575	2794	1234	2540	3312	1882	596	2797	2130	2286
840_::::X-14541	840_::::X-14541	25	274	1	2208	3330	738	274	4273	3630	4555	3631	4437	3263	3459	1525	2896	3996	3041	4375	4283	791	3145	3755	3109	4520
3639_Illnesses of mother: Stroke	3639_Illnesses of mother: Stroke	25	274	1	3116	2389	2148	4264	274	565	530	300	2238	3245	3657	3599	431	3716	3717	438	1000	3894	3808	4573	4371	4501
3647_Illnesses of mother: Severe depression	3647_Illnesses of mother: Severe depression	25	274	1	1855	287	1124	393	948	3456	1702	4357	274	4605	4129	3906	4141	2484	1618	4209	2795	2275	4170	3774	2407	3135
1927_Lateral ventricular volume (GEE, adjusted for age and sex)	1927_Lateral ventricular volume (GEE, adjusted for age and sex)	25	274	1	1216	1816	969	3474	1582	1889	2464	1936	4416	3597	274	3333	1145	2638	4346	3045	1922	440	2158	803	4616	3139
3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	25	274	1	4696	3489	874	4708	3925	3035	4492	1067	4702	3439	2486	1269	1042	3216	2397	4121	4441	274	2119	1907	2847	2797
4383_Epithelial ovarian cancer (high-grade serous)	4383_Epithelial ovarian cancer (high-grade serous)	25	275	1	1287	3293	275	3805	2191	4556	2663	1735	2879	455	4041	598	3757	300	857	3958	1244	2495	3939	3271	807	1578
4722_Fornix (cres) / Stria terminalis mode of anisotropy	4722_Fornix (cres) / Stria terminalis mode of anisotropy	25	275	1	912	345	423	3795	3692	3525	338	275	3911	2141	1155	2853	3816	3650	1355	2398	2544	3702	3771	2763	1303	995
4441_Epstein Barr Virus antigen EA IgG levels	4441_Epstein Barr Virus antigen EA IgG levels	25	275	1	2737	798	933	312	2551	1859	2225	1578	3375	465	275	2079	2877	2126	2986	4487	401	458	2236	4117	4724	2403
727_::::X-11787	727_::::X-11787	25	275	1	418	3298	2874	3299	1352	2265	2588	3575	1644	2696	507	1379	275	3655	3186	1877	2687	3111	711	4110	2133	4658
4036_Alcohol dependency (unrelated genotyped individuals)	4036_Alcohol dependency (unrelated genotyped individuals)	25	275	1	1314	297	3409	4731	1605	4370	2571	4295	3745	1530	1253	3815	2920	1443	3092	4736	2400	275	3900	2400	2667	1996
3573_Pain type(s) experienced in last month: Stomach or abdominal pain	3573_Pain type(s) experienced in last month: Stomach or abdominal pain	25	276	1	276	3906	1906	4381	1131	2326	3031	658	562	1359	4598	3868	2676	2816	2175	666	3281	4705	3756	1412	2281	2989
225_B Mem:%IgE	225_B Mem:%IgE	25	276	1	4605	1088	276	4567	1748	3022	4131	2072	2056	4227	1996	4545	2449	2353	1140	4483	3258	4000	4145	2374	779	1767
542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	25	276	1	3957	4059	3503	4611	4708	3905	276	3236	1654	922	4264	3247	3634	3359	4556	3578	1900	1500	2396	3195	1665	3454
305_CD4mem:%cFTH (1)	305_CD4mem:%cFTH (1)	25	276	1	3870	3544	1877	3510	4538	2459	3756	588	1525	2277	3125	276	2939	4371	289	3688	2778	572	496	3264	1649	2083
3271_Comparative height size at age 10	3271_Comparative height size at age 10	25	276	1	2673	3435	2539	3800	723	2248	2078	4152	2959	4160	1425	3896	1944	821	2628	276	1181	4495	1665	1363	4742	2082
586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	25	276	1	3056	4320	2916	2437	4510	2217	2701	3254	3189	658	1278	1095	607	2019	2627	2602	531	2461	276	4067	4602	4551
2499_TBK1 - Serine/threonine-protein kinase TBK1	2499_TBK1 - Serine/threonine-protein kinase TBK1	25	276	1	527	1431	1074	3930	3157	3895	3262	2626	3933	1565	3152	3526	3424	3686	2532	1721	2642	1947	1457	276	3349	1261
1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	25	277	1	277	4023	4547	2389	3081	4689	990	2152	1853	460	2308	3504	2728	825	1725	970	4295	1266	3707	3584	3711	4140
4381_Epithelial ovarian cancer (all invasive)	4381_Epithelial ovarian cancer (all invasive)	25	277	1	1049	4734	1595	1062	1898	277	3427	4169	1447	3204	4644	834	1623	526	4129	3397	1094	4001	1087	681	1959	4413
656_::::X-03088	656_::::X-03088	25	277	1	3267	2509	2146	2803	915	3612	277	927	4556	1263	3048	334	2045	1116	2696	1980	2484	4444	4012	2083	667	1053
3985_Heart rate recovery at 10 secnds	3985_Heart rate recovery at 10 secnds	25	277	1	2469	3596	4140	1991	612	2335	1146	3448	2592	2263	277	1536	953	3443	3898	3097	3906	671	3304	4163	4009	871
461_Energy::Krebs cycle::succinylcarnitine	461_Energy::Krebs cycle::succinylcarnitine	25	277	1	3812	3359	3354	3556	1457	1402	4249	724	3777	444	3052	3405	2253	894	277	2954	1754	3481	2653	425	1616	4251
2878_PPBP - Connective tissue-activating peptide III	2878_PPBP - Connective tissue-activating peptide III	25	277	1	891	370	471	3377	2488	513	843	1589	3910	3494	1978	3548	1568	3012	2728	3972	277	2864	1587	3092	4595	3120
2004_Primary biliary cirrhosis	2004_Primary biliary cirrhosis	25	277	1	3672	2650	3558	4686	3414	2889	3925	3578	3106	1511	2124	501	737	2218	2475	2996	1525	277	1060	3945	2883	3464
809_::::X-12847	809_::::X-12847	25	277	1	4734	2583	4544	1178	3305	2732	3718	3028	1793	2936	3370	4133	1961	2772	2447	1263	3092	3544	277	471	2864	2608
1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	25	278	1	1240	526	1195	2344	909	4704	1240	4217	1049	1523	3331	963	278	3803	2341	1383	4510	3452	4563	1607	2959	4495
3475_Type of accommodation lived in: A flat, maisonette or apartment	3475_Type of accommodation lived in: A flat, maisonette or apartment	25	278	1	4722	2205	2167	3688	4150	3730	3831	3197	1195	716	1546	3117	3340	278	2166	3616	2884	532	2553	4308	4242	3728
2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	25	278	1	3859	1107	3161	2417	3412	2038	1383	3013	1290	852	4090	4640	1271	3983	3891	4549	2959	2634	749	502	490	278
2808_TPI1 - Triosephosphate isomerase	2808_TPI1 - Triosephosphate isomerase	25	279	1	3744	279	3415	294	3485	4222	3572	2367	3187	4341	4205	1424	540	686	3055	1681	2316	2929	1032	2692	1596	1832
696_::::X-11374	696_::::X-11374	25	279	1	3357	927	414	4196	4104	3503	279	773	830	4261	2532	797	3950	2263	621	1128	4707	1494	4444	3433	2062	1748
1989_Age at death (GEE, adjusted for multivariable)	1989_Age at death (GEE, adjusted for multivariable)	25	279	1	604	1330	1353	1981	3780	1017	2628	279	3957	2935	668	342	1038	2773	939	3334	4299	3637	3853	4417	4014	975
4342_Moderate intesity (conditioning sex and BMI)	4342_Moderate intesity (conditioning sex and BMI)	25	279	1	987	1888	4436	3988	2503	1064	662	4487	1062	749	4238	456	4304	279	374	2812	3611	3695	3741	4627	3975	2859
917_Cholesterol esters in medium LDL	917_Cholesterol esters in medium LDL	25	279	3	291	382	491	639	1730	483	3938	4477	919	4488	453	2642	4181	543	279	1387	1975	2896	2610	2028	3518	555
4126_Creatine kinase	4126_Creatine kinase	25	279	1	1274	719	1181	4376	647	2191	677	2144	907	4528	586	3959	673	1160	2190	279	2524	3246	3641	2431	3888	3254
1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	25	279	1	2312	3138	2596	4718	4441	836	1343	4531	2419	3790	1960	4335	2422	1839	4448	3968	4054	1719	318	279	4181	2206
897_Phospholipids in large LDL	897_Phospholipids in large LDL	25	280	1	280	468	556	289	2300	677	2459	3766	425	4566	502	2575	3802	875	600	1479	1564	3746	2083	1721	3098	1258
1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	280	1	1339	3452	1211	280	4164	3066	1045	1438	3818	4016	3858	2009	2133	2071	1592	3911	3275	1777	374	773	2100	3053
1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	25	280	1	699	1862	2512	2654	280	455	2578	1245	469	2867	1583	2024	4033	2952	1428	316	1737	2911	3892	1802	356	3490
3997_Worrier / anxious feelings (WORRY)	3997_Worrier / anxious feelings (WORRY)	25	280	1	4545	4715	2527	4399	1902	280	2694	4433	4313	2358	4134	4279	1143	961	3874	2774	423	1417	4732	2347	3258	1075
2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	25	280	1	2678	307	3696	3716	601	1971	2468	983	720	2692	2900	3090	4097	280	2999	437	3645	2813	3488	3375	2193	1236
4549_Left entorhinal	4549_Left entorhinal	25	280	1	2159	859	1666	545	1110	4179	1300	622	2476	3737	4667	3688	1510	2099	4505	4493	280	1383	326	4526	2272	4352
764_::::X-12217	764_::::X-12217	25	280	1	1104	2976	2825	1143	3178	681	1693	3682	2573	4326	2819	4436	340	4642	812	3261	3105	280	3251	2586	3095	2080
2906_EPB41 - Protein 4.1	2906_EPB41 - Protein 4.1	25	281	1	1092	281	3208	3524	1991	1825	3548	4622	1789	2416	4622	1575	420	384	2229	3751	3980	2858	4112	4727	1516	4701
1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	25	281	1	1020	367	281	2695	4649	990	3659	3347	371	4634	3217	3068	3975	3415	2076	4090	2869	786	2431	1995	4126	1454
2484_HCK - Tyrosine-protein kinase HCK	2484_HCK - Tyrosine-protein kinase HCK	25	281	1	1189	4129	3406	3612	2721	1209	4122	281	1899	4639	3783	1500	4309	2725	1644	4563	3794	372	4683	1634	399	716
3861_Plateletcrit (two-way meta)	3861_Plateletcrit (two-way meta)	25	281	1	4483	3194	4591	1868	2577	2892	1205	2500	281	1889	320	2759	2617	2620	4741	2858	1578	2601	3210	1155	4403	2714
1758_Breast cancer (FBAT, adjusted for age)	1758_Breast cancer (FBAT, adjusted for age)	25	281	1	2801	3409	472	2053	2293	3790	2253	1416	3576	324	281	1450	3857	1118	3155	3916	350	2320	1188	3935	819	2137
4205_Estimated glomerular filtration rate	4205_Estimated glomerular filtration rate	25	281	1	741	877	2914	1139	1310	2788	454	507	1609	947	1898	281	1636	1002	2463	2373	1420	2108	3692	2865	2295	2110
619_Xenobiotics::Chemical::glycerol 2-phosphate	619_Xenobiotics::Chemical::glycerol 2-phosphate	25	281	1	1292	2250	2416	2227	3506	1295	4279	339	1271	3676	3922	1980	281	1268	3170	4650	2615	3533	646	4555	1410	4496
1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	25	281	1	4651	3374	2976	3258	1588	4030	1610	857	3439	4324	4060	3051	817	3110	281	2769	1323	4536	930	1371	1968	1463
817_::::X-13429	817_::::X-13429	25	281	1	4207	4471	1570	383	600	3796	1865	2817	3170	3101	1339	2320	4203	3075	2810	1393	2664	3333	2950	3903	281	4689
4240_Latent naming speed	4240_Latent naming speed	25	282	1	282	2334	3619	4049	4036	4251	3797	3737	3608	4189	1645	2001	3766	4206	4478	2653	4377	872	2036	1661	877	4185
3447_Impedance measures - Impedance of whole body	3447_Impedance measures - Impedance of whole body	25	282	1	1919	968	282	2791	1318	2160	3706	3664	792	2426	2025	1029	4683	3158	4703	1986	4678	1064	512	4329	1378	796
2657_CKB - Creatine kinase B-type	2657_CKB - Creatine kinase B-type	25	282	1	3961	1814	4376	282	1353	1753	890	1598	3432	2134	3881	4659	403	911	452	1927	3226	4022	414	2085	1914	1617
3177_PRKCG - Protein kinase C gamma type	3177_PRKCG - Protein kinase C gamma type	25	282	1	777	3729	806	1784	2649	3499	1659	282	3714	1918	4005	2961	2342	2450	2202	4442	4669	2258	3464	4460	2851	4552
974_Cutaneous T-cell attracting (CCL27)	974_Cutaneous T-cell attracting (CCL27)	25	282	1	3639	4392	984	1736	2093	2755	2216	918	282	4721	3529	1096	2212	587	1753	2238	791	1460	2371	587	1168	3837
165_Hip circumference (female, adjusted for BMI)	165_Hip circumference (female, adjusted for BMI)	25	282	1	716	3859	1608	4146	702	2426	1540	3409	3855	3931	282	3271	3453	3914	1501	512	469	4185	4536	4233	3097	3091
927_Triglycerides in medium VLDL	927_Triglycerides in medium VLDL	25	282	1	3159	3309	2779	2978	603	2680	709	1559	398	2690	3303	992	4177	3356	282	1174	320	2292	2102	1541	3062	1594
2757_TNC - Tenascin	2757_TNC - Tenascin	25	282	1	4532	1749	3740	1833	1095	2714	4244	4222	531	1089	2502	2095	984	736	2599	2902	3293	4350	3414	282	2948	3355
1154_Insulin at 30 min	1154_Insulin at 30 min	25	282	1	1853	4299	3438	4380	2236	3275	1032	287	1052	939	413	1735	2326	316	4012	2534	3654	3725	3048	2076	4036	282
1937_Total cerebral brain volume (GEE, adjusted for age and sex)	1937_Total cerebral brain volume (GEE, adjusted for age and sex)	25	283	1	1392	283	2482	1462	3747	2819	2542	2006	4647	1906	3403	987	2602	4360	2200	2018	4413	2824	2270	3224	3644	3792
3290_Worrier / anxious feelings	3290_Worrier / anxious feelings	25	283	1	4152	4375	1639	2035	1892	283	2457	4449	2266	3909	1562	3976	1326	1383	4289	2634	368	1640	2880	905	4246	529
1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	283	1	479	811	3171	4562	369	1372	1299	3681	2981	283	1418	298	2880	1120	469	534	2712	1020	1067	2227	2624	2691
4614_CSF	4614_CSF	25	283	1	4698	2128	2193	3595	408	503	1792	590	4582	1221	425	2075	283	1386	4731	807	2567	972	4588	3572	2052	386
135_Waist circumference (female, adjusted for BMI)	135_Waist circumference (female, adjusted for BMI)	25	283	1	541	3977	4299	1024	387	4241	885	2552	3948	2876	4533	3281	4015	947	4069	1705	283	3104	2958	934	1919	1847
712_::::X-11483	712_::::X-11483	25	283	1	3037	1748	286	3374	1385	4419	4027	1669	4140	2824	2823	482	2246	3341	3071	1506	3590	3458	3094	2812	283	4575
2944_POMC - Corticotropin	2944_POMC - Corticotropin	25	284	1	284	3819	4293	1972	1846	1186	355	4102	2937	722	4432	4383	4120	2427	3423	1895	1791	2816	1886	619	3843	471
1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	25	284	1	2270	3492	1031	2108	511	4472	1961	284	928	3985	1636	3746	717	4210	2796	1050	1598	2784	2187	1498	2926	1727
3307_Overall health rating	3307_Overall health rating	25	284	1	3494	657	3547	2342	3919	4103	3423	3785	877	1302	1893	284	4008	3103	4313	2801	1881	328	1364	787	391	2341
2216_ACE2 - Angiotensin-converting enzyme 2	2216_ACE2 - Angiotensin-converting enzyme 2	25	284	1	3634	312	1656	673	3465	1037	2431	1444	2750	3097	883	1366	701	2539	284	1228	3425	1188	1595	4344	3805	3716
4754_Superior longitudinal fasciculus radial diusivities	4754_Superior longitudinal fasciculus radial diusivities	25	284	1	313	2269	3179	3851	1700	2234	2761	1224	4251	4372	1070	1109	2903	2431	4738	3739	938	4639	2116	2752	2565	284
1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	285	1	751	285	2208	3772	3089	1048	4206	1574	936	2144	3948	1587	646	2330	3348	3837	4313	4020	3926	2566	1288	3492
2495_PLK1 - Serine/threonine-protein kinase PLK1	2495_PLK1 - Serine/threonine-protein kinase PLK1	25	285	1	2591	3477	4025	1087	4439	2121	2895	1748	3724	4395	285	1746	2452	452	2241	4066	4600	2289	1659	3583	2395	3069
2307_IFNG - Interferon gamma	2307_IFNG - Interferon gamma	25	285	1	1142	1245	377	1608	1732	2328	2415	866	2882	767	3721	3364	1244	3908	285	566	700	4605	3533	2714	4184	4076
2481_ECM1 - Extracellular matrix protein 1	2481_ECM1 - Extracellular matrix protein 1	25	285	1	1221	3705	2133	2444	304	773	2154	1668	1472	1531	3135	4543	2724	4404	2356	285	3058	2671	3735	4194	4452	2715
2531_LCK - Tyrosine-protein kinase Lck	2531_LCK - Tyrosine-protein kinase Lck	25	285	1	3701	3091	3197	2076	4744	933	3760	1167	3131	4426	720	4280	1151	4269	3448	4120	285	2700	4489	1518	3233	4274
3995_Fed-up feelings (FED_UP)	3995_Fed-up feelings (FED_UP)	25	285	1	2273	4064	2474	4172	4725	1360	3922	1689	2695	559	2500	3292	515	1835	4227	3629	2756	2574	285	2745	1519	373
137_Weight (female)	137_Weight (female)	25	285	1	2028	1636	1759	1125	4138	3739	3862	452	4508	3293	1239	288	1177	2504	434	1864	1111	2962	4009	285	2947	3734
4576_Left insula	4576_Left insula	25	285	1	2552	1920	1394	2799	509	525	2654	2350	1891	3282	1737	4358	1180	1512	3954	4042	960	1441	2632	3507	3240	285
2501_TPSB2 - Tryptase beta-2	2501_TPSB2 - Tryptase beta-2	25	286	1	286	3350	701	2132	2278	4145	2827	3919	1529	3472	1477	2440	4275	4541	3051	3105	3377	1379	1985	2818	4419	2087
2666_FGR - Tyrosine-protein kinase Fgr	2666_FGR - Tyrosine-protein kinase Fgr	25	286	1	967	286	3155	3217	524	4724	858	445	1378	3660	2418	3567	1342	3930	549	3187	2691	2170	1350	4311	4688	2734
902_Concentration of large VLDL particles	902_Concentration of large VLDL particles	25	286	1	4140	3201	2508	2998	655	1898	740	2308	3803	406	3781	1776	1201	2918	286	1847	504	860	4669	983	1909	538
2123_HMOX2 - Heme oxygenase 2	2123_HMOX2 - Heme oxygenase 2	25	287	1	287	3144	460	1848	2229	2139	335	727	2707	1299	3344	2998	4258	617	1806	720	2953	3802	826	993	301	1829
2372_CD4 - T-cell surface glycoprotein CD4	2372_CD4 - T-cell surface glycoprotein CD4	25	287	1	1319	3937	287	2087	577	3132	3462	2156	789	1652	2768	735	3326	444	1925	458	3385	3344	3519	402	1388	1494
677_::::X-09026	677_::::X-09026	25	287	1	977	1235	1602	287	2354	2468	2979	3068	477	4084	2349	1646	2124	1204	1635	1687	885	1844	442	4615	1770	2909
1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	287	1	3648	2678	4082	2830	686	287	1750	4059	3398	1501	309	446	4431	1567	1205	605	1318	607	675	2550	4511	840
3630_Illnesses of father: Lung cancer	3630_Illnesses of father: Lung cancer	25	287	1	1236	4248	1561	775	2054	3507	287	3493	1549	1621	4236	2280	2172	4016	720	4068	4557	4192	1672	3445	4146	826
2274_ARTN - Artemin	2274_ARTN - Artemin	25	287	1	602	2634	3949	572	3257	3606	2545	2340	3801	287	380	4392	1584	3344	3225	3489	1550	2535	863	3083	2903	2509
1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	25	287	1	4692	3756	4565	2440	2844	4081	3464	3803	4246	1977	287	2237	896	2192	1496	1499	1596	4410	1785	2680	4535	2628
235_CD123 on mDC	235_CD123 on mDC	25	287	1	478	2218	1900	4261	4710	3057	1051	1155	1307	2185	2159	2753	1966	287	1704	1648	2829	444	3371	3354	1835	3551
1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	287	1	2068	4566	3498	3399	1203	992	1498	2572	3828	872	1527	1975	3919	1756	2912	675	4222	3620	287	866	2772	2843
2072_BDNF - Brain-derived neurotrophic factor	2072_BDNF - Brain-derived neurotrophic factor	25	287	1	3906	4347	1326	2870	4268	1100	1014	677	1235	2238	801	4159	642	2461	577	4612	4724	1412	2170	1262	287	2605
3389_Friendships satisfaction	3389_Friendships satisfaction	25	288	1	288	1803	3355	3139	4716	4459	2030	1360	3523	4538	2242	1294	3889	1730	3598	4558	4622	3237	3603	3746	3311	1410
2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	25	288	1	4667	2044	288	1495	567	1517	3356	1753	1941	2897	3856	2089	911	3452	4385	664	4374	1568	2800	4160	2015	1210
2606_CADM3 - Cell adhesion molecule 3	2606_CADM3 - Cell adhesion molecule 3	25	288	1	972	4435	1932	1783	288	4695	3811	4284	895	925	3165	1982	3294	4734	4729	365	811	3547	2647	763	1482	544
2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	25	288	1	785	917	1907	1235	3905	1827	4039	288	1868	1721	1169	2854	4508	1884	509	4082	1329	1422	1475	362	2475	801
395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	25	288	1	2695	4342	1951	2675	3300	2451	1781	1158	1460	4443	2617	1049	422	4260	3331	3469	288	445	890	4604	2264	4680
3902_Reticulocyte count (three-way meta)	3902_Reticulocyte count (three-way meta)	25	288	1	3929	3445	909	2504	2485	3133	2729	4323	3977	4088	1313	1430	1182	1990	605	696	4462	2206	1222	4445	288	2880
4517_Left lateral ventricle	4517_Left lateral ventricle	25	289	1	289	1259	4112	4405	4513	1468	4505	4696	3692	3514	3870	1475	3006	2054	2019	4113	4036	745	3376	2184	4188	1213
1191_PGC cross disorder	1191_PGC cross disorder	25	289	1	2732	3139	1911	2260	289	1695	2127	583	2906	615	1282	2107	669	1877	1996	377	4645	3817	2054	345	4504	3784
793_::::X-12717	793_::::X-12717	25	289	1	4181	4096	693	3081	3468	4606	655	3839	4351	289	1298	1801	411	1041	3257	1456	3220	4464	4362	1158	310	1566
303_CD4mem:%Th1* (4)	303_CD4mem:%Th1* (4)	25	289	1	1186	4124	4287	2189	1575	2006	2930	681	3386	2360	483	289	3600	589	4672	2432	3466	3539	1027	3705	1897	3934
4346_Coronary artery disease and triglyceride (bivariate)	4346_Coronary artery disease and triglyceride (bivariate)	25	289	1	1889	1166	795	2102	2449	1975	1088	513	382	4736	336	838	2677	1616	1640	4668	289	1071	2599	658	748	3938
1228_Parkinson Disease (additive model)	1228_Parkinson Disease (additive model)	25	289	1	4122	2575	3713	2319	2522	1994	1832	1470	2304	2009	328	1251	3506	536	3421	2025	2427	289	1143	1467	4591	741
2850_SPARCL1 - SPARC-like protein 1	2850_SPARCL1 - SPARC-like protein 1	25	289	1	1103	4116	2547	1248	881	4056	3196	884	3807	1396	880	3827	1120	2182	1475	643	4490	1618	3147	2337	289	3375
1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	290	1	4220	2170	3914	290	1941	3682	3037	2567	1724	4354	1120	1854	3795	3856	4618	668	869	2637	4233	3112	3855	4152
1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	25	290	1	495	993	651	4382	4121	2039	290	1239	4596	4670	4232	1781	4437	2101	3046	3443	4620	4265	782	1725	1087	2824
202_Estimated glomerular filtration rate based on cystain C	202_Estimated glomerular filtration rate based on cystain C	25	290	1	3999	4201	2410	2869	3787	3490	2032	290	2688	4394	1791	3019	746	4743	3617	2811	4721	3618	887	4672	495	498
1221_Mean Caudate	1221_Mean Caudate	25	290	1	4654	3497	1484	2573	1452	1956	2276	1502	1889	3590	290	4057	1204	3329	1702	1882	1091	769	2175	2871	3292	3468
4046_Rotator cuff injury	4046_Rotator cuff injury	25	290	1	2148	2409	3877	752	3361	1232	4595	3976	1861	3387	4280	2622	4392	4706	428	1037	290	2589	3410	4100	3724	1517
3386_Work/job satisfaction	3386_Work/job satisfaction	25	290	1	4212	4077	791	544	866	3450	2150	860	2074	1462	1899	2771	2317	4174	2131	1162	3827	290	1057	1706	3355	3883
1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	25	290	1	2713	331	4113	4107	3839	1561	2781	2480	2767	2789	2941	2120	3499	1111	3229	2937	955	3063	1372	1710	290	2910
3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	25	290	1	3556	4726	3176	1971	4134	2092	3956	1016	3246	3453	2223	3711	4039	576	493	3276	4737	2804	407	356	2138	290
2943_WNT7A - Protein Wnt-7a	2943_WNT7A - Protein Wnt-7a	25	291	1	3214	291	378	2596	4175	1851	1404	4324	2668	2479	1402	2686	1107	2314	3945	4464	883	1250	907	3471	1135	2647
2891_NXPH1 - Neurexophilin-1	2891_NXPH1 - Neurexophilin-1	25	291	1	4116	2304	882	3889	2922	4436	291	2356	2965	3257	486	1427	1265	566	3992	4185	2618	2118	1020	1601	1369	2222
4619_Left inferior lateral ventricle	4619_Left inferior lateral ventricle	25	291	1	983	963	3332	3822	1920	2545	1663	4016	1068	2181	4071	291	2572	4294	2154	2630	4291	3625	715	3978	916	3586
4355_IL-1beta in gingival crevicular	4355_IL-1beta in gingival crevicular	25	291	1	1600	3187	2870	2086	4208	4396	3539	1285	1328	2334	952	4157	291	3586	4133	4256	3439	413	3534	1695	4114	1775
1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	25	291	1	4357	1237	2734	2867	2678	4675	787	2559	3547	1108	2131	4613	2556	291	2870	2329	964	4054	1304	3901	2813	3160
1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	291	1	2663	2187	2145	4626	1332	1533	4173	2540	1552	1933	2051	1836	2697	3940	291	3812	488	2817	4248	4491	1537	3186
107_Tanner scale	107_Tanner scale	25	291	1	1688	1058	1928	3248	2893	598	4178	4650	2560	1696	2282	4530	4330	2513	2953	3692	291	1326	4738	3547	1256	2250
1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	292	1	4461	4501	3617	3142	2527	2764	4530	2739	3142	292	2020	1110	2607	3148	2474	2322	4739	3876	2167	3678	2416	3432
922_Cholesterol esters in medium VLDL	922_Cholesterol esters in medium VLDL	25	292	1	1009	4040	4261	3570	390	3106	1669	2377	2787	427	1517	896	3189	2268	292	774	924	1408	2611	1608	3790	481
242_PD1 on CD4mem	242_PD1 on CD4mem	25	292	1	4601	3724	3260	3976	2164	1019	2722	4513	2499	4617	4673	1128	1199	299	3640	4260	292	2319	4286	3349	796	1772
1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	292	1	3284	813	1463	4488	3499	969	3719	1260	612	2330	4708	3531	2287	930	2363	2453	2018	292	4033	1533	2998	1114
3343_Age at first live birth (female)	3343_Age at first live birth (female)	25	292	1	4003	3456	3256	1969	3729	3964	4010	2987	3635	752	1986	2413	3410	3656	3626	1810	2436	1013	292	780	860	3542
3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	25	292	1	2924	2711	4041	715	3902	4657	3691	1583	3202	4391	4745	1433	631	4165	1951	4041	2174	1950	977	292	3163	4582
3077_NOTCH1 - Neurogenic locus notch homolog protein 1	3077_NOTCH1 - Neurogenic locus notch homolog protein 1	25	293	1	2554	578	2352	675	3831	3568	4387	293	847	2448	666	2018	4277	482	4357	3079	3164	4046	2940	815	4362	348
3755_Mental distress - Ever sought or received professional help for mental distress	3755_Mental distress - Ever sought or received professional help for mental distress	25	293	1	4014	1170	4392	4111	966	4038	4511	3434	293	1250	2454	3045	2860	4675	4405	3534	3278	2428	2957	796	2188	1456
3216_Frequency of friend/family visits	3216_Frequency of friend/family visits	25	293	1	951	2535	578	3894	3098	378	1807	3882	2561	293	1329	2337	3202	2844	3850	2867	4013	2446	589	4484	3089	3236
1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	25	293	1	2508	2066	533	3982	4466	1717	2480	511	3573	637	3983	293	1841	3800	667	4080	3072	2126	2931	2333	1049	1659
4357_Albuminuria	4357_Albuminuria	25	294	1	3392	294	743	1578	4108	1214	3368	3891	2775	3591	4314	3828	1684	3053	2069	2038	4450	1836	1282	4386	3744	2546
263_DNT:%CD127+TEF	263_DNT:%CD127+TEF	25	294	1	3149	3295	3908	3148	1635	914	3235	3322	294	1784	1803	303	3327	728	2635	1591	894	2522	1264	4222	727	2604
2158_MIA - Melanoma-derived growth regulatory protein	2158_MIA - Melanoma-derived growth regulatory protein	25	294	1	774	4407	4099	421	492	3333	1890	900	2369	3953	1804	4002	294	2261	1829	766	4032	4732	4493	3814	3709	3173
3255_Tea intake	3255_Tea intake	25	294	1	3174	1435	4277	2226	1997	4471	942	3144	2094	4023	835	1851	1548	294	2816	2650	3348	1581	4714	1832	1825	3788
4713_Anterior corona radiata mode of anisotropy	4713_Anterior corona radiata mode of anisotropy	25	294	1	1390	3909	2479	3914	2418	3243	1573	1274	2204	1490	2857	1970	4149	4613	1807	4163	4677	1628	3738	294	2226	909
2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	25	294	1	503	1234	3820	3558	3922	1547	992	2542	3360	1775	2152	4020	3847	1623	3669	3804	1132	3445	4547	1095	2248	294
2339_SPARC - SPARC	2339_SPARC - SPARC	25	295	1	1022	2530	780	4054	1507	2098	295	3091	1871	1163	3249	1511	3532	4588	4241	4315	753	2344	3307	4741	1599	2913
1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	295	1	4267	4200	2378	3875	1842	4721	3297	1862	2242	4599	295	2615	3535	3404	3919	3039	2586	1061	2292	1238	1089	2417
426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	25	295	1	2153	774	3585	3987	3466	3177	4667	4396	493	1103	2185	703	295	4520	4307	3014	1469	461	3963	3451	2931	4147
4295_Morning person (binary)	4295_Morning person (binary)	25	295	1	662	2448	1824	4350	3483	588	1926	3146	4502	1427	2727	2307	4583	1392	3193	3755	1240	2046	295	387	1042	2967
4247_Ambidextrousness	4247_Ambidextrousness	25	296	1	296	631	2859	2532	4442	4161	1633	3327	4270	952	4481	4074	4292	2547	1099	2143	3097	826	2132	1962	2423	3547
762_::::X-12212	762_::::X-12212	25	296	1	2020	2593	296	1877	2157	2907	1765	712	3478	1762	1887	439	3380	2625	2738	4063	2558	602	3401	3222	2113	899
1128_Visceral adipose tissue sttenutation (female)	1128_Visceral adipose tissue sttenutation (female)	25	296	1	1851	4415	560	3476	296	1289	4265	3378	1773	1207	1840	3819	3901	2672	3587	799	1459	4739	3302	3446	2406	3118
4219_Vasodilators used in cardiac diseases	4219_Vasodilators used in cardiac diseases	25	296	1	4640	443	4553	2813	3525	4525	3768	296	1690	1381	994	2314	675	3829	2301	1566	563	3107	1431	2791	1957	3384
1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	25	296	1	4649	3483	1526	3850	4013	2348	1143	4568	1214	296	2586	1731	3859	1900	3068	4087	1943	1397	4321	4148	3127	2236
2983_CA2 - Carbonic anhydrase 2	2983_CA2 - Carbonic anhydrase 2	25	296	1	357	4237	640	1393	2957	616	3526	3105	1192	671	3504	1948	4354	296	529	3511	2701	2773	1642	3624	1435	3673
1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	25	296	1	1868	2284	1367	485	2623	3975	3900	3424	4531	1006	1644	4708	1223	3464	296	3992	1973	4587	1880	629	2108	3319
2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	25	296	1	1070	3670	2863	3040	3146	1250	3813	2609	1622	2846	4626	3151	4029	4703	1553	3425	296	720	1182	1697	3332	3905
1125_Subcutaneous adipose tissue attenuation (female)	1125_Subcutaneous adipose tissue attenuation (female)	25	296	1	2749	3205	3510	4050	3795	418	2069	1773	1601	3294	2774	1607	2755	4258	777	4448	4399	2661	296	1468	1427	4238
2562_LTA LTB - Lymphotoxin alpha2:beta1	2562_LTA LTB - Lymphotoxin alpha2:beta1	25	297	1	4705	3626	3440	2270	821	297	3608	1804	1467	1506	2651	3624	4703	4357	3446	1420	557	4385	2732	3520	2794	4170
386_Amino acid::Histidine metabolism::3-methylhistidine	386_Amino acid::Histidine metabolism::3-methylhistidine	25	297	1	3191	3365	4180	2661	1334	1929	1611	1747	4411	297	953	3259	3932	1507	474	759	819	4714	1754	2054	761	1712
3108_GCKR - Glucokinase regulatory protein	3108_GCKR - Glucokinase regulatory protein	25	297	1	1530	4377	4406	4409	1686	1970	863	1848	3996	2995	3200	297	4018	379	3438	2219	981	4376	2973	1209	3682	4636
3569_Why stopped smoking: Financial reasons	3569_Why stopped smoking: Financial reasons	25	297	1	1191	2903	4483	2937	4069	1767	3523	4017	3005	3490	4096	324	4226	1653	904	3978	297	3139	678	3868	4663	3285
2618_BMPER - BMP-binding endothelial regulator protein	2618_BMPER - BMP-binding endothelial regulator protein	25	297	1	3777	1247	2052	490	1750	548	2064	2661	1087	4047	1790	3319	1968	2909	1164	3915	3372	736	297	945	945	4486
1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	25	297	1	1256	1850	3631	3132	2942	3665	1579	1560	828	3772	2631	444	4675	984	2133	2421	1678	2704	3385	297	915	4106
2975_ANXA2 - Annexin A2	2975_ANXA2 - Annexin A2	25	297	1	4516	4694	2127	3659	1158	2164	4268	1118	3616	1963	793	3545	3516	1054	4387	1300	1040	3328	1375	3180	3839	297
2964_CCL19 - C-C motif chemokine 19	2964_CCL19 - C-C motif chemokine 19	25	298	1	1971	298	1496	3740	3250	3678	731	999	2184	2520	2683	4097	4497	633	2204	3546	1493	4570	2778	4496	996	667
4003_Juvenile idiopathic arthritis with vs without uveitis	4003_Juvenile idiopathic arthritis with vs without uveitis	25	298	1	2118	2879	3514	4522	302	2366	4715	2304	1163	4452	1399	2806	4737	1928	2316	298	4401	4653	2051	3932	3883	3536
2149_CAPN1 CAPNS1 - Calpain I	2149_CAPN1 CAPNS1 - Calpain I	25	298	1	2300	4275	1069	3250	1579	2963	4239	699	2007	668	3233	3584	2302	2910	874	1427	1508	298	2461	1529	1696	3485
4313_Age of initiation of regular smoking	4313_Age of initiation of regular smoking	25	298	1	1463	4017	2096	3466	3764	4560	2373	4074	3830	1940	1289	3598	4371	3502	362	2474	3775	731	4679	298	709	1533
2022_Fibrotic idiopathic interstitial pneumonias	2022_Fibrotic idiopathic interstitial pneumonias	25	299	1	626	299	3338	4663	3863	1328	3069	1638	1118	323	529	3245	2810	1197	3506	4609	3147	4681	2466	4414	2116	2597
181_Waist-hip ratio (male)	181_Waist-hip ratio (male)	25	299	1	2990	1837	4719	3391	641	299	892	1739	943	3243	2552	1599	4172	1357	4630	757	835	1638	1438	2969	715	549
1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	299	1	1348	540	755	1443	3171	4377	299	4112	588	4385	4262	4438	4317	3040	2484	723	2940	1491	638	4206	3980	983
3359_Age high blood pressure diagnosed	3359_Age high blood pressure diagnosed	25	299	1	384	2974	2038	1197	2962	2977	2135	2322	299	1591	4436	3061	2160	4077	1439	1175	3197	1710	1813	2555	3189	2976
3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	299	1	2006	3122	1954	3098	3686	1132	1521	3561	2102	1739	2657	4007	299	1067	735	2200	2898	4541	4689	1754	1730	4334
2929_CSF3 - Granulocyte colony-stimulating factor	2929_CSF3 - Granulocyte colony-stimulating factor	25	299	1	2588	3688	1225	1580	2879	2289	1336	4308	2684	2280	2473	320	3433	2876	2496	3843	1182	299	1313	368	4365	3747
4516_Optic chiasm	4516_Optic chiasm	25	299	1	4594	990	1632	350	830	4652	2636	550	4604	1645	1020	1923	2062	3069	3692	305	534	2845	3905	299	3388	3256
3204_Number of days/week walked 10+ minutes	3204_Number of days/week walked 10+ minutes	25	299	1	1124	789	2159	662	3368	1355	837	3293	3128	4430	3182	4246	4679	2761	1268	4139	4109	4344	1007	3209	299	1844
1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	299	1	989	2764	474	861	3389	4339	4014	631	644	3148	509	2096	1316	4507	2236	2708	2421	4156	941	1401	1028	299
1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	300	1	1152	4383	4222	300	460	851	1743	4168	4739	1503	3400	4394	2944	2002	805	331	4183	4116	1832	1729	4709	1964
286_CD4:%Treg(39-73+)	286_CD4:%Treg(39-73+)	25	300	1	336	3407	4083	2786	585	2561	2886	1774	4004	300	2831	3979	2680	3354	3532	2157	2345	3782	4073	1866	4645	4009
3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	25	300	1	3816	2213	3584	3491	3959	3925	4288	3311	1734	4389	456	300	2922	1650	3579	4542	2464	3598	605	4079	3890	1375
228_Lymph:%DP T	228_Lymph:%DP T	25	300	1	4115	2578	2891	3152	710	2137	2001	1219	3859	1363	1387	2169	1958	365	2178	1966	841	300	424	416	2996	1415
3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	25	300	1	3201	3038	2624	3085	3205	2436	3077	2180	2128	1753	1683	932	2255	3350	880	2469	2713	3329	300	3226	3579	4560
3158_NLGN4X - Neuroligin-4, X-linked	3158_NLGN4X - Neuroligin-4, X-linked	25	301	1	2900	4203	301	841	4219	1778	3203	3938	4691	3276	3867	1696	1840	1217	1664	3962	3959	1297	1242	3651	3536	4130
1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	25	301	1	4608	929	4672	1776	4427	2592	301	4128	576	3356	1675	4141	588	637	3913	2777	2100	2572	4470	2520	4045	3899
3833_Basophil count (two-way meta)	3833_Basophil count (two-way meta)	25	301	1	3409	2870	3847	2261	4553	1598	4494	2917	306	634	3704	3154	2799	301	1252	2796	327	771	626	998	567	3486
1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	301	1	1733	2226	2156	1912	756	1227	2028	3654	3213	1542	1354	4729	3583	4156	3502	301	2083	2999	811	3371	2651	2907
212_Insomnia (female)	212_Insomnia (female)	25	301	1	3991	3854	643	3790	1971	3889	3096	3464	1675	1028	2963	1214	4279	2821	3621	2721	2146	301	4213	1280	3134	4403
898_Total cholesterol in large VLDL	898_Total cholesterol in large VLDL	25	301	1	2657	4327	2698	3207	628	1817	1965	1164	3427	449	1479	436	2109	2242	423	1433	1074	1565	3773	2382	2919	301
787_::::X-12644	787_::::X-12644	25	302	1	1311	4107	1730	302	832	1463	2113	4198	2076	2950	2340	1753	1871	1415	1495	2033	1338	1536	848	808	2255	1990
4271_Worry/vulnerability factors	4271_Worry/vulnerability factors	25	302	2	3881	4277	1378	3482	3788	302	2014	4740	1862	1839	2712	4604	4652	1406	2729	4351	4715	1879	621	659	700	1598
3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	25	302	1	4290	2091	3344	3734	1589	2150	1988	2362	2522	3142	302	3492	3058	2145	3303	2910	3661	1751	2013	959	4664	1976
4422_Herpes simplex virus 2 seropositivity	4422_Herpes simplex virus 2 seropositivity	25	302	1	2443	3818	2817	3452	1380	3378	573	1767	3480	627	1231	302	2973	3106	3118	2933	2917	1331	2331	3931	466	303
1919_Total cerebral brain volume (GEE, adjusted for multivariable)	1919_Total cerebral brain volume (GEE, adjusted for multivariable)	25	302	1	2182	1661	4429	2356	1142	2052	4508	816	2593	1546	2960	2661	2792	3156	302	2787	2384	4476	3363	4029	3063	3628
3771_Depression - Recent changes in speed/amount of moving or speaking	3771_Depression - Recent changes in speed/amount of moving or speaking	25	302	1	3050	2612	2295	3327	627	3151	1791	1354	681	4476	3047	2939	2388	1552	1913	302	2830	673	2374	2638	4669	4434
3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	25	302	1	870	377	4654	3797	2560	4643	2072	1941	2486	1352	653	1576	844	3848	1866	4222	302	1589	2989	1342	1449	4332
4586_Right lateral orbitofrontal	4586_Right lateral orbitofrontal	25	302	1	440	3065	3283	833	985	3821	2805	372	2318	3993	3257	2950	1632	1811	1071	1892	3125	1141	302	2406	2156	4217
4002_Guilty feelings (GUILT)	4002_Guilty feelings (GUILT)	25	302	1	693	2277	3348	2497	1710	3067	4654	1082	3124	802	4575	1945	1008	994	2207	3665	3519	3970	449	3770	4634	302
2754_KLKB1 - Plasma kallikrein	2754_KLKB1 - Plasma kallikrein	25	303	1	1442	1034	303	2402	744	3893	4043	2648	3008	1264	2177	4406	4358	410	1795	1169	1940	4518	3330	4576	3918	3129
609_Peptide::gamma-glutamyl::gamma-glutamylvaline	609_Peptide::gamma-glutamyl::gamma-glutamylvaline	25	303	1	3414	1332	1750	303	2654	2678	814	4280	4103	704	4052	3702	4719	3038	3515	1992	2757	518	1129	4469	1347	1185
2188_C1QA C1QB  C1QC - Complement C1q subcomponent	2188_C1QA C1QB  C1QC - Complement C1q subcomponent	25	303	1	4685	4676	3102	2266	1408	1484	386	1136	303	2210	2839	2186	4069	3343	3854	456	1124	2502	1763	1894	508	3023
1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	303	1	4670	4431	3825	3489	4507	331	2444	2373	2967	303	2863	3233	3416	468	3364	2663	694	1371	506	1933	2469	3508
2194_FGF20 - Fibroblast growth factor 20	2194_FGF20 - Fibroblast growth factor 20	25	303	1	1119	3691	981	419	754	447	3957	2593	3928	4414	303	330	1945	4142	3813	2283	2183	4719	1901	4049	1831	3501
686_::::X-10510	686_::::X-10510	25	303	1	3321	3123	2092	4674	2161	2322	2767	3193	3619	1589	1537	3394	4559	3953	1494	2678	4570	1466	303	1715	2979	1152
2432_CD5L - CD5 antigen-like	2432_CD5L - CD5 antigen-like	25	304	1	1508	3857	304	3627	3436	1198	4594	3831	1414	951	675	345	921	421	1981	1528	4589	346	2372	2408	2128	966
841_::::X-14588	841_::::X-14588	25	304	1	4714	3751	1263	578	3928	4639	4229	304	2487	2111	1657	3308	2289	4131	480	2261	692	4467	2690	2596	3693	1351
2201_IL10 - Interleukin-10	2201_IL10 - Interleukin-10	25	304	1	2197	1528	4426	4435	4743	2860	3897	597	467	3959	2173	1716	1249	3227	2393	1633	1846	304	2509	2228	4189	3704
1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	304	1	2447	1316	587	3436	1637	3884	696	2122	667	1290	1311	2217	3559	4086	3807	3171	4548	2405	304	3474	2165	2428
3408_Average weekly intake of other alcoholic drinks	3408_Average weekly intake of other alcoholic drinks	25	304	1	652	2354	793	2860	400	3955	859	2375	1132	2191	1196	879	2446	3260	322	315	2042	3389	3510	360	304	3833
869_OmegaL7 and L9 and saturated fatty acids	869_OmegaL7 and L9 and saturated fatty acids	25	305	1	2614	2275	2524	305	499	4136	4091	3702	3019	3351	1122	3608	2490	622	1371	584	2403	2266	1409	2464	4192	1865
3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	25	305	1	4386	4191	2293	2479	2693	3699	3120	850	3813	1585	2523	4445	305	3063	4690	4462	3549	1728	1008	3875	3635	4709
1229_Parkinson Disease	1229_Parkinson Disease	25	305	1	4710	4177	4727	4692	1959	3482	472	1060	4695	2285	1277	927	4094	305	3602	1510	4641	592	788	700	1858	3009
499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	25	305	1	3040	3429	1389	4123	1015	3522	1378	1126	3748	1364	975	2203	4725	4661	2198	2278	2031	305	3815	4537	396	1945
981_Interleukin-10	981_Interleukin-10	25	306	1	306	2576	742	2070	564	2776	4153	566	4308	795	1584	2791	3454	1336	3983	2365	1926	3113	4206	753	938	1962
2467_BMP1 - Bone morphogenetic protein 1	2467_BMP1 - Bone morphogenetic protein 1	25	306	1	2041	2461	306	880	1233	2885	4115	1541	2265	3971	1291	3066	2585	1499	2047	993	3776	782	3865	1949	2185	589
594_Peptide::Dipeptide::leucylleucine	594_Peptide::Dipeptide::leucylleucine	25	306	1	1011	3301	2520	4472	1870	1060	2265	2988	3460	306	3690	2119	1435	3565	1688	1678	2620	3898	1046	2486	2730	3683
2361_F10 - Coagulation factor Xa	2361_F10 - Coagulation factor Xa	25	306	1	4106	1641	1981	3902	1915	3002	3779	3718	2234	3096	4198	1786	4257	4059	2862	3592	1312	4601	3805	306	1945	400
675_::::X-08766	675_::::X-08766	25	307	1	4084	379	307	3045	3267	2313	1993	4432	1859	1174	3310	2384	1290	2958	2682	1953	4235	1964	563	2399	4060	914
2659_CST5 - Cystatin-D	2659_CST5 - Cystatin-D	25	307	1	3450	2444	4506	4466	2790	307	4079	3814	1524	1781	4010	3367	1607	1182	885	2302	2301	2449	954	1840	4364	1444
157_Hip circumference (male)	157_Hip circumference (male)	25	307	1	611	2367	2102	3285	4298	3028	3973	443	1544	3840	307	3693	584	1752	2578	4627	1703	4084	1115	2837	1218	336
4339_Walking	4339_Walking	25	307	1	1384	2564	3318	3652	859	3161	2819	350	2598	2163	2428	3196	3125	307	749	952	3990	4333	1089	1007	1781	372
2138_CDH3 - Cadherin-3	2138_CDH3 - Cadherin-3	25	307	1	3202	442	2021	2948	4146	665	3100	553	3160	372	4609	4342	4585	4436	307	4506	1411	1752	4705	4693	4117	3861
4417_Rubella seropositivity	4417_Rubella seropositivity	25	307	1	1306	4436	2242	1261	1587	4165	3892	2742	4525	2651	1709	1376	4151	1471	4257	3977	2367	891	4202	2538	307	3744
3388_Family relationship satisfaction	3388_Family relationship satisfaction	25	307	1	3692	4337	570	1546	3859	2956	833	1370	579	4090	1074	536	1845	2388	3896	4278	3731	4599	1680	2637	3280	307
2614_DKKL1 - Dickkopf-like protein 1	2614_DKKL1 - Dickkopf-like protein 1	25	308	1	3909	1474	1992	3832	4054	783	1390	308	3283	1295	2570	329	2384	2765	3243	3068	1380	529	2512	1543	2410	3638
4202_Chronic kidney disease	4202_Chronic kidney disease	25	308	1	3022	4530	2951	1645	1055	3872	3776	3680	591	4037	3488	2402	853	3973	4095	308	985	1420	790	2563	1900	2640
1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	25	308	1	2765	4669	3334	2512	2174	3982	1309	840	4164	3460	1128	2540	2804	2225	3935	2392	308	3660	3875	384	731	3227
1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	308	1	993	3258	2199	1017	1067	1579	500	4669	2167	1856	3951	1688	3279	4191	1450	3188	1311	2371	4475	2887	308	2901
3890_Monocyte percentage of white cells (three-way meta)	3890_Monocyte percentage of white cells (three-way meta)	25	309	1	4326	3795	2513	1102	1062	1400	2670	3742	1660	1983	1455	309	4691	1216	2235	1625	4207	1196	2238	1683	692	679
1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	25	309	1	3206	4373	3164	4401	1996	2167	961	4656	4074	732	2732	4240	727	1152	309	1891	2607	1809	3166	3995	2698	2525
9_Schizophrenia	9_Schizophrenia	25	309	1	3601	3710	1531	1461	320	570	3683	1654	3342	473	4587	3950	2544	1112	4500	309	399	675	3921	1078	4334	762
993_Interleukin-6	993_Interleukin-6	25	309	1	429	1099	384	4344	812	1624	2650	2020	3387	4620	692	3936	4391	2897	3998	1421	776	309	3576	3827	1268	2949
2091_GFRA2 - GDNF family receptor alpha-2	2091_GFRA2 - GDNF family receptor alpha-2	25	309	1	1784	3333	983	2059	3584	2061	3860	3403	2240	4439	2576	2238	924	4264	2283	2927	1861	3479	309	612	3053	2570
2264_CD22 - B-cell receptor CD22	2264_CD22 - B-cell receptor CD22	25	310	1	3694	1512	4167	1179	3530	1428	310	1211	3184	985	4390	2855	2445	2607	2457	4292	518	609	2252	1052	3968	1959
2455_NTN4 - Netrin-4	2455_NTN4 - Netrin-4	25	310	1	1731	2794	1321	915	2289	2996	490	675	3772	310	2075	2893	963	2650	1958	3785	3417	1153	1691	621	1153	990
2009_Hypertriglyceridemia	2009_Hypertriglyceridemia	25	310	1	2600	3230	1636	3134	3395	3109	3817	3924	3998	3181	2875	1974	4424	3268	310	1676	4532	4017	369	3969	1833	3402
1837_Neck width (GEE, male, adjusted for multivariable)	1837_Neck width (GEE, male, adjusted for multivariable)	25	310	1	2436	4174	3022	1757	2631	2142	658	4238	1962	4732	3836	1103	2307	2389	2593	787	1416	310	4276	1164	3178	4064
914_Concentration of medium HDL particles	914_Concentration of medium HDL particles	25	310	1	2421	3846	2274	4044	3636	2820	771	2268	2125	4705	522	2762	2980	475	4230	2260	3239	3241	310	2174	886	3608
1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	25	310	1	2257	2077	1324	3059	790	4566	4551	3355	1860	3126	2562	2100	3003	1029	2621	1554	1606	2957	4572	310	1949	3176
3898_Platelet distribution width (three-way meta)	3898_Platelet distribution width (three-way meta)	25	310	1	4343	749	3907	2107	1091	1658	842	2674	4444	2470	3227	2892	1948	3957	1369	1470	1112	2699	3475	1232	2628	310
3197_Length of working week for main job	3197_Length of working week for main job	25	311	1	311	2469	3496	2302	2347	2439	2623	3917	4417	2816	2394	1855	4528	2784	2387	3563	3243	1065	2886	3330	626	1446
4165_Juvenile Myoclonic Epilepsy (JME)	4165_Juvenile Myoclonic Epilepsy (JME)	25	311	1	2892	3522	311	1668	3378	2861	4501	3245	4188	3094	2767	3676	523	872	3608	2389	3153	4662	3976	2022	3617	3868
941_Total lipids in small VLDL	941_Total lipids in small VLDL	25	311	1	960	4305	3751	3361	311	2941	2664	1401	3482	1815	1117	3143	4059	1125	383	454	1023	962	3930	2012	2338	1170
1137_Father's age at death	1137_Father's age at death	25	311	1	4453	1196	1095	3958	669	1391	3015	4597	311	2697	1332	2278	408	3066	2322	1065	870	1696	3838	4629	3044	468
40_Reaction time	40_Reaction time	25	311	1	4693	2117	2684	2104	2357	1634	2384	4685	3166	311	3580	3435	4030	2211	2050	2497	2463	986	2073	1021	4179	2638
1172_Heart rate	1172_Heart rate	25	311	1	2780	2811	3795	932	3056	4371	770	3425	1109	943	4549	3505	311	1255	907	4680	1370	1192	1267	4374	710	2975
4717_Cingulum (cingulate gyrus) mode of anisotropy	4717_Cingulum (cingulate gyrus) mode of anisotropy	25	311	1	4308	2186	4407	2913	2884	3477	1398	2815	4014	1031	2871	2592	3806	311	1735	2395	1834	3723	523	1190	1242	4038
1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	25	312	1	3575	628	3919	936	3709	312	430	1258	2302	4458	3437	3560	1777	1153	2242	4127	902	2154	4133	359	3487	2097
3009_MMP14 - Matrix metalloproteinase-14	3009_MMP14 - Matrix metalloproteinase-14	25	312	1	913	934	2695	3959	2724	2589	3328	312	2300	3887	3451	4047	2758	432	445	350	2265	455	2530	495	1814	4020
2451_LRP8 - Low-density lipoprotein receptor-related protein 8	2451_LRP8 - Low-density lipoprotein receptor-related protein 8	25	312	1	4080	2462	4033	3386	3857	4177	2824	3724	2796	1938	312	1243	1246	681	3646	2307	4303	517	2298	4466	2382	3507
3798_Worry subcluster	3798_Worry subcluster	25	312	1	4293	2426	3676	4616	2651	687	3362	3350	2806	1262	2822	4638	4573	1796	4050	2859	4447	312	968	1734	2602	1007
4461_Left pars orbitalis	4461_Left pars orbitalis	25	312	1	4658	1244	3120	4464	2062	2955	4725	2108	3793	2395	1975	814	2925	2859	2580	2126	2579	1864	4450	312	2303	4667
4250_L5 timing	4250_L5 timing	25	312	1	2875	4636	1486	2450	945	3899	2199	1875	1616	3247	2573	3290	4041	1931	1086	2939	4104	4135	1738	714	312	1419
1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	313	1	1717	2019	313	2659	2719	3447	1421	4151	2386	2550	2923	3021	453	2034	2806	3201	1654	4298	807	1115	4654	2412
1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	313	1	1127	1064	2936	1658	313	897	4587	4667	2777	1334	4452	3037	2558	2567	4220	547	560	3499	1807	4721	941	4556
3371_Chest pain or discomfort when walking uphill or hurrying	3371_Chest pain or discomfort when walking uphill or hurrying	25	313	1	2848	1222	2265	2026	2989	1387	2356	2124	4381	2316	961	313	3503	3613	2885	1465	4624	1112	2754	3099	2361	2089
701_::::X-11437	701_::::X-11437	25	313	1	1782	2589	2088	2148	3286	3524	3723	1923	2402	3081	2083	4714	2745	313	3027	3382	658	523	4102	2695	459	4118
2344_VWF - von Willebrand factor	2344_VWF - von Willebrand factor	25	313	1	4468	2451	3425	1092	482	2077	667	1926	1108	1952	2108	3081	3033	1791	3153	313	4502	4691	3341	3396	3309	3004
1965_MMSE score (at exam 5, GEE, adjusted for age)	1965_MMSE score (at exam 5, GEE, adjusted for age)	25	313	1	4327	1285	1789	1205	1357	486	4375	2857	2859	1327	2287	2046	3389	3943	1868	1355	742	3144	2580	313	2409	2905
4520_Left cerebellum white matter	4520_Left cerebellum white matter	25	314	1	314	4658	3587	368	3331	4022	1087	3119	4718	904	2810	417	3870	2155	1793	2745	4329	2225	4109	3090	1493	588
2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	25	314	1	3982	3315	2559	3163	314	3922	2164	537	1390	2460	3774	4217	3907	2104	4216	381	3280	3564	2495	2959	3994	3367
1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	314	1	3252	1755	800	3544	3612	314	550	1031	2173	2298	2898	2641	3936	2020	1748	2137	413	804	2994	924	2766	4099
714_::::X-11491	714_::::X-11491	25	314	1	2968	3545	3187	1239	2825	3307	4121	4318	2393	314	3174	608	1642	490	3133	4564	3975	2672	2004	2685	3078	1043
1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	314	1	853	640	656	4252	650	1522	4445	2932	2274	2877	3060	3314	4098	1234	1408	2472	1986	2062	1697	3869	314	1652
1079_Prostate cancer	1079_Prostate cancer	25	315	1	2319	315	4278	2714	2381	4206	1651	2889	1780	433	1836	1534	4532	2798	1104	3081	3588	2587	1829	4423	614	4607
3626_Treatment/medication code: bendroflumethiazide	3626_Treatment/medication code: bendroflumethiazide	25	315	1	3778	1930	4040	4744	315	3428	3653	3639	1819	4182	2949	804	3572	2586	2624	1104	1583	3006	1477	3920	573	4235
3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	25	315	1	3953	939	2094	2959	1502	315	4422	2759	2175	1777	2916	4625	4060	4139	2963	1102	558	921	1724	3786	2761	3101
4215_Estimated glomerular filtration rate	4215_Estimated glomerular filtration rate	25	315	1	1131	1207	3757	1943	3065	4659	315	807	608	556	3384	669	1796	1419	4324	4000	815	1659	2162	4057	1683	1101
4261_Facial attractiveness (male-coder, female samples)	4261_Facial attractiveness (male-coder, female samples)	25	315	1	2266	3858	747	4389	4541	4413	2601	3896	2425	315	3965	3838	1363	767	2850	2802	4366	1733	3296	4281	2722	3480
680_::::X-09789	680_::::X-09789	25	315	1	3021	4458	1989	3370	4540	4133	2951	1603	933	1671	928	4632	315	3076	4574	2070	2972	1704	3136	2051	350	3243
3855_Mean platelet volume (two-way meta)	3855_Mean platelet volume (two-way meta)	25	315	1	3370	614	3309	3649	2411	515	4213	1625	1882	683	1364	2133	535	1156	1971	966	4486	315	927	2560	4103	1614
2185_INHBA - Inhibin beta A chain	2185_INHBA - Inhibin beta A chain	25	315	1	4365	2572	3511	2395	1032	472	1707	2606	2343	4717	1204	1161	2935	4291	999	1134	627	1972	315	330	1176	4330
4172_Social support - Leisure/social activities: Pub or social club	4172_Social support - Leisure/social activities: Pub or social club	25	316	1	4449	4461	4599	2972	1230	2774	3027	3706	4611	1539	2952	1346	316	1027	924	3494	3110	2948	4273	1437	4625	2494
1156_Fasting glucose main effect	1156_Fasting glucose main effect	25	316	1	3144	4744	2579	3419	3630	2512	2576	2743	4124	2317	3583	1647	851	3321	476	3891	1512	1774	316	1998	792	2134
3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	25	317	1	618	317	3173	491	430	3557	4260	2808	4281	2927	1272	3754	3363	2374	4745	712	1957	3888	3798	1956	4439	1089
4681_Posterior corona radiata axial diusivities	4681_Posterior corona radiata axial diusivities	25	317	1	3261	3547	2522	317	1955	2719	2730	2365	4323	4608	2699	3016	1306	1968	1919	2958	2617	637	3417	2830	1712	816
2959_HBA1 HBB - Hemoglobin	2959_HBA1 HBB - Hemoglobin	25	317	1	3548	3166	4143	3062	3982	3103	1822	4124	817	317	1875	1036	450	2557	1823	1878	2903	1440	2772	4351	1383	3449
871_Glucose	871_Glucose	25	317	1	1630	2049	2342	3992	4206	2658	4392	2341	3349	3739	2236	556	2856	317	4609	3618	2483	1012	2294	3333	3481	4177
1064_Bipolar disorder	1064_Bipolar disorder	25	317	1	1696	1135	1493	3092	2878	1315	1399	1754	1670	3265	4733	2017	1164	3529	2077	1293	3331	1803	2190	4272	1544	317
3226_Difference in mobile phone use compared to two years previously	3226_Difference in mobile phone use compared to two years previously	25	318	1	2498	318	4524	3153	3107	1693	3838	2659	1841	3417	3633	506	719	1888	4235	2530	575	2564	2249	4156	1586	1488
3583_Types of transport used (excluding work): Public transport	3583_Types of transport used (excluding work): Public transport	25	318	1	2688	368	318	594	1834	1552	1634	3635	4713	1140	3095	3955	1831	3582	3325	2815	3115	1961	3596	3596	2949	977
4430_Varicella Zoster Virus IgG levels	4430_Varicella Zoster Virus IgG levels	25	318	1	2870	908	4611	3737	3149	3421	318	3925	546	1829	480	2016	3677	641	3950	3948	3998	3003	3628	4282	4303	3534
3852_Mean corpuscular volume (two-way meta)	3852_Mean corpuscular volume (two-way meta)	25	318	1	4369	3551	3845	2903	2075	1303	3774	3087	1647	318	3222	1698	1387	2252	592	1585	1800	1384	1937	1773	4050	1406
3675_Diagnoses - main ICD10: K80 Cholelithiasis	3675_Diagnoses - main ICD10: K80 Cholelithiasis	25	318	1	2701	3946	4011	3171	3381	2010	1629	4293	921	3949	3466	318	2532	4687	3584	3311	773	2447	1897	3281	2816	1552
2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	25	318	1	2847	2588	4573	506	768	3389	2478	2463	851	3192	4720	1205	318	3542	3310	979	3407	3721	1906	4702	497	3221
4725_Posterior corona radiata mode of anisotropy	4725_Posterior corona radiata mode of anisotropy	25	318	1	755	2431	4535	1964	2972	2865	2470	3316	1282	2305	1032	1386	4554	318	3694	1177	4234	1187	1839	3979	1192	552
3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	25	318	1	368	1188	4295	2703	2428	1592	4073	3269	3786	513	4601	2484	4014	1043	318	3782	4121	4542	2060	1214	359	3037
1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	319	1	745	2407	3016	2065	4650	511	3286	2789	1149	2218	3138	1040	4473	3569	3549	2942	319	3147	1398	2612	1415	1958
241_CD161 on CD4mem	241_CD161 on CD4mem	25	320	1	3723	3521	2186	3460	1020	320	3076	3101	2182	385	3351	3176	1035	1226	2582	950	328	1344	3102	1582	2972	3255
1057_Major depressive disorder	1057_Major depressive disorder	25	320	1	3974	3332	3463	1560	2194	4389	320	531	2530	4150	1042	326	2725	1613	457	2028	2270	4490	1722	3772	1999	820
27_Neuroticism (NEO-FFI)	27_Neuroticism (NEO-FFI)	25	320	1	4256	1631	4200	3296	1251	2047	2187	3715	1145	4649	3015	3263	1131	320	4027	2874	4671	3030	1846	2846	973	4540
3769_Anxiety - Recent restlessness	3769_Anxiety - Recent restlessness	25	320	1	738	3706	4020	2668	1325	1204	3962	3858	1973	2453	3490	2393	4499	1334	4687	4398	4695	3904	3232	3907	3260	320
2291_VCAM1 - Vascular cell adhesion protein 1	2291_VCAM1 - Vascular cell adhesion protein 1	25	321	1	1674	1719	4306	2458	834	4531	4150	3932	3031	2289	2734	1642	4193	2343	3289	1720	321	349	4329	4362	1698	1028
2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	25	321	1	1234	512	2455	3523	3519	3121	2379	2121	1073	639	4470	1600	2429	2719	3947	1138	4643	321	3851	1063	1078	2890
1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	25	321	1	3094	3587	4726	1707	3109	2585	4637	709	2907	3281	1389	1142	1300	1280	898	3136	3086	3046	4295	321	718	1140
4061_Urinary albumin-to-creatinine ratio	4061_Urinary albumin-to-creatinine ratio	25	322	1	322	2280	1551	3174	3022	4411	3690	2054	3209	3684	3231	973	2440	3537	3638	4303	2797	1690	2812	2315	427	3532
198_Urinary albumin-to-creatinine ratio (diabetes positive)	198_Urinary albumin-to-creatinine ratio (diabetes positive)	25	322	1	4241	322	3162	3111	3166	4367	1293	1429	4069	3074	3242	4745	776	2889	2441	3374	1721	3550	822	668	2710	787
633_Xenobiotics::Food component, Plant::piperine	633_Xenobiotics::Food component, Plant::piperine	25	322	1	1698	3254	585	3494	852	322	3616	1093	1281	3951	363	1252	3925	346	3520	385	3336	897	4686	3947	2560	3578
4146_Interventricular septum thickness	4146_Interventricular septum thickness	25	322	1	3302	1407	1521	1456	3622	3956	1548	322	3682	2274	2484	2797	950	2128	2373	3687	1615	3629	2596	2484	772	4102
2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	25	322	1	825	3133	1936	1820	4112	327	3854	4381	3132	1742	322	1071	1919	1677	3169	1684	1292	3738	1951	1829	3361	1031
3801_Hematocrit	3801_Hematocrit	25	322	1	4323	3182	2587	4360	2526	912	1905	3638	1226	4483	2380	2086	542	387	2817	1320	2507	4082	2629	322	793	4733
4248_Parkinson's disease age at onset	4248_Parkinson's disease age at onset	25	322	1	2393	906	2716	2039	932	1539	2814	493	3013	368	4148	1371	3833	1953	1818	3011	2149	3907	3669	3831	322	346
2143_PLAUR - Urokinase plasminogen activator surface receptor	2143_PLAUR - Urokinase plasminogen activator surface receptor	25	323	1	1598	323	1202	831	3315	1553	4263	4681	658	4450	3667	4699	775	1956	4179	4172	2188	2413	1693	2122	2898	2402
1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	25	323	1	2877	2147	762	3154	1563	3431	3615	2154	4480	533	1784	1239	323	1291	2111	2674	2904	1538	699	1345	1490	4415
3611_Treatment/medication code: lisinopril	3611_Treatment/medication code: lisinopril	25	323	1	4169	1566	475	4114	898	1750	4420	4604	1850	4099	3183	3735	2083	1571	2306	646	323	930	2573	2904	4201	3203
1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	25	324	1	2933	1757	2571	324	3957	4343	2897	2756	2549	4077	1997	1279	1546	3837	4331	1377	696	3587	769	1808	4327	4738
2392_CRISP3 - Cysteine-rich secretory protein 3	2392_CRISP3 - Cysteine-rich secretory protein 3	25	324	1	3313	3458	2974	3403	4615	1264	3955	324	360	4690	3967	2997	4463	759	3924	3145	2725	763	366	3137	4287	4211
1184_High-density lipoprotein cholesterol	1184_High-density lipoprotein cholesterol	25	324	1	2998	3311	3862	1452	1455	1990	2780	2930	324	1085	1403	3448	2111	3179	4355	2709	1634	1868	3864	2554	659	2375
636_Xenobiotics::Food component, Plant::stachydrine	636_Xenobiotics::Food component, Plant::stachydrine	25	324	1	1372	1912	3743	1804	3766	3240	4024	4242	2955	807	1247	869	3025	463	324	1094	565	4700	4005	4260	532	4590
3016_NAMPT - Nicotinamide phosphoribosyltransferase	3016_NAMPT - Nicotinamide phosphoribosyltransferase	25	324	1	1455	327	2909	2744	4355	1940	3918	1490	686	1558	3944	1833	2234	1211	993	2512	3848	3607	866	324	4394	3610
1830_Neck length (FBAT, female, adjusted for multivariable)	1830_Neck length (FBAT, female, adjusted for multivariable)	25	325	1	397	2402	325	3841	905	1952	1855	1873	3208	763	2314	4291	2321	3673	1435	763	3679	3151	3500	3820	3978	2653
2413_NRP1 - Neuropilin-1	2413_NRP1 - Neuropilin-1	25	325	1	2330	781	3863	325	4406	2477	1849	2656	1441	4181	2516	1840	3220	2554	794	4744	3723	1838	4247	3212	3031	3429
3165_LEPR - Leptin receptor	3165_LEPR - Leptin receptor	25	325	1	2333	555	1270	504	3270	793	325	1569	4082	3019	4637	2317	1675	2067	3415	4334	3709	1014	3802	2109	3104	4187
4550_Left fusiform	4550_Left fusiform	25	325	1	455	1356	3288	3763	1338	4623	4220	2589	325	3492	1847	3147	4482	1207	1334	2285	986	1850	2327	3640	1728	4566
725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	25	325	1	4194	349	3712	3430	3080	4352	3381	2786	3234	325	3706	2394	4488	2899	3634	823	4095	4177	731	3484	4248	3430
4283_FVC	4283_FVC	25	325	1	876	2138	3767	3878	2818	1861	2520	4116	3314	1100	1663	2271	635	982	4159	1616	2309	2593	325	1628	2101	1110
2701_TPT1 - Translationally-controlled tumor protein	2701_TPT1 - Translationally-controlled tumor protein	25	325	1	4307	3220	1507	1535	4159	1560	2318	382	361	337	861	1340	4454	4337	1208	1589	2284	417	2349	1591	4650	325
2229_KLK11 - Kallikrein-11	2229_KLK11 - Kallikrein-11	25	326	1	326	3881	3218	3682	415	3237	4233	2093	2384	2309	2994	3898	3209	2024	569	1252	822	1296	3266	4674	603	795
1767_Heart failure (free of MI, GEE, adjusted for multivariable)	1767_Heart failure (free of MI, GEE, adjusted for multivariable)	25	326	1	3179	326	1779	4183	4322	4686	1360	4545	4059	4162	1013	3177	668	2278	505	4675	2409	812	3159	1806	1036	2741
1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	326	1	2462	4699	2195	2482	3812	326	3842	4501	2290	3025	1827	812	3970	1078	3332	2833	349	3080	559	1001	1594	1780
3766_Depression - Recent thoughts of suicide or self-harm	3766_Depression - Recent thoughts of suicide or self-harm	25	326	1	3473	4613	4736	3057	4107	4303	1665	326	1878	1662	1819	4372	2186	674	4039	4616	2938	773	944	1811	3666	3251
4734_Uncinate fasciculus mode of anisotropy	4734_Uncinate fasciculus mode of anisotropy	25	326	1	3376	2345	3076	1892	4133	3742	2962	3775	1598	1536	326	806	2765	4518	1204	2871	1534	4701	2380	1167	4151	1038
916_Total cholesterol in medium LDL	916_Total cholesterol in medium LDL	25	327	1	327	775	455	476	2064	1046	4076	3853	715	4242	1106	4731	3234	855	883	1345	2324	2665	3744	2041	1657	1265
3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	25	327	1	3205	2625	4291	327	4153	691	3399	3660	4073	1959	2752	4428	4105	1969	1193	2393	1604	3809	3728	960	4541	1033
3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	25	327	1	2772	3434	4355	3934	1926	2514	2423	1009	1722	631	327	4028	3375	3897	4005	1884	538	3514	3458	1469	1569	3145
2976_CDNF - Cerebral dopamine neurotrophic factor	2976_CDNF - Cerebral dopamine neurotrophic factor	25	327	1	4575	3137	1977	3766	4184	3145	4732	2317	2396	1800	4447	4220	327	603	3024	4146	4176	1658	3157	1664	571	3953
3367_Ever had hysterectomy (womb removed) (female)	3367_Ever had hysterectomy (womb removed) (female)	25	327	1	2093	2375	2879	2824	1848	1079	4354	1978	4519	2336	1368	1233	2000	327	2210	3156	1142	1709	1437	511	2332	4048
1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	25	327	1	2813	1588	4628	3309	3985	3565	3749	2237	4287	575	4248	1701	2463	477	691	4513	2717	327	1197	1877	3460	3074
3996_Nervous feelings (NERV-FEEL)	3996_Nervous feelings (NERV-FEEL)	25	327	1	3650	1634	957	4354	4737	833	3189	4466	4146	3240	4020	3892	4735	2238	2773	4662	2840	748	327	1931	1663	1134
3366_Age at menopause (last menstrual period) (female)	3366_Age at menopause (last menstrual period) (female)	25	327	1	3092	550	1972	4537	4237	3625	2607	4269	2353	3399	2147	2657	3854	4091	4476	2892	3369	1802	1178	327	2694	2387
2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	25	328	1	328	1258	2279	1667	4647	2854	1326	1336	3362	3628	1216	590	2624	2855	727	2447	4044	1827	680	2340	1393	1246
1084_Hemoglobin A1C level	1084_Hemoglobin A1C level	25	328	1	552	1112	1519	2271	4224	1332	3364	4637	4084	2156	4402	2745	2589	328	4699	3521	1497	4355	4105	3976	1084	1935
113_Height	113_Height	25	328	1	1640	4087	1059	3781	818	1418	3727	3703	3509	4514	2182	4054	4495	1976	3403	328	1495	4066	1817	2239	3910	1615
4397_Menstruation quality of life impact: Increased appetite	4397_Menstruation quality of life impact: Increased appetite	25	328	1	3445	3323	3904	3267	2474	2823	3686	2015	4040	2078	2162	3392	2516	2481	819	4207	1422	2815	2364	3576	328	2996
4607_Right insula	4607_Right insula	25	329	1	2852	415	1721	2550	329	794	4746	3583	1908	1985	3457	2847	3415	2681	1948	1545	1474	2353	3143	3379	1048	584
351_gdT:%CM (2)	351_gdT:%CM (2)	25	329	1	2752	2756	3032	4590	3644	1863	1566	329	4424	4070	2686	3043	767	844	2604	4122	1627	1742	1732	2038	3126	3312
421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	25	329	1	1945	1971	1224	1214	697	3144	2465	3178	3001	1060	613	999	805	4694	329	1598	3326	3184	419	415	3494	3625
602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	25	329	1	3875	969	895	3397	4245	2910	2818	475	4250	1863	4487	1849	1653	843	4475	3567	431	3274	329	1589	456	4505
3235_Current tobacco smoking	3235_Current tobacco smoking	25	330	1	790	1854	2355	539	2379	330	853	4182	4618	2632	2546	2825	4252	629	1456	4496	803	4111	4344	1553	3824	1648
3064_JAG2 - Protein jagged-2	3064_JAG2 - Protein jagged-2	25	330	1	417	2779	579	3344	2139	4402	3379	1738	1917	330	2640	4374	3062	4306	4282	1209	2805	746	3545	3639	4316	3064
1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	25	330	1	4600	4574	2118	2711	1312	2532	2254	1660	998	3863	3819	1780	330	2446	2868	2517	3036	3042	1606	757	2223	4108
166_Hip circumference (female, adjusted for BMI)	166_Hip circumference (female, adjusted for BMI)	25	330	1	700	4282	1609	3591	708	1608	1527	2416	3185	3912	432	4164	3418	4745	2525	539	330	3405	4515	2548	2987	3280
1029_Neck Width (GEE, adjusted for age and sex)	1029_Neck Width (GEE, adjusted for age and sex)	25	330	1	3525	3991	3754	2028	3518	4279	1469	1327	684	2369	4377	2391	671	3554	3562	4367	4711	330	4699	4428	1865	4088
2589_CNDP1 - Beta-Ala-His dipeptidase	2589_CNDP1 - Beta-Ala-His dipeptidase	25	331	1	2103	1827	3293	331	4303	1888	2973	3487	1551	1631	359	4631	3555	1531	594	3380	629	2881	409	1625	1870	2388
3281_Mother's age	3281_Mother's age	25	331	1	2026	3412	2344	1689	2151	2871	1990	2051	2799	331	3473	4042	3855	3172	3492	2542	2762	2436	394	1504	1675	2177
1102_High-density lipoprotein - Birth cohorts	1102_High-density lipoprotein - Birth cohorts	25	331	1	995	4227	2428	3597	3422	4544	1168	2878	3567	3573	331	688	2699	3815	4503	3604	4133	2382	2579	4046	769	4092
4392_Menstrual pain medicine use	4392_Menstrual pain medicine use	25	331	1	1816	2598	4718	1001	4040	3085	3394	4724	2078	1156	1384	3778	331	1504	1312	3003	3048	645	2556	4234	1732	632
808_::::X-12844	808_::::X-12844	25	331	1	4742	3736	1133	2112	3663	1290	3299	2221	1765	4623	3592	2672	4540	331	2146	2521	2217	3849	1125	3320	1211	2283
1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	25	331	1	908	3753	3499	4390	3917	3995	3863	3196	4253	3452	2889	2450	3406	752	1557	2259	2888	4072	1383	3190	1939	331
1046_Trochanter BMD (FBAT, adjusted for multivariable)	1046_Trochanter BMD (FBAT, adjusted for multivariable)	25	332	1	332	4628	3083	2290	4034	2628	337	3103	2006	774	2998	520	1376	3857	3766	2675	3992	1771	3831	1346	4042	2203
2226_CX3CL1 - Fractalkine	2226_CX3CL1 - Fractalkine	25	332	1	647	4214	413	332	1286	1659	4580	2610	2323	4437	4251	4008	1219	3273	2197	719	849	2797	3558	688	3526	501
4161_Focal Epilepsy, lesion negative	4161_Focal Epilepsy, lesion negative	25	332	1	3164	355	1535	363	666	4127	1483	3923	3130	4412	4561	503	332	1055	1757	1048	3040	880	448	699	3486	1911
3070_LAG3 - Lymphocyte activation gene 3 protein	3070_LAG3 - Lymphocyte activation gene 3 protein	25	332	1	4332	4604	2744	1975	542	842	4208	2262	1228	472	3104	2207	4066	1064	3397	337	2361	332	1049	592	1576	1554
1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	25	332	1	1558	1365	3121	4119	4313	843	3387	3799	4344	2587	1733	2068	3015	2488	1394	2535	2060	3135	3184	332	518	4717
289_CD4:%Act(25+127+)	289_CD4:%Act(25+127+)	25	332	1	2768	1727	3027	1311	3191	3677	1171	3148	1918	3379	2544	3197	1427	4164	3104	1785	3045	1800	1752	1716	332	4557
1062_Psoriasis	1062_Psoriasis	25	333	1	1343	3186	2396	2839	333	1385	2062	3570	4106	958	3340	4348	3242	4485	3469	356	3785	4034	4280	339	622	3768
2895_SH2D1A - SH2 domain-containing protein 1A	2895_SH2D1A - SH2 domain-containing protein 1A	25	333	1	4179	1565	3632	2630	3807	2747	2527	4227	333	3903	369	1081	1468	3301	1571	4387	1259	3215	1710	4456	2814	706
4567_Left precentral	4567_Left precentral	25	333	1	622	1331	772	643	3244	1741	3791	4389	549	3511	4305	4112	4628	2235	333	4329	769	2757	1361	684	4321	2807
2378_METAP2 - Methionine aminopeptidase 2	2378_METAP2 - Methionine aminopeptidase 2	25	333	1	4529	2470	2460	3940	1029	3978	2696	2839	2201	1231	4431	4139	502	3371	4200	333	3408	473	2267	693	4618	3814
746_::::X-12013	746_::::X-12013	25	334	1	334	3423	1994	2592	3220	1557	3585	510	3712	1066	2068	4515	1604	408	4447	4300	3804	690	3981	4718	3551	4718
4338_Sleep durataion (conditioning sex and BMI)	4338_Sleep durataion (conditioning sex and BMI)	25	334	1	1242	4270	1641	977	3209	334	2439	3619	2902	3147	1497	2860	2420	1282	1411	3903	489	1647	4075	3655	3237	4713
964_Triglycerides in very large VLDL	964_Triglycerides in very large VLDL	25	334	1	2587	1127	2119	3400	4514	3823	334	1550	1030	1388	2667	3590	1532	1399	1970	1856	1331	3687	3635	1984	3540	2665
1983_Walking speed (at exam 7, GEE)	1983_Walking speed (at exam 7, GEE)	25	334	1	3036	3474	1267	3910	2086	2245	1698	2424	3024	1105	3304	370	334	4051	3580	4192	3537	866	1805	2266	2432	982
4364_Vigorous physical activity	4364_Vigorous physical activity	25	334	1	1605	1262	1962	1390	654	3005	2200	4499	2918	1338	4555	2007	3627	1331	402	661	2037	2879	860	334	1995	942
1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	25	334	1	3640	3088	4347	3076	3808	1197	4493	3895	2155	4171	2311	3111	2889	4031	4115	2547	1948	3045	4396	2144	2033	334
3274_Ease of skin tanning	3274_Ease of skin tanning	25	335	1	335	3455	2347	693	3091	3903	1333	2924	2330	1988	3407	762	2016	4543	969	3550	2753	1927	3000	3086	3166	1590
1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	24	335	1	4436	335	2551	987	2140	2646	895	3525	4507	408	601	1563	3546	2302	3217	1368	1903	3263	2189	1919	4703	617
4405_Menstrual quality of life impact: Pressure in the breasts	4405_Menstrual quality of life impact: Pressure in the breasts	25	335	1	2791	3402	335	2562	1486	2895	4606	4315	4665	3862	4630	1669	1221	4240	4716	2685	3754	4160	3624	4159	891	3364
1914_Parietal brain volume (FBAT, adjusted for multivariable)	1914_Parietal brain volume (FBAT, adjusted for multivariable)	25	335	1	3163	4287	1851	4694	2632	3563	3584	3392	3769	3210	335	1860	1720	457	758	4070	1993	2175	2422	928	3093	2798
3252_Bread intake	3252_Bread intake	25	335	1	2715	389	3536	1917	1200	3158	3834	2090	3406	2984	4291	335	782	2724	704	1356	1148	2925	2505	4179	2955	3607
448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	25	335	1	4562	1691	1345	1123	3594	3239	4330	3134	3388	2907	2965	1414	335	2825	3219	3701	2920	1039	2608	1801	3700	1773
801_::::X-12771	801_::::X-12771	25	335	1	2455	4193	779	2673	388	2758	4647	3503	2758	2000	451	1486	2604	4563	3159	335	2078	1773	1808	976	1739	2978
293_CD4:%Act(PD1+127+39-73-)	293_CD4:%Act(PD1+127+39-73-)	25	336	1	2009	4522	336	1555	2491	2979	3472	2965	1999	4624	1669	3096	624	3155	4736	3973	3142	1033	4676	1408	2769	2355
614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	25	336	1	691	3797	4540	4426	4066	3844	506	3019	468	2662	681	336	1560	467	4568	3633	4033	3946	2055	1934	4304	1479
4124_Prothrombin time	4124_Prothrombin time	25	336	1	1610	3890	3006	1662	2857	1629	728	1635	4184	4575	4297	525	1093	625	336	2346	2820	2951	960	3633	1525	4001
3374_Headaches for 3+ months	3374_Headaches for 3+ months	25	337	1	337	1554	3014	3742	3698	2478	1696	3152	2494	1946	2031	989	1901	3067	2298	3195	4341	1356	4447	887	1639	3641
3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	25	337	1	3810	3202	2318	349	2546	4361	1474	337	3906	4381	1916	2483	1574	2121	463	3194	3510	1224	897	2209	3609	3541
3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	25	337	1	3208	2376	970	2006	2115	3159	1953	4368	971	2875	1096	337	1663	4085	2503	682	2662	1000	1671	4073	1633	893
1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	25	337	1	3762	4293	1137	3871	3308	1626	3246	1855	3231	349	2207	1589	4192	2809	337	3137	1908	4240	3799	3889	2120	3245
1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	337	1	1188	2949	4710	1990	4595	1446	3913	2065	2950	4071	1209	373	4406	4656	4295	3808	337	2071	1349	3031	2545	1668
4693_Average across all tracts mean diusivities	4693_Average across all tracts mean diusivities	25	337	1	4668	3312	1695	4296	2535	360	4561	1634	2314	1400	4064	1423	1484	4241	2845	2847	573	3816	337	2951	452	2752
248_CD337 on NK early	248_CD337 on NK early	25	338	1	4423	338	1975	3308	1204	4097	1391	585	3018	351	1324	1586	2071	3516	2377	509	3333	3319	3691	4287	1830	3711
3810_Eosinphil count	3810_Eosinphil count	25	338	1	884	506	1501	3989	338	2911	657	3878	3230	1139	2835	4492	1206	2556	4205	374	3218	1772	3039	2067	3115	4736
4330_Postburn scar pliability	4330_Postburn scar pliability	25	338	1	4728	1398	530	1726	2432	338	1531	2518	4657	1276	371	3135	3893	2988	2798	4633	3287	2628	1706	2737	4489	708
2057_Ulcerative colitis	2057_Ulcerative colitis	25	338	1	3455	2088	2080	3953	3702	2954	4558	338	1416	4334	3761	1959	3584	3668	736	1121	1047	2166	4351	3957	4082	2056
513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	25	338	1	2789	4146	433	3188	4092	1620	3331	4026	338	2313	1424	4408	4146	2189	3708	4425	675	4188	1170	4328	4534	3040
1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	25	338	1	2007	2875	3718	1431	1580	2181	2138	3997	3351	2545	3869	540	3636	338	1198	3349	4464	1914	4143	4725	3037	695
2794_PES1 - Pescadillo homolog	2794_PES1 - Pescadillo homolog	25	338	1	4508	902	1465	2212	1329	3637	3092	543	2186	4211	4378	1509	2956	3647	338	3369	2604	615	3731	4070	2019	2325
1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	25	338	1	2364	805	4622	2909	624	517	3670	4007	1656	3375	2745	1996	3091	461	3937	338	2964	4235	1564	786	2102	1079
2534_PDGFRB - Platelet-derived growth factor receptor beta	2534_PDGFRB - Platelet-derived growth factor receptor beta	25	338	1	1415	2361	3195	2366	1544	3992	3996	2491	1943	1057	3149	2486	2356	4286	3948	978	872	338	4610	1945	1090	4605
559_Lipid::Medium chain fatty acid::laurate (12:0)	559_Lipid::Medium chain fatty acid::laurate (12:0)	25	338	1	4417	2918	3686	3428	671	1800	1029	3029	2973	3851	1755	4737	1625	561	3433	648	1066	3594	4095	338	1013	1477
806_::::X-12830	806_::::X-12830	25	339	1	4720	339	4680	3238	4009	4406	2152	3012	3602	1104	3441	3565	3679	3153	1778	3287	2424	681	2040	1410	3788	4600
417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	25	339	1	1954	3264	1893	339	2098	2668	3306	3471	3002	3283	1586	1190	4397	2298	462	4002	2103	3459	2651	2127	1409	1952
3737_Depression - Ever had prolonged loss of interest in normal activities	3737_Depression - Ever had prolonged loss of interest in normal activities	25	339	1	1951	3075	3401	1359	4008	1984	2409	2805	3572	339	3083	4700	1377	1265	1105	3560	2878	3908	4219	2704	1201	3903
4583_Right inferior temporal	4583_Right inferior temporal	25	339	1	4314	3437	1233	2282	2873	3519	2685	4118	4447	2500	4132	339	2878	395	3141	3682	2176	486	4564	1503	522	2106
2420_ACP5 - Tartrate-resistant acid phosphatase type 5	2420_ACP5 - Tartrate-resistant acid phosphatase type 5	25	339	1	1581	1611	2494	3109	3200	1655	810	4095	4500	4219	4171	3118	2493	4046	339	3398	4702	3820	4111	4360	4243	3741
970_Concentration of chylomicrons and extremely large VLDL particles	970_Concentration of chylomicrons and extremely large VLDL particles	25	339	1	2347	1694	3959	1473	2477	4454	1345	1622	3361	903	3773	3647	1176	1212	862	3504	735	3506	4521	1674	4640	339
4598_Right precentral	4598_Right precentral	25	340	1	3230	340	2200	625	1543	3805	2528	798	3904	1642	2482	527	3237	1808	3918	2906	4186	725	1332	3703	2515	4087
2067_TIMP2 - Metalloproteinase inhibitor 2	2067_TIMP2 - Metalloproteinase inhibitor 2	25	340	1	1986	833	340	677	3399	3560	794	2371	1093	425	3959	1155	3660	4315	818	4378	3252	2322	1135	4601	1280	3798
2723_SKP1 - S-phase kinase-associated protein 1	2723_SKP1 - S-phase kinase-associated protein 1	25	340	1	2099	1775	4301	4491	495	340	2812	3541	3944	3047	3366	1510	4222	1136	4338	821	418	1217	2928	4039	1530	2693
2464_SERPINC1 - Antithrombin-III	2464_SERPINC1 - Antithrombin-III	25	340	1	1904	1996	4690	1475	2106	3061	4504	2706	2068	340	1077	2266	1519	3975	3078	2204	2002	4277	1602	1560	983	3635
4448_Left entorhinal	4448_Left entorhinal	25	340	1	4253	2262	1956	1678	833	4676	1913	378	4682	1040	1236	4100	593	4547	3871	1247	3594	2578	340	4327	4366	2517
4439_Hepatitis B HBs antigen IgG levels	4439_Hepatitis B HBs antigen IgG levels	25	341	1	341	2453	975	3438	2257	2130	3086	845	3276	4287	1063	366	1446	2924	3824	868	4010	1404	3201	3859	3605	3154
3656_Alcohol - Alcohol drinker status: Never	3656_Alcohol - Alcohol drinker status: Never	25	341	1	4288	3017	814	969	2645	2924	1119	3811	4385	454	1113	4565	2710	1988	860	2751	4554	4649	3762	570	341	472
1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	25	342	1	342	1396	2395	1876	420	480	2936	4347	3951	2162	855	2829	2875	3499	4414	590	1734	3788	3031	2307	691	3207
4069_Drinks per week	4069_Drinks per week	25	342	1	3258	2546	3995	342	3544	1010	2521	2939	2495	853	2359	3481	4164	4372	4550	2341	3106	2736	1547	2991	4260	3549
3175_IL17RC - Interleukin-17 receptor C	3175_IL17RC - Interleukin-17 receptor C	25	342	1	2141	2054	836	3519	3723	4341	3022	3407	342	2187	3287	4675	812	1570	2065	4027	3666	2865	3370	2982	780	2915
984_Interleukin-16	984_Interleukin-16	25	342	1	1545	4390	848	1864	2052	2542	2910	671	1556	4529	3590	4045	2239	2469	674	4586	2379	462	2803	4668	4080	342
2113_CST3 - Cystatin-C	2113_CST3 - Cystatin-C	25	343	1	1794	3870	3414	1463	3935	3501	1719	2618	3301	2113	2584	343	1932	4509	2023	1119	1083	3197	2328	3087	4290	3086
1990_Age at death (FBAT, adjusted for birth-cohort)	1990_Age at death (FBAT, adjusted for birth-cohort)	25	343	1	1725	2558	3047	638	3991	3201	2806	2370	1606	742	447	1326	2741	3755	343	2007	3689	1215	4086	2095	1765	2841
4728_Retrolenticular part of internal capsule mode of anisotropy	4728_Retrolenticular part of internal capsule mode of anisotropy	25	343	1	4534	2724	3776	590	3283	3038	1048	2794	2341	3932	2899	3678	4721	4505	2815	4562	3029	591	708	883	2670	343
2336_CCL3 - C-C motif chemokine 3	2336_CCL3 - C-C motif chemokine 3	25	344	1	344	3454	4283	2222	3151	2500	4237	1688	1201	4441	3319	3386	2092	2734	573	3974	4405	4229	3949	3551	830	1873
4578_Right caudal middle frontal	4578_Right caudal middle frontal	25	344	1	3676	1269	4288	344	4509	1051	3376	1695	3729	2783	3435	2074	1707	3015	442	4293	1821	4178	2220	1574	2958	3775
996_Interleukin-9	996_Interleukin-9	25	344	1	3608	3259	4032	1604	491	344	2813	1310	4320	709	1674	3380	2696	2468	949	574	1618	606	1549	1126	1204	458
2458_HFE2 - Hemojuvelin	2458_HFE2 - Hemojuvelin	25	344	1	537	3992	4224	1207	4336	1015	1007	4185	3890	4286	2288	2572	2163	4045	3475	2581	972	4026	344	3232	2088	2830
126_Height (male)	126_Height (male)	25	345	1	1134	3040	2180	1425	4499	345	4280	4191	4613	3582	4169	3799	3661	4263	1346	4231	2656	2360	1571	3634	2218	976
1886_Shaft Width (FBAT, male, adjussted for multivariable)	1886_Shaft Width (FBAT, male, adjussted for multivariable)	25	345	1	1360	1410	396	4191	652	4635	3269	1609	2617	345	1057	514	4445	3087	2965	1213	1577	909	4570	1009	3201	1694
1991_Age at death (GEE, adjusted for birth-cohort)	1991_Age at death (GEE, adjusted for birth-cohort)	25	346	1	1404	1050	1419	346	3012	3206	2294	2383	3658	1979	381	3464	1992	2125	2330	2561	4649	1842	2969	707	2881	1531
3788_Insomnia (female)	3788_Insomnia (female)	25	346	1	459	4128	4721	4098	2655	3248	346	824	1565	4271	3968	2588	2371	594	1616	3262	3599	1083	4612	551	4338	2868
397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	25	346	1	1789	2286	2212	1206	2180	2657	3081	4682	1577	1183	1933	3674	346	391	1740	1686	4432	3074	487	2152	3715	1508
4467_Left precuneus	4467_Left precuneus	25	346	1	507	3943	1838	1006	767	1101	860	3421	4744	2094	2543	2503	4598	564	1258	368	1053	3289	713	346	4694	2829
3370_Duration of other exercises	3370_Duration of other exercises	25	347	1	2840	3318	4593	902	1573	4310	4655	4737	347	4216	3913	3409	2906	4100	2183	1101	1983	1212	3413	2317	605	3011
4651_Cingulum (cingulate gyrus) fractional anisotropy	4651_Cingulum (cingulate gyrus) fractional anisotropy	25	347	1	2416	500	2967	4503	3281	2636	3093	2979	2348	1344	4494	700	983	413	3142	4641	347	613	2731	1194	1407	2023
3628_Illnesses of father: Heart disease	3628_Illnesses of father: Heart disease	25	347	1	3453	2762	573	1927	2184	4276	3016	1478	1703	725	3195	1154	2325	1651	612	1955	549	640	347	818	3782	3276
1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	348	1	1574	2778	2941	631	573	2447	4737	2485	2568	4153	1480	348	4700	3998	2385	592	3426	4262	3827	1377	4360	2598
1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	25	349	1	1042	2365	4125	727	3934	2766	349	586	4263	1222	4367	4602	1542	956	2169	1317	730	1762	1243	2710	1015	1045
2227_SPINT1 - Kunitz-type protease inhibitor 1	2227_SPINT1 - Kunitz-type protease inhibitor 1	25	349	1	4120	3422	4639	2362	1928	3117	4138	349	2664	712	971	4618	4285	4495	1103	783	1136	2846	350	3837	849	3984
3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	25	349	1	4565	1333	2892	4142	4078	3228	3740	917	349	4536	1297	2030	3289	2404	3782	3205	1542	3766	2256	1141	3412	385
2340_CCL18 - C-C motif chemokine 18	2340_CCL18 - C-C motif chemokine 18	25	349	1	1147	1807	4262	2001	2464	4122	4371	3233	813	389	2566	1650	349	4335	3964	1952	2502	524	2885	1975	3461	700
1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	349	1	3225	3997	3028	1906	3117	501	897	1333	1578	445	1575	974	2425	456	4000	3970	405	2792	1838	349	2917	3927
1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	350	1	3590	3784	350	4387	1798	886	1839	2929	4235	2061	4700	4439	1699	4380	3357	2541	2200	1845	3270	4343	4607	4537
2591_DDR2 - Discoidin domain-containing receptor 2	2591_DDR2 - Discoidin domain-containing receptor 2	25	350	1	1199	3344	1296	679	4724	4321	622	882	527	350	2931	4039	2346	1034	2440	4130	3696	400	2385	872	3499	2847
3256_Coffee intake	3256_Coffee intake	25	350	1	1900	1880	2275	1866	1102	2331	1080	3257	1969	4644	1066	3190	3667	350	4454	753	2928	2033	4259	897	1803	2359
336_NKeff:%2-158a+	336_NKeff:%2-158a+	25	350	1	1666	2915	1205	4070	1738	1437	1884	4189	1411	2682	857	1972	4281	1790	4692	4046	4650	3966	2264	350	3954	1127
4466_Left precentral	4466_Left precentral	25	351	1	776	4049	351	2092	4518	2156	1836	4271	4549	1537	3824	2409	3701	2680	1921	2528	1652	4696	1747	630	4187	3509
2667_FCN3 - Ficolin-3	2667_FCN3 - Ficolin-3	25	351	1	4066	975	4505	968	3449	2492	1190	351	885	4419	3240	570	1495	4305	4492	3371	3734	2054	2237	432	720	4081
2761_CFH - Complement factor H	2761_CFH - Complement factor H	25	351	1	743	3444	4116	4086	787	4066	4670	702	858	884	804	356	577	1481	4033	1008	916	848	3554	1354	1878	351
3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	25	352	1	4445	1480	4536	352	4465	1770	2095	2777	2786	3596	2256	4672	489	693	2168	4155	3424	3586	1630	1579	4008	3891
2144_MAPT - Microtubule-associated protein tau	2144_MAPT - Microtubule-associated protein tau	25	352	1	3395	1830	3358	486	3326	3847	804	3491	1573	2968	3017	352	2120	4744	3462	2869	3924	2349	3654	1397	4660	3137
899_Cholesterol esters in large VLDL	899_Cholesterol esters in large VLDL	25	352	1	2629	4253	2067	3019	403	3493	1150	1434	1066	3343	710	1045	4684	3264	378	895	352	383	1792	2377	4619	2079
1889_Shaft Width (GEE, female, adjussted for age)	1889_Shaft Width (GEE, female, adjussted for age)	25	352	1	3023	1523	2033	2449	4736	2143	3549	2976	390	2143	2196	3419	2756	1141	608	634	3230	352	2087	3709	3925	3165
3202_Job involves shift work	3202_Job involves shift work	25	352	1	4375	3813	1128	4709	3916	1565	1270	2557	2193	1687	637	4584	3554	1774	3271	2554	3655	2828	1741	352	4698	2716
2665_FGFR3 - Fibroblast growth factor receptor 3	2665_FGFR3 - Fibroblast growth factor receptor 3	25	353	1	2473	895	2164	353	1797	1723	473	745	1632	2129	4482	2116	3693	4276	2434	1767	3600	649	2387	2967	2729	3511
3189_Number of self-reported cancers	3189_Number of self-reported cancers	25	353	1	1064	1903	1444	531	786	3643	353	3887	1602	1092	4398	2378	4239	687	2780	1154	2508	454	3941	2962	4528	1069
3577_Social support - Leisure/social activities: Pub or social club	3577_Social support - Leisure/social activities: Pub or social club	25	353	1	772	3055	1896	2683	3057	547	3527	353	3493	1725	1439	500	1507	1772	4733	1651	1685	3632	3146	1539	2573	4604
1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	25	353	1	4203	4712	3170	2099	2039	881	1898	1906	3233	4169	833	3224	1570	4006	1523	1194	790	3463	2468	2838	353	4299
485_Lipid::Carnitine metabolism::palmitoylcarnitine	485_Lipid::Carnitine metabolism::palmitoylcarnitine	25	354	1	2633	1445	2950	4722	2530	354	3617	2953	2168	1492	2388	4161	3842	4433	3671	3708	3879	796	2226	2654	4562	4565
491_Lipid::Essential fatty acid::linoleate (18:2n6)	491_Lipid::Essential fatty acid::linoleate (18:2n6)	25	354	1	4611	1537	2317	1268	3041	2779	1356	1054	2846	354	1732	4413	4487	4447	3979	4454	3400	4334	1999	4486	4493	3024
1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	354	1	3187	2174	2106	3270	3564	4405	3252	4154	3089	2619	354	3429	1746	1165	4677	1774	2254	1162	1917	2525	542	1460
1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	25	354	1	1584	3054	3977	4231	956	1671	3816	1972	3414	500	1957	4688	978	3474	1826	354	2416	789	958	4425	2756	2200
1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	354	1	1139	4434	2757	3133	463	2434	4127	3828	3945	3224	802	2843	1650	2051	4501	1017	354	850	1177	1623	2768	4628
3781_Depression - Trouble falling asleep	3781_Depression - Trouble falling asleep	25	354	1	1953	3066	3560	2369	3996	541	3873	2735	1095	1624	435	4465	3484	3788	3808	620	1889	582	354	652	397	1098
581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	25	354	1	3787	3027	1875	3567	2049	1094	4546	1141	3575	3610	1731	2057	3219	4476	3189	1675	3782	1584	2601	394	354	3316
4684_Retrolenticular part of internal capsule axial diusivities	4684_Retrolenticular part of internal capsule axial diusivities	25	354	1	1894	703	4512	2604	2822	1108	1219	4542	2189	1547	2387	4214	3127	3830	2395	4739	965	711	1828	2099	455	354
3273_Skin colour	3273_Skin colour	25	355	1	355	3843	3205	488	1677	3546	774	1590	2974	3366	3717	628	2404	2883	1052	2739	3522	2247	4222	4499	4498	1841
3756_Mental distress - Ever suffered mental distress preventing usual activities	3756_Mental distress - Ever suffered mental distress preventing usual activities	25	355	1	3852	2728	355	2199	3532	2301	3746	2251	2088	3983	2228	1208	3595	3742	3161	1913	3345	4170	671	3159	2840	4691
2244_C5 - C5a anaphylatoxin	2244_C5 - C5a anaphylatoxin	25	355	1	4271	786	2004	2721	487	4680	2027	1405	355	3091	2545	2299	384	2456	3248	452	3966	3191	674	537	1603	1176
4498_Right precuneus	4498_Right precuneus	25	355	1	3486	2961	1344	4494	1319	3015	4338	2625	4517	2537	355	4212	4243	2977	3993	3153	2260	1929	4430	2445	1333	3473
610_Peptide::Polypeptide::bradykinin, des-arg(9)	610_Peptide::Polypeptide::bradykinin, des-arg(9)	25	355	1	1810	4350	2462	3354	2368	2221	4320	1656	4179	3083	794	4718	2628	418	1271	3085	355	495	3158	4605	3922	1189
4415_Varicella Zoster Virus seropositivity	4415_Varicella Zoster Virus seropositivity	25	355	1	1490	4131	1556	3381	1621	4118	465	4439	2281	3972	912	3607	2370	2664	2718	4685	1666	4375	3200	4635	355	4003
2516_EPHA1 - Ephrin type-A receptor 1	2516_EPHA1 - Ephrin type-A receptor 1	25	355	1	2776	1042	2331	1636	3221	4688	3150	819	4462	4622	821	3839	4734	2992	2497	4053	4471	447	3290	3636	3873	355
494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	25	356	1	3360	4329	4381	1835	1823	3714	2546	356	2731	3107	1502	1229	4542	4038	693	3340	3761	3343	1730	2286	1705	2533
3773_Anxiety - Recent worrying too much about different things	3773_Anxiety - Recent worrying too much about different things	25	357	1	404	1483	2977	357	1460	903	3934	2474	2781	2493	1665	815	3409	976	4624	1095	4112	2009	4718	1517	3466	4411
1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	357	1	1444	4100	4711	2533	1232	357	4313	3235	2656	2236	803	4694	861	1075	4567	3260	2876	2716	3051	3663	3164	2524
527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	25	357	1	4081	4567	3244	556	3794	1939	3319	357	2350	1746	2255	3803	3204	4606	3360	2599	3499	4145	1616	492	711	1440
3079_NRCAM - Neuronal cell adhesion molecule	3079_NRCAM - Neuronal cell adhesion molecule	25	357	1	465	2790	1388	4619	1144	1526	4704	473	4356	4255	357	3853	474	2652	1467	4695	2392	3035	386	585	1541	3722
2465_AURKB - Aurora kinase B	2465_AURKB - Aurora kinase B	25	357	1	3734	4657	1685	2438	2440	1625	2354	2484	4479	4571	3751	4066	357	2490	503	957	4744	366	4082	4114	1547	1936
3270_Comparative body size at age 10	3270_Comparative body size at age 10	25	357	1	456	509	1970	971	3477	420	1073	2966	3591	2201	4073	3032	3606	2352	1236	4560	2688	3493	3212	357	1164	1224
1214_Alcohol consumption (male)	1214_Alcohol consumption (male)	25	357	1	3911	4007	4133	801	2598	988	1370	1887	2305	3967	2374	4683	3070	1391	4378	3031	4495	2679	3329	3175	357	2316
2738_HBEGF - Heparin-binding EGF-like growth factor	2738_HBEGF - Heparin-binding EGF-like growth factor	25	358	1	2481	2908	3964	358	3373	2718	1545	1511	1029	3513	2633	3013	1494	4464	4657	2415	671	1971	2194	1826	2145	4664
653_::::X-02973	653_::::X-02973	25	358	1	2928	3266	685	389	977	841	3176	3467	3929	1330	1215	728	2648	358	3157	1321	1694	1030	358	2796	4307	605
1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	25	358	1	2131	2733	4208	2944	4730	4305	711	1298	1251	2155	1588	3357	3207	3003	358	4503	4181	4098	1635	2196	3328	2738
1023_Neck Cross-Sectional Moment of Inertia (GEE)	1023_Neck Cross-Sectional Moment of Inertia (GEE)	25	359	1	2597	2753	359	1459	3880	747	2720	1799	2703	842	3715	2077	2667	3932	1999	1529	3011	2619	3924	3802	1726	3252
2745_CXCL10 - C-X-C motif chemokine 10	2745_CXCL10 - C-X-C motif chemokine 10	25	359	1	713	3426	3636	3907	359	3504	4538	3888	1759	2103	4620	3923	2791	2512	2000	838	3932	924	4449	1309	575	2326
4649_Average across all tracts fractional anisotropy	4649_Average across all tracts fractional anisotropy	25	359	1	2720	868	1929	3580	3443	359	2393	969	3983	4233	1629	3764	2806	2796	1918	3354	914	4715	4021	4271	1976	1931
4737_Average across all tracts radial diusivities	4737_Average across all tracts radial diusivities	25	359	1	4178	1953	3885	4347	4283	553	4522	821	1947	2198	4429	2178	1512	3166	1548	3223	1645	2418	359	2668	519	1107
3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	25	360	1	3583	4247	2042	360	4478	2781	3212	2461	3171	1459	3602	720	2460	2906	1326	2590	3800	3863	3951	2950	3082	1684
3346_Ever taken oral contraceptive pill (female)	3346_Ever taken oral contraceptive pill (female)	25	360	1	2862	2850	583	4400	4230	1436	3466	1542	3799	3938	2874	3072	360	4160	3231	3672	2976	1697	948	2803	2579	3034
343_NKearly:%337+158b+	343_NKearly:%337+158b+	25	360	1	2204	3461	1142	2007	3487	3372	1958	4450	1123	3172	1397	1333	1846	360	891	2437	1434	4473	3366	1181	2064	2269
2475_CHEK2 - Serine/threonine-protein kinase Chk2	2475_CHEK2 - Serine/threonine-protein kinase Chk2	25	360	1	1156	2722	3063	4163	1813	3400	3885	4388	4414	2630	4342	4031	4102	924	1080	3599	360	405	1930	3367	4692	638
2836_COLEC11 - Collectin-11	2836_COLEC11 - Collectin-11	25	360	1	2524	2303	2308	2544	2653	4712	4188	839	421	4159	2668	3274	1941	2584	3811	2956	3516	360	2650	2929	1371	2774
4508_Cerebellar vermal lobules VI VII	4508_Cerebellar vermal lobules VI VII	25	360	1	3972	536	1339	1011	2876	1399	1165	540	3141	4278	859	3634	1166	2535	1005	2805	1250	1998	360	833	2875	4479
4043_Height	4043_Height	25	360	1	1706	1947	1534	4658	2325	3284	3773	448	2597	1337	4742	4009	1543	3937	3842	1246	783	3316	2063	906	360	474
2452_LY9 - T-lymphocyte surface antigen Ly-9	2452_LY9 - T-lymphocyte surface antigen Ly-9	25	361	1	521	361	1945	3317	3754	2906	2839	1344	869	3365	614	2102	1933	4682	2432	4236	2803	3238	4301	2977	4397	1685
2146_NTRK3 - NT-3 growth factor receptor	2146_NTRK3 - NT-3 growth factor receptor	25	361	1	624	3912	444	3778	2015	2608	4554	1346	786	3559	914	1843	2632	491	361	3775	3165	1247	418	2517	1102	2165
1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	361	1	1512	2353	1790	425	417	4320	1775	3863	4439	3109	3985	3510	3369	1427	3372	361	3994	1220	3259	4192	858	1644
1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	25	361	1	3139	1869	3942	1225	3480	1063	3800	4174	4176	4368	1300	4653	1679	749	665	3752	361	596	1106	3882	1305	3676
1887_Shaft Width (GEE, male, adjussted for multivariable)	1887_Shaft Width (GEE, male, adjussted for multivariable)	25	361	1	2964	2355	1474	3569	3230	1235	1539	3453	4181	2119	2417	1689	3934	653	4226	3235	979	928	3501	2825	361	3066
2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	25	362	1	4050	1733	362	2788	1480	1594	4025	3164	2686	574	1721	1799	843	557	2607	1244	4732	2362	1949	542	1810	2255
778_::::X-12443	778_::::X-12443	25	362	1	724	3209	1798	3028	3850	1393	813	2040	362	2845	392	1194	2471	1944	3106	2128	411	365	1210	4214	2293	3718
589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	25	362	1	4585	1731	620	4065	4154	2904	1130	423	1038	362	2779	4616	2363	3105	2444	3226	2109	2158	3272	683	1172	3351
2341_PTN - Pleiotrophin	2341_PTN - Pleiotrophin	25	362	1	563	566	4378	2283	974	4054	1570	970	3533	1875	3252	362	4319	438	3366	3057	812	4437	4041	1383	4177	3166
3807_Neutrophil count	3807_Neutrophil count	25	362	1	2683	1805	4250	611	4614	579	1963	4172	3672	2851	1015	2175	3964	362	2435	2843	1189	3781	1548	2010	4558	3087
4206_Estimated glomerular filtration rate	4206_Estimated glomerular filtration rate	25	363	1	854	1198	3303	1161	1340	2982	363	868	1279	1205	2007	390	2711	1151	3293	2095	1392	2029	4513	2678	2039	1693
1760_Breast cancer (FBAT, adjusted for age and BMI)	1760_Breast cancer (FBAT, adjusted for age and BMI)	25	363	1	2233	3672	536	2218	2965	4432	2376	2822	4704	363	593	2262	3232	885	3093	4543	462	1291	1116	3193	1054	3815
4523_Left putamen	4523_Left putamen	25	363	1	4378	1926	2481	4168	1613	3020	2377	1414	4451	2265	982	3042	916	363	4512	1945	3176	3862	2351	790	437	1405
942_Concentration of small VLDL particles	942_Concentration of small VLDL particles	25	363	1	1761	4110	3204	3700	392	1707	1853	2190	3201	1117	1445	560	3099	1913	363	795	1108	1063	2993	2202	3864	619
3610_Treatment/medication code: multivitamins	3610_Treatment/medication code: multivitamins	25	363	1	3622	3117	4514	1595	4694	2797	1821	3006	2914	823	976	4735	1460	4480	3823	2818	4210	4677	667	363	2323	2454
4671_Average across all tracts axial diusivities	4671_Average across all tracts axial diusivities	25	363	1	2038	3950	2326	3232	2641	865	376	4399	2728	824	4450	2782	649	3693	3299	2641	4427	2249	2598	2165	363	2682
4534_Right thalamus proper	4534_Right thalamus proper	25	363	1	4648	3576	3810	3220	2435	4667	1675	2588	2985	3750	2103	4176	2375	3421	2245	3344	3467	3422	3082	4396	3397	363
246_CD56 on NK eff	246_CD56 on NK eff	25	364	1	3102	2370	3278	1875	364	1580	2197	3850	3291	3738	2828	3743	1561	3548	2934	732	2099	2735	1637	4626	3110	1786
2079_PLA2G2E - Group IIE secretory phospholipase A2	2079_PLA2G2E - Group IIE secretory phospholipase A2	25	364	1	4358	4290	3799	695	531	866	3520	2537	364	2881	3308	4270	1596	1199	759	617	3995	3378	3650	1561	1797	3623
1091_Alcohol dependence	1091_Alcohol dependence	25	364	1	1340	764	883	738	1745	4008	1655	2515	3896	1260	364	2984	4402	1643	1634	1196	3772	3965	1107	1265	3083	519
2971_EREG - Epiregulin	2971_EREG - Epiregulin	25	364	1	4297	3369	2456	2180	4418	840	4299	1744	3627	1376	4725	2474	880	1744	4515	3115	1630	4588	2439	564	364	3783
1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	25	365	1	365	1629	1840	4277	2618	2341	2711	3246	2466	3017	2402	2652	749	4169	4287	4242	3390	3719	4523	4125	2163	701
223_Mature B:%Memory	223_Mature B:%Memory	25	365	1	1368	2351	3616	2097	2832	365	829	1615	1760	2190	677	3112	981	3776	512	3466	422	490	1217	1369	2307	4562
2504_BCL2 - Apoptosis regulator Bcl-2	2504_BCL2 - Apoptosis regulator Bcl-2	25	365	1	2531	3862	3777	3943	4623	3354	3017	365	2800	3342	3390	1898	4605	1180	4018	2539	2021	4154	2644	1843	3585	2751
1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	25	365	1	3501	695	1677	2762	2809	2888	788	4606	3686	3368	365	1244	3249	4581	4333	3248	901	3735	4428	4253	1167	3528
1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	25	365	1	3030	440	2706	4302	2697	2617	2882	3609	4063	1759	2219	1056	2301	811	407	2280	2079	4697	1963	365	2375	1914
2242_AIF1 - Allograft inflammatory factor 1	2242_AIF1 - Allograft inflammatory factor 1	25	365	1	1677	1419	4590	3069	1383	3244	4061	3815	1988	3515	4697	3981	2734	3719	4291	2275	3347	4713	681	1868	1492	365
1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	366	1	4204	4738	4462	1091	2450	3722	366	3113	1342	4438	2924	2441	3782	1872	1398	3029	3708	1615	2981	1665	3852	3416
2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	25	366	1	3067	4166	1313	2276	3555	2629	1837	1812	2666	511	366	3994	3752	2299	4701	4504	3015	4531	2656	2648	4704	4386
1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	25	367	1	3481	624	4692	367	1884	1652	2634	4688	1761	1779	4478	1615	1288	4348	690	3350	4219	4141	3315	2757	4539	1173
1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	367	1	2649	2012	3235	1999	4346	367	1167	2368	2861	4420	3837	4451	4017	4383	4224	2142	3168	1459	3043	4393	4707	4452
3043_CD226 - CD226 antigen	3043_CD226 - CD226 antigen	25	367	1	601	1506	3513	1324	3575	2826	367	2820	1914	2734	470	3174	1567	4572	1289	4615	823	4630	2114	3860	1920	3587
3286_Irritability	3286_Irritability	25	367	1	3358	3653	2621	1333	4305	1876	1899	4702	4075	4033	1500	4534	2500	1369	367	4275	3956	4208	1992	3463	2563	1776
261_CD8:%SCM	261_CD8:%SCM	25	367	1	477	2175	3315	1732	1390	2533	1375	2952	4200	4367	1526	4301	3728	499	2407	2725	367	3085	4484	4140	3066	4404
1759_Breast cancer (GEE, adjusted for age)	1759_Breast cancer (GEE, adjusted for age)	25	367	1	4021	2525	3700	4337	1856	1316	3983	4042	1982	2202	782	3495	1788	2714	1982	4707	579	1019	949	3016	367	3467
2811_AMN - Protein amnionless	2811_AMN - Protein amnionless	25	368	1	680	4311	1428	2394	2172	4203	368	4082	4302	504	1576	1931	726	4555	2495	2948	3166	1172	1664	782	2974	742
1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	368	1	454	3815	2688	3615	1376	3021	2390	4495	2303	2540	1915	1354	368	3596	3480	3746	4139	3388	1334	3341	2991	2138
4071_Number of sexual partners	4071_Number of sexual partners	25	369	1	2025	531	881	369	4611	1052	2182	2385	1689	1415	3066	930	4045	4373	2221	1574	3846	436	1461	3324	2943	4011
1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	25	369	1	1157	3740	2989	3837	1566	4524	883	369	3491	3400	2042	1235	1429	964	3779	4653	3025	825	2869	1387	1327	3265
3901_Red cell distribution width (three-way meta)	3901_Red cell distribution width (three-way meta)	25	369	1	4317	577	3637	1829	1256	1034	2540	735	4550	4407	4211	1152	641	369	4682	3889	1448	4073	1077	2877	4090	729
4074_Body Mass Index	4074_Body Mass Index	25	369	1	4226	4255	3460	3416	4148	1734	3382	2869	2149	1348	4505	3514	3036	506	2686	3580	3365	663	4154	4696	369	494
650_::::X-01911	650_::::X-01911	25	370	1	3511	3059	1315	370	3463	2081	2196	2543	1645	603	1281	3131	2146	2656	1183	3075	623	750	3505	762	2346	2884
2480_DKK4 - Dickkopf-related protein 4	2480_DKK4 - Dickkopf-related protein 4	25	370	1	2188	474	1054	1821	3965	4473	687	370	1386	1238	411	768	2840	2829	3938	3434	3300	3413	2441	2891	3165	2496
119_Extreme Waist-hip ratio (adjusted for BMI)	119_Extreme Waist-hip ratio (adjusted for BMI)	25	370	1	889	576	1402	2672	2413	3817	1108	1522	3922	1564	1067	2788	4265	919	370	762	3880	2756	4622	969	3450	1314
4682_Posterior limb of internal capsule axial diusivities	4682_Posterior limb of internal capsule axial diusivities	25	370	1	3903	2305	1786	3237	4043	2195	2787	818	2863	2150	2882	2067	4400	3740	3870	4553	4305	3972	4575	3916	3382	370
4590_Right parahippocampal	4590_Right parahippocampal	25	371	1	371	2644	4366	2177	4290	1005	3199	3278	2852	2543	2642	2795	1241	1488	4173	3127	567	2165	2389	571	882	1181
2967_MMP13 - Collagenase 3	2967_MMP13 - Collagenase 3	25	371	1	2976	3432	2884	1743	371	3436	2208	1908	731	434	1754	3130	4460	3144	4484	1268	4297	2508	2215	4624	2171	2886
4718_Cingulum (hippocampus) mode of anisotropy	4718_Cingulum (hippocampus) mode of anisotropy	25	371	1	3537	3493	4276	1294	1917	4001	1109	4594	4649	4177	2316	1718	2807	371	4654	1176	2255	1806	3625	4438	4024	560
3030_RPS3 - 40S ribosomal protein S3	3030_RPS3 - 40S ribosomal protein S3	25	371	1	2077	4024	2408	1176	1330	2724	3420	1657	3017	1357	2202	2952	1275	1804	1399	1001	371	2412	1030	3440	2519	2732
4514_3rd ventricle	4514_3rd ventricle	25	371	1	3396	1630	2258	3744	2304	4700	1050	3694	3699	3062	4290	1887	1416	3471	1623	3073	3288	371	4435	3454	2051	2595
735_::::X-11843	735_::::X-11843	25	371	1	2903	3211	3729	2682	3802	2599	3469	2638	4627	3286	4085	3972	3837	1939	1395	4611	1702	4738	3257	2284	371	4613
1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	24	372	1	2256	1934	372	2581	3413	4000	2967	3114	4011	3325	4346	3534	1058	1619	4011	3579	2555	1345	3571	1685	4039	2409
4297_Extreme obesity (childhood)	4297_Extreme obesity (childhood)	25	372	1	3479	3707	3659	372	3591	1591	4451	2410	1628	493	1482	3987	1904	766	1691	4727	3008	1897	4496	3824	982	456
1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	372	1	1801	4569	949	1569	3557	3343	1828	3466	372	702	1142	2249	1815	2102	3134	3034	4098	716	1948	1890	4241	435
2613_CD84 - SLAM family member 5	2613_CD84 - SLAM family member 5	25	372	1	4694	1084	2567	3995	2524	1744	1217	1658	4201	1519	372	4568	591	3595	688	3818	4461	474	1275	2208	1443	1257
2_Attention deficit hyperactivity disorder	2_Attention deficit hyperactivity disorder	25	372	1	3228	2003	3333	3274	2234	3471	1237	4239	2257	3078	3011	1321	2917	2358	372	1983	3638	838	3134	909	1693	3574
3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	25	372	1	1750	4508	647	2465	1249	4535	4599	2850	3415	4370	4716	3856	2983	4545	4586	1537	1765	4353	4374	2254	372	3249
1123_Subcutaneous adipose tissue attenuation	1123_Subcutaneous adipose tissue attenuation	25	373	1	4409	3540	2785	4162	1968	4664	2564	3069	4338	820	1165	3660	3495	4321	1128	1750	3325	373	3784	4172	1737	2267
1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	374	1	2642	4080	374	2140	1951	1207	1019	4098	4537	660	1968	2516	1621	1257	2490	3562	1450	4449	4567	510	1067	2961
3264_Average weekly beer plus cider intake	3264_Average weekly beer plus cider intake	25	374	1	2116	4579	4698	4372	4676	2028	1107	374	4600	4418	2648	778	3265	2753	4361	2951	4670	845	2221	736	635	1670
1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	374	1	3766	2178	4049	3874	4192	746	3344	2767	2632	466	4556	4269	2729	4409	392	3909	374	1419	4155	1046	1767	4685
2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	25	374	1	3209	1270	1201	1326	3040	3942	426	881	4597	4398	2440	2385	623	4330	3485	3603	4068	3276	4481	1779	3057	374
3477_Own or rent accommodation lived in: Own with a mortgage	3477_Own or rent accommodation lived in: Own with a mortgage	25	375	1	1983	2549	375	3825	2252	2101	2381	2145	2714	3475	669	4656	3228	2941	1224	4035	4298	2363	4091	4137	4423	670
1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	25	375	1	3848	598	3827	862	4577	1537	4318	4619	375	2092	1274	4641	741	2732	3070	2582	2581	423	1678	1938	4638	3997
3314_Hearing difficulty/problems with background noise	3314_Hearing difficulty/problems with background noise	25	375	1	804	1102	3365	1522	3891	3497	3417	609	1753	375	4318	821	3990	3738	1472	3329	3414	4322	1673	4664	3096	4645
142_Height	142_Height	25	375	1	1176	2084	537	1651	771	4653	4013	1651	3606	3955	2603	4307	4566	4041	3253	375	397	2747	2568	3853	3809	1368
2963_LYZ - Lysozyme C	2963_LYZ - Lysozyme C	25	375	1	3806	3371	1369	2919	872	4316	3587	1169	2449	3358	3491	3934	481	2960	1837	733	4288	4119	525	3432	4509	375
406_Amino acid::Tryptophan metabolism::indolepropionate	406_Amino acid::Tryptophan metabolism::indolepropionate	25	376	1	2684	4026	376	3673	2022	1571	4454	3253	3109	1612	1130	3841	3713	565	3526	4147	2624	1199	2526	735	2954	4032
272_CD4:%RTE	272_CD4:%RTE	25	376	1	1026	545	691	3356	1083	1933	646	376	1783	1056	1009	2098	990	1378	1954	2131	3144	1623	1352	910	451	3299
1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	25	377	1	1517	3176	3645	377	2664	3403	1374	2915	596	976	3383	1218	1171	3680	682	662	4047	638	4593	4661	3668	4696
822_::::X-13548	822_::::X-13548	25	377	1	443	2958	1118	787	1785	2761	3869	3669	671	3042	3413	377	3198	1879	3043	4698	3828	3764	3228	1327	4677	2444
3243_Dried fruit intake	3243_Dried fruit intake	25	377	1	827	651	2748	3302	930	1897	1862	1293	897	4433	4210	763	4051	377	1854	3337	2271	643	3044	938	1034	1008
3260_Variation in diet	3260_Variation in diet	25	377	1	1217	4245	4018	4514	4536	3235	1769	1666	2024	2463	4345	3699	2912	4530	2433	3835	4605	3390	391	377	3483	1838
1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	25	378	1	1046	892	630	4158	3851	2129	2122	2112	378	1094	2206	3904	541	3790	2262	3002	2398	3836	2718	2744	2228	3374
2744_IL7 - Interleukin-7	2744_IL7 - Interleukin-7	25	378	1	3952	2956	1740	411	4035	3681	1716	3545	4467	3085	1242	378	765	596	814	3815	4630	1945	4511	2652	1298	785
1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	25	378	1	3597	4372	3722	3657	936	2144	3839	1271	2129	3116	691	4122	378	2464	3932	1652	2492	1330	2827	1225	4561	4329
3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	25	379	1	379	2037	420	2808	1414	1301	1991	1815	2414	2161	1306	3694	2223	3414	2936	4554	2865	1508	2925	3675	1904	3643
3056_IL17RB - interleukin-17 receptor B	3056_IL17RB - interleukin-17 receptor B	25	379	1	2512	3868	3257	4528	2885	379	1845	2028	2339	2978	1051	1834	3305	2234	2805	2256	3190	2190	865	4454	4495	3527
1025_Femoral Neck Length (GEE, adjusted for age and sex)	1025_Femoral Neck Length (GEE, adjusted for age and sex)	25	379	1	3712	2809	3739	464	2544	2740	425	3492	3436	4220	2666	2919	971	2999	1679	1899	3010	4028	379	4215	2556	709
4199_Waist-hip ratio (female)	4199_Waist-hip ratio (female)	25	380	1	2551	2276	2160	3330	1882	826	2156	4331	2648	1594	964	2006	1051	4514	613	2810	2931	4455	4596	4150	380	1547
3946_HbA1c	3946_HbA1c	25	381	1	684	655	381	2225	4221	4140	2885	2649	2112	3520	896	773	1835	2780	1520	2798	3567	424	4182	844	1607	4399
846_::::X-14662	846_::::X-14662	25	381	1	3753	3072	3144	381	1294	4555	2695	747	3074	3894	676	1895	3038	4012	2703	1830	4333	1720	3267	4121	2861	4040
1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	381	1	2480	1017	4096	2632	3618	381	2412	3633	4538	3555	2475	887	3215	3292	1969	3639	1086	2326	3163	3208	2830	4090
245_CD34 on Stem	245_CD34 on Stem	25	381	1	2784	3464	2306	2733	3628	4159	2585	2254	2142	4548	1787	3520	4575	381	4028	4258	3255	1348	3474	3455	3781	753
4468_Left rostral anterior cingulate	4468_Left rostral anterior cingulate	25	381	1	1607	1518	3953	2676	4657	2833	2326	3173	515	1862	3612	4205	1196	3412	4019	1093	4120	1321	381	3352	2594	2237
2748_NTF3 - Neurotrophin-3	2748_NTF3 - Neurotrophin-3	25	382	1	382	3594	845	4521	1978	1549	643	2730	2263	468	1673	3255	1082	3821	2854	1158	1739	3969	1774	3591	2771	1721
3632_Illnesses of father: Chronic bronchitis/emphysema	3632_Illnesses of father: Chronic bronchitis/emphysema	25	382	1	2415	3375	962	3088	1039	4354	1027	2981	4705	932	4712	1472	382	2722	3816	2299	4037	1353	1933	3816	4713	878
1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	25	382	1	4063	4056	4212	2843	798	2994	1640	4649	4529	4702	3279	2607	3223	744	382	2649	935	3426	1425	933	2779	4381
2153_HGF - Hepatocyte growth factor	2153_HGF - Hepatocyte growth factor	25	382	1	1959	2358	3051	2490	2290	3322	1616	888	4404	1015	2054	659	3253	3020	3277	1070	382	3464	4442	931	3795	1482
2732_CCL24 - C-C motif chemokine 24	2732_CCL24 - C-C motif chemokine 24	25	382	1	4216	1373	1863	519	3750	1562	551	3393	3821	1081	540	3779	3763	831	1549	2228	1901	3713	382	3200	3234	2436
3563_Vitamin and mineral supplements: Vitamin C	3563_Vitamin and mineral supplements: Vitamin C	25	383	1	4551	383	2711	557	3973	4041	2556	1066	2972	3413	1293	3460	3978	819	412	2320	4629	1239	4163	4119	3546	2107
562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	25	383	1	3631	3304	383	4450	2841	2481	4065	4125	3755	3093	2759	1504	484	2837	910	3256	3343	3291	1563	4728	1795	3908
1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	25	383	1	4131	890	654	615	3054	383	1094	4249	2392	2970	4682	1307	4385	1050	760	4246	409	4304	3392	2847	3745	1622
947_Sphingomyelins	947_Sphingomyelins	25	383	1	2321	1973	3420	914	896	4326	383	2957	1308	1890	2090	678	1404	621	4656	1918	946	2772	2433	4132	708	4627
3246_Processed meat intake	3246_Processed meat intake	25	383	1	1397	2806	4051	4665	3665	542	4182	2803	4233	4376	383	3453	2847	1341	1036	3793	449	2117	2876	1188	2414	4151
2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	25	383	1	2056	1155	3918	460	2652	3983	3386	1156	441	2748	446	4562	1026	383	1540	900	2532	3088	1904	2172	948	2014
2644_CSF1 - Macrophage colony-stimulating factor 1	2644_CSF1 - Macrophage colony-stimulating factor 1	25	383	1	2592	1622	2039	2162	2959	417	4181	3280	1208	1577	2135	1120	2305	4414	2554	4569	383	1322	3028	4631	494	1649
1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	25	383	1	3922	4302	3157	4498	4394	2567	2491	4684	3374	3002	2886	1298	3666	1610	1567	3427	1073	3934	383	819	4238	1620
1984_Age at natural menopause (FBAT, adjusted for multivariable)	1984_Age at natural menopause (FBAT, adjusted for multivariable)	25	384	1	1852	384	2427	405	2772	4482	2565	1203	4113	1389	3072	4726	2419	670	1993	4138	2744	1368	2507	1310	2643	3701
2840_FCRL3 - Fc receptor-like protein 3	2840_FCRL3 - Fc receptor-like protein 3	25	384	1	4552	840	2272	1893	2950	1796	4743	2530	2722	4031	642	4629	3151	3643	384	2282	2418	760	1021	1592	1474	970
2187_GDF5 - Growth/differentiation factor 5	2187_GDF5 - Growth/differentiation factor 5	25	384	1	1485	4006	4245	3359	1651	3533	1268	1503	1074	3312	709	2366	2865	3054	972	3317	843	384	668	2448	1341	4304
2692_PRDX1 - Peroxiredoxin-1	2692_PRDX1 - Peroxiredoxin-1	25	384	1	4433	3848	4488	3338	4396	1954	3887	4266	4325	3641	1886	1015	838	1837	3371	2773	1628	3168	1725	3005	384	1861
2720_PGAM1 - Phosphoglycerate mutase 1	2720_PGAM1 - Phosphoglycerate mutase 1	25	385	1	3831	385	1016	3089	3419	2591	1745	4716	1252	1446	1961	4198	3629	2892	3347	1137	3495	2157	1607	2657	3767	4698
3416_Bipolar and major depression status	3416_Bipolar and major depression status	25	385	1	2457	3247	1784	4395	3958	3130	2382	2701	3673	1045	4244	4354	385	1441	2726	2031	937	2844	1683	3478	545	4529
380_Amino acid::Glycine, serine and threonine metabolism::glycine	380_Amino acid::Glycine, serine and threonine metabolism::glycine	25	385	1	3687	1546	2457	2179	3597	1959	1763	3880	4257	594	4607	4399	2593	385	1560	4438	1687	1481	1581	3921	1780	1886
3285_Miserableness	3285_Miserableness	25	385	1	4679	2653	2614	624	4339	3910	3174	1282	2672	762	920	2351	3856	4607	385	4651	4122	953	1577	423	918	731
3368_Chest pain or discomfort walking normally	3368_Chest pain or discomfort walking normally	25	386	1	2187	386	1338	1020	3830	4621	4615	2827	2069	3486	4119	906	2975	2373	2493	2294	2867	770	3471	2954	2093	4553
2268_CCL23 - C-C motif chemokine 23	2268_CCL23 - C-C motif chemokine 23	25	386	1	1267	3900	2007	4721	4012	2377	4723	4366	2647	386	2305	1986	2959	4595	4016	3301	4468	1749	3770	3767	1503	2973
2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	25	386	1	441	3794	1094	657	4341	4437	3895	2780	1380	1683	2669	386	2665	2408	3066	1888	3936	2922	2376	4706	1718	848
1060_Breast cancer	1060_Breast cancer	25	386	1	1516	4333	4102	3373	3006	4172	4517	1776	1317	3897	705	1682	2760	1568	386	2900	3918	2584	4006	3567	2144	2663
3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	25	386	1	4031	3042	1113	2894	1223	3750	2247	400	765	718	922	3665	3011	4521	4007	386	1641	950	3791	4251	2743	2657
3350_Bilateral oophorectomy (both ovaries removed) (female)	3350_Bilateral oophorectomy (both ovaries removed) (female)	25	387	1	1345	387	2440	1940	3410	4630	3468	2169	2475	2424	4013	3180	1857	1330	3387	3146	3895	2885	3945	3136	2075	3854
2753_PLG - Plasminogen	2753_PLG - Plasminogen	25	387	1	1929	1018	387	1308	2323	2378	4062	4728	3558	4139	3566	3159	4186	3869	3224	3252	3070	4503	4548	2732	4580	3428
4063_Estimated glomerular filtration rate based on serum creatinine	4063_Estimated glomerular filtration rate based on serum creatinine	25	387	1	788	1339	3604	1315	1213	3031	387	1435	1136	920	2817	561	2586	1148	2372	1961	1929	1416	4485	1544	2004	1805
78_Femoral Neck BMD (males)	78_Femoral Neck BMD (males)	25	387	1	2795	1411	1437	4320	4500	2932	3660	2216	387	2642	4125	3240	3807	3033	2452	4369	2911	537	2082	1341	2775	425
2949_COTL1 - Coactosin-like protein	2949_COTL1 - Coactosin-like protein	25	387	1	1416	1556	3646	1553	2132	4578	4401	1605	2785	1063	3670	4610	2008	4068	387	2377	3254	3142	1970	3401	3331	2749
3956_Ankle injury (random effect)	3956_Ankle injury (random effect)	25	387	1	762	1970	763	4028	2735	409	3724	4664	3391	2622	2564	2087	1586	2598	2246	2492	994	1355	387	2433	2535	844
4564_Left pericalcarine	4564_Left pericalcarine	25	387	1	1107	1650	3916	2522	2050	3185	2992	3340	1961	3919	4057	1351	1372	396	2951	920	4745	1181	3165	2422	4542	387
116_Variability of Height	116_Variability of Height	25	388	1	1684	388	1965	2201	3763	2475	2065	1191	1233	1576	2703	2407	1899	4670	1724	2140	4199	987	3498	859	2072	3277
4340_Walking (conditioning sex and BMI)	4340_Walking (conditioning sex and BMI)	25	388	1	2280	1091	417	1722	625	3829	4709	388	1795	1401	2804	3940	3438	4333	3399	904	4690	3251	884	3108	2446	1041
4490_Right paracentral	4490_Right paracentral	25	389	1	648	2141	389	2408	1313	1760	1904	4416	2541	4231	4308	727	2748	2001	745	2837	499	2550	2178	3894	2438	2113
1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	25	389	1	2902	1776	4478	863	3558	389	413	1068	1343	1441	2662	3650	3282	1980	3276	3240	1552	2599	3889	1137	4178	1993
1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	389	1	2864	2064	4199	1585	4194	1925	389	4303	864	2724	3333	634	1228	1222	4080	3926	2173	3806	4632	3588	4296	1441
477_Lipid::Carnitine metabolism::acetylcarnitine	477_Lipid::Carnitine metabolism::acetylcarnitine	25	389	1	2127	2513	2356	2951	1441	1057	1063	3790	389	1305	3653	3242	2863	2788	3830	2483	3893	4165	3303	3008	2470	3248
2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	25	389	1	3417	2552	1007	4040	4375	2211	3259	4406	748	4695	389	3861	1308	3352	3241	3224	4746	2152	2971	3946	744	4502
1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	25	390	1	390	3722	1292	2245	1496	3564	4285	4700	1265	4642	2457	1186	4456	1971	2921	3492	804	1812	3235	519	1053	3691
2047_Periodontal complex trait 2	2047_Periodontal complex trait 2	25	390	1	4380	3791	2672	2493	843	2063	1462	1358	3022	1801	1267	612	1579	636	4147	4656	390	608	1220	4436	4549	4365
3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	25	390	1	1401	4048	1218	2377	4519	2683	4209	3960	1206	2666	4032	550	2594	1017	3131	4530	3446	390	1689	2711	4603	1286
4076_Body Mass Index (female)	4076_Body Mass Index (female)	25	390	1	3564	3275	4316	1703	2085	1835	3471	1504	3832	1438	4104	2373	1825	1377	2988	3825	3483	1550	2704	3698	390	663
2547_AGT - Angiotensinogen	2547_AGT - Angiotensinogen	25	391	1	766	800	1948	391	1829	4638	3514	1992	4413	2804	4507	1554	2209	2233	1219	1171	3633	3005	3442	3003	3352	4012
3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	25	391	1	4703	1236	2435	3048	2582	1814	999	1588	4526	391	3246	1389	3458	4690	628	4368	1376	795	1449	4000	3212	4398
2482_FETUB - Fetuin-B	2482_FETUB - Fetuin-B	25	391	1	4437	2746	3023	2012	2571	654	1114	1148	738	2507	3180	2171	1826	656	403	3150	391	810	4349	4014	3599	2372
3283_Number of full sisters	3283_Number of full sisters	25	392	1	1018	680	3683	3863	4289	1443	4191	541	1671	2641	643	392	2843	2272	1713	2938	4586	4103	2854	1462	4621	505
4541_Right ventral DC	4541_Right ventral DC	25	392	1	2433	3024	3495	2499	4222	2509	4432	4244	2174	1914	3008	2701	3909	2178	1171	2476	3103	3313	392	4088	1958	1266
1857_Neck average buckling ratio (GEE, male, adjussted for age)	1857_Neck average buckling ratio (GEE, male, adjussted for age)	25	392	1	4337	1956	884	2095	3888	2486	836	1471	2963	730	3297	4521	1652	2760	3080	3724	2431	3526	4460	3450	392	3611
695_::::X-11334	695_::::X-11334	25	393	1	1804	1023	393	2939	2178	3143	4072	1069	3987	2293	3548	2261	2097	1624	700	1471	1879	3759	3454	3564	1875	4488
4273_Long sleep	4273_Long sleep	25	393	1	4163	1323	2476	776	3616	3603	1555	393	4389	608	2148	445	4155	3817	3719	3271	2709	481	1095	2193	448	2701
71_High-density lipoprotein cholesterol	71_High-density lipoprotein cholesterol	25	393	1	4018	3552	2292	2110	1537	4661	1739	2949	393	4095	2435	689	2613	1820	4365	4312	2482	2859	3936	3310	3714	2585
3013_MAPK14 - Mitogen-activated protein kinase 14	3013_MAPK14 - Mitogen-activated protein kinase 14	25	393	1	398	510	4452	2083	2338	3649	3257	2049	1808	393	3178	4389	1666	4087	840	1601	3707	4070	4279	3204	3067	4072
4155_E/A ratio	4155_E/A ratio	25	393	1	2404	4594	2391	1740	959	1284	3621	3922	744	2052	4024	2805	2162	4304	1952	986	393	435	1598	4511	1267	3576
2570_CGA TSHB - Thyroid Stimulating Hormone	2570_CGA TSHB - Thyroid Stimulating Hormone	25	393	1	4580	1955	2666	1509	2327	938	3430	2044	3823	3728	2320	4541	3790	3114	3122	586	1515	4706	1084	393	697	1175
2711_HINT1 - Histidine triad nucleotide-binding protein 1	2711_HINT1 - Histidine triad nucleotide-binding protein 1	25	393	1	1082	3778	1370	2940	2788	2040	4636	1256	2322	1470	1243	781	4409	3505	2279	4282	3796	621	4070	3457	393	1273
1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	25	394	1	394	2504	2984	2294	2118	3287	3725	4002	2651	4172	1241	2550	1251	2401	3039	1836	3318	1685	796	793	1462	1453
1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	25	394	1	511	3141	394	1119	2514	4600	1718	3376	1056	4291	2756	826	2672	435	2863	4508	4585	4423	1596	4395	1412	692
3401_Loud music exposure frequency	3401_Loud music exposure frequency	25	394	1	4615	2078	2438	1405	3233	2965	2798	394	3864	926	1428	2903	4617	3196	915	3016	1242	2830	2206	3797	4546	3448
1932_Parietal brain volume (FBAT, adjusted for age and sex)	1932_Parietal brain volume (FBAT, adjusted for age and sex)	25	394	1	4033	4423	2628	3903	2681	3713	3557	2229	3046	3935	394	1496	686	521	560	4150	1342	3048	1359	752	4712	4643
211_Insomnia (male)	211_Insomnia (male)	25	394	1	2357	1001	480	2459	4248	4698	4331	1719	4264	1335	428	2303	2067	3375	1119	4582	1589	2764	2199	3594	394	2383
311_CD4nv:%R6+R4-	311_CD4nv:%R6+R4-	25	395	1	4724	395	1236	3893	4247	3966	1588	414	3097	3917	4080	3456	4726	2070	4610	2194	3067	1264	2050	4431	4710	4192
4609_Cerebellar vermal lobules VI VII	4609_Cerebellar vermal lobules VI VII	25	395	1	4316	2614	395	789	3455	3111	1212	2770	4384	4428	924	1792	1032	3317	3560	3574	4350	2542	3080	1321	4066	3687
2575_ADIPOQ - Adiponectin	2575_ADIPOQ - Adiponectin	25	395	1	1149	3602	1633	3870	395	4249	4640	4369	698	2562	1807	4124	2675	4494	3636	1003	3821	505	1530	2783	4380	597
3089_ICAM5 - Intercellular adhesion molecule 5	3089_ICAM5 - Intercellular adhesion molecule 5	25	395	1	4187	4159	520	1238	2173	395	3107	1002	4307	1972	3429	2956	1099	2592	2929	3676	3604	3044	3730	3526	1694	1587
1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	25	395	1	3407	3651	2658	3162	1849	3544	2123	3354	3266	395	1030	3888	3137	1321	1310	1291	3533	3402	3286	679	3520	2869
3240_Cooked vegetable intake	3240_Cooked vegetable intake	25	395	1	1822	2684	689	4580	4369	2275	2879	3229	977	786	2955	3167	395	1159	1417	4408	3353	2742	4208	4270	2368	3633
3131_ABL2 - Abelson tyrosine-protein kinase 2	3131_ABL2 - Abelson tyrosine-protein kinase 2	25	395	1	4583	4551	829	3093	2484	1653	718	2068	412	1185	4374	2849	864	2807	395	2661	3597	4273	606	2250	3765	2860
1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	395	1	4457	4289	1934	3702	454	3933	972	3265	4020	2977	3329	3703	4560	1013	1710	395	4590	2923	784	2143	4195	4451
140_Waist-hip ratio (male, adjusted for BMI)	140_Waist-hip ratio (male, adjusted for BMI)	25	396	1	3380	3007	2105	396	477	1926	1800	663	1597	2596	932	607	1461	3506	3858	656	4633	3417	439	1459	2646	2411
1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	396	1	1069	3766	3180	1826	4044	725	1351	2950	2372	4610	396	3723	3914	1247	3846	3955	4515	2462	4257	1821	3619	1370
1215_Alcohol consumption (female)	1215_Alcohol consumption (female)	25	396	1	1101	4361	4542	2796	3447	436	1387	1728	2961	4117	2079	396	4549	3510	3519	2915	2833	778	2953	2575	1158	2022
3724_Frequency of inability to cease drinking in last year	3724_Frequency of inability to cease drinking in last year	25	396	1	3374	3869	1197	4650	4658	4518	2327	1092	2691	796	588	1188	2669	2824	3702	3957	3535	1385	396	2485	4667	4389
4505_Right transverse temporal	4505_Right transverse temporal	25	396	1	2618	3948	487	2374	3425	3628	2944	3756	4513	2385	4618	1896	2361	3913	1413	3310	3302	1644	1052	396	1151	1905
4286_FEV1	4286_FEV1	25	397	1	3344	535	4373	4618	607	3335	4425	3841	442	1230	2001	2415	1854	397	4152	1905	2668	2317	3897	644	3673	1992
4635_Right thalamus proper	4635_Right thalamus proper	25	397	1	410	1730	3653	2759	4717	3127	398	1454	4361	4170	2623	799	3397	1539	397	3538	3695	976	3522	2754	1202	969
814_::::X-13069	814_::::X-13069	25	397	1	3204	2898	4124	1567	1766	1670	2594	1746	3326	3386	2724	1839	1731	1890	1221	670	2902	2479	397	2271	3018	2376
1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	25	397	1	2287	3319	399	3698	4276	3003	1789	1572	4644	4297	3034	4427	1450	4158	1460	4374	3139	3785	4483	2888	3242	397
575_Lipid::Sterol, Steroid::cortisone	575_Lipid::Sterol, Steroid::cortisone	25	398	1	2184	4639	3913	3083	3974	1763	2002	4220	4675	930	398	3113	3032	4386	4397	1709	3619	744	1686	3975	1417	1125
1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	398	1	558	4033	994	1709	4128	3833	4570	2898	4331	3978	2362	398	1722	1318	4034	3710	1629	3617	3640	515	4469	4288
904_Triglycerides in large VLDL	904_Triglycerides in large VLDL	25	398	1	4010	4150	2813	2575	665	1754	1093	1246	4468	415	3658	756	629	2190	398	1887	687	1447	4680	1097	1862	443
1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	398	1	4395	3515	2538	2868	456	3980	1859	2823	4162	3364	2467	4259	3407	1736	1556	398	4588	1593	398	981	4093	3926
4112_Sodium	4112_Sodium	25	398	1	1724	2000	594	2142	3904	1689	1412	4202	721	1574	4513	1135	3983	4287	3899	2778	2281	497	2308	398	3459	500
2173_IL37 - Interleukin-37	2173_IL37 - Interleukin-37	25	399	1	1533	3381	3901	1227	952	2148	2372	2062	3302	3535	1084	2789	1098	2275	4132	399	2251	2904	2878	719	4739	571
2224_COMMD7 - COMM domain-containing protein 7	2224_COMMD7 - COMM domain-containing protein 7	25	399	1	4434	2975	1618	3704	3476	1998	2242	4209	3490	1461	2995	4284	946	3185	4374	2461	1776	1683	2628	4603	1308	399
2860_C5 C6 - Complement C5b-C6 complex	2860_C5 C6 - Complement C5b-C6 complex	25	400	1	1032	1391	2868	769	3429	400	2852	2784	4202	1578	4082	3478	3709	3304	4172	1664	2613	3638	610	991	3420	1527
2681_RGMA - Repulsive guidance molecule A	2681_RGMA - Repulsive guidance molecule A	25	400	1	3521	1992	4451	2621	2490	2385	757	3801	4044	2581	3004	400	2198	1684	3298	2625	3692	2078	3411	1768	1899	2185
2014_Response following 8-week treatment of MDD subjects	2014_Response following 8-week treatment of MDD subjects	25	400	1	1704	1787	4374	4698	547	594	3187	3055	1440	3232	4361	2146	400	616	1674	2152	3484	4436	1043	919	4120	1081
3679_Diagnoses - main ICD10: M54 Dorsalgia	3679_Diagnoses - main ICD10: M54 Dorsalgia	25	400	1	1136	3962	636	2228	3498	1857	3968	3759	2969	3127	4665	918	1647	2983	400	3168	2775	2162	2975	4248	2186	3305
2862_IL3RA - Interleukin-3 receptor subunit alpha	2862_IL3RA - Interleukin-3 receptor subunit alpha	25	401	1	4407	3663	1729	2368	4549	3457	401	1755	3696	2194	2910	4233	3512	3420	1358	4691	1971	1545	2174	4662	1524	3264
3050_EPHA10 - Ephrin type-A receptor 10	3050_EPHA10 - Ephrin type-A receptor 10	25	401	1	2570	2179	1664	1559	4664	2754	1794	2682	2009	4136	4657	4595	419	3927	1864	4614	4459	1695	401	4277	879	1738
2798_P4HB - Protein disulfide-isomerase	2798_P4HB - Protein disulfide-isomerase	25	402	1	1041	402	1119	2725	3910	4096	2008	3902	3584	2993	4221	1048	4504	3552	1364	4343	3362	1819	3034	3322	2531	3451
197_Urinary albumin-to-creatinine ratio	197_Urinary albumin-to-creatinine ratio	25	402	1	3082	1164	409	402	2348	999	4183	4228	1680	3997	3334	3517	2240	2212	3206	923	3891	2910	3817	3213	1322	4053
361_mDCL%274+	361_mDCL%274+	25	402	1	4618	4042	4195	3545	4486	919	402	4611	4057	2533	2411	1482	2283	1615	3233	2727	844	3512	2775	1276	3901	4224
1092_Gastric cancer	1092_Gastric cancer	25	402	1	1088	2364	3531	431	849	1721	4269	3255	1931	402	3187	2494	2965	2574	3429	1199	2343	1032	3530	775	840	1095
2363_RARRES2 - Retinoic acid receptor responder protein 2	2363_RARRES2 - Retinoic acid receptor responder protein 2	25	402	1	3857	1761	3231	1167	1803	3385	899	4642	2208	1049	402	485	1540	446	958	1702	1594	3252	2319	4637	2154	912
4376_Hypothyroidism	4376_Hypothyroidism	25	402	1	1668	1281	2857	4281	611	2228	820	1831	4735	3130	3059	805	2949	974	2472	402	2328	3890	1896	4531	2158	2801
1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	25	402	1	1476	2195	2254	1292	4435	614	1226	2642	3419	4302	2661	707	1273	1787	4393	2015	402	2210	918	1835	1840	684
2783_LCMT1 - Leucine carboxyl methyltransferase 1	2783_LCMT1 - Leucine carboxyl methyltransferase 1	25	403	1	3003	2911	4470	1677	2508	4011	4004	3009	3886	2723	4316	871	2329	3988	3706	1039	3269	1671	849	1748	403	504
1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	404	1	3247	758	2327	4604	1983	1099	4584	404	4598	941	1980	2188	3057	2470	1207	2767	1817	2970	3696	3544	3552	1336
3654_Smoking status: Never	3654_Smoking status: Never	25	404	1	1760	3035	3727	3918	2084	743	736	640	1284	1884	1230	1963	3311	1962	1287	404	1022	2945	1336	1318	1081	490
1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	25	404	1	3981	1981	631	2840	2177	4237	2563	805	1085	2564	1734	3283	2412	3277	3836	4524	2535	1401	404	2522	908	4245
825_::::X-13619	825_::::X-13619	25	405	1	1944	2472	2669	1633	1189	2236	2278	4463	3869	4183	4190	405	1950	920	1768	1869	725	1329	3152	577	3120	2838
388_Amino acid::Lysine metabolism::glutaroyl carnitine	388_Amino acid::Lysine metabolism::glutaroyl carnitine	25	405	1	4058	1409	3633	3336	4093	1376	4194	960	1505	3461	2133	4538	448	733	4322	3744	2789	3716	405	2065	4343	2414
1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	25	405	1	4154	2198	3765	4520	1035	2342	2896	3319	3125	1678	596	943	4153	661	1043	2266	1650	1473	3984	2270	2537	405
2248_HAT1 - Histone acetyltransferase type B catalytic subunit	2248_HAT1 - Histone acetyltransferase type B catalytic subunit	25	406	1	2868	2571	463	725	2350	770	536	669	406	2443	2126	2469	792	4014	2526	3766	2660	971	4093	1740	1434	2768
2246_MAPK3 - Mitogen-activated protein kinase 3	2246_MAPK3 - Mitogen-activated protein kinase 3	25	406	1	3924	610	1209	507	3873	913	3188	2074	1492	1802	3268	2165	4496	1305	3583	3994	406	1787	4728	3051	2738	780
94_Birth weight	94_Birth weight	25	406	1	3081	2777	3844	1504	4099	4335	997	3595	778	551	1891	4630	418	2729	3847	2632	1412	406	3992	595	4257	3323
1211_Type 2 Diabetes	1211_Type 2 Diabetes	25	406	1	1277	4359	1651	1682	2301	3190	4665	2011	2448	1289	1398	2852	2742	4075	2771	420	1409	2834	1981	4176	406	3675
3162_SET - Protein SET	3162_SET - Protein SET	25	407	1	407	2417	1782	1705	2281	2048	3597	654	3352	622	1299	624	2121	2582	721	3183	3547	1308	3698	3801	787	2516
797_::::X-12729	797_::::X-12729	25	407	1	1768	3233	4405	3279	407	3736	1129	3169	1384	1208	1928	1723	3262	2274	4061	415	3501	634	4334	2348	3720	2918
839_::::X-14473	839_::::X-14473	25	407	1	2647	2944	1987	4166	3492	407	3981	889	3668	778	2561	420	928	3237	3984	1911	788	3754	3011	582	1387	2744
1986_Age at natural menopause (FBAT)	1986_Age at natural menopause (FBAT)	25	407	1	3418	710	2485	1216	1551	1902	780	3753	1497	2314	3772	407	988	4147	1084	956	1954	1109	466	3312	1796	4598
2563_CCL22 - C-C motif chemokine 22	2563_CCL22 - C-C motif chemokine 22	25	407	1	3020	3567	2465	708	1229	2667	950	4623	4341	4633	2194	1555	4547	407	1627	954	647	4546	2700	4480	4481	2016
3234_Daytime dozing / sleeping (narcolepsy)	3234_Daytime dozing / sleeping (narcolepsy)	25	407	1	4410	2040	1980	2306	3960	3581	2282	2843	4732	4032	781	3088	4523	3501	4056	2237	2488	4703	2767	3652	407	2857
2930_GPC3 - Glypican-3	2930_GPC3 - Glypican-3	25	408	1	3032	408	3459	1190	2668	1317	3099	3128	836	4500	1513	2967	644	2203	2422	3514	1757	2124	3721	2412	3969	1741
1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	24	408	1	3896	1306	1827	3882	2835	2201	2270	3192	4318	2677	408	3269	820	4713	1299	2733	3620	2841	3525	2462	2660	2437
37_Loneliness (case/control)	37_Loneliness (case/control)	25	408	1	1625	1736	3212	4088	1678	4229	4701	1214	545	1240	797	4532	757	3449	1478	1027	4205	3906	408	2735	4217	3726
4121_Alkaline phosphatase	4121_Alkaline phosphatase	25	408	1	3868	2520	2563	1218	3727	3762	4110	3400	1190	4731	4744	4559	3815	3594	3144	2334	4736	2431	432	408	3640	499
2511_CA13 - Carbonic anhydrase 13	2511_CA13 - Carbonic anhydrase 13	25	408	1	2323	2413	2379	3185	2002	3153	3604	2632	453	4475	4711	2301	3421	443	4086	1594	570	4059	3604	978	4297	408
4260_Facial attractiveness (female-coder)	4260_Facial attractiveness (female-coder)	25	409	1	3318	741	3159	4053	409	4239	1726	2785	4240	2014	955	1882	1696	2730	4013	1606	3213	887	2342	4595	3128	784
3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	25	409	1	1772	4316	3586	3892	2264	4146	3102	4482	823	2073	1822	1304	409	1344	3649	1555	4083	2605	1318	2242	4594	3096
4687_Superior fronto-occipital fasciculus axial diusivities	4687_Superior fronto-occipital fasciculus axial diusivities	25	409	1	1840	4714	3969	3348	4436	2830	1187	1827	4737	4662	3908	1952	2049	3878	409	3929	4666	678	560	2006	3105	1623
4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	25	409	1	2970	3467	4552	782	920	3828	4576	949	2207	588	1484	846	3352	1723	851	409	1816	4065	2092	2910	3471	740
3471_Impedance measures - Trunk predicted mass	3471_Impedance measures - Trunk predicted mass	25	409	1	4558	1557	769	4542	4672	1564	4415	2445	1385	4277	4179	3651	3899	3823	3663	4523	4433	409	904	3378	4252	915
3420_Pairs matching test - Number of incorrect matches in round	3420_Pairs matching test - Number of incorrect matches in round	25	410	1	1845	2810	3270	410	1715	741	4532	2349	751	3077	2975	1742	1582	2072	2058	1186	4693	1763	2729	1411	4063	1920
3981_25-Hydroxyvitamin D level	3981_25-Hydroxyvitamin D level	25	410	1	3260	665	2775	4655	1688	1536	2912	3834	4562	410	3151	1249	1641	3416	3358	2730	2669	3255	4411	1175	3140	3694
3494_Coffee type: Ground coffee (include espresso, filter etc)	3494_Coffee type: Ground coffee (include espresso, filter etc)	25	410	1	3364	2156	3053	4541	4277	3434	3009	770	2327	1868	410	3782	3368	552	4651	4498	2123	893	3323	2170	1635	600
1192_Refractive error	1192_Refractive error	25	410	1	2460	2202	1588	2139	1985	4732	4491	1292	3102	2347	1109	410	3066	1450	4668	3227	3640	4673	1036	2571	2482	3050
3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	25	410	1	1182	1873	4216	1200	1114	2262	1774	4132	1708	1135	2917	1953	2517	2972	3076	410	1498	2883	2100	2868	1821	3067
2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	25	410	1	3858	2788	982	3500	4024	3141	4699	4345	1115	3322	1725	3313	3367	2210	2565	4325	410	4050	4212	1816	1501	1720
227_mDC:%CD1c-	227_mDC:%CD1c-	25	412	1	2951	3892	3927	3726	457	2868	1327	1273	724	3852	3905	3916	2397	4159	1151	412	3877	961	3564	4740	1536	2788
2301_CXCL5 - C-X-C motif chemokine 5	2301_CXCL5 - C-X-C motif chemokine 5	25	413	1	3496	1408	4647	4474	413	4099	4590	831	3824	1483	3291	2040	2061	1724	1536	428	4465	2057	3504	2507	1429	2327
1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	25	414	1	2095	414	3035	1421	1275	495	2272	602	4425	3747	422	4218	1529	657	2905	652	2887	1060	4741	2541	2413	2731
3265_Average weekly spirits intake	3265_Average weekly spirits intake	25	414	1	2716	2804	2478	2170	4524	4430	414	1000	3519	1796	742	3869	995	2175	3832	4131	2039	1252	4665	4542	2257	3235
359_mDC:%64-274-	359_mDC:%64-274-	25	414	1	3729	973	3349	4359	1361	970	4548	1715	1051	2843	4605	1368	414	470	2830	754	2570	3418	3610	4363	758	4004
591_Peptide::Dipeptide::aspartylphenylalanine	591_Peptide::Dipeptide::aspartylphenylalanine	25	414	1	3931	1808	4638	1422	1175	4070	1026	3394	4078	1418	2293	3777	3235	414	4191	1110	4337	3164	3264	3361	2634	2939
457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	25	414	1	2785	3124	1601	1211	868	1881	4712	4196	1231	2577	3685	3515	3722	1722	4145	414	2119	1605	1639	2358	1039	2350
1931_Occipital brain volume (GEE, adjusted for age and sex)	1931_Occipital brain volume (GEE, adjusted for age and sex)	25	414	1	2744	2319	3307	2178	984	438	3175	1817	3251	1724	1706	2703	4325	3339	4400	2462	420	414	813	3326	4130	723
4463_Left pericalcarine	4463_Left pericalcarine	25	415	1	415	2390	678	4469	3199	2610	3901	427	600	2665	822	4506	1110	2984	1281	1624	2054	4316	4191	1968	3690	3162
3735_Depression - Frequency of depressed days during worst episode of depression	3735_Depression - Frequency of depressed days during worst episode of depression	25	415	1	2349	4085	1628	3537	2574	3094	1407	415	4291	1888	4545	3894	3702	3535	1976	2257	3232	3354	3108	1202	3863	1030
921_Total cholesterol in medium VLDL	921_Total cholesterol in medium VLDL	25	415	1	1830	4001	2966	3553	419	1772	2105	2568	4448	714	1894	543	2354	2451	415	858	943	1432	3258	1986	4412	662
1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	25	415	1	2098	561	2493	3571	2786	1600	3129	568	2952	2706	4619	3846	2536	1009	1101	3190	1078	4504	415	1573	660	3500
1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	25	416	1	1464	416	2799	1610	2543	3468	4483	3792	2022	4344	4713	1426	1101	3771	2576	1695	712	3357	1802	2413	3539	2590
4504_Right supramarginal	4504_Right supramarginal	25	416	1	4715	4173	4205	416	1117	3512	4149	589	3418	3250	3684	1438	1454	1713	859	2656	4014	4315	3509	755	4165	4430
2716_MBD4 - Methyl-CpG-binding domain protein 4	2716_MBD4 - Methyl-CpG-binding domain protein 4	25	416	1	3535	4145	1620	2728	1866	2743	539	3554	416	3185	3330	911	3362	4635	4271	887	4307	991	1925	3431	1642	4155
1_Attention deficit hyperactivity disorder	1_Attention deficit hyperactivity disorder	25	416	1	4041	2524	1014	3372	1482	2435	3810	3740	3956	416	3036	1967	1417	2207	3890	4466	3554	1373	3560	3061	981	2151
2182_SHH - Sonic hedgehog protein	2182_SHH - Sonic hedgehog protein	25	416	1	1734	773	4673	3141	3042	2626	2713	1655	3919	1315	1897	416	3140	2041	2353	4490	4094	2233	3395	2380	1301	4462
3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	25	416	1	3213	3130	3279	4213	3148	1521	1329	2920	2518	2270	3710	1331	1981	416	2723	1233	1933	3186	2388	2457	2390	4350
577_Lipid::Sterol, Steroid::epiandrosterone sulfate	577_Lipid::Sterol, Steroid::epiandrosterone sulfate	25	416	1	2382	3341	710	1998	619	3820	3112	2129	2789	3774	4328	2906	1646	2428	2669	416	2813	1407	2027	2326	3841	4670
3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	25	417	1	4617	3329	991	2776	2736	3726	3240	417	1009	1317	1220	2236	4452	2527	4244	1807	4069	3580	2576	2807	4551	3373
1922_Hippocampal volume (FBAT, adjusted for age and sex)	1922_Hippocampal volume (FBAT, adjusted for age and sex)	25	417	1	1780	645	2261	4440	3370	4131	1593	463	1119	3584	417	4485	1580	2862	3317	2054	3251	3911	3317	3504	2844	4002
4606_Right transverse temporal	4606_Right transverse temporal	25	417	1	1482	739	1682	4410	3457	2783	3843	4551	4630	2768	1935	1470	2794	1528	2142	3821	610	2504	3612	2222	417	445
1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	25	418	1	4311	418	2276	1615	2017	4403	1230	3885	3766	3977	2110	1230	3556	4282	1318	4009	3746	2358	734	4416	2073	3244
3445_Impedance measures - Body Mass Index (BMI)	3445_Impedance measures - Body Mass Index (BMI)	25	418	2	4388	4490	3609	2975	2900	3825	3535	2387	1743	418	3847	3784	4636	2047	1934	3408	2861	468	2525	2132	1205	1356
2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	25	418	1	2441	4742	4264	2257	2541	3315	1850	3157	4673	4557	4284	418	1686	2284	3434	3117	3266	1637	1451	3550	1819	3795
2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	25	418	1	3522	2255	940	3849	1285	4364	826	1495	1839	3615	4357	1906	4426	1104	3709	1303	2793	2223	878	418	1608	4017
3088_SEMA6A - Semaphorin-6A	3088_SEMA6A - Semaphorin-6A	25	419	1	888	4418	2844	3648	2007	1993	1035	4134	3392	1853	744	419	3586	465	2074	2399	1530	4230	1843	4593	695	1938
4562_Left pars orbitalis	4562_Left pars orbitalis	25	420	1	4701	2748	2554	2930	3063	2603	420	3615	676	2844	2166	3140	2119	1919	3504	3942	3915	4101	3216	2908	826	3743
1218_Alcohol consumption (dichotomous, female)	1218_Alcohol consumption (dichotomous, female)	25	420	1	868	725	1035	1721	4512	4158	4473	420	3091	989	3185	1444	1075	1609	2740	3095	2525	2745	1459	4646	543	1371
765_::::X-12230	765_::::X-12230	25	420	1	756	2795	3259	4079	3566	2609	3998	4113	420	3882	3903	1828	2905	3867	2055	2646	4581	4071	4624	4201	4485	4419
4702_Inferior fronto-occipital fasciculus mean diusivities	4702_Inferior fronto-occipital fasciculus mean diusivities	25	420	1	4325	3408	667	2923	2867	1378	3318	496	2451	3397	2485	3241	2398	4737	1832	3393	3109	2823	879	3914	1661	420
279_CD8:%39+	279_CD8:%39+	25	421	1	2738	421	3188	1099	1578	3056	3482	1621	3788	1665	4069	2296	4514	3131	2466	1968	1847	4485	1417	2526	2683	1580
3621_Treatment/medication code: metformin	3621_Treatment/medication code: metformin	25	421	1	2619	1592	1629	3314	421	2790	1986	504	2780	1471	713	2444	2177	4352	3290	609	3035	4460	1862	3188	1384	1669
604_Peptide::gamma-glutamyl::gamma-glutamylleucine	604_Peptide::gamma-glutamyl::gamma-glutamylleucine	25	421	1	1225	3677	1590	4254	1425	3760	4741	3239	2836	4021	421	1476	2474	3189	2927	3381	4636	3981	4008	1475	3638	3218
3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	25	421	1	2052	1809	1846	4483	3983	4439	2568	1238	1430	1648	3797	2731	3800	4412	421	3878	2114	604	3368	1142	4584	2260
1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	25	421	1	2519	2931	4569	4313	2273	3449	3428	1954	3871	3423	3121	3116	2206	1312	2643	1184	421	4737	4338	892	835	4331
963_Phospholipids in very large VLDL	963_Phospholipids in very large VLDL	25	421	1	2338	1677	4636	2182	3674	4357	463	2198	2407	799	3676	4334	1142	1144	1246	1401	1221	3918	4671	1516	4267	421
45_Self-reported tiredness	45_Self-reported tiredness	25	422	1	2069	2695	2872	4244	1994	4173	1916	4588	3950	422	3663	2083	3118	3802	3538	1931	4376	4563	2708	3867	3291	3556
2050_Periodontal complex trait 5 - Pg trait	2050_Periodontal complex trait 5 - Pg trait	25	422	1	4725	1478	3699	430	4575	1159	496	2847	2754	2719	4616	4681	4072	422	1530	4240	3337	4225	2261	2641	4518	1143
1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	422	1	4342	2434	2544	3130	2125	2991	1057	3749	1398	3443	505	4554	613	3318	4490	1575	1601	422	877	3780	3401	3075
2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	25	423	1	423	2740	1433	2588	741	937	1152	4001	3789	2902	1679	4728	3794	3735	3525	967	1853	443	2674	3160	2723	3179
2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	25	423	1	800	3564	2401	2836	2126	3921	3602	4031	3322	878	1388	423	1762	1032	1694	4359	1346	4016	3167	4420	4249	4046
3106_PPID - Peptidyl-prolyl cis-trans isomerase D	3106_PPID - Peptidyl-prolyl cis-trans isomerase D	25	423	1	2250	1570	1424	3243	3472	2818	4513	722	2945	4541	2356	664	993	423	1717	2613	503	1586	4457	593	3369	2755
99_Pubertal growth (female)	99_Pubertal growth (female)	25	423	1	3733	3296	4091	1392	2707	4682	2577	1006	2553	3691	2591	788	2430	2683	3014	4030	4049	2514	423	1703	1282	664
4739_Cingulum (cingulate gyrus) radial diusivities	4739_Cingulum (cingulate gyrus) radial diusivities	25	423	1	3772	1169	4662	2230	3030	638	3967	698	4454	3099	4216	3617	3568	732	3222	4526	1691	3814	1674	4498	423	717
1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	25	423	1	1205	2029	1930	1617	3001	3795	1578	2810	1177	3391	3969	3363	2350	3868	1108	3186	2158	3300	2148	2035	4293	423
1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	25	424	1	424	3975	612	2743	3943	1401	553	3876	2744	3823	1591	2735	2406	3028	4063	2110	2434	4468	2340	2251	2868	4376
4145_Pulse pressure	4145_Pulse pressure	25	424	1	846	4424	424	3609	1854	4005	1172	4467	520	760	2389	2576	1039	3603	498	1438	2417	818	1619	3391	1775	3872
1095_Diastolic Blood Pressure	1095_Diastolic Blood Pressure	25	424	1	858	3825	4525	3170	2610	3368	593	4602	424	713	1150	747	3256	3593	3479	2251	2955	1054	2575	1882	2170	2545
492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	25	424	1	928	2343	4608	957	4370	2540	2177	1690	2520	3301	3463	2008	2661	4620	651	3306	1266	3583	4317	2786	424	3650
545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	25	425	1	1609	1267	425	1438	1201	3205	2158	4301	1027	2081	2926	618	1493	790	3953	2826	4443	2184	2794	1614	2945	2945
630_Xenobiotics::Food component, Plant::ergothioneine	630_Xenobiotics::Food component, Plant::ergothioneine	25	425	1	1073	2493	1261	2825	425	4112	3167	3366	1619	438	2909	1074	3448	1902	2292	962	4022	4161	3812	4022	4722	1472
2479_CTSV - Cathepsin L2	2479_CTSV - Cathepsin L2	25	425	1	2355	3695	4401	2617	799	1494	2034	3862	4315	2925	4141	3483	1700	425	748	1879	1667	3129	1737	2309	1375	493
3470_Impedance measures - Trunk fat-free mass	3470_Impedance measures - Trunk fat-free mass	25	425	1	3963	2165	635	4122	4655	2096	2652	1386	1040	3901	4499	3407	2979	3877	4151	4412	2994	425	1227	3752	4648	1146
3791_Ease of getting up in the morning	3791_Ease of getting up in the morning	25	426	1	426	4718	2089	758	2001	4265	1523	852	2049	1498	4530	1983	3134	3661	2180	888	4346	1921	4385	1456	4105	1020
2926_SELL - L-Selectin	2926_SELL - L-Selectin	25	426	1	1109	1555	426	2015	1627	1569	1292	2903	4015	2974	1458	3204	1828	2691	2282	4693	3384	3054	4125	3348	1070	3706
2988_DPT - Dermatopontin	2988_DPT - Dermatopontin	25	426	1	4274	2713	899	3941	1811	426	2625	1348	2292	3667	1235	1145	3377	1987	4565	2484	2280	3975	1261	4507	2995	3952
2925_SFN - 14-3-3 protein sigma	2925_SFN - 14-3-3 protein sigma	25	426	1	3985	2101	3768	4241	3810	3556	1025	2466	1595	4380	1938	3321	1705	426	4539	2174	4084	1166	556	1085	2419	2827
4452_Left isthmus cingulate	4452_Left isthmus cingulate	25	426	1	2489	4276	561	1065	1322	1703	758	4058	3381	1689	1538	1966	428	1622	1189	3584	3460	1666	4361	1619	426	1795
782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	25	427	1	1094	599	3113	427	2669	3664	4172	3606	1976	4570	3884	680	734	4540	2636	1459	1991	1941	3982	3311	2276	3107
118_Extreme Height	118_Extreme Height	25	427	1	2664	3844	1145	3845	861	4212	1315	2450	3524	4506	427	4449	1235	1554	2861	1385	805	4110	608	4690	4635	4221
366_Amino acid::Alanine and aspartate metabolism::aspartate	366_Amino acid::Alanine and aspartate metabolism::aspartate	25	427	1	2189	3669	4606	2136	4162	2785	1597	3026	2119	3102	1405	3069	427	615	3230	932	2924	667	3204	3611	3972	4420
2617_KDR - Vascular endothelial growth factor receptor 2	2617_KDR - Vascular endothelial growth factor receptor 2	25	427	1	3900	3023	3809	1416	592	4496	3554	4130	1405	1833	4320	721	2893	696	4730	1746	427	654	557	2529	1368	2424
1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	25	427	1	3677	3089	1649	3385	2340	856	3755	2192	4239	2047	434	3162	4145	3440	3025	1630	1661	2732	4397	3228	1372	427
4512_Brain stem	4512_Brain stem	25	428	1	2143	3673	2104	428	1896	4539	1556	3267	3290	2133	3262	2793	945	4672	4178	1863	4226	551	1346	4472	4686	1302
4386_Epithelial ovarian cancer (Borderline serous and mucinous)	4386_Epithelial ovarian cancer (Borderline serous and mucinous)	25	428	1	3162	2496	3980	1132	428	2519	3928	4311	3866	663	4564	1527	2383	4510	3195	813	2237	4477	2590	2832	1106	2711
2483_GZMH - Granzyme H	2483_GZMH - Granzyme H	25	428	1	4038	481	4226	4456	4095	428	751	3153	455	854	1601	3119	1639	3759	2312	1679	3216	2644	3369	1970	4306	4721
1988_Age at death (FBAT, adjusted for multivariable)	1988_Age at death (FBAT, adjusted for multivariable)	25	429	1	470	3466	1458	429	471	2967	1302	1286	2653	1996	4418	836	2727	2027	2367	3258	1343	4342	1929	1615	3949	3077
2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	25	429	1	2154	3760	1097	3853	1212	2161	1937	3447	1809	2355	429	1312	4505	2640	3227	2522	3177	4226	2710	464	4034	2212
1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	25	430	1	1078	2061	3816	3660	692	2244	4397	3036	4339	430	3364	3250	4634	3604	4225	832	1093	2339	4659	3345	4212	3958
4511_Right basal forebrain	4511_Right basal forebrain	25	430	1	2085	810	2901	2555	3779	2900	1511	1549	785	3784	2174	4251	430	3032	1645	2407	3341	3548	3768	4616	1707	1240
3149_CKAP2 - Cytoskeleton-associated protein 2	3149_CKAP2 - Cytoskeleton-associated protein 2	25	430	1	3918	860	732	1593	1161	3280	595	3413	1728	3409	2981	3185	3398	1210	1831	4446	1222	2616	544	3058	430	2643
717_::::X-11529	717_::::X-11529	25	431	1	431	1347	481	3235	4429	2805	3013	1330	4710	1297	813	960	3221	534	2254	2438	906	3647	3539	2362	2696	2858
3721_Frequency of memory loss due to drinking alcohol in last year	3721_Frequency of memory loss due to drinking alcohol in last year	25	431	1	4265	3102	3849	4256	431	618	3735	929	4268	4630	3622	1484	2570	3567	4376	632	4185	4308	1490	2420	3862	1770
1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	25	431	1	4579	3076	751	3876	3664	1768	1382	1959	1737	1943	4189	907	1256	4259	431	4020	1306	4658	997	777	4471	1576
4653_Corticospinal tract fractional anisotropy	4653_Corticospinal tract fractional anisotropy	25	432	1	4341	4229	4134	3173	3435	3646	3716	2560	432	3141	578	4065	3160	3325	478	1814	2506	3714	2393	3606	3090	885
1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	432	1	646	3288	1278	2719	2596	1066	1778	1884	3041	2918	2628	3211	3442	2704	2858	1532	1893	432	1085	3403	4473	4408
394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	25	433	1	3897	433	3852	4179	1017	1161	4503	3846	3961	1272	1115	2974	3422	2066	2746	4048	535	4284	4617	4404	1223	2265
1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	25	433	1	4659	2301	1678	656	2205	1480	433	1403	3739	4699	1124	945	3602	796	2615	3906	1024	2988	1902	971	884	2395
504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	25	433	1	1565	4158	1727	3945	2690	4087	570	1702	4216	4711	1520	433	3643	4243	3833	4350	4445	762	2048	3231	4011	2105
2204_IL22 - Interleukin-22	2204_IL22 - Interleukin-22	25	433	1	847	1160	4101	4717	776	1162	574	3388	924	1269	2343	3222	3288	4124	4043	2470	4231	3179	433	494	1107	2313
1178_Insomnia	1178_Insomnia	25	434	1	434	3034	2032	3265	823	3708	1185	2646	708	1333	554	1314	2826	1703	1033	851	4170	3841	1592	1224	4475	1049
1225_Mean Thalamus	1225_Mean Thalamus	25	434	1	781	2435	4074	1039	587	3285	2396	2958	2136	4549	888	1649	860	460	3065	434	505	4275	2097	2327	4091	4367
1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	25	434	1	1433	1734	938	4000	847	782	2686	1631	843	450	1127	1981	2055	4224	684	649	3569	3590	2799	586	434	4731
2326_CCL23 - Ck-beta-8-1	2326_CCL23 - Ck-beta-8-1	25	435	1	435	1861	3100	3415	3722	4254	1886	2326	2565	1768	1325	4489	3136	1601	2080	2952	2020	3573	2343	4236	4402	2589
926_Phospholipids in medium VLDL	926_Phospholipids in medium VLDL	25	435	1	1874	3899	3194	3549	435	1843	2475	1930	4481	690	1949	668	2380	2273	448	880	993	1804	3684	2147	4735	718
4242_Rapid automised naming of letters	4242_Rapid automised naming of letters	25	435	1	4522	4531	3906	2078	2614	4185	1876	435	2543	2972	4004	1806	3710	3642	598	1632	957	701	1857	2905	633	624
3597_Non-cancer illness code, self-reported: hypertension	3597_Non-cancer illness code, self-reported: hypertension	25	435	1	3607	910	3602	4561	3624	3472	812	2534	435	1790	2862	1512	1230	1873	1270	2247	2314	4452	4272	3515	3692	3572
629_Xenobiotics::Drug::salicyluric glucuronide*	629_Xenobiotics::Drug::salicyluric glucuronide*	25	435	1	1014	1318	2581	2488	4410	2004	2932	2667	2954	3833	4557	2304	3224	3332	2345	4152	3671	630	435	1940	4538	2064
3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	25	436	1	3633	436	715	1410	2344	2682	1736	1786	4145	3995	3937	4695	2507	1436	4487	4324	854	4593	3638	1525	2596	1308
177_Waist circumference (female, adjusted for BMI)	177_Waist circumference (female, adjusted for BMI)	25	436	2	996	1657	1964	754	2061	1187	4117	436	1996	1141	2867	4531	2023	1577	1461	739	3861	3212	1023	4336	2342	448
463_Energy::Oxidative phosphorylation::phosphate	463_Energy::Oxidative phosphorylation::phosphate	25	436	1	3288	3609	788	3144	1974	4262	3003	1394	1155	436	2600	3749	2145	945	2368	1757	4082	1923	1286	4165	3993	3417
1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	436	1	4060	2297	3488	3245	2819	3898	4174	3130	2092	3406	436	3544	3566	3820	2762	3699	4708	3470	1294	1751	956	4074
3643_Illnesses of mother: Chronic bronchitis/emphysema	3643_Illnesses of mother: Chronic bronchitis/emphysema	25	436	1	4443	1913	2411	2091	2261	4681	805	1996	887	1707	2204	3530	4040	436	3005	835	871	1067	3918	768	3728	778
3492_Coffee type: Decaffeinated coffee (any type)	3492_Coffee type: Decaffeinated coffee (any type)	25	436	1	3093	3476	2394	1328	1609	2264	781	1058	1515	4583	1191	4684	1445	1066	1505	1299	3356	2380	4640	2295	436	2475
3467_Impedance measures - Arm predicted mass (left)	3467_Impedance measures - Arm predicted mass (left)	25	436	2	1408	1909	904	2953	4390	993	4315	4099	1522	4204	4140	2688	4387	4723	3876	4704	4322	478	662	2992	3129	436
2866_KNG1 - Kininogen-1	2866_KNG1 - Kininogen-1	25	437	1	3721	4488	437	589	1464	2204	1159	2104	3942	1842	4181	2636	823	4492	3272	457	1767	3517	588	4309	1681	4424
4212_Glycine level (male)	4212_Glycine level (male)	25	437	1	4544	2114	3433	437	1514	1950	466	3865	3605	4308	2802	1857	487	813	2045	2737	4252	1793	495	2724	4430	2931
4547_Left caudal middle frontal	4547_Left caudal middle frontal	25	437	1	1237	2641	576	905	515	4288	437	4609	4403	2480	3175	454	4178	3899	1817	814	2738	4514	4573	3573	4072	1917
486_Lipid::Carnitine metabolism::stearoylcarnitine	486_Lipid::Carnitine metabolism::stearoylcarnitine	25	437	1	1366	478	4338	647	1060	787	1587	3225	4115	3052	1038	3946	437	2003	1772	1875	728	4638	4250	4043	4312	1596
1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	25	437	1	3363	870	1616	2841	4574	3101	3210	1789	3188	2346	4040	2684	778	4534	437	3661	930	989	1994	3138	3616	2934
1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	25	437	1	4406	4281	2066	3666	3203	2231	3144	4420	1960	2247	3964	3467	2261	1912	1290	3566	1632	437	4599	1144	4047	3970
3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	25	438	1	1777	2356	1592	2262	4288	2650	2417	2125	3646	3969	3832	4128	2076	2789	1670	3702	438	4491	4022	2725	1522	2952
1285_Visceral fat by CT (GEE, adjusted for age and sex)	1285_Visceral fat by CT (GEE, adjusted for age and sex)	25	438	1	1285	3505	3533	699	4446	828	952	1317	3477	3338	3852	1157	636	1805	4482	2008	642	2185	438	2073	2732	696
1839_Neck width (GEE, female, adjusted for age)	1839_Neck width (GEE, female, adjusted for age)	25	438	1	4087	1919	2676	849	2072	3960	2707	2745	762	1513	4201	1363	3956	1039	1214	1285	4734	593	4197	438	2892	3306
4021_Double eyelid	4021_Double eyelid	25	439	1	3275	689	2035	2902	439	1260	1323	1279	1041	3040	2616	4421	804	3962	444	1262	1778	514	2265	756	1965	2195
2142_ICAM3 - Intercellular adhesion molecule 3	2142_ICAM3 - Intercellular adhesion molecule 3	25	439	1	2726	3779	4409	3215	3000	439	1601	4150	2417	1126	3511	3343	3974	4071	4470	1784	2268	3384	1935	932	2030	1122
3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	25	439	1	2394	783	1742	1381	753	4067	439	797	4458	4257	4453	3750	2394	3080	2116	1026	2342	3236	1545	1250	1262	3389
2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	25	439	1	703	4688	1865	4295	4667	2710	3113	439	3891	4057	1475	1086	2900	1348	1031	1837	4225	4270	4531	4564	3775	4239
536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	25	439	1	3860	4288	1582	3669	1141	792	1443	3522	4736	439	3866	4503	1774	1782	2672	1458	2500	3669	1102	4737	2427	2413
1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	439	1	3627	1071	4246	3530	3864	4619	2492	3518	4068	1366	1581	3671	1693	439	2480	1590	2207	2474	1002	548	4160	1629
106_Tanner scale (male)	106_Tanner scale (male)	25	439	1	2676	4224	4660	1588	3366	2220	3937	3937	4054	784	3887	4366	4405	3101	4206	2502	1438	3524	1894	2180	439	1335
3496_Hair colour (natural, before greying): Red	3496_Hair colour (natural, before greying): Red	25	440	1	3814	2006	3599	3936	4294	4252	440	795	2093	2154	2684	4323	4328	4395	744	4178	1147	2663	2688	2476	1455	2141
1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	25	440	1	2467	2652	1328	1663	1433	2498	904	4120	440	827	722	1435	2600	590	3877	657	2465	3860	2872	3738	2588	1167
1201_Focal epilepsy	1201_Focal epilepsy	25	440	1	2516	1273	3805	4206	3118	1465	3384	3140	2380	3537	2947	827	2245	3021	2358	2836	3756	3792	440	2944	3358	2370
312_CD4nv:%Th1	312_CD4nv:%Th1	25	441	1	2108	1335	2149	759	441	3326	3441	441	4194	4501	2258	2051	2953	1458	2671	541	2181	2760	842	2094	770	4703
1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	441	1	4315	3903	2519	4021	3658	3948	825	2926	2556	2262	1223	441	4494	3492	3311	4491	4425	3429	1103	500	1311	1742
1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	25	441	1	1126	2154	2437	3779	2190	3267	1274	3308	3943	2057	3999	2694	441	1893	2187	3305	3766	1948	2435	2066	1688	3730
427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	25	441	1	1231	571	555	860	2558	4033	3275	2243	3865	2570	4368	2214	2934	2340	4252	3386	3122	1578	441	2751	3422	2302
2192_FGF18 - Fibroblast growth factor 18	2192_FGF18 - Fibroblast growth factor 18	25	442	1	442	1857	3861	2338	2415	2441	3232	2419	728	1215	600	4509	3069	2392	4619	1621	3241	1782	1483	4509	4610	3529
1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	25	442	1	2545	3451	442	1386	3356	1711	864	2538	1929	1002	482	1342	1186	4332	945	1668	2370	4339	4065	3863	4522	1256
3891_Mean platelet volume (three-way meta)	3891_Mean platelet volume (three-way meta)	25	442	1	2562	986	4173	4628	1680	442	3401	2149	3176	528	606	1474	1834	1547	3588	567	4311	579	1162	3843	2451	2263
4289_PEF	4289_PEF	25	442	1	3332	4560	3520	1229	667	3154	2047	3443	2376	3015	3392	823	513	3243	1074	442	3681	4475	2373	2031	4377	577
392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	25	442	1	1468	2109	2123	3214	875	4291	2410	4208	2725	2164	3461	2722	4430	4528	4598	2056	1300	442	4312	3817	4617	1954
2620_PPP3R1 - Calcineurin subunit B type 1	2620_PPP3R1 - Calcineurin subunit B type 1	25	443	1	3176	1061	443	1987	4190	1194	962	2441	4285	3715	1782	718	1687	3428	3335	4460	2704	1131	1395	4608	3079	2817
994_Interleukin-7	994_Interleukin-7	25	443	1	3256	3958	1155	443	3773	4340	4433	3484	3060	3254	749	913	1097	1030	1857	4072	3107	4144	2222	3934	2890	3421
1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	25	444	1	444	4459	1065	562	2199	1127	4081	1226	4203	3583	3021	4517	3045	1553	2968	2464	3847	4396	2861	2437	4690	3597
2411_ASAH2 - Neutral ceramidase	2411_ASAH2 - Neutral ceramidase	25	444	1	2332	3887	3320	3998	3390	444	3012	2366	3768	4002	1355	1365	521	3173	4508	1831	4648	3160	4130	918	3484	527
196_Estimated glomerular filtration rate based on serum creatinine	196_Estimated glomerular filtration rate based on serum creatinine	25	444	1	1316	3062	3829	3365	3398	473	730	2874	4510	927	3740	1771	2907	4107	3523	4114	4406	2559	444	4394	3576	1427
379_Amino acid::Glycine, serine and threonine metabolism::betaine	379_Amino acid::Glycine, serine and threonine metabolism::betaine	25	445	1	791	2966	1046	1542	795	3046	445	3855	2469	793	2441	3265	3569	4619	2749	1483	4229	2877	4685	4424	1354	2384
2496_REN - Renin	2496_REN - Renin	25	445	1	1066	4655	3648	980	4455	1364	986	4009	2280	3100	3550	2357	699	4403	2145	1327	2003	4446	445	2536	866	3294
403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	25	446	1	1300	446	3896	2928	2729	1190	983	997	3261	3819	1085	4488	1785	2432	2690	3558	1234	3747	609	4167	870	4041
89_Infant head circumference	89_Infant head circumference	25	446	1	4540	4155	1600	446	2096	2290	2235	1132	3086	1409	2911	2466	1302	3526	1382	1692	3851	4403	3095	3109	4232	520
2603_MMEL1 - Membrane metallo-endopeptidase-like 1	2603_MMEL1 - Membrane metallo-endopeptidase-like 1	25	446	1	1114	1446	3082	3052	3029	3590	3857	446	2403	834	3890	3320	3390	3905	3738	3065	1558	1590	694	2898	2524	1343
1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	25	446	1	4561	1560	749	4310	2778	2355	2380	2055	4390	446	3460	3108	4716	1404	2795	1607	2548	4397	2813	3940	2284	2662
2122_IL6ST - Interleukin-6 receptor subunit beta	2122_IL6ST - Interleukin-6 receptor subunit beta	25	446	1	3667	2596	3654	3084	3570	1923	2981	3844	2004	4073	1772	3752	3190	3583	1942	791	446	4004	4651	2642	3308	1857
659_::::X-04494	659_::::X-04494	25	446	1	2705	4691	1284	4423	1053	1348	1614	1108	1137	1439	2594	1022	1023	2475	4347	3961	1764	446	4717	1867	678	1416
2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	25	446	1	1108	3016	2707	2391	1905	1136	4140	4034	2898	4509	3042	1320	1822	3969	4582	2090	3387	4648	446	3614	3953	2728
2448_IGFBP7 - Insulin-like growth factor-binding protein 7	2448_IGFBP7 - Insulin-like growth factor-binding protein 7	25	446	1	2915	4627	1542	4160	4640	3062	1805	2872	3609	1026	524	2293	992	764	3018	3447	3498	2972	707	3842	446	2293
1904_Hippocampal volume (FBAT, adjusted for multivariable)	1904_Hippocampal volume (FBAT, adjusted for multivariable)	25	446	1	750	1301	2758	818	2565	2600	4145	822	1107	1395	536	4294	4645	2489	3199	2139	1854	3896	459	3622	747	446
3865_Red cell distribution width (two-way meta)	3865_Red cell distribution width (two-way meta)	25	447	1	3253	447	3297	3745	1372	1244	4088	522	3027	4251	4424	3569	3987	1117	3722	4486	1466	3320	591	4087	2055	889
4006_Osteoarthritis (hospital diagnosed)	4006_Osteoarthritis (hospital diagnosed)	25	447	1	1665	2924	588	4504	3082	3224	1180	2513	3554	4504	837	447	3203	3462	2907	2637	2603	4237	3878	4619	3069	496
3849_Lymphocyte percentage of white cells (two-way meta)	3849_Lymphocyte percentage of white cells (two-way meta)	25	447	1	2452	1495	477	1900	4181	1500	3713	3852	3485	2784	3117	2164	447	1114	3383	2529	1496	2050	1174	3122	3356	1831
3065_AMICA1 - Junctional adhesion molecule-like	3065_AMICA1 - Junctional adhesion molecule-like	25	447	1	3507	3151	4438	2068	3560	3997	1938	1032	3454	4656	1989	4742	849	447	3061	3625	1674	4168	4139	2314	4733	1207
2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	25	447	1	1541	839	4307	1905	4293	1351	4669	3027	3893	3238	2116	2277	465	3272	447	1358	1163	1002	762	2983	1907	3435
2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	25	447	1	1678	4312	2781	1598	1323	4284	4123	1547	1388	2325	4701	4645	2188	2715	2347	447	2922	2102	3384	3510	4339	867
4060_Estimated glomerular filtration rate based on cystain C	4060_Estimated glomerular filtration rate based on cystain C	25	448	1	448	467	609	1014	3285	3413	3293	2227	654	1905	1815	3399	3834	3208	2568	1274	4310	904	2907	961	4465	3465
1602_tPA (at exam 5, FBAT, adjusted for age and sex)	1602_tPA (at exam 5, FBAT, adjusted for age and sex)	25	448	1	4402	4118	3477	448	870	3165	4048	2130	3139	4431	2989	4027	3408	2347	4104	466	552	1283	4621	3131	2162	1080
743_::::X-11876	743_::::X-11876	25	448	1	3983	2346	1811	3977	448	4519	921	1252	4221	2832	4153	4058	2635	906	1676	992	4733	2762	851	1578	1403	769
4256_Sleep midpoint	4256_Sleep midpoint	25	448	1	3217	4285	4659	3541	3604	448	1870	2052	3597	815	711	4493	3464	4302	4391	3300	4637	2790	2711	3249	1967	4454
2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	25	448	1	4067	949	3828	3451	2850	3737	448	4425	3650	4507	2017	2406	829	3403	1216	4415	1924	4551	677	1220	3061	3890
3620_Treatment/medication code: amlodipine	3620_Treatment/medication code: amlodipine	25	448	1	1925	2685	3451	2826	2493	2170	1900	2421	2097	4686	1465	448	4503	2900	1414	3921	4662	1317	4368	947	673	2229
1031_Neck Width (GEE, adjusted for multivariable)	1031_Neck Width (GEE, adjusted for multivariable)	25	448	1	1811	1479	4561	2635	3627	4470	1031	3310	593	4130	4632	2584	3129	448	3307	3805	3751	2202	4395	2373	2300	3472
2870_CLEC11A - Stem Cell Growth Factor-alpha	2870_CLEC11A - Stem Cell Growth Factor-alpha	25	449	1	4642	449	1283	3754	2168	2305	585	4533	3061	3876	4191	1949	2565	1963	4566	2753	2190	3325	1112	4102	2543	2985
1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	449	1	2081	2742	1227	2655	962	1518	1731	2128	4077	2700	2493	4624	1740	1221	3050	3203	3566	3397	3030	3516	449	3803
2664_FGFR2 - Fibroblast growth factor receptor 2	2664_FGFR2 - Fibroblast growth factor receptor 2	25	450	1	450	4335	1571	4353	2302	1623	2408	3530	906	4738	3226	4073	3785	3806	2901	3938	4409	1214	2043	4581	2032	2127
3259_Major dietary changes in the last 5 years	3259_Major dietary changes in the last 5 years	25	450	1	2652	2896	1720	2023	1857	3616	544	3751	2311	3378	490	4228	1170	4134	450	695	3903	4493	2935	2501	2103	3201
1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	450	1	1129	2675	1302	4164	2961	3554	4054	2280	3180	4638	1661	1260	3455	3479	889	1314	857	3682	450	3898	2792	2972
2365_ULBP2 - NKG2D ligand 2	2365_ULBP2 - NKG2D ligand 2	25	450	1	2523	1860	2502	4245	2561	2607	2511	2711	4615	1593	3848	1165	768	1131	3351	2240	1527	1757	2281	3744	450	689
3796_Depressive symptoms	3796_Depressive symptoms	25	451	1	1174	788	3407	3290	3508	2296	2194	1967	586	451	3787	4292	4661	4048	3977	4517	4309	3086	4152	4375	3868	1869
508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	25	451	1	3978	1251	4697	591	3632	1791	2614	3596	1967	4436	4124	2153	3010	3522	2156	451	3962	4655	1094	4021	4100	3481
2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	25	451	1	792	2126	1235	1299	1488	2838	1943	1137	4061	3385	3173	1645	2085	525	546	636	1735	451	925	4278	1233	2337
3295_Guilty feelings	3295_Guilty feelings	25	452	1	881	1846	2068	452	2680	4641	1600	2896	1945	2466	3696	4397	4240	2792	1859	3557	4227	484	3964	3933	1992	3855
2088_CDH1 - Cadherin-1	2088_CDH1 - Cadherin-1	25	452	1	2225	4595	4724	3448	452	1543	3088	1925	2439	3193	3314	609	3274	3140	1249	532	2842	2895	4068	2702	2313	3807
1042_Shaft Width (FBAT, adjusted for multivariable)	1042_Shaft Width (FBAT, adjusted for multivariable)	25	453	1	553	2430	453	4417	2776	3881	1712	1624	2606	1957	1846	2872	457	4277	1660	2684	2714	1242	4412	1159	2227	4484
3432_Symbol digit substitution test - Number of symbol digit matches attempted	3432_Symbol digit substitution test - Number of symbol digit matches attempted	25	453	1	1213	4438	3444	1036	4415	4164	1358	2267	2804	1158	2791	1485	4362	2841	453	3947	2401	2520	2476	3587	2936	3951
103_Late pubertal growth (male)	103_Late pubertal growth (male)	25	453	1	1755	4032	3566	4551	880	1502	2797	1047	1500	4019	626	3382	2499	4470	1867	453	1842	3087	3592	513	3407	3047
476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	25	453	1	2395	1744	1686	1642	4494	4209	764	526	874	4126	629	1408	2726	1206	3152	4699	3057	639	806	453	4626	3543
4009_Osteoarthritis of hip or knee (hospital diagnosed)	4009_Osteoarthritis of hip or knee (hospital diagnosed)	25	454	1	3632	1428	454	1213	1625	932	2925	4273	2991	4454	4437	4060	655	3129	3002	3819	3472	679	4281	3337	2334	2538
2428_CA10 - Carbonic anhydrase-related protein 10	2428_CA10 - Carbonic anhydrase-related protein 10	25	455	1	3930	2768	1020	3169	2779	1528	3787	3822	2199	4485	1462	455	4103	3488	849	3928	4740	3616	4549	2723	3151	3835
1144_Disposition index (adjusted for BMI)	1144_Disposition index (adjusted for BMI)	25	455	1	4205	3755	2074	4455	4609	3763	2668	1178	3235	3482	4126	4518	2992	1809	2993	3013	2614	4555	455	1094	2914	4626
4194_Systolic Blood Pressure	4194_Systolic Blood Pressure	25	456	1	588	4378	1660	3326	2545	456	477	3916	816	2879	3273	1802	1962	3812	629	3952	3247	2882	3927	1333	3530	4270
784_::::X-12544	784_::::X-12544	25	457	1	2276	1522	457	3435	4376	3652	2244	3898	4449	4687	2028	4582	4244	3169	3297	3925	3257	1237	3850	2376	3443	1082
1189_Aortic-valve calcification	1189_Aortic-valve calcification	25	458	1	2107	787	4109	2038	4344	3953	458	1641	3500	1525	3816	3034	4386	2249	1655	3175	3945	2453	3965	1772	3859	3399
1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	25	458	1	1806	4740	2720	3888	634	2053	3646	3714	458	2153	4242	4029	3341	3297	2446	627	4595	3709	3774	4050	2887	1584
3269_Breastfed as a baby	3269_Breastfed as a baby	25	458	1	1198	3262	3055	3342	3438	2590	1479	3566	1719	458	4106	4146	3313	1132	1243	2304	4079	1198	2003	3390	1928	1722
2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	25	458	1	3495	1746	3107	2612	3234	1833	2079	3187	3445	3929	3854	3126	3113	458	1565	833	4276	2361	4707	2712	2788	3260
2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	25	458	1	3950	4010	3614	1950	4366	2069	3931	491	505	2109	1409	1223	632	2471	458	4170	3383	3227	3263	1853	4250	3194
2232_XRCC6 - X-ray repair cross-complementing protein 6	2232_XRCC6 - X-ray repair cross-complementing protein 6	25	459	1	4420	1154	3990	4728	2100	3034	459	3772	4460	2352	1333	4577	4063	4417	1143	3498	3342	3324	2927	4522	3800	2865
3155_KRT18 - Keratin, type I cytoskeletal 18	3155_KRT18 - Keratin, type I cytoskeletal 18	25	459	1	3654	4031	3175	1137	1172	2193	840	495	4043	2392	459	4326	471	1518	4433	1965	2995	531	3922	3996	4490	4246
826_::::X-13658	826_::::X-13658	25	459	1	1210	1098	2784	1910	3977	3261	2286	2752	1243	2498	4726	459	2524	1812	2822	1642	3042	4327	2819	698	1213	3257
4279_FVC	4279_FVC	25	460	1	3506	1954	3625	2689	3770	1949	2715	1643	4301	944	1738	3184	670	2091	4536	2955	4597	3699	460	1563	759	894
1180_Insomnia (female)	1180_Insomnia (female)	25	461	1	4030	4644	4198	461	1860	4487	4092	3764	2867	2639	3865	770	1195	1335	2386	2005	3524	3662	1341	916	4501	3865
1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	25	462	1	1080	462	2027	3948	2149	4715	3942	1262	491	851	4366	1295	3977	1454	1020	1319	4618	4393	4240	2914	3681	3809
4595_Right pericalcarine	4595_Right pericalcarine	25	462	1	4191	1640	3665	2241	3765	4520	2986	2793	822	4423	1678	462	2469	3948	4474	1238	4556	4190	3247	1961	3510	999
1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	25	462	1	3736	2608	871	3055	735	715	4633	734	2821	2517	1765	2916	3039	3165	4198	462	4220	2674	2705	2056	784	677
4067_Cognitive performance	4067_Cognitive performance	25	462	1	4682	4272	2664	1455	4560	3068	4366	2931	1494	2231	1869	2650	4509	3079	3431	4167	1747	1092	4099	462	3798	614
665_::::X-05907	665_::::X-05907	25	462	1	3466	4728	2983	3962	3666	4065	3330	1742	4455	4390	4508	3542	2652	4551	2900	4228	4279	3386	932	3621	1610	462
2612_RBP4 - Retinol-binding protein 4	2612_RBP4 - Retinol-binding protein 4	25	463	1	1086	463	1379	4075	2910	4138	2290	3928	4658	3552	942	3053	2952	4577	1245	3949	2979	4729	2069	1241	2181	2532
2931_IL1A - Interleukin-1 alpha	2931_IL1A - Interleukin-1 alpha	25	463	1	815	3462	1289	4614	2267	4478	966	3516	479	3924	496	841	3432	1640	1017	749	3704	3109	463	4147	3294	4039
2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	25	464	1	3750	464	3177	1492	1867	3993	2744	3047	4533	1783	2665	3667	2113	2164	2590	2199	3416	3960	1042	3952	781	3640
2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	25	464	1	2911	2556	2814	1397	464	1709	4190	3904	1102	3880	2984	3840	881	4030	4079	542	4318	2032	1962	3398	4203	1433
420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	25	464	1	539	2149	2742	559	2167	464	1001	3458	1707	3662	1533	1640	4079	4628	3470	2216	4053	3821	2555	1571	1362	897
2812_CST2 - Cystatin-SA	2812_CST2 - Cystatin-SA	25	464	1	4717	1191	1674	4411	1973	1486	4083	4372	2751	2951	564	1259	2603	2990	464	3595	2950	1091	3928	3106	1414	645
2828_IFNL2 - Interferon lambda-2	2828_IFNL2 - Interferon lambda-2	25	464	1	1462	1695	4354	1700	534	2124	3208	1186	2726	610	2237	2738	3770	4155	1755	464	1827	3805	809	2252	535	3272
2733_CFB - Complement factor B	2733_CFB - Complement factor B	25	464	1	1150	692	4075	2732	1509	4631	3804	2295	2463	4346	1681	1273	4444	3672	4523	1041	4296	4606	4246	2705	1836	464
2740_IL17D - Interleukin-17D	2740_IL17D - Interleukin-17D	25	465	1	1937	465	3534	1929	2154	754	2463	2799	965	3668	2880	3775	4305	3723	2501	4591	807	3530	619	3879	1426	2809
561_Lipid::Medium chain fatty acid::undecanoate (11:0)	561_Lipid::Medium chain fatty acid::undecanoate (11:0)	25	465	1	3229	4397	465	4037	3841	3319	1342	3594	2995	478	2825	2533	4613	3509	3487	3219	4656	2907	746	588	3314	2457
3800_Total blood hemoglobin	3800_Total blood hemoglobin	25	465	1	3683	4352	859	1611	3614	3492	1893	2970	4717	2001	465	1347	2216	3120	2022	1058	3043	3902	3619	1859	1266	2832
2807_TKT - Transketolase	2807_TKT - Transketolase	25	465	1	2717	626	3418	515	2590	2173	3821	2092	3325	2647	3611	3084	3081	1313	523	1241	1415	465	1215	2553	2618	1462
983_Interleukin-13	983_Interleukin-13	25	466	1	3359	3827	1545	3662	4354	466	4588	3597	2507	2085	2337	1559	3715	3313	1247	3589	3283	2053	1489	2611	1132	3065
4409_Vaginal discharge: Metrorrhagia	4409_Vaginal discharge: Metrorrhagia	25	466	1	2603	3004	4178	731	4544	4015	1681	3856	2854	3963	4631	2741	1179	4364	466	3461	1677	4332	2147	1130	3601	3874
1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	25	468	1	4619	1145	1813	941	3086	1714	2999	2603	2616	2584	3880	468	1923	3512	4171	2463	1566	4207	4436	3181	3522	1035
1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	469	1	469	4194	4183	686	3336	2470	1434	1077	1883	1497	4162	1232	4291	4459	3407	3680	1301	4029	2141	4744	3560	3234
497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	25	469	1	2295	1086	469	3289	3397	3599	2523	3636	1485	3194	967	1789	689	472	1974	3667	4242	2937	4079	3834	4071	3626
2231_KLK8 - Kallikrein-8	2231_KLK8 - Kallikrein-8	25	469	1	2988	4047	4465	469	3374	612	3631	938	3888	1961	1068	3732	2277	1176	4575	3008	2981	912	4477	3258	4125	1937
4486_Right lingual	4486_Right lingual	25	469	1	3587	4279	3040	1687	4120	4567	2248	1883	2538	1077	2265	4572	4730	2523	2012	2490	3839	1044	469	1730	469	2116
2290_CLEC11A - Stem Cell Growth Factor-beta	2290_CLEC11A - Stem Cell Growth Factor-beta	25	470	1	3105	470	1057	3639	1794	4036	566	1515	552	4534	1801	4109	3297	1856	2357	914	3183	2048	3997	3353	2893	4237
2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	25	470	1	476	1220	2862	1501	4343	4701	1037	3162	2027	4635	4042	2185	2105	2149	2078	3131	3205	470	2379	3293	4046	743
1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	25	470	1	4319	1728	4601	3685	2400	2696	3236	3550	1152	1588	2719	3745	4197	3151	1307	1463	3991	1646	1035	4530	470	4637
1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	25	471	1	471	1218	1340	2586	2155	3712	3732	2876	3461	4001	4610	4171	1294	3197	4229	4238	1011	2729	4243	4331	4431	3580
3749_Traumatic events - Someone to take to doctor when needed as a child	3749_Traumatic events - Someone to take to doctor when needed as a child	25	471	1	3009	3002	3213	471	4167	3488	4186	878	3243	3642	2895	1765	2073	4058	3408	4729	1505	3437	2759	3369	2180	1904
378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	25	471	1	2886	2619	3707	3594	4482	3674	4550	2816	2456	1123	4506	3984	4388	4443	2335	4047	2511	471	3389	2789	3927	2705
3527_Transport type for commuting to job workplace: Cycle	3527_Transport type for commuting to job workplace: Cycle	25	471	1	4504	4072	858	1108	729	3705	4146	2813	2588	4340	909	699	2744	978	507	1614	3395	2531	471	896	3716	3533
96_Height SDS (female at age 10)	96_Height SDS (female at age 10)	25	472	1	1293	2207	4554	4365	472	3584	1307	2439	2527	4116	1611	2038	1617	2007	4367	600	1672	895	4737	4325	1071	2825
3562_Vitamin and mineral supplements: Vitamin B	3562_Vitamin and mineral supplements: Vitamin B	25	472	1	1034	2666	1901	2539	1447	3480	1973	472	3465	2200	4107	3564	1068	1242	734	4743	537	4591	2923	855	1717	4144
3567_Why stopped smoking: Illness or ill health	3567_Why stopped smoking: Illness or ill health	25	472	1	2622	4528	600	4684	2459	3444	2947	4546	1327	530	472	4579	1346	549	3295	1936	1992	4505	635	1357	743	3504
2289_PTHLH - Parathyroid hormone-related protein	2289_PTHLH - Parathyroid hormone-related protein	25	472	1	3361	2172	1878	1234	3817	3086	1175	1924	4728	3822	3098	472	692	2741	4577	3435	3071	4289	1895	2064	4382	2040
4390_Dysmenorrhea pain severity	4390_Dysmenorrhea pain severity	25	472	1	4604	3413	3521	1348	2760	1185	4624	4019	1246	4355	2987	4535	716	1816	3601	1354	1704	1204	472	3668	4632	3046
1003_Macrophage inflammatory protein-1 (CCL3)	1003_Macrophage inflammatory protein-1 (CCL3)	25	473	1	2132	1601	3206	3803	2830	1718	2875	4135	473	3618	4087	2276	1059	3550	3641	4624	3172	506	3490	2935	639	1077
570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	25	473	1	2145	2965	1864	1191	1967	2799	2232	3384	3881	2954	3693	1090	473	3626	1964	660	1152	4424	978	4380	3527	3663
2541_MPL - Thrombopoietin Receptor	2541_MPL - Thrombopoietin Receptor	25	473	1	3596	2731	1562	2667	3734	3494	1503	3371	3924	3523	2582	4257	1364	620	3799	3416	3245	1904	3477	4353	2132	473
1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	25	474	1	3077	1770	3468	1913	3372	1633	2329	1356	961	474	1466	1241	3880	3091	2867	3838	550	3471	1068	4219	2488	2315
1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	25	475	1	4238	1103	589	993	2562	475	2110	1819	1179	756	3749	3578	1112	1853	3089	2478	484	768	3870	1679	1640	947
229_mDC:%CD1c+	229_mDC:%CD1c+	25	475	1	1976	4448	4342	4391	552	2399	475	958	597	4358	3758	1341	1853	2430	589	516	4308	2296	3469	4300	2304	1764
585_Nucleotide::Purine metabolism, guanine containing::guanosine	585_Nucleotide::Purine metabolism, guanine containing::guanosine	25	475	1	1438	3619	3410	1766	2220	1581	1748	1338	1321	1399	475	994	2942	3813	838	2627	3298	2565	4078	1138	3884	2427
3914_Disc area	3914_Disc area	25	475	1	3118	923	3134	4229	1790	1488	1389	668	3264	2208	1011	1184	475	597	582	2281	3534	4143	1858	696	911	4492
3964_Gestational weight gain (offspring, early)	3964_Gestational weight gain (offspring, early)	25	475	1	1115	4097	2708	1956	3013	3495	1612	1297	4567	3614	1471	3171	903	1810	2269	1337	475	1859	3513	3147	2834	4687
2174_LAMA1 LAMB1  LAMC1 - Laminin	2174_LAMA1 LAMB1  LAMC1 - Laminin	25	476	1	4044	552	1681	655	3028	1454	712	1113	3846	1705	2844	476	3268	3111	578	3600	4527	3414	3675	2798	1550	810
1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	25	478	1	2264	501	4341	2308	2511	4248	1935	503	3297	963	478	3334	633	1763	3255	1153	568	624	898	2162	897	4359
667_::::X-06226	667_::::X-06226	25	478	1	1908	3944	2277	4536	3159	3168	3970	1281	1413	2366	3258	3447	3727	478	2752	3479	729	2832	1025	1636	4517	4602
4460_Left pars opercularis	4460_Left pars opercularis	25	478	1	4232	4708	1044	3911	986	3594	1594	1487	508	2791	3957	2498	3924	4449	2524	478	4188	1262	3867	3476	2993	2052
2590_MASP1 - Mannan-binding lectin serine protease 1	2590_MASP1 - Mannan-binding lectin serine protease 1	25	479	1	3150	1966	1762	812	2108	4476	1732	2253	857	539	1411	1811	4296	4497	1612	3985	479	2693	1919	2780	4263	4062
3353_Number of cigarettes previously smoked daily	3353_Number of cigarettes previously smoked daily	25	480	1	2231	3041	1009	4701	760	2960	1352	4628	2669	2714	1879	3600	3954	480	3971	2587	3810	3420	1944	3541	2907	3088
3409_Education - Qualifications	3409_Education - Qualifications	25	481	1	4206	2471	1743	2213	2626	1916	2778	3457	4087	481	2120	1721	4428	3084	4160	2935	2044	1907	515	568	986	3920
738_::::X-11849	738_::::X-11849	25	481	1	1223	972	1114	3860	3227	811	3250	2483	3353	2560	481	1345	4370	3045	1738	2608	3791	3090	3543	2581	4374	3434
1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	481	1	1161	4543	4701	3799	3032	1117	664	2294	3920	3483	1982	481	4027	3374	1013	4269	3803	3905	2026	3620	2858	1957
2053_Advanced adenoma	2053_Advanced adenoma	25	482	1	524	4696	482	1272	699	4481	2902	1335	3531	2131	3694	2643	1772	849	635	999	1404	4151	1384	3480	2477	3044
4690_Uncinate fasciculus axial diusivities	4690_Uncinate fasciculus axial diusivities	25	482	1	1967	4207	4437	2159	2573	2993	2498	1433	482	3764	1984	822	3072	4578	2820	1126	2812	2464	4568	3768	2111	710
2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	25	483	1	1766	717	1366	1364	2079	1282	2074	4648	4369	3724	3244	2459	3040	1904	1077	2252	483	4427	4173	4256	4608	4098
2262_CTF1 - Cardiotrophin-1	2262_CTF1 - Cardiotrophin-1	25	483	1	3560	850	2782	3293	1198	815	1290	732	2038	3645	2636	2710	1149	2698	4479	492	1925	4174	1026	1857	483	2012
1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	25	484	1	484	742	4072	1240	1235	2354	1857	4589	4532	1168	937	1139	1597	1389	921	3440	3660	1088	2895	2557	1050	543
564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	25	484	1	2605	3573	1700	1515	2591	2007	3808	3381	4312	4246	1112	4004	2431	484	994	4124	3582	3448	4194	3007	2343	3442
3458_Impedance measures - Leg fat-free mass (left)	3458_Impedance measures - Leg fat-free mass (left)	25	484	2	1990	3853	1018	1312	3757	3040	3530	4413	1283	4466	3956	4137	4022	4471	829	4395	2253	960	484	2025	3842	628
1195_Asthma (male)	1195_Asthma (male)	25	484	1	3451	2845	3630	3032	4374	3148	2559	4675	3720	3570	3808	2590	3457	4586	3576	3998	4277	1386	4332	1873	1874	484
2162_PSPN - Persephin	2162_PSPN - Persephin	25	485	1	621	4102	2945	1060	1934	2570	747	2983	2117	1673	1884	3201	3493	1061	2199	3077	4169	2049	2941	485	2571	1639
3080_NRXN1 - Neurexin-1-beta	3080_NRXN1 - Neurexin-1-beta	25	486	1	921	2111	504	730	3475	2975	1466	715	3433	486	3579	4555	4010	541	4142	3714	2248	2051	3453	2323	2371	4461
1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	25	487	1	1570	2258	2058	487	1516	4342	4274	2263	821	4429	2884	2958	1618	3370	2015	1292	1636	3189	3611	2458	2349	1763
3429_Fluid intelligence test - FI6 : conditional arithmetic	3429_Fluid intelligence test - FI6 : conditional arithmetic	25	487	1	3464	4668	3145	3137	1736	3369	1864	617	764	487	3804	3256	3456	2407	3042	4572	1005	4425	2407	671	2978	1840
1074_Serum levels of soluble E-selectin with T1D	1074_Serum levels of soluble E-selectin with T1D	25	487	1	2962	4687	4586	3070	2576	2852	4009	759	3654	3372	2961	487	3176	4062	4319	1804	4070	3057	2377	4647	3586	3761
3403_Fluid intelligence test - FI5 : family relationship calculation	3403_Fluid intelligence test - FI5 : family relationship calculation	25	488	1	2146	2720	488	1646	2040	3043	1738	4352	1369	1736	4267	3358	3592	3852	4468	1919	2006	4735	2765	3519	2017	3397
3495_Hair colour (natural, before greying): Blonde	3495_Hair colour (natural, before greying): Blonde	25	488	1	918	1357	535	3937	488	2358	2116	1315	1309	4416	4323	4339	3941	1414	870	1514	1825	3225	3935	2370	4200	4612
3135_MMP16 - Matrix metalloproteinase-16	3135_MMP16 - Matrix metalloproteinase-16	25	488	1	3069	2771	3719	2296	4431	488	1321	2652	3452	4319	3559	4285	2564	4270	2925	4702	548	2401	2689	1909	2937	1730
3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	25	488	1	3066	4440	2714	2138	3079	3706	682	2447	488	4105	2607	3836	1814	3551	4074	1802	977	662	1492	4008	1885	3005
556_Lipid::Medium chain fatty acid::caproate (6:0)	556_Lipid::Medium chain fatty acid::caproate (6:0)	25	488	1	1871	1967	1598	4412	4199	4216	4210	4015	3815	1090	488	1549	4236	1535	3149	3420	3080	2138	1848	2671	3964	1061
4686_Superior corona radiata axial diusivities	4686_Superior corona radiata axial diusivities	24	488	1	677	498	2643	4156	2308	1545	3271	4502	4585	3543	4428	4033	2766	488	3052	2006	1631	3600	2760	955	889	941
3984_Heart rate increase	3984_Heart rate increase	25	489	1	763	4332	2819	489	3402	3666	1646	3657	3990	1693	3625	4678	2641	934	4195	3230	1909	4466	2137	2367	2142	3550
1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	25	489	1	1679	2113	4578	2285	489	2771	1520	3170	4392	1697	4270	4248	1155	3971	1316	610	1446	1469	1559	2257	4643	2892
4048_Plantar fasciitis	4048_Plantar fasciitis	25	489	1	2711	1792	3734	593	4673	4603	1208	489	4300	3911	2246	3638	1830	1218	3309	3824	3410	2886	4232	4552	3549	602
128_Hip circumference (male)	128_Hip circumference (male)	25	489	1	2957	4654	3920	3550	1542	3474	1055	1221	2533	2291	494	3706	3498	2510	1180	2931	4598	2243	4392	2590	3866	489
422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	25	490	1	1271	1785	490	1822	3377	1548	3961	2586	2623	1414	935	1305	4013	2588	2839	3367	4357	2125	1290	1131	2192	2784
1108_Subcutaneous adipose tissue volume	1108_Subcutaneous adipose tissue volume	25	490	1	3265	3154	1902	4444	3638	4130	2965	4532	1262	2717	3888	490	3291	3871	4214	4475	3060	1342	2041	1286	3102	891
655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	25	490	1	1849	966	912	1959	4187	3059	1992	3793	548	3082	1942	1574	2712	1599	3997	3148	490	2304	2297	2452	3937	3246
2133_LTBR - Tumor necrosis factor receptor superfamily member 3	2133_LTBR - Tumor necrosis factor receptor superfamily member 3	25	491	1	3799	3610	2705	753	4489	4480	2167	2404	3450	4218	491	4486	4089	1519	3999	4174	640	3705	1429	806	1169	2318
3377_Number of spontaneous miscarriages (female)	3377_Number of spontaneous miscarriages (female)	25	491	1	701	2209	2594	1938	1984	2346	1639	2765	3113	4637	948	1820	2128	940	491	3881	824	908	3448	2491	4527	697
4143_Diastolic Blood Pressure	4143_Diastolic Blood Pressure	25	492	1	1941	2467	1390	2566	4042	3999	847	1853	1401	1729	1392	2058	3384	3182	492	625	1348	2423	4077	4483	3168	2242
519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	25	494	1	2518	2210	4482	601	2682	1427	3296	3510	4165	2637	2656	494	2850	1418	827	4713	3221	4543	4308	2919	4333	1729
1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	25	495	1	2906	495	1139	3303	4312	3711	3158	3563	3100	1540	4427	4172	4353	3896	3312	3834	1792	2179	4393	3119	1804	2094
2373_IL2RA - Interleukin-2 receptor subunit alpha	2373_IL2RA - Interleukin-2 receptor subunit alpha	25	495	1	673	2885	1676	1886	2113	3671	4346	3778	1276	2602	495	4564	1284	3832	4452	3956	1681	4384	2769	3667	4144	4740
1103_Insulin - Birth cohorts	1103_Insulin - Birth cohorts	25	495	1	2260	3322	4232	2546	3524	3862	3470	780	950	2481	3260	1541	495	2581	2727	3663	4509	915	3337	600	3374	3659
1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	496	1	3948	3802	2405	1928	1205	1922	4531	4459	3079	3011	1201	534	2737	496	825	1909	2032	1107	3565	3295	4679	1704
928_MonoLunsaturated fatty acids	928_MonoLunsaturated fatty acids	25	497	1	2997	959	4683	646	497	3306	2541	2345	1254	3571	2122	1544	4625	4731	1469	593	830	2626	892	2385	1777	3880
23_Major depressive disorder (females)	23_Major depressive disorder (females)	25	497	1	931	4211	1548	3249	4056	3885	4107	3731	3967	1934	1805	3035	3167	1196	2205	2872	2956	3958	497	3886	1317	1564
771_::::X-12329	771_::::X-12329	25	498	1	4331	3810	498	4648	3834	2184	3814	3504	4565	649	1481	1872	1281	1232	2117	4377	2554	1180	1506	1657	1350	1201
3309_Wears glasses or contact lenses	3309_Wears glasses or contact lenses	25	498	1	3895	2640	3561	2331	498	3356	1756	2163	3015	1044	2078	3821	3697	1768	2068	572	2527	1377	3829	1212	1271	997
1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	25	498	1	2339	808	1517	4406	2089	1423	498	3011	881	3191	1167	4719	2626	3417	1039	4085	3496	1159	3249	689	3351	2246
2253_PRKCD - Protein kinase C delta type	2253_PRKCD - Protein kinase C delta type	25	498	1	1501	4401	3590	959	3717	1380	3011	2554	3383	955	2608	498	627	1633	3917	2543	925	1748	691	2886	2045	2742
4579_Right cuneus	4579_Right cuneus	25	498	1	2722	3450	1663	975	3024	3883	537	3227	980	1431	866	1334	2914	4220	1407	1570	1998	498	2180	1551	4228	1610
3223_Length of mobile phone use	3223_Length of mobile phone use	25	499	1	3356	1095	499	4571	1532	4447	4437	4336	1637	2380	3132	4200	1973	3109	3321	829	3303	1899	4357	4541	4237	755
774_::::X-12428	774_::::X-12428	25	499	1	4177	3077	2283	499	3979	1832	3767	707	1442	3076	1990	3022	4490	3390	4434	3606	3624	1579	4630	1101	3854	4694
471_Lipid::Bile acid metabolism::taurocholate	471_Lipid::Bile acid metabolism::taurocholate	25	499	1	2969	3782	1550	4059	642	3009	3193	683	1221	2891	1449	499	3631	2342	561	3797	4539	4402	1355	569	4390	3693
3649_Illnesses of siblings: Stroke	3649_Illnesses of siblings: Stroke	25	500	1	500	4321	4684	1962	3369	2538	3644	3875	3826	3326	957	3270	3024	1124	2597	3089	3016	2714	1041	3833	786	1987
2759_F2 - Thrombin	2759_F2 - Thrombin	25	500	1	4242	2910	500	620	2731	3952	3906	3944	2169	3665	4456	936	1938	1072	3739	1703	2426	2788	1688	814	2250	1313
3041_CD274 - Programmed cell death 1 ligand 1	3041_CD274 - Programmed cell death 1 ligand 1	25	500	1	697	1716	4066	500	3408	4443	2087	2009	3822	1587	1927	4151	3726	4681	4041	3627	1519	642	4129	3615	1312	3124
3236_Past tobacco smoking	3236_Past tobacco smoking	25	500	1	4102	2056	4581	533	2542	500	857	1713	815	1859	1037	2567	2902	3406	2170	3651	1215	3273	1953	2726	1108	2778
1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	500	1	4121	3907	1140	3760	1845	2323	2884	4122	3104	2536	500	3306	2820	4385	4010	1935	3718	1360	1216	1883	2742	4472
3744_Cannabis use - Ever taken cannabis	3744_Cannabis use - Ever taken cannabis	25	500	1	2916	2999	818	4348	2647	949	3720	946	1566	2227	2070	3049	910	1371	3287	4478	1355	1147	500	556	1083	513
3882_High light scatter reticulocyte count (three-way meta)	3882_High light scatter reticulocyte count (three-way meta)	25	501	1	2486	2934	645	1973	3482	3179	2575	3705	2355	4657	2093	759	1327	3481	501	1524	1282	1963	3076	895	670	725
4557_Left medial orbitofrontal	4557_Left medial orbitofrontal	25	501	1	3888	1007	3606	3520	2536	730	991	4067	773	2126	4209	2899	4541	2255	1629	976	2287	1423	501	2911	686	4137
1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	501	1	678	4619	4086	3240	4692	4610	2550	4395	4660	3670	3404	4204	2946	1545	2681	3832	3294	2801	2565	4497	501	758
1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	502	1	2574	502	1093	4211	3265	3784	3610	3952	633	1855	2567	3996	4157	2850	1297	4097	2269	3534	1740	3684	4289	4379
3387_Health satisfaction	3387_Health satisfaction	25	502	1	3121	3747	2117	3390	4731	4170	4608	2423	3716	502	2812	3077	4171	2476	1121	2584	1433	1633	3969	2117	3611	2296
3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	25	502	1	2074	4498	571	3126	2494	4365	4583	3224	3122	4434	1624	2761	2260	1021	502	3792	2801	2167	2021	1480	1377	3724
779_::::X-12450	779_::::X-12450	25	502	1	3689	3728	2918	1404	784	3927	2703	1418	4346	1992	1147	2161	4007	876	2896	3518	4153	4338	3872	1818	2099	502
2029_Crohn's Disease	2029_Crohn's Disease	25	503	1	4174	1450	923	1454	1889	2543	569	2583	2996	888	646	2506	3891	3044	1339	4272	3136	1350	503	899	4567	1879
2969_STC1 - Stanniocalcin-1	2969_STC1 - Stanniocalcin-1	25	503	1	1736	1995	1232	4239	2554	1122	1256	3137	3763	4593	2897	3104	1280	4319	2315	1399	2458	1163	1029	503	2894	3940
1053_Neuroblastoma	1053_Neuroblastoma	25	504	1	617	1545	2925	3686	3048	504	2942	4294	3665	4511	3399	3129	1644	2951	1515	973	3453	594	3122	1777	3812	3127
3179_SRC - Proto-oncogene tyrosine-protein kinase Src	3179_SRC - Proto-oncogene tyrosine-protein kinase Src	25	504	1	896	3947	4641	2167	3827	1747	2233	901	1539	2820	860	1452	819	3310	504	1122	3513	1570	856	2936	1746	1123
1206_Longevity (>= 90 yrs vs < 65 yrs)	1206_Longevity (>= 90 yrs vs < 65 yrs)	25	504	1	2927	3960	2439	3517	2970	2939	4396	3984	1964	3350	2956	1315	1147	1634	2122	504	1389	1860	3795	1511	1174	836
3792_Daytime napping	3792_Daytime napping	25	504	1	4462	3652	2262	1058	3751	2728	1475	1341	1921	1606	3145	787	2627	4438	1276	2379	1087	981	504	1874	1866	908
557_Lipid::Medium chain fatty acid::caprylate (8:0)	557_Lipid::Medium chain fatty acid::caprylate (8:0)	25	505	1	3845	3904	2942	505	1891	3432	3333	3338	2724	4493	2310	4173	1509	4550	4464	1146	4393	927	1975	3438	2086	788
4480_Right fusiform	4480_Right fusiform	25	505	1	1219	3162	4016	3003	3858	729	505	4353	3177	2348	2731	4717	3051	1905	2877	3316	2977	1639	2191	3694	4057	2485
258_CD8mem:%CD31+	258_CD8mem:%CD31+	25	505	1	1608	1378	1908	2976	3085	563	2385	1193	3443	2929	1596	2720	505	3659	2508	3634	1865	4276	4672	4667	1143	4570
2071_APOE - Apolipoprotein E	2071_APOE - Apolipoprotein E	25	506	1	849	3415	1572	1730	4461	3330	3443	2142	1071	4207	2503	3583	3357	3942	506	2291	1797	3724	3938	1266	1820	4538
3854_Monocyte percentage of white cells (two-way meta)	3854_Monocyte percentage of white cells (two-way meta)	25	507	1	3849	3479	1130	1541	1021	556	1613	4666	2755	2367	2781	507	3195	3485	3168	1638	4076	2313	2250	2933	1559	640
4678_Fornix (cres) / Stria terminalis axial diusivities	4678_Fornix (cres) / Stria terminalis axial diusivities	25	507	1	970	1363	4193	3645	3407	2867	4694	1161	1154	748	2870	3280	507	1841	2827	3747	926	4003	593	1887	1990	3349
2676_MAPK8 - Mitogen-activated protein kinase 8	2676_MAPK8 - Mitogen-activated protein kinase 8	25	508	1	2356	1642	2997	2817	4564	4729	1631	2488	2185	1944	508	1687	2034	4329	4345	1894	1069	1829	642	3256	4563	3645
4367_Coronary artery disease in diabetes	4367_Coronary artery disease in diabetes	25	508	1	3533	3541	3281	4120	1418	4040	873	4620	3706	1485	3123	508	3425	1521	2348	991	2408	4243	2269	4373	1526	3942
2000_Weight	2000_Weight	25	508	1	2753	3968	2902	2925	2627	1858	3231	2998	1682	1646	1054	4603	664	2040	3755	2429	4705	3567	508	4143	689	1809
418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	25	509	1	4138	3588	4270	509	2460	3071	4185	3812	1402	3432	1296	4596	4639	2183	3466	1755	2312	1332	4491	3363	2244	3546
48_Age at first birth (female)	48_Age at first birth (female)	25	509	1	4103	3284	2586	2578	4634	2958	509	4282	2930	741	1092	4064	3334	2048	3656	2712	4264	2543	3090	1966	1721	4450
213_Lymph:%CD4	213_Lymph:%CD4	25	509	1	1699	2002	2851	1470	2355	4446	1915	989	509	519	1866	2265	2749	1985	1877	3112	4107	3923	1569	1724	1021	3307
3745_Happiness and subjective well-being - General happiness	3745_Happiness and subjective well-being - General happiness	25	509	1	2438	2970	3160	3727	2534	4197	4041	1378	3629	509	2677	1353	3489	4702	2275	4317	2879	1288	2474	3545	3357	3409
4494_Right pericalcarine	4494_Right pericalcarine	25	509	1	4376	4430	4455	3252	2107	2881	4236	1788	1116	4307	811	509	1916	3734	3084	1416	600	4674	3860	3601	3046	1426
60_Educational attainment	60_Educational attainment	25	509	1	2838	4685	2486	1823	1301	3611	3475	3363	2345	4053	4473	1879	4739	926	2290	1592	3659	3917	509	1191	3470	3863
1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	510	1	3664	2432	1445	2543	3462	1840	4577	3734	4254	2901	3954	2213	510	3154	3753	4644	2471	2279	4668	2216	3261	4110
646_Xenobiotics::Xanthine metabolism::caffeine	646_Xenobiotics::Xanthine metabolism::caffeine	25	511	1	607	1986	3652	1878	2159	3640	511	3662	3119	4188	3431	1794	1403	2651	2990	3866	1398	2695	4127	1122	894	2845
484_Lipid::Carnitine metabolism::oleoylcarnitine	484_Lipid::Carnitine metabolism::oleoylcarnitine	25	511	1	1349	1020	1547	4173	4084	3193	4641	2343	1536	2354	3337	511	4315	3348	4534	3870	2184	2901	2165	3477	2467	2684
4406_Menstrual quality of life impact: Sleepiness	4406_Menstrual quality of life impact: Sleepiness	25	511	1	1844	1906	4300	1079	3358	633	3864	4547	3630	2398	609	3960	4100	703	3138	2482	4375	4215	4167	2627	4236	511
1094_Systolic Blood Pressure	1094_Systolic Blood Pressure	25	512	1	4568	1045	3222	3080	3344	4465	1427	4006	605	3500	3893	1446	512	4602	2695	2052	4727	3951	3495	4503	1245	4665
2951_FGA FGB FGG - D-dimer	2951_FGA FGB FGG - D-dimer	25	513	1	2981	1550	513	747	3695	1493	2864	3854	3730	3174	3352	636	2090	571	2760	1419	2622	4278	3297	4703	1662	3230
3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	25	513	1	1015	2604	4215	574	3620	4257	1416	908	513	935	2134	1778	2041	1637	3505	3733	4285	1104	4199	3114	857	4569
4615_3rd ventricle	4615_3rd ventricle	25	513	1	4746	1968	4160	2710	1382	4711	1708	4292	1521	4089	4423	3330	2058	2052	3101	2342	3344	513	4343	1361	1980	2870
480_Lipid::Carnitine metabolism::decanoylcarnitine	480_Lipid::Carnitine metabolism::decanoylcarnitine	25	514	1	4435	3939	1472	711	3887	4713	2782	1806	1222	3190	4325	3664	2599	514	2787	2277	2835	4454	1109	854	2546	3817
1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	514	1	2568	3525	3957	3079	3142	812	1200	2995	4635	1756	2232	2403	2153	2239	4089	2192	1990	2809	514	3276	1324	2225
3238_Exposure to tobacco smoke at home	3238_Exposure to tobacco smoke at home	25	515	1	4340	4313	515	1813	3496	4658	3426	4029	1150	4432	3348	3770	815	3909	3184	2573	2737	2253	3609	3686	922	3737
3881_High light scatter percentage of red cells (three-way meta)	3881_High light scatter percentage of red cells (three-way meta)	25	515	1	2106	3873	603	2209	3371	1687	1263	3367	2317	4415	2681	1318	1805	4032	554	1360	984	2207	2942	645	515	1255
3565_Vitamin and mineral supplements: Vitamin E	3565_Vitamin and mineral supplements: Vitamin E	25	516	1	4497	3159	4000	516	3548	734	2648	1538	3343	990	1363	2287	1780	4135	2032	4110	1131	2218	2311	1242	2499	4369
909_Leucine	909_Leucine	25	518	1	3391	518	1996	773	3385	2113	3920	3727	3589	4328	1842	895	1341	1555	3545	1989	3054	585	3383	2470	724	3764
1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	518	1	2369	1619	1192	4184	3688	922	4261	623	2251	2702	1963	3101	852	1317	4644	2960	2926	4430	518	4704	1137	1013
3354_Age stopped smoking	3354_Age stopped smoking	25	518	1	4335	4121	1384	3107	4349	3092	4520	4101	3601	2180	3346	1480	1236	2323	2852	2551	2804	2245	1491	518	2576	1675
2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	25	519	1	3122	2594	2492	710	519	895	2954	1189	1306	3113	658	2728	3466	2335	2253	1816	1725	2345	3215	2926	2428	1926
1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	519	1	802	2182	1738	2224	963	3907	519	1982	4326	4125	4411	2365	3882	4479	3668	3486	4328	4408	804	1898	4349	3563
373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	25	519	1	4488	538	2163	2995	4517	4586	4310	2164	1084	1941	1543	2490	2874	2360	519	3684	2113	1689	2797	829	2002	4436
1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	519	1	4372	2600	3191	821	3944	1152	3889	2527	2589	3016	3879	557	3445	2199	4553	4051	519	619	1830	941	4154	4564
3399_Tinnitus	3399_Tinnitus	25	521	1	1232	1879	521	3676	1499	1234	524	2524	4488	1408	3236	3237	876	2393	2941	4670	2692	3900	2317	1378	4133	3414
4395_Menstruation quality of life impact: Acne	4395_Menstruation quality of life impact: Acne	25	521	1	1749	2336	660	3631	4047	3528	1149	2620	2442	521	4281	1150	638	1834	1429	1369	4155	3391	3194	1783	1692	3713
699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	25	522	1	2950	2268	941	3495	3350	4374	2777	4170	1382	2933	903	522	4351	3463	3069	3229	2836	2410	2597	1096	2232	4019
1152_Incremental insulin 30 min	1152_Incremental insulin 30 min	25	522	1	4336	750	2719	3620	1687	929	2171	751	1714	4449	3524	3347	522	2322	1980	2091	1298	2827	3656	4045	2625	2506
4044_Body Mass Index	4044_Body Mass Index	25	522	1	2839	3725	1807	3719	4639	845	2143	1955	1509	4451	3339	3349	1370	522	2714	4742	3237	1909	3785	3173	3567	4682
1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	523	1	2836	2534	4311	1952	2955	871	2438	1524	4366	2946	4613	2851	2057	3024	4427	4379	523	3686	4429	1409	4515	3786
1181_Sleep duration	1181_Sleep duration	25	524	1	3236	4622	3428	4243	4598	2581	4292	4476	4297	3644	1338	524	3819	2866	2897	4465	4200	3159	4736	3619	4258	3263
1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	25	524	1	1389	921	4244	2647	757	1397	2218	4276	3702	1423	1046	2000	1863	2575	3273	524	4020	1249	1058	958	3583	2112
3008_SCGB2A1 - Mammaglobin-B	3008_SCGB2A1 - Mammaglobin-B	25	524	1	1839	3218	2727	3687	2995	4468	582	932	3664	2987	3718	4227	4162	4679	932	3022	1113	2939	524	1072	1430	3568
740_::::X-11852	740_::::X-11852	25	524	1	3566	1756	4689	2684	3667	1631	4196	2796	4378	1465	2490	1814	1388	583	4483	2076	3548	4260	2079	1247	1452	524
852_Alanine	852_Alanine	25	525	1	3123	1014	1252	525	4212	3187	2049	4738	4298	3807	3513	1124	583	1696	3262	2077	3296	2602	603	1178	3787	4523
2911_PDIA3 - Protein disulfide-isomerase A3	2911_PDIA3 - Protein disulfide-isomerase A3	25	525	1	1168	1437	1090	597	1776	2898	525	2740	3642	1989	2257	2591	2138	1339	982	4084	4245	2122	4034	1830	3822	819
1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	525	1	4470	4625	3200	3012	1127	591	3024	525	3156	4547	1321	4103	654	3086	4465	1139	659	3136	3217	1488	3501	1389
3986_Heart rate recovery at 20 secnds	3986_Heart rate recovery at 20 secnds	25	525	1	1834	4153	2048	3708	841	1773	1092	4319	3224	2124	2504	4698	525	3870	3627	4427	3925	564	3289	3690	4379	3400
3300_Frequency of tiredness / lethargy in last 2 weeks	3300_Frequency of tiredness / lethargy in last 2 weeks	25	526	1	2314	4502	3525	2234	3177	3879	1269	1636	3571	873	1202	2699	526	4500	3745	4657	4379	787	1190	795	3631	1268
4662_Retrolenticular part of internal capsule fractional anisotropy	4662_Retrolenticular part of internal capsule fractional anisotropy	25	526	1	1739	3277	1269	1931	1520	4315	3954	1679	3212	3209	1401	983	1268	1875	1968	770	3143	526	648	3098	2219	1274
43_Social deprivation	43_Social deprivation	25	527	1	2134	2659	4073	3286	1722	527	4687	2506	2015	4719	2805	589	2054	1685	2177	2458	2650	2457	2714	2364	2486	1192
734_::::X-11820	734_::::X-11820	25	527	1	2825	1192	1268	634	4594	4349	1470	4473	4700	2774	527	3527	4381	2176	1587	2201	1096	2545	3646	2007	2895	673
4719_Corticospinal tract mode of anisotropy	4719_Corticospinal tract mode of anisotropy	25	527	1	1183	2404	2218	685	1539	1566	1016	3494	4593	1692	3481	1181	4470	527	4547	2332	2245	3001	4342	1362	2781	1585
3594_Mineral and other dietary supplements: Calcium	3594_Mineral and other dietary supplements: Calcium	25	527	1	1882	3203	2454	2457	1027	2428	1861	2382	689	1872	3525	1467	4195	2564	3495	1382	2740	4690	3492	4366	527	2676
3391_Ever depressed for a whole week	3391_Ever depressed for a whole week	25	528	1	3269	528	3001	4356	4338	3149	1123	2985	1805	3690	3768	1494	3314	667	3841	3896	4373	4589	4000	2203	3419	955
3799_Red blood cell count	3799_Red blood cell count	25	528	1	2211	2690	4333	2191	2969	528	1819	2426	1812	3435	3362	1286	1752	1395	1562	4536	1012	1303	3968	4439	531	4175
3844_Hemoglobin concentration (two-way meta)	3844_Hemoglobin concentration (two-way meta)	25	529	1	3945	2130	3142	4033	2271	1584	3094	4687	2944	2446	4199	529	4704	2076	1533	3385	4390	2595	4238	2849	2874	2295
1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	25	530	1	1963	530	4294	4078	1576	2442	1221	3956	4379	4460	1954	894	2752	3357	3380	1081	3116	1583	1622	4002	4033	1412
2619_CDH12 - Cadherin-12	2619_CDH12 - Cadherin-12	25	530	1	4228	3679	4508	4027	2903	1932	3772	2269	664	4192	1991	530	4136	3115	4116	1474	2033	2971	2448	3073	1074	3133
1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	25	530	1	3385	3647	4575	4094	3034	2810	4255	4601	3732	2712	1446	924	2873	530	2510	1801	1043	1265	1739	1305	3742	4542
2796_GPI - Glucose-6-phosphate isomerase	2796_GPI - Glucose-6-phosphate isomerase	25	530	1	4632	3179	2905	2877	3214	1115	4322	2573	3451	1512	3375	693	1726	2787	530	4137	1036	4040	2939	3630	3703	3992
2525_IL15RA - Interleukin-15 receptor subunit alpha	2525_IL15RA - Interleukin-15 receptor subunit alpha	25	531	1	3907	848	531	3384	4041	4514	4167	4274	1133	2591	3818	2604	4694	3517	2775	3617	875	2691	2856	1590	2455	2486
1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	25	531	1	838	920	2051	4068	1645	1706	4410	2790	3819	2509	1187	3257	3440	1562	4587	3348	2291	2004	3473	2721	2003	531
2152_EGFR - Epidermal growth factor receptor	2152_EGFR - Epidermal growth factor receptor	25	534	1	725	2623	1723	534	3998	2327	786	2454	3955	987	1380	2388	2509	3454	2281	2125	4593	1573	4298	1161	1264	2679
2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	25	534	1	1303	1709	2722	1861	1260	4381	534	4632	2753	1694	3130	2081	1087	666	3367	1188	1927	2268	4543	2987	3180	2786
2569_TGFB3 - Transforming growth factor beta-3	2569_TGFB3 - Transforming growth factor beta-3	25	535	1	3010	1596	774	1616	535	2076	3880	1790	4236	1893	2304	1706	640	4655	3126	2548	3978	2914	979	695	4065	4510
2260_SERPINA3 - Alpha-1-antichymotrypsin	2260_SERPINA3 - Alpha-1-antichymotrypsin	25	535	1	1907	1972	3506	596	2436	981	2060	3184	2453	535	1463	4525	3303	4603	1034	543	4592	3538	3620	1231	1690	4022
1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	536	1	4321	3271	1111	3538	536	3759	3835	3215	2296	3939	3855	4313	3468	3210	2061	1806	641	4501	2740	1788	4056	702
4561_Left pars opercularis	4561_Left pars opercularis	25	536	1	2547	4721	2718	4659	1653	1713	3664	626	536	3403	4372	3067	2535	4196	1628	810	1455	2183	3433	4590	1892	4050
230_mDC:%X-Presenting	230_mDC:%X-Presenting	25	536	1	1527	567	4021	2831	4728	3331	2590	1507	3970	536	1383	2316	1296	1384	2059	4171	3896	2473	1572	710	1986	1437
3325_Relative age voice broke (male)	3325_Relative age voice broke (male)	25	536	1	4011	3219	3004	4263	4481	4186	1667	701	2935	3376	4650	4614	1215	4004	3552	1012	536	4241	3636	555	2168	2775
3641_Illnesses of mother: Bowel cancer	3641_Illnesses of mother: Bowel cancer	25	536	1	4450	4236	2423	2251	4113	1910	1271	708	1857	3999	4653	1200	3665	1705	3886	4430	3835	1038	536	1597	2522	2287
2098_IGFBP2 - Insulin-like growth factor-binding protein 2	2098_IGFBP2 - Insulin-like growth factor-binding protein 2	25	537	1	4273	537	4475	2858	4270	1572	1918	1577	3713	4704	4461	752	3877	782	2100	3389	3798	2655	3018	1069	2454	1096
648_Xenobiotics::Xanthine metabolism::theobromine	648_Xenobiotics::Xanthine metabolism::theobromine	25	538	1	4141	1380	1121	3689	538	2166	3234	4709	4478	4726	1516	972	2465	3049	4232	1701	3482	1430	1942	880	1863	1407
1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	538	1	1278	1851	3804	1317	2176	1722	1906	755	2896	538	864	1871	3519	4125	3618	3030	3540	1516	714	3855	1963	3140
1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	538	1	3283	3989	3550	3075	3127	3119	2311	1905	1867	3775	1598	2848	4653	538	2276	2310	2151	3933	4584	3771	2314	2068
3846_High light scatter reticulocyte count (two-way meta)	3846_High light scatter reticulocyte count (two-way meta)	25	538	1	4729	3875	808	1741	3017	4611	3504	3767	4494	4005	2624	1885	996	1973	538	1096	1400	911	1583	1546	949	1025
2635_TNF - Tumor necrosis factor	2635_TNF - Tumor necrosis factor	25	539	1	1892	1796	3690	4635	4569	4183	4011	3106	4131	2721	3476	3605	3588	539	4631	4625	2899	1622	3449	1662	4059	4096
4318_Anti-Mullerian hormone	4318_Anti-Mullerian hormone	25	540	1	3475	2533	2303	540	3861	3876	4673	3725	2988	3530	3176	4473	1019	1777	2732	2189	2583	1891	3846	1349	572	1105
1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	540	1	1842	3603	602	1701	1634	4309	1505	1481	1567	540	1542	3809	3543	3305	2331	4003	2819	4228	1113	4447	1250	2432
2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	25	540	1	4023	861	2831	3617	2663	652	4085	582	2886	2427	1597	2704	1506	3278	4342	1428	3854	540	3219	3395	1400	4433
294_CD4mem:%Th1* (1)	294_CD4mem:%Th1* (1)	25	541	1	2409	2710	541	3501	1101	1213	3228	4507	1236	4175	2145	3848	2087	3351	661	1092	2041	3503	2161	1758	3557	550
3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	25	543	1	543	2018	822	1041	1696	3667	2579	1323	2752	1817	3147	4099	1669	854	2711	3330	693	2021	4141	3608	4398	901
2781_IGF1R - Insulin-like growth factor 1 receptor	2781_IGF1R - Insulin-like growth factor 1 receptor	25	543	1	2072	4713	2790	4699	543	880	929	3601	1615	4685	1881	3882	3867	2833	3729	687	3637	1854	4319	3013	873	3915
1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	25	543	1	2255	1652	4335	1814	1961	4101	1586	3498	2219	2375	3315	3852	543	1681	2653	2677	4591	4157	4692	3729	2457	2635
1923_Hippocampal volume (GEE, adjusted for age and sex)	1923_Hippocampal volume (GEE, adjusted for age and sex)	25	544	1	1583	4710	2252	3712	2466	4026	4217	2403	4584	2793	544	1870	2379	3244	2381	2689	3870	1933	3358	4370	1496	1492
3136_SHC1 - SHC-transforming protein 1	3136_SHC1 - SHC-transforming protein 1	25	544	1	1497	3355	771	3097	1927	3526	1892	2264	2505	3335	2976	4634	1043	1661	1659	2286	4430	544	4146	3392	1679	1785
4416_Toxoplasmosis seropositivity	4416_Toxoplasmosis seropositivity	25	544	1	1505	669	3554	1433	3122	4299	1889	3385	4252	707	979	1760	3611	4314	3379	1069	1050	4253	857	867	544	3655
4170_Loneliness (MTAG)	4170_Loneliness (MTAG)	25	545	1	545	4035	4559	2000	3155	2730	3178	2579	2231	2650	2361	996	3540	4290	4714	4168	2360	2692	3493	837	2474	2551
3960_Gestational weight gain (maternal, total)	3960_Gestational weight gain (maternal, total)	25	545	1	1513	2391	545	996	3111	2560	1137	2718	4261	2108	549	3410	3324	972	2736	2036	882	2437	2779	2556	4310	2771
1935_Temporal brain volume (GEE, adjusted for age and sex)	1935_Temporal brain volume (GEE, adjusted for age and sex)	25	545	1	2136	2236	3124	856	545	2151	1160	1604	1114	2753	1641	1542	1712	4636	1630	552	1391	3059	1348	639	2699	1483
1297_Adiponectin (GEE, adjusted for age and sex)	1297_Adiponectin (GEE, adjusted for age and sex)	25	545	1	2624	1422	3596	859	644	4533	545	864	3268	2673	1357	3506	4083	1665	3344	582	1582	4136	3818	2948	3359	3850
3390_Financial situation satisfaction	3390_Financial situation satisfaction	25	545	1	3241	2223	2663	2128	2977	4195	3125	545	937	870	901	3666	1767	4288	4100	4537	2802	2277	3662	3839	928	3103
4253_Sleep duration (mean)	4253_Sleep duration (mean)	25	546	1	546	4541	3230	4250	2930	3579	3536	2037	1796	3255	2010	2468	2539	968	4262	3588	1492	3462	4426	3424	1978	1217
2784_LIN7B - Protein lin-7 homolog B	2784_LIN7B - Protein lin-7 homolog B	25	546	1	2932	546	1260	4145	4285	3673	1590	3907	932	1257	4678	3054	1757	3330	909	3170	1540	3944	1663	2738	4309	3621
2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	25	546	1	2818	942	4336	894	2801	4152	1334	3559	2040	2815	3531	4416	546	2496	2147	1560	3955	3983	3226	1861	2817	3539
4301_Arms-arm fat ratio (male)	4301_Arms-arm fat ratio (male)	25	546	1	2244	1905	3305	1265	4520	2140	4262	904	2609	2030	2307	1858	1114	3797	3866	2010	3817	4325	846	546	3211	1165
2896_SLITRK5 - SLIT and NTRK-like protein 5	2896_SLITRK5 - SLIT and NTRK-like protein 5	25	547	1	547	2256	2655	650	1432	2903	2192	1304	3889	1761	700	2817	4311	2254	2337	2916	4209	3153	3045	3625	4088	4446
3161_SEMA3E - Semaphorin-3E	3161_SEMA3E - Semaphorin-3E	25	547	1	2596	4328	4240	1809	2480	2663	547	563	1299	2885	993	1018	3035	2930	2768	2331	4718	2623	4150	2378	2434	3516
4093_Verbal-numerical reasoning	4093_Verbal-numerical reasoning	25	547	1	1628	4568	4410	2407	3753	3836	1049	1008	547	2167	3398	3098	3318	2148	3695	4606	2381	2251	2980	1430	4496	3512
3546_Mouth/teeth dental problems: Bleeding gums	3546_Mouth/teeth dental problems: Bleeding gums	25	547	1	940	3568	3832	850	3440	2330	1151	2549	2399	2613	4133	1481	4419	2421	4167	4262	3663	4189	1800	2255	547	4317
2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	25	548	1	548	565	4431	2322	3705	3207	1826	1316	652	2756	2446	3622	3476	4040	1466	3453	2754	3411	1479	1413	4012	832
1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	25	548	1	3285	3533	3745	548	4642	1377	705	2508	1487	3794	838	3636	2393	765	1909	2922	2147	3827	2420	4683	4095	1455
669_::::X-06267	669_::::X-06267	25	548	1	2966	1505	4146	4640	4495	1091	3137	4351	4151	3206	4062	675	1198	865	1680	2665	2462	548	2017	949	3413	3206
1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	549	1	3317	3006	549	2480	3522	2505	3000	4634	3599	2482	1062	1118	3635	2791	2086	2340	4352	3601	1614	4433	2677	2883
834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	25	549	1	3946	2948	2014	3021	549	3441	1105	1599	582	2384	2983	3411	2916	1897	4025	908	2443	1792	3255	2923	856	2606
1129_Ratio of visceral-tosubcutaneous adipose tissue volume	1129_Ratio of visceral-tosubcutaneous adipose tissue volume	25	550	1	3090	4409	550	4738	4535	3573	4136	1899	2693	2338	4202	2139	2183	2752	670	3946	3970	3685	4695	2572	4572	3342
2312_JAM2 - Junctional adhesion molecule B	2312_JAM2 - Junctional adhesion molecule B	25	550	1	1251	1802	3721	958	4653	2401	1925	3052	1507	2261	618	2269	4316	4708	3773	3934	3687	4745	3084	3178	550	2789
1032_Neck Section Modulus (FBAT, adjusted for age and sex)	1032_Neck Section Modulus (FBAT, adjusted for age and sex)	25	551	1	2887	2287	2421	4267	1921	551	766	1803	739	4403	2769	1422	2872	1541	2173	2409	2402	2302	4471	950	1023	1918
2743_IL6R - Interleukin-6 receptor subunit alpha	2743_IL6R - Interleukin-6 receptor subunit alpha	25	551	1	3460	3982	3985	3042	4174	3619	562	551	2826	4262	1730	3541	1738	3293	1506	4669	3161	2240	1708	4367	2873	3138
2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	25	552	1	4143	1651	3487	1536	1415	1027	2731	552	2562	2132	1335	4740	4158	1898	2483	721	3005	946	1434	3580	2155	626
1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	25	552	1	1947	3376	2458	2277	2666	3639	3411	3797	3210	552	4413	1222	1876	2276	1165	3042	1639	3801	738	915	4653	2642
2831_SFTPD - Pulmonary surfactant-associated protein D	2831_SFTPD - Pulmonary surfactant-associated protein D	25	552	1	1357	3570	1773	2370	1210	2071	3648	2612	3934	1282	702	2182	645	3142	3062	2795	3894	4120	3821	3399	552	2617
828_::::X-13741	828_::::X-13741	25	553	1	4159	1511	553	2404	914	1026	3619	3699	2708	4133	4322	2411	3462	975	4540	3765	714	3269	2902	4449	4393	4222
1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	25	553	1	4061	940	1637	553	1788	4018	4697	886	3303	4288	2866	4278	2273	2138	4299	4248	1867	4520	3893	3032	3895	4220
1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	25	553	1	2534	2144	1002	853	4365	636	3551	4552	553	1757	1618	1183	4182	1527	2072	4287	2677	2697	845	3809	2463	1326
4602_Right superior frontal	4602_Right superior frontal	25	553	1	4699	569	3842	3192	3212	2521	3159	1894	2344	4525	3981	2004	2718	553	3264	2917	3074	2860	2443	1570	688	2305
1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	553	1	2938	4292	1457	2046	4360	1324	3295	2526	4727	2566	4224	2435	3700	2747	3148	3731	553	4138	1204	2632	1420	3939
3313_Hearing difficulty/problems	3313_Hearing difficulty/problems	25	553	1	4672	3349	1253	1797	933	4306	4356	1127	3088	2938	3692	955	2367	4641	1990	1018	1899	3396	844	1379	553	798
18_Former versus current smokers	18_Former versus current smokers	25	554	1	1004	554	4002	2557	4719	1712	2771	3478	4386	3449	1420	4673	1758	1106	2560	2571	644	2855	1513	662	1975	2826
599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	25	554	1	2012	3150	4005	3917	1827	2973	1182	4349	2910	1358	4334	950	895	554	4250	1015	3840	3761	4135	3530	1261	4373
2258_UBE2I - SUMO-conjugating enzyme UBC9	2258_UBE2I - SUMO-conjugating enzyme UBC9	25	555	1	555	2901	2633	2429	3190	751	4716	1662	4262	1601	4359	4119	1380	950	723	1628	705	3408	4613	4600	1741	2507
3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	25	555	1	3847	1383	4026	1780	1804	2773	2570	555	2916	1175	1257	2801	2423	4527	3060	1491	1089	703	1540	3566	2904	3038
234_Lymph:%NK	234_Lymph:%NK	25	555	1	2820	2969	4728	875	1446	1434	2421	3212	1762	746	3067	1933	555	4701	3340	1068	2711	1035	4352	1022	4432	3032
2267_MDK - Midkine	2267_MDK - Midkine	25	555	1	4196	2103	872	878	1521	4259	2917	3275	2675	4543	2200	2881	4223	4705	2091	1762	3938	555	2044	4244	3495	3998
1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	25	557	1	2202	3356	2220	2690	557	3914	4216	3332	3029	3424	3342	2951	696	2942	3117	1261	1994	997	818	758	2256	1229
2957_CCL16 - C-C motif chemokine 16	2957_CCL16 - C-C motif chemokine 16	25	557	1	4489	3560	4256	3461	2476	1183	4254	2855	3473	4569	557	1447	2495	928	2013	3265	1718	3762	836	4524	3390	2312
3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	25	557	1	3287	4562	3859	1669	865	2899	1846	1249	2161	4725	4376	938	4382	4192	557	681	3596	4008	3567	4075	1355	2700
4287_FVC	4287_FVC	25	558	1	2999	1924	4369	3990	3645	1365	2978	4504	1199	1380	3049	2127	1080	2624	1754	1091	3052	4099	2436	3366	558	1553
3883_Immature fraction of reticulocytes (three-way meta)	3883_Immature fraction of reticulocytes (three-way meta)	25	559	1	1779	3112	4081	2927	3261	2254	1700	2391	1519	3845	2239	559	1398	3752	823	1587	4011	3861	3271	618	1113	4243
1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	559	1	3853	2813	1393	670	2498	2750	3707	2235	1657	4173	910	4743	1620	913	656	3509	4086	559	1246	2986	1742	3484
2553_EPO - Erythropoietin	2553_EPO - Erythropoietin	25	560	1	1825	2232	1669	3577	1417	2136	4458	3053	892	2273	1342	1993	3725	1564	3736	560	1590	1721	4386	2676	4728	3172
93_Birth length	93_Birth length	25	561	1	3271	3877	3062	3376	561	755	1454	4653	2387	2664	4394	4108	4491	2467	3804	906	1206	4352	3605	2906	4684	2687
16_Posttraumatic stress disorder	16_Posttraumatic stress disorder	25	561	1	1922	3442	3600	3939	4129	3935	561	1443	1617	4060	3193	1099	3007	1229	3675	3857	2557	3998	1677	4446	3010	3410
1026_Femoral Neck Length (FBAT, adjusted for multivariable)	1026_Femoral Neck Length (FBAT, adjusted for multivariable)	25	561	1	4370	4683	1127	4714	3617	3099	785	4133	3620	2233	1178	741	561	3125	1279	1916	1126	586	3331	4602	587	567
2439_DLL4 - Delta-like protein 4	2439_DLL4 - Delta-like protein 4	25	561	1	2941	3235	3903	1415	604	3894	2157	2043	3191	1695	1653	4083	3336	2285	3012	561	1917	733	3555	2664	3503	3148
3253_Cereal intake	3253_Cereal intake	25	562	1	3563	2866	1537	2691	4533	731	908	746	1977	1353	562	4319	4543	1918	1404	4659	1755	3901	1966	3575	4025	1374
1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	25	562	1	3188	1625	1273	3035	2517	2894	710	4661	3550	3812	4031	2933	1474	562	4497	4592	2140	1336	3162	3649	1636	1064
3174_CST1 - Cystatin-SN	3174_CST1 - Cystatin-SN	25	562	1	4588	3504	2652	4085	4172	3627	2163	3201	2586	2189	2066	3630	3884	833	4188	3315	4099	3093	562	3844	1871	4349
3958_Antisocial behavior (male)	3958_Antisocial behavior (male)	25	562	1	4195	901	2290	1121	2740	4188	3929	3452	1490	2861	3882	3297	1305	3875	2702	2638	3222	788	2967	2734	2733	562
4565_Left postcentral	4565_Left postcentral	25	564	1	564	3354	3186	2965	4158	3115	4480	2047	3875	4492	4337	1006	3769	3353	2453	4725	3683	3125	1497	2869	2466	1059
453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	25	564	1	2815	2163	564	4097	1326	2576	3629	1540	718	3145	4529	1529	3525	2122	2110	4404	3826	4391	3810	2342	2876	2030
3867_Reticulocyte fraction of red cells (two-way meta)	3867_Reticulocyte fraction of red cells (two-way meta)	25	564	1	2959	2412	4661	1250	2657	3344	1598	3949	3711	4505	4522	1732	1391	1157	564	728	3697	2352	2074	4365	1156	4633
3970_GLP-1 stimulated insulin secretion	3970_GLP-1 stimulated insulin secretion	25	565	1	2644	1859	2517	2634	3396	1344	3598	2444	565	2857	2266	861	2568	4097	4294	4571	4710	605	1634	1210	3509	1641
4720_External capsule mode of anisotropy	4720_External capsule mode of anisotropy	25	565	1	606	1413	4187	4652	4586	3669	2581	1915	713	3604	4583	565	1952	3427	3175	4339	1660	3288	2945	2772	2908	3292
3851_Mean corpuscular hemoglobin (two-way meta)	3851_Mean corpuscular hemoglobin (two-way meta)	25	565	1	3365	1998	4213	3467	2523	1803	4305	4722	2710	1013	3815	2174	565	1164	2134	3954	1102	3639	3616	4047	2586	1188
3330_Fractured/broken bones in last 5 years	3330_Fractured/broken bones in last 5 years	25	565	1	4020	4618	1920	883	2421	3620	874	2361	4726	3809	2676	1831	4271	1370	1199	893	1337	3158	4017	1359	4484	565
313_CD4nv:%TFH (1)	313_CD4nv:%TFH (1)	25	566	1	957	4535	1855	843	3241	3302	693	4424	2065	2850	729	643	3244	3623	566	3377	3574	1983	3937	1939	1165	1603
723_::::X-11550	723_::::X-11550	25	567	1	4598	1780	3300	3262	1316	567	2155	833	2837	677	2057	2836	3218	568	4727	3220	1856	2893	1309	3133	687	581
2102_MMP9 - Matrix metalloproteinase-9	2102_MMP9 - Matrix metalloproteinase-9	25	567	1	1522	4466	4259	3331	1691	3589	3075	1810	1296	567	3997	3843	2579	3841	4660	4581	3865	2432	3814	3524	584	4284
4553_Left isthmus cingulate	4553_Left isthmus cingulate	25	568	1	2016	2867	1086	3696	1386	1514	3001	3368	2260	568	3170	4369	927	3580	3650	4631	2186	2511	4264	3962	2912	1468
1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	25	568	1	2169	2846	3933	3041	3682	2937	3047	3716	2738	3512	568	2971	4011	635	3835	4267	2267	4694	1073	1484	4460	1249
1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	25	568	1	3979	4252	3376	2848	1644	2202	1072	1307	2526	3601	4484	3490	4465	3951	568	1270	636	1363	1468	4007	1764	2147
1058_Amyotrophic lateral sclerosis	1058_Amyotrophic lateral sclerosis	25	568	1	1099	1710	582	1337	813	696	3730	1725	3222	3742	4158	1578	4216	1001	3951	2071	1813	568	3372	2344	1659	1819
358_earlyB:%27+	358_earlyB:%27+	25	568	1	1418	2723	709	1819	2481	2855	3221	1163	1649	4017	4272	1938	2849	1799	4526	1290	3149	1911	568	2450	2950	2582
2952_ENG - Endoglin	2952_ENG - Endoglin	25	569	1	4345	4439	569	2616	1271	3932	3517	4689	2435	2275	2329	4302	2134	3922	3129	2559	4208	1756	4615	3023	2803	2419
2642_BMP6 - Bone morphogenetic protein 6	2642_BMP6 - Bone morphogenetic protein 6	25	569	1	3500	1010	3709	4574	4566	1924	4286	1644	688	814	569	1703	4564	1767	1113	3649	2652	2652	4275	2665	2452	1428
1112_Visceral sdipose tissue volume (male)	1112_Visceral sdipose tissue volume (male)	25	569	1	4029	4358	3657	633	3716	2205	1635	871	3453	1877	4279	4001	3214	2491	1997	4271	1852	4212	3503	3275	569	4128
1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	570	1	634	2124	3793	4442	2439	1077	3460	1696	1511	2250	570	4431	4565	1393	2350	4505	1951	876	928	1960	2839	3446
4429_Cytomegalovirus seropositivity	4429_Cytomegalovirus seropositivity	25	570	1	1072	2798	3819	2804	4389	2501	2593	3044	1365	2209	3453	1455	570	4283	2906	4205	3668	2209	660	3143	2559	1380
1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	25	571	1	895	1240	4428	1951	1090	1050	2495	4206	2643	3491	571	3635	4267	4406	4047	1526	3199	3791	3718	2155	995	2924
332_NKeff:%Act(335+)	332_NKeff:%Act(335+)	25	571	1	2631	668	2281	3691	1932	862	1644	2489	3417	4250	3321	715	3723	1396	571	3865	4055	1537	1860	2813	1182	4577
2707_CDC37 - Hsp90 co-chaperone Cdc37	2707_CDC37 - Hsp90 co-chaperone Cdc37	25	573	1	839	1835	2264	3750	775	1044	1806	4214	573	1861	2004	942	3016	4026	4302	828	3615	2737	1511	2690	578	3877
1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	25	574	1	2651	3473	2076	1777	3196	3238	3276	574	1454	3329	4037	3383	856	2660	3606	1610	2406	2662	643	2447	3425	1086
368_Amino acid::Butanoate metabolism::2-aminobutyrate	368_Amino acid::Butanoate metabolism::2-aminobutyrate	25	575	1	2541	3836	3680	575	3133	1487	3565	3064	3561	2387	3188	1907	2208	2695	3838	1289	2957	4521	684	1195	869	1589
2449_IL24 - Interleukin-24	2449_IL24 - Interleukin-24	25	575	1	1283	3478	2996	2147	3448	2931	3497	575	649	3841	2393	1584	1310	809	2333	2577	1273	4089	3325	1000	2000	1245
768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	25	575	1	2263	849	3367	1249	4515	1453	4406	2707	2362	4384	3978	1748	685	3437	4277	2752	3304	3068	575	2343	2791	4601
2459_TFPI - Tissue factor pathway inhibitor	2459_TFPI - Tissue factor pathway inhibitor	25	576	1	576	4016	2475	2208	1047	2630	4578	3370	624	3153	2050	2840	2118	2412	4238	3786	2208	777	1277	3148	4291	3363
3989_Heart rate recovery at 50 secnds	3989_Heart rate recovery at 50 secnds	25	576	1	2471	3842	2882	3358	576	1335	1357	1983	4577	967	2156	2302	1374	1198	2141	4263	2355	1134	2511	3762	2487	2473
4456_Left medial orbitofrontal	4456_Left medial orbitofrontal	25	576	1	4674	730	4058	3856	918	2513	870	2562	1803	3692	2912	4216	2040	1758	4146	576	3981	2282	966	2427	2351	4290
3402_Fluid intelligence test - FI3 : word interpolation	3402_Fluid intelligence test - FI3 : word interpolation	25	576	1	3657	2706	4176	3960	2110	1169	4251	3490	3369	1194	1149	3726	2643	3859	1235	2932	4178	1781	4456	778	4218	576
1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	25	577	1	3717	4365	2226	577	2209	3023	611	2821	2334	666	2763	3420	922	2886	4612	2592	3084	691	4468	1921	1105	4536
2515_CSNK2A1 - Casein kinase II subunit alpha	2515_CSNK2A1 - Casein kinase II subunit alpha	25	578	1	4501	3637	1816	1280	1255	3044	4683	3049	3980	4491	698	3971	1995	578	738	2672	1567	4272	3855	3197	923	583
1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	25	578	1	2734	1822	4344	909	2911	4366	1043	1206	4217	3565	1761	4580	3655	1876	4134	2501	4688	578	1889	2260	2703	3081
3615_Treatment/medication code: lansoprazole	3615_Treatment/medication code: lansoprazole	25	579	1	1685	2132	2602	3658	3139	2255	4319	579	3659	3426	1617	731	3013	1238	1586	3177	2885	2106	2117	2081	927	979
1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	25	579	1	2756	1345	2605	4327	3471	2397	1414	2247	3023	2689	2030	3949	3531	4437	579	4142	2523	785	4453	583	4251	2649
3718_Amount of alcohol drunk on a typical drinking day	3718_Amount of alcohol drunk on a typical drinking day	25	579	1	4419	4336	2446	4563	4625	4019	3960	1266	1825	3291	2638	2131	987	3217	1304	4500	1647	4340	579	3335	3570	3142
1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	25	580	1	3223	1338	3939	3086	3301	920	1952	580	2737	3300	3492	1942	1189	1965	2598	1208	2282	3990	1509	3637	1160	3401
2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	25	580	1	3145	1624	2182	3477	4713	3382	2063	1769	1781	924	3204	870	1002	580	4455	1414	1839	2135	2537	2381	2638	2763
4380_Phltrium width	4380_Phltrium width	25	580	1	1164	3251	803	4388	3756	3892	3172	2452	3982	1942	4043	2687	2743	581	580	3020	4540	2850	1624	1556	1166	3662
425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	25	580	1	3289	4325	3557	4425	2752	4021	1847	2117	2488	3429	2951	3922	4588	1065	1087	4545	1572	580	4702	1392	3632	2821
2898_PPY - Pancreatic hormone	2898_PPY - Pancreatic hormone	25	581	1	1427	4039	720	1258	2929	581	1376	1594	2308	1343	4580	2355	2803	3326	3182	1451	2319	4644	1118	4237	3447	3059
2749_NTF4 - Neurotrophin-4	2749_NTF4 - Neurotrophin-4	25	581	1	3126	1210	1152	1129	2708	3396	2519	1172	4114	3106	4645	581	3597	4355	2799	2239	2752	3882	3178	4042	1773	3310
1141_Chronotype	1141_Chronotype	25	582	1	582	3468	925	4288	4521	861	707	3869	1618	3044	3950	3142	747	4010	1468	2276	2893	1557	3680	4382	1903	2569
2765_TG - Thyroglobulin	2765_TG - Thyroglobulin	25	583	1	2363	583	1266	3420	3173	1392	2005	684	3099	1618	3709	2480	1907	1167	1357	4014	2222	1183	2150	3974	2362	4117
44_Household income	44_Household income	25	583	1	3431	2737	756	1181	4296	4108	3949	1979	3236	583	3523	1686	3839	1302	1896	3730	1874	1754	636	3971	815	1211
2190_C3 - C3a anaphylatoxin des Arginine	2190_C3 - C3a anaphylatoxin des Arginine	25	583	1	4043	3700	1468	1817	3543	1720	2903	3889	2179	3522	583	4601	1703	2896	1927	4531	2654	3290	1508	4084	2705	3447
4605_Right supramarginal	4605_Right supramarginal	25	583	1	3970	3398	2929	955	4430	2864	2181	641	3197	1326	4002	2225	1394	1682	583	4694	4731	2880	3877	889	4623	4648
3650_Illnesses of siblings: Breast cancer	3650_Illnesses of siblings: Breast cancer	25	584	1	3113	3043	2778	4587	3094	2021	3503	4457	2727	2905	3568	4542	3502	2344	763	1486	584	2540	3126	3669	3713	1216
3770_Depression - Trouble falling or staying asleep. or sleeping too much	3770_Depression - Trouble falling or staying asleep. or sleeping too much	25	586	1	2022	586	3397	1838	3941	2270	1942	4253	987	914	1739	3181	630	952	4161	3487	3721	3367	3176	4658	1989	4509
4483_Right isthmus cingulate	4483_Right isthmus cingulate	25	586	1	3995	2562	3822	3413	4254	3888	2776	3284	3426	586	4383	3881	2091	4538	1026	3505	1730	4318	1317	2029	2013	1750
3092_SCARF1 - Scavenger receptor class F member 1	3092_SCARF1 - Scavenger receptor class F member 1	25	586	1	2898	2020	4705	2694	2018	4416	1690	968	2720	4029	3230	3805	586	4431	3405	3703	3160	917	2748	2597	4571	3968
4756_Uncinate fasciculus radial diusivities	4756_Uncinate fasciculus radial diusivities	25	587	1	3971	2053	2320	3973	4644	2708	3224	1241	587	3381	3099	3027	3826	1529	3909	2921	2454	2028	2075	4708	2109	3735
2787_L1CAM - Neural cell adhesion molecule L1	2787_L1CAM - Neural cell adhesion molecule L1	25	587	1	1693	3523	3085	796	1034	2471	1280	3998	2306	2779	2104	587	1811	1150	3196	876	3427	3298	1755	4700	3981	1975
2061_F11 - Coagulation Factor XI	2061_F11 - Coagulation Factor XI	25	587	1	1483	2968	2037	2765	3689	1611	4020	3553	4621	2538	2786	3234	587	1582	2639	1248	3556	1736	3574	1382	3847	1778
2489_PAK3 - Serine/threonine-protein kinase PAK 3	2489_PAK3 - Serine/threonine-protein kinase PAK 3	25	588	1	2453	3310	4445	3621	2967	1477	4087	4360	4367	2017	1269	2638	4569	4370	588	2783	3361	3578	3248	4719	842	3217
1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	588	1	2954	3340	2294	1514	1371	1029	2198	705	4295	2170	2513	4062	1065	4575	3653	1991	588	1946	820	2390	3184	3887
2714_LMNB1 - Lamin-B1	2714_LMNB1 - Lamin-B1	25	589	1	3137	589	2289	3634	3197	1752	1595	4586	4364	2871	4699	2129	2280	4199	2847	3384	2023	2796	2053	1756	2048	4094
1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	590	1	590	935	2407	2453	1581	4483	1279	3746	1924	3049	3131	1738	4696	1271	4372	3041	3853	1292	1191	1741	2657	1070
4337_Sleep durataion	4337_Sleep durataion	25	590	1	1012	3659	649	1417	3427	590	1984	4024	2548	3534	4192	3144	4545	1161	2005	3927	604	2366	4421	4569	3655	3789
1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	24	590	1	878	2714	2144	3120	4063	2398	3313	1970	2325	4353	897	3910	594	3903	590	2284	1537	2003	3173	2456	2426	2694
3351_Had other major operations	3351_Had other major operations	25	590	1	1622	3149	2509	3759	1157	4253	3218	1499	1701	1955	3064	2313	3504	4739	2570	2151	1456	3233	4440	3560	2489	590
682_::::X-10395	682_::::X-10395	25	592	1	667	1172	1422	1728	2095	4051	592	716	4661	4497	4130	4612	1024	3796	1006	3094	2167	2011	2870	2108	4600	1373
2958_CGA CGB - Human Chorionic Gonadotropin	2958_CGA CGB - Human Chorionic Gonadotropin	25	592	1	1940	1655	1318	2854	2718	1704	862	1877	592	4453	3571	4697	3862	2811	1893	3512	954	1169	3055	3792	4547	1178
3393_Number of depression episodes	3393_Number of depression episodes	25	592	1	2712	1594	3379	1511	3759	3337	1796	3151	2931	4524	3547	2823	889	4446	3727	2527	1518	3744	2499	1977	592	2058
3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	25	593	1	1007	1150	4738	2156	3687	1999	3510	593	1026	1869	2345	4567	1274	1776	4162	2983	3812	2315	1729	3151	4335	2951
4485_Right lateral orbitofrontal	4485_Right lateral orbitofrontal	25	593	1	1575	2325	3505	632	937	1900	838	1431	3709	3740	2764	3604	4439	4060	593	1308	1676	1347	893	2363	940	4382
4752_Superior corona radiata radial diusivities	4752_Superior corona radiata radial diusivities	25	594	1	1426	3495	1558	2882	2312	3870	2093	605	693	3619	3673	3585	2114	4425	1752	2766	858	1702	594	4589	4441	862
4062_Urinary albumin-to-creatinine ratio	4062_Urinary albumin-to-creatinine ratio	25	595	1	2354	1682	595	4427	1810	2464	1788	1165	3157	4232	939	1805	4122	3174	1405	2162	4326	1340	1213	4448	1131	1933
2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	25	595	1	2227	2843	4267	2611	3106	4300	4586	3625	2831	4544	1717	1892	595	4342	2675	1841	2537	833	1424	1123	1444	1117
4617_Optic chiasm	4617_Optic chiasm	25	597	1	4366	1525	4235	2887	597	3183	3413	4640	631	2837	927	1976	4050	3228	645	750	4124	2967	3919	1129	3362	4625
3900_Red blood cell count (three-way meta)	3900_Red blood cell count (three-way meta)	25	597	1	3350	1343	1481	1666	4183	4397	1249	2066	4218	597	745	1202	4302	1984	1677	4402	3520	1794	2533	2621	3085	611
3369_Frequency of other exercises in last 4 weeks	3369_Frequency of other exercises in last 4 weeks	25	597	1	3393	1451	4157	2151	3602	1558	1648	3987	894	2615	3229	4744	857	4473	3261	4100	1158	4383	3535	597	2666	2111
247_CD56 on 2+NK eff	247_CD56 on 2+NK eff	25	598	1	3399	2482	3831	2656	4573	2516	3893	3429	2312	2883	2505	2334	3276	4467	1424	4463	1622	4604	3614	3299	1342	598
315_CD8mem:%PD1+R6+	315_CD8mem:%PD1+R6+	25	600	1	4625	1393	4423	600	893	1140	3059	4561	2202	2228	849	2665	1668	2754	2984	938	1464	1562	2305	3514	1954	884
4675_Corticospinal tract axial diusivities	4675_Corticospinal tract axial diusivities	25	600	1	1981	1590	1295	3259	2069	4742	4166	2925	2509	3034	4395	600	1490	3984	1568	2312	4353	3492	3047	1140	4598	3403
1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	600	1	2827	3530	1940	1641	1572	4002	2706	2581	3114	2994	2876	1275	4250	600	2308	678	3027	3810	4581	2700	2267	1728
1841_Neck width (GEE, male, adjusted for age)	1841_Neck width (GEE, male, adjusted for age)	25	602	1	1596	1617	2930	3552	758	2123	670	4200	1686	3587	2273	4267	2189	3665	1856	602	4269	1413	3211	1696	3600	4518
4214_Type 2 Diabetes	4214_Type 2 Diabetes	25	603	1	1118	2042	3335	603	1186	3552	738	4730	1459	3973	2187	4177	1892	1950	1654	919	3964	4231	4080	1694	841	3893
4005_Osteoarthritis (self reported)	4005_Osteoarthritis (self reported)	25	603	1	2397	1040	4529	1338	4353	1651	791	603	1695	1951	2489	2135	3587	3121	3166	3035	3602	1726	2482	1160	1987	3753
1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	25	603	1	4269	1231	4516	3531	999	3688	3091	2123	4169	1954	3411	2401	2167	2968	603	3681	3264	3628	3221	3656	4244	4199
1110_Subcutaneous adipose tissue volume (female)	1110_Subcutaneous adipose tissue volume (female)	25	604	1	3349	604	1583	3439	3670	3070	2825	2724	3767	1261	2643	4437	795	2605	3132	3611	971	3230	4038	2925	4661	3195
798_::::X-12734	798_::::X-12734	25	605	1	2464	4369	1746	4532	4333	4210	4195	4515	3774	3643	4568	605	2191	3590	3288	3601	1375	2204	3459	1104	3676	2033
4013_Major depressive disorder (ICD-coded)	4013_Major depressive disorder (ICD-coded)	25	606	1	2584	3762	2511	3447	4516	2233	1257	879	4594	4539	1372	4030	3301	3571	2823	2716	2520	2459	1340	606	2392	3564
2851_SPHK2 - Sphingosine kinase 2	2851_SPHK2 - Sphingosine kinase 2	25	607	1	4596	4389	607	1156	4060	915	2600	4714	3350	3347	2741	2241	3958	829	2088	2981	1911	2338	800	2351	3942	4573
4599_Right precuneus	4599_Right precuneus	25	607	1	2151	4729	1578	2949	2583	1451	1843	4004	4065	3681	607	4288	4728	3731	4348	3383	4420	4011	4103	3487	1260	2247
2066_PROK1 - Prokineticin-1	2066_PROK1 - Prokineticin-1	25	608	1	2497	608	2079	2393	3423	1175	4706	1938	3585	3813	4624	1618	2690	3997	2940	2001	4534	3431	4488	2371	2773	1761
4372_Free thyroxine (FT4)	4372_Free thyroxine (FT4)	25	608	1	1361	751	4541	2528	608	850	1679	756	935	4363	2758	691	1622	1457	1608	1860	2229	3751	3794	2259	1523	3862
2488_LYN - Tyrosine-protein kinase Lyn, isoform B	2488_LYN - Tyrosine-protein kinase Lyn, isoform B	25	610	1	2475	1476	4260	3442	1031	3255	610	4063	2491	3763	4552	3279	1457	1289	1293	1064	4582	3633	1649	3297	4368	808
1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	610	1	1829	3615	2399	1491	4407	2633	1061	3435	4244	2817	2814	4193	1108	757	610	1994	4635	2561	4307	3325	2975	2611
3609_Treatment/medication code: omega-3/fish oil supplement	3609_Treatment/medication code: omega-3/fish oil supplement	25	611	1	649	2060	3770	1596	1243	647	2215	4047	4412	2583	4655	611	2611	1100	1196	3339	1561	1662	3825	4266	1465	2673
2233_MET - Hepatocyte growth factor receptor	2233_MET - Hepatocyte growth factor receptor	25	611	1	3776	4398	4203	3735	1022	2247	2530	2222	4276	2229	1973	3226	1331	1397	3328	611	2682	2064	4418	3414	3103	1511
2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	25	611	1	2476	1948	3818	3563	3510	4666	2708	1901	2986	1819	1326	3762	3653	4239	4031	4331	3958	611	4561	2861	3650	3187
2445_GPC2 - Glypican-2	2445_GPC2 - Glypican-2	25	612	1	612	2570	3268	1724	1218	3318	3516	3147	4109	2296	1098	2802	1347	2286	3451	1024	4369	4361	1478	853	3350	3012
758_::::X-12116	758_::::X-12116	25	612	1	4132	4137	2339	2503	2406	2727	3312	2177	2008	612	3733	4642	1589	3319	3034	1072	4344	798	3688	2080	4525	2534
415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	25	612	1	4571	2176	2809	2874	2501	2429	3217	4610	3771	2065	3196	3145	1036	1463	2123	2034	612	3366	917	2013	4593	835
4575_Left transverse temporal	4575_Left transverse temporal	25	612	1	3002	2486	2703	4110	3997	4674	4510	3120	3059	2866	1088	3673	4247	925	2543	3379	3825	1747	612	1039	4628	1582
1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	25	612	1	2479	4393	1240	3110	4675	2474	2624	1793	1392	2476	3596	1717	4601	2976	3966	1530	3006	3866	1287	984	612	1793
439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	25	613	1	2417	4216	3875	3677	2986	789	3405	2893	3338	2556	998	1662	3027	613	3198	3810	3204	2749	1203	4723	1714	1995
3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	25	613	1	3742	3337	1689	815	2185	1831	3307	3621	1879	3848	3223	615	3929	2006	4392	1791	613	743	1257	2200	717	1638
58_College completion	58_College completion	25	613	1	2496	3208	3447	3352	4413	1090	3789	1474	1576	2504	4623	3768	1564	1737	1833	4584	768	2758	613	1967	3641	2333
3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	25	613	1	2540	4513	2515	4462	788	4477	3555	1374	1302	4103	3650	1530	4681	4280	3108	3875	1379	2775	2030	1013	613	4440
3173_ALCAM - CD166 antigen	3173_ALCAM - CD166 antigen	25	613	1	4329	4170	1710	3663	863	1819	4463	2200	3137	2249	1779	840	3731	1646	4107	884	767	2310	770	3149	967	613
3160_PIM1 - Serine/threonine-protein kinase pim-1	3160_PIM1 - Serine/threonine-protein kinase pim-1	25	614	1	3073	4133	1098	614	2921	2212	3759	3642	4740	3595	4363	4249	2205	806	3054	2404	3783	3932	4327	2237	649	3313
3897_Plateletcrit (three-way meta)	3897_Plateletcrit (three-way meta)	25	614	1	4151	4724	3979	658	2288	1621	614	3500	726	4619	1981	3901	1229	3410	3724	3213	1186	3118	3480	822	3186	1528
35_Loneliness (linear)	35_Loneliness (linear)	25	614	1	2761	2542	3732	3769	2606	4627	3183	1231	1434	3010	4628	2750	3452	3709	614	2324	4071	2055	1136	2719	3904	2031
3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	25	616	1	3194	4108	3667	1154	2038	2524	1830	1821	1842	616	4089	1634	2861	1954	4537	2431	842	3145	808	2190	3799	3250
42_Self-rated health	42_Self-rated health	25	616	1	4252	654	4543	2096	3820	3715	2494	3637	1991	1196	4047	4223	3529	2503	4642	1976	931	806	991	1568	616	1358
2585_CTSE - Cathepsin E	2585_CTSE - Cathepsin E	25	617	1	1265	2086	4615	2642	2552	1775	1196	2937	4616	617	2708	4558	622	3224	1079	3696	3354	2191	964	4479	4609	3847
4308_Osteoarthritis of hit or knee	4308_Osteoarthritis of hit or knee	25	618	1	900	3622	2046	2114	618	2094	3170	3095	4501	3657	1255	3182	2678	2718	1488	700	3933	4548	2829	4040	4081	2073
657_::::X-03094	657_::::X-03094	25	618	1	3528	3720	1737	1874	2717	2319	1880	4061	4699	4612	898	3601	702	618	3994	3144	2145	4251	1662	4528	2676	1496
3978_Lean body mass (appendicular)	3978_Lean body mass (appendicular)	25	618	1	3490	4542	4453	3572	1359	624	4738	883	2017	1012	3408	3354	913	3956	618	4731	1935	3369	1430	1869	4068	1239
47_Age at first birth	47_Age at first birth	25	619	1	2890	619	3806	1472	3004	2674	641	3672	2563	1810	1374	2633	2998	2415	3209	2808	3148	3051	1816	839	1265	1355
1762_Prostate cancer (FBAT, adjusted for age)	1762_Prostate cancer (FBAT, adjusted for age)	25	619	1	2704	3084	4303	619	2495	4645	3971	3102	793	3253	1395	627	3186	3432	1979	1035	1850	3141	1721	4178	3232	2421
4059_Estimated glomerular filtration rate based on cystain C	4059_Estimated glomerular filtration rate based on cystain C	25	619	1	3949	4012	1454	3226	4011	4642	619	710	3878	4296	1290	3254	2334	1036	2849	4145	3470	4519	3667	3563	3507	4262
818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	25	619	1	1532	1608	4325	840	4735	1007	1628	619	3850	3777	1041	4370	1727	4740	4362	1722	3788	1509	1597	4294	4324	3943
1891_Shaft Width (GEE, male, adjussted for age)	1891_Shaft Width (GEE, male, adjussted for age)	25	619	1	4448	3032	2804	2717	2519	1852	2789	4580	3963	4290	4597	1189	619	1235	3171	3590	1802	1354	1390	4103	656	4314
1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	620	1	2656	3090	3013	1706	965	620	2613	666	4191	860	2058	3272	1233	2223	3285	802	840	3065	1076	1717	3727	2580
2691_NACA - Nascent polypeptide-associated complex subunit alpha	2691_NACA - Nascent polypeptide-associated complex subunit alpha	25	620	1	811	1035	2069	873	2743	3650	2803	4705	2569	3671	1992	620	2262	853	809	4721	2719	749	4292	3327	3950	4111
1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	25	620	1	3278	3598	2190	2131	2557	4053	1956	4083	1410	4111	3655	1203	2621	927	1662	2081	4074	3299	620	3793	2235	4249
4333_Polycystic ovary syndrome	4333_Polycystic ovary syndrome	25	620	1	3471	3378	2382	2973	1550	4119	4101	3698	4213	3735	3097	3935	2808	989	1470	2557	3490	1872	2750	3559	3303	620
4438_Helicobacter pylori IgG levels	4438_Helicobacter pylori IgG levels	25	621	1	1335	4472	3019	3006	3306	2914	1895	2428	621	3725	4728	4460	977	4020	1821	3757	3065	1279	3280	2189	3656	2289
3730_Depression - Age at last episode of depression	3730_Depression - Age at last episode of depression	25	621	1	2575	2335	3429	771	3432	3656	4243	4305	2927	2896	3810	886	1821	2750	2678	3641	1439	4453	4024	2753	621	3381
2284_CGA LHB - Luteinizing hormone	2284_CGA LHB - Luteinizing hormone	25	624	1	4524	3856	2487	702	1093	4142	835	2875	1204	1017	1592	3709	2244	1579	624	2106	3874	1546	3014	3623	4104	3935
4169_Open-angle glaucoma (random-effect model)	4169_Open-angle glaucoma (random-effect model)	25	624	1	1323	2291	3940	3970	3631	1373	2838	2162	3622	2477	3779	1637	1965	3819	1922	4499	1688	882	624	2204	3153	1708
4492_Right pars orbitalis	4492_Right pars orbitalis	25	626	1	3474	3632	1123	2150	1190	2082	1582	3057	3219	2450	683	3989	4641	4512	4211	626	4719	1688	3828	982	1401	2704
2250_KPNA2 - Importin subunit alpha-1	2250_KPNA2 - Importin subunit alpha-1	25	627	1	2800	2555	3826	916	4166	1708	4349	627	2815	3001	863	3611	2700	2736	1529	3561	2396	4218	3559	1018	4652	1487
3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	25	628	1	3000	4196	786	1759	2843	2496	3298	4427	1300	2799	628	1862	3658	1715	2824	3780	2675	3314	652	1145	2262	4216
482_Lipid::Carnitine metabolism::laurylcarnitine	482_Lipid::Carnitine metabolism::laurylcarnitine	25	628	1	4500	699	2350	2211	3761	4215	3923	4040	4696	1655	4535	2128	3172	628	1989	3740	2906	1465	1181	922	4124	3055
3342_Birth weight of first child (female)	3342_Birth weight of first child (female)	25	629	1	994	1068	3436	4601	2102	822	2357	1929	4394	2474	2980	4289	3912	3805	1798	1547	2853	629	4306	4334	1772	2906
1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	25	630	1	1076	3927	1648	3478	4380	4147	2867	1808	4088	630	4472	3122	1081	1079	3742	2941	2783	2318	2172	1565	804	3990
2566_CXCL12 - Stromal cell-derived factor 1	2566_CXCL12 - Stromal cell-derived factor 1	25	631	1	3428	3593	868	3650	1929	2494	750	4491	2301	4486	4301	2324	2484	631	2558	2318	2733	910	1266	3841	1539	1849
2132_LAYN - Layilin	2132_LAYN - Layilin	25	632	1	632	3945	655	4148	3639	4563	2629	3406	855	4382	2526	4304	2848	2894	4410	4257	3543	2151	1333	2852	1794	4029
4319_Life satisfaction (univariate)	4319_Life satisfaction (univariate)	25	633	1	633	2658	2056	995	960	1489	1817	4733	934	2239	2541	3834	1975	2134	1514	4283	3951	2754	1907	3664	4320	728
692_::::X-11315	692_::::X-11315	25	633	1	1224	1797	3787	1996	3424	3911	4367	633	3367	2813	1856	4375	4390	1891	4705	2611	2724	1534	1873	4135	2149	3025
4539_Right amygdala	4539_Right amygdala	25	633	1	2305	1529	4417	4064	1011	2933	1362	3871	1758	1561	2278	633	1084	2061	1881	2249	4516	2953	2547	1555	3642	4063
194_Estimated glomerular filtration rate based on cystain C	194_Estimated glomerular filtration rate based on cystain C	25	633	1	4493	1922	1518	2602	4603	3576	2834	1369	4340	2751	2432	2329	3332	3918	633	1030	1790	890	1993	4048	766	1342
1116_Visceral sdipose tissue volume (adjusted for BMI, female)	1116_Visceral sdipose tissue volume (adjusted for BMI, female)	25	633	1	1877	2940	1799	2447	3876	1243	3966	2217	4083	998	3729	1964	4336	1325	2556	3399	633	4171	2774	4408	3367	2464
2042_Attention function - Standard error of hit reaction time - Child	2042_Attention function - Standard error of hit reaction time - Child	25	634	1	4503	3916	2064	4339	4525	2622	1816	2157	634	1091	1753	3974	1007	2141	4044	2914	4003	1137	2817	2118	1138	1771
4474_Left transverse temporal	4474_Left transverse temporal	25	635	1	2718	3129	1241	3780	3778	4529	4745	2684	2101	2943	1375	1192	1211	1596	3734	3046	2645	1182	1005	635	2641	2451
795_::::X-12726	795_::::X-12726	25	637	1	3140	3237	1165	3796	762	2347	3715	4727	1870	1926	3558	4563	3688	2696	637	1852	3888	3166	1505	1530	4674	4297
2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	25	638	1	3617	1828	2006	4169	2771	852	638	3989	1620	1270	2036	4707	1357	1437	2997	2631	3030	2314	3883	1794	2584	3475
3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	25	639	1	1687	1852	3984	2850	759	3358	639	3655	4032	2785	890	929	2047	1595	1535	2750	2233	2726	2400	1316	2659	4587
3145_CD86 - T-lymphocyte activation antigen CD86	3145_CD86 - T-lymphocyte activation antigen CD86	25	639	1	2697	2906	1715	4364	4534	971	2921	1818	639	4446	1903	4458	788	1585	2617	4429	2983	2014	2792	2688	1040	3436
3375_Time since last prostate specific antigen (PSA) test	3375_Time since last prostate specific antigen (PSA) test	25	639	1	2578	2067	2969	3305	4227	2707	3599	4312	3484	2988	2331	4721	2458	981	639	1418	4028	4381	3631	4013	3905	719
2584_CASP3 - Caspase-3	2584_CASP3 - Caspase-3	25	640	1	1255	2441	3893	2520	3545	2238	3888	971	3281	4235	1654	1566	967	649	773	2412	2306	2639	3999	640	1161	916
3566_Vitamin and mineral supplements: Multivitamins +/- minerals	3566_Vitamin and mineral supplements: Multivitamins +/- minerals	25	642	1	3820	2393	3595	4058	2456	1944	1866	1963	642	3782	2378	1306	1192	2074	3315	2424	1137	3427	2639	3781	2366	2810
357_earlyB:%27+38-	357_earlyB:%27+38-	25	642	1	1895	3731	2171	1965	2402	2049	875	1332	1373	642	2753	1436	2601	2505	1588	995	2779	3527	1421	4640	3689	2418
4503_Right superior temporal	4503_Right superior temporal	25	642	1	4650	4499	4702	2777	1094	3698	4334	4287	2607	4104	4247	4107	1878	2728	1363	2391	2404	2030	2894	1856	2502	642
4379_BRCA1/2-negative breast cancer	4379_BRCA1/2-negative breast cancer	25	643	1	753	1544	4520	4167	1013	3780	4335	3502	1694	1451	1948	2250	643	4653	1803	1334	745	4419	1123	1351	2740	917
2172_CSF3R - Granulocyte colony-stimulating factor receptor	2172_CSF3R - Granulocyte colony-stimulating factor receptor	25	643	1	814	4209	2430	3239	2849	2998	1234	3346	4528	4337	2199	1278	1764	643	3910	1609	3644	2477	3499	1891	773	4273
3548_Mouth/teeth dental problems: Toothache	3548_Mouth/teeth dental problems: Toothache	25	643	1	3898	3655	2667	4407	3815	1795	2033	2102	760	4578	895	2765	3335	3382	643	4433	2193	3561	3386	4015	1650	1340
4341_Moderate intesity	4341_Moderate intesity	25	644	1	3340	4396	3038	1329	2101	644	1871	2021	2261	991	3433	658	1657	1710	1935	3565	1265	1427	3985	3125	4745	1814
3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	25	644	1	4097	4061	2373	3502	2475	1466	1668	3287	3069	2862	1910	3717	2694	2377	1420	4298	2047	2677	1636	3815	2136	644
3764_Depression - Recent poor appetite or overeting	3764_Depression - Recent poor appetite or overeting	25	645	1	2232	3776	4532	3030	1871	1679	645	1758	2570	1082	2123	2740	1144	1130	1528	2376	4660	2186	1709	2857	4505	1004
2986_CRK - Adapter molecule crk	2986_CRK - Adapter molecule crk	25	646	1	1202	1439	646	2935	2658	4441	2348	1763	1162	1392	3253	3727	4170	2537	1870	3373	4384	4239	1476	1367	1098	978
4750_Retrolenticular part of internal capsule radial diusivities	4750_Retrolenticular part of internal capsule radial diusivities	25	646	1	3735	1052	993	1260	2335	1268	3940	3005	3486	1823	4310	2436	4498	3123	1387	3645	2415	1018	2464	646	2804	1442
1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	25	649	1	4563	2142	3517	4439	2043	694	2926	2897	3514	3258	4460	649	3333	3620	2174	1242	1479	3231	2581	2008	3568	2001
644_Xenobiotics::Xanthine metabolism::3-methylxanthine	644_Xenobiotics::Xanthine metabolism::3-methylxanthine	25	649	1	2926	1123	889	4463	3360	3297	1033	3007	3900	2676	4286	3466	4461	4640	2431	2434	2224	3947	3068	649	3268	1425
1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	650	1	4559	3178	1976	1831	1444	650	2090	3213	4350	3915	1995	1897	3264	1202	1412	1083	4696	4412	1193	3959	4691	2369
3075_RTN4R - Reticulon-4 receptor	3075_RTN4R - Reticulon-4 receptor	25	650	1	1247	3748	2828	2735	2756	3692	1317	4506	2196	2166	2216	3616	3236	2184	1311	1727	650	1898	3135	1040	4021	1100
3624_Treatment/medication code: glucosamine product	3624_Treatment/medication code: glucosamine product	25	650	1	1053	4122	1887	3756	1734	3290	3223	3154	763	2105	2381	4651	2715	3612	2637	4102	3897	3889	2037	2044	3073	650
91_Childhood obesity	91_Childhood obesity	25	652	1	795	967	652	3665	4317	2768	3435	1920	2503	1599	4056	2676	4695	2851	4023	4215	2741	3484	3021	1908	4002	1295
4613_Brain stem	4613_Brain stem	25	652	1	706	3648	2269	1346	2753	3880	652	2865	4209	773	1712	1336	2559	4669	4068	4605	4661	2821	4713	1519	3564	1190
1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	25	652	1	3509	2224	1417	1220	2723	2276	744	2842	1157	891	1426	3246	3898	2069	652	2784	2011	2097	4293	1672	3439	4448
2625_MSR1 - Macrophage scavenger receptor types I and II	2625_MSR1 - Macrophage scavenger receptor types I and II	25	653	1	653	4635	1886	2195	3895	925	4086	1508	3655	2764	4354	2711	4273	2744	1789	4520	2479	4712	2111	3277	1598	2489
2302_ESAM - Endothelial cell-selective adhesion molecule	2302_ESAM - Endothelial cell-selective adhesion molecule	25	653	1	4664	2093	3807	1717	3822	4062	1749	653	4158	2122	2452	1415	3888	800	3771	1917	3140	3117	2188	729	1998	2828
3181_SPOCK1 - Testican-1	3181_SPOCK1 - Testican-1	25	654	1	3523	4536	3660	3731	1982	2688	3061	1807	4503	654	3512	1057	3930	2217	701	2863	3717	2221	4445	4333	1601	4617
1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	25	654	1	4247	3411	1352	4501	1863	1153	3754	2225	3232	1039	3546	951	3999	3697	967	4320	3538	1714	1198	2879	654	2174
2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	25	655	1	2834	3708	3759	882	2765	3430	1532	1151	655	4256	1541	1991	4135	2619	2485	3460	1020	4716	2995	1766	2682	3362
3987_Heart rate recovery at 30 secnds	3987_Heart rate recovery at 30 secnds	25	656	1	1783	4357	1803	3360	879	984	656	4572	3880	1329	1225	2539	1513	3677	3049	4107	3046	1396	3765	3074	3042	3685
2093_CCL5 - C-C motif chemokine 5	2093_CCL5 - C-C motif chemokine 5	25	656	1	1650	2285	3508	1882	2083	2942	1053	4263	4659	656	3065	2714	3194	2658	1015	4294	2141	1290	4480	1693	1232	2753
4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	656	1	1295	2676	3168	4584	3854	3452	681	687	991	1741	656	898	3514	4410	4585	4335	1116	755	3709	1910	2275	2170
2433_CFC1 - Cryptic protein	2433_CFC1 - Cryptic protein	25	657	1	2674	3196	2015	1772	1815	3176	3748	752	4474	3277	780	3335	3281	2232	657	1928	1233	3040	2185	886	2206	2307
4665_Superior fronto-occipital fasciculus fractional anisotropy	4665_Superior fronto-occipital fasciculus fractional anisotropy	25	657	1	1586	2672	2114	3160	1344	1788	3678	3124	4662	3313	3069	4160	1915	3876	4296	1341	2182	657	837	3189	1447	3462
4047_Medial collateral ligament injury	4047_Medial collateral ligament injury	25	658	1	658	2243	1056	3983	2773	1919	3592	2434	3364	3454	858	1699	665	3001	3220	1168	2601	1571	3487	1892	3737	4668
1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	658	1	1559	2191	1185	2628	3255	2834	1406	2801	2622	3575	775	1756	658	3831	4516	2673	3444	1429	2908	3508	926	1929
3581_Types of transport used (excluding work): Car/motor vehicle	3581_Types of transport used (excluding work): Car/motor vehicle	25	658	1	3797	2480	3991	2355	3180	3890	3568	4496	993	4680	1868	4495	1690	3861	658	4118	2735	877	2508	987	3220	3085
342_NKearly:%337+335+R7-	342_NKearly:%337+335+R7-	25	658	1	3890	1139	1733	990	3342	4508	4053	3483	2895	4554	4581	2162	2829	1815	3406	928	1359	658	1727	3757	3451	748
4173_Social support - Leisure/social activities: Sports club or gym	4173_Social support - Leisure/social activities: Sports club or gym	25	659	1	2277	659	2956	3568	1244	3102	4542	1512	4234	2515	4017	1050	4264	4310	4329	1394	2791	969	1892	2269	2900	4189
3297_Frequency of depressed mood in last 2 weeks	3297_Frequency of depressed mood in last 2 weeks	25	659	1	2943	1674	659	1474	1660	4552	3104	1517	2361	1086	2404	3361	2818	4034	2332	2301	2852	4558	2668	2765	2503	4295
2324_FGF2 - Fibroblast growth factor 2	2324_FGF2 - Fibroblast growth factor 2	25	660	1	4721	3119	2235	3195	1030	660	4223	1159	690	4108	4098	4647	1217	4567	3454	692	1226	1177	3621	1445	3664	3537
1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	25	660	1	3435	737	1011	826	1138	4176	2316	1775	4005	4265	2829	2216	660	2634	2519	3126	4039	3520	3764	4279	1363	1452
3082_CD200 - OX-2 membrane glycoprotein	3082_CD200 - OX-2 membrane glycoprotein	25	661	1	842	2708	2660	1448	4682	1582	2424	1860	1372	661	4544	2103	3604	3281	1607	2944	1999	2248	4304	4536	3797	4210
446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	25	663	1	711	1610	4564	3534	4239	1555	4484	1428	3618	3871	1834	3215	663	3889	1750	4435	3514	3482	3583	4302	2119	2718
2202_IL16 - Interleukin-16	2202_IL16 - Interleukin-16	25	664	1	4270	2465	4236	664	3733	2738	1563	3777	2564	4129	689	3298	1682	4428	2321	2086	3572	4709	3736	817	3296	3281
3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	25	664	1	920	2063	2691	3951	3093	664	1882	1482	2713	3793	3642	3244	2679	3952	2583	3655	2448	4722	2959	2003	4253	1085
3847_Immature fraction of reticulocytes (two-way meta)	3847_Immature fraction of reticulocytes (two-way meta)	25	665	1	1260	3924	2982	4677	4297	2044	1627	4454	3707	665	4315	1377	2687	4327	1897	3457	1997	3939	3528	1690	874	2583
1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	25	665	1	3368	3744	1332	2847	2374	888	2807	1528	2233	3734	665	2507	676	1439	2189	4224	1787	776	3759	1281	3938	2998
593_Peptide::Dipeptide::glycylvaline	593_Peptide::Dipeptide::glycylvaline	25	665	1	3304	3646	4128	1088	3581	4647	3647	2956	2472	2066	3215	847	2288	1108	2302	4509	3755	4540	665	1759	2356	3839
2117_EFNA5 - Ephrin-A5	2117_EFNA5 - Ephrin-A5	25	665	1	1185	1576	1191	3625	1897	3348	4431	4204	2034	2464	3728	3493	3599	1709	2531	2882	2001	4287	905	1795	665	4391
2718_MSLN - Mesothelin	2718_MSLN - Mesothelin	25	666	1	1412	1392	1635	2315	3033	2083	1924	1573	3047	2865	3001	808	3675	3102	1683	3054	1709	2802	2032	963	666	1550
1342_Resistin (FBAT, adjusted for age, sex and BMI)	1342_Resistin (FBAT, adjusted for age, sex and BMI)	25	667	1	4186	1011	870	3758	1240	2641	1630	4359	1716	667	796	4096	1174	2117	2832	2021	1476	4420	4138	2932	3608	3904
2259_YES1 - Tyrosine-protein kinase Yes	2259_YES1 - Tyrosine-protein kinase Yes	25	669	1	944	2501	669	3291	4651	2422	4650	1885	3968	3956	1921	3722	3047	4232	4532	1260	2215	1174	4255	2859	3607	3535
3037_PRSS2 - Trypsin-2	3037_PRSS2 - Trypsin-2	25	669	1	985	4651	792	1237	4211	2554	3562	3794	3870	2660	4025	1644	2215	4450	4504	3646	1494	1650	4423	669	3651	3371
217_NKT:%4+R5-	217_NKT:%4+R5-	25	670	1	1796	670	1243	760	1491	2690	2004	930	2243	949	2572	2674	1014	3077	1642	3335	2276	4625	4200	840	4096	2856
2821_NGF - beta-nerve growth factor	2821_NGF - beta-nerve growth factor	25	670	1	1005	1836	844	4185	2188	670	3684	1270	4289	3445	3822	4168	2683	3486	2606	3217	4342	4076	2090	3027	1573	4393
4420_Influenza A seropositivity	4420_Influenza A seropositivity	25	670	1	1336	2330	2570	1189	2691	3352	3744	3517	3843	2510	2426	670	989	3233	1788	3356	3418	1200	3234	4698	4440	989
2245_CHEK1 - Serine/threonine-protein kinase Chk1	2245_CHEK1 - Serine/threonine-protein kinase Chk1	25	670	1	2423	2308	959	4147	4671	4426	1132	890	1568	1449	4222	1168	1209	3570	2450	2161	4463	1099	1147	670	1086	4686
829_::::X-13859	829_::::X-13859	25	671	1	2617	671	838	2317	3980	2953	2310	1005	1255	1178	3846	3516	2089	2869	3378	1328	2293	1554	2960	4307	4536	680
2400_IDE - Insulin-degrading enzyme	2400_IDE - Insulin-degrading enzyme	25	671	1	3058	2889	3746	2821	4136	4329	671	2503	1452	4321	3520	4404	3849	2337	3342	3297	3816	1587	2216	3332	3190	3950
3648_Illnesses of siblings: Heart disease	3648_Illnesses of siblings: Heart disease	25	674	1	1276	3085	674	1933	2256	3386	1885	2595	2126	4682	2081	2037	2598	2317	4396	3855	1746	3108	2532	2459	3192	1121
4642_Right ventral DC	4642_Right ventral DC	25	674	1	3065	3845	3772	674	1111	3575	1576	1094	3503	2586	1076	2886	1594	2287	1336	3179	2623	3959	1303	1269	4590	2009
2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	25	675	1	2361	675	4386	4071	3975	3717	2763	3836	1816	4673	2610	1651	2443	1882	3963	4140	3289	1484	3975	3472	4140	2623
443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	25	676	1	2883	2438	1231	676	1546	797	1139	4373	727	4484	4656	1033	2470	1048	3564	803	4290	3846	4340	3490	3804	1924
3289_Nervous feelings	3289_Nervous feelings	25	676	1	3400	4138	1117	4475	4453	676	3519	4241	3538	2653	3911	2618	3558	2014	2057	4019	1819	982	1496	1527	2852	1103
149_Body Mass Index (female > 50 yrs)	149_Body Mass Index (female > 50 yrs)	25	677	1	949	677	4010	1902	3749	4325	2604	3149	1489	4478	1139	4685	2044	3132	3098	3319	1333	4167	2736	3404	2587	1678
3763_Depression - Recent feelings of depression	3763_Depression - Recent feelings of depression	25	677	1	4176	2581	3450	3253	4686	3684	2865	4224	677	4650	4203	2151	4663	3910	3978	2191	1169	2854	1072	2063	3991	2994
3780_Depression - Did your sleep change?	3780_Depression - Did your sleep change?	25	677	1	2991	2643	1172	2456	3643	4061	3508	4715	4720	4487	3009	1227	677	3450	2402	1379	1906	3812	1463	2884	1220	1502
2922_COL8A1 - Collagen alpha-1(VIII) chain	2922_COL8A1 - Collagen alpha-1(VIII) chain	25	678	1	4180	678	1831	3748	853	1675	4734	4028	3161	3916	4719	2042	4261	1941	3099	1375	3819	4631	3177	2192	3475	3143
1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	25	678	1	1562	2313	1979	678	3295	1406	4604	2580	1611	3341	2029	1019	3197	4629	813	1364	1198	1333	3657	3808	1842	2190
2196_GDF11 - Growth/differentiation factor 11	2196_GDF11 - Growth/differentiation factor 11	25	679	1	2124	3185	3054	1923	2339	3309	2888	3779	771	4215	3454	4188	2548	679	2725	936	2035	1483	1444	3483	4106	809
2001_Height	2001_Height	25	680	1	2980	1085	1122	680	1393	4559	2323	1712	4207	3182	2138	3395	2492	3967	4382	2406	3489	4149	953	2475	944	2145
2529_SERPINA4 - Kallistatin	2529_SERPINA4 - Kallistatin	25	680	1	1110	1180	2116	2513	3699	4730	3991	2539	680	3128	2371	3822	2612	3320	4157	3635	4190	2060	2192	3830	898	2505
4530_Right lateral ventricle	4530_Right lateral ventricle	25	680	1	1576	4599	3388	2702	3352	1867	2229	1321	1364	2594	2456	2934	1553	1885	3892	4381	4323	680	2284	1376	4586	2548
3622_Treatment/medication code: cod liver oil capsule	3622_Treatment/medication code: cod liver oil capsule	25	681	1	1097	3347	948	2423	681	2687	970	1993	835	4034	2154	1127	970	1974	681	1487	1269	4594	990	4514	2090	3996
447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	25	681	1	1409	2681	3783	4637	4310	3417	2068	1389	4242	1974	2423	2736	4720	3225	3242	4183	681	2536	1878	4598	3335	3955
2354_FGF5 - Fibroblast growth factor 5	2354_FGF5 - Fibroblast growth factor 5	25	681	1	2128	4125	2749	4479	2597	2541	4409	1195	1225	3957	4065	2330	2823	4684	2632	2825	2168	2496	1766	4463	681	1878
1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	681	1	3212	1939	3935	4048	4705	1719	985	3903	4372	1538	2447	3198	1297	2771	4552	2132	2777	3116	4664	1455	2828	681
1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	682	1	2692	682	1427	3078	4745	3832	2400	935	4122	3730	3963	995	816	2799	950	1819	3730	1436	3977	3088	2437	2914
300_CD4mem:%Th1* (3)	300_CD4mem:%Th1* (3)	25	683	1	1591	3394	764	2299	2416	3981	4037	1720	683	4606	2780	1740	3809	4686	1780	4385	1302	1598	2788	1895	3528	815
1921_Frontal lobe volume (GEE, adjusted for age and sex)	1921_Frontal lobe volume (GEE, adjusted for age and sex)	25	686	1	3630	2521	3190	4565	4102	2620	2591	686	848	1267	3010	3563	1983	3381	2128	2572	3250	3307	2762	2785	2117	3797
3349_Ever used hormone-replacement therapy (HRT) (female)	3349_Ever used hormone-replacement therapy (HRT) (female)	25	686	1	2634	960	4623	4666	2218	1265	2775	4011	3556	4039	1549	3978	4518	1688	3278	2182	4525	3383	2354	1621	4611	686
3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	25	687	1	4530	1707	2291	1733	4065	4387	2462	1782	3273	2833	2982	3345	1005	1147	1169	3997	1500	2143	1893	2870	1861	687
1035_Neck Section Modulus (GEE, adjusted for multivariable)	1035_Neck Section Modulus (GEE, adjusted for multivariable)	25	689	1	3384	3321	1916	3838	2319	2463	4343	905	1376	2490	695	3501	3199	2764	689	3874	2683	3152	886	1576	3778	4236
4000_Suffer from 'nerves' (SUF-NERV)	4000_Suffer from 'nerves' (SUF-NERV)	25	692	1	916	4584	3224	2741	4628	692	4070	4186	975	2909	3909	1785	3371	2280	961	2929	2573	2341	919	4232	4470	2301
816_::::X-13215	816_::::X-13215	25	694	1	3518	3268	2650	3382	946	4232	2844	1272	2336	4479	694	2374	1557	3145	2660	1734	2760	3442	2394	4400	2478	3326
3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	25	696	1	2658	1453	3069	2219	1783	3027	2723	3129	2599	696	2264	3512	3059	1264	3684	4547	4004	4607	912	3942	2224	2514
3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	25	696	1	1369	1048	2653	871	3835	4028	3680	1280	4363	4198	2632	2172	3156	4225	3419	3890	3559	696	1502	1405	2778	3575
3640_Illnesses of mother: Lung cancer	3640_Illnesses of mother: Lung cancer	25	697	1	3272	2381	3540	1659	3445	3961	2794	4005	3560	2982	697	1381	4666	1644	1440	2662	1996	851	1534	2302	3200	1747
4428_Epstein Barr Virus antigen VCA seropositivity	4428_Epstein Barr Virus antigen VCA seropositivity	25	698	1	1282	3048	1645	4630	698	703	3130	4385	2762	1426	1682	1253	4595	1586	3318	3163	3662	1670	1443	3948	3791	4727
2308_IL1R1 - Interleukin-1 receptor type 1	2308_IL1R1 - Interleukin-1 receptor type 1	25	698	1	4554	1615	1262	1112	3562	2851	698	2302	3757	4093	848	4093	3562	3143	3785	3321	3375	3700	2202	2435	4318	3413
1925_Hippocampal volume (GEE, adjusted for multivariable)	1925_Hippocampal volume (GEE, adjusted for multivariable)	25	698	1	1423	3606	4314	3626	3541	1473	4559	3533	4058	2686	1035	962	1133	4167	2537	4473	2810	2187	2600	3661	907	698
1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	25	700	1	4145	3316	3886	700	1426	4228	3564	1071	1843	2568	731	1390	837	2873	1965	1183	1035	820	4535	3732	1729	3781
3282_Number of full brothers	3282_Number of full brothers	25	700	1	2542	769	1769	3136	1206	718	3705	2127	3011	715	2405	1995	3087	700	1110	985	2608	2725	1099	3766	1867	3660
3619_Treatment/medication code: ibuprofen	3619_Treatment/medication code: ibuprofen	25	701	1	2921	4225	3731	1779	2981	3954	3404	2895	3336	1617	3514	2874	2322	701	3337	2679	3310	2919	2557	2889	2240	4366
1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	25	702	1	3291	2089	2910	3738	2035	4455	2098	2329	3053	3560	4177	4359	4555	3584	3746	3596	2945	702	3253	884	1436	3298
1903_Frontal lobe volume (GEE, adjusted for multivariable)	1903_Frontal lobe volume (GEE, adjusted for multivariable)	25	703	1	1019	4058	3086	4707	2424	2371	1400	1081	703	849	810	1641	1382	4444	3082	2651	1064	4209	4697	2359	2496	2661
4596_Right postcentral	4596_Right postcentral	25	704	1	2174	1543	3858	3485	1703	3055	704	3135	1832	2098	4128	2218	2336	2991	906	2425	4552	3489	3319	1803	3254	2363
2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	25	704	1	1529	2595	750	4150	3126	4344	2994	2565	3275	1132	704	2482	2991	3007	2504	2441	4118	3334	2918	3121	4043	3102
3396_Other sociodemographic factors - Private healthcare	3396_Other sociodemographic factors - Private healthcare	25	704	1	3305	1043	2645	2464	1747	3602	3884	3771	2641	758	2748	4591	704	1560	2259	3913	2057	1620	2832	1642	3006	3321
3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	25	705	1	4258	4523	922	2883	1139	1236	1929	1484	917	3136	3137	2862	3817	1359	2913	2118	1510	4080	1758	705	4127	4343
3768_Anxiety - Recent trouble relaxing	3768_Anxiety - Recent trouble relaxing	25	706	1	4025	1644	3269	3773	1561	3334	3459	4250	903	1375	3051	706	3208	2550	1758	2168	1539	3073	758	2480	3136	4209
2183_CRLF2 - Cytokine receptor-like factor 2	2183_CRLF2 - Cytokine receptor-like factor 2	25	707	1	2796	2515	4076	3596	1583	4510	1571	3188	2422	2976	2379	1451	4073	3323	2933	707	3651	3636	4409	2663	2736	4418
2889_KYNU - Kynureninase	2889_KYNU - Kynureninase	25	708	1	4374	2744	2259	3521	2296	3039	708	4472	752	1723	2612	2856	2771	1215	1161	2856	3725	1389	778	2993	2672	2201
38_Verbal-numerical reasoning	38_Verbal-numerical reasoning	25	708	1	915	3480	4151	3812	3526	2814	3982	3041	2095	2337	708	3454	2377	3959	4518	3180	3700	4612	3733	3502	4001	3167
2909_IL3 - Interleukin-3	2909_IL3 - Interleukin-3	25	709	1	3851	2828	2183	1573	4539	1599	4312	2109	3623	4688	1832	2405	1775	709	2584	2845	4602	1629	4740	2093	2712	3879
371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	25	713	1	3013	3114	1833	1672	2803	713	752	4175	3093	2623	2705	4252	3080	3605	4717	1854	1360	758	2330	1531	3368	4592
4075_Body Mass Index (male)	4075_Body Mass Index (male)	25	713	1	3862	3664	2432	3942	2953	948	4567	786	3873	1047	1967	3797	3386	1240	3612	3160	3228	935	3512	4371	756	713
2543_NTRK1 - High affinity nerve growth factor receptor	2543_NTRK1 - High affinity nerve growth factor receptor	25	715	1	1230	4205	4691	2718	3889	1992	4552	2291	3248	753	3388	2463	715	904	4213	2853	2107	3365	2906	1010	3307	4184
2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	25	715	1	1063	2709	3243	4576	1821	3709	4726	3480	970	1197	3831	1588	3374	2578	1241	4636	1657	4659	2368	4577	816	715
105_Tanner scale (female)	105_Tanner scale (female)	25	716	1	4481	3079	716	3692	3473	3764	3859	4412	4429	2442	4311	2270	4314	4582	1845	1056	1470	951	1380	2655	1581	2573
2921_LPO - Lactoperoxidase	2921_LPO - Lactoperoxidase	25	716	1	1965	1635	1848	4175	2197	1168	4374	3843	736	2893	2318	1263	2971	716	3907	1245	4644	1928	3148	2842	1678	4710
1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	717	1	2406	3790	4184	804	3095	2518	4482	4613	2827	4176	717	2341	4478	2515	4597	2877	4483	3914	4192	3234	3290	2743
1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	25	717	1	3404	794	1066	2190	2845	3011	1534	2057	2970	2230	1561	2168	2140	3710	2317	3693	717	3146	2490	3677	1002	2631
4501_Right superior frontal	4501_Right superior frontal	25	718	1	3927	1376	1502	1302	3520	4720	1364	2141	4147	3304	3517	4519	718	2079	2467	4479	1760	4395	969	1514	2122	4384
1999_Hip circumference	1999_Hip circumference	25	718	1	3161	4345	760	1243	3739	1262	3215	4317	2172	1922	1320	1082	1336	718	4326	3706	4117	1559	4244	4211	2726	3043
3885_Lymphocyte percentage of white cells (three-way meta)	3885_Lymphocyte percentage of white cells (three-way meta)	25	718	1	1123	2164	2627	2502	2625	1934	1294	2085	3217	3687	3851	2985	873	2720	2339	3966	2067	1364	718	1567	4078	3089
3582_Types of transport used (excluding work): Walk	3582_Types of transport used (excluding work): Walk	25	718	1	3562	1933	4061	1883	1912	2102	2657	3933	4568	2937	2954	4290	1515	3050	3968	3074	1201	4097	2680	718	1745	3113
1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	719	1	4541	4210	2488	2196	3961	719	3944	3675	2571	3717	4327	4560	1200	4638	1698	3638	1122	3350	742	1370	3469	2616
4224_Agents acting on the renin-angiotensin system	4224_Agents acting on the renin-angiotensin system	25	719	1	3059	1940	3352	3581	1264	3896	3643	3331	4247	3920	3444	776	1492	2914	719	4372	2685	2898	3852	2773	4279	4439
1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	25	720	1	4073	3684	863	2098	4229	4505	3068	4362	1669	3205	4121	2813	975	1669	3393	3729	771	4457	4185	720	3687	3881
2059_Type 2 Diabetes	2059_Type 2 Diabetes	25	722	1	722	1388	2947	1729	3673	4633	4339	2574	2540	3585	3419	819	1440	2853	3481	933	2890	3765	1096	3194	3729	1899
3612_Treatment/medication code: ramipril	3612_Treatment/medication code: ramipril	25	722	1	3678	2373	722	2048	3906	4050	4275	3133	1407	3921	4263	1092	842	729	1525	1004	3656	875	2529	4398	2845	2629
2799_PSMA2 - Proteasome subunit alpha type-2	2799_PSMA2 - Proteasome subunit alpha type-2	25	725	1	2557	1843	2803	1946	2384	4240	3304	725	2209	2652	3035	2519	1465	4532	4554	3652	2578	4182	816	2264	1938	2542
2573_DKK1 - Dickkopf-related protein 1	2573_DKK1 - Dickkopf-related protein 1	25	725	1	3011	832	3773	1572	2122	2168	4443	3348	2299	2350	3759	3391	725	3739	2132	1747	3196	2698	1978	3836	2600	4726
1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	25	725	1	2798	1141	2500	2406	3078	2573	3679	4136	1698	3548	3101	829	1022	725	4513	3986	2096	2956	2741	2542	4514	1746
670_::::X-06307	670_::::X-06307	25	725	1	3893	1464	4411	3033	3856	4486	2124	4584	955	2021	905	2462	2123	3034	2152	2953	3292	1968	2408	725	1792	3822
4506_Right insula	4506_Right insula	25	726	1	2759	1696	2820	3582	726	1854	3591	4414	3759	1657	2463	4221	4067	1789	3004	4311	4043	1024	3837	3071	3867	1790
1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	726	1	4266	2674	4079	4404	2091	4273	4417	3034	3459	3032	2729	1014	1601	726	2073	3660	4609	2546	3983	4164	3561	1481
4252_Number of sleep episodes	4252_Number of sleep episodes	25	727	1	4076	4189	4322	2403	1193	4725	1705	4695	1621	4435	727	1031	4654	3972	3236	2998	973	2920	2450	2854	3022	2839
2124_Human-virus - Protein E7_HPV16	2124_Human-virus - Protein E7_HPV16	25	727	1	3166	1341	1530	4099	2741	4549	3463	3943	2249	3947	3883	3813	4185	1243	852	3937	2915	2330	1777	727	4143	956
1306_Insulin sensitivity (FBAT, adjusted for age and sex)	1306_Insulin sensitivity (FBAT, adjusted for age and sex)	25	728	1	2725	3299	728	2665	3478	2033	2788	3513	2053	3675	1083	2475	2122	3591	3201	2881	757	4615	3588	1836	1855	2353
1910_Temporal horn volume (FBAT, adjusted for multivariable)	1910_Temporal horn volume (FBAT, adjusted for multivariable)	25	729	1	729	1320	2651	3064	3911	1246	2205	2852	2551	1286	1251	1369	1030	3662	2216	2549	4647	2416	4660	4697	1778	1739
3910_Vertical cup-disc ratio	3910_Vertical cup-disc ratio	25	730	1	3443	2384	3225	4181	1859	4171	2389	3145	2385	3940	2436	2361	968	1071	730	4439	4720	1755	4164	3219	2317	3544
558_Lipid::Medium chain fatty acid::heptanoate (7:0)	558_Lipid::Medium chain fatty acid::heptanoate (7:0)	25	730	1	3375	2699	4732	1980	3653	2502	3290	2248	1196	1814	1073	4238	2358	2390	3912	4204	3603	3656	1366	730	4044	2681
4629_Left ventral DC	4629_Left ventral DC	25	732	1	2939	4479	4614	4386	4201	4485	1697	3558	1438	4512	2210	1026	2753	3235	732	2648	1245	1952	4074	4410	4098	2946
4723_Genu of corpus callosum mode of anisotropy	4723_Genu of corpus callosum mode of anisotropy	25	734	1	734	3793	3774	2605	4408	3841	4199	4745	3007	2497	3651	2807	2921	2679	3211	3103	1843	4140	3408	3616	2718	3636
2405_KREMEN2 - Kremen protein 2	2405_KREMEN2 - Kremen protein 2	25	734	1	1262	4476	1668	4668	3568	1439	3266	1144	4195	2870	3076	3106	3385	2687	4323	4590	4604	923	4571	734	4167	3558
3242_Fresh fruit intake	3242_Fresh fruit intake	25	735	1	1879	1177	1032	2891	2292	3728	3454	1935	4377	4193	3012	2504	1756	735	4316	2361	2337	3964	3268	4264	1177	1988
1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	736	1	3325	3274	2888	4341	4202	736	4515	2886	3316	2179	4434	3056	1795	2713	2318	4013	1284	1526	1378	1681	3138	3579
1120_Pericardial adipose tissue volume (adjusted for height and weight)	1120_Pericardial adipose tissue volume (adjusted for height and weight)	25	737	1	1996	1194	4204	1126	3708	1630	4177	2418	737	4378	3380	1676	3838	4365	1849	1685	2594	4671	3717	2201	4230	4371
1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	737	1	3960	3955	4605	2125	3992	2307	3023	4402	1113	2625	3044	2619	2169	1401	3743	3884	1006	737	3364	1334	4421	2204
1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	25	738	1	3238	1037	965	1144	2676	1370	2021	3649	2416	2015	738	3024	2811	3031	4021	2718	2900	3332	4580	3923	3013	4374
1149_Corrected insulin response	1149_Corrected insulin response	25	738	1	3938	2913	2822	2548	3176	1000	1354	3913	3397	3655	1353	1561	2610	842	4087	3121	1294	1913	2088	1449	3879	738
2596_FCN1 - Ficolin-1	2596_FCN1 - Ficolin-1	25	741	1	3976	3574	4413	3980	869	2030	2448	3569	1844	1101	1638	4551	3403	1183	3322	741	2605	4586	1804	4495	946	2446
3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	25	742	1	2374	2332	3071	1471	2060	3260	742	3077	818	4746	3102	1005	3130	3480	4607	3062	903	1278	1070	1572	2225	2556
4729_Splenium of corpus callosum mode of anisotropy	4729_Splenium of corpus callosum mode of anisotropy	25	743	1	778	1266	3097	1420	2120	3518	3528	743	3112	3817	1515	1062	2072	2501	3400	1430	4336	1861	983	4306	1723	1022
2222_CDH5 - Cadherin-5	2222_CDH5 - Cadherin-5	25	743	1	2972	1778	1008	4117	885	2295	4523	3433	1112	1596	3986	743	4140	2486	2903	1219	3747	2994	4265	4290	2725	4105
4437_Herpes simplex virus 2 IgG levels	4437_Herpes simplex virus 2 IgG levels	25	743	1	1861	1892	3651	4089	2991	980	4545	1670	1709	4714	2005	2420	4165	4435	743	3491	3211	4678	3633	3313	4055	4186
3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	25	743	1	2750	2626	3232	1357	4218	2723	2099	2969	3347	2763	2773	3401	4286	2645	2581	2636	3779	2806	743	3069	2199	3076
3587_Types of physical activity in last 4 weeks: Strenuous sports	3587_Types of physical activity in last 4 weeks: Strenuous sports	25	746	1	3033	3502	4448	991	4608	4608	3650	2078	3496	1614	746	3172	2977	4180	3339	3591	4339	3200	803	1419	2678	1625
547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	25	747	1	3781	1340	902	1005	3019	2676	3545	3647	3193	3152	3058	4498	4080	840	2685	3774	2394	4024	2881	747	1007	3328
2191_FAM107A - Protein FAM107A	2191_FAM107A - Protein FAM107A	25	748	1	1211	2234	2766	2852	1939	2634	2015	2960	4214	1745	1441	748	2608	3598	2761	1046	2061	2917	805	3728	1736	3770
22_Clozapine-Induced Agranulocytosis/Granulocytopenia	22_Clozapine-Induced Agranulocytosis/Granulocytopenia	25	748	1	3665	3047	2357	3257	980	3135	3377	3985	3356	2544	1882	4598	1957	748	3088	1178	1706	2483	3352	4262	2364	2379
1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	24	748	1	4686	3660	2746	1909	1629	2024	1848	1629	3293	1852	4649	3232	1034	2439	3860	1544	748	3874	3948	3482	3789	1208
2184_ULBP3 - NKG2D ligand 3	2184_ULBP3 - NKG2D ligand 3	25	748	1	1547	958	3196	2336	1712	1886	3883	1090	4277	2616	3216	1009	3071	3005	3581	1543	1930	2711	3772	748	2642	4264
2044_Severe gingival inflammation	2044_Severe gingival inflammation	25	749	1	2635	2821	3580	749	2975	3264	4108	2151	1278	4561	3214	4321	3732	1795	1167	4687	2451	3023	4252	2545	4265	4437
2824_FGF12 - Fibroblast growth factor 12	2824_FGF12 - Fibroblast growth factor 12	25	750	1	3276	3103	4228	1110	1526	2415	3805	2928	3632	938	750	1694	1566	1363	1940	1472	1814	4329	2783	1875	4444	2922
674_::::X-08402	674_::::X-08402	25	751	1	1775	2100	3895	4646	1402	877	4297	2208	2358	4653	1061	3553	3621	2562	4399	2785	4454	1022	751	4614	4292	807
2280_GHR - Growth hormone receptor	2280_GHR - Growth hormone receptor	25	752	1	752	1663	1176	2897	3609	752	3569	3297	3595	3634	4240	1572	2457	1780	2027	3764	3629	3053	3813	2759	1331	3146
1145_Insulin secretion rate (adjusted for BMI)	1145_Insulin secretion rate (adjusted for BMI)	25	752	1	1258	2484	2247	1490	3318	2271	3084	4084	1457	2685	4086	4078	2514	4027	752	2844	4378	1649	3526	3002	3733	1254
3519_Current employment status: In paid employment or self-employed	3519_Current employment status: In paid employment or self-employed	25	754	1	754	3167	2521	4265	2097	4045	4012	4411	2721	3396	4589	4056	3217	2700	2476	4310	4286	3012	3953	2131	4276	4180
3729_Depression - Age at first episode of depression	3729_Depression - Age at first episode of depression	25	754	1	801	1039	3031	3736	3714	2336	754	1331	909	4616	4329	4670	4355	1015	1519	2970	3673	3675	1212	2661	1574	3910
4436_Herpes simplex virus 1 IgG levels	4436_Herpes simplex virus 1 IgG levels	25	754	1	4092	4732	2680	1391	3153	2487	1242	3436	3649	1663	754	4352	2962	1716	873	2477	4623	3825	1377	2806	3710	957
4249_Diurnal inactivity duration	4249_Diurnal inactivity duration	25	757	1	1452	1980	2374	2801	3978	4592	4015	3482	3844	757	2431	1212	4582	1590	4696	4091	3858	3623	2513	2263	851	4037
4310_Osteoarthritis of knee	4310_Osteoarthritis of knee	25	758	1	3829	2036	3007	1484	3129	3398	1095	4478	1699	2912	4151	3593	3147	3715	2456	1708	758	1937	1556	3357	3193	1458
3866_Reticulocyte count (two-way meta)	3866_Reticulocyte count (two-way meta)	25	760	1	3956	1701	4458	4689	4685	4182	1558	3244	2862	1904	4160	3055	3117	4188	1050	2029	4232	1519	760	3466	1719	4561
4291_Asthma	4291_Asthma	25	761	1	769	1990	3236	3791	3758	761	4714	2348	4476	3269	2299	3849	2129	4219	2162	3426	2577	2625	4476	4585	1345	2652
4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	761	1	2463	1679	4539	1291	2935	878	3590	3940	3931	4510	1123	2960	2417	4141	2654	3069	761	1712	3278	3645	4388	4214
512_Lipid::Inositol metabolism::scyllo-inositol	512_Lipid::Inositol metabolism::scyllo-inositol	25	764	1	1178	4678	1306	904	3786	2320	4218	2696	3072	2797	764	3366	4413	2670	780	1329	3478	4564	4527	3989	4058	793
1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	25	765	1	2846	765	1242	3061	2538	2452	1154	894	3034	2212	2128	3323	3168	1163	1685	2624	3901	4214	1249	2226	4574	3385
2101_CCL2 - C-C motif chemokine 2	2101_CCL2 - C-C motif chemokine 2	25	765	1	2767	1120	2849	3767	1422	2784	2689	4050	2547	3223	1672	2859	3020	3387	3956	1488	2496	2284	3489	3542	765	2648
1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	25	766	1	4027	2996	3404	1395	4590	766	3976	1606	1172	1447	4679	3326	2614	2056	1269	1859	3262	1855	1422	2827	2675	2898
3595_Mineral and other dietary supplements: Zinc	3595_Mineral and other dietary supplements: Zinc	25	766	1	3572	3281	1726	3633	1429	3592	2441	4291	824	766	3159	4254	1921	3544	926	902	2655	2198	1761	2037	912	919
4113_Potassium	4113_Potassium	25	766	1	4444	3967	4012	1549	3145	4218	1250	4371	3363	3361	2629	1533	2651	4630	1008	1979	2087	766	4316	1029	4427	2492
3341_Number of live births (female)	3341_Number of live births (female)	25	766	1	2897	1878	2507	2779	2463	1638	4293	4400	4687	3290	4079	1797	1064	3367	3313	2832	2974	2293	766	1331	1365	1299
566_Lipid::Short chain fatty acid::valerate	566_Lipid::Short chain fatty acid::valerate	25	767	1	2714	2500	3421	3280	4620	767	3370	2717	3798	1373	3806	3325	1425	1097	3901	4358	3276	868	3097	1110	3094	3866
3999_Worry too long after embarrassment (WORR-EMB)	3999_Worry too long after embarrassment (WORR-EMB)	25	768	1	2805	2981	3522	2137	3837	1609	1124	1109	1848	2193	768	3074	2455	1732	1462	4036	3797	3245	894	2102	1504	2669
788_::::X-12645	788_::::X-12645	25	770	1	2044	1741	2346	3224	2909	2046	916	3515	770	3712	4546	1126	3124	3923	4135	1281	1555	1298	2347	2135	1941	2624
4546_Left caudal anterior cingulate	4546_Left caudal anterior cingulate	25	771	1	3183	3824	1116	2795	2046	1042	3758	1439	4309	2082	4120	771	3822	1101	2691	926	2565	4124	1881	2810	2885	3980
4402_Menstruation quality of life impact: Joint pina	4402_Menstruation quality of life impact: Joint pina	25	771	1	4671	1021	3612	3278	1152	3539	3222	2281	2993	2609	1945	2777	771	3711	2880	2499	4408	3542	3025	2924	4447	4693
565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	25	771	1	3681	2293	2928	935	3883	3540	3899	1974	1332	3199	1292	2109	2583	2083	2203	4451	4161	3449	771	2850	3572	1459
1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	25	772	1	3203	4126	3202	1109	782	4589	772	2973	1069	836	3591	2621	3019	2639	1067	1835	4668	4035	1080	1337	4605	1983
4025_Excessive sweating	4025_Excessive sweating	25	772	1	1312	3701	850	4151	1088	4626	2180	772	3279	4145	3510	944	4596	4089	2181	3278	4457	2866	4254	2119	1752	3015
1158_Fasting glucose interaction (adjusted for BMI)	1158_Fasting glucose interaction (adjusted for BMI)	25	773	1	3114	4638	773	891	2189	4554	1946	3501	1461	2960	1279	2219	1304	4430	3975	4129	2540	3280	1971	1538	3732	2698
255_CD3 on 127+DN T	255_CD3 on 127+DN T	25	773	1	2477	4141	1734	2785	773	2097	3731	4528	779	4464	2491	4012	4690	1759	2899	2097	2672	4544	2442	1494	3229	3343
2607_NID2 - Nidogen-2	2607_NID2 - Nidogen-2	25	775	1	1321	2929	3626	1354	2679	1286	4632	1181	3749	2488	1340	2718	2462	4746	775	3169	1145	3984	4282	1936	2359	2660
2858_C3 - Complement C3b	2858_C3 - Complement C3b	25	777	1	4209	4491	1671	1230	2567	1911	3453	1291	2667	1115	777	2464	1688	4674	1756	3897	3486	1966	2056	1809	3633	3969
3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	25	778	1	4381	2074	4038	4273	1387	3014	1509	778	1920	2137	2151	2557	1986	3804	1701	1352	2470	3149	1609	1613	3757	1202
400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	25	778	1	2986	4115	2413	4067	2280	2037	4744	3622	2412	4459	1004	1724	3598	1485	2950	778	2489	2440	3024	1858	3448	3112
652_::::X-02269	652_::::X-02269	25	781	1	4318	2527	1960	1349	2377	1242	3205	4033	1550	3789	3813	928	1137	3695	2875	1573	2839	3258	781	2223	1155	3407
2658_CST4 - Cystatin-S	2658_CST4 - Cystatin-S	25	783	1	2466	1621	2384	783	3603	3710	2153	2991	3488	4587	1651	842	3533	3447	3732	3572	4007	1346	1702	3009	1170	1703
1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	25	783	1	4283	3253	4669	4262	4022	1124	4003	2584	2987	2588	3960	3406	2832	3616	2855	3406	1340	1867	783	1112	4693	3857
1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	24	784	1	784	4223	1957	3576	4007	3370	2504	2003	802	4058	1045	1659	2235	1098	4744	3848	3974	1380	3365	1577	1472	2966
851_Acetate	851_Acetate	25	784	1	4156	4634	784	877	4272	1314	1638	3547	4107	2760	3917	798	3477	1937	4620	3568	3648	3562	1351	1253	3594	1895
2803_SPHK1 - Sphingosine kinase 1	2803_SPHK1 - Sphingosine kinase 1	25	785	1	3170	1552	3298	1563	785	3204	3284	1111	3107	4410	2959	3408	1349	2143	1464	1900	3961	2702	4081	3825	2440	3705
1160_Fasting insulin main effect (adjusted for BMI)	1160_Fasting insulin main effect (adjusted for BMI)	25	785	1	3394	807	1705	2856	2650	1915	1815	3883	1218	2600	1168	2505	3037	785	3843	2731	1682	3523	1440	1588	1566	2962
1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	25	785	1	1752	1946	4531	1367	4169	1343	2269	2501	1711	2955	1459	4362	2063	2822	3508	4128	4351	4053	785	1871	3702	1538
1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	25	789	1	4430	3013	2328	2473	789	1491	4581	2692	4489	906	2852	1348	4321	966	2755	1315	2730	1940	4237	1675	1144	1253
1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	25	790	1	2353	1740	1860	1466	4580	4492	4487	2310	1077	2617	3589	790	1324	2533	1712	3569	2767	2443	1487	4202	3940	1238
1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	25	790	1	3232	4046	4197	1587	2821	2281	2360	4726	1949	4396	4462	4680	4701	4696	2369	3675	2951	3309	4416	1124	790	2422
688_::::X-11204	688_::::X-11204	25	791	1	1691	791	4723	2926	3768	4106	4441	4039	2501	3230	1060	4432	3026	1868	1956	1848	863	2370	1864	1307	1799	1834
1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	25	792	1	4526	792	2024	4453	1753	2269	3198	982	2012	4015	2797	4129	2272	2405	3914	869	4212	2092	4018	3174	4658	3219
1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	25	792	1	904	4478	1416	4015	3579	3266	792	1582	4002	2593	2499	2066	3350	4549	2143	2715	4414	3815	824	1886	3705	1796
3133_CALR - Calreticulin	3133_CALR - Calreticulin	25	792	1	3109	2016	1821	4470	1351	3459	1324	3780	3525	2165	2091	2281	3973	1750	3757	831	4024	792	4253	1804	2028	2391
1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	25	794	1	1564	4432	3677	2304	3613	1848	2433	3519	3492	1722	2673	2803	1576	4728	3930	3536	794	2384	2739	3394	4457	1586
2630_GPT - Alanine aminotransferase 1	2630_GPT - Alanine aminotransferase 1	25	795	1	1814	1844	4062	800	4697	795	3322	1121	966	1318	3859	2509	3938	3494	3038	2098	1514	4351	2012	2175	1051	2813
2602_PRSS27 - Serine protease 27	2602_PRSS27 - Serine protease 27	25	795	1	2307	4254	3381	2666	4026	2149	795	4603	1729	2171	3563	839	2093	1520	4469	2027	4174	1894	1831	4490	1286	4113
353_IgE+B:%27+	353_IgE+B:%27+	25	796	1	3371	1784	1198	4269	4263	1529	2347	3717	2228	2058	4565	1868	3955	1773	3662	2852	796	3132	1871	3577	4019	2702
2552_CNTF - Ciliary Neurotrophic Factor	2552_CNTF - Ciliary Neurotrophic Factor	25	797	1	1515	1519	862	1919	4231	2639	797	2978	3542	1394	2478	4633	1979	4561	2343	4024	1028	3007	3811	3537	2992	4126
4198_Waist-hip ratio (male)	4198_Waist-hip ratio (male)	25	798	1	3478	1000	3562	1361	1725	1758	4652	4490	4608	3588	3056	1734	798	2283	3541	2928	2600	3729	4339	1549	4568	2371
761_::::X-12206	761_::::X-12206	25	800	1	2249	3773	2729	4445	4371	1499	800	1052	3507	4515	3826	4142	2732	1191	3728	3814	3033	1669	3516	2294	2433	3209
2528_INSR - Insulin receptor	2528_INSR - Insulin receptor	25	801	1	2408	965	3146	2301	801	4380	2649	3540	2282	1603	3581	4388	3831	4318	1665	860	1524	3543	2094	3707	2424	1682
4697_Corticospinal tract mean diusivities	4697_Corticospinal tract mean diusivities	25	801	1	2246	1976	1403	2381	1299	4461	818	2290	2181	2123	4422	801	1470	1940	848	1085	3018	2234	3677	4467	3646	1215
4159_Childhood Absence Epilepsy	4159_Childhood Absence Epilepsy	25	802	1	4620	1193	802	4675	4633	2229	4007	4109	4003	1069	1972	1122	1227	1154	1929	3405	4538	2481	3819	1978	3885	1758
1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	25	806	1	2517	4202	1374	806	2979	2315	4534	4563	2059	1398	4405	1752	1279	1135	2034	4079	4361	2452	1427	1651	2129	4480
2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	25	808	1	3837	4161	3782	1830	4086	1745	2084	808	1833	1212	1626	4232	3908	3770	1504	4251	3248	1029	4626	4357	1485	4410
4445_Left caudal anterior cingulate	4445_Left caudal anterior cingulate	25	809	1	3873	4385	2523	4289	2244	1278	809	3892	3431	1259	2186	3810	830	3400	3457	2546	1705	1888	2105	2229	3223	1562
2282_IGFBP4 - Insulin-like growth factor-binding protein 4	2282_IGFBP4 - Insulin-like growth factor-binding protein 4	25	809	1	3919	4463	3471	4622	3456	4634	1722	4614	3726	4551	3795	3954	3490	2011	2486	4376	1689	809	2631	4533	1072	4124
1929_Temporal horn volume (GEE, adjusted for age and sex)	1929_Temporal horn volume (GEE, adjusted for age and sex)	25	811	1	1924	4045	2568	1369	3294	3509	3979	1543	1956	3855	3391	811	4077	2477	1830	4441	2049	2985	4577	4241	3647	3922
2275_CYCS - Cytochrome c	2275_CYCS - Cytochrome c	25	811	1	2271	3886	2325	3113	2419	3834	4098	1780	1144	1948	4393	1079	2764	4592	3887	4089	3939	1302	3367	811	2412	4534
3248_Beef intake	3248_Beef intake	25	812	1	1469	3933	4368	2011	3387	1546	1873	3800	2221	4079	4722	4003	1318	2901	3691	889	2198	2017	2834	1239	4032	812
755_::::X-12094	755_::::X-12094	25	814	1	3767	814	3802	2641	1590	4322	1735	4704	896	2381	2883	2328	2387	4650	3955	1700	2768	3379	2807	3130	3856	1349
4012_Probable major dpressive disorder	4012_Probable major dpressive disorder	25	815	1	3048	2023	3012	1632	4556	3854	3733	3025	4282	3509	4036	1553	2883	3992	4281	2713	4321	1776	815	1091	2231	2526
4307_Osteoarthritis	4307_Osteoarthritis	25	816	1	4509	1662	2646	4283	3964	1864	2298	3930	3986	4013	1831	4578	3055	2665	3265	4684	2732	1365	1418	816	1651	1350
2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	25	817	1	1055	3624	3143	817	2401	4098	1883	4556	4473	2698	3224	2446	1381	2457	3048	2102	2935	4728	1503	4686	3649	2984
3292_Worry too long after embarrassment	3292_Worry too long after embarrassment	25	817	1	3606	3420	3262	2105	3832	1574	1365	1639	1381	2410	817	3568	4284	2050	1861	4075	3809	3167	946	2280	1346	2544
1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	25	819	1	1352	3799	2535	2494	4460	928	819	1103	4335	1070	2272	1606	1028	969	4309	2780	1335	2040	3608	3880	1063	2925
295_CD4mem:%Th17	295_CD4mem:%Th17	25	821	1	4233	3001	2464	3884	2479	1128	3335	880	4578	1965	2811	4384	3678	4594	1150	2687	4621	821	1977	3800	4520	3329
4640_Right amygdala	4640_Right amygdala	25	822	1	4231	1584	1586	1485	822	4298	4597	1513	3296	3976	2792	2987	2630	3218	4369	1100	4338	3840	3734	3642	3902	824
2418_SFRP1 - Secreted frizzled-related protein 1	2418_SFRP1 - Secreted frizzled-related protein 1	25	822	1	3593	996	2777	1318	4196	2259	1688	2858	2905	4513	4704	1007	1312	3931	4676	3991	2765	4472	4320	3993	822	2339
302_CD4mem:R6+	302_CD4mem:R6+	25	828	1	828	1811	3855	2906	2874	898	3926	851	3814	3569	3861	3680	4163	3648	3073	2980	3922	2136	1890	4673	4404	2196
1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	25	829	1	829	4593	3943	2727	4253	4388	4350	4566	3738	2405	4639	3378	2433	1668	4408	4086	3376	2862	4414	4657	1595	1759
1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	25	830	1	2985	3911	2510	3484	3207	4009	830	1076	1683	2800	1069	3155	847	1052	3644	2273	2970	2020	4134	4139	2605	3003
450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	25	831	1	2908	3956	3163	2478	2588	1092	898	2781	3284	1765	4358	865	2645	2201	831	1602	2782	2512	4284	1271	2798	2017
1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	25	831	1	1728	4019	4121	4002	1195	1422	3476	2081	3087	1680	2023	3173	2582	2163	2647	1812	4684	831	3291	2460	3930	1753
3107_PSME3 - Proteasome activator complex subunit 3	3107_PSME3 - Proteasome activator complex subunit 3	25	834	1	3697	1993	4676	1516	3681	834	2631	2056	3753	4572	4053	4046	4260	3945	1912	1719	1443	1313	2996	2792	2764	2671
2609_OCIAD1 - OCIA domain-containing protein 1	2609_OCIAD1 - OCIA domain-containing protein 1	25	835	1	2788	835	3900	4609	4335	1435	2317	1149	4133	3069	988	2417	3106	884	896	3503	1167	3101	2982	2471	1114	2352
3880_Hemoglobin concentration (three-way meta)	3880_Hemoglobin concentration (three-way meta)	25	835	1	4744	2083	3084	4558	2334	1606	3055	2732	2123	1084	3306	835	3886	1778	1419	3467	4658	2530	3060	2984	3222	4033
4664_Superior corona radiata fractional anisotropy	4664_Superior corona radiata fractional anisotropy	25	837	1	837	3168	3090	2827	3735	2396	4684	1493	4634	4009	1974	3507	3083	2169	4094	2594	3784	1244	3722	4299	3810	1267
4593_Right pars orbitalis	4593_Right pars orbitalis	25	838	1	2117	1777	1943	838	1287	3105	1086	3264	4008	2024	2776	2820	3259	3933	3582	861	3646	3122	3472	2365	4434	2155
3057_IL20RA - Interleukin-20 receptor subunit alpha	3057_IL20RA - Interleukin-20 receptor subunit alpha	25	839	1	4476	3759	4408	4711	1109	1430	3914	1571	1334	839	1824	4464	3077	1205	4591	2292	4514	2585	965	2221	3205	3125
572_Lipid::Sterol, Steroid::androsterone sulfate	572_Lipid::Sterol, Steroid::androsterone sulfate	25	839	1	2365	1853	1783	2769	1659	3604	1064	2213	4422	3105	4277	2593	2673	2875	3449	839	4519	3663	2562	1769	4197	4073
1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	25	839	1	3731	3764	4175	2861	3323	1642	1670	2984	4192	2097	1556	4544	2004	916	4600	1381	839	933	1532	1103	4436	3200
1909_Lateral ventricular volume (GEE, adjusted for multivariable)	1909_Lateral ventricular volume (GEE, adjusted for multivariable)	25	843	1	3257	4520	1100	1389	3150	2400	3939	2406	2116	3160	1976	2692	3791	3960	3769	4405	1166	1307	2133	1203	2649	843
4243_Rapid automised naming of objects	4243_Rapid automised naming of objects	25	844	1	844	4511	3149	3225	3036	4511	3596	3497	3138	3797	3976	3075	4333	4251	2505	1220	3415	1514	3523	3080	4277	2114
1208_FEV1	1208_FEV1	25	844	1	2740	1349	3881	2359	844	2594	4730	3915	3092	1691	1194	1339	4334	4506	3944	1468	1283	4191	2122	891	4223	887
3380_Systolic Blood Pressure (automated reading)	3380_Systolic Blood Pressure (automated reading)	25	844	1	4009	2104	3291	2390	3860	1550	2427	4297	844	942	3026	2570	1967	1569	2674	2338	4654	1062	1849	2774	1509	1279
1928_Temporal horn volume (FBAT, adjusted for age and sex)	1928_Temporal horn volume (FBAT, adjusted for age and sex)	25	844	1	1250	2068	1587	2623	3912	1731	1121	3873	1855	844	1161	866	898	1494	2201	2552	4504	3317	4328	4715	1667	1091
2421_CCDC80 - Coiled-coil domain-containing protein 80	2421_CCDC80 - Coiled-coil domain-containing protein 80	25	845	1	3129	4701	2829	3770	2984	3572	3143	4370	3837	4030	2069	978	2815	2838	845	1365	3711	1216	3587	2679	1815	3751
1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	846	1	2945	846	2726	2495	3872	4679	3336	972	2735	1572	2169	3312	1832	4350	2879	2566	2422	3376	1416	4453	1334	3262
2774_DCTN2 - Dynactin subunit 2	2774_DCTN2 - Dynactin subunit 2	25	846	1	2602	2062	1229	879	3047	2438	2948	2207	3965	846	3872	3524	4124	2560	1240	2179	3912	4280	4379	3988	1150	3639
4495_Right postcentral	4495_Right postcentral	25	846	1	1890	882	2620	1063	1665	2387	1810	2119	1858	3020	4737	1462	3993	1858	1736	1388	4175	4079	3708	3437	846	1749
2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	25	847	1	1615	4703	2251	1891	4391	3783	1840	2712	4498	3580	847	3329	2763	4347	2841	2655	4681	2107	2198	1076	2387	3192
3811_Basophil count	3811_Basophil count	25	851	1	1193	1385	3240	851	2387	2625	1604	1937	914	1278	2026	1025	4626	1382	4423	2545	2481	4537	2541	2957	2506	4091
1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	852	1	2526	4517	2668	2320	4037	1570	3704	853	852	2855	1988	2048	1424	3851	1550	3096	2455	1323	1945	2808	1793	1900
4691_Anterior corona radiata mean diusivities	4691_Anterior corona radiata mean diusivities	25	852	1	2478	1575	4674	2844	4589	1978	4109	965	1624	2403	4420	1888	3405	3637	4177	3789	2028	1021	1462	4535	852	4030
3229_Getting up in morning	3229_Getting up in morning	25	853	1	2053	4015	4733	1057	1910	3838	1157	2346	853	1280	2583	925	4119	4253	2874	1032	3130	1034	3096	1678	2841	1021
2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	25	855	1	2610	3494	2604	1841	1667	3395	3809	1976	3960	3697	3910	4053	2750	4413	925	1424	1399	1025	855	4111	1237	3780
51_Number of children ever born (female)	51_Number of children ever born (female)	25	856	1	1098	4307	2360	2079	1194	1083	2128	4470	2901	856	3600	4727	3423	967	1915	3436	1931	4741	2115	2658	2842	2697
4656_Fornix (cres) / Stria terminalis fractional anisotropy	4656_Fornix (cres) / Stria terminalis fractional anisotropy	25	856	1	3807	3674	3779	3872	3165	1765	4629	3314	1463	3156	4591	2742	1405	2879	3902	3840	1454	885	3419	856	1045	3977
4147_Posterior wall thickness	4147_Posterior wall thickness	25	858	1	3614	1065	1891	1246	1694	1678	2169	1617	3457	3095	4612	4201	858	1008	1226	1074	1544	1066	2930	2881	1046	3602
237_CD32 on pDC	237_CD32 on pDC	25	859	1	1838	3331	4227	4582	2014	3731	2071	3382	4402	4625	3875	3170	2773	3578	1262	2643	4154	1374	859	2651	910	2920
1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	25	861	1	1993	4221	861	4084	3263	3196	1507	1759	2134	1602	1585	4403	3828	2758	1085	2387	3539	3468	2503	1901	3275	3513
3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	25	861	1	3732	1732	1050	1183	3844	2947	1860	2535	2848	1283	1853	3476	3682	931	861	4162	3916	4300	1345	1974	3059	3325
1097_Mean Arterial Pressure	1097_Mean Arterial Pressure	25	862	1	1738	2618	2403	4538	2365	3858	1034	1268	862	2414	3081	2245	2550	4536	2515	2950	3327	2131	2720	3233	2760	2543
1069_Diabetic Nephropathy in Type 1 Diabetes	1069_Diabetic Nephropathy in Type 1 Diabetes	25	863	1	1931	2835	3889	2472	2827	1792	1919	1757	1101	3950	4740	4658	3945	2380	1040	1389	3469	2767	895	863	3731	3348
679_::::X-09706	679_::::X-09706	25	868	1	1870	2655	2886	918	1273	3725	1428	1852	1280	3144	992	3536	868	2081	2667	2155	3875	3131	4639	4575	4113	929
626_Xenobiotics::Drug::metoprolol acid metabolite*	626_Xenobiotics::Drug::metoprolol acid metabolite*	25	869	1	1753	3507	869	1839	2518	1040	3247	2076	2822	4351	2704	2352	3946	3178	3323	4345	4579	2058	4388	3291	2664	4638
2431_CD48 - CD48 antigen	2431_CD48 - CD48 antigen	25	869	1	3703	2569	3902	4414	971	1258	2324	1409	3216	2708	3382	1442	869	1260	997	1435	4389	2325	1247	1823	1082	2674
1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	25	870	1	4572	2058	2153	3616	2141	1906	2070	870	1754	3592	1843	2528	1520	2648	4251	2880	2329	1738	3300	3854	953	2070
2159_PLA2G2A - Phospholipase A2, membrane associated	2159_PLA2G2A - Phospholipase A2, membrane associated	25	871	1	871	1215	1872	2781	3945	2928	3974	2951	4408	2919	3803	1612	2441	3866	2194	3960	921	1150	4381	3810	3278	4531
598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	25	871	1	3940	4086	3469	2067	4561	3424	871	4051	3083	992	4285	2013	1676	3096	1689	1842	4608	2570	3761	1600	2866	3840
2211_PPBP - Neutrophil-activating peptide 2	2211_PPBP - Neutrophil-activating peptide 2	25	871	1	1843	2827	3219	1685	4282	2572	4731	2318	4303	2062	3665	3854	2351	1532	4663	3456	898	2800	871	1051	1973	4497
2588_CLEC7A - C-type lectin domain family 7 member A	2588_CLEC7A - C-type lectin domain family 7 member A	25	871	1	3780	2155	1897	1084	2502	2099	2880	3031	2665	1581	2818	3150	2571	2445	2603	1553	1886	2783	1698	871	2085	2503
3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	25	872	1	1572	2194	1126	2622	3225	2488	4536	4341	872	2631	3022	2136	1658	1162	2056	4065	4573	3996	1767	3927	3513	1744
3526_Transport type for commuting to job workplace: Public transport	3526_Transport type for commuting to job workplace: Public transport	25	873	1	1626	873	3668	3714	2520	963	1090	3573	2978	1990	2854	1087	4019	1250	4163	3614	1808	1917	3923	4613	3342	2929
472_Lipid::Bile acid metabolism::taurodeoxycholate	472_Lipid::Bile acid metabolism::taurodeoxycholate	25	875	1	948	1146	4324	3675	3521	4264	1689	897	2030	1710	1414	3086	982	1946	964	3510	1330	1563	875	4623	1932	1158
3148_CPE - Carboxypeptidase E	3148_CPE - Carboxypeptidase E	25	876	1	3101	3718	2086	2247	2964	2559	3712	973	1904	2413	4627	1532	3695	2685	2856	3630	2053	1100	1712	876	2507	2849
2249_HDAC8 - Histone deacetylase 8	2249_HDAC8 - Histone deacetylase 8	25	877	1	3553	2411	1712	1089	4364	4069	3886	1587	2715	1124	4256	4070	1012	877	4046	4365	3882	4528	2725	1490	2837	2748
3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	25	877	1	1521	1397	1442	1684	3367	1615	2145	2545	3241	3656	2277	4337	2094	4227	1073	1742	877	3563	3334	1323	4426	3474
1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	25	878	1	2147	1530	3377	2305	3595	3096	2234	1216	3666	1605	4193	3619	3616	4499	1602	3001	878	3707	1050	4550	3490	3314
551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	25	879	1	3706	3874	3384	893	1040	4304	4328	3004	2873	948	1701	4282	1614	2012	2230	879	1675	4532	2398	2024	2821	4279
2696_RPS7 - 40S ribosomal protein S7	2696_RPS7 - 40S ribosomal protein S7	25	880	1	4700	3805	2821	1862	3587	2005	4589	2653	2977	880	2416	2166	1141	4398	2778	1304	1866	4051	2455	3047	3188	3408
1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	25	882	1	4235	1157	4513	3718	1872	3404	3177	4421	1012	4517	2596	1293	882	2435	1007	1711	1646	3205	1259	4517	2835	1056
2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	25	883	1	2919	2001	2931	2651	3930	2989	3583	4721	3155	2759	1578	2976	3481	883	2029	3707	1014	3279	3191	4177	3478	4337
3203_Age completed full time education	3203_Age completed full time education	25	885	1	2301	3607	2255	1131	4666	4479	3072	3531	4509	885	4563	1146	3414	3191	4320	4112	1848	3614	2350	2802	950	2488
1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	25	885	1	1453	4274	4153	3037	4311	1415	4556	1870	1965	909	2284	2283	2761	4214	3164	3409	2494	2375	885	2500	2582	3499
2580_BMP10 - Bone morphogenetic protein 10	2580_BMP10 - Bone morphogenetic protein 10	25	887	1	2895	4648	4063	4581	4116	2261	887	1890	1663	3086	4360	2298	4228	3107	3363	2603	1744	1661	3674	4191	1275	2447
2713_ING1 - Inhibitor of growth protein 1	2713_ING1 - Inhibitor of growth protein 1	25	889	1	4577	1457	4285	1802	2041	1322	4189	1080	4010	1346	969	889	1929	1793	3239	2384	4692	1821	4673	2795	4239	4285
2080_PLA2G5 - Calcium-dependent phospholipase A2	2080_PLA2G5 - Calcium-dependent phospholipase A2	25	889	1	1748	2306	4050	4321	1524	2450	3902	2432	1818	1923	1557	3864	2306	1367	1275	1915	3422	3089	889	3954	4531	3806
301_CD4mem:%PD1-R6+	301_CD4mem:%PD1-R6+	25	891	1	4495	1897	3608	2501	2891	3191	3403	891	3468	3373	3578	2910	1755	1801	1518	2824	2486	966	999	4586	1624	2537
2412_NID1 - Nidogen-1	2412_NID1 - Nidogen-1	25	896	1	2884	4219	1527	2422	3382	1255	1036	3306	2200	3853	4647	2090	3491	2874	1298	2068	2072	4176	2943	4648	2161	896
15_Posttraumatic stress disorder	15_Posttraumatic stress disorder	25	898	1	2192	2405	4137	2638	4124	2729	1547	4743	2545	3860	4683	4017	4307	3369	3522	4105	4665	898	3117	1332	4622	1076
1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	902	1	950	4601	4054	1460	1777	2503	3553	1277	3090	902	2599	1420	3922	2785	4254	1790	3215	2874	1374	3229	1783	3330
4378_High blood pressure	4378_High blood pressure	25	903	1	3517	1083	4734	3814	3210	4697	1203	2333	1555	2805	3962	3012	3463	2214	903	3470	4481	3256	2572	3411	3780	4325
424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	25	903	1	2217	4280	2060	4374	1718	4550	2846	4520	4099	2888	4114	1977	1820	2115	3770	3476	2058	3748	903	2629	1248	4640
507_Lipid::Glycerolipid metabolism::glycerol	507_Lipid::Glycerolipid metabolism::glycerol	25	904	1	2228	1163	2463	1547	4706	4513	4610	4679	1367	2349	3646	3781	904	1991	2326	3174	3249	3015	4533	1941	3170	3117
3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	25	905	1	2318	2095	905	2985	2711	2424	4682	2328	3120	3776	4173	3010	3395	2963	4602	3076	1860	2660	1163	4418	2673	2904
1207_Longevity (>= 85 yrs vs < 65 yrs)	1207_Longevity (>= 85 yrs vs < 65 yrs)	25	905	1	3761	1918	4658	2871	3055	3018	4512	4117	3487	3854	3535	4418	2788	905	4245	4730	2726	2044	3719	2438	2468	3196
125_Body Mass Index (female)	125_Body Mass Index (female)	25	907	1	3838	1051	3052	3671	3061	1471	1941	959	3000	4299	1407	1523	2472	4123	3176	4585	2097	1875	4369	2130	2184	907
1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	25	908	1	2727	4095	2555	3909	4275	1716	3042	1379	2676	3625	1036	1035	4433	908	1544	1995	1679	1110	2520	2218	2970	1653
14_Posttraumatic stress disorder	14_Posttraumatic stress disorder	25	909	1	3980	2736	2470	981	1345	4745	3695	1040	4380	3327	4625	1310	2392	3377	3958	2585	2038	2211	1126	1149	909	1999
3322_Most recent bowel cancer screening	3322_Most recent bowel cancer screening	25	913	1	2841	1056	4675	4144	3783	3439	4657	913	2340	2136	3210	2905	1603	2258	1860	4361	1157	3507	1781	3038	3209	4453
3993_Irritability (IRR)	3993_Irritability (IRR)	25	913	1	3883	2847	3153	2298	3993	1525	3450	4237	4224	3878	2365	4502	2730	1025	1446	4156	2845	4306	2316	1757	913	1309
4057_Estimated glomerular filtration rate based on serum creatinine	4057_Estimated glomerular filtration rate based on serum creatinine	25	914	1	2571	3421	3840	2063	3339	1587	1006	1377	1057	3163	2333	1094	2852	2290	4390	4666	1785	2178	2937	914	4526	923
367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	25	917	1	3309	1430	4430	1844	3821	2909	3952	1305	4052	1167	1909	4183	917	3822	970	3157	1701	1746	2403	4676	2833	3584
3483_Milk type used: Soya	3483_Milk type used: Soya	25	918	1	3493	1167	2181	1026	1825	3719	918	2564	3344	3121	3833	3168	1463	1426	2163	2579	2973	1328	3129	1495	2965	3664
3357_Likelihood of resuming smoking	3357_Likelihood of resuming smoking	25	918	1	4412	4647	1396	3730	3084	935	2754	2731	3134	2771	3987	2818	1855	1978	3090	4022	918	1693	2285	4731	3736	3068
4472_Left superior temporal	4472_Left superior temporal	25	918	1	2901	3645	1365	1231	3803	1182	4341	2894	3345	1074	4524	4430	1563	1006	3384	2511	2150	1626	1413	2283	3529	918
338_NKeff:%Kir+ (3)	338_NKeff:%Kir+ (3)	25	919	1	1864	2076	2324	919	4173	2051	2997	1939	1502	4276	4574	2630	2324	2411	4683	4516	2154	3909	1265	3778	4355	2216
4257_Facial attractiveness (male-coder)	4257_Facial attractiveness (male-coder)	25	920	1	3585	3714	2935	1090	3921	1359	2719	2147	4023	3661	1358	2653	1092	2540	2376	3012	3544	3472	1391	2391	920	2831
2646_IL5 - Interleukin-5	2646_IL5 - Interleukin-5	25	921	1	3128	2316	4584	3843	4496	2744	4137	2019	3413	3551	3311	4689	3524	1929	1502	1210	3693	3936	2874	3046	3898	921
2419_SEMA3A - Semaphorin-3A	2419_SEMA3A - Semaphorin-3A	25	934	1	1938	3393	2867	3831	2104	1013	3919	2860	3700	4636	2717	3988	4746	2955	3990	3542	2395	1761	934	2960	3849	1484
3257_Hot drink temperature	3257_Hot drink temperature	25	935	1	4007	3538	1625	1076	3343	1143	3270	2840	2612	4201	3439	4573	2461	3170	2462	3110	1030	3070	1176	935	3305	2935
3188_Pulse rate (automated reading)	3188_Pulse rate (automated reading)	25	935	1	3655	3118	3758	1570	4602	3672	4497	2528	1121	2555	3863	2631	1909	2078	2412	4643	4280	1164	2983	4520	935	2000
1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	937	1	1320	937	2223	1714	4244	1462	3294	2623	3211	3143	4008	3370	2176	4715	1130	4352	1440	4616	4373	3497	3892	2429
396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	25	937	1	1172	2719	4699	1597	3141	4378	3658	3820	2723	3791	2878	3551	2793	1233	4524	4234	1285	937	4565	1959	3498	3900
416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	25	941	1	941	4132	1343	3602	3195	1074	3908	1708	2118	2688	2466	990	3509	2297	957	4360	3844	3961	3032	1593	2376	3199
590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	25	944	1	3487	4645	944	1228	1850	3118	2251	3414	3467	1685	2836	2190	1998	1057	4606	2339	4221	2713	2418	1930	3996	3767
3363_Age started hormone-replacement therapy (HRT) (female)	3363_Age started hormone-replacement therapy (HRT) (female)	25	945	1	2029	3801	4568	4471	1008	4541	4360	2183	3764	3810	2460	3498	2150	3181	2808	945	3530	2350	3205	3939	1843	3647
3035_SSRP1 - FACT complex subunit SSRP1	3035_SSRP1 - FACT complex subunit SSRP1	25	952	1	1273	1434	3756	3505	4723	952	1804	1459	3194	4249	2399	3539	4341	2422	3819	1559	1268	2415	3670	1432	2585	3609
1080_Prostate cancer	1080_Prostate cancer	25	952	1	3821	4469	3551	3227	4125	1643	1499	952	4055	3151	2534	3691	4248	3664	4353	4380	4365	2933	3491	2262	1911	2477
1187_Parkinson disease	1187_Parkinson disease	25	957	1	1478	1649	1134	1574	1657	3032	1510	3909	2289	3438	1747	4241	957	2348	3568	2096	1202	2470	1250	1969	1321	3060
62_Age at menopause	62_Age at menopause	25	957	1	4158	4206	2589	4544	1128	2681	4450	1861	3952	4409	2787	1219	1937	2525	3693	3107	2703	4006	2787	957	1884	4477
1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	961	1	3905	3098	3024	3810	3162	3984	4528	3404	2360	1854	4150	2156	961	3073	2437	2800	4417	2848	1912	2048	2749	2630
1059_Diabetic Nephropathy in Type 1 Diabetes	1059_Diabetic Nephropathy in Type 1 Diabetes	25	962	1	3083	4036	1867	1799	1960	962	3501	1663	1626	2299	4392	3627	3521	4289	4109	3502	1743	3465	2157	1293	4233	1919
4349_Heart failure	4349_Heart failure	25	965	1	2747	1054	1830	965	1711	3864	3265	4021	3574	2747	2533	1274	4435	2717	4637	3529	2112	3438	3269	4080	2068	3341
2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	25	965	1	3879	2751	2371	2145	4696	2359	3351	2332	1992	1131	3238	965	3548	4176	4529	4390	1711	2311	1594	2092	977	4208
2424_ANGPTL3 - Angiopoietin-related protein 3	2424_ANGPTL3 - Angiopoietin-related protein 3	25	967	1	1399	2807	1524	2036	2211	4034	4388	2460	967	4248	3610	2614	1117	3002	4666	1160	2450	3407	1629	3992	3144	1632
435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	25	968	1	3616	2004	3748	4248	1375	3505	968	3953	1600	1840	4410	2564	1626	2649	3235	1415	4138	2612	4716	3736	2484	3354
1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	25	976	1	2004	976	3594	1117	1708	1520	1017	1706	2194	4555	1121	3085	2050	3936	1486	4349	3937	2547	3230	1997	4533	2126
3392_Longest period of depression	3392_Longest period of depression	25	977	1	4000	2420	1021	2466	2814	2557	1267	3995	4299	2462	3924	3851	1633	2458	1998	2963	3295	2333	2951	977	2176	1823
3059_IL23R - Interleukin-23 receptor	3059_IL23R - Interleukin-23 receptor	25	980	1	3755	2882	2392	2383	1704	3607	3651	3481	3147	1984	3245	2640	1262	4121	2038	3204	1855	2450	3746	3465	980	4449
3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	25	983	1	1133	1666	3129	4457	1755	4382	2398	2176	1963	1494	3294	2039	3673	3213	3459	983	4412	2112	4410	2613	3426	1695
1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	25	983	1	3352	2730	2040	1983	2555	1006	1089	4434	4119	3447	1049	4702	1178	4525	2137	1522	983	4152	2900	4184	1724	4310
1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	985	1	1051	3351	1995	1800	4261	4221	4017	1213	4546	2790	2413	1910	1581	1365	3628	4225	3635	3875	3682	985	2709	4242
2241_WIF1 - Wnt inhibitory factor 1	2241_WIF1 - Wnt inhibitory factor 1	25	986	1	3442	3768	2887	4199	4072	2298	4386	3544	986	2573	1055	2347	1711	2086	2265	1937	2051	4213	2254	4316	3074	4082
523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	25	996	1	3441	2328	2542	2838	4559	4137	3540	3161	3037	2112	4490	1401	2467	4017	1620	3860	2377	1341	996	3943	2616	4213
3150_CPNE1 - Copine-1	3150_CPNE1 - Copine-1	25	998	1	1363	3534	4467	3966	4546	3613	4689	1269	1884	4018	1331	3486	3056	3082	4350	2473	3677	2217	4443	4231	2182	998
2315_MBL2 - Mannose-binding protein C	2315_MBL2 - Mannose-binding protein C	25	1000	1	1158	2548	1540	3782	4576	2109	2612	4460	3472	2757	1000	1815	1577	4279	3710	3396	4021	3734	1784	2899	2497	2958
705_::::X-11442	705_::::X-11442	25	1003	1	1350	1994	4317	2387	3136	4224	4247	1185	1059	1711	1952	3008	4003	1003	3151	4057	2330	1825	2998	1366	2095	3823
1284_Visceral fat by CT (FBAT, adjusted for age and sex)	1284_Visceral fat by CT (FBAT, adjusted for age and sex)	25	1003	1	1604	2065	4257	1444	4256	1808	4642	3072	2642	4700	2427	2938	3169	3090	1003	4354	1272	4494	2560	4246	2393	3282
4604_Right superior temporal	4604_Right superior temporal	25	1004	1	1071	1567	3615	3450	1148	4390	2204	1749	3039	2711	3401	4454	1769	2646	2428	1481	4640	1004	2070	4699	3347	1161
3887_Mean corpuscular hemoglobin (three-way meta)	3887_Mean corpuscular hemoglobin (three-way meta)	25	1021	1	2682	3324	3650	3102	2559	1862	2899	4210	2429	1097	2270	1266	1054	1473	1840	4216	1021	2482	3262	3811	2526	1392
1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	1024	1	4411	3111	2612	3421	2749	1199	4679	3577	4105	2172	1024	4328	1337	2636	2442	3308	4057	3364	4722	3607	2082	3514
265_CD8:%RTE	265_CD8:%RTE	25	1024	1	4139	4140	3537	4225	4428	4143	3357	3802	4046	2400	3643	1041	3596	1024	2487	3402	4012	1822	1542	3054	3273	1951
224_B Mem:%IgA	224_B Mem:%IgA	25	1026	1	2137	2691	2177	1656	1026	1461	2077	1849	3694	2940	1404	1329	2194	1231	2320	1672	2453	1805	2123	1236	3021	3063
2998_GP1BA - Platelet glycoprotein Ib alpha chain	2998_GP1BA - Platelet glycoprotein Ib alpha chain	25	1028	1	2949	1044	2536	1675	4038	1028	2355	4438	3897	3075	1614	3120	3258	1093	2113	3496	1213	2942	2594	2756	3610	1994
1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	1030	1	3134	2715	4201	3150	1592	3897	1589	1030	2818	2281	3541	4123	4167	4187	4613	3272	3507	1591	4132	2931	2089	1540
287_CD4:%Treg(73+)	287_CD4:%Treg(73+)	25	1033	1	1033	4681	3147	3378	1086	2141	2938	3505	4688	1579	2279	4118	1489	2423	3818	2683	2522	2861	4249	3421	2777	4166
1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	25	1033	1	4246	2995	1643	1579	2444	2946	2337	3218	1033	2786	1607	1958	4128	4566	1841	2135	4162	2600	4040	1713	1832	2499
1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	25	1042	1	2399	2980	4098	1042	3668	3852	2240	3096	4311	3051	2125	3252	2800	2459	1873	3092	4569	2323	2693	3928	4454	2159
2486_KLK7 - Kallikrein-7	2486_KLK7 - Kallikrein-7	25	1042	1	4046	2415	2807	2736	2241	2731	3682	2289	3066	2680	4738	4472	4577	3100	3282	2946	3509	4220	4492	2163	2505	1042
546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	25	1043	1	1057	1911	3749	1203	1087	2922	3281	1287	3221	4141	3221	4344	2427	2572	1266	2595	2659	2295	1670	1043	2906	2588
563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	25	1046	1	3887	1046	3073	2560	2505	4117	2734	3574	2784	1171	2139	4705	3793	3904	3828	1167	4543	3843	1186	3528	4730	4589
2578_ARSA - Arylsulfatase A	2578_ARSA - Arylsulfatase A	25	1056	1	3914	2551	3989	3561	2263	3917	2378	3719	1928	1563	4550	2877	1534	3104	1056	1157	1299	1834	4002	4444	2509	2991
641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	25	1057	1	2707	4739	4640	3835	4004	2418	1647	4245	2829	2802	4369	4105	3575	4207	2785	2231	1057	3130	2853	4361	1641	3960
1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	1058	1	4147	1627	1692	4589	1489	3537	2602	4299	4535	3796	3103	1058	3762	2057	3345	4738	2674	4447	2363	3284	1628	1864
2299_DSG1 - Desmoglein-1	2299_DSG1 - Desmoglein-1	25	1062	1	1356	2732	1062	2339	1108	2613	1166	3551	1835	3608	1774	1817	3812	1995	3125	1447	1690	2498	4537	1958	4329	2781
700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	25	1065	1	3530	1174	1282	3646	2469	1174	2334	2131	2631	2781	4109	1579	1163	2945	1824	2265	4725	1621	2691	1512	2739	1065
2592_DKK3 - Dickkopf-related protein 3	2592_DKK3 - Dickkopf-related protein 3	25	1073	1	4306	1724	4509	4194	3683	2706	3703	3526	2447	4331	2581	3397	2095	1467	2063	4660	3475	1073	4245	4596	2897	1893
759_::::X-12188	759_::::X-12188	25	1074	1	2511	1458	1760	1489	3008	2126	1074	4328	4132	2178	2627	2368	1661	3315	2460	2536	1648	2478	4633	1620	1122	2430
1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	25	1081	1	1551	3685	3105	4654	1471	1470	2757	4489	1081	3663	3508	3219	2693	1273	3490	1163	1408	2494	1412	1778	4240	3843
1105_Systolic Blood Pressure - Birth cohorts	1105_Systolic Blood Pressure - Birth cohorts	25	1084	1	2922	1279	2823	3022	2405	3209	3879	3840	3411	2149	1950	2452	3619	1084	2410	3314	4215	1496	1471	3688	2018	2028
3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	25	1084	1	3790	2511	2176	2379	3504	3768	3833	3967	2130	2356	1983	2429	1369	4486	1497	3532	4603	1084	4530	3407	3613	1577
745_::::X-12007	745_::::X-12007	25	1092	1	1495	1092	3457	4729	3268	2632	2758	2892	3329	4050	2034	3331	1849	4721	3103	2175	3658	3787	2528	3331	3755	4066
4201_Body Mass Index	4201_Body Mass Index	25	1094	1	3111	4084	1654	4240	2913	2182	4378	4281	3740	3702	2925	4746	3836	4138	4380	3917	2800	1969	1331	1712	1094	1567
2919_CMPK1 - UMP-CMP kinase	2919_CMPK1 - UMP-CMP kinase	25	1095	1	2974	3184	2993	1095	3881	1920	4133	3755	2367	1246	2251	2173	4130	3699	3305	4064	3565	3198	1943	3308	4139	3393
1098_Body Mass Index - Birth cohorts	1098_Body Mass Index - Birth cohorts	25	1096	1	1096	2855	3853	4349	2193	3926	1419	2278	2692	4641	4108	4593	3537	1225	4430	3773	1795	3031	3806	2622	3871	3445
2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	25	1096	1	4002	2427	1096	3263	2065	1764	3274	4231	3207	1321	3114	3559	3277	4392	2698	1647	2612	3546	2977	4355	3325	1561
3575_Pain type(s) experienced in last month: Knee pain	3575_Pain type(s) experienced in last month: Knee pain	25	1096	1	3977	1508	3271	3161	3625	3596	2677	4448	1129	2882	3939	4553	2997	3679	4314	3353	3815	2174	3585	2167	1096	2278
568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	25	1100	1	3554	4698	4097	3295	1389	2407	2383	4530	4506	4027	3724	3877	3633	3826	2539	1449	2435	1555	1100	3949	2707	1539
1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	1100	1	1328	4152	2198	2674	3409	1266	3496	4062	3598	3881	4246	3299	4519	3747	4058	3674	1195	4286	2454	1100	1367	3750
1101_Glucose - Birth cohorts	1101_Glucose - Birth cohorts	25	1101	1	2152	1899	1101	4007	2635	3662	3764	3708	2743	4243	2275	3404	2298	2543	3359	1960	3532	2766	1793	3461	3628	3029
2689_DNAJB1 - DnaJ homolog subfamily B member 1	2689_DNAJB1 - DnaJ homolog subfamily B member 1	25	1106	1	2782	1367	4492	2709	2585	3401	1106	1257	4038	1949	4635	4433	1111	2609	3690	1985	3627	3330	3100	3300	1768	2806
4119_Aspartate aminotransferase	4119_Aspartate aminotransferase	25	1115	1	1599	4727	2625	4308	4274	3380	3697	4592	4352	1592	4444	4424	4740	1719	3286	3249	4045	1115	3907	2308	2539	3304
4475_Left insula	4475_Left insula	25	1117	1	4296	4184	2897	4214	1814	1828	3668	2315	3080	4282	2590	4069	1609	1170	3651	3007	2967	1117	2535	4677	2118	1546
4259_Facial attractiveness (female-coder, male samples)	4259_Facial attractiveness (female-coder, male samples)	25	1120	1	4367	3485	4439	2915	1120	1644	3509	2096	2248	3384	2483	1285	1379	3965	3258	1933	2723	2609	2515	3082	1785	2559
3537_Attendance/disability/mobility allowance: Disability living allowance	3537_Attendance/disability/mobility allowance: Disability living allowance	25	1120	1	3135	1665	3092	1561	4284	3777	3371	2118	3043	1433	4023	3273	3292	3088	2629	4538	2858	2435	2672	1120	4026	3852
1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	25	1130	1	1241	3095	3203	1130	3058	1421	3747	2972	3553	2906	1199	3748	1844	3487	4595	3277	3506	4296	4223	1852	4557	3561
3516_Heating type(s) in home: Gas central heating	3516_Heating type(s) in home: Gas central heating	25	1130	1	2386	4548	1505	3679	3038	4434	1931	2611	3006	3218	2820	4048	3344	2964	1892	1130	3013	4440	2370	4645	4620	1470
3428_Fluid intelligence test - FI5 : family relationship calculation	3428_Fluid intelligence test - FI5 : family relationship calculation	25	1132	1	4739	3500	1132	4249	3260	3212	4162	3320	3734	2041	4417	3900	4558	2804	4317	1641	2493	2077	2052	2110	2809	1338
3551_Vascular/heart problems diagnosed by doctor: High blood pressure	3551_Vascular/heart problems diagnosed by doctor: High blood pressure	25	1134	1	3124	1788	3723	2411	3501	3301	1657	2505	1374	2924	3276	2423	2217	1134	1367	1907	3688	3069	2160	3549	3614	4139
760_::::X-12189	760_::::X-12189	25	1134	1	4691	2102	4643	1681	4168	3865	3500	2699	4292	4223	3360	1582	2774	2842	1134	2591	3471	1783	1370	1718	3688	3115
3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	25	1135	1	3488	3390	1868	3622	2793	3120	3007	3361	3874	3954	1589	1292	4278	1779	3705	3859	4679	2921	2266	1135	1893	3777
50_Number of children ever born	50_Number of children ever born	25	1137	1	2779	1680	3341	3978	3691	1784	2823	3411	3033	4683	3024	4635	1259	1543	2307	3822	1942	4549	1137	2285	2612	1294
4255_Sleep efficiency	4255_Sleep efficiency	25	1172	1	4569	4003	1815	2610	2926	3767	3425	3651	1520	4275	2360	1965	1602	3765	3385	1172	3545	4456	2638	1645	2331	2685
2221_BCAM - Basal Cell Adhesion Molecule	2221_BCAM - Basal Cell Adhesion Molecule	25	1175	1	3307	1690	2830	4493	2728	3463	4040	1209	3390	2183	2163	1175	1856	3979	2991	3346	3868	2252	4473	3076	3834	3095
2731_C6 - Complement component C6	2731_C6 - Complement component C6	25	1180	1	4591	4444	3672	4379	1565	1927	2003	3691	4574	4195	4464	4706	3227	3072	4438	2449	2246	4331	4694	1180	1812	4490
541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	25	1181	1	2956	3399	4603	2017	1225	4072	4064	2556	1181	2067	4313	4072	1737	3630	2454	3459	2210	3143	1651	3434	2547	3732
715_::::X-11497	715_::::X-11497	25	1184	1	3798	3617	4393	2203	4570	3064	4428	1184	2628	1704	3468	4192	4049	4382	2379	1776	2460	2281	3658	2503	2909	4702
3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	25	1186	1	2510	2041	4511	3919	4358	4219	2325	1411	2534	3272	2587	3230	2541	1381	3373	2333	4184	3693	4467	2682	1186	4655
1288_Waist circumference by CT (FBAT, adjusted for age and sex)	1288_Waist circumference by CT (FBAT, adjusted for age and sex)	25	1196	1	1196	3418	4209	1618	2468	2188	2977	2380	4198	4166	4717	3291	1976	3418	3810	4393	2963	3897	4662	3603	3659	2060
4241_Rapid alternating stimulus test for letters/numbers	4241_Rapid alternating stimulus test for letters/numbers	25	1197	1	1197	4515	3346	4039	3379	3114	2162	3485	1975	4106	2115	4386	2142	4711	1726	2328	3150	4311	4314	2617	4583	4739
1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	25	1197	1	4082	1498	1617	1738	4635	3138	3987	2155	4396	4140	4309	2696	2885	4092	1197	4583	1868	2397	2067	2716	4067	2091
1070_Familial Parkinson Disease	1070_Familial Parkinson Disease	25	1200	1	4644	1229	1652	1918	2899	3721	2562	4559	3190	2922	4298	2799	2037	3900	1459	1200	1882	1285	2884	3359	2823	3959
1954_Similarities raw score (FBAT, adjusted for multivariable)	1954_Similarities raw score (FBAT, adjusted for multivariable)	25	1205	1	1729	4090	4238	3414	3002	3257	3288	2412	3435	2412	1966	1928	3184	4211	4735	2496	3745	2458	4709	1205	3706	3002
661_::::X-04498	661_::::X-04498	25	1207	1	1727	3775	3941	4598	3697	2483	1207	2914	3750	2393	4435	2404	4591	2522	3443	3726	4659	2451	1633	4368	2558	3860
4477_Right caudal middle frontal	4477_Right caudal middle frontal	25	1208	1	1730	1208	3395	1335	3269	3871	4566	3329	3579	3870	3594	4300	3603	3792	3013	4038	1463	3591	2136	3085	3264	3588
847_::::X-14745	847_::::X-14745	25	1209	1	1669	4213	3655	4615	3287	3234	1209	1829	2338	1386	3077	3266	2631	1771	2352	4406	3141	3606	2156	4488	1996	1248
4377_Resting heart rate	4377_Resting heart rate	25	1211	1	4439	3003	2034	1901	4351	3349	4001	2964	1211	2288	4218	1598	3321	2346	4305	2148	4223	1780	3913	4473	3252	3832
478_Lipid::Carnitine metabolism::carnitine	478_Lipid::Carnitine metabolism::carnitine	25	1211	1	1995	2893	3905	4506	4242	4113	3635	2687	2195	2762	1254	1900	2338	2226	3333	2327	2429	3473	2091	1211	3952	2152
833_Peptide::Dipeptide::X-14189--leucylalanine	833_Peptide::Dipeptide::X-14189--leucylalanine	25	1222	1	1538	4612	4722	2460	1222	2282	2081	2828	2957	1479	4258	4182	1491	1228	3789	1910	4491	3749	1822	2893	4094	3552
1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	25	1226	1	2822	1253	2585	1226	1731	3974	2736	3886	2614	2903	3769	4605	4650	1298	4156	2809	4017	3394	1952	2880	1257	4471
29_Openness to Experience (NEO-FFI)	29_Openness to Experience (NEO-FFI)	25	1233	1	2454	3428	2090	2644	2507	4308	2924	3721	3394	2848	1735	3951	4410	2036	1432	4705	2528	1541	1233	3794	4028	4678
2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	25	1238	1	2247	4231	3764	1447	3610	4731	2659	3670	3373	3918	2096	3535	1444	3540	3703	2405	1238	2734	4677	2197	4500	4588
4404_Menstrual quality of life impact: Nervousness	4404_Menstrual quality of life impact: Nervousness	25	1240	1	3779	2627	3932	4143	3913	4355	3220	3262	3058	4567	1240	1431	1970	3285	3382	4494	2984	3720	2383	4268	4023	4281
4374_Free thyroxine (FT4, female)	4374_Free thyroxine (FT4, female)	25	1244	1	1872	4673	3857	2756	2826	2568	1248	1244	3259	3146	3634	2028	4269	1922	1771	3214	3911	1337	3993	4312	4627	4142
1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	1253	1	2168	4117	4284	2567	3229	1724	3783	1342	2627	4422	4295	3076	1418	4195	2857	2763	3157	2805	1253	4638	2627	2320
726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	25	1257	1	2935	4228	4310	2205	3798	4489	3994	3427	2943	3875	3896	4271	1963	1949	4304	1370	2226	2689	3649	1257	3441	3099
1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	25	1267	1	3997	1540	1594	3053	3140	3755	3502	4398	1267	1484	4469	3125	2884	2891	1317	3575	1462	2000	3008	4058	1513	2759
72_Triglycerides cholesterol	72_Triglycerides cholesterol	25	1282	1	3085	3743	3973	4497	4279	2786	1282	3093	3535	2559	2693	1774	2751	1800	3725	4470	2514	1468	2820	3958	2867	4481
3568_Why stopped smoking: Health precaution	3568_Why stopped smoking: Health precaution	25	1282	1	1797	4684	3526	4095	2438	1585	4474	2393	3071	3072	4515	4361	3594	4483	1282	2724	3872	2168	3415	2261	2719	2323
2582_CDH6 - Cadherin-6	2582_CDH6 - Cadherin-6	25	1289	1	2506	3039	3002	4408	4727	4220	4407	4207	1289	1555	4067	1695	3689	3327	3354	2660	3063	2682	3578	3789	2516	3719
4528_Left ventral DC	4528_Left ventral DC	25	1289	1	2011	4707	4331	3282	2983	3498	3350	3250	1417	3187	4466	2069	2845	2030	1558	4511	3763	1289	4675	3557	3626	1673
4391_Dysmenorrhea (quality of life impact)	4391_Dysmenorrhea (quality of life impact)	25	1304	1	3783	2217	2949	3090	2795	4570	4066	2008	4076	3578	1356	2949	1808	1304	4258	3605	2368	4047	2585	3743	3281	3686
1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	1305	1	2051	2620	1305	3260	4558	3792	1933	4523	2090	3824	3617	1629	2813	4421	4165	2455	4478	3957	2859	2955	2795	4735
4479_Right entorhinal	4479_Right entorhinal	25	1308	1	1707	1510	1310	4704	1944	3874	1621	1308	4056	3046	1432	2531	3213	3558	2473	2907	3801	3257	2534	1953	2081	3268
3604_Non-cancer illness code, self-reported: depression	3604_Non-cancer illness code, self-reported: depression	25	1319	1	1805	1799	4362	3859	3797	3479	1422	4367	2741	3699	3041	3844	3028	1938	3514	2776	3710	3123	3830	1319	3786	2321
4581_Right fusiform	4581_Right fusiform	25	1325	1	2689	3621	3539	2899	4721	1575	2043	2905	3652	2853	2577	3100	1325	3119	2509	4622	4292	4492	2857	2187	3738	1735
1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	25	1363	1	4298	3878	1363	2318	2805	2995	3667	2024	2788	1750	2536	2716	2825	3881	4689	3134	4701	2192	1486	3835	1488	3110
1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	1373	1	1373	4322	2848	2106	2265	2041	4147	4322	3365	2934	3320	3141	3610	4278	2944	4096	4607	2931	4076	3776	3348	3776
1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	25	1382	1	2804	2665	4034	1746	3875	3653	3213	2287	2190	2780	2832	2948	2204	1670	3158	2133	1382	3127	2445	3944	1613	3831
780_::::X-12456	780_::::X-12456	25	1386	1	2049	1386	2471	4328	2217	4448	2387	2773	1499	2192	3199	1707	1818	4478	2263	3211	3758	4038	1558	2873	2822	4344
775_::::X-12435	775_::::X-12435	25	1392	1	2449	3589	3812	2019	3771	3000	1762	4072	1968	1755	2150	1392	3290	2366	2659	3362	3340	4469	2306	3904	4313	3333
2535_BCAN - Brevican core protein	2535_BCAN - Brevican core protein	25	1400	1	3076	3410	4746	1792	2216	3718	4619	2160	3747	4059	1789	1608	4026	2311	4158	1440	2040	4346	3062	1400	3962	2614
3182_SPOCK2 - Testican-2	3182_SPOCK2 - Testican-2	25	1408	1	3789	2131	3492	4645	3836	1746	3677	4394	3371	2221	2650	2150	1612	3824	1733	4021	4455	2476	4172	2316	1408	1815
438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	25	1410	1	2284	2166	3211	2072	3130	4450	2472	3334	1885	3360	1788	1708	4104	3845	4381	2619	1410	3476	3294	3653	1708	4521
1970_MMSE score (at exam 7, FBAT, adjusted for age)	1970_MMSE score (at exam 7, FBAT, adjusted for age)	25	1451	1	1451	2046	1974	3592	2204	2686	1881	2185	3607	3943	3899	4382	3830	3808	4249	1726	2211	2163	2210	3753	3256	4442
621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	25	1457	1	4669	3896	4656	1457	3869	4064	1724	4440	1533	3669	3689	3731	4071	3150	4026	4519	3273	4299	3800	4166	3341	3223
412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	25	1490	1	2161	1901	3266	2056	3188	3754	4259	3697	2960	2008	2618	1490	3866	2716	4545	2973	3767	3496	1684	4515	3476	4103
3493_Coffee type: Instant coffee	3493_Coffee type: Instant coffee	25	1498	1	2855	3893	3037	3204	4132	2480	4163	1633	2964	3731	3212	3046	1498	4217	2240	4655	4545	2100	2130	3499	3182	2043
2610_OLR1 - Oxidized low-density lipoprotein receptor 1	2610_OLR1 - Oxidized low-density lipoprotein receptor 1	25	1500	1	2593	3389	2946	1500	2390	4435	2109	4184	4731	3474	2253	2682	2213	4363	2926	4158	3799	2376	3832	1862	4741	3591
1905_Hippocampal volume (GEE, adjusted for multivariable)	1905_Hippocampal volume (GEE, adjusted for multivariable)	25	1526	1	2831	3611	2927	2934	2815	1794	4535	2596	4086	4362	3197	2457	2410	3660	1526	3375	2491	3106	3324	2158	2092	3045
3473_Reported occurrences of cancer	3473_Reported occurrences of cancer	25	1542	1	4726	3126	2496	3954	2525	4312	3763	2273	4205	2773	3686	3289	3640	2267	2634	1542	4327	3466	4644	2166	1564	4586
4262_Facial attractiveness (female-coder, female samples)	4262_Facial attractiveness (female-coder, female samples)	25	1563	1	3726	3010	1999	4092	4404	3967	4128	2325	2792	3805	3526	2380	3474	2493	1563	4159	2545	3576	2057	4551	2928	4647
3340_Had menopause (female)	3340_Had menopause (female)	25	1568	1	3051	4339	3286	3792	4207	1597	2219	4064	2066	3436	3271	3228	4670	4209	4592	3116	2571	3847	3113	2965	4085	1568
220_T:%Vd1	220_T:%Vd1	25	1597	1	3027	2379	2466	3423	1795	4263	1897	1737	1735	3155	3355	3895	1836	3757	1597	3732	4201	2026	3961	4738	3286	2536
266_DPT:%Exhausted	266_DPT:%Exhausted	25	1634	1	3519	4243	2577	4656	4530	1829	2174	2702	3410	2090	2303	3656	4510	2946	1902	1634	4203	1790	3430	4378	4326	1734
1088_Neuroblastoma	1088_Neuroblastoma	25	1886	1	3402	2181	4251	3074	1886	1938	3480	2963	3331	3557	3118	1921	4459	4275	2976	4173	3214	3881	2233	3056	3627	2510
3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	25	1956	1	4736	2212	4400	2640	2688	2802	2766	3769	4632	4049	3289	2252	2190	3836	4604	4279	4580	1956	4092	3505	3704	4042
